Citrus Sinensis ID: 003605
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 808 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.773 | 0.840 | 0.535 | 1e-178 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.530 | 0.605 | 0.429 | 7e-87 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.454 | 0.804 | 0.456 | 2e-85 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.422 | 0.474 | 0.471 | 2e-84 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.361 | 0.428 | 0.513 | 5e-83 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.356 | 0.441 | 0.513 | 1e-81 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.428 | 0.889 | 0.439 | 2e-81 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.398 | 0.422 | 0.487 | 3e-81 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.444 | 0.705 | 0.416 | 7e-81 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.397 | 0.758 | 0.478 | 5e-80 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 627 bits (1617), Expect = e-178, Method: Compositional matrix adjust.
Identities = 368/687 (53%), Positives = 447/687 (65%), Gaps = 62/687 (9%)
Query: 144 PPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFM 203
P + DC T C EP T+TP GSPCGCV+PM+V L LSVA ++ FP+ +EL E+AAG ++
Sbjct: 93 PSSHDCQQT-CVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTYL 151
Query: 204 KQSQVRIIGANA-AEQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDY 262
+QSQV+I+GA+A +E KTVV +LVPLGEKFDNTTA L YQRF HK+V + + FGDY
Sbjct: 152 EQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGDY 211
Query: 263 EVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNNGRATKPEGVDVPKRRQKY-----GLSG 317
EV ++ YPG+P S P +G +G+ P G+ +P + G+
Sbjct: 212 EVTHISYPGIPSSSP----------NGDVTGD-----APGGLPIPINATTFANKSQGIGF 256
Query: 318 GMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSG 377
IAI+ LS FV ++L A ++ K+K + V +L S K GA + S
Sbjct: 257 RTIAIIALSGFV-LILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSA 315
Query: 378 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVA 437
S S S SS+AT S KTF+ SE+EKAT F A R+LGEGGFG VY G ++DGT+VA
Sbjct: 316 RSSGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVA 375
Query: 438 VKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH 497
VK+L R +Q REF+AEVEMLSRLHHRNLVKLIGICIE + RCL+YEL+ NGSVESHLH
Sbjct: 376 VKLLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH 435
Query: 498 GVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557
L WDARLKIALGAAR LAYLHEDS+PRVIHRDFK+SN+LLE DFTPKVSDFG
Sbjct: 436 -----EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 490
Query: 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 617
LAR A E S+HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GR+PVDM+
Sbjct: 491 LAREAT-EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMS 549
Query: 618 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 677
QP G+ENLV WARPLL +REGLE+++DP+L FD +AKVAAIASMCV EV HRPFM
Sbjct: 550 QPSGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFM 609
Query: 678 GEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDL 737
GEVVQALKL+ N+ DE + D DS V + D S N
Sbjct: 610 GEVVQALKLIYNDADE---------TCGDYCSQKDSSVPDSADFKGDLAPSDSSWWNLTP 660
Query: 738 GLDTGRRLSLSYLFSSSARSGKEESELFRRYSS--------------SGPLRTGRGRQFW 783
L G+ S + SG E R +S+ SGPLR R R+ +
Sbjct: 661 RLRYGQ---ASSFITMDYSSGPLEDMENRPHSASSIPRVGGLILPNRSGPLRPMRSRRNF 717
Query: 784 QRIRRLVGGSDSEHGAVFS---LWPGS 807
R+R GS SEHG S LW G+
Sbjct: 718 FRLR----GSMSEHGGPSSSRHLWSGN 740
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 7e-87, Method: Compositional matrix adjust.
Identities = 191/445 (42%), Positives = 252/445 (56%), Gaps = 16/445 (3%)
Query: 304 VDVPKRRQKYGL-SGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKS-HACQAEEVPQSLQT 361
+D P G+ +G ++ I V A V L W L + K A +V S +
Sbjct: 265 LDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMS 324
Query: 362 SHVKPSGAAGLMVGS---GLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILG 418
S + A M S G S S+ S S FS E+ KAT F +LG
Sbjct: 325 STARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLG 384
Query: 419 EGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 478
EGGFG VY G+L DG VAVK LK QG REF AEVE LSR+HHR+LV ++G CI
Sbjct: 385 EGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGD 444
Query: 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 538
R L+Y+ + N + HLHG E + L W R+KIA GAAR LAYLHED PR+IHRD
Sbjct: 445 RRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 501
Query: 539 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVY 598
KSSNILLE +F +VSDFGLAR A+D + HI+TRV+GTFGY+APEYA +G L KSDV+
Sbjct: 502 KSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSGKLTEKSDVF 560
Query: 599 SYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT---SREGLERIIDPSLGNDVPFDS 655
S+GVV+LEL++GRKPVD +QP G E+LV WARPL++ E + + DP LG +
Sbjct: 561 SFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESE 620
Query: 656 VAKVAAIASMCVQPEVQHRPFMGEVVQALK-LVCNECDEAKEVGSA---SSSQDDMSIDL 711
+ ++ A CV+ RP MG++V+A + L + +G + +S+Q I L
Sbjct: 621 MFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNSAQQSAEIRL 680
Query: 712 DSKVSTGSGQLPDPLQRHYSVPNYD 736
+++ GS H S + D
Sbjct: 681 FRRMAFGSQNYSTDFFSHSSYNSRD 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 173/379 (45%), Positives = 232/379 (61%), Gaps = 12/379 (3%)
Query: 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFL 453
+A TF+ E+ AT NF LGEGGFG VY G LD G VAVK L R QG REFL
Sbjct: 70 AAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFL 129
Query: 454 AEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK 513
EV MLS LHH NLV LIG C + R LVYE +P GS+E HLH + + L W+ R+K
Sbjct: 130 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMK 189
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573
IA GAA+ L +LH+ ++P VI+RDFKSSNILL+ F PK+SDFGLA+ + H+STR
Sbjct: 190 IAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTR 249
Query: 574 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633
VMGT+GY APEYAMTG L VKSDVYS+GVV LEL++GRK +D P G++NLVAWARPL
Sbjct: 250 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLF 309
Query: 634 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC-- 691
R ++ DP L P ++ + A+ASMC+Q + RP + +VV AL + N+
Sbjct: 310 NDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAYD 369
Query: 692 ---DEAK----EVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRR 744
D+++ E G+ +++D SK + D + + N D+ + R
Sbjct: 370 PSKDDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRETARILNRDINRE--RA 427
Query: 745 LSLSYLFSSSARSGKEESE 763
++ + ++ S R + +SE
Sbjct: 428 VAEAKMWGESLREKRRQSE 446
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (805), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 179/380 (47%), Positives = 237/380 (62%), Gaps = 39/380 (10%)
Query: 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 458
F+ E+ + T F S ++GEGGFG VY G+L +G VA+K LK V +G REF AEVE+
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
+SR+HHR+LV L+G CI EQ R L+YE +PN +++ HLHG K L W R++IA+GA
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
A+ LAYLHED P++IHRD KSSNILL+ +F +V+DFGLAR D HISTRVMGTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLAR-LNDTAQSHISTRVMGTF 534
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638
GY+APEYA +G L +SDV+S+GVV+LEL++GRKPVD +QP G+E+LV WARP L E
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLI--EA 592
Query: 639 LER-----IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 693
+E+ ++DP L ND V K+ A+ CV+ RP M +VV+AL
Sbjct: 593 IEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL--------- 643
Query: 694 AKEVGSASSSQDDMSIDLDSKVSTG------SGQLPDPLQ--RHYSVPNYDLGLDTGRRL 745
++DD+S DL + V G SGQ + ++ R S + DLG +TG
Sbjct: 644 --------DTRDDLS-DLTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGTNTGYYP 694
Query: 746 SLSYLFSSSARSGKEESELF 765
S Y S S ES F
Sbjct: 695 SQDYATSHEYES---ESRAF 711
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 153/298 (51%), Positives = 203/298 (68%), Gaps = 6/298 (2%)
Query: 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 458
FS E+ + T F +LGEGGFG VY GVL DG +VAVK LK QG REF AEVE+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
+SR+HHR+LV L+G CI EQ R LVY+ +PN ++ HLH + + W+ R+++A GA
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPV--MTWETRVRVAAGA 444
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD-EESRHISTRVMGT 577
AR +AYLHED PR+IHRD KSSNILL++ F V+DFGLA+ A + + + H+STRVMGT
Sbjct: 445 ARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGT 504
Query: 578 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL---T 634
FGY+APEYA +G L K+DVYSYGV++LEL++GRKPVD +QP G E+LV WARPLL
Sbjct: 505 FGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAI 564
Query: 635 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692
E + ++DP LG + + ++ A+ CV+ RP M +VV+AL + D
Sbjct: 565 ENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATD 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (780), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 151/294 (51%), Positives = 206/294 (70%), Gaps = 6/294 (2%)
Query: 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 454
S TF+ E+ +AT F + +LG+GGFG V+ G+L G +VAVK LK QG REF A
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 455 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 514
EVE++SR+HHR+LV LIG C+ R LVYE +PN ++E HLHG K + W RLKI
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLKI 381
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
ALG+A+ L+YLHED +P++IHRD K+SNIL++ F KV+DFGLA+ A D + H+STRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRV 440
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 634
MGTFGY+APEYA +G L KSDV+S+GVV+LEL++GR+PVD ++LV WARPLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 635 --SREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
S EG E + D +GN+ + +A++ A A+ CV+ + RP M ++V+AL+
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 303 bits (777), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 162/369 (43%), Positives = 230/369 (62%), Gaps = 23/369 (6%)
Query: 361 TSHVKPSGAAGLMVGSGLDSASLSFGSSIATYT------------GSAKTFSASEIEKAT 408
++ +K A+ + S S S GSS A+++ + K FS SE++ AT
Sbjct: 6 SNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEILQNANLKNFSLSELKSAT 65
Query: 409 GNFDASRILGEGGFGLVYSGVLDD----------GTKVAVKVLKRVDQQGGREFLAEVEM 458
NF ++GEGGFG V+ G +D+ G +AVK L + QG RE+LAE+
Sbjct: 66 RNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINY 125
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
L +L H NLVKLIG C+EE+ R LVYE + GS+E+HL PL W+ R+++ALGA
Sbjct: 126 LGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGA 185
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
AR LA+LH ++ P+VI+RDFK+SNILL+ ++ K+SDFGLAR ++ H+STRVMGT
Sbjct: 186 ARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQ 244
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638
GY APEY TGHL VKSDVYS+GVV+LELLSGR+ +D QP G+ NLV WARP LT++
Sbjct: 245 GYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRR 304
Query: 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVG 698
L R++DP L K+A +A C+ + + RP M E+V+ ++ + + + +KE
Sbjct: 305 LLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQ 364
Query: 699 SASSSQDDM 707
+ S D++
Sbjct: 365 NPQISIDNI 373
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 303 bits (777), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 162/332 (48%), Positives = 213/332 (64%), Gaps = 10/332 (3%)
Query: 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 454
S + FS E+ AT F +LGEGGFG VY GVL D VAVK LK QG REF A
Sbjct: 414 SRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKA 473
Query: 455 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 514
EV+ +SR+HHRNL+ ++G CI E R L+Y+ +PN ++ HLH + L W R+KI
Sbjct: 474 EVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAG--TPGLDWATRVKI 531
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
A GAAR LAYLHED PR+IHRD KSSNILLE++F VSDFGLA+ A+D + HI+TRV
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT-HITTRV 590
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL- 633
MGTFGY+APEYA +G L KSDV+S+GVV+LEL++GRKPVD +QP G E+LV WARPLL
Sbjct: 591 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 650
Query: 634 --TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE- 690
T E + DP LG + + ++ A+ C++ RP M ++V+A + E
Sbjct: 651 NATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEED 710
Query: 691 CDEAKEVGSA---SSSQDDMSIDLDSKVSTGS 719
+G + +S+Q I L +++ GS
Sbjct: 711 LTNGMRLGESEIINSAQQSAEIRLFRRMAFGS 742
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 7e-81, Method: Compositional matrix adjust.
Identities = 158/379 (41%), Positives = 237/379 (62%), Gaps = 20/379 (5%)
Query: 311 QKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAA 370
+ L+G + +V+ + FV + +C + K K + E++ S+ + P
Sbjct: 56 RNVALTGLITGVVLGATFVLLGVCIFVCFYKRKKRKLKKKKKEDIEASINRDSLDPKD-- 113
Query: 371 GLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL 430
DS +L SS F+ ++ KAT NF + +LG+GGFG V+ GVL
Sbjct: 114 --------DSNNLQQWSSSEI---GQNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVL 162
Query: 431 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490
DGT VA+K LK QG REF AE++ +SR+HHR+LV L+G CI R LVYE +PN
Sbjct: 163 VDGTLVAIKQLKSGSGQGEREFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNK 222
Query: 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550
++E HLH +KE + W R+KIALGAA+ LAYLHED +P+ IHRD K++NIL++ +
Sbjct: 223 TLEFHLH--EKERPVMEWSKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYE 280
Query: 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 610
K++DFGLARS++D ++ H+STR+MGTFGY+APEYA +G L KSDV+S GVV+LEL++G
Sbjct: 281 AKLADFGLARSSLDTDT-HVSTRIMGTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITG 339
Query: 611 RKPVDMTQP-PGQENLVAWARPLLT---SREGLERIIDPSLGNDVPFDSVAKVAAIASMC 666
R+PVD +QP +++V WA+PL+ + + ++DP L ND + + ++ A A+
Sbjct: 340 RRPVDKSQPFADDDSIVDWAKPLMIQALNDGNFDGLVDPRLENDFDINEMTRMVACAAAS 399
Query: 667 VQPEVQHRPFMGEVVQALK 685
V+ + RP M ++V+A +
Sbjct: 400 VRHSAKRRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (766), Expect = 5e-80, Method: Compositional matrix adjust.
Identities = 156/326 (47%), Positives = 203/326 (62%), Gaps = 5/326 (1%)
Query: 364 VKPSGAAGLMVGSGLDSASLSFGSSIATYTGS-AKTFSASEIEKATGNFDASRILGEGGF 422
V G G LD L+ + TG A+TF+ E+ +ATGNF + LGEGGF
Sbjct: 58 VNNEGGVGKEDQLSLDVKGLNLNDQV---TGKKAQTFTFQELAEATGNFRSDCFLGEGGF 114
Query: 423 GLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481
G V+ G ++ +V A+K L R QG REF+ EV LS H NLVKLIG C E R
Sbjct: 115 GKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRL 174
Query: 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSS 541
LVYE +P GS+E HLH + PL W+ R+KIA GAAR L YLH+ +P VI+RD K S
Sbjct: 175 LVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCS 234
Query: 542 NILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG 601
NILL D+ PK+SDFGLA+ + H+STRVMGT+GY AP+YAMTG L KSD+YS+G
Sbjct: 235 NILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFG 294
Query: 602 VVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA 661
VV+LEL++GRK +D T+ +NLV WARPL R +++DP L P + + A
Sbjct: 295 VVLLELITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALA 354
Query: 662 IASMCVQPEVQHRPFMGEVVQALKLV 687
I++MCVQ + RP + +VV AL +
Sbjct: 355 ISAMCVQEQPTMRPVVSDVVLALNFL 380
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 808 | ||||||
| 255546109 | 1282 | conserved hypothetical protein [Ricinus | 0.929 | 0.585 | 0.738 | 0.0 | |
| 359484309 | 992 | PREDICTED: receptor-like serine/threonin | 0.940 | 0.766 | 0.690 | 0.0 | |
| 357449795 | 1478 | Serine/threonine protein kinase PBS1 [Me | 0.891 | 0.487 | 0.688 | 0.0 | |
| 124360779 | 986 | Protein kinase [Medicago truncatula] | 0.891 | 0.730 | 0.688 | 0.0 | |
| 224122486 | 1156 | predicted protein [Populus trichocarpa] | 0.910 | 0.636 | 0.683 | 0.0 | |
| 356558353 | 1255 | PREDICTED: receptor-like serine/threonin | 0.889 | 0.572 | 0.691 | 0.0 | |
| 449436078 | 1050 | PREDICTED: receptor-like serine/threonin | 0.873 | 0.672 | 0.679 | 0.0 | |
| 224112136 | 664 | predicted protein [Populus trichocarpa] | 0.810 | 0.986 | 0.749 | 0.0 | |
| 359482516 | 873 | PREDICTED: receptor-like serine/threonin | 0.834 | 0.772 | 0.706 | 0.0 | |
| 356545725 | 1270 | PREDICTED: uncharacterized protein LOC10 | 0.904 | 0.575 | 0.679 | 0.0 |
| >gi|255546109|ref|XP_002514114.1| conserved hypothetical protein [Ricinus communis] gi|223546570|gb|EEF48068.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/773 (73%), Positives = 630/773 (81%), Gaps = 22/773 (2%)
Query: 55 DIPMPPPVNHSPSK--GPVVPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPT 109
D P P PSK GPV PSF+PTSR+ HY PPP++ S SPSH P PV V
Sbjct: 379 DFSSPAPAYSPPSKQQGPVASPSFLPTSRRTHYAPPPISPGSSASPSHFHFPKPVINVSP 438
Query: 110 SPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPP------------NADCSTTICTEP 157
+PSPSPT+ASG T++P+L P+ SPS P PP N DCS+T+C EP
Sbjct: 439 APSPSPTAASGWTKMPILSPEVSPSGSSPRSPKMPPRPPVHALPPPPPNEDCSSTVCVEP 498
Query: 158 YTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA- 216
YTNTPPGSPCGCV PMQVGLRLSVALYTFFPLVSELA EIA GVFMKQSQVRI+GANAA
Sbjct: 499 YTNTPPGSPCGCVLPMQVGLRLSVALYTFFPLVSELAQEIATGVFMKQSQVRIMGANAAS 558
Query: 217 EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSP 276
+QP+KTVVL DLVPLGE+FDNTTA LT+ RFWHKQVVIK+S+FGDYEVLYVRYPGLPPSP
Sbjct: 559 QQPEKTVVLIDLVPLGERFDNTTAVLTFHRFWHKQVVIKASFFGDYEVLYVRYPGLPPSP 618
Query: 277 PSASSSIGIIDDGPYSGNN--GRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLC 334
+ S I IIDDGPYSGNN R KP GVDV KR +K GL GMIAI+ LSA +A++LC
Sbjct: 619 -PSPSGITIIDDGPYSGNNNNARTIKPLGVDVHKRHRKDGLGAGMIAIISLSASLALILC 677
Query: 335 SAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTG 394
SA AWVLL +++ Q PQ L S KPSG G ++GSGL SASLSFGSSIA YTG
Sbjct: 678 SAVAWVLLVRHRGRMSQPTPTPQPLPPSGAKPSGTTGSVIGSGLSSASLSFGSSIAPYTG 737
Query: 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 454
SAKTFS S+IE+AT NF+ASRILGEGGFG VYSGVL+DGTKVAVKVLKR D QGGREFLA
Sbjct: 738 SAKTFSISDIERATNNFNASRILGEGGFGRVYSGVLEDGTKVAVKVLKRDDHQGGREFLA 797
Query: 455 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 514
EVEMLSRLHHRNLVKLIGIC EE+ARCLVYELIPNGSVESHLHG DKESAPL WDAR++I
Sbjct: 798 EVEMLSRLHHRNLVKLIGICTEERARCLVYELIPNGSVESHLHGADKESAPLDWDARIRI 857
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
ALGAAR LAYLHEDSSP VIHRDFKSSNILLEHDFTPKVSDFGLAR+AMDE++RHISTRV
Sbjct: 858 ALGAARGLAYLHEDSSPHVIHRDFKSSNILLEHDFTPKVSDFGLARTAMDEDNRHISTRV 917
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 634
MGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM QPPGQENLVAWARPLLT
Sbjct: 918 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVVLELLTGRKPVDMLQPPGQENLVAWARPLLT 977
Query: 635 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEA 694
S+EGLE I DPSLG DVPFDSVAKVAAIASMCVQPEV +RPFMGEVVQALKLVCNECDEA
Sbjct: 978 SKEGLEIITDPSLGPDVPFDSVAKVAAIASMCVQPEVSNRPFMGEVVQALKLVCNECDEA 1037
Query: 695 KEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSS 754
KEVGS S S D+S+D+D++ S GSG + DP Q VPNYD D R LS+S LFS+S
Sbjct: 1038 KEVGSRSPSW-DISVDMDAEASAGSGHMRDPFQNRTIVPNYDSEPDIERGLSMSDLFSTS 1096
Query: 755 ARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLWPGS 807
R G++ S FRRYSSSGPLRTGRG+Q WQR+RRL G S SEHG +F +WP +
Sbjct: 1097 VRYGRQASGSFRRYSSSGPLRTGRGKQLWQRMRRLTGESVSEHGGIFRIWPAA 1149
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484309|ref|XP_003633096.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2643), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 568/823 (69%), Positives = 630/823 (76%), Gaps = 63/823 (7%)
Query: 32 PPSTPPLSVDGKRVGK-----PVAEPSYDIPMPPPVNHSP--SKGPVVPPSFIPTSRKRH 84
P S+P +S G+ P SY IP P P + P S P PP +P + H
Sbjct: 187 PASSPSMSFSKHHRGRNKITGPAPASSYLIPPPSPRHQGPVISPAPSHPPKSLPNRTRTH 246
Query: 85 YGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSAS-------------------GQTELP 125
+ P PLN P SR+ + SPSP+S + ++P
Sbjct: 247 HAPLPLN-----------PGSRISPAHSPSPSSLTYPSPAPSPSPTLIYCHVCICTLQVP 295
Query: 126 LLPPKSSPSEPIRAFPP---------------PPPNADCSTTICTEPYTNTPPGSPCGCV 170
L PK SPS PP PPPN DCS +CTEP TNTPPGSPCGCV
Sbjct: 296 FLSPKISPSR----LPPSSKMPAPPPVQALPPPPPNQDCSAIVCTEPNTNTPPGSPCGCV 351
Query: 171 WPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAAE-QPDKTVVLTDLV 229
PMQV LRL+VALYTFFPLVSELA EIAAGVFM+QSQVRI+GANAA + +KT+VL DLV
Sbjct: 352 LPMQVQLRLNVALYTFFPLVSELAEEIAAGVFMRQSQVRIMGANAASPEAEKTIVLIDLV 411
Query: 230 PLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDG 289
PLGEKFDNTTAFLTYQRFW KQVVIK+ +FGDYEV+YV YPGLPPSPPSA SSI +ID+G
Sbjct: 412 PLGEKFDNTTAFLTYQRFWGKQVVIKNLFFGDYEVIYVNYPGLPPSPPSAPSSITMIDNG 471
Query: 290 PYSG--NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKS 347
PYSG NNGR P GVDV K R K+GLSG +IAI+VLSA VAVVLCSA AWV LFK
Sbjct: 472 PYSGQGNNGRTIHPLGVDVHKNRHKHGLSGSVIAIIVLSASVAVVLCSAVAWVFLFKKTD 531
Query: 348 HACQAEEVPQ--SLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIE 405
C + VP +L S +P GAAG +VGS SASLSFGSSIATYTGSAKTFSA++IE
Sbjct: 532 --CIGQPVPTQAALVPSLARPPGAAGSVVGSAPSSASLSFGSSIATYTGSAKTFSAADIE 589
Query: 406 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR 465
+AT NFD SRILGEGGFG VYSGVL+DGTKVAVKVLKR D QGGREFLAEVEMLSRLHHR
Sbjct: 590 RATDNFDDSRILGEGGFGRVYSGVLEDGTKVAVKVLKRDDHQGGREFLAEVEMLSRLHHR 649
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
NLVKLIGIC EE+ RCLVYELIPNGSVESHLHG DKE+APL W AR+K+ALGAAR LAYL
Sbjct: 650 NLVKLIGICTEERTRCLVYELIPNGSVESHLHGADKETAPLDWGARIKVALGAARGLAYL 709
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR+AMDEE+RHISTRVMGTFGYVAPEY
Sbjct: 710 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARTAMDEENRHISTRVMGTFGYVAPEY 769
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645
AMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQENLVAWARPLLTS+EGL+ +ID
Sbjct: 770 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVAWARPLLTSKEGLQTMIDL 829
Query: 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQD 705
SLG+DVPFDSVAKVAAIASMCVQPEV HRPFMGEVVQALKLVCNECDE KE GS S SQ+
Sbjct: 830 SLGSDVPFDSVAKVAAIASMCVQPEVSHRPFMGEVVQALKLVCNECDETKEAGSKSGSQE 889
Query: 706 DMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELF 765
D+S+DLD+ VS+ SGQLPDP H+ V Y GLD LS+S LFS+SAR G++ S F
Sbjct: 890 DLSLDLDTGVSSASGQLPDPSHAHFPVSTYGSGLDAETGLSVSELFSTSARFGRQPSGSF 949
Query: 766 RRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLWPGSY 808
RRYSSSGPLRTGR R FWQR+RR GGS SEHG +F L PGS+
Sbjct: 950 RRYSSSGPLRTGRARHFWQRMRRNSGGSVSEHGIMFRLRPGSH 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357449795|ref|XP_003595174.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] gi|355484222|gb|AES65425.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 990 bits (2560), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/747 (68%), Positives = 589/747 (78%), Gaps = 27/747 (3%)
Query: 72 VPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLP 128
+PPSF+PT+R+RH P P+N + SP P+ +PVS+V +PSPS + T++P P
Sbjct: 735 IPPSFLPTNRRRHNAPAPMNRGSADSPFTFPIQSPVSQVSPAPSPSFKTFPHSTKIPFHP 794
Query: 129 PK--------SSPSEPI----RAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVG 176
PK SP +PI +A PPPPPN DC + +C+EPYTN+PPG PC C+WPM+VG
Sbjct: 795 PKISPQRSFSKSPKKPILPRVQALPPPPPNEDCLSFVCSEPYTNSPPGVPCMCIWPMRVG 854
Query: 177 LRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKF 235
LRL+V LYTFFPLVSELA EI++GVFMKQSQVRI+GANAA +QPDKT L DLVPLGE+F
Sbjct: 855 LRLNVPLYTFFPLVSELASEISSGVFMKQSQVRIMGANAATDQPDKTDALIDLVPLGEQF 914
Query: 236 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYS--G 293
DNTTAFLT RFWHK+VVIKSSYFGDYEVLY+ YPGLPPSPP SS+ +ID GPYS G
Sbjct: 915 DNTTAFLTSDRFWHKKVVIKSSYFGDYEVLYISYPGLPPSPPLPPSSVNMIDGGPYSNNG 974
Query: 294 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAE 353
NNGR KP GVD+ KR+ + GLS G+IAI+ LS+F+A+VLCSAA + L+ K++ H +++
Sbjct: 975 NNGRTIKPLGVDIQKRQHRSGLSKGIIAIIALSSFLAIVLCSAAVFALI-KFRDHVSESQ 1033
Query: 354 --EVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNF 411
P+ S K G AG SAS SF SSIA Y GSAKTFS +EIEKAT NF
Sbjct: 1034 PTSTPRVFPPSLTKTPGTAGPSNAGA--SASTSFRSSIAAYAGSAKTFSMNEIEKATDNF 1091
Query: 412 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
SRILGEGGFGLVYSG L+DG+KVA KVLKR D G REFL+EVEMLSRLHHRNLVKLI
Sbjct: 1092 HPSRILGEGGFGLVYSGNLEDGSKVAFKVLKREDHHGDREFLSEVEMLSRLHHRNLVKLI 1151
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531
GIC E RCLVYELIPNGSVESHLHGVD+E +PL W AR+KIALGAAR LAYLHEDSSP
Sbjct: 1152 GICTELSFRCLVYELIPNGSVESHLHGVDREKSPLDWSARIKIALGAARGLAYLHEDSSP 1211
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 591
VIHRDFKSSNILLE+DFTPKVSDFGLAR+A DE++RHISTRVMGTFGYVAPEYAMTGHL
Sbjct: 1212 HVIHRDFKSSNILLENDFTPKVSDFGLARTAADEDNRHISTRVMGTFGYVAPEYAMTGHL 1271
Query: 592 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651
LVKSDVYSYGVV+LELL+GRKPVD +QPPGQENLVAWARPLLTSREGLE IIDPSLG++V
Sbjct: 1272 LVKSDVYSYGVVLLELLTGRKPVDFSQPPGQENLVAWARPLLTSREGLEVIIDPSLGSNV 1331
Query: 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDL 711
PFDSVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNECDEAKE GS SS++D S D
Sbjct: 1332 PFDSVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNECDEAKEAGSTSSNKDGSSSDF 1391
Query: 712 DSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSS 771
T + QLPD Q H + NYD G+D LS S +FSSSAR ++ S FRR+S S
Sbjct: 1392 ----YTVTEQLPDNFQSHSAAANYDFGVDIENGLSTSEIFSSSARFERQVSGSFRRHSYS 1447
Query: 772 GPLRTGRGRQFWQRIRRLVGGSDSEHG 798
GPLRTGR ++ W IR+L GGS SEHG
Sbjct: 1448 GPLRTGRSKRLWHIIRKLSGGSVSEHG 1474
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|124360779|gb|ABN08751.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 988 bits (2554), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/747 (68%), Positives = 589/747 (78%), Gaps = 27/747 (3%)
Query: 72 VPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLP 128
+PPSF+PT+R+RH P P+N + SP P+ +PVS+V +PSPS + T++P P
Sbjct: 243 IPPSFLPTNRRRHNAPAPMNRGSADSPFTFPIQSPVSQVSPAPSPSFKTFPHSTKIPFHP 302
Query: 129 PK--------SSPSEPI----RAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVG 176
PK SP +PI +A PPPPPN DC + +C+EPYTN+PPG PC C+WPM+VG
Sbjct: 303 PKISPQRSFSKSPKKPILPRVQALPPPPPNEDCLSFVCSEPYTNSPPGVPCMCIWPMRVG 362
Query: 177 LRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKF 235
LRL+V LYTFFPLVSELA EI++GVFMKQSQVRI+GANAA +QPDKT L DLVPLGE+F
Sbjct: 363 LRLNVPLYTFFPLVSELASEISSGVFMKQSQVRIMGANAATDQPDKTDALIDLVPLGEQF 422
Query: 236 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYS--G 293
DNTTAFLT RFWHK+VVIKSSYFGDYEVLY+ YPGLPPSPP SS+ +ID GPYS G
Sbjct: 423 DNTTAFLTSDRFWHKKVVIKSSYFGDYEVLYISYPGLPPSPPLPPSSVNMIDGGPYSNNG 482
Query: 294 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAE 353
NNGR KP GVD+ KR+ + GLS G+IAI+ LS+F+A+VLCSAA + L+ K++ H +++
Sbjct: 483 NNGRTIKPLGVDIQKRQHRSGLSKGIIAIIALSSFLAIVLCSAAVFALI-KFRDHVSESQ 541
Query: 354 --EVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNF 411
P+ S K G AG SAS SF SSIA Y GSAKTFS +EIEKAT NF
Sbjct: 542 PTSTPRVFPPSLTKTPGTAGPSNAGA--SASTSFRSSIAAYAGSAKTFSMNEIEKATDNF 599
Query: 412 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
SRILGEGGFGLVYSG L+DG+KVA KVLKR D G REFL+EVEMLSRLHHRNLVKLI
Sbjct: 600 HPSRILGEGGFGLVYSGNLEDGSKVAFKVLKREDHHGDREFLSEVEMLSRLHHRNLVKLI 659
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531
GIC E RCLVYELIPNGSVESHLHGVD+E +PL W AR+KIALGAAR LAYLHEDSSP
Sbjct: 660 GICTELSFRCLVYELIPNGSVESHLHGVDREKSPLDWSARIKIALGAARGLAYLHEDSSP 719
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 591
VIHRDFKSSNILLE+DFTPKVSDFGLAR+A DE++RHISTRVMGTFGYVAPEYAMTGHL
Sbjct: 720 HVIHRDFKSSNILLENDFTPKVSDFGLARTAADEDNRHISTRVMGTFGYVAPEYAMTGHL 779
Query: 592 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651
LVKSDVYSYGVV+LELL+GRKPVD +QPPGQENLVAWARPLLTSREGLE IIDPSLG++V
Sbjct: 780 LVKSDVYSYGVVLLELLTGRKPVDFSQPPGQENLVAWARPLLTSREGLEVIIDPSLGSNV 839
Query: 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDL 711
PFDSVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNECDEAKE GS SS++D S D
Sbjct: 840 PFDSVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNECDEAKEAGSTSSNKDGSSSDF 899
Query: 712 DSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSS 771
T + QLPD Q H + NYD G+D LS S +FSSSAR ++ S FRR+S S
Sbjct: 900 ----YTVTEQLPDNFQSHSAAANYDFGVDIENGLSTSEIFSSSARFERQVSGSFRRHSYS 955
Query: 772 GPLRTGRGRQFWQRIRRLVGGSDSEHG 798
GPLRTGR ++ W IR+L GGS SEHG
Sbjct: 956 GPLRTGRSKRLWHIIRKLSGGSVSEHG 982
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122486|ref|XP_002330493.1| predicted protein [Populus trichocarpa] gi|222872427|gb|EEF09558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 987 bits (2552), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 546/799 (68%), Positives = 610/799 (76%), Gaps = 63/799 (7%)
Query: 65 SPSKGPVVPPSFIPTSRKRHYGPPPL----NSVSPSHSPLPTPVSRVPTSPSPSPTSASG 120
S +GPV+PPSF+PTSR + Y PL +S + SH P PV V +PSP+ T+ASG
Sbjct: 366 SKQQGPVMPPSFLPTSRHKQYAFSPLGTPDSSNNASHYRYPKPVIIVSPTPSPTQTAASG 425
Query: 121 QTELPLLPPKSSPSEPIRAFPPPPP----------------NADCSTTICTEPYTNTPPG 164
T++P L PK+SPS F P N DCSTT+CTEPYTNTPPG
Sbjct: 426 WTKMPALSPKASPS----GFSSRTPKMPPLPPLHTLPPPPPNEDCSTTVCTEPYTNTPPG 481
Query: 165 SPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANA-AEQPDKTV 223
SPC CV PMQVGL +SVALYTFFPLVSELA EIAAGVFMKQ QVRIIGANA ++Q +KT+
Sbjct: 482 SPCRCVLPMQVGLGVSVALYTFFPLVSELAQEIAAGVFMKQGQVRIIGANAPSQQLEKTI 541
Query: 224 VLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSI 283
VL DLVPLGE+FDN+TA LTY RFW KQVVI S+FGDYEVLYVRY GLPP PP A I
Sbjct: 542 VLIDLVPLGERFDNSTALLTYLRFWKKQVVINPSFFGDYEVLYVRYLGLPPPPPMAPFGI 601
Query: 284 GIIDDGPYSGN--NGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVL 341
IIDDGPYSGN N R KP GVDV KR++K GL+GG+IAI+ +S FVA+VL SA A L
Sbjct: 602 AIIDDGPYSGNDNNARMIKPLGVDVHKRKRKDGLAGGIIAIIAVSGFVALVLFSAVALAL 661
Query: 342 LFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSA 401
LFK++ HA Q V Q L S VKPSG AG ++GSGL SASLSF SSI YTGSAKTFS
Sbjct: 662 LFKHRDHASQPASVLQPLPPSVVKPSGIAGSLIGSGLSSASLSFASSIPAYTGSAKTFSK 721
Query: 402 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 461
S+IE+AT +FDASRILGEGGFGLVYSGVL+DGTKVAVKVLKR DQQGGREFLAEVEMLSR
Sbjct: 722 SDIERATSSFDASRILGEGGFGLVYSGVLEDGTKVAVKVLKRNDQQGGREFLAEVEMLSR 781
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG----------------------- 498
LHHRNLVKLIGIC EE +R LVYELI NGSVESHLHG
Sbjct: 782 LHHRNLVKLIGICTEECSRSLVYELIANGSVESHLHGSRLALSEFSYLDQESYLLDKESM 841
Query: 499 ---------VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 549
VDKESA L WDAR+KIALGAAR LAYLHEDSSPRVIHRDFKSSNILLEHDF
Sbjct: 842 FYNMNMLVWVDKESA-LNWDARIKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLEHDF 900
Query: 550 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
TPKVSDFGLAR+A+DEE+RHIST+VMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+
Sbjct: 901 TPKVSDFGLARTALDEENRHISTQVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 960
Query: 610 GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQP 669
GRKPVDM+QPPGQENLVAWARP LT++EGLE IIDP+L DVPFDSVAKVAAIASMCVQP
Sbjct: 961 GRKPVDMSQPPGQENLVAWARPFLTTKEGLEVIIDPTLATDVPFDSVAKVAAIASMCVQP 1020
Query: 670 EVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRH 729
EV HRPFM EVVQALKLV NECDEAKE+ S SSSQ D+SI +D++VS SGQL D L+
Sbjct: 1021 EVSHRPFMSEVVQALKLVSNECDEAKELDSRSSSQ-DLSIYMDAEVSAVSGQLRDSLRSQ 1079
Query: 730 YSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRL 789
V NYD D R L SY FS+S G++ S RR SSGPL+TGRGR+ +QR+ RL
Sbjct: 1080 ALVHNYDSEPDIERGLVDSYFFSTSDGCGRQGSGSLRR-CSSGPLKTGRGRELFQRM-RL 1137
Query: 790 VGGSDSEHGAVFSLWPGSY 808
G S SE G +F +WPGS+
Sbjct: 1138 TGESVSERGTIFKMWPGSH 1156
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558353|ref|XP_003547471.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2503), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/749 (69%), Positives = 584/749 (77%), Gaps = 30/749 (4%)
Query: 73 PPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPP 129
PPS +PTS +RH+ PPP+N SVSPS + +PV++V +PSP + T++PL PP
Sbjct: 519 PPSPLPTSGQRHHAPPPMNTGSSVSPSSLHIQSPVNQVSPAPSPIFNISPHSTKIPLHPP 578
Query: 130 KSSPSEP------------IRAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGL 177
K SPS P +A PPPPPN DC + +C+EPYT+TPPG+PC CVWPM+VGL
Sbjct: 579 KVSPSRPSSKIPKKPVRPRFQALPPPPPNEDCISVVCSEPYTSTPPGAPCKCVWPMKVGL 638
Query: 178 RLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFD 236
RLSV+LYTFFPLVSE A EIA GVFMKQSQVRI+GA+AA +QPDKT+V DLVPLGE+FD
Sbjct: 639 RLSVSLYTFFPLVSEFASEIATGVFMKQSQVRIMGADAANQQPDKTIVFIDLVPLGEEFD 698
Query: 237 NTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSG--N 294
NTTAFLT +RFWHKQVVIK+SYFGDY VLYV YPGLPPSPP SSI IID GPYSG N
Sbjct: 699 NTTAFLTSERFWHKQVVIKTSYFGDYVVLYVTYPGLPPSPPLPPSSISIIDGGPYSGGGN 758
Query: 295 NGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEE 354
NGR KP GVD+ KR+ + GLS G+IA++ LS F+ V LC AAA + FKY+ H Q
Sbjct: 759 NGRTIKPLGVDISKRQHRGGLSKGIIAVIALSVFLVVALCFAAA-LASFKYRDHVSQTPS 817
Query: 355 VPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDAS 414
P+ L P A ++ G L SAS SF SSIA YTGSAKT S ++IEKAT NF AS
Sbjct: 818 TPRILPPLTKAPGAAGSVVGGG-LASASTSFRSSIAAYTGSAKTLSMNDIEKATDNFHAS 876
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
R+LGEGGFGLVYSG+L+DGTKVAVKVLKR D QG REFL+EVEMLSRLHHRNLVKLIGIC
Sbjct: 877 RVLGEGGFGLVYSGILEDGTKVAVKVLKREDHQGNREFLSEVEMLSRLHHRNLVKLIGIC 936
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
E RCLVYELIPNGSVESHLHG DKE++PL W ARLKIALG+AR LAYLHEDSSP VI
Sbjct: 937 AEVSFRCLVYELIPNGSVESHLHGADKENSPLDWSARLKIALGSARGLAYLHEDSSPHVI 996
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
HRDFKSSNILLE+DFTPKVSDFGLAR+A DE +RHISTRVMGTFGYVAPEYAMTGHLLVK
Sbjct: 997 HRDFKSSNILLENDFTPKVSDFGLARTAADEGNRHISTRVMGTFGYVAPEYAMTGHLLVK 1056
Query: 595 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 654
SDVYSYGVV+LELL+GRKPVDM+QPPGQENLVAWARPLL+S EGLE +IDPSLG DVP D
Sbjct: 1057 SDVYSYGVVLLELLTGRKPVDMSQPPGQENLVAWARPLLSSEEGLEAMIDPSLGPDVPSD 1116
Query: 655 SVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSK 714
SVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNECDEA+E GS+SSS D
Sbjct: 1117 SVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNECDEARETGSSSSSVDLSHSR---- 1172
Query: 715 VSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPL 774
QL D LQ +S NYD G+D L S LFSSSAR G+ S FRR+S SGPL
Sbjct: 1173 ------QLSDNLQGQFSATNYDSGVDIENGLLASELFSSSARYGRRVSGSFRRHSYSGPL 1226
Query: 775 RTGRGRQFWQRIRRLVGGSDSEHGAVFSL 803
TGR ++ WQ IR+L GGS SEHG +F L
Sbjct: 1227 NTGRSKRLWQIIRKLSGGSVSEHGTMFKL 1255
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436078|ref|XP_004135821.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] gi|449489947|ref|XP_004158466.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2482), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/740 (67%), Positives = 570/740 (77%), Gaps = 34/740 (4%)
Query: 84 HYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSP-TSASGQTELPLLPPKSSPSEPIRAFPP 142
HY PPPL V SPSPSP SG T PPK+SPS+P P
Sbjct: 328 HYAPPPL---------------VVHVSPSPSPHQKISGHTRRHFYPPKASPSKPSAKSPK 372
Query: 143 PPP---------NADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSEL 193
P N DC TT C EPYTNTPPGSPCGCVWPMQ+GLRLSV+LYTFFPLVSEL
Sbjct: 373 MSPIHTLPPPPPNEDCLTTQCIEPYTNTPPGSPCGCVWPMQIGLRLSVSLYTFFPLVSEL 432
Query: 194 AGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQV 252
A EIA GVF+KQSQVRIIGANAA +QPDKTV+L DLVPLGEKFDNTTAFLTYQRFWHK+V
Sbjct: 433 AAEIAVGVFVKQSQVRIIGANAANQQPDKTVILIDLVPLGEKFDNTTAFLTYQRFWHKKV 492
Query: 253 VIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPY--SGNNGRATKPEGVDVPKRR 310
IK+SYFG+YEVLYVRYPGLP SPPS S I ++ PY + N+ RA KP GVDV R+
Sbjct: 493 SIKASYFGNYEVLYVRYPGLPQSPPSGDSGI---ENEPYFSNSNDARAVKPIGVDVQNRQ 549
Query: 311 QKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAA 370
K LSGG+IAIV LS VAVVLC A AW+LLFK CQ + P +S KPSGA
Sbjct: 550 HKNKLSGGIIAIVALSTTVAVVLCVATAWILLFKRNDGLCQPKPTPHVSLSSLNKPSGAG 609
Query: 371 GLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL 430
G ++ + SASLS GSSIA Y+GSAKTFSA +IE+AT NFD SRILGEGGFG VY G+L
Sbjct: 610 GSVMATMPSSASLSIGSSIAPYSGSAKTFSAPDIERATNNFDPSRILGEGGFGRVYRGIL 669
Query: 431 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490
+DGT+VAVKVLKR D QGGREFLAEVEMLSRLHHRNLVKLIGIC EE++R LVYELIPNG
Sbjct: 670 EDGTEVAVKVLKRDDLQGGREFLAEVEMLSRLHHRNLVKLIGICTEERSRSLVYELIPNG 729
Query: 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550
SVESHLHGVDKE+APL W++R+KIALGAAR L+YLHEDSSPRVIHRDFKSSNILLEHDFT
Sbjct: 730 SVESHLHGVDKETAPLDWESRVKIALGAARGLSYLHEDSSPRVIHRDFKSSNILLEHDFT 789
Query: 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 610
PKVSDFGLAR+AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+G
Sbjct: 790 PKVSDFGLARTAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 849
Query: 611 RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 670
RKPVDM+QPPG+ENLV+WARPLLTS+EGL+ IID S+ ++VPF+++AKVAAIASMCVQPE
Sbjct: 850 RKPVDMSQPPGEENLVSWARPLLTSKEGLDVIIDKSIDSNVPFENIAKVAAIASMCVQPE 909
Query: 671 VQHRPFMGEVVQALKLVCNECDEAKEVGS-ASSSQDDMSIDLDSKVSTGSGQLPDPLQRH 729
V HRPFMGEVVQALKLVCN+C+ +E S A SS + +ID + ++ S + D
Sbjct: 910 VSHRPFMGEVVQALKLVCNQCNTTRETSSHAGSSPESSTIDTNDDEASSSRYMLDSFHSE 969
Query: 730 YSVPNYDLGLDT-GRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRG-RQFWQRIR 787
Y VPN GLD+ LS+S L ++S +GK+ES R SS P R G+G R FW+R+R
Sbjct: 970 YLVPNSFPGLDSIDTHLSISDLLNTSIGNGKQESRSLERCFSSSPHRIGKGKRNFWERMR 1029
Query: 788 RLVGGSDSEHGAVFSLWPGS 807
R G S SEHG W GS
Sbjct: 1030 RYSGNSISEHGMPTKTWSGS 1049
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112136|ref|XP_002332826.1| predicted protein [Populus trichocarpa] gi|222833257|gb|EEE71734.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/666 (74%), Positives = 552/666 (82%), Gaps = 11/666 (1%)
Query: 146 NADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQ 205
+ADCS T+CTEPYTNTPPGSPCGCV PMQVGL +SVALYTFFPLVSELA EIA GVFMKQ
Sbjct: 7 SADCSATVCTEPYTNTPPGSPCGCVLPMQVGLSVSVALYTFFPLVSELAQEIATGVFMKQ 66
Query: 206 SQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEV 264
SQV IIGANAA +QP+KT++L DLVPLGE+FDNTTAF YQRFWHKQVVI S+FGDYEV
Sbjct: 67 SQVHIIGANAASQQPEKTIILVDLVPLGERFDNTTAFFIYQRFWHKQVVINPSFFGDYEV 126
Query: 265 LYVRYPGLPPSPPSASSSIGIIDDGPYSG--NNGRATKPEGVDVPKRRQKYGLSGGMIAI 322
LYVRY GLPPSP A S I IIDDGPYSG NN R KP GVDV R+ K GL G+IAI
Sbjct: 127 LYVRYLGLPPSPHLAPSGIAIIDDGPYSGDDNNARTIKPLGVDV-HRKHKNGLGHGVIAI 185
Query: 323 VVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSAS 382
+ LS VA+VL SA AW LLF+++ A Q+E V Q L S VKPSG AG +VGSGL SAS
Sbjct: 186 IALSGVVALVLFSAVAWALLFRHRDRASQSETVLQPLPPSVVKPSGIAGSLVGSGLSSAS 245
Query: 383 LSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK 442
LSFGSSI Y GSAKTFS S+IE+AT +FDASRILGEGGFG VY GVL+DGTKVA+KVLK
Sbjct: 246 LSFGSSIPAYAGSAKTFSTSDIERATNSFDASRILGEGGFGRVYCGVLEDGTKVAIKVLK 305
Query: 443 RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKE 502
R DQQGGREFLAEVEMLSRLHHRNLVKLIGIC EE++R LVYELIPNGSVESHLHG
Sbjct: 306 RDDQQGGREFLAEVEMLSRLHHRNLVKLIGICTEERSRSLVYELIPNGSVESHLHG---- 361
Query: 503 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562
SA L WDAR+KIALGAAR LAYLHEDSSP VIHRDFKSSNILLEHDFTPKVSDFGLAR+A
Sbjct: 362 SASLDWDARIKIALGAARGLAYLHEDSSPCVIHRDFKSSNILLEHDFTPKVSDFGLARTA 421
Query: 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
+DEE++HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQ
Sbjct: 422 LDEENQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQ 481
Query: 623 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
ENLV WARPLLTS+EGL+ IIDPSLG+DVPFDSVAKVAAIASMCVQPEV +RPFMGEVVQ
Sbjct: 482 ENLVTWARPLLTSKEGLKLIIDPSLGSDVPFDSVAKVAAIASMCVQPEVSNRPFMGEVVQ 541
Query: 683 ALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTG 742
ALKLV NECDEAKE+ S SSSQ +SID+D++VS SGQL Q H V NYD D
Sbjct: 542 ALKLVSNECDEAKELDSRSSSQ-GLSIDMDAEVSAVSGQLRGAFQNHALVLNYDSEPDIE 600
Query: 743 RRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFS 802
R L +S L S+S G+E RR SSGPLR RGR+ +++ RL G + SE G +F
Sbjct: 601 RGLPVSDLLSTSVGYGREGCGSLRR-CSSGPLRKVRGRELLRKM-RLTGETVSERGTIFK 658
Query: 803 LWPGSY 808
+WPGS+
Sbjct: 659 MWPGSH 664
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482516|ref|XP_002275886.2| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2431), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/682 (70%), Positives = 557/682 (81%), Gaps = 8/682 (1%)
Query: 130 KSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPL 189
K+ P + PPPPPN DC++ CTEP T TPPGSPCGCVWP+QV LRLSVALYTFFPL
Sbjct: 195 KTPPPPLVWTLPPPPPNEDCASLTCTEPLTYTPPGSPCGCVWPIQVKLRLSVALYTFFPL 254
Query: 190 VSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFW 248
VSELA EIAAGV + SQVRI+GANAA +Q DKT++L DLVPLGEKF++TTAF Y++FW
Sbjct: 255 VSELADEIAAGVSLNHSQVRIMGANAANQQLDKTIILIDLVPLGEKFNHTTAFSIYEKFW 314
Query: 249 HKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSG--NNGRATKPEGVDV 306
K+ IK+S +G YE LYVRYPGLPPSPPS+ S+I DDG YSG NNGR KP GVDV
Sbjct: 315 LKKFFIKTSLYGGYEALYVRYPGLPPSPPSSISNI---DDGSYSGHGNNGRVMKPLGVDV 371
Query: 307 PKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKP 366
P++ QK+GL G MI ++VLS+ V+C A AWVL+ K + H QAE++P SL +S KP
Sbjct: 372 PQK-QKHGLGGSMITVIVLSSVTGFVICIAVAWVLVLKCRGHVHQAEDIPHSLISSFAKP 430
Query: 367 SGAAG-LMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLV 425
SGAAG +M+GS S S+SF S + TYTGSAKTFS ++IE+AT NFDASR+LGEGGFGLV
Sbjct: 431 SGAAGSMMLGSRTSSTSVSFSSGVVTYTGSAKTFSLNDIERATDNFDASRVLGEGGFGLV 490
Query: 426 YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485
Y G+LDDG +VAVKVLKR DQQGGREFLAEVEMLSRLHHRNLVKLIGIC EE RCLVYE
Sbjct: 491 YRGILDDGVEVAVKVLKRDDQQGGREFLAEVEMLSRLHHRNLVKLIGICTEEHTRCLVYE 550
Query: 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545
L+PNGSVESHLHGVDKE++PL W AR+KIALGAAR LAYLHEDSSPRVIHRDFKSSNILL
Sbjct: 551 LVPNGSVESHLHGVDKEASPLDWGARMKIALGAARGLAYLHEDSSPRVIHRDFKSSNILL 610
Query: 546 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVIL 605
EHDFTPKVSDFGLAR+A+DE ++HISTRVMGTFGY+APEYAMTGHLLVKSDVYSYGVV+L
Sbjct: 611 EHDFTPKVSDFGLARTALDEGNKHISTRVMGTFGYLAPEYAMTGHLLVKSDVYSYGVVLL 670
Query: 606 ELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASM 665
ELL+GRKPVD++QPPGQENLVAWARPLLT++EGLE IIDP+L + PFDS AKVAAIASM
Sbjct: 671 ELLTGRKPVDLSQPPGQENLVAWARPLLTTKEGLETIIDPALKSSSPFDSAAKVAAIASM 730
Query: 666 CVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDP 725
CVQPEV HRPFMGEVVQALKLVC+E DE K++ S S SQ+++SID+ K S G+L +
Sbjct: 731 CVQPEVSHRPFMGEVVQALKLVCSEYDETKDLASKSFSQENLSIDVIRKSSRVLGELLEV 790
Query: 726 LQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQR 785
Q H+ V +D DT LS+S L S+S ++S FRRYSSSGPL TGR R+FWQR
Sbjct: 791 SQVHHPVAGHDSSFDTKMALSVSDLVSTSMGFEGQDSGSFRRYSSSGPLSTGRRREFWQR 850
Query: 786 IRRLVGGSDSEHGAVFSLWPGS 807
+RR GGS SEHG F LWP S
Sbjct: 851 LRRSSGGSASEHGFSFKLWPRS 872
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545725|ref|XP_003541286.1| PREDICTED: uncharacterized protein LOC100816296 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 940 bits (2430), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/754 (67%), Positives = 586/754 (77%), Gaps = 23/754 (3%)
Query: 72 VPPSFIPTSRKRHYGPPPLNSVSPSHSP---LPTPVSRVPTSPSPSPTSASGQTELPLLP 128
+PP P S +RH+ PP+NS S + + +V +PSPS AS T + P
Sbjct: 518 IPPLLPPRSGQRHHVSPPINSSSSVSPFSSPIHSNTGQVSPAPSPSIKFASHPTGSTIFP 577
Query: 129 PKSSPSEPIRAFP------------PPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVG 176
PK +PSE P PPPPN DC +T+CTEPYTN+PPG PC CVWPM+VG
Sbjct: 578 PKVAPSESSSKRPKMPLLPQVQVLPPPPPNEDCISTVCTEPYTNSPPGEPCRCVWPMRVG 637
Query: 177 LRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKF 235
LRLSV+LYTFFPLVSELA EIA GVFMKQSQVRI+GANAA +QP+KTVVL DLVPLGE+F
Sbjct: 638 LRLSVSLYTFFPLVSELASEIATGVFMKQSQVRIMGANAADQQPEKTVVLIDLVPLGEEF 697
Query: 236 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYS--G 293
DNTTAF T RFWHK V+IK+ YFGDY+VLYV YPGLPPSPP SS+ + + GPYS G
Sbjct: 698 DNTTAFFTSDRFWHKMVIIKAFYFGDYDVLYVSYPGLPPSPPLPPSSLNMFNGGPYSTDG 757
Query: 294 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAE 353
NNGR KP GVD+ KR+QK GLS G+I+ + +S +AVVLC+AAAWV+ FK++ H Q+
Sbjct: 758 NNGRTIKPIGVDILKRQQKVGLSRGIISTIAVSVSLAVVLCAAAAWVM-FKFRDHVSQSA 816
Query: 354 EVPQSLQT-SHVKPSGAAGLM--VGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGN 410
P+ L S K G AG + G+G+ S S SF SSIA YTGSAKTFS ++I+KAT +
Sbjct: 817 STPRQLSPPSLTKEPGTAGSLRGAGAGVGSVSTSFRSSIAAYTGSAKTFSTNDIKKATDD 876
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 470
F ASRILGEGGFGLVYSG+L+DGTKVAVKVLKR D G REFLAEVEMLSRLHHRNLVKL
Sbjct: 877 FHASRILGEGGFGLVYSGILEDGTKVAVKVLKREDHHGDREFLAEVEMLSRLHHRNLVKL 936
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
IGICIE R LVYEL+PNGSVES+LHGVD+ ++PL W AR+KIALGAAR LAYLHEDSS
Sbjct: 937 IGICIENSFRSLVYELVPNGSVESYLHGVDRGNSPLDWGARMKIALGAARGLAYLHEDSS 996
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 590
PRVIHRDFKSSNILLE DFTPKVSDFGLAR+A DEE++HISTRVMGTFGYVAPEYAMTGH
Sbjct: 997 PRVIHRDFKSSNILLEDDFTPKVSDFGLARTATDEENKHISTRVMGTFGYVAPEYAMTGH 1056
Query: 591 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 650
LLVKSDVYSYGVV+LELL+GRKPVDM+Q PGQENLVAWARPLLTS+EG E +ID SLG D
Sbjct: 1057 LLVKSDVYSYGVVLLELLTGRKPVDMSQAPGQENLVAWARPLLTSKEGCEAMIDQSLGTD 1116
Query: 651 VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK-EVGSASSSQDDMSI 709
VPFDSVAKVAAIASMCVQPEV +RPFM EVVQALKLVC+ECDEAK E GS+S S +D+S+
Sbjct: 1117 VPFDSVAKVAAIASMCVQPEVSNRPFMSEVVQALKLVCSECDEAKEESGSSSFSLEDLSV 1176
Query: 710 DLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYS 769
DL +ST SGQL D Q S N+D G+D R L+ S +FSSSAR G+ ES FRR S
Sbjct: 1177 DLALGISTVSGQLSDNFQSQLSGTNFDSGVDIERGLAASEIFSSSARFGRAESGSFRRNS 1236
Query: 770 SSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSL 803
SGPLRTGR RQ WQ IR L GS SEHG + L
Sbjct: 1237 YSGPLRTGRSRQLWQIIRSLSSGSVSEHGTMLKL 1270
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 808 | ||||||
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.805 | 0.584 | 0.658 | 2.6e-228 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.777 | 0.844 | 0.523 | 1.8e-158 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.434 | 0.484 | 0.540 | 3.9e-102 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.540 | 0.617 | 0.429 | 5e-89 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.471 | 0.559 | 0.446 | 2.4e-85 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.507 | 0.538 | 0.429 | 2.5e-83 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.487 | 0.547 | 0.430 | 3.2e-83 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.366 | 0.412 | 0.518 | 2.8e-82 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.356 | 0.441 | 0.513 | 2.5e-81 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.389 | 0.486 | 0.484 | 8.2e-81 |
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2145 (760.1 bits), Expect = 2.6e-228, Sum P(2) = 2.6e-228
Identities = 440/668 (65%), Positives = 505/668 (75%)
Query: 137 IRAFXXXXXNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGE 196
++AF N+DCS+TIC EPYTNTPPGSPCGCVWP+QV LRLS+ALY FFP+VSE A E
Sbjct: 446 LQAFPPPPPNSDCSSTICLEPYTNTPPGSPCGCVWPIQVELRLSMALYDFFPMVSEFARE 505
Query: 197 IAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIK 255
I+AGVFMKQSQVRI+GANAA EQP+K++VL DLVPLG+KFDN TA LTYQRFW K+V I
Sbjct: 506 ISAGVFMKQSQVRIMGANAASEQPEKSIVLIDLVPLGDKFDNMTAMLTYQRFWSKKVYID 565
Query: 256 SSYFGDYEVLYVRXXXXXXXXXXXXXXXXXXXXXXXXXNNGRATKPEGVDVPKRRQKYGL 315
FG Y+V+YVR NNGRA KP GVDVP++ +K L
Sbjct: 566 EPIFGGYDVIYVRYPGLPASPPTSGMTIIDQGPYSGN-NNGRAVKPLGVDVPRKPRKKEL 624
Query: 316 SGGMIAIVVLSAFVAVVLCSAAAWVLLFK-YKSHACQAEEVPQSLQT--SHVKPSGAAGL 372
+GG IA++VLSA + LC W L+F+ + ++ P + + S KPSG+A
Sbjct: 625 NGGSIAVIVLSAAAFIGLCFVIVWFLVFRRQRDRRRLSKRTPLARPSLPSLSKPSGSARS 684
Query: 373 MVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDD 432
+ GS S SLSF SSIA +T SAKTF+ASEI KAT NFD SR+LGEGGFG VY GV DD
Sbjct: 685 LTGSRFSSTSLSFESSIAPFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDD 744
Query: 433 GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492
GTKVAVKVLKR DQQG REFLAEVEMLSRLHHRNLV LIGICIE++ R LVYELIPNGSV
Sbjct: 745 GTKVAVKVLKRDDQQGSREFLAEVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSV 804
Query: 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 552
ESHLHG+DK S+PL WDARLKIALGAAR LAYLHEDSSPRVIHRDFKSSNILLE+DFTPK
Sbjct: 805 ESHLHGIDKASSPLDWDARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPK 864
Query: 553 VSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 611
VSDFGLAR+A+D+E +RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GR
Sbjct: 865 VSDFGLARNALDDEDNRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 924
Query: 612 KPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEV 671
KPVDM+QPPGQENLV+W RP LTS EGL IID SLG ++ FDS+AKVAAIASMCVQPEV
Sbjct: 925 KPVDMSQPPGQENLVSWTRPFLTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEV 984
Query: 672 QHRPFMGEVVQALKLVCNECDEAKEVGSASS-SQDDMSIDLDSKVSTGSGQLPDPLQRHY 730
HRPFMGEVVQALKLV NECDEAKE+ S +S S+DD D ++ S G + R+
Sbjct: 985 SHRPFMGEVVQALKLVSNECDEAKELNSLTSISKDDFRDDTQAESSCGDSSAR--MARYP 1042
Query: 731 SVPNYDLGLDTGXXXXXXXXXXXXXXXGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLV 790
+PNYD DT G+ F R S+SGPL +GRG+ FWQ++RRL
Sbjct: 1043 LLPNYDSEPDT---ERGLSTSEMYTGSGR-----FERQSNSGPLTSGRGKSFWQKMRRLS 1094
Query: 791 GGSDSEHG 798
GS SEHG
Sbjct: 1095 TGSLSEHG 1102
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1544 (548.6 bits), Expect = 1.8e-158, P = 1.8e-158
Identities = 354/676 (52%), Positives = 434/676 (64%)
Query: 148 DCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQ 207
DC T C EP T+TP GSPCGCV+PM+V L LSVA ++ FP+ +EL E+AAG +++QSQ
Sbjct: 97 DCQQT-CVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTYLEQSQ 155
Query: 208 VRIIGANA-AEQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLY 266
V+I+GA+A +E KTVV +LVPLGEKFDNTTA L YQRF HK+V + + FGDYEV +
Sbjct: 156 VKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGDYEVTH 215
Query: 267 VRXXXXXXXXXXXXXXXXXXXXXXXXXNNGRAT--KPEGVDVPKRRQKY-----GLSGGM 319
+ NG T P G+ +P + G+
Sbjct: 216 I-----------------SYPGIPSSSPNGDVTGDAPGGLPIPINATTFANKSQGIGFRT 258
Query: 320 IAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLD 379
IAI+ LS FV +++ A +++ K+K + V +L S K GA + S
Sbjct: 259 IAIIALSGFVLILVLVGAISIIV-KWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARS 317
Query: 380 SASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVK 439
S S S SS+AT S KTF+ SE+EKAT F A R+LGEGGFG VY G ++DGT+VAVK
Sbjct: 318 SGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVK 377
Query: 440 VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV 499
+L R +Q REF+AEVEMLSRLHHRNLVKLIGICIE + RCL+YEL+ NGSVESHLH
Sbjct: 378 LLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-- 435
Query: 500 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559
L WDARLKIALGAAR LAYLHEDS+PRVIHRDFK+SN+LLE DFTPKVSDFGLA
Sbjct: 436 ---EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 492
Query: 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 619
R A E S+HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GR+PVDM+QP
Sbjct: 493 REAT-EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQP 551
Query: 620 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 679
G+ENLV WARPLL +REGLE+++DP+L FD +AKVAAIASMCV EV HRPFMGE
Sbjct: 552 SGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGE 611
Query: 680 VVQALKLVCNECDEA-KEVGSASSSQDDMSIDL--DSKVSTGSGQLPDPLQRHYSVPNY- 735
VVQALKL+ N+ DE + S S S D D S S P R+ ++
Sbjct: 612 VVQALKLIYNDADETCGDYCSQKDSSVPDSADFKGDLAPSDSSWWNLTPRLRYGQASSFI 671
Query: 736 DLGLDTGXXXXXXXXXXXXXXXGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLV---GG 792
+ +G + + + SGPLR R R+ + R+R + GG
Sbjct: 672 TMDYSSGPLEDMENRPHSASSIPRVGGLILP--NRSGPLRPMRSRRNFFRLRGSMSEHGG 729
Query: 793 -SDSEHGAVFSLWPGS 807
S S H LW G+
Sbjct: 730 PSSSRH-----LWSGN 740
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 3.9e-102, Sum P(3) = 3.9e-102
Identities = 199/368 (54%), Positives = 251/368 (68%)
Query: 322 IVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSA 381
++++ + A VL A VL+ S A + E+ P + + VKP LD+
Sbjct: 306 LILIFSIAAGVLILAIITVLVIC--SRALREEKAPDPHKEA-VKPRN---------LDAG 353
Query: 382 SLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVL 441
S FG S+ + S + S E+++AT NF+++ ILGEGGFG VY G+L DGT VA+K L
Sbjct: 354 S--FGGSLP-HPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKL 410
Query: 442 KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--RCLVYELIPNGSVESHLHGV 499
QG +EF E++MLSRLHHRNLVKL+G + L YEL+PNGS+E+ LHG
Sbjct: 411 TSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGP 470
Query: 500 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559
+ PL WD R+KIAL AAR LAYLHEDS P VIHRDFK+SNILLE++F KV+DFGLA
Sbjct: 471 LGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLA 530
Query: 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 619
+ A + H+STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QP
Sbjct: 531 KQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 590
Query: 620 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 679
GQENLV W RP+L ++ LE ++D L P + +V IA+ CV PE RP MGE
Sbjct: 591 SGQENLVTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGE 650
Query: 680 VVQALKLV 687
VVQ+LK+V
Sbjct: 651 VVQSLKMV 658
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 5.0e-89, Sum P(2) = 5.0e-89
Identities = 195/454 (42%), Positives = 259/454 (57%)
Query: 295 NGRATKPEGVDVPKRRQKYGL-SGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKS-HACQA 352
N +P +D P G+ +G ++ I V A V L W L + K A
Sbjct: 257 NNPTLRPP-LDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSG 315
Query: 353 EEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGS--SIATYTGSAKT-FSASEIEKATG 409
+V S +S + A M S AS GS S + G++K FS E+ KAT
Sbjct: 316 GDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATN 375
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
F +LGEGGFG VY G+L DG VAVK LK QG REF AEVE LSR+HHR+LV
Sbjct: 376 GFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVS 435
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
++G CI R L+Y+ + N + HLHG E + L W R+KIA GAAR LAYLHED
Sbjct: 436 IVGHCISGDRRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGAARGLAYLHEDC 492
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
PR+IHRD KSSNILLE +F +VSDFGLAR A+D + HI+TRV+GTFGY+APEYA +G
Sbjct: 493 HPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSG 551
Query: 590 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT---SREGLERIIDPS 646
L KSDV+S+GVV+LEL++GRKPVD +QP G E+LV WARPL++ E + + DP
Sbjct: 552 KLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPK 611
Query: 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK-LVCNECDEAKEVGSA---SS 702
LG + + ++ A CV+ RP MG++V+A + L + +G + +S
Sbjct: 612 LGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNS 671
Query: 703 SQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYD 736
+Q I L +++ GS H S + D
Sbjct: 672 AQQSAEIRLFRRMAFGSQNYSTDFFSHSSYNSRD 705
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 2.4e-85, Sum P(2) = 2.4e-85
Identities = 182/408 (44%), Positives = 249/408 (61%)
Query: 294 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSH--ACQ 351
NNG T P P + + G +GG++AI V+ V + L W + +
Sbjct: 217 NNGNNTLPSSS--PGKSE-VG-TGGIVAIGVIVGLVFLSLFVMGVWFTRKRKRKDPGTFV 272
Query: 352 AEEVPQSLQTSHVKPSGAAGLMVGSG------LDSASLS---FGSSIATYTGSAKT-FSA 401
+P S +S P G+ ++ S + S S S + SS + + ++ FS
Sbjct: 273 GYTMPPSAYSS---PQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSY 329
Query: 402 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 461
E+ + T F +LGEGGFG VY GVL DG +VAVK LK QG REF AEVE++SR
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
+HHR+LV L+G CI EQ R LVY+ +PN ++ HLH + + W+ R+++A GAAR
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPV--MTWETRVRVAAGAARG 447
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGY 580
+AYLHED PR+IHRD KSSNILL++ F V+DFGLA+ A + + + H+STRVMGTFGY
Sbjct: 448 IAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGY 507
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL---TSRE 637
+APEYA +G L K+DVYSYGV++LEL++GRKPVD +QP G E+LV WARPLL E
Sbjct: 508 MAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENE 567
Query: 638 GLERIIDPSLG-NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
+ ++DP LG N +P + V A A+ CV+ RP M +VV+AL
Sbjct: 568 EFDELVDPRLGKNFIPGEMFRMVEAAAA-CVRHSAAKRPKMSQVVRAL 614
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 2.5e-83, Sum P(2) = 2.5e-83
Identities = 184/428 (42%), Positives = 249/428 (58%)
Query: 314 GLSGGMIAIVVLSAFVAVVLCSAAAWVLLFK----YKSHACQAEEVPQSLQTSHVKPSGA 369
G+S G +A+V+L+ VV C L Y P+S ++ +K +
Sbjct: 332 GVSIG-VALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRS-DSALLKTQSS 389
Query: 370 AGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV 429
A L VG+ + + S + S + FS E+ AT F +LGEGGFG VY GV
Sbjct: 390 APL-VGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGV 448
Query: 430 LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489
L D VAVK LK QG REF AEV+ +SR+HHRNL+ ++G CI E R L+Y+ +PN
Sbjct: 449 LPDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPN 508
Query: 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 549
++ HLH L W R+KIA GAAR LAYLHED PR+IHRD KSSNILLE++F
Sbjct: 509 NNLYFHLHAAGTPG--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNF 566
Query: 550 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
VSDFGLA+ A+D + HI+TRVMGTFGY+APEYA +G L KSDV+S+GVV+LEL++
Sbjct: 567 HALVSDFGLAKLALDCNT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 625
Query: 610 GRKPVDMTQPPGQENLVAWARPLL---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMC 666
GRKPVD +QP G E+LV WARPLL T E + DP LG + + ++ A+ C
Sbjct: 626 GRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAAC 685
Query: 667 VQPEVQHRPFMGEVVQALKLVCNE-CDEAKEVGSA---SSSQDDMSIDLDSKVSTGSGQL 722
++ RP M ++V+A + E +G + +S+Q I L +++ GS
Sbjct: 686 IRHSATKRPRMSQIVRAFDSLAEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNY 745
Query: 723 P-DPLQRH 729
D L R+
Sbjct: 746 STDSLTRN 753
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 3.2e-83, Sum P(3) = 3.2e-83
Identities = 181/420 (43%), Positives = 242/420 (57%)
Query: 357 QSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKT-FSASEIEKATGNFDASR 415
Q Q+S G AG G S G+ + GS +T FS E+ + T F
Sbjct: 319 QQQQSSMGNSYGTAG---GGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFARKN 375
Query: 416 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
ILGEGGFG VY G L DG VAVK LK QG REF AEVE++SR+HHR+LV L+G CI
Sbjct: 376 ILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCI 435
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
+Q R L+YE + N ++E HLHG K L W R++IA+G+A+ LAYLHED P++IH
Sbjct: 436 SDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIH 493
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 595
RD KS+NILL+ ++ +V+DFGLAR D H+STRVMGTFGY+APEYA +G L +S
Sbjct: 494 RDIKSANILLDDEYEAQVADFGLAR-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 552
Query: 596 DVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--REG-LERIIDPSLGNDVP 652
DV+S+GVV+LEL++GRKPVD TQP G+E+LV WARPLL G L +ID L
Sbjct: 553 DVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYV 612
Query: 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLD 712
V ++ A+ CV+ RP M +VV+AL +CD + G S+ I +
Sbjct: 613 EHEVFRMIETAAACVRHSGPKRPRMVQVVRAL-----DCDG--DSGDISNG-----IKIG 660
Query: 713 SKVSTGSGQLPDPLQRHYSVP-NYDLGLDTGXXXXXXXXXXXXXXXGKE-ESELF--RRY 768
+ SGQ + + + + D +++G G E E+ F RR+
Sbjct: 661 QSTTYDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDFSGNESETRPFNNRRF 720
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 2.8e-82, Sum P(2) = 2.8e-82
Identities = 157/303 (51%), Positives = 210/303 (69%)
Query: 386 GSSIATYTGSAKT-FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV 444
G+ + G++K F+ E+ + T F S ++GEGGFG VY G+L +G VA+K LK V
Sbjct: 344 GTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSV 403
Query: 445 DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESA 504
+G REF AEVE++SR+HHR+LV L+G CI EQ R L+YE +PN +++ HLHG K
Sbjct: 404 SAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLP 461
Query: 505 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564
L W R++IA+GAA+ LAYLHED P++IHRD KSSNILL+ +F +V+DFGLAR D
Sbjct: 462 VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLAR-LND 520
Query: 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 624
HISTRVMGTFGY+APEYA +G L +SDV+S+GVV+LEL++GRKPVD +QP G+E+
Sbjct: 521 TAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEES 580
Query: 625 LVAWARPLLTS--REG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV 681
LV WARP L +G + ++DP L ND V K+ A+ CV+ RP M +VV
Sbjct: 581 LVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVV 640
Query: 682 QAL 684
+AL
Sbjct: 641 RAL 643
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
Identities = 151/294 (51%), Positives = 206/294 (70%)
Query: 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 454
S TF+ E+ +AT F + +LG+GGFG V+ G+L G +VAVK LK QG REF A
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 455 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 514
EVE++SR+HHR+LV LIG C+ R LVYE +PN ++E HLHG K + W RLKI
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLKI 381
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
ALG+A+ L+YLHED +P++IHRD K+SNIL++ F KV+DFGLA+ A D + H+STRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRV 440
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 634
MGTFGY+APEYA +G L KSDV+S+GVV+LEL++GR+PVD ++LV WARPLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 635 --SREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
S EG E + D +GN+ + +A++ A A+ CV+ + RP M ++V+AL+
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 758 (271.9 bits), Expect = 8.2e-81, Sum P(3) = 8.2e-81
Identities = 158/326 (48%), Positives = 218/326 (66%)
Query: 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 454
S TF+ E+ +AT F + +LG+GGFG V+ GVL G +VAVK LK QG REF A
Sbjct: 259 SKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQA 318
Query: 455 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARLK 513
EVE++SR+HHR+LV L+G CI R LVYE +PN ++E HLHG E P + W RLK
Sbjct: 319 EVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHG---EGRPTMEWSTRLK 375
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573
IALG+A+ L+YLHED +P++IHRD K+SNIL++ F KV+DFGLA+ A D + H+STR
Sbjct: 376 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTR 434
Query: 574 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633
VMGTFGY+APEYA +G L KSDV+S+GVV+LEL++GR+PVD ++LV WARPLL
Sbjct: 435 VMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL 494
Query: 634 T--SREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK--LVC 688
S +G E + D + N + +A++ A A+ CV+ + RP M ++V+AL+ +
Sbjct: 495 NRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSL 554
Query: 689 NECDEAKEVGSASS-SQDDMSIDLDS 713
++ +E G ++ S S D DS
Sbjct: 555 SDLNEGMRPGQSNVYSSYGGSTDYDS 580
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00016557001 | SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (681 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 808 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 5e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.001 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 1e-54
Identities = 88/283 (31%), Positives = 129/283 (45%), Gaps = 41/283 (14%)
Query: 414 SRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNL 467
+ LGEG FG VY G L +VAVK LK +Q EFL E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
VKL+G+C EE+ +V E + G + S+L K L L AL AR + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES-RHISTRV----MGTFGYVA 582
S IHRD + N L+ + K+SDFGL+R D++ R ++ M A
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM------A 171
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641
PE G KSDV+S+GV++ E+ + G +P PG N L + L +
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--LKNGYRLPQ 224
Query: 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
P + ++ + C + + RP E+V+ L
Sbjct: 225 ----------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 84/277 (30%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 415 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
+ LGEG FG VY G L +VAVK LK +Q EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
KL+G+C EE+ +V E +P G + +L L L AL AR + YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
S IHRD + N L+ + K+SDFGL+R + ++ + ++APE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647
G KSDV+S+GV++ E+ + G +P PG N L L +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--LKKGYRLPK------ 225
Query: 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
P + ++ + C + + RP E+V+ L
Sbjct: 226 ----PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 44/284 (15%)
Query: 415 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
+ LGEG FG VY G L TKVAVK LK ++ EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+G+C + + +V E +P G + L K L L++AL A+ + YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV-----AP 583
S +HRD + N L+ + K+SDFGL+R +++ G + AP
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLPIKWMAP 173
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
E G KSDV+S+GV++ E+ + G +P P +++ E LE +
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLELL 217
Query: 643 IDPSLGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
D G P + ++ + C + + RP E+V+ L
Sbjct: 218 ED---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 73/195 (37%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIGIC 474
LGEGGFG VY G KVA+K++K+ D E L E+E+L +L+H N+VKL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+E LV E GS++ L + L D L+I L L YLH S +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 535 HRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 592
HRD K NILL + K++DFGL++ + + ++GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 593 VKSDVYSYGVVILEL 607
KSD++S GV++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 6e-49
Identities = 76/203 (37%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLI 471
R LG G FG VY G VAVK+LK+ + + + E+ +L RL H N+V+LI
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531
++ LV E G L PL D KIAL R L YLH +
Sbjct: 65 DAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE-YAMTGH 590
+IHRD K NILL+ + K++DFGLA+ + + S ++T V GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAK-KLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 591 LLVKSDVYSYGVVILELLSGRKP 613
K DV+S GV++ ELL+G+ P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 86/282 (30%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 469
+ LGEG FG VY G L T+VAVK LK + R +FL E ++ +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 470 LIGICIEEQARCLVYELIPNGSVESHL-----HGVDKESAPLGWDARLKIALGAARALAY 524
L+G+C EE+ LV E + G + +L E + L L A+ A+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
L S + +HRD + N L+ D K+SDFGL+R D++ T ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643
G KSDV+S+GV++ E+ + G P PG N L L +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-----PGLSN--EEVLEYLRKGYRLPK-- 228
Query: 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P D ++ + C Q + + RP E+V+ L+
Sbjct: 229 -PEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 6e-45
Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIG 472
LGEG FG VY G VA+KV+K+ + RE L E+++L +L H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+ +E LV E G + L + S +AR AL YLH S
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED---EAR-FYLRQILSALEYLH---SKG 117
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
++HRD K NILL+ D K++DFGLAR + ++T V GT Y+APE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFV-GTPEYMAPEVLLGKGYG 174
Query: 593 VKSDVYSYGVVILELLSGRKP 613
D++S GV++ ELL+G+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+LG G FG VY + D G +AVK L ++ E+ +LS L H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 472 GICIEEQARCL-VY-ELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLH 526
G +E+ L ++ E + GS+ S L K P+ R +I G LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQILEG----LAYLH 118
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
S ++HRD K +NIL++ D K++DFG A+ D E+ + V GT ++APE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
+D++S G ++E+ +G+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 87/293 (29%), Positives = 134/293 (45%), Gaps = 37/293 (12%)
Query: 414 SRILGEGGFGLVYSGVLD---DGT--KVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 467
+ LGEG FG V D D T +VAVK L ++Q +F E+E+L L H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 468 VKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
VK G+C + R L+ E +P+GS+ +L + + L + + + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYL 125
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVA 582
S R IHRD + NIL+E + K+SDFGLA+ + E+ + + G F Y A
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWY-A 180
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLS-GRK-------PVDMTQPPGQENLVAWARPLLT 634
PE T SDV+S+GV + EL + G + M + +V LL
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 635 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687
E L R PS ++V +D + +C + E Q RP +++ + +
Sbjct: 241 EGERLPR--PPSCPDEV-YD-------LMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 7/199 (3%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 470
F R LG G FG V+ G+ + +VA+K+LK D ++F EV+ L RL H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
+C + ++ EL+ GS+ + L E L + + +A A +AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLR--SPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 590
IHRD + NIL+ D KV+DFGLAR + +E ++S+ + + APE A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 591 LLVKSDVYSYGVVILELLS 609
KSDV+S+G+++ E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNL 467
R LGEG FG V+ G +D VAVK LK R+ F E E+L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVD--------KESAPLGWDARLKIALG 517
VK G+C E +V+E + +G + L HG D L L+IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
A + YL +S +HRD + N L+ +D K+ DFG++R + + M
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 578 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
++ PE M +SDV+S+GVV+ E+ + G++P
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 417 LGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+G+GGFG VY G +VA+KV+K ++ + + E+++L + H N+VK G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 476 EEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
++ +V E GS++ + ES A + + L YLH +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTES----QIA--YVCKELLKGLEYLHSN---G 118
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
+IHRD K++NILL D K+ DFGL+ D ++R+ ++GT ++APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYD 175
Query: 593 VKSDVYSYGVVILELLSGRKP 613
K+D++S G+ +EL G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (316), Expect = 3e-31
Identities = 84/358 (23%), Positives = 128/358 (35%), Gaps = 24/358 (6%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL-HHR 465
++ R LGEG FG VY D VA+KVL + + FL E+++L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
N+VKL +E + LV E + GS+E L PL L I AL YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 526 HEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTR----VMGTFGY 580
H +IHRD K NILL K+ DFGLA+ D S +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 581 VAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637
+APE + + SD++S G+ + ELL+G P + + + L E
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-----LKIILE 229
Query: 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV-QALKLVCNECDEAKE 696
+ L P + + + + ++R + L +
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 697 VGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSS 754
+ + L + L + D + +
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHN 347
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476
+G+G FG V G G KVAVK LK D + FLAE +++ L H NLV+L+G+ ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 536
+V E + GS+ +L + A + +L AL + YL E +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 537 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSD 596
D + N+L+ D KVSDFGLA+ + S ++ + APE KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKFSTKSD 181
Query: 597 VYSYGVVILELLS-GRKP 613
V+S+G+++ E+ S GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 73/201 (36%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIGI 473
+G+G FG VY GVL T+VAVK + + FL E E+L + H N+VKLIG+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
C+++Q +V EL+P GS+ + L K+ L L+++L AA + YL S
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT----FGYVAPEYAMTG 589
IHRD + N L+ + K+SDFG++R EE I T G + APE G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 590 HLLVKSDVYSYGVVILELLSG 610
+SDV+SYG+++ E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 12/202 (5%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
R LG G FG V+ G+ ++ T VAVK LK ++FLAE +++ +L H L++L +C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
E+ +V EL+ GS+ +L G L + +A A +AYL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 592
HRD + N+L+ + KV+DFGLAR ++ R F + APE A+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAALYNRFS 182
Query: 593 VKSDVYSYGVVILELLS-GRKP 613
+KSDV+S+G+++ E+++ GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 73/205 (35%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLI 471
R LG G FG V+ G + TKVAVK LK G FL E +++ +L H LV+L
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531
+C EE+ +V E + GS+ L E L + +A A +AYL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTG 589
IHRD + NIL+ + K++DFGLAR D+E + R F + APE A G
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYG 179
Query: 590 HLLVKSDVYSYGVVILELLS-GRKP 613
+KSDV+S+G+++ E+++ GR P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 20/211 (9%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK--VLKRVDQQGGREFLAEVEMLSRLHHRN 466
N+ ++G G FG+VY G+ L+ G VA+K L+++ ++ + + E+++L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD--ARL--KIALGAARAL 522
+VK IG + ++ E NGS L + K+ P A ++ G L
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQG----L 112
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
AYLHE VIHRD K++NIL D K++DFG+A + +++ S+ ++ V+GT ++A
Sbjct: 113 AYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDAS-VVGTPYWMA 167
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
PE SD++S G ++ELL+G P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 75/206 (36%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 417 LGEGGFGLVYSGV--LDDGT--KVAVKVLKRVDQQGG-REFLAEVEMLSRLHHRNLVKLI 471
LG G FG V GV + G +VAVK LK+ G +EFL E ++++L H +V+LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI-ALGAARALAYLHEDSS 530
G+C E LV EL P G + +L + P + LK A A +AYL
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL--KKRREIP---VSDLKELAHQVAMGMAYLESK-- 114
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMT 588
+HRD + N+LL + K+SDFG++R A+ S + G + + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKP 613
G KSDV+SYGV + E S G KP
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 20/211 (9%)
Query: 415 RILGEGGFGLVYSGV---LDDGTK--VAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
++LG G FG VY GV + K VA+KVL+ + +E L E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+GIC+ Q L+ +L+P G + ++ +G L + A+ ++YL E
Sbjct: 73 RLLGICLSSQV-QLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 529 SSPRVIHRDFKSSNILLEHDFTP---KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
R++HRD + N+L++ TP K++DFGLA+ +E + + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 586 AMTGHLLVKSDVYSYGVVILELLS-GRKPVD 615
+ KSDV+SYGV + EL++ G KP +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 89/270 (32%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 416 ILGEGGFGLVYSGVLDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+LG+G FG V+ G L D T VAVK K + Q+ +FL+E +L + H N+VKLIG+C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+ Q +V EL+P G S L K+ L +K AL AA +AYL S I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
HRD + N L+ + K+SDFG++R D+ S + APE G +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 595 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 654
SDV+SYG+++ E S + + PG N A RE +E+ S P D
Sbjct: 175 SDVWSYGILLWETFS----LGVCPYPGMTNQQA--------REQVEKGYRMSCPQKCPDD 222
Query: 655 SVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
V + C + ++RP E+ + L
Sbjct: 223 ----VYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 27/219 (12%)
Query: 417 LGEGGFGLVYSGVL------DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 467
LGEG FG VY G L T VA+K LK Q +EF E E++S L H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARLKIA 515
V L+G+C +EQ C+++E + +G + L G + + L L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
+ A + YL SS +HRD + N L+ T K+SDFGL+R + + ++ +
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
++ PE + G +SD++S+GVV+ E+ S G +P
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 414 SRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLV 468
R +GEG FG VY GV ++ VAVK K RE FL E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
KLIG+ E +V EL P G + S+L V+K S L + + + + ALAYL
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLA--SLILYSYQLSTALAYLE-- 124
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
S R +HRD + N+L+ K+ DFGL+R +++ES + +++ ++APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINF 182
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKP 613
SDV+ +GV + E+L G KP
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+ +G+G FG VY DG +K L + ++ + L EV++L +L+H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531
E+ C+V E G + + KE P + L + AL YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------Y 585
+++HRD K NI L + K+ DFG+++ + T V GT Y++PE Y
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQNKPY 180
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKP 613
KSD++S G V+ EL + + P
Sbjct: 181 N------YKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476
+G G FGLV+ G + KVA+K + R +F+ E +++ +L H LV+L G+C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 536
CLV+E + +G + +L + + L + L +AYL + VIHR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 537 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSD 596
D + N L+ + KVSDFG+ R +D++ ST + +PE KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 597 VYSYGVVILELLS-GRKPVD 615
V+S+GV++ E+ S G+ P +
Sbjct: 184 VWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 417 LGEGGFGLVYSGVLDDGT----KVAVKVLKRVDQQGG-REFLAEVEMLSRLHHRNLVKLI 471
LG+G FG+V G VAVK LK +FL E ++ L H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLG--WDARLKIALGAARALAYLHEDS 529
G+ + +V EL P GS+ L + D ++IA G + YL
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLE--- 114
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST---RVMGTFGYVAPEYA 586
S R IHRD + NILL D K+ DFGL R+ E ++ +V F + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 587 MTGHLLVKSDVYSYGVVILELLS-GRKP 613
T SDV+ +GV + E+ + G +P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 73/223 (32%), Positives = 111/223 (49%), Gaps = 34/223 (15%)
Query: 415 RILGEGGFGLVYSG----VLDDGT---KVAVKVLKR--VDQQGGREFLAEVEMLSRLHHR 465
LG G FG VY G +L G+ +VAVK L++ DQ+ +EFL E ++S +H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP---LGWDARLKIALGAARAL 522
N+VKL+G+C+ + + ++ EL+ G + S+L E L L I L A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 523 AYLHEDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMD------EESRHIS 571
YL + IHRD + N L+ + D K+ DFGLAR E +
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 572 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
R M APE + G +SDV+S+GV++ E+L+ G++P
Sbjct: 177 VRWM------APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 417 LGEGGFGLVY----SGVLDDGTK--VAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 470
LGEG FG V+ +L + K VAVK LK + ++F E E+L+ L H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 471 IGICIEEQARCLVYELIPNGSVESHL--HGVDKE---------SAPLGWDARLKIALGAA 519
G+C E + +V+E + +G + L HG D + L L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
+ YL +S +HRD + N L+ K+ DFG++R + + R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREG 638
++ PE + +SD++S+GVV+ E+ + G++P W + L++ E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP--------------WYQ--LSNTEA 233
Query: 639 LERIIDPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEV 680
+E I + G ++ P +V AI C Q E Q R + ++
Sbjct: 234 IECI---TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476
LG G FG+V+ G VA+K+++ +F+ E +++ +L H NLV+L G+C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 536
++ +V E + NG + ++L + LG + L + A+ YL + IHR
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 537 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPEYAMTGHLLV 593
D + N L+ D KVSDFGLAR +D++ T GT + PE
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 594 KSDVYSYGVVILELLSGRK 612
KSDV+S+GV++ E+ S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 83/262 (31%), Positives = 125/262 (47%), Gaps = 34/262 (12%)
Query: 416 ILGEGGFGLVYSGVLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
I+GEG FG V G G KVAVK +K V Q FL E ++++LHH+NLV+L+G+
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV- 67
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
I +V EL+ G++ + L + + L+ +L A + YL S +++
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLE---SKKLV 122
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
HRD + NIL+ D KVSDFGLAR S + + + APE K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKL-PVKWTAPEALKHKKFSSK 177
Query: 595 SDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 653
SDV+SYGV++ E+ S GR P P ++ +E E ++ + P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY----------------PKMSLKEVKEC-VEKGYRMEPPE 220
Query: 654 DSVAKVAAIASMCVQPEVQHRP 675
A V + + C + E + RP
Sbjct: 221 GCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 72/214 (33%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 471
+ +G G +G+V S V G KVA+K + V D + L E+++L L H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 472 GICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
I +V EL+ E+ LH V K PL D R L YLH
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR------HISTRVMGTFGY 580
S VIHRD K SNIL+ + K+ DFGLAR +E ++ TR Y
Sbjct: 121 ---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW-----Y 172
Query: 581 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
APE ++ K+ D++S G + ELL RKP
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 93/295 (31%), Positives = 131/295 (44%), Gaps = 41/295 (13%)
Query: 415 RILGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLV 468
R+LGEG FG V Y D G VAVK LKR Q + E+ +L L+H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 469 KLIGICIE--EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
K G C E + L+ E +P GS+ +L K L L A +AYLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHK--LNLAQLLLFAQQICEGMAYLH 124
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAP 583
S IHRD + N+LL++D K+ DFGLA+ A+ E + R G F Y A
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWY-AV 179
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLSG--------RKPVDMTQPP-GQENLVAWARPLLT 634
E SDV+S+GV + ELL+ +K +M P GQ +V L+
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV----RLIE 235
Query: 635 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689
E R+ P + P + V + C + E + RP ++ LK + +
Sbjct: 236 LLERGMRLPCP---KNCPQE----VYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 79/287 (27%), Positives = 131/287 (45%), Gaps = 38/287 (13%)
Query: 415 RILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNL 467
R LG+G FG+VY G+ T+VA+K + R EFL E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES------APLGWDARLKIALGAARA 521
V+L+G+ Q +V EL+ G ++S+L E+ P +++A A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
+AYL + +HRD + N ++ D T K+ DFG+ R + + + + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 640
APE G KSDV+S+GVV+ E+ + +P G N E L+
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-----QGLSN-----------EEVLK 232
Query: 641 RIIDPSLGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ID G D+P + K+ + MC Q + RP E+V +LK
Sbjct: 233 FVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 73/216 (33%), Positives = 111/216 (51%), Gaps = 20/216 (9%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLIGI 473
LG G FG V+ G + TKVA+K LK QG FLAE ++ +L H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+E ++ E + NGS+ L E L + + +A A +A++ +
Sbjct: 70 VTQEPIY-IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKNY--- 123
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHL 591
IHRD +++NIL+ K++DFGLAR D E + R F + APE G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 180
Query: 592 LVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENL 625
+KSDV+S+G+++ E+++ GR P MT P +NL
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ-QGGREFLA----EVEMLSRLHHRNLV 468
+LG G FG VY G+ LDDG AVK + D Q G+E + E+ +LS+L H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+ +G EE + EL+P GS+ L P+ +I LG L YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH-- 119
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM- 587
+HRD K +NIL++ + K++DFG+A+ + E + G+ ++APE
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKS-FKGSPYWMAPEVIAQ 175
Query: 588 TGHLLVKSDVYSYGVVILELLSGRKP 613
G + +D++S G +LE+ +G+ P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG-----REFLAEVEMLSRLHH 464
+F+ +G+G FG+V+ V +V +K++D E + E +L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP--LGWDARLKIALGAARAL 522
+++ +++ +V E NG + L P W ++I LG L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
A+LH S +++HRD KS N+ L+ K+ D G+A+ D + + + ++GT Y++
Sbjct: 115 AHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLS 169
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
PE KSDV++ GVV+ E +G+ P D
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 469
+++G G FG V G L K VA+K LK R +FL E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L G+ + + ++ E + NGS++ L D + + + G A + YL E +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH------ISTRVMGTFGYVAP 583
+HRD + NIL+ + KVSDFGL+R D E+ + I R + AP
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAP 177
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPV-DMT 617
E SDV+S+G+V+ E++S G +P DM+
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-24
Identities = 79/273 (28%), Positives = 132/273 (48%), Gaps = 23/273 (8%)
Query: 416 ILGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
++ G G Y G + +G + VK + V+ +E+ + +L H N+VKLIG+C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLC 752
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
E+ L++E I ++ L L W+ R KIA+G A+AL +LH SP V+
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
+ I+++ P + L + IS+ YVAPE T + K
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 595 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 654
SD+Y +G++++ELL+G+ P D + ++V WAR S L+ IDPS+ DV +
Sbjct: 859 SDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWAR-YCYSDCHLDMWIDPSIRGDVSVN 916
Query: 655 S--VAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ +V +A C + RP +V++ L+
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ +G+G FG V G G KVAVK +K + + FLAE ++++L H NLV+L+G+
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 475 IEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHL 591
+HRD + N+L+ D KVSDFGL + A ST+ G + APE
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKF 176
Query: 592 LVKSDVYSYGVVILELLS-GRKP 613
KSDV+S+G+++ E+ S GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 469
R++G+G FG VY G L D AVK L R+ D + +FL E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L+GIC+ + LV ++P + + E+ + L A+ + YL +
Sbjct: 61 LLGICLPSEGSPLV--VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVMGTFGYVAPEYAM 587
S + +HRD + N +L+ FT KV+DFGLAR D+E S H T ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 588 TGHLLVKSDVYSYGVVILELLS 609
T KSDV+S+GV++ EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 83/262 (31%), Positives = 125/262 (47%), Gaps = 30/262 (11%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476
LG G FG V+ G + TKVAVK LK FL E +++ +L H LV+L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 536
E+ +V E + GS+ L D E L + +A A +AY+ + IHR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126
Query: 537 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 594
D +S+NIL+ K++DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 595 SDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 653
SDV+S+G+++ EL++ GR P PG N RE LE+ ++ P
Sbjct: 184 SDVWSFGILLTELVTKGRVPY-----PGMNN-----------REVLEQ-VERGYRMPCPQ 226
Query: 654 DSVAKVAAIASMCVQPEVQHRP 675
D + + C + + + RP
Sbjct: 227 DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+G G FG VY+ V LD G +AVK ++ D + +E E+++L L H NLVK G+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSSP 531
+ + + E G++E L D + L LAYLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRIL------DEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV---MGTFGYVAPE---Y 585
++HRD K +NI L+H+ K+ DFG A + + + V GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCA-VKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKP 613
+D++S G V+LE+ +G++P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNLV 468
+GEG +G VY G VA LK++ + +E + E+++L +L H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 469 KLIGICIEEQARC--LVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALAY 524
+L I + +V+E + + L G+ D ++++K L Y
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-----DLTGLLDSPEVKFT-ESQIKCYMKQLLEGLQY 115
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH S ++HRD K SNIL+ +D K++DFGLAR S + RV+ T Y PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 585 YAMTGHLLV-------KSDVYSYGVVILELLSGR 611
LL+ + D++S G ++ EL G+
Sbjct: 172 ------LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 417 LGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
LG G +G VY GV VAVK LK D EFL E ++ + H NLV+L+G+C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
E ++ E + G++ +L +++ L +A + A+ YL + + IH
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNA--VVLLYMATQISSAMEYLEKKN---FIH 127
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 595
RD + N L+ + KV+DFGL+R M ++ + APE +KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 596 DVYSYGVVILELLS-GRKP---VDMTQ 618
DV+++GV++ E+ + G P +D++Q
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 71/225 (31%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 407 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-H 463
TG F+ ++GEG +G VY G VA+K++ + D++ E E +L + +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE--EEIKEEYNILRKYSN 61
Query: 464 HRNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 517
H N+ G I++ LV EL GSV + G+ K+ L + I
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
R LAYLHE+ +VIHRD K NILL + K+ DFG+ SA + + +GT
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV--SAQLDSTLGRRNTFIGT 176
Query: 578 FGYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKPV-DM 616
++APE +SDV+S G+ +EL G+ P+ DM
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476
LG G FG+V G VA+K++K EF+ E +++ +L H LV+L G+C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 536
++ +V E + NG + ++L K P L++ +AYL S + IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS---QLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 537 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPEYAMTGHLLV 593
D + N L++ KVSDFGL+R +D+E T +G+ + PE +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 594 KSDVYSYGVVILELLS-GRKPVD 615
KSDV+++GV++ E+ S G+ P +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 5e-23
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH 463
N R LGEG FG V+ D VAVK LK ++F E E+L+ L
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDK----ESAP---LGWDARLKI 514
H ++VK G+C+E +V+E + +G + L HG D E L L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
A A + YL +S +HRD + N L+ + K+ DFG++R + +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
M ++ PE M +SDV+S GVV+ E+ + G++P
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 44/290 (15%)
Query: 415 RILGEGGFGLVYSGVL----DDGTK--VAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNL 467
R LG G FG VY G+ D + VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL-HGVDKESAP--LGWDARLKIALGAARALAY 524
V+LIG+ E R ++ EL+ G ++S L + P L L A A+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 525 LHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
L E+ IHRD + N LL K++DFG+AR R M ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 640
PE + G K+DV+S+GV++ E+ S G P PG+ N +E +E
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-----PGRTN-----------QEVME 232
Query: 641 RI-----IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ +DP G P V I + C Q + RP +++ ++
Sbjct: 233 FVTGGGRLDPPKGCPGP------VYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 474
LG+G G+VY G A+K + + R+ L E++ L +VK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+E +V E + GS L + K+ + IA + L YLH +I
Sbjct: 69 YKEGEISIVLEYMDGGS----LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR--HII 122
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV------MGTFGYVAPEYAMT 588
HRD K SN+L+ K++DFG+ S+ + + +GT Y++PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGI--------SKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 589 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 627
+D++S G+ +LE G+ P PPGQ +
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 415 RILGEGGFGLVYSGVL--DDGT--KVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNL 467
+ILGEG FG V G L DDG+ KVAVK +K +D E FL+E + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 468 VKLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAP--LGWDARLKIALGAA 519
+KLIG+C E + ++ + +G + S L P L LK + A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE---SRHISTRVMG 576
+ YL S+ IHRD + N +L D T V+DFGL++ + I+ +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV- 179
Query: 577 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 636
++A E KSDV+++GV + E+ + T PG EN
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVEN-----------H 222
Query: 637 EGLERIIDPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
E + + GN + P D + ++ + C + + + RP ++ + L
Sbjct: 223 EIYDYLRH---GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 415 RILGEGGFGLVYSG------VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
R LGEG FG V+ D VAVK LK ++F E E+L+ L H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHL--HGVD----------KESAPLGWDARLKIAL 516
K G+C + +V+E + +G + L HG D + LG L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 576
A + YL +S +HRD + N L+ + K+ DFG++R + + M
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 577 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
++ PE M +SDV+S+GV++ E+ + G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 415 RILGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGR---EFLAEVEMLSRLHHRN 466
R LGEG FG V Y D+ G +VAVK LK + GG + E+E+L L+H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHEN 67
Query: 467 LVKLIGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+VK GIC E+ L+ E +P+GS++ +L + + +LK A+ + + Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAP 583
L S + +HRD + N+L+E + K+ DFGL ++ D+E + + + AP
Sbjct: 125 L---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLS 609
E + + SDV+S+GV + ELL+
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 79/207 (38%), Positives = 109/207 (52%), Gaps = 25/207 (12%)
Query: 417 LGEGGFGLVYSGV--LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLI 471
LG+G FG V V D G A+KVLK+ + ++ L E +LSR++H +VKL
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLHED 528
E+ LV E P G + SHL KE AR +I L AL YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVL----ALEYLH-- 110
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM- 587
S +I+RD K NILL+ D K++DFGLA+ E SR +T GT Y+APE +
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFC-GTPEYLAPEVLLG 167
Query: 588 TGHLLVKS-DVYSYGVVILELLSGRKP 613
G+ K+ D +S GV++ E+L+G+ P
Sbjct: 168 KGY--GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 7e-22
Identities = 80/284 (28%), Positives = 137/284 (48%), Gaps = 32/284 (11%)
Query: 415 RILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNL 467
R LG+G FG+VY G D T+VAVK + R EFL E ++ ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDARLK----IALGAARA 521
V+L+G+ + Q +V EL+ +G ++S+L + + E+ P L+ +A A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
+AYL ++ + +HRD + N ++ HDFT K+ DFG+ R + + + + ++
Sbjct: 132 MAYL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641
APE G SD++S+GVV+ E+ S + + P Q L++ + L+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQG---------LSNEQVLKF 233
Query: 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
++D D P + +V + MC Q + RP E+V LK
Sbjct: 234 VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRL-HH 464
+F +I+GEG F V + + A+K+L +++ ++ ++ E E+L+RL H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 465 RNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
++KL +++ V E PNG + ++ R A AL
Sbjct: 62 PGIIKLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTRFYAAE-ILLALE 116
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-------- 575
YLH S +IHRD K NILL+ D K++DFG A+ +D S S +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNIDSQI 172
Query: 576 -----------GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
GT YV+PE SD+++ G +I ++L+G+ P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 8e-22
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIG 472
LGEG +G+VY G VA+K ++ +++ G L E+ +L L H N+VKL+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 473 ICIEEQARCLVYELIPNGSVESHLHG-VDKESAPLGWDARL--KIALGAARALAYLHEDS 529
+ E+ LV+E + L +DK PL L I R LAY H
Sbjct: 66 VIHTERKLYLVFEYC-----DMDLKKYLDKRPGPL--SPNLIKSIMYQLLRGLAYCH--- 115
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S R++HRD K NIL+ D K++DFGLAR+ R + V+ T Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTHEVV-TLWYRAPE----- 168
Query: 590 HLLVKSDVYSYGV-------VILELLSGR 611
+L+ S YS V + E+++G+
Sbjct: 169 -ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-22
Identities = 79/262 (30%), Positives = 125/262 (47%), Gaps = 30/262 (11%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VS 71
Query: 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 536
E+ +V E + GS+ L G + L + +A A +AY+ + +HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 537 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 594
D +++NIL+ + KV+DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 595 SDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 653
SDV+S+G+++ EL + GR P PG N R +L E R+ P
Sbjct: 184 SDVWSFGILLTELTTKGRVPY-----PGMVN-----REVLDQVERGYRMPCPP------- 226
Query: 654 DSVAKVAAIASMCVQPEVQHRP 675
+ + + C + E + RP
Sbjct: 227 ECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 71/241 (29%), Positives = 109/241 (45%), Gaps = 41/241 (17%)
Query: 405 EKATGNFDASRILGEGGFGLVYS----GVL--DDGTKVAVKVLKR-VDQQGGREFLAEVE 457
E N + R +G+G FG V+ G+L + T VAVK+LK +F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 458 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNG------------SVESHLHGVDKESA- 504
+++ H N+VKL+G+C + CL++E + G + S H
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 505 -----PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559
PL +L IA A +AYL E + +HRD + N L+ + K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 560 RS--AMD----EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRK 612
R+ + D E+ I R M PE +SDV++YGVV+ E+ S G +
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231
Query: 613 P 613
P
Sbjct: 232 P 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 416 ILGEGGFGLVY----SGVLDDGTK--VAVKVL-KRVDQQGGREFLAEVEMLSRLHHRNLV 468
LG G FG V+ G+ ++G + V VK L K D+ EF E++M +L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHL----HGVDK-ESAPLGWDARLKIALGAARALA 523
+L+G+C E + ++ E G ++ L +K + PL ++ + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
+L S+ R +HRD + N L+ KVS L++ + E + ++ ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
E KSDV+S+GV++ E+ + G P L+ E L R+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP----------------FYGLSDEEVLNRL 231
Query: 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
L VP +++ + + C + RP E+V AL
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 72/285 (25%), Positives = 137/285 (48%), Gaps = 32/285 (11%)
Query: 414 SRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRN 466
SR LG+G FG+VY G+ + T+VA+K + R EFL E ++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES------APLGWDARLKIALGAAR 520
+V+L+G+ + Q ++ EL+ G ++S+L + E AP +++A A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
+AYL+ + + +HRD + N ++ DFT K+ DFG+ R + + + + +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640
++PE G SDV+S+GVV+ E+ + + + P Q +++ + L
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQG---------MSNEQVLR 232
Query: 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+++ L D P + + + MC Q + RP E++ ++K
Sbjct: 233 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 416 ILGEGGFGLVYSGVLDDGTK----VAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 469
++G G FG V G L K VA+K LK ++Q R+FL+E ++ + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNIIH 69
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L G+ + + ++ E + NG+++S L D + + L+ G A + YL E +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEMN 126
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAPEYA 586
+HRD + NIL+ + KVSDFGL+R D+ S T +G + APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 587 MTGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIID 644
SDV+SYG+V+ E++S G +P DM S + + I+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------------------SNQDVINAIE 225
Query: 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
P D + + C Q + RP G++V L
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 47/223 (21%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+GEG G VY G +VA+K + R+ +Q + E+ ++ H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 476 EEQARCLVYELIPNGS------------VESHLHGVDKESAPLGWDARLKIALGAARALA 523
+V E + GS E + V +E + L
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL---------------QGLE 130
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
YLH S VIHRD KS NILL D + K++DFG A E+S+ S V+GT ++AP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAP 185
Query: 584 E------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 620
E Y K D++S G++ +E+ G P + +PP
Sbjct: 186 EVIKRKDYGP------KVDIWSLGIMCIEMAEGEPPY-LREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ LG G FG V+ G ++ TKVAVK LK + FL E ++ L H LV+L +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+E+ ++ E + GS+ L E + + + A +AY+ + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YI 125
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 592
HRD +++N+L+ K++DFGLAR D E + R F + APE G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFT 182
Query: 593 VKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 624
+KSDV+S+G+++ E+++ G+ P PG N
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPY-----PGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 416 ILGEGGFGLVYSGVLDDGTKVAVK--VLKRVDQQGG----REFLAEVEMLSRLHHRNLVK 469
+LG+G +G VY G+ + G +AVK L + + EV++L L H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+G C+++ + E +P GS+ S L PL K +AYLH +
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR----SAMDEESRHISTRVMGTFGYVAPEY 585
V+HRD K +N++L + K+ DFG AR + ++ + GT ++APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKP 613
KSD++S G + E+ +G+ P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVK---VLKRVDQQGGREFL-------AEVEMLSRLHH 464
++G+G +G VY + + G +AVK + + + +E+E L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
N+V+ +G E+ + E +P GS+ S L + L ++ G LAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAY 123
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH S ++HRD K+ N+L++ D K+SDFG+++ + D + + G+ ++APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 585 YAMTGH--LLVKSDVYSYGVVILELLSGRKP 613
+ K D++S G V+LE+ +GR+P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476
LG+G FG V+ G + TKVA+K LK FL E +++ +L H LV L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAV-VS 71
Query: 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 536
E+ +V E + GS+ L D + L + +A A +AY+ + IHR
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERMN---YIHR 126
Query: 537 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 594
D +++NIL+ + K++DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 595 SDVYSYGVVILELLS-GRKP 613
SDV+S+G+++ EL++ GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
LG G G+V + G +AVK ++ +++ ++ L E+++L + + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKE--SAPLGWDARLKIALGAARALAYLHEDSSPR 532
+ E + GS++ L V LG KIA+ + L YLHE
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK-- 121
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
+IHRD K SNIL+ K+ DFG++ ++ ++ +GT Y+APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYS 177
Query: 593 VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID---PSLGN 649
VKSD++S G+ ++EL +GR P PP P E L+ I++ P L +
Sbjct: 178 VKSDIWSLGLSLIELATGRFPY----PP-------ENDPPDGIFELLQYIVNEPPPRLPS 226
Query: 650 DV 651
Sbjct: 227 GK 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 417 LGEGGFGLVYSGVL-----DDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKL 470
LGE FG +Y G L D VA+K LK ++ Q EF E +++ LHH N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 471 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 515
+G+ +EQ C+++E + G + L G K S G L IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG--DFLHIA 130
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
+ A + YL SS +H+D + NIL+ K+SD GL+R + + + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
++ PE M G SD++S+GVV+ E+ S G +P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 32/278 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 469
+++G G FG V+ G+L + VA+K LK + R +FL+E ++ + H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L G+ + + ++ E + NG+++ +L D E + L+ G A + YL S
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---S 124
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE-ESRHISTRVMGTFGYVAPEYAMT 588
+HRD + NIL+ + KVSDFGL+R D+ E + ++ + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIIDPS 646
SDV+S+G+V+ E++S G +P DM S + + I+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDM------------------SNHEVMKAINDG 226
Query: 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
P D + V + C Q + RP ++V L
Sbjct: 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 417 LGEGGFGLVY----SGVL-----------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLS 460
LGEG FG V+ G+ VAVK+L+ V + +FL E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESA--------PLGWDARL 512
RL + N+++L+G+C+ + C++ E + NG + L + ES + L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
+A+ A + YL +S +HRD + N L+ + +T K++DFG++R+ + I
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
R + ++A E + G SDV+++GV + E+ +
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 40/239 (16%)
Query: 417 LGEGGFGLVYSGVLDDGTK-----------------VAVKVLKRVDQQGGR-EFLAEVEM 458
LGEG FG V+ + + VAVK+L+ + R +FL EV++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAP----------- 505
LSRL N+++L+G+C++E C++ E + NG + L H +D +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 506 --LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563
+ + + L +AL A + YL SS +HRD + N L+ + T K++DFG++R+
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
+ I R + ++A E + G SDV+++GV + E+L + QP G+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 23/282 (8%)
Query: 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLH 463
GNF + +G+G F +VY + L DG VA+K ++ +D + ++ L E+++L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
H N++K + IE +V EL G + + K+ + K + AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
++H S R++HRD K +N+ + K+ D GL R + + S ++GT Y++P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643
E KSD++S G ++ E+ + + P + NL + + +E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCKK-------IEKCD 224
Query: 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P L D ++ + S C+ P+ + RP + V+Q K
Sbjct: 225 YPPLPADH---YSEELRDLVSRCINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 35/283 (12%)
Query: 415 RILGEGGFGLVYSGVLDDGTK----VAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLV 468
+++G G FG V SG L K VA+K LK ++Q R+FL+E ++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNII 68
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
L G+ + + +V E + NGS+++ L D + + L+ G A + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL--- 122
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE-ESRHISTRVMGTFGYVAPEYAM 587
S +HRD + NIL+ + KVSDFGL+R D+ E+ + + + APE
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 588 TGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIIDP 645
SDV+SYG+V+ E++S G +P +M+ + ++ + E R+ P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----------QDVIKAIEEGYRL--P 229
Query: 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL-KLV 687
+ P D A + + C Q + RP ++V L KL+
Sbjct: 230 A-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHH 464
+ +GEG +G+V S G KVA+K + + Q F L E+++L R H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKH 62
Query: 465 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
N++ ++ I I + +V EL+ E+ L+ + K + L D
Sbjct: 63 ENIIGILDI-IRPPSFESFNDVYIVQELM-----ETDLYKLIK-TQHLSNDHIQYFLYQI 115
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS--TRVMG 576
R L Y+H S V+HRD K SN+LL + K+ DFGLAR A D E H T +
Sbjct: 116 LRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA-DPEHDHTGFLTEYVA 171
Query: 577 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 611
T Y APE + K+ D++S G ++ E+LS R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 65/232 (28%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 396 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-LKRVDQQGGREFL 453
A+ +E+ K ++LG G FG V+ G+ + +G + + V +K + + GR+
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 454 AEV--EMLS--RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 509
E+ ML+ L H +V+L+GIC + LV +L P GS+ H+ + L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVR---QHRDSLDPQ 109
Query: 510 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569
L + A+ + YL E R++HR+ + NILL+ D +++DFG+A ++ ++
Sbjct: 110 RLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPP 620
+ ++A E + G +SDV+SYGV + E++S G +P +P
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+G G FG V+SG L D T VAVK + + +FL E +L + H N+V+LIG+C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
++Q +V EL+ G + L E L +++ AA + YL S I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE---SKHCI 116
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 592
HRD + N L+ K+SDFG++R +E+ + ST M + APE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 593 VKSDVYSYGVVILELLS 609
+SDV+S+G+++ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 4e-20
Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 14/208 (6%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKV----AVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLV 468
++LG G FG VY G+ + +G V A+K+L + EF+ E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+G+C+ + LV +L+P+G + ++H + +G L + A+ + YL E
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
R++HRD + N+L++ K++DFGLAR +E + + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKPVD 615
+SDV+SYGV I EL++ G KP D
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGI 473
+GEG +G+VY G VA+K +K + G + L E+++L L+H N++KL+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 474 CIEEQARCLVYELIPNGSVESHL-HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+ LV+E + ++ L + L + LA+ H S
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR----HISTRVMGTFGYVAPE--YA 586
++HRD K N+L+ + K++DFGLARS R ++ TR Y APE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTR-----WYRAPELLLG 172
Query: 587 MTGHLLVKSDVYSYGVVILELLSGR 611
G+ D++S G + ELLS R
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 410 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRL 462
N + LG G FG V D KVAVK+LK RE L +E++++S L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 463 -HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
+H N+V L+G C ++ E G + + L K + L + L + A+
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKG 153
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI---STRVMGTF 578
+A+L +S IHRD + N+LL H K+ DFGLAR M+ +S ++ + R+
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN-DSNYVVKGNARL--PV 207
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
++APE +SDV+SYG+++ E+ S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 71/203 (34%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 417 LGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
LG+G FG V Y + D+ G VAVK L+ + R+F E+E+L L H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 472 GICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
G+C R LV E +P GS+ +L K L L A + + YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAPEYA 586
S R +HRD + NIL+E + K+ DFGL + + ++ + R G F Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTK-VLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 587 MTGHLLVKSDVYSYGVVILELLS 609
V SDV+S+GVV+ EL +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 417 LGEGGFGLVYSGVLDDGTK---VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIG 472
LG G FG V GV K VA+KVLK +++ R E + E E++ +L + +V++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 530
+C E +A LV E+ G + L G K+ + L ++++G + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMG----MKYLEGKN- 115
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMT 588
+HRD + N+LL + K+SDFGL++ A+ + + R G + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKP 613
+SDV+SYG+ + E S G+KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 470
LGEG + +VY + G VA+K +K +++ ++ + E+++L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDS 529
+ + + LV+E + E+ L V K+ + + A +K L R L YLH +
Sbjct: 68 LDVFGHKSNINLVFEFM-----ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
++HRD K +N+L+ D K++DFGLARS +R ++ +V+ T Y APE
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTHQVV-TRWYRAPE----- 172
Query: 590 HLLVKS-------DVYSYGVVILELLSGRKP 613
LL + D++S G + ELL R P
Sbjct: 173 -LLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 415 RILGEGGFGLVYSGVL----DDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLV 468
R+LG+G FG L +D + V K L R+ ++ R+ L E+ +LS L H N++
Sbjct: 6 RVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62
Query: 469 KLIGICIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+++ + E G++ G E + W A++Y+
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYI 117
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H+ ++HRD K+ NI L K+ DFG+++ + E T V+GT Y++PE
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVGTPYYMSPEL 172
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 626
KSD+++ G V+ ELL+ ++ D T P NLV
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 417 LGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 472
LG+GGFG V + V G A K L KR+ ++ G + L E ++L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLHEDS 529
+ CLV L+ G ++ H++ V + P A +I G L +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA-RAIFYAAQIICG----LEHLHQR- 114
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
R+++RD K N+LL+ ++SD GLA + GT GY+APE
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGE 169
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
D ++ G + E+++GR P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 417 LGEGGFGLVY----SGVLDDGTK-------------VAVKVLKRVDQQGGR-EFLAEVEM 458
LGEG FG V+ G+ K VAVK+L+ + R +FL E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR------- 511
+SRL N+++L+ +CI C++ E + NG + L + + A D
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 512 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571
+ +A A + YL SS +HRD + N L+ ++T K++DFG++R+ + I
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 572 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
R + +++ E + G SDV+++GV + E+L+
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ LG G FG+V+ G KVA+K + +F+ E +++ +L H LV+L G+C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+++ +V E + NG + L+ + + L D L + + YL +S I
Sbjct: 69 TQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
HRD + N L+ KVSDFG+ R +D+E S+ + PE K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 595 SDVYSYGVVILELLS-GRKP 613
SDV+S+GV++ E+ + G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 409 GNFDASRILGEGGFGLVYSGVLDDGTK--VAVK-VLKRVDQQGGREFLAEVEMLSRLHHR 465
LGEG G V + T A+K + + ++ L E+E+
Sbjct: 1 EKIVELSRLGEGAGGSV-TKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 466 NLVKLIGICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
+VK G ++E + + E GS++S V K +G KIA + L+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG---- 579
YLH ++IHRD K SNILL K+ DFG+ S + + GTF
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLAGTFTGTSF 168
Query: 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV--DMTQPPG 621
Y+APE + SDV+S G+ +LE+ R P + P G
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 416 ILGEGGFGLVYSGVLD--DGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+G+G FG V V DG + K + + ++ ++ ++EV +L L H N+V+
Sbjct: 7 TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 472 GICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH--E 527
I+ + L V E G + + KE + + +I AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 587
D V+HRD K +NI L+ + K+ DFGLA+ + +S T V GT Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYV-GTPYYMSPEQLN 183
Query: 588 TGHLLVKSDVYSYGVVILELLSGRKP 613
KSD++S G +I EL + P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 28/207 (13%)
Query: 417 LGEGGFGLVYS-GVLDDGTKVAVK--VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+GEG G+V+ + G VA+K L+R++ + L E++ L H +VKL+ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDARLK-IALGAARALAYLHEDSSP 531
LV E +P S L V + E PL +A++K + +AY+H +
Sbjct: 68 FPHGSGFVLVMEYMP-----SDLSEVLRDEERPLP-EAQVKSYMRMLLKGVAYMHAN--- 118
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 591
++HRD K +N+L+ D K++DFGLAR +EE R S +V T Y APE L
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE------L 171
Query: 592 LVKS-------DVYSYGVVILELLSGR 611
L + D+++ G + ELL+G
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 16/221 (7%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL 462
EI + + + + LG G FG V+ + TKVAVK +K FLAE ++ L
Sbjct: 2 EIPRESLKLE--KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 58
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 522
H LVKL + +E ++ E + GS+ L + PL + + A +
Sbjct: 59 QHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGM 115
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GY 580
A++ + + IHRD +++NIL+ K++DFGLAR D E + R F +
Sbjct: 116 AFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKW 169
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQP 619
APE G +KSDV+S+G++++E+++ GR P M+ P
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 417 LGEGGFGLVYSG-VLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+GEG +G+V G VA+K K D+ + L EV++L +L H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+ LV+E + + L ++ L DA +A+AY H S +
Sbjct: 69 FRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNI 121
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 593
IHRD K NIL+ K+ DFG AR A+ T + T Y APE LLV
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPE------LLV 174
Query: 594 KS-------DVYSYGVVILELLSGR 611
DV++ G ++ ELL G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 31/277 (11%)
Query: 415 RILGEGGFGLVYSGV-LDDGTK----VAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
++LG G FG VY G+ + DG VA+KVL+ + +E L E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+GIC+ + LV +L+P G + + V + +G L + A+ ++YL E
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDY---VRENKDRIGSQDLLNWCVQIAKGMSYLEE- 127
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
R++HRD + N+L++ K++DFGLAR +E+ + + ++A E +
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647
+SDV+SYGV + EL++ G KP D AR + E ER+ P +
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----------AREIPDLLEKGERLPQPPI 235
Query: 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
V I C + + RP E+V
Sbjct: 236 -------CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVD---QQGGREFLAEVEMLSRLHHR 465
+F+ R++G+G FG V D K+ A+K + + + R L E +L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALA 523
LV L +E+ LV +L+ G + HL E W + AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI------VLALE 114
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
YLH S +IHRD K NILL+ ++DF +A + ++T GT GY+AP
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAP 168
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
E V D +S GV E L G++P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
LG+G FG VY + G A K+++ ++ +F+ E+++LS H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
E ++ E G+++S + + L + AL +LH +VIH
Sbjct: 73 YENKLWILIEFCDGGALDSI---MLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL--- 592
RD K+ NILL D K++DFG++ + + +GT ++APE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184
Query: 593 --VKSDVYSYGVVILELLSGRKP 613
K+D++S G+ ++EL P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 417 LGEGGFGLVY-----------------SGVLDDGTKVAVKVLKR-VDQQGGREFLAEVEM 458
LGEG FG V+ + D VAVKVL+ +FL EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH-------GVDKESAPLGWDAR 511
LSRL N+ +L+G+C + C++ E + NG + L G+ S L +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 512 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571
L +A A + YL S +HRD + N L+ ++T K++DFG++R+ + +
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 572 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
R ++A E + G KSDV+++GV + E+L+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 71/210 (33%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 415 RILGEGGFGLVYSGVLD--DGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKL 470
R +G G FG+V+S V D DG +VA+K + V Q + E++ML H N++
Sbjct: 6 RPIGYGAFGVVWS-VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 471 IGI-------CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARAL 522
+ I EE +V EL+ +S LH + PL D +K+ L R L
Sbjct: 65 LDILQPPHIDPFEEIY--VVTELM-----QSDLHKIIVSPQPLSSD-HVKVFLYQILRGL 116
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
YLH S ++HRD K N+L+ + K+ DFGLAR +ES+H++ V+ + Y A
Sbjct: 117 KYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRA 172
Query: 583 PEYAM-TGHLLVKSDVYSYGVVILELLSGR 611
PE M + H D++S G + ELL R
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 410 NFDASRILGEGGFGLVYSGV------LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL 462
N + LGEG FG V T VAVK+LK R+ L+E +L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDAR---------- 511
+H +++KL G C ++ L+ E GS+ S L K + LG D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 512 ---------LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562
+ A +R + YL E ++HRD + N+L+ K+SDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
+E+S ++ ++A E +SDV+S+GV++ E+++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 1e-17
Identities = 76/224 (33%), Positives = 108/224 (48%), Gaps = 45/224 (20%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTK--VAVKVLK-------RVDQQGGREFLAEVEMLSR 461
++ + LG+G +G+V+ + D TK VA+K K D Q R F E+ L
Sbjct: 9 YEILQKLGKGAYGIVWKAI-DRRTKEVVALK--KIFDAFRNATDAQ--RTF-REIMFLQE 62
Query: 462 L-HHRNLVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALG 517
L H N+VKL+ + E + LV+E + E+ LH V + A + D + I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIR--ANILEDVHKRYIMYQ 115
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM---DEESRHISTRV 574
+AL Y+H S VIHRD K SNILL D K++DFGLARS + + T
Sbjct: 116 LLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGV------VIL-ELLSGR 611
+ T Y APE +L+ S Y+ GV IL E+L G+
Sbjct: 173 VATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHR 465
++ R++G G FG+V+ D V +K + V+Q E LA E ++L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHP 59
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
N+++ +E++A +V E P G++ ++ + ++ L D L + AL ++
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLALHHV 117
Query: 526 HEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
H + ++HRD K+ NILL+ H K+ DFG+++ S+ + V+GT Y++PE
Sbjct: 118 H---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPE 171
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 620
KSD+++ G V+ EL S ++ + P
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLA---EVEMLSRLH 463
N+ ++LG+G FG VY +D G ++AVK + + +E A E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
H +V+ G +++ + E +P GSV+ L K L K +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVE 118
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFGYVA 582
YLH S ++HRD K +NIL + K+ DFG ++ S + V GT +++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 583 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKP 613
PE ++G K+DV+S G ++E+L+ + P
Sbjct: 176 PE-VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTK----VAVKVLKRVDQ-QGGREFLAEVEMLSRLHH 464
F ++LG G FG VY G+ + +G K VA+K L+ + +E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
++ +L+GIC+ + L+ +L+P G + L V + +G L + A+ + Y
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
L E R++HRD + N+L++ K++DFGLA+ +E + + ++A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVD 615
+ +SDV+SYGV + EL++ G KP D
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG------REFLAEVEMLSRLHHRNL 467
+ LG G F Y + GT +AVK + V E+ +++RL+H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAARALAYL 525
++++G E+ L E + GSV L G KE+ + + +L R L+YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 526 HEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESR--HISTRVMGTFGY 580
HE+ ++IHRD K +N+L++ +++DFG A + + +++GT +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+APE DV+S G VI+E+ + + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 416 ILGEGGFGLVYSG-VLDDGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 470
++GEG FG V + DG ++ A+K +K + R+F E+E+L +L HH N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHG------------VDKESAPLGWDARLKIALGA 518
+G C L E P+G++ L + ++ L L A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
AR + YL S + IHRD + NIL+ ++ K++DFGL+R + ++ + MG
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK-KTMGRL 185
Query: 579 G--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
++A E SDV+SYGV++ E++S
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVL-----KRVDQQGGREFLAEVEMLSRLHHRNLVKL 470
+G G +G+V S + KVA+K + R+D + L E+++L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID---AKRTLREIKLLRHLDHENVIAI 69
Query: 471 IGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
I +VYEL+ ++ LH + + S L D R L Y+
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S V+HRD K SN+LL + K+ DFGLAR+ E T + T Y APE
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDFMTEYVVTRWYRAPE- 178
Query: 586 AMTGHLLVKS-------DVYSYGVVILELLSGRKPV 614
LL+ DV+S G + ELL GRKP+
Sbjct: 179 -----LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 417 LGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVK 469
LGE FG VY G L + VA+K LK + + EF E M SRL H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 470 LIGICIEEQARCLVYELIPNG---------SVESHLHGVDKE---SAPLGWDARLKIALG 517
L+G+ +EQ +++ + S S + D + + L + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
A + +L SS V+H+D + N+L+ K+SD GL R + + +
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 578 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+++PE M G + SD++SYGVV+ E+ S G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 37/214 (17%)
Query: 420 GGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHRNLVKLIGICI 475
G +G V+ G A+KV+K+ D + L E ++LS+ +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 476 EEQARCLVYELIPNGSVESHLHGV---DKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
++ LV E +P G + S L V D++ A R+ IA AL YLH S
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------RIYIAEIVL-ALEYLH---SNG 113
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI--------STRVMGTFGYVAPE 584
+IHRD K NIL++ + K++DFGL S + R I R++GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGL--SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 585 YAMTGHLLVKS-----DVYSYGVVILELLSGRKP 613
+L + D +S G ++ E L G P
Sbjct: 172 V-----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 23/214 (10%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
LG+G FG VY + G A KV++ ++ +++ E+E+L+ +H +VKL+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDSSPRVI 534
+ ++ E P G+V++ + +D+ + +++ I AL YLH S ++I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVICRQMLEALQYLH---SMKII 132
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL-- 592
HRD K+ N+LL D K++DFG+ SA + ++ +GT ++APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 593 ---VKSDVYSYGVVILELLSGRKPVDMTQPPGQE 623
K+D++S G+ ++E+ +PP E
Sbjct: 191 PYDYKADIWSLGITLIEMAQ-------IEPPHHE 217
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGI 473
+G G +VY+ + L + KVA+K + +++ E EV+ +S+ +H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDSS 530
+ LV + GS L + K S P G IA + L YLH S
Sbjct: 68 FVVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYA 586
IHRD K+ NILL D + K++DFG+ SA + + +V +GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGV--SASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 587 MTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPP 620
H K+D++S+G+ +EL +G P PP
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYS-KYPP 212
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 411 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 466
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+V L + A CLV L+ G ++ H++ + + G + AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-----RAVFYAAEICCGLE 116
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+ R+++RD K NILL+ ++SD GLA E + I RV GT GY+APE
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGRV-GTVGYMAPEVV 173
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
D ++ G ++ E+++G+ P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
FD LGEG +G VY + + G VA+KV+ V++ +E + E+ +L + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEE-DLQEIIKEISILKQCDSPYIVK 62
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
G + +V E GSV + +K L + I + L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S + IHRD K+ NILL + K++DFG++ + + +T V+GT ++APE
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
K+D++S G+ +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVK--VLKRVDQQG---GREFLA----EVEMLSRLHHR 465
++G G FG VY G+ G +AVK L V R L E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
N+V+ +G ++ + E +P GSV + L+ L + +I G L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKG----LNYL 122
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-------VMGTF 578
H + +IHRD K +NIL+++ K+SDFG+++ E+ +ST+ + G+
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQGSV 176
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV-DMTQ 618
++APE K+D++S G +++E+L+G+ P D TQ
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 35/292 (11%)
Query: 411 FDASRILGEGGFGLVYSGVL--DDGT--KVAVKVLKR--VDQQGGREFLAEVEMLSRLHH 464
F R+LG+G FG V L +DG+ KVAVK+LK EFL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 465 RNLVKLIGICIEEQAR------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL 516
N++KLIG+ + +A+ ++ + +G + + L + +E L ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 576
A + YL SS IHRD + N +L + T V+DFGL++ +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 577 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 635
++A E SDV+++GV + E+++ G+ P G EN + L
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVEN--SEIYNYLIK 230
Query: 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687
L++ P D + V + C PE + RP + L+L+
Sbjct: 231 GNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 417 LGEGGFGLVYSGV--LDDGTKVAVK-VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
LG G G V S V + GT +A K V ++ L E++++ +V G
Sbjct: 13 LGAGNGGSV-SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+ E C+ E + GS L + K+ P+ + KIA+ L YL+ R+
Sbjct: 72 FLNENNICMCMEFMDCGS----LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RI 125
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 593
+HRD K SNIL+ K+ DFG++ E I+ +GT Y++PE G V
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 594 KSDVYSYGVVILELLSGRKPVDM 616
KSDV+S G+ I+EL G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 416 ILGEGGFGLVYSGVLD-DGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 470
++GEG FG V ++ DG K+ A+K+LK + R+F E+E+L +L HH N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 471 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 515
+G C + E P G++ L HG ++ L L+ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT---ASTLTSQQLLQFA 125
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
A + YL S + IHRD + N+L+ + K++DFGL+R E ++ + M
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVYVK-KTM 177
Query: 576 GTFG--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
G ++A E KSDV+S+GV++ E++S
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKV-LKRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 472
++GEG +G+V + G VA+K L+ D + ++ + E+ ML +L H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 530
+ ++ LV+E + + ++ D E P G D K R + + H S
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAPEYAMTG 589
+IHRD K NIL+ K+ DFG AR+ A E + T + T Y APE
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPE----- 170
Query: 590 HLLVKS-------DVYSYGVVILELLSG 610
LLV D+++ G ++ E+L+G
Sbjct: 171 -LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 417 LGEGGFGLVY------SGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 470
LG+GGFG V +G L K+ K LK+ ++G + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
+ CLV ++ G + H++ VD+E+ L +LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 590
R+I+RD K N+LL++D ++SD GLA D +S+ + GT G++APE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 591 LLVKSDVYSYGVVILELLSGRKP 613
D ++ GV + E+++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 416 ILGEGGFGLVYSGVLD-DGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 470
++GEG FG V + DG ++ A+K +K + R+F E+E+L +L HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 471 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 515
+G C L E P+G++ L + ++ L L A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST---ASTLSSQQLLHFA 118
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
AR + YL + + IHRD + NIL+ ++ K++DFGL+R + ++ + M
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK-KTM 170
Query: 576 GTFG--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
G ++A E SDV+SYGV++ E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 23/280 (8%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK---VLKRVDQQGGREFLAEVEMLSRLHHR 465
NF + +G G F VY L D VA+K + + +D + ++ + E+++L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
N++K + IE+ +V EL G + + K+ + K + A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S RV+HRD K +N+ + K+ D GL R + + S ++GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645
KSD++S G ++ E+ + + P L + + +E+ P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP-----------FYGDKMNLFSLCQKIEQCDYP 226
Query: 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
L + K+ + SMC+ P+ RP +G V Q K
Sbjct: 227 PLPTE---HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 417 LGEGGFGLVYSGVLD--DGTK-VAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLI 471
LG G FG V G+ K VAVK+LK + E L E ++ +L + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 472 GICIEEQARCLVYELIPNGSVESHL----HGVDKESAPLGWDARLKIALGAARALAYLHE 527
GIC E ++ LV EL G + L H +K L ++++G + YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL----VHQVSMG----MKYLEE 113
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 585
+ +HRD + N+LL K+SDFGL++ A+ + + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 586 AMTGHLLVKSDVYSYGVVILELLS-GRKP 613
KSDV+S+GV++ E S G+KP
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 461
E E +LG+G +G+VY+ L ++A+K + D + + E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG-----VDKESAPLGWDARLKIAL 516
L HRN+V+ +G E + E +P GS+ + L D E + + ++
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFG----LARSAMDEESRHIS 571
L YLH++ +++HRD K N+L+ + K+SDFG LA E+
Sbjct: 118 --LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET---- 168
Query: 572 TRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQP 619
GT Y+APE G+ +D++S G I+E+ +G+ P +++ +P
Sbjct: 169 --FTGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 78/225 (34%), Positives = 107/225 (47%), Gaps = 24/225 (10%)
Query: 396 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG---RE 451
A+ FS + EK F R +G G FG VY + VA+K + +Q ++
Sbjct: 5 AELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 452 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 511
+ EV L +L H N ++ G + E LV E GS S + V K+ PL
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSA-SDILEVHKK--PLQEVEI 117
Query: 512 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571
I GA + LAYLH S IHRD K+ NILL T K++DFG A S + + +
Sbjct: 118 AAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSA-SLVSPANSFV- 172
Query: 572 TRVMGTFGYVAPE--YAM-TGHLLVKSDVYSYGVVILELLSGRKP 613
GT ++APE AM G K DV+S G+ +E L+ RKP
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 409 GNFDASRILGEGGFGLVY-SGVLDDGTKVAVK---VLKRVDQQGGREFLAEVEMLSRLHH 464
NF + +G G F VY + L DG VA+K + +D + + + E+++L +L+H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
N++K IE+ +V EL G + + K+ + K + AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
+H S RV+HRD K +N+ + K+ D GL R + + S ++GT Y++PE
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644
KSD++S G ++ E+ + + P + NL + + +E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKK-------IEQCDY 225
Query: 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675
P L +D + + + + +MC+ P+ + RP
Sbjct: 226 PPLPSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+G G +G VY + G VA+KV+K E+ ML H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDSSPR 532
+V E GS++ PL + L+IA + LAYLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ---VTRGPL---SELQIAYVCRETLKGLAYLHET---G 121
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR--VMGTFGYVAPEYA---M 587
IHRD K +NILL D K++DFG++ + + I+ R +GT ++APE A
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSA----QLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 588 TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 620
G K D+++ G+ +EL QPP
Sbjct: 178 KGGYDGKCDIWALGITAIELAEL-------QPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKR------VDQQGGREFLAEVEMLSRLHHRNLVKL 470
+G G FG V G G A V+K D+Q FL EV+ L+H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHG----VDKESAPLGWDARLKIALGAARALAYLH 526
+G CIE LV E P G ++++L V + + D ++A A L +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLH 117
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+ IH D N L D + K+ D+GLA E+ ++APE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 587 MTGH--LLV-----KSDVYSYGVVILEL 607
LL KS+++S GV + EL
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 411 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 466
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+V L + A CLV L+ G ++ H++ + G+D + AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM----GNPGFDEE-RAVFYAAEITCGLE 116
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+ R+++RD K NILL+ ++SD GLA + E+ I RV GT GY+APE
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV 173
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
D + G +I E++ G+ P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVL--------KRVDQQGGREFLAEVEMLS 460
+F+ + LG G FG V K A+K+L K+V+ L E +L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRILQ 56
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 517
+ H LV L G ++ LV E +P G + SHL + P AR ++ L
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP---VARFYAAQVVL- 112
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-- 575
AL YLH +++RD K N+LL+ D K++DFG A + + R
Sbjct: 113 ---ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA--------KRVKGRTYTL 158
Query: 576 -GTFGYVAPEYAM-TGHLLVKS-DVYSYGVVILELLSGRKP 613
GT Y+APE + G+ K+ D ++ G++I E+L+G P
Sbjct: 159 CGTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 416 ILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRNL 467
LGEG FG V ++ + VAVK+LK ++ + ++E+EM+ + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI------------- 514
+ L+G+C +E +V E +G++ L + P G A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 515 ---ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571
A AR + +L +S + IHRD + N+L+ D K++DFGLAR + +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 572 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
T ++APE +SDV+S+GV++ E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 53/219 (24%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--------LAEVEMLSRL-HHRN 466
LG+G FG VY + G VA+K +K+ +F L EV+ L +L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHPN 59
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDARLKIALGAARALAY 524
+VKL + E V+E +E +L+ + D++ P I + LA+
Sbjct: 60 IVKLKEVFRENDELYFVFEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR-----HISTRVMGTFG 579
+H+ HRD K N+L+ K++DFGLAR SR ++STR
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTR-----W 163
Query: 580 YVAPEYAMTGHLLVKSDVYS-------YGVVILELLSGR 611
Y APE +L++S YS G ++ EL + R
Sbjct: 164 YRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 29/221 (13%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 467
FD +GEG +G VY D G VA+K ++ +++ G A E+++L +L+HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 468 VKLIGICIEEQ----------ARCLVYELIPN---GSVESHLHGVDKESAPLGWDARLKI 514
V L I ++Q A LV+E + + G +ES L ++ + +K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK----SFMKQ 124
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
L L Y H+ + +HRD K SNILL + K++DFGLAR EESR + +V
Sbjct: 125 LL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 575 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 614
+ T Y PE + + DV+S G ++ EL + +KP+
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 31/213 (14%)
Query: 415 RILGEGGFGLVY-----SGVLDDGTKVAVKVLK--------RVDQQGGREFLAEVEMLSR 461
++LG+G FG V+ +G D G A+KVLK RV + R+ LAEV
Sbjct: 2 KVLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV----- 55
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
+H +VKL E L+ + + G + + L KE D + +A A A
Sbjct: 56 -NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLA-ELALA 110
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
L +LH S +I+RD K NILL+ + K++DFGL++ ++D E + S GT Y+
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 582 APEYA-MTGHLLVKSDVYSYGVVILELLSGRKP 613
APE GH +D +S+GV++ E+L+G P
Sbjct: 166 APEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 415 RILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL--- 470
R LG G GLV+S V D +VAVK + D Q + L E++++ RL H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 471 -----------IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD-ARLKIALGA 518
+G E + +V E +E+ L V E PL + ARL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEY-----METDLANV-LEQGPLSEEHARL-FMYQL 123
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMG- 576
R L Y+H S V+HRD K +N+ + D K+ DFGLAR +D H G
Sbjct: 124 LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGL 179
Query: 577 -TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 611
T Y +P ++ + K+ D+++ G + E+L+G+
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 411 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 466
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+V L + A CLV ++ G ++ H++ + G++ + AA L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFEEE-RALFYAAEILCGLE 116
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+ ++RD K NILL+ ++SD GLA + ES I RV GT GY+APE
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
+ D + G +I E++ G+ P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVK--VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+GEG +G+V+ + G VA+K V D + L E+ ML +L H NLV LI +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 474 CIEEQARCLVYELIPN---GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
++ LV+E + +E + GV + KI +A+ + H
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-------KKIIWQTLQAVNFCH---K 118
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLAR---SAMDEESRHISTRVMGTFGYVAPEYAM 587
IHRD K NIL+ K+ DFG AR D+ + +++TR Y APE
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE--- 170
Query: 588 TGHLLVKS-------DVYSYGVVILELLSG 610
LLV DV++ G V ELL+G
Sbjct: 171 ---LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 411 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 466
F R+LG+GGFG V + V G A K L KR+ ++ G L E +L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+V L + A CLV ++ G ++ H++ + G+D + I AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFDEQRAI-FYAAELCCGLE 116
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+ R+++RD K NILL+ ++SD GLA E + RV GT GY+APE
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGRV-GTVGYMAPEVI 173
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
D + G +I E++ G+ P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 410 NFDASRILGEGGFGLVYSGV---LDDGTKVAVKVLKRVDQQG--GREFLAEVEMLSRLH- 463
++ + LG+G +G+V S + VA+K + V + + L E+++L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 464 HRNLVKLIGICIEEQARC----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GA 518
H+N+ L + I L EL+ E+ LH + + PL DA + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLT-DAHFQSFIYQI 114
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMG 576
L Y+H S V+HRD K N+L+ D K+ DFGLAR S E+ T +
Sbjct: 115 LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 577 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 614
T Y APE ++ K+ DV+S G ++ ELL GRKPV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 417 LGEGGFGLVYSGVLDDG---TKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
+G G FG V G ++ G +V VK L+ Q +FL E + L H NL++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 530
C E LV E P G ++ +L K + D ++A A L +LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL-MTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA--MT 588
IH D N LL D T K+ D+GL+ + E+ ++ ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 589 GHLLV-----KSDVYSYGVVILELLS-GRKP 613
G+LLV +S+V+S GV I EL G +P
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLHHRN 466
F+ +GEG +G+VY G VA+K ++ +++ G L E+ +L L H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 467 LVKLIGICIEEQARC--LVYELIPNGSVESHLHG-VDKESAPLGWDARLK-IALGAARAL 522
+V+L + + + LV E E L +D P ++++K + L R L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFS-ESQVKCLMLQLLRGL 121
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
YLHE+ +IHRD K SN+LL K++DFGLAR ++ ++ +V+ T Y A
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVV-TLWYRA 176
Query: 583 PE--YAMTGHLLVKSDVYSYGVVILELLSGR 611
PE T + D+++ G ++ ELL+ +
Sbjct: 177 PELLLGCTTYTT-AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 410 NFDASRILGEGGFGLVYS-GVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 466
+F + LG+G +G VY L D A+K L + Q+ + + E+ +L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
++ ++ C+V E P G + + K+ + +I + R L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
E +++HRD KS+NILL + K+ D G+++ ++++ +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
KSD++S G ++ E+ + P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
LG+G FG VY + G A KV+ ++ +++ E+++L+ H N+VKL+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
E ++ E G+V++ + +++ PL + AL YLHE+ ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH----- 590
RD K+ NIL D K++DFG+ SA + + +GT ++APE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 591 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE 623
K+DV+S G+ ++E+ +PP E
Sbjct: 185 YDYKADVWSLGITLIEMAQ-------IEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 28/227 (12%)
Query: 415 RILGEGGFGLVYSGVL---DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLHHRN 466
+ LGEG FG V G L D KVAVK +K R + + +FL+E + H N
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPN 61
Query: 467 LVKLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGA 518
+++LIG+C++ ++ + +G + S L P ++ K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
A + YL SS IHRD + N +L + V+DFGL++ + +
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 624
++A E KSDV+S+GV + E+ + G+ P PG EN
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 410 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRLHHRNL 467
D +GEG G+V + G +VAVK + QQ RE L EV ++ H N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPNI 78
Query: 468 VKLIGICIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAY 524
V++ + +V E + G++ +H +++ A + L +AL++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLAVLKALSF 130
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH + VIHRD KS +ILL D K+SDFG E R S ++GT ++APE
Sbjct: 131 LH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPE 185
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
+ D++S G++++E++ G P +PP Q
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPY-FNEPPLQ 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRN 466
+ +G G +G+V S + G KVA+K + + L E+++L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 467 LVKLIGICIEEQARC----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA-RA 521
++ + I A +V +L+ ES LH + PL + ++ L R
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLT-EEHIRYFLYQLLRG 119
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS--TRVMGTFG 579
L Y+H S VIHRD K SN+L+ D ++ DFG+AR + H T + T
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 580 YVAPE--YAMTGHLLVKSDVYSYGVVILELLSGRKPV 614
Y APE ++ + D++S G + E+L GR+ +
Sbjct: 177 YRAPELLLSLPEYTT-AIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHH---RNLVKL 470
++G G +G VY G + G VA+K++ + EV +LS+L N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHE 527
G ++ ++ E GSV + + ++ P+ A I++ AL Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPI---AEKYISVIIREVLVALKYIHK 119
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 587
VIHRD K++NIL+ + K+ DFG+A +++ S ST V GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 588 TGHLL-VKSDVYSYGVVILELLSGRKP 613
G K+D++S G+ I E+ +G P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--QQGGREFLA---EVEMLSRLHH 464
++ + +GEG FG +Y + + V+K +D + +E A EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIY--LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHL---HGVD-KESAPLGWDARLKIALGAAR 520
N+V E +V E G + + GV E L W ++I+LG
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG--- 113
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
L ++H+ +++HRD KS NI L + K+ DFG+AR D S ++ +GT
Sbjct: 114 -LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPY 167
Query: 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
Y++PE K+D++S G V+ EL + + P +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 417 LGEGGFGLVYSGV---LDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 466
LGEG FG V LD TKVAVK+LK ++ + ++E+EM+ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLH-----GVDKESAP-------LGWDARLKI 514
++ L+G C ++ ++ E G++ +L G++ P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
++APE +SDV+S+GV++ E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 417 LGEGGFGLVYSGVL--------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 466
LGEG FG V D VAVK+LK + + ++E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLH------------GVDKESAPLGWDARLKI 514
++ L+G+C +E ++ E G++ L L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
A AR + YL S R IHRD + N+L+ D K++DFGLAR D + ++
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
++APE +SDV+S+G+++ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 474
+G+G FG VY + VA+KV+ + + E + E++ LS+ + K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
++ ++ E GS L + L I L YLHE+ I
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---GKI 120
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
HRD K++NILL + K++DFG++ S+ +T V GT ++APE K
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR-NTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 595 SDVYSYGVVILELLSGRKP 613
+D++S G+ +EL G P
Sbjct: 179 ADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 417 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+GEG G+V + V G VAVK + QQ EV ++ H N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 476 EEQARCLVYELIPNGS---VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+V E + G+ + +H +++ A + L +AL+ LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------AVCLAVLKALSVLH---AQG 136
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
VIHRD KS +ILL HD K+SDFG E R S ++GT ++APE
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYG 194
Query: 593 VKSDVYSYGVVILELLSGRKPVDMTQPP 620
+ D++S G++++E++ G P +PP
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY-FNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGI 473
+G G +G V + G +VAVK L R Q + E+ +L + H N++ L+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKES----APLGWDARLKIALGAARALAYLHEDS 529
++ E + + +HL G D + L D + R L Y+H
Sbjct: 85 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S +IHRD K SN+ + D K+ DFGLAR DE + +++TR Y APE +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 590 -HLLVKSDVYSYGVVILELLSGR 611
H D++S G ++ ELL+GR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 417 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+GEG G+V + G +VAVK + QQ EV ++ HH N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 476 EEQARCLVYELIPNGS---VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+V E + G+ + +H +++ A + L RAL+YLH
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLSVLRALSYLHNQG--- 138
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
VIHRD KS +ILL D K+SDFG E + S ++GT ++APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYG 196
Query: 593 VKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
+ D++S G++++E++ G P +PP Q
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY-FNEPPLQ 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSR-LHHRNLVKLIG- 472
LG G +G+V + GT +AVK ++ V+ Q + L ++++ R + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 473 --------ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
IC+E L + + G+ LG KIA+ +AL Y
Sbjct: 69 LFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPEDILG-----KIAVSIVKALEY 118
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH S VIHRD K SN+L+ + K+ DFG++ +D ++ T G Y+APE
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---TIDAGCKPYMAPE 173
Query: 585 Y----AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE 623
VKSDV+S G+ ++EL +GR P D + P Q+
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 415 RILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQG--GREFLAEVEMLSRLHHRNLVKLI 471
+G G +G V S G KVA+K L R Q + E+ +L + H N++ L+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 472 GICIEEQARCLVYELIPNGSVE--------SHLHGVD----KESAPLGWDARLKIALGAA 519
+ P S+E +HL G D + L D +
Sbjct: 81 DV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
R L Y+H S +IHRD K SNI + D K+ DFGLAR DE + +++TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 580 YVAPEYAMT-GHLLVKSDVYSYGVVILELLSGR 611
Y APE + H D++S G ++ ELL+G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIG 472
++G+G +G+V S + G KVA+K + V + L E+++L L H ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 473 ICIEEQAR-----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
I + R +V+EL+ ES LH V K + L + RAL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-TRVMGTFGYVAPEYA 586
+ V HRD K NIL D K+ DFGLAR A ++ I T + T Y APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 176
Query: 587 MTGHLLVKS----DVYSYGVVILELLSGR 611
+ G K D++S G + E+L+G+
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+G G FGLV S G VA+K + + + E+++L L H N++ L I
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 474 CIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
I V EL+ + LH + S PL R L Y+H S
Sbjct: 78 FISPLEDIYFVTELL-----GTDLHRL-LTSRPLEKQFIQYFLYQILRGLKYVH---SAG 128
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
V+HRD K SNIL+ + K+ DFGLAR + + ++STR Y APE +T
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKY 183
Query: 593 -VKSDVYSYGVVILELLSGRKPV 614
V+ D++S G + E+L G KP+
Sbjct: 184 DVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 417 LGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 472
LG+GGFG V + V + G A K L KR+ ++ G + L E E+L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+ CLV L+ G ++ H++ V + G + I A LH S
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGER----GLEMERVIHYSAQITCGILHLHSM-D 115
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
+++RD K N+LL+ ++SD GLA D ++ T+ GT GY+APE
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYS 172
Query: 593 VKSDVYSYGVVILELLSGRKP 613
D ++ G I E+++GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 415 RILGEGGFGLVYSGVLDDGTK----VAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 468
RILG G FG + G L +K VA+ L+ D+Q R FLAE L + H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIV 69
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L G+ +V E + NG+++S L K L + + G A + YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFG-LARSAMDEESRHISTRVMGTFGYVAPEYAM 587
+H+ + +L+ D K+S F L E+ + + + APE
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS--EAIYTTMSGKSPVLWAAPEAIQ 181
Query: 588 TGHLLVKSDVYSYGVVILELLS-GRKPV-DMT 617
H SDV+S+G+V+ E++S G +P DM+
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 50/287 (17%)
Query: 417 LGEGGFGLVYSGVL-------DDGTKVAVKVLKRVDQQGGREFLAEVE---MLSRLHHRN 466
LG+G F +Y GVL G V V+ +V R+ LA E ++S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
LVKL G+C+ +V E + G ++ LH +K + L W +L +A A AL YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 527 EDSSPRVIHRDFKSSNILL-----EHDFTP--KVSDFGLARSAMDEESRHISTRVMGTFG 579
+ +++H + NIL+ + P K+SD G+ + + E R +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIP 169
Query: 580 YVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637
++APE G L + +D +S+G +LE+ S G+E L L+S E
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN----------GEEPLST-----LSSSE 214
Query: 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684
D + +P A++A + + C + RP +++ L
Sbjct: 215 KERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 417 LGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
LG GGFG V V A+K +K+ V+ +E E+L +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+++ ++ E G + + L + AR IA A YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLHNRG--- 113
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHL 591
+I+RD K N+LL+ + K+ DFG A+ +S + GT YVAPE + G+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 592 LVKSDVYSYGVVILELLSGRKP 613
D +S G+++ ELL+GR P
Sbjct: 171 FS-VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 69/225 (30%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHR 465
T ++ +G+G +G VY DG+ AVK+L + E AE +L L +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 466 NLVKLIGI------CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 519
N+VK G+ + Q LV EL GSV + G+ L I GA
Sbjct: 80 NVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
L +LH + R+IHRD K +NILL + K+ DFG+ SA +R +GT
Sbjct: 139 LGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTSTRLRRNTSVGTPF 193
Query: 580 YVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQP 619
++APE + DV+S G+ +EL G P+ P
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+G+G G VY+ + + G +VA+K + Q + E+ ++ H N+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVIH 138
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 595
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 596 DVYSYGVVILELLSGRKP 613
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 451 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 510
+ + E+++L + +V G + + E + GS++ L KE+ + +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEI 104
Query: 511 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570
K+++ R LAYL E +++HRD K SNIL+ K+ DFG++ +D +
Sbjct: 105 LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 158
Query: 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA-WA 629
+ +GT Y++PE H V+SD++S G+ ++EL GR P+ PP + L A +
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI---PPPDAKELEAIFG 215
Query: 630 RPLLTSREGLERIIDP 645
RP++ EG I P
Sbjct: 216 RPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 46/219 (21%)
Query: 417 LGEGGFGLVYSG-VLDDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHH-RNLVKLIG- 472
+G G G VY G +AVK ++R ++ + L +++++ + H +VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 473 --------ICIEEQARCL------VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
IC+E + CL + IP LG K+ +
Sbjct: 83 FITDSDVFICMELMSTCLDKLLKRIQGPIP--------------EDILG-----KMTVAI 123
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
+AL YL E VIHRD K SNILL+ K+ DFG++ +D +++ TR G
Sbjct: 124 VKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCA 178
Query: 579 GYVAPEY----AMTGHLLVKSDVYSYGVVILELLSGRKP 613
Y+APE +++DV+S G+ ++EL +G+ P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRL---HHRN 466
+GEG +G VY L+ G VA LK+V E L E+ +L +L H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVA---LKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 467 LVKLIGIC-IEEQARC----LVYELIPNGSVESHLHG-VDKESAP-LGWDARLKIALGAA 519
+V+L+ +C R LV+E V+ L + K P L + +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
R + +LH S R++HRD K NIL+ D K++DFGLAR E + T V+ T
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLW 171
Query: 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
Y APE + D++S G + EL R+P
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLHHRNLVKL 470
LGEG FG VY + G VA LK++ ++ F L E+++L +L H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 471 IGICIEE-----QARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALA 523
I + +E + R VY + P ++ L G+ + S L ++++K L +
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENPSVKLT-ESQIKCYMLQLLEGIN 129
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE---------ESRHISTRV 574
YLHE+ ++HRD K++NIL+++ K++DFGLAR T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 575 MGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGR 611
+ T Y PE + T + D++ G V E+ + R
Sbjct: 187 VVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 41/274 (14%)
Query: 417 LGEGGFGLVYSGVLDD-GTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHH-RNLVKLIGI 473
+G G FG V + GT +AVK ++ VD++ + L +++++ R +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 474 CIEEQARCLVYELIPNGSVES---HLHGVDKESAP---LGWDARLKIALGAARALAYLHE 527
E + EL+ + S++ +++ V K P LG KIA+ +AL YL E
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 587
+ ++IHRD K SNILL+ + K+ DFG++ +D ++ TR G Y+APE
Sbjct: 126 EL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERID 180
Query: 588 TGHLL---VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644
V+SDV+S G+ + E+ +G+ P W + L +++
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWNSVF----DQLTQVVK 225
Query: 645 ---PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675
P L N + ++C+ + RP
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 72/261 (27%), Positives = 111/261 (42%), Gaps = 32/261 (12%)
Query: 402 SEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 460
S + G F+ ++G G +G VY G + G A+KV+ V + E E+ ML
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLK 67
Query: 461 RL-HHRNLVKLIGICIE------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK 513
+ HHRN+ G I+ + LV E GSV + + W A
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-- 125
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573
I R LA+LH + +VIHRD K N+LL + K+ DFG+ SA + +
Sbjct: 126 ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNT 180
Query: 574 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVILELLSGRKPV-DM----------T 617
+GT ++APE +SD++S G+ +E+ G P+ DM
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 618 QPPGQENLVAWARPLLTSREG 638
PP + W++ + EG
Sbjct: 241 NPPPKLKSKKWSKKFIDFIEG 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 417 LGEGGFGLVYS----GVLDDGTK----VAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 466
LGEG FG V G+ D K VAVK+LK ++ + ++E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA----------- 515
++ L+G C ++ ++ E G++ +L + P G + IA
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 516 -----LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570
AR + YL +S + IHRD + N+L+ + K++DFGLAR + +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
+T ++APE +SDV+S+GV++ E+ +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 416 ILGEGGFGLVYSG-VLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
ILG G G VY L +AVKV+ + + ++ ++E+E+L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
E + E + GS++ ++ E LG +IA+ + L YL S ++
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLW---SLKI 116
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 593
+HRD K SN+L+ K+ DFG++ ++ I+ +GT Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGI 172
Query: 594 KSDVYSYGVVILELLSGRKP 613
SDV+S G+ +EL GR P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 73/237 (30%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRLHH 464
F R +G G FG VY D V +K++ G + + + EV+ L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
N ++ G + E LV E + S L V K+ PL I GA + LAY
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEIAAITHGALQGLAY 140
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH S +IHRD K+ NILL K++DFG A A S +GT ++APE
Sbjct: 141 LH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
Query: 585 YAMT---GHLLVKSDVYSYGVVILELLSGRKPV-DMTQPPGQENLVAWARPLLTSRE 637
+ G K DV+S G+ +EL + P+ +M ++ P L S E
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 68/279 (24%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRV------DQQGGRE-------FLAEVEML-SRL 462
LG G FG VY V + LK + + RE ++EV ++ +L
Sbjct: 8 LGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 522
H N+V+ +E +V +LI + H + + ++ + I + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
YLH++ R++HRD +NI+L D ++DFGLA+ E T V+GT Y
Sbjct: 127 RYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-GQENLVAWARPLLTSREGLER 641
PE K+DV+++G ++ ++ QPP N+++ A + +E
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC-------TLQPPFYSTNMLSLATKI------VEA 228
Query: 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 680
+ +P L + + V + + C+ P+ + RP + +V
Sbjct: 229 VYEP-LPEGMYSE---DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 70/238 (29%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRVDQQGGREF 452
S KT + ++ +G+G +G V+ VL+ +G+K AVK+L + E
Sbjct: 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEI 61
Query: 453 LAEVEMLSRLH-HRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPL 506
AE +L L H N+VK G+ ++ + LV EL GSV + G K +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 507 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566
I A L +LH + + IHRD K +NILL + K+ DFG+ SA
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTS 176
Query: 567 SRHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQP 619
+R +GT ++APE L + DV+S G+ +EL G P+ P
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 78/270 (28%), Positives = 115/270 (42%), Gaps = 28/270 (10%)
Query: 396 AKTFSASEIEKATGNFDASRILGEGGFGLVY-SGVLDDGTKVAVKVLKRVDQQGG---RE 451
A+ F + EK F R +G G FG VY + + + VA+K + +Q ++
Sbjct: 5 AELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 452 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 511
+ EV L +L H N ++ G + E LV E + S L V K+ PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEI 117
Query: 512 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571
+ GA + LAYLH S +IHRD K+ NILL K+ DFG A
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX---- 170
Query: 572 TRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPV-DMTQPPGQENLVA 627
+GT ++APE + G K DV+S G+ +EL + P+ +M ++
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 628 WARPLLTSR---EGLERIIDPSLGNDVPFD 654
P L S E +D L +P D
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCL-QKIPQD 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 417 LGEGGFGLVYSGVLDDGTK-VAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLIG 472
+G G FG VY + VAVK + +Q ++ + EV+ L +L H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
++E LV E + S L V K+ PL I GA + LAYLH S
Sbjct: 89 CYLKEHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHN 141
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT---G 589
+IHRD K+ NILL K++DFG A + S +GT ++APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
K DV+S G+ +E L+ RKP
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 417 LGEGGFGLVYS----GVLDD----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 466
LGEG FG V G+ D VAVK+LK + + ++E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA------------RLKI 514
++ L+G C ++ ++ E G++ +L +D +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + + +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
++APE +SDV+S+GV++ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 84/332 (25%), Positives = 143/332 (43%), Gaps = 57/332 (17%)
Query: 353 EEVPQSLQTSHVKPSGAAG--LMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATG- 409
E++ + +H G +G M LD S ++ A + ++I ++
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERS-HNNNAGEDEDEEKMIDNDINRSPNK 66
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
++ I+G G FG+VY + +D KVA+K + + Q RE L ++ L+H N++
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINII 122
Query: 469 KLIGICIEEQAR--------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGA 518
L E + +V E IP +V ++ + + + PL L
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL-- 179
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAM--DEESRHISTRVM 575
RALAY+H S + HRD K N+L++ + T K+ DFG A++ + +I +R
Sbjct: 180 CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 576 GTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILE------LLSGRKPVDMTQPPGQEN 624
Y APE + T H+ D++S G +I E + SG+ VD
Sbjct: 236 ----YRAPELMLGATNYTTHI----DLWSLGCIIAEMILGYPIFSGQSSVD--------Q 279
Query: 625 LVAWARPLLTSREGLERIIDPSLGNDVPFDSV 656
LV + L T E + ++P+ D+ F V
Sbjct: 280 LVRIIQVLGTPTEDQLKEMNPNYA-DIKFPDV 310
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 417 LGEGGFGLVYSG----VLDDG----TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
LG+G F ++ G V D G T+V +KVL + + F M+S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
G+C+ +V E + GS++++L +K + W +L++A A AL +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 529 SSPRVIHRDFKSSNILL--EHDF---TP---KVSDFGLARSAMDEESRHISTRVMGTFGY 580
+ H + + N+LL E D P K+SD G++ + + +E + R+ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERI----PW 170
Query: 581 VAPE-YAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQP 619
V PE +L + +D +S+G + E+ SG KP+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRN 466
G F+ ++G G +G VY G + G A+KV+ V E E+ ML + HHRN
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRN 64
Query: 467 LVKLIGICIE------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
+ G I+ + LV E GSV + + W A I R
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
L++LH+ +VIHRD K N+LL + K+ DFG+ SA + + +GT +
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYW 177
Query: 581 VAPEYAMTGH-----LLVKSDVYSYGVVILELLSGRKPVDMTQP 619
+APE KSD++S G+ +E+ G P+ P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 57/226 (25%)
Query: 418 GEGGFGLVYSGVL---DDGTKVAVKVLK-RVDQQGGREFLA--EVEMLSRLHHRNLVKLI 471
G G +G VY DG + A+K K +Q G A E+ +L L H N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 472 GICIEEQARC--LVYE-------------------LIPNGSVESHLHGVDKESAPLGWDA 510
+ +E + L+++ IP V+S L
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW------------- 115
Query: 511 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEE 566
+I G + YLH + V+HRD K +NIL+ + K+ D GLAR +
Sbjct: 116 --QILNG----VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAP 165
Query: 567 SRHIST--RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLS 609
+ ++ V+ T Y APE + K+ D+++ G + ELL+
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 417 LGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGI 473
+G+G FG V+ G+ D+ T+ VA+K++ + + E + E+ +LS+ + K G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+++ ++ E + GS L E PL I + L YLH S +
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLH---SEKK 122
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 593
IHRD K++N+LL K++DFG+A D + + +GT ++APE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDS 180
Query: 594 KSDVYSYGVVILELLSGRKPVDMTQP 619
K+D++S G+ +EL G P P
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 417 LGEGGFGLVYSGVLDDGTKV--AVKVLKRV---DQQGGREFLAEVE--MLSRLHHRNLVK 469
LG+G FG VY V D +KVLK + + A E +LS+L H +VK
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 470 LIGICIEEQARCLVYELIP----NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+E A C++ E + +E H S + +++ LG + Y+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG----VHYM 122
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H+ R++HRD K+ NI L+++ K+ DFG++R M S ++T GT Y++PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SCDLATTFTGTPYYMSPEA 176
Query: 586 AMTGHLLVKSDVYSYGVVILEL 607
KSD++S G ++ E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 417 LGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGI 473
+G+G FG VY G+ D+ TK VA+K++ + + E + E+ +LS+ + + G
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
++ ++ E + GS L + PL I + L YLH S R
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLH---SERK 122
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 593
IHRD K++N+LL K++DFG+A D + + +GT ++APE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDF 180
Query: 594 KSDVYSYGVVILELLSGRKPVDMTQP 619
K+D++S G+ +EL G P P
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 420 GGFGLVY-SGVLDDGTKVAVKVLKRVDQQGGRE---FLAE-VEMLSRLHHRNLVKLIGIC 474
G FG VY + G A+KVLK+ D + AE M+ + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+ LV E + G S + K L D + + LH+ +I
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
HRD K N+L++ K++DFGL+R+ + + + +GT Y+APE +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGL------ENKKFVGTPDYLAPETILGVGDDKM 173
Query: 595 SDVYSYGVVILELLSGRKPVDMTQP 619
SD +S G VI E L G P P
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 416 ILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLI 471
I+G GGFG VY D G A+K L KR+ + G L E MLS + + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 472 GICIEEQAR---CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLH 526
+ + +L+ G + HL HGV E+ + A +I LG L ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA--EIILG----LEHMH 114
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
V++RD K +NILL+ ++SD GLA ++ H S +GT GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 587 MTGHLLVKS-DVYSYGVVILELLSGRKP 613
G S D +S G ++ +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 415 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR--VDQQGGRE-FLAEVEMLSRLHHRNLVKL 470
R+LG+G FG V + + + G AVKVLK+ + Q E + E +LS + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 471 IGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+ C + R V E + G + H+ + AR A AL +LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAA-EITSALMFLHDKG 116
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
+I+RD K N+LL+H+ K++DFG+ + + ++ GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEM 171
Query: 590 HLLVKSDVYSYGVVILELLSGRKPVD 615
D ++ GV++ E+L G P +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
KI++ R L YL E ++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA-WARP 631
+GT Y++PE H V+SD++S G+ ++E+ GR P+ PP + L A + RP
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI---PPPDAKELEAMFGRP 213
Query: 632 LLTSREGLERIIDPSLGNDVP 652
+ D P
Sbjct: 214 VSEGEAKESHRPVSGHPPDSP 234
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
+GEG +G+VY G VA+K ++ + G A E+ +L L+H N+V+L+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARL--KIALGAARALAYLHEDSS 530
E LV+E + + ++ ++ +S+P G D L + +AY H S
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAYCH---S 117
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG- 589
RV+HRD K N+L++ + K++DFGLAR A R + V+ T Y APE +
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
D++S G + E+++ R+P
Sbjct: 176 QYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRV----DQQGGREF-LAEVEMLSRLHHRNLVKL 470
+GEG +G V+ + VA LKRV D +G L E+ +L L H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVA---LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 471 IGICIEEQARCLVYELIP----------NGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
+ ++ LV+E NG ++ + + +
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-------------VKS-FMFQLLK 110
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
LA+ H S V+HRD K N+L+ + K++DFGLAR A R S V+ T Y
Sbjct: 111 GLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWY 165
Query: 581 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 614
P+ L S D++S G + EL + +P+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 466
NF +GEG +G+VY G VA+K ++ + G A E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYL 525
+VKL+ + E LV+E + + ++ + PL +K L + LA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL---PLIKSYLFQLLQGLAFC 116
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S RV+HRD K N+L+ + K++DFGLAR A R + V+ T Y APE
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEI 171
Query: 586 AM-TGHLLVKSDVYSYGVVILELLSGR 611
+ + D++S G + E+++ R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-12
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 431 DDGTKVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLI--GICIEEQARCLVYE 485
G +VA+K+L+ + + F E + +RL+H N+V L+ G V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545
+P ++ L L ++ L ALA H ++HRD K NI++
Sbjct: 60 YVPGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112
Query: 546 -EHDFTP--KVSDFGLAR-----SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDV 597
+ P KV DFG+ D + +T V+GT Y APE + SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 598 YSYGVVILELLSGRKPV 614
Y++G++ LE L+G++ V
Sbjct: 173 YAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 7e-12
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 12/228 (5%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+G+G G VY+ + + G +VA++ + Q + E+ ++ + N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVIH 139
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 595
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 596 DVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-ARPLLTSREGLERI 642
D++S G++ +E++ G P P L+A P L + E L I
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 414 SRILGEGGFGLVYSGVLDDGT-----KVAVKVLKRVDQQGGRE-----FLAEVEMLSRLH 463
S +L EG FG ++ G+L D +V VK +K E L E +L L
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLS 66
Query: 464 HRNLVKLIGICIEEQARCLVYELIPN-GSVESHL----HGVDKESAPLGWDARLKIALGA 518
H+N++ ++ +CIE+ V N G+++ L G L + +A+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM--------DEESRHI 570
A ++YLH VIH+D + N +++ + K++D L+R D E+R +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
++A E + SDV+S+GV++ EL++
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 38/212 (17%)
Query: 417 LGEGGFGLVYSGVLDDGT--KVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIG 472
+G G +G V S D KVAVK L R Q R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 473 ICIEEQARCLVYELIPNGSVE--------SHLHGVDKES----APLGWDARLKIALGAAR 520
+ P S+E ++L G D + L + + R
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
L Y+H S +IHRD K SN+ + D ++ DFGLAR A DE + +++TR Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 581 VAPEYAMTG-HLLVKSDVYSYGVVILELLSGR 611
APE + H D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
+GEG +G+VY G G VA+K ++ ++ G A E+ +L L H N+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED----- 528
++E L++E + + ++ +L +S P G + A +YL++
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYL-----DSLPKGQ------YMDAELVKSYLYQILQGIL 115
Query: 529 --SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVA 582
S RV+HRD K N+L+++ K++DFGLAR+ I RV + T Y A
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------GIPVRVYTHEVVTLWYRA 169
Query: 583 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKPV 614
PE + D++S G + E+ + +KP+
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 9e-12
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+G+G G VY+ + + G +VA+K + Q + E+ ++ + N+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLH---SNQVIH 138
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 595
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 596 DVYSYGVVILELLSGRKP 613
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 69/219 (31%), Positives = 101/219 (46%), Gaps = 45/219 (20%)
Query: 416 ILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
I+G GGFG VY D G A+K L KR+ + G E LA L+ R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA-------LNERIMLSLVS 52
Query: 473 -------ICIE-----EQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIA 515
+C+ C + +L+ G + HL HGV E + R +I
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK-----EMRFYATEII 107
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
LG L ++H V++RD K +NILL+ ++SD GLA ++ H S +
Sbjct: 108 LG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---V 156
Query: 576 GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
GT GY+APE G S D +S G ++ +LL G P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 44/194 (22%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLHHRNLVK 469
+G+G FG V+ VA LK+V + +E F L E+++L L H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 470 LIGICIEE---QARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
LI IC + R LV+E + + A L + +K L +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEF------------CEHDLAGLLSNKNVKFTLSEIKK 123
Query: 522 --------LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRH-I 570
L Y+H +++HRD K++NIL+ D K++DFGLAR S +
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 571 STRVMGTFGYVAPE 584
+ RV+ T Y PE
Sbjct: 181 TNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+G+G G V++ + + G +VA+K + Q + E+ ++ L + N+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
+V E + GS+ + + A + R +AL +LH + +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQALEFLHAN---QVIH 138
Query: 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 595
RD KS N+LL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 596 DVYSYGVVILELLSGRKP 613
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHR 465
+F+ +LG+G FG V ++ A+K+LK+ V Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 466 NLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+ + C + R V E + G + H+ V K P +I++G L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVAP 583
LH +I+RD K N++L+ + K++DFG+ + M + ++TR GT Y+AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAP 170
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
E D ++YGV++ E+L+G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLH---HRNLVKL 470
+G G +G VY G VA+K ++ + G + EV +L RL H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 471 IGICI-----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+ +C E LV+E + + + ++L V P + + R L +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-TRVMGTFGYVAPE 584
H + ++HRD K NIL+ K++DFGLAR S ++ T V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPE 177
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPV 614
+ D++S G + E+ RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 410 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREF-LAEVEMLSR 461
NF+ R+LG G +G V+ G D G A+KVLK+ V + E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 462 LHHRN-LVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGA 518
+ LV L + L+ + + G + +HL+ + ES R+ IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE-----VRVYIA-EI 114
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGT 577
AL +LH+ +I+RD K NILL+ + ++DFGL++ +EE R S GT
Sbjct: 115 VLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGT 169
Query: 578 FGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKP 613
Y+APE GH D +S GV+ ELL+G P
Sbjct: 170 IEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 417 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
+GEG G+V + G +VAVK++ QQ EV ++ H+N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535
+ ++ E + G++ + L + + +AL YLH S VIH
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 536 RDFKSSNILLEHDFTPKVSDFGL-ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 594
RD KS +ILL D K+SDFG A+ + D R ++GT ++APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGTE 197
Query: 595 SDVYSYGVVILELLSGRKP 613
D++S G++++E++ G P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLK-----RVDQQGGREFLAEVEMLSRL 462
+ + + +G G FG V+ V D ++ A+KV+ R+ Q+ + E +L +
Sbjct: 2 DLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQE--QHVHNEKRVLKEV 58
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 522
H +++L +++ ++ E +P G + S+L + S G L A AL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEIVCAL 114
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
YLH S +++RD K NILL+ + K++DFG A+ D + + GT Y+A
Sbjct: 115 EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLA 166
Query: 583 PE-YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG 621
PE GH D ++ G++I E+L G P P G
Sbjct: 167 PEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLA---EVEMLSRLH 463
N+ ++LG+G FG VY D G ++AVK ++ + + +E A E+++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 464 HRNLVKLIGICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
H +V+ G + R L E +P GS++ L K L + K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST--------- 572
++YLH S ++HRD K +NIL + K+ DFG S+ + T
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFG--------ASKRLQTICLSGTGMK 167
Query: 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
V GT +++PE K+D++S G ++E+L+ + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE--------------FLAEVEMLSR 461
LGEG +G V G VA+K +K ++ L E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAAR 520
+ H N++ L+ + +E LV +++ S L V L ++++K I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLT-ESQVKCILLQILN 130
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-----AMDEESRHI---ST 572
L LH+ +HRD +NI + K++DFGLAR D S+
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 573 RVMG----TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
M T Y APE M + D++S G + ELL+G KP
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP 232
|
Length = 335 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 419 EGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHHRNLVKLIGI 473
EG +G+VY G VA+K LK ++ G F L E+ +L +L H N+V + +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FPITSLREINILLKLQHPNIVTVKEV 72
Query: 474 CIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDSS 530
+ +V E VE L + + + +K + L +A+LH++
Sbjct: 73 VVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 590
++HRD K+SN+LL + K+ DFGLAR T+++ T Y APE
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPE------ 176
Query: 591 LLV-------KSDVYSYGVVILELLSGRKPV 614
LL+ D++S G + ELL+ +KP+
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 4/115 (3%)
Query: 500 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559
++S PL D L+ + A+ + +L +S IHRD + N+LL K+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
R M++ + + ++APE V+SDV+SYG+++ E+ S G+ P
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 415 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGREF-LAEVEMLSRL-HHRNLVK 469
++LG+G FG V L ++ AVKVLK+ + Q E + E +L+ H L +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 470 LIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
L C + + R V E + G + H+ + P +I LG L +LHE
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHER 115
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
+I+RD K N+LL+ + K++DFG+ + + ++ GT Y+APE ++
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE-ILS 169
Query: 589 GHLLVKS-DVYSYGVVILELLSGRKPVD 615
+ D ++ GV++ E+L+G+ P +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKR----VDQQGGREFLAEVEMLSR------LH 463
++LG+G FG V+ L A+K LK+ +D E M+ +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD------VECTMVEKRVLSLAWE 54
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
H L L ++ V E + G + H+ K P +I G L
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQ 110
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
+LH S +++RD K NILL+ D K++DFG+ + M +++ + GT Y+AP
Sbjct: 111 FLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAP 165
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
E + D +S+GV++ E+L G+ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-11
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLA---EVEMLSRLH 463
N+ ++LG+G FG VY +D G ++A K ++ + +E A E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 464 HRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
H +V+ G C+ ++A + E +P GSV+ L K L K
Sbjct: 63 HERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILE 117
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFG 579
++YLH S ++HRD K +NIL + K+ DFG ++ R V GT
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+++PE K+DV+S G ++E+L+ + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 416 ILGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLAEVEML----------SRLHH 464
+LG G FG V ++ A+K LK+ D R+ EVE L + H
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RD---EVESLMCEKRIFETANSERH 61
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
LV L C + + C V E G + H+H D S P + LG L
Sbjct: 62 PFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLG----LQ 115
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
YLHE+ ++++RD K N+LL+ + K++DFGL + M R ST GT ++AP
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST-FCGTPEFLAP 170
Query: 584 EYAMTGHLLVKS-----DVYSYGVVILELLSGRKP 613
E L S D + GV+I E+L G P
Sbjct: 171 EV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 43/212 (20%)
Query: 417 LGEGGFGLVYSG-VLDDGTKVAVKVLKR----VDQQGGREFLAEVEMLSRL-HHRNLVKL 470
+GEG F V G A+K +K+ ++Q L E++ L RL H N+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63
Query: 471 IGICIEEQARCL----------VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
I + + + L +YELI PL +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG-----RKR-------PLPEKRVKSYMYQLLK 111
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVMGTF 578
+L ++H + + HRD K NIL+ D K++DFG R + + +ISTR
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTEYISTR----- 162
Query: 579 GYVAPEYAMT-GHLLVKSDVYSYGVVILELLS 609
Y APE +T G+ K D+++ G V E+LS
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLK-RVDQQG-GREFLA--EVEMLSRLHHRNLVKLIG 472
+GEG +G+VY D T + + K R++Q+ G A E+ +L + H N+V+L
Sbjct: 10 IGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARL-KIAL-GAARALAYLHEDS 529
+ E+ LV+E + + ++ H+ +S+P + RL K L R +AY H
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-----DSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 530 SPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM- 587
S RV+HRD K N+L++ K++DFGLAR A R + V+ T Y APE +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 588 TGHLLVKSDVYSYGVVILELLSGR 611
+ H D++S G + E+++ +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 440 VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV 499
V+ ++ Q+G L E +L ++H +++++ + C+V +P+ S + + + +
Sbjct: 94 VVLKIGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-L 147
Query: 500 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559
K S PL D L I L YLH R+IHRD K+ NI + + D G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 619
+ + + + GT APE K+D++S G+V+ E+L+ + P
Sbjct: 205 QFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
Query: 620 PGQENLVAWARPLLTSREGLERII 643
E + + L +II
Sbjct: 262 STPEE------YVKSCHSHLLKII 279
|
Length = 357 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
LGEG + VY G +G VA+KV+ R+ ++ G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
++ LV+E + + +DK L + R L+Y+H+ +
Sbjct: 72 IHTKETLTLVFEYVHTDLCQY----MDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLL 592
+HRD K N+L+ K++DFGLAR+ H + + T Y P+ + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 593 VKSDVYSYGVVILELLSG 610
D++ G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 17/248 (6%)
Query: 417 LGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGI 473
+G+G FG V+ G+ D+ T+ VA+K++ + + E + E+ +LS+ + K G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
++ ++ E + GS L + + LK L + L YLH S +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLH---SEKK 122
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 593
IHRD K++N+LL K++DFG+A D + + +GT ++APE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDS 180
Query: 594 KSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWARPLLTSR--EGLERIIDPSLGND 650
K+D++S G+ +EL G P P L+ P LT + + ID L D
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240
Query: 651 VPFDSVAK 658
F AK
Sbjct: 241 PSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 466
NF LGEG + VY G G VA+K + +D + G A E+ ++ L H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHEN 59
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAY 524
+V+L + E LV+E + + ++ ++ D D + +A+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
HE+ RV+HRD K N+L+ K++DFGLAR A S V+ T Y AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV-TLWYRAPD 170
Query: 585 YAMTGHLLVKS-DVYSYGVVILELLSGR 611
+ S D++S G ++ E+++GR
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 414 SRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNL 467
SR+LG G G V + + DG AVKV VD +G E AEV L ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKV---VDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 468 VKLIGICIEEQAR------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 515
VK C E+ A+ LV + G + + K + +
Sbjct: 94 VK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---REHEAG 146
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
L + L +H S +IHRD KS+NILL + K+ DFG ++ S +
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
GT YVAPE K+D++S GV++ ELL+ ++P D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 417 LGEGGFGLVYSGVLDDGTKV--AVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
LG+G +G VY VL T V A+K ++ +D+ + + E+++L + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
E A + E + GS++ L+ + + D +I + L +L E+ + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 592
IHRD K +N+L+ + K+ DFG+ S S ++ +G Y+APE +G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 593 -----VKSDVYSYGVVILELLSGRKP 613
V+SDV+S G+ ILE+ GR P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 50/212 (23%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 417 LGEGGFGLVYSGVLDD---------GTKVAVKVLKRVDQQGGRE----FLAEVEMLSRLH 463
LG G +Y+G+L+ + +KV+ +V R+ F M+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
H+++V L G+C+ + +V E + G ++ +H ++S L + K+A A AL+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119
Query: 524 YLHEDSSPRVIHRDFKSSNILL-----EHDFTP--KVSDFGLARSAMDEESRHISTRVMG 576
YL ED ++H + + NILL + + P K+SD G+ + + + +
Sbjct: 120 YL-EDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VE 170
Query: 577 TFGYVAPEYAM-TGHLLVKSDVYSYGVVILEL 607
++APE + +L + +D +S+G + E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 409 GNFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLH 463
+F+ +++G G FG V+ V D T A+KVL++ D + AE ++L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
+VKL +E+ LV E +P G + + L + K+ P AR IA AL
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVL-ALD 115
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 559
+H IHRD K NIL++ D K++DFGL
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 560 ---RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
R ++ R + +GT Y+APE ++ D +S GV++ E+L G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
LGEG + VY G G VA+K + R++ + G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 474 CIEEQARCLVYELIPNG---SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
++ LV+E + ++ G+ + L L R LAY H+
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCHQR-- 122
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM--- 587
RV+HRD K N+L+ K++DFGLAR A S+ S V+ T Y P+ +
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLLGST 179
Query: 588 --TGHLLVKSDVYSYGVVILELLSGR 611
+ L D++ G + E+ +GR
Sbjct: 180 EYSTSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLA---EVEMLSRLH 463
N+ ++LG G FG VY D G ++AVK + Q+ +E A E+++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 464 HRNLVKLIGICI---EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
H +V+ G C+ EE+ + E +P GS++ L K L + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-------- 572
++YLH S ++HRD K +NIL + K+ DFG S+ I T
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG--------ASKRIQTICMSGTGI 166
Query: 573 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
V GT +++PE K+DV+S ++E+L+ + P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRV----DQQGGREFLAEVEMLSRLHHRN 466
++LG+GG+G V+ G A+KVLK+ +Q+ AE +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAARALAY 524
+V LI L+ E + G + HL G+ E + + + +AL +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------H 115
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH+ +I+RD K NILL+ K++DFGL + ++ E + ++ GT Y+APE
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPE 170
Query: 585 YAM-TGHLLVKS-DVYSYGVVILELLSGRKP 613
M +GH K+ D +S G ++ ++L+G P
Sbjct: 171 ILMRSGH--GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 470
+G G +G V S + G KVA+K L R Q E A E+ +L + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS---ELFAKRAYRELRLLKHMKHENVIGL 79
Query: 471 IGICIEEQAR---CLVYELIP-NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+ + + + Y ++P G+ L +K L D + + L Y+H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK----LSEDRIQFLVYQMLKGLKYIH 135
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+ +IHRD K N+ + D K+ DFGLAR E + ++ TR Y APE
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVI 187
Query: 587 MTG-HLLVKSDVYSYGVVILELLSGR 611
+ H D++S G ++ E+L+G+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 67/248 (27%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 409 GNFDASRILGEGGFGLVY-SGVLDDGTKVAVKVLKR-----VDQQGGREFLAEVEMLSRL 462
+F +G+GG+G V+ + D G VA+K +K+ +++ R L E ++L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTT 58
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAAR 520
LVKL+ +++ L E +P G + L+ GV E + A + A+ A
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
L Y IHRD K N L++ K++DFGL++ + + V+G+ Y
Sbjct: 119 ELGY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDY 164
Query: 581 VAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWA---- 629
+APE Y T D +S G ++ E L G P + P ENL W
Sbjct: 165 MAPEVLRGKGYDFT------VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
Query: 630 RPLLTSRE 637
RP+
Sbjct: 219 RPVYDDPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLH---HRNL 467
+GEG +G V+ L +G + LKRV Q G E + EV +L L H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 468 VKLIGICI-----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 522
V+L +C E LV+E + + + ++L V + P + + R L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT--ETIKDMMFQLLRGL 123
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
+LH S RV+HRD K NIL+ K++DFGLAR + T V+ T Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRA 177
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 614
PE + D++S G + E+ RKP+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 415 RILGEGGFGLVYSGVLDD--GTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKL 470
+ +G G G+V + D G VAVK L R +Q + E+ +L ++H+N++ L
Sbjct: 27 KPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 471 IGI-----CIEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+ + +EE Q LV EL+ + +D E R+ L + L
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE--------RMSYLL--YQMLCG 135
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
+ S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPE 192
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSG 610
+ D++S G ++ EL+ G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLDD--GTK--VAVKVLKR--VDQQGGRE-FLAEVEMLSRL 462
+F+ +LG+G FG V +L + GT A+K+LK+ + Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 463 HHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
+ + C + R V E + G + H+ V K P +IA+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG---- 113
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 580
L +LH S +I+RD K N++L+ + K++DFG+ + + +TR GT Y
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDY 167
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
+APE D +++GV++ E+L+G+ P D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 410 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREFL-AEVEMLSR 461
NF+ ++LG G +G V+ D G A+KVL++ V + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 462 LHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA- 519
+ + + + +A+ L+ + + G + +HL+ D S + ++ G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEII 115
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
AL +LH+ +++RD K NILL+ + ++DFGL++ + EE + GT
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIE 171
Query: 580 YVAPEY--AMTGHLLVKSDVYSYGVVILELLSGRKP 613
Y+APE GH D +S G++I ELL+G P
Sbjct: 172 YMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 417 LGEGGFG---LVYSGVLDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+GEG FG LV S +DG + +K + ++ + E EV +LS + H N+V+
Sbjct: 8 IGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 472 GICIEEQARCLVYELIPNGSVESHLHG----VDKESAPLGWDARLKIALGAARALAYLHE 527
E +V + G + ++ + E L W ++ + AL ++H+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR---SAMDEESRHISTRVMGTFGYVAPE 584
+++HRD KS NI L D T K+ DFG+AR S ++ ++ +GT Y++PE
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-----LARTCIGTPYYLSPE 171
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS 609
KSD+++ G V+ E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 31/240 (12%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGT--KVAVKVLKR---VDQQGGREFLAEVEMLSRLHH 464
+F+ R LG G FG V + VA+K ++ + Q+ +E ++L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
V L G +E LV E + G + L + +G +I L Y
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEY 146
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
L S +++RD K N+LL+ D K++DFG A+ ++R + + GT Y+APE
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTR--TYTLCGTPEYIAPE 198
Query: 585 YAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643
+ GH +D ++ G+ I E+L G PP N PLL ++ LE II
Sbjct: 199 ILLNVGHGKA-ADWWTLGIFIYEILVG-------CPPFYAN-----EPLLIYQKILEGII 245
|
Length = 340 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKLIG 472
+G G FG V + T VA V+K + EFL + + L H N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 473 ICIEEQARCLVYELIPNGSVESHL-----HGVDKESAPLGWDARLKIALGAARALAYLHE 527
C+E LV+E G ++S+L H + + L ++A A + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHK 117
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY-- 585
+ +H D N L D T KV D+G+ S E+ ++APE
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 586 AMTGHLLVK-----SDVYSYGVVILELL 608
G L+ S+V++ GV + EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 36/113 (31%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
K+++ + L YL E +++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 107 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 625
+GT Y++PE H V+SD++S G+ ++E+ GR P+ PP + L
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI---PPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 3/183 (1%)
Query: 431 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490
D KV K + D++ +E+ L+ H +VK + L+ E G
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550
+ + KE P ++ L + + L E S +++HRD KS+NI L
Sbjct: 151 DLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 610
K+ DFG ++ D S +++ GT Y+APE K+D++S GV++ ELL+
Sbjct: 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 611 RKP 613
+P
Sbjct: 268 HRP 270
|
Length = 478 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
LGEG + VY G+ +G VA+KV+ + + G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 474 CIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
++ V+E + + H G+ + L R LAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQ-- 122
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 590
++HRD K N+L+ + K++DFGLAR A S+ S+ V+ T Y P+ + G
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPD-VLLGA 178
Query: 591 LLVKS--DVYSYGVVILELLSGR 611
S D++ G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 470
+G G +G V S + G KVA+K L R Q E A E+ +L + H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS---EIFAKRAYRELTLLKHMQHENVIGL 79
Query: 471 IGICIEEQARCLVYE---LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
+ + + + ++P +++ L + PL D + L Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMP--YMQTDLQKI--MGHPLSEDKVQYLVYQMLCGLKYIH- 134
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 587
S +IHRD K N+ + D K+ DFGLAR A E + ++ TR Y APE +
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 588 TG-HLLVKSDVYSYGVVILELLSGR 611
H D++S G ++ E+L+G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 61/244 (25%), Positives = 97/244 (39%), Gaps = 54/244 (22%)
Query: 409 GNFDASRILGEGGFGLVYSGVLDD---GTKVAVKVLKRVDQQGG----REFLAEVEMLSR 461
+D R++G+GG G VY D +VA+K + R D + FL E ++ +
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAY--DPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAAD 58
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIP----------------NGSVESHLHGVDKESAP 505
L H +V + IC + VY +P S+ L +K S
Sbjct: 59 LIHPGIVPVYSICSDGDP---VYYTMPYIEGYTLKSLLKSVWQKESLSKELA--EKTSVG 113
Query: 506 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565
A L I + Y+H S V+HRD K NILL + D+G A E
Sbjct: 114 ----AFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166
Query: 566 ESRHIST----------------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
E + +++GT Y+APE + +D+Y+ GV++ ++L+
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
Query: 610 GRKP 613
P
Sbjct: 227 LSFP 230
|
Length = 932 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 45/208 (21%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 425 VYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKLIGICIEEQAR 480
+Y G+ ++ +V ++ K+ +G E++ L R+ N++K+ G I+
Sbjct: 36 IYKGIFNN-KEVIIRTFKK-FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID---- 89
Query: 481 CLVYELIPNGSVE------SHLHGV-DKESAPLGWDARLKIALGAARALAYLHE-DSSPR 532
+ + +P S+ +L V DKE L + +L +A+ + L L++ + P
Sbjct: 90 --IVDDLPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY-----VAPEYAM 587
+++ S + L+ ++ K+ GL + ++++ M F Y + EY
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF--MVYFSYKMLNDIFSEY-- 199
Query: 588 TGHLLVKSDVYSYGVVILELLSGRKPVD 615
+K D+YS GVV+ E+ +G+ P +
Sbjct: 200 ----TIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 417 LGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGI 473
LGEG + V+ G L + VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 474 CIEEQARCLVYELIPN---------GSVESHLHGVDKESAPLGWDARLKIAL-GAARALA 523
+++ LV+E + G++ S +H V KI L R LA
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHNV-------------KIFLYQILRGLA 118
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
Y H +V+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPP 173
Query: 584 EYAM-TGHLLVKSDVYSYGVVILELLSGR 611
+ + + + D++ G + E+ SGR
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 415 RILGEGGFG-LVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKL 470
++LG+G FG ++ G A+K+LK+ + + L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 471 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 528
+ C V E + G + HL V E + A + AL YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI------VSALDYLH-- 112
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
S ++++RD K N++L+ D K++DFGL + + + + GT Y+APE
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLED 169
Query: 589 GHLLVKSDVYSYGVVILELLSGRKP 613
D + GVV+ E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 13/179 (7%)
Query: 434 TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 493
K V+ + Q+GG E +L ++H ++++L G + CL+ +P +
Sbjct: 114 NKTCEHVVIKAGQRGGT--ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTD 168
Query: 494 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 553
+ + K + + L I RA+ YLHE+ R+IHRD K+ NI + H +
Sbjct: 169 LYCYLAAKRNIAIC--DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCL 223
Query: 554 SDFGLARSAMD-EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 611
DFG A +D +++ GT APE D++S G+V+ E+ +
Sbjct: 224 GDFGAACFPVDINANKYYGW--AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 417 LGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGI 473
LGEG + VY G L D VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 474 CIEEQARCLVYELIPNGSVES--------HLHGVDKESAPLGWDARLKIAL-GAARALAY 524
E++ LV+E + + ++H V K+ L R L Y
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNV-------------KLFLFQLLRGLNY 119
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
H +V+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPD 174
Query: 585 YAM-TGHLLVKSDVYSYGVVILELLSGR 611
+ + + D++ G + E+ +GR
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 410 NFDASRILGEGGFGLVY-----SGVLDDGTKVAVKVLKR---VDQQGGREFL-AEVEMLS 460
NF+ ++LG G +G V+ SG D G A+KVLK+ V + E E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSG-HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 461 RLHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA- 518
+ + + + + L+ + I G + +HL ++ + ++I G
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEI 114
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
AL +LH+ +I+RD K NILL+ + ++DFGL++ ++E + GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTI 170
Query: 579 GYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 624
Y+AP+ GH D +S GV++ ELL+G P + G++N
Sbjct: 171 EYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVD---GEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 467
++LG+G FG V +L G A+K+LK+ + + L E +L H L
Sbjct: 1 KLLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 468 VKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAY 524
L + R C V E G + HL V E + A + ALG Y
Sbjct: 58 TAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------Y 110
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH S V++RD K N++L+ D K++DFGL + + + + T GT Y+APE
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYLAPE 165
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
D + GVV+ E++ GR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLH 463
+F+ LG G FG V G A+K LK ++ Q + E +L L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV--QHVAQEKSILMELS 76
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
H +V ++ +E + E + G + +HL + + ++ L A
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFE 132
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
YLH +I+RD K N+LL++ KV+DFG A+ D + + GT Y+AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184
Query: 584 EYAMT-GHLLVKS-DVYSYGVVILELLSGRKP 613
E + GH K+ D ++ GV++ E ++G P
Sbjct: 185 EVIQSKGH--GKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 39/247 (15%)
Query: 380 SASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAV 438
S+S S SS A+ + + S SE+E+ +G G G VY + G A+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYAL 104
Query: 439 KVL-KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH 497
KV+ + R+ E+E+L ++H N+VK + ++ E + GS+E
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 498 GVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557
++ A D +I G +AYLH ++HRD K SN+L+ K++DFG
Sbjct: 165 ADEQFLA----DVARQILSG----IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 558 LAR---SAMDEESRHISTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVILE 606
++R MD + + GT Y++PE T G+ D++S GV ILE
Sbjct: 214 VSRILAQTMDPCNSSV-----GTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILE 265
Query: 607 LLSGRKP 613
GR P
Sbjct: 266 FYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHHRN 466
F+ ++GEG +G+V TK V + K D + E L E++ML L N
Sbjct: 3 FEVLGVVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW--DARLKIALGAARALAY 524
+V+L LV+E + +E E P G + +A+ +
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLEL------LEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
H++ ++HRD K N+L+ H+ K+ DFG AR+ + E S T + T Y +PE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSPE 171
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGR 611
+ D++S G ++ EL G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGIC 474
LGEG + V+ G VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYLHEDSSPRV 533
E+ LV+E + +S L L +KI + R L+Y H+ ++
Sbjct: 73 HTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLL 592
+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+ + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 593 VKSDVYSYGVVILELLSGR 611
D++ G ++ E+ +GR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 415 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 469
+++G+G FG V + DG+ AVKVL++ + ++ +AE +L L H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L + V + + G + HL +E L AR A A A+ YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARF-YAAEVASAIGYLH--- 113
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S +I+RD K NILL+ ++DFGL + ++ E ++ GT Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE 171
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 16/152 (10%)
Query: 470 LIGI--CIEEQARC-LVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAY 524
L+G+ C + +R LV E + G + H+ K E + A + IAL +
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------F 111
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LHE +I+RD K N+LL+ D K++D+G+ + + ++ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPE 166
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 616
D ++ GV++ E+++GR P D+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 13/190 (6%)
Query: 432 DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491
KV VK + GG+ E+++L + HR ++ LI + C+V +P
Sbjct: 118 QRKKVIVKAV-----TGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK 169
Query: 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551
+ + VD+ S PL + + I ALAYLH +IHRD K+ NI L+
Sbjct: 170 CDLFTY-VDR-SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 611
+ DFG A GT +PE K+D++S G+V+ E+
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
Query: 612 KPVDMTQPPG 621
+ Q
Sbjct: 285 VTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHR 465
+++ + +G G +G VY L G AVK++K + G +F E+ M+ H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARAL 522
N+V G + + + E GS++ H + PL + L+IA + L
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPL---SELQIAYVCRETLQGL 119
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
AYLH +HRD K +NILL + K++DFG+A ++ S +GT ++A
Sbjct: 120 AYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMA 174
Query: 583 PEYAM---TGHLLVKSDVYSYGVVILELLSGRKPV 614
PE A G D+++ G+ +EL + P+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHR 465
+F+ +LG+G FG V ++ A+K+LK+ V Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 466 NLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+ + C + R V E + G + + V + P +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVAP 583
LH S +I+RD K N++L+ + K++DFG+ + M + ++T+ GT Y+AP
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCGTPDYIAP 170
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
E D +++GV++ E+L+G+ P +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 415 RILGEGGFGLVYSGVLDDGTKV-AVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKL 470
R++G G + V L ++ A+KV+K+ D + E + + + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 471 IGICIEEQARCL-VYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAYLHE 527
+ C + ++R V E + G + H+ K E + A + +AL YLHE
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE 114
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 587
+I+RD K N+LL+ + K++D+G+ + + ++ GT Y+APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILR 169
Query: 588 TGHLLVKSDVYSYGVVILELLSGRKPVDM 616
D ++ GV++ E+++GR P D+
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 415 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 469
+++G+G FG V + DG AVKVL++ + ++ + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L V + + G + HL +E + AR A A AL YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARF-YAAEIASALGYLH--- 113
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S +I+RD K NILL+ ++DFGL + ++ ++ GT Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQ 171
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 417 LGEGGFGLV---YSGVLDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+G G G+V Y VLD VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 472 GI-----CIEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR-ALAY 524
+ +EE Q LV EL+ + +D E R+ L + +
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLLYQMLCGIKH 134
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPE 188
Query: 585 YAMTGHLLVKSDVYSYGVVILE------LLSGRKPVD 615
+ D++S G ++ E L GR +D
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
L +LH +I+RD K N+LL+ D K++DFG+ + M+ E + ++ GT Y
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 581 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
+APE + G +S D +S+GV++ E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHR 465
++D +++G G FG V KV A+K+L + + + F E ++++ +
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW----DARLKIALGAARA 521
+V+L +++ +V E +P G + + + D P W A + +AL A +
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHS 160
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
+ +IHRD K N+LL+ K++DFG MDE +GT Y+
Sbjct: 161 MG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMK-MDETGMVRCDTAVGTPDYI 210
Query: 582 APEYAMT----GHLLVKSDVYSYGVVILELLSGRKP 613
+PE + G+ + D +S GV + E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
L +LH S +I+RD K N++L+ D K++DFG+ + + ++R ++ GT Y+
Sbjct: 109 LQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYI 163
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
APE D +S+GV++ E+L G+ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 470 LIGI--CIEEQARC-LVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAY 524
L+G+ C + ++R V E + G + H+ K E + A + +AL +
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------F 111
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LHE +I+RD K N+LL+ + K++D+G+ + + ++ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPE 166
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVD---MTQPPGQ 622
D ++ GV++ E+++GR P D M+ P Q
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 42/216 (19%)
Query: 415 RILGEGGFGLV---YSGVLDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 469
+ +G G G+V Y V G VA+K L R + + E+ ++ ++H+N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 470 LIGI-----CIEE-QARCLVYELIPNGSVESHLHGV-----DKESAPLGWDARLKIALGA 518
L+ + +EE Q LV EL+ +++L V D E R+ L
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMDLDHE--------RMSYLLYQ 126
Query: 519 AR-ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE--ESRHISTRVM 575
+ +LH S +IHRD K SNI+++ D T K+ DFGLAR+A + ++ TR
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 182
Query: 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 611
Y APE + D++S G ++ E++ G
Sbjct: 183 ----YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 33/241 (13%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHR 465
+F+ + +G G +G VY ++ G A+KV+K + G +F E+ M+ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
N+V G + + E GS++ H + PL ++ + L YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYL 122
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H +HRD K +NILL + K++DFG++ ++ S +GT ++APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEV 177
Query: 586 AMT---GHLLVKSDVYSYGVVILELLSGRKPVD----------MT----QPPGQENLVAW 628
A G D+++ G+ +EL + P+ MT QPP ++ + W
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237
Query: 629 A 629
+
Sbjct: 238 S 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 415 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHRNLVKL 470
++LG+G FG V L +V A+KVLK+ + Q + + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 471 IGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+ C + + R V E + G + + K P +R A AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---RSRF-YAAEVTLALMFLHRHG 116
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
VI+RD K NILL+ + K++DFG+ + + +T GT Y+APE
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL 171
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
D ++ GV++ E+++G+ P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 55/219 (25%)
Query: 415 RILGEGGFGLVYSGVL--DDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRNLVK- 469
R++G+G +G V S V DG + +K L + ++ + E ++LS+L H N+V
Sbjct: 6 RVVGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 470 -------------LIGIC--------IEEQARCLVYELIPNGSVESHLHGVDKESAPLGW 508
++G C ++EQ +L+P E+ + W
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG----KLLP-------------ENQVVEW 107
Query: 509 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568
++ A AL YLHE ++HRD K+ N+ L KV D G+AR + E
Sbjct: 108 FVQI------AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQC 156
Query: 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILEL 607
+++ ++GT Y++PE KSDV++ G + E+
Sbjct: 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 7/120 (5%)
Query: 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551
VE G + PL + + + AR + +L +S + IHRD + NILL +
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVV 212
Query: 552 KVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
K+ DFGLAR + R R+ ++APE +SDV+S+GV++ E+ S
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 467
++LG+G FG V +L G A+K+L++ + + + E +L H L
Sbjct: 1 KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA--ARALAYL 525
L C V E G + HL +E AR GA AL YL
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARF---YGAEIVSALEYL 111
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S V++RD K N++L+ D K++DFGL + + + + GT Y+APE
Sbjct: 112 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 166
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKP 613
D + GVV+ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 4/96 (4%)
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
A+ +++L +S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
++APE +SDV+SYG+++ E+ S G P
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 417 LGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
+G+G FG V D ++ A+K +++ V + LAE +L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+ LV I G + HL +E AR A AL LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ---REGRFDLSRARFYTA-ELLCALENLHKFN--- 113
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
VI+RD K NILL++ + DFGL + M ++ + + GT Y+APE + GH
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPEL-LLGHGY 170
Query: 593 VKS-DVYSYGVVILELLSGRKP 613
K+ D ++ GV++ E+L+G P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 37/248 (14%)
Query: 399 FSASEIEKAT----GNFDASRILGEGGFGLV---YSGVLDDGTKVAVKVLKR--VDQQGG 449
F + EI +T + + +G G G+V Y +L+ VA+K L R +Q
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 450 REFLAEVEMLSRLHHRNLVKLIGI-----CIEE-QARCLVYELIPNGSVESHLHGVDKES 503
+ E+ ++ ++H+N++ L+ + +EE Q +V EL+ + +D E
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE- 126
Query: 504 APLGWDARLKIALGAAR-ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562
R+ L + +LH S +IHRD K SNI+++ D T K+ DFGLAR+A
Sbjct: 127 -------RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
+ + T + T Y APE + D++S G ++ E++ G PG
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-----VLFPGT 228
Query: 623 ENLVAWAR 630
+++ W +
Sbjct: 229 DHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 415 RILGEGGFG--LVYSGVLDDGTKVAVKVLK----RVDQQGGREFLAEVEMLSRLHHRNLV 468
R++GEG FG L+ V D K A+K ++ + R+ E +L+++ H N+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+ +V E G + + + D L+ + + ++HE
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIK--LQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
RV+HRD KS NI L + K+ DFG AR + + T V GT YV PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYACTYV-GTPYYVPPEIWEN 174
Query: 589 GHLLVKSDVYSYGVVILELLSGRKP 613
KSD++S G ++ EL + + P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 76/305 (24%), Positives = 121/305 (39%), Gaps = 65/305 (21%)
Query: 410 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRLHH 464
+F++ +++G G FG V D G A+K+L++ D +Q G AE ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG-HIRAERDILVEADS 60
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARAL 522
+VK+ ++ L+ E +P G + + L D E + A +A+ + L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA----------------------- 559
+ IHRD K N+LL+ K+SDFGL
Sbjct: 121 GF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 560 -----RSAMDEES-----RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
S E+ R ++ +GT Y+APE M D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 610 GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQP 669
G P P QE + ++ +E L I P +VP AK + C
Sbjct: 232 GYPPFCSETP--QETY----KKVMNWKETL--IFPP----EVPISEKAKDLILRFCC--- 276
Query: 670 EVQHR 674
E +HR
Sbjct: 277 EWEHR 281
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 469
+++G+G FG V DG AVKVL++ ++++ + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L + V + + G + HL +E + AR A A AL YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S +++RD K NILL+ ++DFGL + + + +T GT Y+APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQ 171
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
D + G V+ E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 67/242 (27%), Positives = 95/242 (39%), Gaps = 52/242 (21%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKV--AVKVL-KRVDQQGGR--EFLAEVEMLSRLHHR 465
F ++LG+G G V+ V GT A+KVL K+ + + L E E+L+ L H
Sbjct: 3 FKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHL----HGVDKESAPLGWDARLKIALGAARA 521
L L E CLV + P G + L E AR A A
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-----VARFYAAEVLL-A 115
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD----------------- 564
L YLH +++RD K NILL +SDF L++ +
Sbjct: 116 LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 565 ----------EESRHISTRVMGTFGYVAPEY-AMTGHLLVKSDV--YSYGVVILELLSGR 611
EE S +GT Y+APE + GH S V ++ G+++ E+L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILLYEMLYGT 229
Query: 612 KP 613
P
Sbjct: 230 TP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 415 RILGEGGFG-LVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKL 470
++LG+G FG ++ G A+K+LK+ V + L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 471 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 528
C V E G + HL V E + A + AL YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI------VSALDYLH-- 112
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
S V++RD K N++L+ D K++DFGL + + + + + GT Y+APE
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLED 170
Query: 589 GHLLVKSDVYSYGVVILELLSGRKP 613
D + GVV+ E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 3e-07
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 451 EFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVYELIPNGSVESHLHGVDKESAPLGW 508
+ + EV ++ L H+N+V+ I + + Q ++ E G + ++ K +
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 509 DARLKIALGAARALAYLHE----DSSPRVIHRDFKSSNILLEHDF--------------- 549
A + I ALAY H + RV+HRD K NI L
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 550 --TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVIL 605
K+ DFGL+++ E H +GT Y +PE + T KSD+++ G +I
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 606 ELLSGRKP 613
EL SG+ P
Sbjct: 235 ELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 61/274 (22%)
Query: 411 FDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRN 466
F + LG G FG V + +D A+K L++ D + AE ++L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAY 524
+V+L ++ V + IP G + S L G+ E + A L A+ + + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------- 559
IHRD K NIL++ D K++DFGL
Sbjct: 123 ---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 560 --------------------RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYS 599
R A + R ++ ++GT Y+APE + D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 600 YGVVILELLSGRKPVDMTQP-PGQENLVAWARPL 632
GV++ E+L G+ P P Q ++ W L
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSR------ 461
+FD +++G G FG V+++ K Q + L++ EM+ R
Sbjct: 44 DFDVIKVIGRGAFG-------------EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFF 90
Query: 462 ------LHHRN---LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL 512
+ H N +V+L +++ +V E +P G + + + D P W AR
Sbjct: 91 WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKW-ARF 146
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
A AL +H S IHRD K N+LL+ K++DFG MD
Sbjct: 147 YTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MDANGMVRCD 201
Query: 573 RVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILELLSGRKP 613
+GT Y++PE + G+ + D +S GV + E+L G P
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 48/243 (19%)
Query: 410 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHR 465
+F++ +++G G FG V D G A+K+L++ D ++ AE ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALA 523
+VK+ +++ L+ E +P G + + L D E A + A +A+ A L
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 559
+ IHRD K N+LL+ K+SDFGL
Sbjct: 122 F---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 560 -------RSA--MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 610
R A + R ++ +GT Y+APE M D +S GV++ E+L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 611 RKP 613
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 55/221 (24%), Positives = 84/221 (38%), Gaps = 29/221 (13%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
+ + + T VAVK L ++ + E+ +L H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDS 529
I + +V L+ GS E L E P L IA AL Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--- 118
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG--------YV 581
S IHR K+S+ILL D +S + S + R RV+ F ++
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ---RVVHDFPKSSVKNLPWL 175
Query: 582 APEY---AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 619
+PE + G+ KSD+YS G+ EL +G P
Sbjct: 176 SPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 504 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563
+PL + + + AR + +L +S + IHRD + NILL + K+ DFGLAR
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 564 DEES--RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPP 620
+ R S R+ ++APE +SDV+S+GV++ E+ S G P P
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-----P 278
Query: 621 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 680
G + + E +R+ D + P ++ ++ I C Q + + RP +
Sbjct: 279 GVQ----------INEEFCQRLKDGTRMR-APENATPEIYRIMLACWQGDPKERPTFSAL 327
Query: 681 VQAL 684
V+ L
Sbjct: 328 VEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHR 465
+++ +++G G FG V KV A+K+L + + + F E ++++ +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW----DARLKIALGAARA 521
+V+L +++ +V E +P G + + + D P W A + +AL A +
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHS 160
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
+ + IHRD K N+LL+ K++DFG M++E +GT Y+
Sbjct: 161 MGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYI 210
Query: 582 APEYAMT----GHLLVKSDVYSYGVVILELLSGRKP 613
+PE + G+ + D +S GV + E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 5/126 (3%)
Query: 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 543
Y+ + V++ L D S L L AR + +L +S +HRD + N+
Sbjct: 214 YKGSNDSEVKNLLS--DDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 544 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 603
LL K+ DFGLAR M + + ++APE SDV+SYG++
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 604 ILELLS 609
+ E+ S
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 61/272 (22%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVD----QQGGREFLAEVEMLSRLHHR 465
F + +G G FG V D + A+K L++ D Q AE ++L+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA-HVKAERDILAEADNE 61
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALA 523
+VKL ++ V + IP G + S L G+ +E AR IA A+
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-----ARFYIA-ELTCAIE 115
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 559
+H+ IHRD K NIL++ D K++DFGL
Sbjct: 116 SVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 560 -----------------RSAMDEESRHISTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYG 601
R + R ++ ++GT Y+APE TG+ + D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVG 231
Query: 602 VVILELLSGRKPVDMTQPPG-QENLVAWARPL 632
V++ E+L G+ P P Q ++ W L
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 37/184 (20%)
Query: 481 CLVYELIPNGSVESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFK 539
C+V E + G + L K L D AR+ A AL YLH + ++HRD K
Sbjct: 77 CMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLK 128
Query: 540 SSNILLEHDFTPKVSDFGLAR------------SAMDEESRHISTR-VMGTFGYVAPEYA 586
N+L+ K++DFGL++ +++++R + V GT Y+APE
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP---------------VDMTQPPGQENLVAWARP 631
+ D ++ G+++ E L G P D+ P G E L A A+
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQD 248
Query: 632 LLTS 635
L++
Sbjct: 249 LISR 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLKR---VDQQGGREFLAEVEMLSRLHH 464
+FD ++G G FG V V + T A+KV+K+ + Q+ F E ++LS +
Sbjct: 2 DFDVKSLVGRGHFGEVQV-VREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD---KESAPLGWDARLKIALGAARA 521
+ +L ++ LV E P G + S L+ + E + A L +A+ +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
+ Y +HRD K N+L++ K++DFG A + + S +GT Y+
Sbjct: 121 MGY---------VHRDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNSKLPVGTPDYI 170
Query: 582 APEY--AMTGHLL----VKSDVYSYGVVILELLSGRKP 613
APE M G V+ D +S GV+ E++ GR P
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 417 LGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK------ 469
+G+G FG VY D ++ A+KVL + +E +A+ E+ + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 470 ---LIGICIEEQARC---LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
++G+ Q LV + + G + HL KE A+ IA AL
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFSEDRAKFYIA-ELVLALE 110
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
+LH+ +++RD K NILL+ + DFGL+++ + + + GT Y+AP
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAP 165
Query: 584 EYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
E + K D +S GV++ E+ G P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMG 576
A+ + +L +S + IHRD + NILL + K+ DFGLAR + R R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 577 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
++APE ++SDV+S+GV++ E+ S G P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 415 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 469
+++G+G FG V K AVKVL++ + ++ + ++E +L + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L V + I G + HL +E L AR A A AL YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARF-YAAEIASALGYLH--- 113
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S +++RD K NILL+ ++DFGL + ++ ++ GT Y+APE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ 171
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 62/270 (22%), Positives = 103/270 (38%), Gaps = 61/270 (22%)
Query: 415 RILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFL---AEVEMLSRLHHRNLVKL 470
+ LG G FG V + +D A+K L++ D + AE ++L+ + +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 471 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 528
++ V + IP G + S L V E + A L +A+ + + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF---- 122
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLA----------------------------- 559
IHRD K NIL++ D K++DFGL
Sbjct: 123 -----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 560 ----------------RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 603
+ A + R ++ ++GT Y+APE + D +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 604 ILELLSGRKPVDMTQPP-GQENLVAWARPL 632
+ E+L G+ P P Q ++ W L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 57/249 (22%)
Query: 410 NFDASRILGEGGFG---LVYSGVLDDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL 462
+F++ +++G G FG LV D G A+K L++ + +Q AE ++L+
Sbjct: 2 DFESIKVIGRGAFGEVRLVQK--KDTGHIYAMKKLRKSEMLEKEQVA-HVRAERDILAEA 58
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAAR 520
+ +VKL +E L+ E +P G + + L D E + A +A+ +
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH 118
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA-------RSAMDEESRHIST- 572
L Y IHRD K N+LL+ K+SDFGL R+ H
Sbjct: 119 KLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 573 -----------------------RVM-----GTFGYVAPEYAMTGHLLVKSDVYSYGVVI 604
R + GT Y+APE + + D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 605 LELLSGRKP 613
E+L G P
Sbjct: 230 YEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGRE---FLAEVEMLSRLHHR 465
+F+ +++G G FG V L + KV A+K+L + + E F E ++L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARAL 522
+ L +E LV + G + + L + E + A + IA+ + L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
Y +HRD K NIL++ + +++DFG M++ + S V GT Y++
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 583 PEY--AM---TGHLLVKSDVYSYGVVILELLSGRKP 613
PE AM G + D +S GV + E+L G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 420 GGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475
G FG VY G + +K+ AVKV+K+ +++ + AE + L+ +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 476 EEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
LV E + G V+S LH D+E A +K A AL YLH
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALALDYLHRHG--- 124
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566
+IHRD K N+L+ ++ K++DFGL++ ++ E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 502 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561
ES L + + + A + +L +S +HRD + N+L+ K+ DFGLAR
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 562 AMDEESRHISTRVMGTF---GYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609
M +S +IS TF ++APE SDV+S+G+++ E+ +
Sbjct: 289 IM-RDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 34/135 (25%), Positives = 42/135 (31%), Gaps = 15/135 (11%)
Query: 24 QGSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPP-----VNHSPSKGPVVPPSFIP 78
QGS P P + P P +P P P S P P S P
Sbjct: 206 QGSPIAAQPAPQPQQPSPLSLISAPSLHPQ-RLPSPHPPLQPQTASQQSPQPPAPSSRHP 264
Query: 79 TSRKRHYGPPPLNSVSPSHSPLPTPVSRVP---------TSPSPSPTSASGQTELPLLPP 129
S GPP +++ L P S P P P P+ A + P
Sbjct: 265 QSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQS 324
Query: 130 KSSPSEPIRAFPPPP 144
P +P R P PP
Sbjct: 325 ALQPQQPPREQPLPP 339
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 18/177 (10%)
Query: 455 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG------VDKESAPLGW 508
E+ L RL+H N++K IEE R + + L+ D + PL
Sbjct: 213 EILALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 509 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568
R I A+ Y+H ++IHRD K NI L D + DFG A ++E
Sbjct: 268 QTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKERE 322
Query: 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPV-DMTQPPGQE 623
+GT +PE +D++S G+++L++LS P+ D PG++
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 32/148 (21%), Positives = 54/148 (36%), Gaps = 16/148 (10%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV--KLIG 472
++L G VY + +K+ ++ G + EV +L L + L K++
Sbjct: 4 KLLKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLA 60
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+ L+ E I G + +KE IA A LA LH+
Sbjct: 61 SGESDGWSYLLMEWIE-GETLDEVSEEEKE----------DIAEQLAELLAKLHQLPLLV 109
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLAR 560
+ H D NIL++ + D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 25/148 (16%), Positives = 38/148 (25%), Gaps = 7/148 (4%)
Query: 26 SADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHY 85
+ P P+ + S V P S
Sbjct: 300 PSSPGSGPAPSSPRASSSSSS----SRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSR 355
Query: 86 GPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTS-ASGQTELPLLPPKSSPSEPIRAFPPPP 144
PPP + SP P P+ P + + PT + + + P P
Sbjct: 356 PPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPRPS 415
Query: 145 PNADCSTTICTEPYTNTPPGSPCGCVWP 172
P + + Y P +P G WP
Sbjct: 416 PLDAGAAS--GAFYARYPLLTPSGEPWP 441
|
Length = 1352 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 475
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-----LHEDSS 530
R + L+ + + H + A +++ G ++L Y +H +
Sbjct: 69 SHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 531 PRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHIS--TRVMGTFGYVAPE 584
V+HRD K +NIL+ + K++D G AR + + ++ V+ TF Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 585 YAMTGHLLVKS-DVYSYGVVILELLS 609
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-05
Identities = 36/150 (24%), Positives = 44/150 (29%), Gaps = 10/150 (6%)
Query: 26 SADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHY 85
SA P PP P +G VA P PS+ P P+ R
Sbjct: 2833 SAQPTAPPPPPGPPPPSLPLGGSVA------PGGDVRRRPPSRSPAAKPAAPARPPVRRL 2886
Query: 86 GPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPP 145
P VS S P + P P P PP+ P P P PP
Sbjct: 2887 ARPA---VSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPL 2943
Query: 146 NADCSTTICTEPYTNTPPGSPCGCVWPMQV 175
EP + P G + P +V
Sbjct: 2944 APTTDPAGAGEP-SGAVPQPWLGALVPGRV 2972
|
Length = 3151 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+F+ +++G G FG +VAV +K ++ + L + EML R
Sbjct: 2 DFEIIKVIGRGAFG-----------EVAVVKMKHTERIYAMKILNKWEMLKRAE------ 44
Query: 470 LIGICIEEQARCLVYELIPNGSV------------ESHLH-------GVDKESAPLGWDA 510
C E+ LV NG E++L+ G D + ++
Sbjct: 45 --TACFREERNVLV-----NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED 97
Query: 511 RLKIALG---AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567
RL + A + +H +HRD K N+LL+ + +++DFG + +
Sbjct: 98 RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157
Query: 568 RHISTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVILELLSGRKP 613
S V GT Y++PE AM G + D +S GV + E+L G P
Sbjct: 158 VQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 28/73 (38%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 410 NFDASRILGEGGFGLVYS------GVLDDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRL 462
N + LG G FG V G D+ +VAVK+LK RE L +E+++LS L
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98
Query: 463 -HHRNLVKLIGIC 474
H+N+V L+G C
Sbjct: 99 GQHKNIVNLLGAC 111
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-05
Identities = 40/171 (23%), Positives = 54/171 (31%), Gaps = 26/171 (15%)
Query: 22 TVQGSADPDVPPSTP-------------PLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSK 68
++ ADP PP TP P R P A P+ P P +
Sbjct: 2694 SLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASP-ALPAAPAPPAVPAGPATPG 2752
Query: 69 GPVVPPS-------FIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQ 121
GP P P PP P+ + L +P+ P+ A+
Sbjct: 2753 GPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVL 2812
Query: 122 TELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWP 172
LPP +SP+ P+ PPP + T P P G V P
Sbjct: 2813 APAAALPPAASPAGPL-----PPPTSAQPTAPPPPPGPPPPSLPLGGSVAP 2858
|
Length = 3151 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 36/112 (32%), Positives = 51/112 (45%), Gaps = 13/112 (11%)
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH---- 569
I GA R L YLH++ IHR+ K+S+IL+ D +S S + +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 570 ----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP-VDM 616
ST V+ + G+ VKSD+YS G+ EL +GR P DM
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 57/243 (23%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLAEVEMLS 460
+I+ +T F +LGEG FG V D K AVK+++ V + R+ E++ +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEA-WDRKRKEYCAVKIVRNVPKYT-RDAKIEIQFME 180
Query: 461 RLHHRN------LVKL----------IGICIEEQARCLVYELIPNGSVESHLHGVDKESA 504
++ + L+K+ + I + + CL+ ++ +G SH H
Sbjct: 181 KVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF-SHRH------- 232
Query: 505 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE----------HDFTP--- 551
+I AL Y H + ++H D K NIL+E + P
Sbjct: 233 ------LAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 552 ---KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 608
++ D G DE RH T ++ T Y +PE + + +D++S G +I EL
Sbjct: 285 CRVRICDLG---GCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 609 SGR 611
+G+
Sbjct: 340 TGK 342
|
Length = 467 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 475
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 476 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-----LHEDSS 530
R + L+ + + H + A +++ ++L Y +H +
Sbjct: 69 SHSDRKVW--LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 531 PRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHIS--TRVMGTFGYVAPE 584
V+HRD K +NIL+ + K++D G AR + + ++ V+ TF Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 585 YAMTGHLLVKS-DVYSYGVVILELLS 609
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 22/124 (17%), Positives = 32/124 (25%), Gaps = 6/124 (4%)
Query: 24 QGSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKR 83
+ D DV + S G+ A PS P V PS +
Sbjct: 156 EEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSL--- 212
Query: 84 HYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPP 143
PP +S P P+ P + + P+ P + P
Sbjct: 213 ---PPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPA 269
Query: 144 PPNA 147
P
Sbjct: 270 PIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 45/180 (25%), Positives = 69/180 (38%), Gaps = 26/180 (14%)
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALA 523
N+V L + E + LV + G + SH+ E W A + +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
LH + ++ RD +NILL+ +++ F D + Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 584 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-----QENLVAW----ARPLLT 634
E D +S G ++ ELL+G+ V+ P G N+ W AR LL
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSEEARSLLQ 210
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-04
Identities = 26/138 (18%), Positives = 41/138 (29%), Gaps = 8/138 (5%)
Query: 29 PDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPP 88
P P+ P R +P P PP + + P+ S R P
Sbjct: 2741 PPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPS 2800
Query: 89 PLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNAD 148
P + + + + P + +P + SP+ + P PP PPPP
Sbjct: 2801 PWDP-ADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPG-------PPPPSLPL 2852
Query: 149 CSTTICTEPYTNTPPGSP 166
+ PP
Sbjct: 2853 GGSVAPGGDVRRRPPSRS 2870
|
Length = 3151 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY--AM-- 587
+HRD K N+LL+ + +++DFG + + S +GT Y++PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLR-LLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 588 -TGHLLVKSDVYSYGVVILELLSGRKP 613
G + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 33/161 (20%), Positives = 51/161 (31%), Gaps = 21/161 (13%)
Query: 32 PPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLN 91
PP T P+ + K P P ++ P + P S +PT PPPL
Sbjct: 348 PPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQ 407
Query: 92 SVSPSHSPLPTPVSRVP----TSPSPSPTSASGQTELPLLPPKSS--------------- 132
+ P PL + ++ P + P S + L PP+S
Sbjct: 408 -LMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIG 466
Query: 133 -PSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWP 172
P + P PP A + ++ + G P
Sbjct: 467 PPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLP 507
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 30/164 (18%), Positives = 42/164 (25%), Gaps = 27/164 (16%)
Query: 19 FAFTVQGSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVV------ 72
S P + P PP V
Sbjct: 2608 PRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRA 2667
Query: 73 -------PPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELP 125
S P +R P + S++ P P P +P P+P + T LP
Sbjct: 2668 RRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPP-----PPTPEPAPHALVSATPLP 2722
Query: 126 LLPP---KSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSP 166
P ++SP+ P PP P + P P P
Sbjct: 2723 PGPAAARQASPALPAAPAPPAVPAGPAT------PGGPARPARP 2760
|
Length = 3151 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK-VLKRVDQQG-GREFLAEVEMLSRLHHRN 466
++ +GEG +G VY + G VA+K +D++G L E+ +L L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 467 -LVKLIGICIEEQAR-----CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIALGAA 519
+V+L+ + E+ LV+E + + ++ + + PL
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-KVSDFGLARSAMDEESRHISTRVMGTF 578
+ +A+ H V+HRD K N+L++ K++D GL R+ + T + T
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTL 175
Query: 579 GYVAPEYAMTG-HLLVKSDVYSYGVVILELLSG 610
Y APE + H D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 23/160 (14%)
Query: 410 NFDASRILGEGGFG---LVYSGVLDDGTKVAVKVLKRV-----DQQGGREFLAEVEMLSR 461
+F +++G+G FG LV D G A+K L + DQ AE ++L+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLA--HVKAERDVLAE 57
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAA 519
+V L + Q L+ E +P G + + L D E + A +A+ A
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559
L + IHRD K NIL++ K+SDFGL+
Sbjct: 118 HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 31/122 (25%), Positives = 46/122 (37%), Gaps = 9/122 (7%)
Query: 48 PVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRV 107
P A + P P P VPP P + + P + +S +P P R+
Sbjct: 185 PGAALAPSAPPPTP------SAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHP-QRL 237
Query: 108 PTSPSP-SPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSP 166
P+ P P +AS Q+ P P P PP P+A + + ++ PP P
Sbjct: 238 PSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPP-QP 296
Query: 167 CG 168
G
Sbjct: 297 FG 298
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 7/138 (5%)
Query: 32 PPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLN 91
P TPP S++ G+ +P S P + P + P+
Sbjct: 357 PTWTPPSSLEDLSAGR---HHPKRASLPTRKRRSARHAAT-PFARGPGGDDQTRPAAPVP 412
Query: 92 SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCST 151
+ P+ +P P P S P +P P++ G + P PP+ P P A P P + D +T
Sbjct: 413 ASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAP--ATEPAPDDPDDAT 470
Query: 152 TICTEPY-TNTPPGSPCG 168
+ PP P
Sbjct: 471 RKALDALRERRPPEPPGA 488
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 36/151 (23%), Positives = 44/151 (29%), Gaps = 19/151 (12%)
Query: 26 SADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHY 85
PD PP +P P +P P P+ G V P R R
Sbjct: 2616 PLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPR-----RARRL 2670
Query: 86 GPPPLNSVSPSHSP----LPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFP 141
G S SP P V + + P P P P+ +P + A P
Sbjct: 2671 GRAAQAS-SPPQRPRRRAARPTVGSLTSLADPPP---------PPPTPEPAPHALVSATP 2720
Query: 142 PPPPNADCSTTICTEPYTNTPPGSPCGCVWP 172
PP A P PP P G P
Sbjct: 2721 LPPGPAAARQASPALPAAPAPPAVPAGPATP 2751
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 32/143 (22%), Positives = 38/143 (26%), Gaps = 6/143 (4%)
Query: 29 PDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPP 88
PD PP + G P P P P + P PS H P
Sbjct: 2589 PDAPPQSARPRAPVDDRGDPRGPAP---PSPLPPDTHAPDPPPPSPSPAANEPDPHPPPT 2645
Query: 89 PLNSVSPSHSPLPTPVSRVPTSPSPS-PTSASGQTELPLLPPKSSPSEPIRAF--PPPPP 145
P P P VSR + AS + P + + PPPPP
Sbjct: 2646 VPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPP 2705
Query: 146 NADCSTTICTEPYTNTPPGSPCG 168
T PPG
Sbjct: 2706 PTPEPAPHALVSATPLPPGPAAA 2728
|
Length = 3151 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 30/161 (18%), Positives = 48/161 (29%), Gaps = 17/161 (10%)
Query: 25 GSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRH 84
G PP+ + + + P +PS P PP P +
Sbjct: 145 GPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASP 204
Query: 85 YGPPPLNSVSPSHS---PLPTPVSRVPTSPSPSPTSASGQTE----------LPLLPPKS 131
P + +S S S P P + S S +S+S + LP P +
Sbjct: 205 RPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPIT 264
Query: 132 SPSEPIRAFPPPPPNADCST----TICTEPYTNTPPGSPCG 168
P+ A P++ + E + P SP
Sbjct: 265 LPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGS 305
|
Length = 1352 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 808 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.23 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.93 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.85 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.68 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.5 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.47 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.39 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.04 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.03 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.78 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.74 | |
| PLN02236 | 344 | choline kinase | 96.45 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.21 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.15 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.14 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.02 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.73 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.71 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.31 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 94.99 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.98 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.7 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.21 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 94.17 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.1 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.76 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.74 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.53 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-58 Score=509.55 Aligned_cols=290 Identities=57% Similarity=0.946 Sum_probs=257.3
Q ss_pred CcccCCHHHHHHHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeee
Q 003605 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474 (808)
Q Consensus 395 s~~~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 474 (808)
..+.|++++|..||++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46789999999999999999999999999999999999999999998764433156699999999999999999999999
Q ss_pred eecc-ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCccee
Q 003605 475 IEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 553 (808)
Q Consensus 475 ~~~~-~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL 553 (808)
.+.+ +.+||||||+||+|+++|++.... .|+|.+|++||.++|+||+|||+.+.++|||||||++|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 499999999999999999964433 7999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 003605 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 554 ~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
+|||+|+..... .....+...||.+|+||||+..+.++.|+|||||||+|+||+||+.+.+........+++.|++..+
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999754331 1222111179999999999999999999999999999999999999998776666777999998888
Q ss_pred ccccccccccCCCCC-CCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 634 TSREGLERIIDPSLG-NDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~-~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
.+. .+.+++|+.+. ..++. +++.++..++.+|++.++++||+|.||+++|+.+.
T Consensus 298 ~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 765 78999999987 56664 68999999999999999999999999999996554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=411.49 Aligned_cols=258 Identities=34% Similarity=0.589 Sum_probs=213.0
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeecc-ceEEEEeecCCC
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-ARCLVYELIPNG 490 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LV~Ey~~~G 490 (808)
.+.||+|+||+||+|.+.....||||++.... ....++|.+|+.+|.+++|||||+|+|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 35599999999999999843449999997532 222669999999999999999999999999887 799999999999
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-cceecccccccccccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-~vKL~DFGLa~~~~~~~~~~ 569 (808)
+|.++|+.. ....++|..+++||.+||+||.|||+++. |||||||++||||+.++ ++||+|||+++...... .
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 999999854 34579999999999999999999998863 99999999999999997 99999999998643221 2
Q ss_pred cccccccccccccchhhh--cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~--~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
..+...||..|||||++. ...|+.|+||||||++||||+||+.||..... ..+.. .++....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~-------------~v~~~~~ 263 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVAS-------------AVVVGGL 263 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHH-------------HHHhcCC
Confidence 233468999999999999 56999999999999999999999999975432 11111 1122222
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhh
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 693 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~~ 693 (808)
+...+.++...+..++.+||+.||++||++.|++..|+.+......
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 3334445678899999999999999999999999999988776543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=425.55 Aligned_cols=263 Identities=29% Similarity=0.496 Sum_probs=225.8
Q ss_pred CCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
.+....+.||+|+||+||+|... +...||||.||+.... ...+|++|+++|+.|+|+|||+|+|+|.+++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44555678999999999999843 3467999999976555 7889999999999999999999999999999999
Q ss_pred EEEeecCCCCcccccccccc------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcc
Q 003605 482 LVYELIPNGSVESHLHGVDK------E----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~------~----~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~v 551 (808)
||+|||..|+|.+||+.... . ..+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999974321 1 234899999999999999999999998 9999999999999999999
Q ss_pred eecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~ 630 (808)
||+||||+|.....++.+...+-.-..+||+||.++.++||.+||||||||||||+++ |+.|+.....
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----------- 711 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----------- 711 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----------
Confidence 9999999999888887777666667889999999999999999999999999999999 9999865332
Q ss_pred hhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 631 ~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
++.++-+-+..+ -..++++..++..|+..||+.+|++||+++||-..|+...+..
T Consensus 712 -----~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 -----QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -----HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 222332333333 3467888999999999999999999999999999999775543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=403.43 Aligned_cols=254 Identities=32% Similarity=0.490 Sum_probs=218.4
Q ss_pred eeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 413 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
..+.||+|-||.||.|.++....||||.++.. ....++|.+|+++|++|+|+|||+|+|+|..++.++||||||++|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 35689999999999999997779999999864 34457899999999999999999999999998899999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.+||+. ..+..++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||...+ +......
T Consensus 289 l~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~ 362 (468)
T KOG0197|consen 289 LDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASE 362 (468)
T ss_pred HHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC-CceeecC
Confidence 999975 34557889999999999999999999998 99999999999999999999999999994433 3333444
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~ 651 (808)
...-...|.|||.+..+.|+.|||||||||+||||+| |+.|+..... ..+-+.++...+-..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVLELLERGYRLPR 425 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHHHHHhccCcCCC
Confidence 4455778999999999999999999999999999999 9999864321 112234455555667
Q ss_pred ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 652 ~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
|..+...+.+|+..||+.+|++|||++.+...|+++...
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 788899999999999999999999999999999887553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=385.17 Aligned_cols=256 Identities=29% Similarity=0.425 Sum_probs=213.9
Q ss_pred cCCHHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec-ccchhhHHHHHHHHHHhhcccccceeEEeeee
Q 003605 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 475 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 475 (808)
.+++.||+.. +.||+|..|+|||+.++ +++.+|+|.+.. .+....+++.+|++++++.+|||||.++|.|.
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 3566676654 68999999999999987 788999999953 45566789999999999999999999999999
Q ss_pred ecc-ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeeecCCCccee
Q 003605 476 EEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKV 553 (808)
Q Consensus 476 ~~~-~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILLd~~~~vKL 553 (808)
..+ ...++||||++|||++++... ..+++...-+|+.++++||.|||+ ++ ||||||||+||||+..|++||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKi 220 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKI 220 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEe
Confidence 998 499999999999999999632 458999999999999999999996 55 999999999999999999999
Q ss_pred cccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 003605 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 554 ~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
||||.++.+.+. .....+||..|||||.+++..|+.++||||||+.|+|+++|+.|+.... ....+|+
T Consensus 221 cDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~----~~~~~~~---- 288 (364)
T KOG0581|consen 221 CDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN----PPYLDIF---- 288 (364)
T ss_pred ccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC----CCCCCHH----
Confidence 999999876443 4456789999999999999999999999999999999999999996541 1112222
Q ss_pred ccccccccccCCCCCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 634 TSREGLERIIDPSLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+.+..|++..- ...+. ....++..++..||++||.+||++.|++++
T Consensus 289 ---~Ll~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 289 ---ELLCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---HHHHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22333444211 12233 377899999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=433.83 Aligned_cols=268 Identities=29% Similarity=0.529 Sum_probs=218.6
Q ss_pred CCHHHHHHHhCCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeec
Q 003605 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE 477 (808)
Q Consensus 399 fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 477 (808)
++++++. ..|...++||+|+||.||+|+. .++..||||+++..... ..+|++++++++|||||+++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4455544 4567788999999999999997 47899999998754322 23568899999999999999999999
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
+..++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||..+.++|+||||||+||+++.++..++. ||
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 99999999999999999995 38999999999999999999997766779999999999999999888875 66
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
....... .....++..|+|||++.+..++.|+|||||||++|||+||+.||+.... ....++.|++..... .
T Consensus 828 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~ 899 (968)
T PLN00113 828 LPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-C 899 (968)
T ss_pred ccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-c
Confidence 5543211 1223578999999999999999999999999999999999999964332 345677887654432 2
Q ss_pred ccccccCCCCCCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 003605 638 GLERIIDPSLGND--VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 638 ~l~~ivD~~l~~~--~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
....++|+.+... .+.++..++.+++.+||+.+|++||+|+||+++|+.+.+
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3455667766443 345677789999999999999999999999999997755
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=388.50 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=211.8
Q ss_pred CCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.+|...++||+|||+.+|+++. ..|+.||+|++.+ ......+...+||+|.+.|+|||||+|+++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999997 7899999999965 23445677899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
|+|++|+|.++++ .+..+++.++..+..||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999985 4567999999999999999999999998 99999999999999999999999999987754
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
++.+ ....+||+.|+|||++.....+..+||||+|||||-||+|++||+..... +.+..+..
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------------ety~~Ik~ 232 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------------ETYNKIKL 232 (592)
T ss_pred cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------------HHHHHHHh
Confidence 4333 34679999999999999989999999999999999999999999753211 11111211
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
... ..|.....+..+||.++|+.||.+||++++|+..
T Consensus 233 ~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 NEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111 1233455678899999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=398.67 Aligned_cols=266 Identities=27% Similarity=0.459 Sum_probs=224.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-C---CCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-D---GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-d---g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
...++++||.|.||.||+|+++ . ...||||.||.. .+...++|+.|+.||+++.||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4557899999999999999986 2 356999999974 4555679999999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
|||+||+|+.||+..+ ..+.|.+..-++.+||.||.||-+.+ +|||||.++|||++.+..+||+||||+|.+.+
T Consensus 710 EyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999998654 34899999999999999999999998 99999999999999999999999999997655
Q ss_pred cccccccccc--ccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 565 EESRHISTRV--MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 565 ~~~~~~~~~~--~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
+. ....+.. .-..+|.|||.+..+++|.+|||||||+||||.++ |.+||-... +. .+-.
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------NQ-dVIk 845 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------NQ-DVIK 845 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------hH-HHHH
Confidence 43 2222222 22578999999999999999999999999999988 999984321 11 1222
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhhhhhcCC
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGS 699 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~~~~~~~~ 699 (808)
.++..++-..|+++...|.+|++.||++|-.+||++.||+..|.++++..+.-+....
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~ 903 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAP 903 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCC
Confidence 3455566677889999999999999999999999999999999999887665544443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=371.73 Aligned_cols=201 Identities=31% Similarity=0.528 Sum_probs=180.7
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.++|...+.||+|+||+||+|+++ ++..||||.+... .....+....||++|+.++|+|||+|++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888888999999999999976 7899999999754 5566778899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC------Ccceeccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD------FTPKVSDFGL 558 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~------~~vKL~DFGL 558 (808)
|||.+|+|.+||+. ...+++.+...++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999973 336999999999999999999999998 9999999999999764 4589999999
Q ss_pred ccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCC
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQ 618 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~ 618 (808)
||.+.. .......+|++-|||||+++.++|+.|+|+||.|+||||+++|+.||+...
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 998753 334456889999999999999999999999999999999999999997543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.37 Aligned_cols=265 Identities=26% Similarity=0.428 Sum_probs=207.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEe------eCCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeEEeeeeecc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l------~dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~ 478 (808)
..++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +|+||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 356789999999999999999974 235679999997532 33456799999999999 8999999999987654
Q ss_pred -ceEEEEeecCCCCcccccccccc--------------------------------------------------------
Q 003605 479 -ARCLVYELIPNGSVESHLHGVDK-------------------------------------------------------- 501 (808)
Q Consensus 479 -~~~LV~Ey~~~GsL~~~L~~~~~-------------------------------------------------------- 501 (808)
..++||||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864221
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccccccccc
Q 003605 502 --ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579 (808)
Q Consensus 502 --~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~ 579 (808)
....+++.++++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0235889999999999999999999988 99999999999999999999999999986533222222223446788
Q ss_pred cccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHH
Q 003605 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 658 (808)
Q Consensus 580 Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~ 658 (808)
|+|||++.+..++.++|||||||+||||++ |..||...... ..+.. .+.... ....+......
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~~~----------~~~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQ----RLKDGT----------RMRAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHH----HHhcCC----------CCCCCCCCCHH
Confidence 999999999999999999999999999997 99999653321 11111 011000 01112234467
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 659 VAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 659 l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
+.+|+.+||+.||++||++.||++.|+.+..+
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 89999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.89 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=211.5
Q ss_pred CcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeEEee-eeeccc-eEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGI-CIEEQA-RCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~-~~~~~~-~~LV~ 484 (808)
+|.+++.||+|.||+|||+. +.+|..||.|.++- .+....++...|+.+|++|+|||||+++++ +.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677899999999999998 55899999999873 456667789999999999999999999994 555555 79999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--EEeeeecccCeeecCCCcceeccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR--VIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~--IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|||..|+|...++...+.+..+++.++|+++.|+++||..+|..- ++ |+||||||.||+|+.+|.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999888888889999999999999999999999842 33 999999999999999999999999999977
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
... .......+||+.||+||.+....|+.||||||+||++|||+.-+.||... ++...-..+.. .
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~q-g------ 243 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQ-G------ 243 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHc-C------
Confidence 543 23345678999999999999999999999999999999999999999642 33332222111 0
Q ss_pred cCCCCCCCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 643 IDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 643 vD~~l~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.+ ...+ .-++..+..|+..|+..|++.||+.-.+++.+.
T Consensus 244 ---d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 ---DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 00 1122 456788999999999999999998655544443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=396.11 Aligned_cols=265 Identities=30% Similarity=0.491 Sum_probs=223.0
Q ss_pred hCCcceeeeeeecCcEEEEEEEee--CCC----EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccce
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD--DGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~--dg~----~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 480 (808)
..+....+.||+|.||.||+|.+. +|. .||||.+++. +.+...+|++|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667789999999999999975 343 4899999864 566778999999999999999999999999999999
Q ss_pred EEEEeecCCCCcccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 481 CLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~---~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
++++|||++|+|..||+..+. ....|...+.+.|+.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999986532 2456899999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
||+...+.++.......+-...|||||.++++.|+.|+|||||||+|||++| |..||...... +-+..|.+ .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~~~~-----g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLDVLE-----G 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHHHHh-----C
Confidence 9997766666555555455689999999999999999999999999999999 99999643221 11111111 1
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
. +-+.+..+...+.+++.+||+.+|++||++..|++.+..+.+...
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1 223566778899999999999999999999999999998877654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=360.25 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=202.2
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc-------hhhHHHHHHHHHHhhcccccceeEEeeeeecc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~-------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 478 (808)
..+.|.+.+.||+|+||.|-+|... +|+.||||++++... .......+|+++|++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4466788899999999999999854 899999999975211 12234579999999999999999999999999
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC---Ccceecc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD---FTPKVSD 555 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~---~~vKL~D 555 (808)
..|||+||+++|.|.+++-. ...+.+.....++.|++.|+.|||+.+ |+||||||+||||..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999853 345777888899999999999999999 9999999999999665 7899999
Q ss_pred cccccccccccccccccccccccccccchhhhcCCC---ccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 003605 556 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL---LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 556 FGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
||+|+... ........+||+.|.|||++.+..+ ..|.|+||+|||||-+++|..||...... ..+.
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~------ 391 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLK------ 391 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHH------
Confidence 99999764 2334456789999999999987643 34789999999999999999999753321 1111
Q ss_pred cccccccccccCCCCC--CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 633 LTSREGLERIIDPSLG--NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+++..-.+. ...-.+...+..+++.+||..||++||++.|+++.
T Consensus 392 -------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 392 -------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111111110 01113456788999999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=350.22 Aligned_cols=260 Identities=19% Similarity=0.364 Sum_probs=206.9
Q ss_pred CcccCCHHHHHHHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchh---hHHHHHHHHHHhhcccccceeEE
Q 003605 395 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG---GREFLAEVEMLSRLHHRNLVKLI 471 (808)
Q Consensus 395 s~~~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~ 471 (808)
+.+.++.++++.. ....||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|.+++|+||++++
T Consensus 11 ~~~~i~~~~i~~~-----~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDKY-----TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCCC-----CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 3455677776322 236799999999999998 58999999997543322 46788999999999999999999
Q ss_pred eeeee----ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeeeecccCeeec
Q 003605 472 GICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLE 546 (808)
Q Consensus 472 g~~~~----~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~-~~p~IiHrDIKpsNILLd 546 (808)
|++.+ ....++||||+++|+|.++++. ...++|...++++.+++.||+|||+. + ++||||||+|||++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~ 157 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVT 157 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEEC
Confidence 99877 3467899999999999999963 24689999999999999999999985 5 78999999999999
Q ss_pred CCCcceecccccccccccccccccccccccccccccchhhhc--CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcch
Q 003605 547 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 624 (808)
Q Consensus 547 ~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~ 624 (808)
+++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~ 229 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KE 229 (283)
T ss_pred CCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HH
Confidence 99999999999987543221 23457889999999876 6889999999999999999999999974321 11
Q ss_pred hHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 625 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 625 lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
+... .... ......+......+.+++.+||+.||++||++.||++.|+.+.
T Consensus 230 ~~~~---i~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 230 IYDL---IINK----------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHH---HHhc----------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111 1110 0111122234567999999999999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=363.12 Aligned_cols=265 Identities=25% Similarity=0.439 Sum_probs=220.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.....+.++||+|-||.|..+....+..||||+++... ....++|.+||++|.+|+|||||+|+|+|..++.+|+|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34556678999999999999999888999999998654 44458999999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
|++|+|.+||...... .++-...++|+.|||.||+||.+.+ +|||||.++|||+|.++++||+|||++|.+...+
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999754322 2455677889999999999999887 9999999999999999999999999999888888
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh--CCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT--G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
+.++..+.+-..+|||+|.+..++++.+||||+|||.|||+++ ...||..... ++.++-+..++..... ..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~-~~--- 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGR-QV--- 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCc-ce---
Confidence 8887777788899999999999999999999999999999866 7788864332 2333332222221111 11
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.-..|.-+...+.+++.+||+.|-++||+++++...|++.
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112445667899999999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=369.60 Aligned_cols=271 Identities=25% Similarity=0.432 Sum_probs=214.4
Q ss_pred CCHHHHHHHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeee
Q 003605 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476 (808)
Q Consensus 399 fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 476 (808)
.+.++++.-.+.+.+.+.||+|.||+||+|.+.. .||||+|+.. ..+..+.|.+|+..|++-+|.||+-|.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3446666667777788999999999999999862 6999999853 34567899999999999999999999999998
Q ss_pred ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
... .+|+.+|++.+|+.|||..+ ..++..+.++||.|||+||.|||.++ |||||||..||||+++++|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 766 99999999999999999543 46889999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhc---CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
||+..-..-.........-|...|||||+++. ..|+..|||||||+|+|||+||..||.... . +..-|+ +
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~---dqIifm---V 605 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-R---DQIIFM---V 605 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-h---hheEEE---e
Confidence 99853222111112223346788999999974 468999999999999999999999997211 1 111111 0
Q ss_pred ccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 634 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
..+....+.. ....++..+|.+|+..||..++++||.+.+|+..|+++....
T Consensus 606 GrG~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 606 GRGYLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cccccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 1111011111 122356678999999999999999999999999998887654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.35 Aligned_cols=264 Identities=26% Similarity=0.455 Sum_probs=205.4
Q ss_pred CCcceeeeeeecCcEEEEEEEeeC-----------------CCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDD-----------------GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKL 470 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~d-----------------g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L 470 (808)
++|.+.+.||+|+||.||++.+++ +..||+|.++.. ......+|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998542 336999998753 23345689999999999999999999
Q ss_pred EeeeeeccceEEEEeecCCCCcccccccccc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 003605 471 IGICIEEQARCLVYELIPNGSVESHLHGVDK---------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535 (808)
Q Consensus 471 ~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~---------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiH 535 (808)
++++.+.+..++||||+++|+|.+++..... ....++|.++++|+.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998854211 1135789999999999999999999988 999
Q ss_pred eeecccCeeecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh--CCCC
Q 003605 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKP 613 (808)
Q Consensus 536 rDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT--G~~P 613 (808)
|||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544333233334456789999999998999999999999999999987 4566
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 614 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 614 ~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
|..... .....++......... .. ....+......+.+|+.+||+.+|++||++.||++.|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGR--QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccc--cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 653321 2222222211111000 00 00112234467899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=352.21 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=202.6
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
-++|++.++||+|+||+||.++.. +++.+|+|++++. .....+...+|..+|.+++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999854 6899999999752 334567788999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
+||+.||.|..+|. +...+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||||+...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999995 3345888888888999999999999999 9999999999999999999999999998544
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... ..+...+||+.|||||++.+..|+..+|.||+|+++|||++|..||... +...+...+...+
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------~~~~~~~~I~~~k------- 241 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------DVKKMYDKILKGK------- 241 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------cHHHHHHHHhcCc-------
Confidence 322 2334478999999999999999999999999999999999999999643 2333333332221
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 676 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 676 (808)
+ ...+.-...+..+++...|..||++|..
T Consensus 242 ---~-~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ---L-PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ---C-CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 0 1122223467889999999999999963
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=371.76 Aligned_cols=268 Identities=28% Similarity=0.461 Sum_probs=218.3
Q ss_pred HHHHHHHhCCcceeeeeeecCcEEEEEEEeeC--C--CE-EEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEe
Q 003605 401 ASEIEKATGNFDASRILGEGGFGLVYSGVLDD--G--TK-VAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472 (808)
Q Consensus 401 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~d--g--~~-VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g 472 (808)
...++-..++....++||+|+||.||+|.+.. + .. ||||..+. .......+|++|+++|+.++|+|||+|+|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34455556677777999999999999999763 2 23 89999984 45677789999999999999999999999
Q ss_pred eeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcce
Q 003605 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 552 (808)
Q Consensus 473 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vK 552 (808)
++..+..+++|||+|.||+|++||+... ..++..++++++.++|+||+|||.++ +|||||.++|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999997432 36999999999999999999999998 99999999999999999999
Q ss_pred ecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 003605 553 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 553 L~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~ 631 (808)
|+||||++.... .......-.-...|+|||.+..+.|+.++|||||||++||+++ |..||...... .+.
T Consensus 303 ISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~----- 372 (474)
T KOG0194|consen 303 ISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVK----- 372 (474)
T ss_pred eCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHH-----
Confidence 999999875421 1111111235679999999999999999999999999999999 88898643221 111
Q ss_pred hcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 003605 632 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 632 ~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
..++........+......+..++.+|+..+|++||+|.+|.+.|+.+.....
T Consensus 373 --------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 373 --------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11222233334455667788999999999999999999999999998876654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.05 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=205.7
Q ss_pred hCCcceeeeeeecCcEEEEEEEe------eCCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccc
Q 003605 408 TGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 479 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l------~dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 479 (808)
.++|++.+.||+|+||.||+|+. +++..||||+++.. .....+.+.+|++++..+ +|+||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688889999999999999973 24568999999743 233456789999999999 89999999999999999
Q ss_pred eEEEEeecCCCCcccccccccc----------------------------------------------------------
Q 003605 480 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 501 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~---------------------------------------------------------- 501 (808)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864221
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 502 -------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 502 -------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
....++|..+++|+.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125889999999999999999999988 999999999999999999999999999865433222
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.......++..|+|||++.+..++.++|||||||++|||++ |..||..... ......+... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~~~--------------~~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMIKE--------------GY 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHHHh--------------Cc
Confidence 22223345678999999999999999999999999999998 8888864321 1122222111 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
....+.....++.+|+.+||+.||++||++.||++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111112245789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=362.33 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=206.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccc
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 479 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 479 (808)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999998742 34579999997532 33356788999999999 89999999999999999
Q ss_pred eEEEEeecCCCCcccccccccc----------------------------------------------------------
Q 003605 480 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 501 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~---------------------------------------------------------- 501 (808)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998853210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccc
Q 003605 502 --------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573 (808)
Q Consensus 502 --------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~ 573 (808)
....++|.++++|+.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1135889999999999999999999988 99999999999999999999999999976543222222223
Q ss_pred cccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 574 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 574 ~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+.. .+........+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~--------------~~~~~~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYK--------------MVKRGYQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHH--------------HHHcccCccCC
Confidence 345678999999999999999999999999999997 99998643221 11111 00111111111
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
.....++.+++.+||+.+|++||++.+|++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 223467899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.49 Aligned_cols=251 Identities=34% Similarity=0.586 Sum_probs=196.1
Q ss_pred ceeeeeeecCcEEEEEEEee-----CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 412 DASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 412 ~~~~~LG~G~fG~VYkg~l~-----dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++.+.||.|.||.||+|.+. .+..|+||.++.. .....++|.+|++++++++|+||++++|+|...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999987 3567999999753 33457899999999999999999999999998888999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.++|+.. ....++|.++++|+.|+++||+|||+.+ ++|+||+++|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999753 2356999999999999999999999988 999999999999999999999999999865322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
..............|+|||.+....++.++||||||+++|||++ |+.|+.... ..++... + .....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~---~-~~~~~------ 223 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEK---L-KQGQR------ 223 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHH---H-HTTEE------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc---c-ccccc------
Confidence 22222233456789999999999999999999999999999999 778875431 1111111 1 11110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
...+......+.+++.+||+.+|++||++.+|++.|
T Consensus 224 ----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112223456789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=341.95 Aligned_cols=258 Identities=30% Similarity=0.506 Sum_probs=208.2
Q ss_pred CCcceeeeeeecCcEEEEEEEeeC------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~d------g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
++|++.+.||+|+||.||+|.... ...||+|.++... .....+|.+|++++.+++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778999999999999998642 2579999987432 334567999999999999999999999999989999
Q ss_pred EEEeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC
Q 003605 482 LVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 549 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~ 549 (808)
++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 1145889999999999999999999998 99999999999999999
Q ss_pred cceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 003605 550 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAW 628 (808)
Q Consensus 550 ~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w 628 (808)
.+||+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986543333233334456789999999998999999999999999999998 9999864322 122221
Q ss_pred hhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 629 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 629 ~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.. .......+.....++.+|+.+||+.+|++||++.||++.|+.
T Consensus 239 i~--------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IR--------------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH--------------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 111112234456789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=362.76 Aligned_cols=239 Identities=28% Similarity=0.505 Sum_probs=201.9
Q ss_pred eeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 413 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
.++.||.|+.|.||+|++. ++.||||+++... ..+|+.|++|+|+||+.|.|+|.....+|+|||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3578999999999999997 7899999987432 2578899999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
++.|+ .+..+.-.....|..+||.||.|||.+. |||||||.-||||..+..+||+|||-++...+. . ..-
T Consensus 200 ~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-S--TkM 269 (904)
T KOG4721|consen 200 YEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-S--TKM 269 (904)
T ss_pred HHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-h--hhh
Confidence 99995 3456888889999999999999999998 999999999999999999999999999865433 1 122
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...||..|||||++.+...++|.|||||||||||||||..||..-+.. .+-|- +-...|.-..+
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwG------------VGsNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWG------------VGSNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEe------------ccCCcccccCc
Confidence 467999999999999999999999999999999999999999643211 11111 11112233456
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
..+..-|.-|+++||+..|..||++++|+..|+
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 677788999999999999999999999999885
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=346.67 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=205.3
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCC----EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~----~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.+|+..+.||+|+||.||+|++. +++ .||||.++.. .....++|.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 344 3899998753 334567899999999999999999999999864 5689
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|+||+++|+|.++++.. ...+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999642 345889999999999999999999988 999999999999999999999999999865
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||+.... ..+..+. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~~~~~----~~~----- 227 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL----EKG----- 227 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----hCC-----
Confidence 43222221222334678999999999999999999999999999998 9999864321 1111111 100
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
.....+..+...+.+++.+||+.+|++||++.+++..|..+..+.
T Consensus 228 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001112233457889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.09 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=204.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee----CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~----dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.++||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++|+||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999864 35689999998542 33456799999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+++|+|.+++... ...++|.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999632 246899999999999999999999988 9999999999999999999999999876432
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
.... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~------------ 222 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAVE------------ 222 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHH------------
Confidence 2111 11112335678999999999999999999999999999875 9999964321 11111110
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
+ ......+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus 223 -~-~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 223 -D-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -C-CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 001112234456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.49 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=201.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.|+..+.||+|+||+||++... +|+.||||.+.... ......+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999864 78999999986432 2334568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999887532 2235899999999999999999999988 999999999999999999999999999764322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ......||..|+|||++.+..++.++|||||||+||||++|+.||.......... ..... +.+
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~----------~~~- 219 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDRR----------VKE- 219 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHHH----------hhc-
Confidence 1 1233468999999999999999999999999999999999999997543211110 00000 000
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 683 (808)
....++......+.+|+.+||+.||++||+ ++|+++.
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011123334567899999999999999997 7887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.64 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=204.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeecc--ceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ--ARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV~E 485 (808)
.++...+.||+|+||+||++... +|+.+|||.+...+....+.+.+|+.+|.+++|+|||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34566789999999999999976 48999999987654333677899999999999999999999855544 5899999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-CCcceeccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMD 564 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-~~~vKL~DFGLa~~~~~ 564 (808)
|+++|+|.+++.... . .|++..+.+++.||++||+|||+++ |||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999997432 2 6999999999999999999999998 999999999999999 79999999999986543
Q ss_pred -ccccccccccccccccccchhhhcCCC-ccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 565 -EESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 565 -~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
...........||+.|||||++..+.. ..++|||||||+++||+||+.||... .....+.-.....
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~------- 238 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRE------- 238 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhcc-------
Confidence 111122334779999999999986543 35999999999999999999999643 1111111111111
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.....++.....+..+++.+|+..+|++|||+.++++....
T Consensus 239 ---~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 239 ---DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ---CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 11123444556788999999999999999999999887654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.39 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=209.9
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeec
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 477 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 477 (808)
...++|+..+.||+|+||.||++... +...+|+|+++.. ......++.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567889999999999999999864 2357999998753 334456789999999999 799999999999999
Q ss_pred cceEEEEeecCCCCccccccccc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee
Q 003605 478 QARCLVYELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~------------~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL 545 (808)
+..+++|||+++|+|.++++... .....++|..+++++.|++.||+|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999986421 22346899999999999999999999987 9999999999999
Q ss_pred cCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003605 546 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 624 (808)
Q Consensus 546 d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~ 624 (808)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HH
Confidence 9999999999999986543322222223345678999999998899999999999999999998 8888853221 11
Q ss_pred hHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 625 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 625 lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
+... +........+......+.+++.+|++.+|++||++.||++.|+.+.
T Consensus 243 ~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKL--------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH--------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111 1111111223344568999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=338.23 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=208.0
Q ss_pred CCcceeeeeeecCcEEEEEEEeeC------CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~d------g~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..++|.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998643 478999999865443 4678999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccccc----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcc
Q 003605 482 LVYELIPNGSVESHLHGVD----------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~----------~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~v 551 (808)
+||||+++|+|.++++... .....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997532 12345889999999999999999999988 9999999999999999999
Q ss_pred eecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~ 630 (808)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .....+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH
Confidence 9999999975433222222234456788999999999999999999999999999999 9999864321 22222211
Q ss_pred hhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 631 ~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
. ......+......+.+++.+||+.+|++||++.||++.|+
T Consensus 239 ~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 Q--------------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred c--------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 0001112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=339.54 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=211.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
++|.+.+.||+|+||.||+|... ++..+++|.++.......+.|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999743 345689999886655566789999999999999999999999999999999
Q ss_pred EEeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCc
Q 003605 483 VYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~ 550 (808)
||||+++++|.++++.... ....++|..+++++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999964321 1235899999999999999999999998 999999999999999999
Q ss_pred ceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 003605 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 629 (808)
Q Consensus 551 vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~ 629 (808)
++|+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |+.||..... .......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence 99999999976543332223334556788999999999999999999999999999999 9999864322 1111111
Q ss_pred hhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 630 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 630 ~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
. .... ...+......+.+++.+||+.+|++||++.+|+++|+++...
T Consensus 239 ----~---------~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 ----T---------QGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----h---------CCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0 0000 011122346789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.94 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=210.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
++|.+.+.||+|+||+||++... ++..+|+|.++.......+.+.+|++++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999842 345689999987666667789999999999999999999999999999999
Q ss_pred EEeecCCCCccccccccc---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCccee
Q 003605 483 VYELIPNGSVESHLHGVD---------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 553 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~---------~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL 553 (808)
||||+++++|.++++... .....++|.++++++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 12235899999999999999999999988 999999999999999999999
Q ss_pred cccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhh
Q 003605 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 554 ~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |..||..... .......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---
Confidence 99999976533222222233445778999999998899999999999999999999 8988864321 1111111
Q ss_pred cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
.. .. . ...+......+.+|+.+||+.+|.+||++.||++.|+.+...
T Consensus 236 ~~-~~-~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQ-GR-V---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred Hc-CC-c---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00 00 0 001122345789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.05 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=207.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee----CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~----dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.+.||+|+||+||+|.+. +...||||.++.. ......+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999874 2457999998753 334456899999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+++++|.++++.. ...++|.++++++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999642 236899999999999999999999988 9999999999999999999999999998764
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~----------- 223 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVED----------- 223 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHc-----------
Confidence 2222222222345678999999998899999999999999999998 999985322 1112121110
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
......+......+.+++.+|++.+|++||++.||++.|+++
T Consensus 224 ---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 ---GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001111233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.34 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=207.3
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..++|++.+.||+|+||.||+|...+++.||||.++... ...++|.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 356789999999999999999998878889999987532 3457899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.+++.... ...++|..+++++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999996432 346899999999999999999999988 9999999999999999999999999998654221
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ........+..|+|||++.+..++.++||||||+++|||+| |+.||..... ..+.... +.
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~--------------~~ 219 (261)
T cd05068 158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQV--------------DQ 219 (261)
T ss_pred c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH--------------Hc
Confidence 1 11111223457999999998899999999999999999999 9999864321 1111110 00
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
......+......+.+++.+|++.+|++||++.++++.|++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11111223345679999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.30 Aligned_cols=259 Identities=27% Similarity=0.498 Sum_probs=205.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 479 (808)
.+++|++.+.||+|+||.||+|... +++.||||+++... .....+|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999753 34679999986432 2345678999999999999999999999999899
Q ss_pred eEEEEeecCCCCccccccccccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCccee
Q 003605 480 RCLVYELIPNGSVESHLHGVDKE------SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 553 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~------~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL 553 (808)
.++||||+++|+|.++++..... ...++|..++.++.|++.||+|||+.+ ++||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 234788999999999999999999987 999999999999999999999
Q ss_pred cccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhh
Q 003605 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 554 ~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||..... .....+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--
Confidence 99999876543322222223345788999999999899999999999999999999 7888854321 11111110
Q ss_pred cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+... ...+......+.+++.+|++.+|++||++.|+++.|+
T Consensus 236 -----------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 -----------EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -----------cCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 1122234467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.82 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=206.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.++|++.+.||+|+||.||+++.. ++..||+|.++.. .....+++.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999976 6888999998753 23445679999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.++++. ...+++..+..++.|++.||+|||+.+ .|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999853 235889999999999999999999753 3999999999999999999999999998755322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-hccccc-------
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP-LLTSRE------- 637 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~-~~~~~~------- 637 (808)
......|+..|+|||++.+..++.++|||||||++|||+||+.||...... .+...... .....+
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCccccC
Confidence 123356899999999999999999999999999999999999999643321 11111000 000000
Q ss_pred -------------------------ccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 638 -------------------------GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 638 -------------------------~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
....++..............++.+++.+||+.||++||++.|+++..-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 000000000000001124467899999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=338.23 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=207.4
Q ss_pred CcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
+|.+.+.||+|+||.||+|+.. ....+++|.++... ....+++.+|+.+++.++|+||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578999887533 3345689999999999999999999999999999999
Q ss_pred EEeecCCCCcccccccccc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccC
Q 003605 483 VYELIPNGSVESHLHGVDK--------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 542 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~--------------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsN 542 (808)
++||+.+|+|.+++..... ....++|.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999864221 1235889999999999999999999988 9999999999
Q ss_pred eeecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCC
Q 003605 543 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPG 621 (808)
Q Consensus 543 ILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~ 621 (808)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999976543322211223345678999999998899999999999999999999 9999864321
Q ss_pred cchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 003605 622 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 622 ~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
..+..+.. .......+......+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 236 -~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 -ERLFNLLK--------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHHh--------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12222211 111112223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=335.28 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=212.3
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
+...+|...++||+|+||.||+|...+++.+|+|.++.......+++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888899999999999999988899999999987666566789999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.++++.. ....++|.+++.++.+++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999743 2346899999999999999999999988 999999999999999999999999999765332
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. .......++..|++||.+.++.++.++||||||+++|||++ |+.||..... .....+..
T Consensus 158 ~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~-------------- 218 (261)
T cd05148 158 V--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT-------------- 218 (261)
T ss_pred c--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH--------------
Confidence 1 11123345678999999998899999999999999999998 8999864321 11222111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.......+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111112233445678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.97 Aligned_cols=255 Identities=25% Similarity=0.413 Sum_probs=207.2
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.++|++.+.||+|+||.||+|...+++.||+|.++.. ....+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578899999999999999999888889999998753 334578999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++|+|.++++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999999642 2346889999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.......++..|+|||++....++.++|||||||++|||+| |+.||..... .....+.... . .
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~----~------~-- 222 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRG----Y------R-- 222 (261)
T ss_pred -eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcC----C------C--
Confidence 11223345678999999998889999999999999999999 9999864221 1222221100 0 0
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
..........+.+++.+|+..+|++||+++++.+.|++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.14 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=204.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 68899999997532 234567889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.++++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999952 345889999999999999999999998 99999999999999999999999999975432
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHHhhhhhccccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~~~~l~~iv 643 (808)
......||..|+|||++.+..++.++|||||||+||||++|+.||........ ..+..|.. .+.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------~~~--- 218 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-------TLQ--- 218 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-------ccc---
Confidence 22345689999999999999999999999999999999999999975332111 11111110 000
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.. .........++.+++.+||..+|++||++.|+++.
T Consensus 219 ~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0100 00012334678899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=357.54 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=209.9
Q ss_pred CcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
.|...+.||+|+.|.||.+.. .+++.||||++........+-+++|+.+|+..+|+|||++++.|..+++++.|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 455567899999999999984 4788999999987777777889999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.|.+.. ..+++.++..|+.+++.||+|||.++ |+|||||.+||||+.++++||+|||+|..+.....
T Consensus 354 ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999853 34999999999999999999999998 99999999999999999999999999987755433
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
..+..+||+.|||||++....|..|.||||||++++||+-|..||-...+.. .-|. +. .... +.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr----AlyL---Ia-~ng~-----P~-- 488 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYL---IA-TNGT-----PK-- 488 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH----HHHH---Hh-hcCC-----CC--
Confidence 3456789999999999999999999999999999999999999996432211 1110 11 0111 11
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+......|.+++.+||+.|+++|++++|+|++
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 12234456789999999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.66 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=207.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeEEeeeeecc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~ 478 (808)
..++|.+.++||+|+||.||+|+.. .+..||||+++... ....+.|.+|+++|.++. |+||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888999999999999999853 23469999997532 334567999999999996 999999999999999
Q ss_pred ceEEEEeecCCCCcccccccccc---------------------------------------------------------
Q 003605 479 ARCLVYELIPNGSVESHLHGVDK--------------------------------------------------------- 501 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~--------------------------------------------------------- 501 (808)
..+||||||++|+|.++|+....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864311
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeec
Q 003605 502 -----------------------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 546 (808)
Q Consensus 502 -----------------------------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd 546 (808)
....++|.++++++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0134889999999999999999999988 99999999999999
Q ss_pred CCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 003605 547 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENL 625 (808)
Q Consensus 547 ~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~l 625 (808)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+||||++ |..||...... ..+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH
Confidence 999999999999986543222222223456788999999999899999999999999999997 99998643211 111
Q ss_pred HHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 003605 626 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 626 v~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
... .... .....+......+.+++.+||+.+|++||++.+|+++|+.++.
T Consensus 350 ~~~----~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNK----IKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH----HhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111 0000 0011122344678999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.56 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=202.7
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
++|++.+.||+|+||.||++.+.++..+|+|.++.. ....++|.+|++++++++|+||++++++|.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357788999999999999999888889999998643 3335689999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.++++.. ...++|..++.++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999998642 235899999999999999999999988 999999999999999999999999998764322211
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|+|||++....++.++||||||+++|||++ |+.||..... .....+... .. ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~----~~---~~~---- 221 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISR----GF---RLY---- 221 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----CC---CCC----
Confidence 1112235568999999988889999999999999999999 8999864321 122222111 00 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.+......+.+++.+||+.+|++||++.|+++.|
T Consensus 222 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1122335789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=336.52 Aligned_cols=266 Identities=20% Similarity=0.267 Sum_probs=201.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|++.+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999976 6789999999753 23345678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|++++.|..+.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999877665442 2346899999999999999999999988 999999999999999999999999999865332
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhh-hhh-------ccccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA-RPL-------LTSRE 637 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~-~~~-------~~~~~ 637 (808)
.. .......|+..|+|||++.+..++.++|||||||++|||++|+.||......+........ .+. .....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 21 1223456899999999999989999999999999999999999999653321110000000 000 00000
Q ss_pred ccccccCCCCCC------CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 638 GLERIIDPSLGN------DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 638 ~l~~ivD~~l~~------~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.......+.... .+.......+.+++.+||+.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000010000 011123457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=334.86 Aligned_cols=257 Identities=27% Similarity=0.471 Sum_probs=205.0
Q ss_pred CCcceeeeeeecCcEEEEEEEe-----eCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l-----~dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
++|++.+.||+|+||+||+|.+ .++..||+|.++.. ..+...+|.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999984 24678999999753 33445689999999999999999999999999999999
Q ss_pred EEeecCCCCcccccccccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC
Q 003605 483 VYELIPNGSVESHLHGVDK-------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 549 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~-------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~ 549 (808)
||||+++++|.++++.... ....+++.+.+.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235889999999999999999999988 99999999999999999
Q ss_pred cceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 003605 550 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAW 628 (808)
Q Consensus 550 ~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w 628 (808)
.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986543332222233445778999999988889999999999999999999 8888854321 111111
Q ss_pred hhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 629 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 629 ~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
... ......+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 239 ~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 239 VRK--------------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHc--------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 110 0001122234467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.29 Aligned_cols=264 Identities=26% Similarity=0.400 Sum_probs=206.5
Q ss_pred hCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeEEeeeeec-c
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE-Q 478 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~-~ 478 (808)
.++|++.++||+|+||.||+|... +++.||+|+++... ....+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457889999999999999999742 34789999997532 23346788999999999 899999999988654 5
Q ss_pred ceEEEEeecCCCCcccccccccc---------------------------------------------------------
Q 003605 479 ARCLVYELIPNGSVESHLHGVDK--------------------------------------------------------- 501 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~--------------------------------------------------------- 501 (808)
..++++||+++|+|.++++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccccccccccc
Q 003605 502 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581 (808)
Q Consensus 502 ~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~ 581 (808)
....++|..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0136899999999999999999999988 9999999999999999999999999998654322222222345677899
Q ss_pred cchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHH
Q 003605 582 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVA 660 (808)
Q Consensus 582 APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~ 660 (808)
|||++.+..++.++|||||||+||||++ |..||...... ..+.... ... .....+.....++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~----------~~~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRL----KEG----------TRMRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHH----hcc----------CCCCCCccCCHHHH
Confidence 9999999999999999999999999998 99998643221 1111111 000 01111223446789
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 661 AIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 661 ~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
+++.+||+.+|++||++.||+++|+.++++
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=333.58 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=206.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
+.|+...++|+|+||.|||++.+ +|+.||||++... +..-.+-.++||++|++|+|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999976 7999999999753 33445668899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
||+. ++.+-|. .....++.+...+++.|+++|+.|+|+++ +|||||||+||||..++.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9976 4434343 23345888999999999999999999998 99999999999999999999999999998753
Q ss_pred cccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHh--------hhhhcccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW--------ARPLLTSR 636 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w--------~~~~~~~~ 636 (808)
.....+..+.|.+|+|||.+.+ -+|....|||+.||++.||++|..-|-...+-++-.++.- .+.++...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3344567789999999999987 6889999999999999999999988865544333222211 11111111
Q ss_pred cccccccCCC------CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 637 EGLERIIDPS------LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 637 ~~l~~ivD~~------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.-+.-|. +...++ ....-+++++..||+.||.+|++-+|++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 111122 234578999999999999999999999853
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.12 Aligned_cols=264 Identities=23% Similarity=0.407 Sum_probs=211.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeC-----CCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeee-ccc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQA 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~d-----g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~ 479 (808)
..++|.+.++||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35688899999999999999999765 688999998754 33445778999999999999999999999876 467
Q ss_pred eEEEEeecCCCCccccccccccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKE----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 555 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~----~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~D 555 (808)
.++++||+++|+|.+++...... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 79999999999999998654322 146899999999999999999999988 99999999999999999999999
Q ss_pred cccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcc
Q 003605 556 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLT 634 (808)
Q Consensus 556 FGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~ 634 (808)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHc---
Confidence 999986544333222233456778999999998889999999999999999999 9999964321 222222211
Q ss_pred cccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 635 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 635 ~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
... ..........+.+++.+|+..+|++||++.||++.|+.+.++
T Consensus 235 -~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 -GYR----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -CCC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 000 001112345789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=330.03 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=206.3
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.+|.+.+.||+|+||.||+|... +++.||+|+++.. ....+++.+|++++++++|+||++++++|..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999965 5889999998753 344578999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.+++... ....++|..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998642 2345899999999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
. ......++..|+|||++.+..++.++|||||||++|||++ |..|+..... .. +.... ...
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~---~~~~~-----------~~~ 221 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQ---VYELL-----------EKG 221 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HH---HHHHH-----------HCC
Confidence 1 1112234568999999999999999999999999999998 8888864221 11 11111 011
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.....+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122333456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=343.16 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=200.2
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|++++.+++|+||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57889999999999999999975 6889999999753 2234567899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999863 235888999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~----------~ 229 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKIL----------A 229 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHh----------c
Confidence 21 234689999999999999999999999999999999999999964221 11111111 1
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 683 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 683 (808)
..+ .++......+.+++.+||+.||++|++ +.++++.
T Consensus 230 ~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 230 GRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 110 112223456889999999999999996 5666543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.80 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=204.6
Q ss_pred hCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 482 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 482 (808)
.+.|+..++||+|.||.||||+ +.+|+.||+|+++... .....-..+||.||++|+||||++|.+...+. +..||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457777899999999999998 4589999999998543 33445667999999999999999999999877 68899
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|+|||+. +|.-++. .....++..++..++.|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||||+.+
T Consensus 196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999976 8888775 33456899999999999999999999998 999999999999999999999999999976
Q ss_pred ccccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhH----------Hhhhh
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV----------AWARP 631 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv----------~w~~~ 631 (808)
....... .+..+-|.+|+|||++.+. .|+.+.|+||.||||.||++|+..+....+.++.+.+ .|...
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 5443333 4556689999999999874 7899999999999999999999998765543332221 12210
Q ss_pred hcccccccccccCC------CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 632 LLTSREGLERIIDP------SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 632 ~~~~~~~l~~ivD~------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.+. ...++.+ .+.+. -.......++|+..+|..||.+|.|+.++++
T Consensus 348 kLP----~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLP----HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCC----cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 010 0011111 11111 1123456788999999999999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=328.93 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=209.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||+|+.. +++.||||.++. .......+|.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999965 789999998864 22344567899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.........+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654444456889999999999999999999988 99999999999999999999999999876533
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||..... +...+...... ...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~-------~~~ 225 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQ-------CDY 225 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhc-------CCC
Confidence 221 11234578899999999988899999999999999999999999854221 11122111110 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
+ ..........+.+++.+||+.+|++||++.||++.|+.+
T Consensus 226 ~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 P---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 111223446789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=362.63 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=206.7
Q ss_pred CcceeeeeeecCcEEEEEEEee-C-CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-D-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-d-g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++|+.++|+|||+++++|...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999854 3 6788999876555555567888999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++|+|.++|+........+++.++..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999998754444557899999999999999999999988 99999999999999999999999999986543332
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....... ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~---~~~~~~~----------~~~ 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---RE---IMQQVLY----------GKY 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HH---HHHHHHh----------CCC
Confidence 2233456799999999999999999999999999999999999999964221 11 1111110 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01122344678999999999999999999999753
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.94 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=202.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCC----EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~----~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
++|++.+.||+|+||+||+|++. +++ .+++|.+.... .....++..|+.+++++.|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777889999999999999864 444 47778775432 2334678889999999999999999999864 56789
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
++||+++|+|.++++. ....++|..++.|+.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999963 2346899999999999999999999988 999999999999999999999999999865
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.............++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+.++. .... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~----~~~~---~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLL----EKGE---R 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCC---c
Confidence 43332222334557789999999999999999999999999999998 9999864322 1111111 1111 0
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
.. .+......+.+++.+|+..+|++||++.|+++.|+.+.++
T Consensus 230 ~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LA-------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 01 1112235678899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.09 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=203.3
Q ss_pred cceeeeeeecCcEEEEEEEeeC----CCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccc-----
Q 003605 411 FDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA----- 479 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~d----g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~----- 479 (808)
|.+.+.||+|+||.||+|.+.. +..||||+++.. .....+++.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998652 367999998743 23445689999999999999999999999876554
Q ss_pred -eEEEEeecCCCCccccccccc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 480 -RCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 480 -~~LV~Ey~~~GsL~~~L~~~~--~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
.++++||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 699999999999999986432 12346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~----- 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR----- 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-----
Confidence 99986543332222222335678999999988889999999999999999999 8888854321 11222211
Q ss_pred ccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
+.. ....+......+.+++.+|++.||++||++.||++.|+++
T Consensus 230 --------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 --------HGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------cCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0112334556899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.45 Aligned_cols=242 Identities=25% Similarity=0.341 Sum_probs=196.9
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
++||+|+||.||++... +|+.||||+++.. ......++.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 7899999999753 2334467889999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~ 570 (808)
+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 99999853 346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCC
Q 003605 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 650 (808)
Q Consensus 571 ~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~ 650 (808)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... ... + ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~---~~~--------~----~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI---LME--------E----IR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHH---HcC--------C----CC
Confidence 2345699999999999999999999999999999999999999964221 1111111 000 0 01
Q ss_pred CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 651 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 651 ~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
++......+.+++.+||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2233456788999999999999999 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=362.25 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=216.3
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeCC-CEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeEEee-eee------c
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDDG-TKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGI-CIE------E 477 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~dg-~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~-~~~------~ 477 (808)
...++++.++|.+|||+.||.|.+..+ ..||+|++-..++...+...+||++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 446678899999999999999998765 999999998778888999999999999997 9999999993 322 1
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
-+.+|.||||.+|+|-|++..+... .|++.++++|+.++++|+++||.. .|+|||||||-+||||..+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 3568999999999999999754433 499999999999999999999988 5889999999999999999999999999
Q ss_pred ccccccccccc-----cccc--ccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 003605 558 LARSAMDEESR-----HIST--RVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 627 (808)
Q Consensus 558 La~~~~~~~~~-----~~~~--~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~ 627 (808)
.|......... .+.. ...-|+.|+|||++. +...++|+|||+|||+||-|+....||+...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------- 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------- 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence 98643221100 0000 123589999999875 5678999999999999999999999997432
Q ss_pred hhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 628 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 628 w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
-..|++..+.-.....+...|.+||+.||+.||++||++.||++.+.++....
T Consensus 263 -----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 -----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22355555444444578899999999999999999999999999998877654
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=327.94 Aligned_cols=248 Identities=29% Similarity=0.440 Sum_probs=197.9
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
+.||+|+||.||+|+.. +++.||+|.+... .......|.+|++++++++|+||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999975 7899999987643 334456899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.++++. ....++|.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999863 2345899999999999999999999988 9999999999999999999999999987543211111111
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~ 651 (808)
....+..|+|||.+.++.++.++|||||||++|||++ |..||..... ..... .++.......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~--------------~~~~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTRE--------------AIEQGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHH--------------HHHcCCCCCC
Confidence 1223467999999999999999999999999999998 8888854221 11111 1111111122
Q ss_pred ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 652 ~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+......+.+++.+|++.+|++||++.||+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3334568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.08 Aligned_cols=267 Identities=28% Similarity=0.413 Sum_probs=202.7
Q ss_pred cceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhh--cccccceeEEeeeeecc----ceEEEE
Q 003605 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR--LHHRNLVKLIGICIEEQ----ARCLVY 484 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~~----~~~LV~ 484 (808)
..+.++||+|+||.||||.+. ++.||||++. .+..+.|.+|-+|++. ++|+||++|+++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 344578999999999999997 5999999986 4556789999998885 58999999999976555 889999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCcEEeeeecccCeeecCCCcceeccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS------SPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~------~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
||.++|+|.+||. ...++|....+|+..+++||+|||+.. +|+|+|||||++||||.+|+++.|+||||
T Consensus 288 ~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999995 246999999999999999999999763 57899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhcCC-C-----ccccceeeHHHHHHHHHhCCCCCCC-CCCCCcchhH-----
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH-L-----LVKSDVYSYGVVILELLSGRKPVDM-TQPPGQENLV----- 626 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~-----s~kSDVwSfGvvLlELlTG~~P~~~-~~~~~~~~lv----- 626 (808)
|..+.........-..+||.+|||||++.+.- + -.+.||||+|.|||||++.-.-++. ..++-+.-..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98776443333333478999999999987542 2 2368999999999999997655432 1111111000
Q ss_pred ----HhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 627 ----AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 627 ----~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
+-++.....+.....+-|... ....+..+.+.+..||+.|++.|-|+.=|.+.+.++...
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111111111111222222111 125678899999999999999999999998888776443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=340.23 Aligned_cols=263 Identities=23% Similarity=0.383 Sum_probs=208.8
Q ss_pred hCCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 408 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.+.|++.++||.|..++||+|+. ..++.||||++.-. .....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46789999999999999999995 46799999999732 23336889999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
||.+||+.+.++..-.. .+++..+..|+.++++||.|||.++ .||||||+.|||||.+|.+||+|||.+..+.+.
T Consensus 105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999754433 4899999999999999999999999 999999999999999999999999998766554
Q ss_pred cccccc--cccccccccccchhhhc--CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 566 ESRHIS--TRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 566 ~~~~~~--~~~~Gt~~Y~APE~l~~--~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
..+... ...+||+.|||||+++. ..|+.|+||||||+...||.+|..||....+- ..-+... .+....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-kvLl~tL-------qn~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-KVLLLTL-------QNDPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-HHHHHHh-------cCCCCC
Confidence 432221 45689999999999654 46899999999999999999999999754321 1111110 011111
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+..+........+.+++..||++||++|||++++++.
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111112222344579999999999999999999999863
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.67 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=223.0
Q ss_pred HHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccce
Q 003605 402 SEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 402 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 480 (808)
++++--..++...++||-|-||.||.|+++ -.-.||||.|+.. .-..++|+.|..+|+.++|+|+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 444444556777899999999999999987 3467999999864 45578999999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
|+|+|||.+|+|.+||+.+.+ ..++--..+.+|.||+.||+||..++ +|||||.++|+|+.++..+||+||||++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999986544 34666778999999999999999988 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
.+..+.+.. .....-...|.|||-+....++.|+|||+|||+||||.| |..||-.-+ ...+
T Consensus 414 lMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqV 475 (1157)
T KOG4278|consen 414 LMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQV 475 (1157)
T ss_pred hhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHH
Confidence 765433221 112233578999999999999999999999999999999 888885321 1123
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
..++...++.+.++.+..++.+|+++||+++|.+||+++|+.+.++.+..+
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 345555666677888999999999999999999999999999999877654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.19 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=200.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999976 6899999998642 2234567889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.++++. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999853 346899999999999999999999998 99999999999999999999999999976532
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~---~~~i~~---------- 212 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGI---YEKILA---------- 212 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHh----------
Confidence 1 1234689999999999988899999999999999999999999964321 111 111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 683 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 683 (808)
.. ..++......+.+++.+||+.||++|++ +.|+++.
T Consensus 213 ~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 213 GK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 0122223457889999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=331.81 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=204.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeC------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~d------g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 479 (808)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678999999999999999999753 5678999886433 3445679999999999999999999999999899
Q ss_pred eEEEEeecCCCCcccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC---ccee
Q 003605 480 RCLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKV 553 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~---~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~---~vKL 553 (808)
.++||||+++++|.++++.... ....++|.++++++.|++.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999965321 1235899999999999999999999988 99999999999998754 5999
Q ss_pred cccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhh
Q 003605 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 554 ~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||+.... ..+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~--- 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFV--- 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---
Confidence 99999986532222111122234568999999999999999999999999999997 9999864322 1111111
Q ss_pred cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
........+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 -----------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 -----------TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 001111123334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.84 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=205.2
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc----cc-hhhHHHHHHHHHHhhcc-cccceeEEeeeeecc
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV----DQ-QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ 478 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~----~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~ 478 (808)
...++|.+.+.||+|.||+|+.|... +++.||||++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 35678999999999999999999854 7899999977542 11 33456778999999998 999999999999999
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Ccceecccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFG 557 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DFG 557 (808)
..++||||+.+|+|.+++.. ..++.+.+..+++.|++.|++|||+++ |+|||||++|||||.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999963 456888999999999999999999998 9999999999999999 999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCC-Cc-cccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGH-LL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .....+.+...
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKG 238 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcC
Confidence 998653 1223345678999999999999877 75 78999999999999999999998522 11111111111
Q ss_pred ccccccccCCCCCCCCChhh-HHHHHHHHHHccccCCCCCCCHHHHH
Q 003605 636 REGLERIIDPSLGNDVPFDS-VAKVAAIASMCVQPEVQHRPFMGEVV 681 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~~~~~~-~~~l~~Li~~Cl~~dP~~RPsm~eVl 681 (808)
.- .++... ..++..++.+|+..||.+|+++.||+
T Consensus 239 ~~------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EF------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Cc------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 112222 57889999999999999999999998
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.93 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=211.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||+|... +|+.||+|.++. ......+++.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999976 889999998863 22334568999999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.........+++.+++.++.++++||+|||+.+ |+||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998654444556899999999999999999999988 99999999999999999999999999875432
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
... ......++..|+|||++.+..++.++|||||||++|||++|+.||.... .++.++......
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~---------- 222 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEK---------- 222 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhc----------
Confidence 211 1123457889999999998889999999999999999999999985432 122222111110
Q ss_pred CCCCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 645 PSLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 645 ~~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
......+. .....+.+++.+||..+|++||++.+|+++|+.+
T Consensus 223 -~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 -CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00011111 3446788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=333.09 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=203.7
Q ss_pred CcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
+|++.+.||+|+||.||+|... ++..||||+++.... ...++|.+|+.++..++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566788999999999999864 246899999975432 234678899999999999999999999999999999
Q ss_pred EEeecCCCCccccccccc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCc
Q 003605 483 VYELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~------------~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~ 550 (808)
++||+.+++|.+++.... .....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985211 11235889999999999999999999988 999999999999999999
Q ss_pred ceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 003605 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 629 (808)
Q Consensus 551 vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~ 629 (808)
+||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... ..+....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 99999999886543332222233456789999999998899999999999999999998 8888754221 1111111
Q ss_pred hhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 630 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 630 ~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.+.. ....+.+....+.+++..|++.+|++||+++||++.|+
T Consensus 240 -------------~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 240 -------------RNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -------------HcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1111 11223445577899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.62 Aligned_cols=267 Identities=29% Similarity=0.411 Sum_probs=205.7
Q ss_pred ceeeeeeecCcEEEEEEEe-----eCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceEEE
Q 003605 412 DASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLV 483 (808)
Q Consensus 412 ~~~~~LG~G~fG~VYkg~l-----~dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV 483 (808)
...+.||+|+||+||++.. .++..||+|.++... ....+.|.+|++++++++|+||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 367889999997543 33457889999999999999999999998654 357899
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+++|+|.+++.. ..++|.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999852 24899999999999999999999998 9999999999999999999999999997654
Q ss_pred ccccc-ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 564 DEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 564 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
..... .......++..|+|||.+....++.++||||||+++|||+||..|+...... ......+...... ...+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMT-VVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccc-hhhhhhh
Confidence 32211 1112234566799999998889999999999999999999999998643221 1111111111000 0111222
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
++.......+......+.+++.+|++.+|++||++++|++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222222234445678999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.22 Aligned_cols=264 Identities=26% Similarity=0.406 Sum_probs=208.5
Q ss_pred hCCcceeeeeeecCcEEEEEEEee--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 477 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~--------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 477 (808)
.++|.+.+.||+|+||.||++... ++..+|+|.++.. ......++.+|++++.++ +|+||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999752 2356999999753 234456788999999999 799999999999999
Q ss_pred cceEEEEeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee
Q 003605 478 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL 545 (808)
+..++||||+++|+|.++++.... ....++|.++++++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975321 1235899999999999999999999988 9999999999999
Q ss_pred cCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003605 546 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 624 (808)
Q Consensus 546 d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~ 624 (808)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HH
Confidence 9999999999999875533221111122234568999999998889999999999999999998 8888853221 11
Q ss_pred hHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 625 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 625 lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
+.... ........+......+.+++.+|+..+|++||++.||++.|+++....
T Consensus 251 ~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 LFKLL--------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHH--------------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 11110 001111122334568889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.45 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=192.9
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
|+..+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999865 78999999996532 3345679999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.+.. .+.+..+..|+.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++......
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 99987643 3566788899999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccccccccchhhhc-----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 569 HISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~-----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
.......||..|+|||++.. ...+.++|||||||+||||++|+.||......+...+.... ..
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~--------- 290 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CM--------- 290 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hc---------
Confidence 11234568999999998743 23356899999999999999999999733221111111100 00
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
......+.....++.+|+.+||+.||++||++.||++.
T Consensus 291 --~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 --SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011222344678999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.07 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=210.2
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~ 481 (808)
..++|...+.||+|+|++||+|+.. .++.+|||++.+ ..+...+....|-+.|.+| .||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4568899999999999999999954 789999999964 2334445677899999999 7999999999999999999
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+|+||++||+|.++|+.. ..+++.....+|.+|+.||+|||+++ ||||||||+|||||+|+++||+|||-|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999743 35888889999999999999999998 99999999999999999999999999987
Q ss_pred ccccccc---------ccc--cccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 003605 562 AMDEESR---------HIS--TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 562 ~~~~~~~---------~~~--~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~ 630 (808)
+...... ... ...+||..|.+||++..+..+..+|+|+||||||+|+.|+.||....+ +.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yl---- 294 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YL---- 294 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HH----
Confidence 6543221 111 347899999999999999999999999999999999999999975432 11
Q ss_pred hhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 631 ~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.+.+|++ +.-.++........+|+.+.|..||.+|.+..||.++.
T Consensus 295 -------iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 -------IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1112221 11234444557889999999999999999999987763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=343.42 Aligned_cols=253 Identities=24% Similarity=0.297 Sum_probs=203.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|.+.+.||+|+||+||+|... +++.||||+++.. .......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999976 7899999999753 2244567899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999632 46899999999999999999999988 99999999999999999999999999976543
Q ss_pred cc---------------------------ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCC
Q 003605 565 EE---------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 617 (808)
Q Consensus 565 ~~---------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~ 617 (808)
.. .........||..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223456899999999999999999999999999999999999999753
Q ss_pred CCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 003605 618 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-MGEVVQA 683 (808)
Q Consensus 618 ~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-m~eVl~~ 683 (808)
... ..........+ .+...........+.+++.+|+. +|++||+ +.|+++.
T Consensus 234 ~~~------~~~~~i~~~~~--------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQ------ETYNKIINWKE--------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHH------HHHHHHhccCC--------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 311 11111111000 00000111135678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.38 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=207.6
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeC------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccce
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~d------g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 480 (808)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.++..++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578899999999999999998642 3689999987542 34456789999999999999999999999999999
Q ss_pred EEEEeecCCCCcccccccccc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceec
Q 003605 481 CLVYELIPNGSVESHLHGVDK------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 554 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~ 554 (808)
++||||+++|+|.++++.... ....++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999964322 1235889999999999999999999988 9999999999999999999999
Q ss_pred ccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhc
Q 003605 555 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 555 DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
|||+++...............++..|+|||.+.++.++.++|||||||++|||+| |+.||..... .....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh---
Confidence 9999986544332222233456789999999998899999999999999999998 8888854321 12222111
Q ss_pred ccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 634 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+. .....+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 236 ----------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ----------DG-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----------cC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00 011122334578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.40 Aligned_cols=269 Identities=26% Similarity=0.376 Sum_probs=204.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee-----CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeec--cceE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARC 481 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-----dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~ 481 (808)
++|++.+.||+|+||.||++..+ ++..||||+++.......++|.+|++++++++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999742 5789999999876666677899999999999999999999987543 4679
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+|+||+++|+|.+++... ...++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999632 235899999999999999999999998 99999999999999999999999999986
Q ss_pred cccccccc-cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc---c
Q 003605 562 AMDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR---E 637 (808)
Q Consensus 562 ~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~---~ 637 (808)
........ ......++..|+|||++.+..++.++|||||||++|||++|..++...... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 54322211 111222345699999999889999999999999999999987765322110 000000000000 0
Q ss_pred ccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 638 ~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.+.++++.......+......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00111111111112234456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.61 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=209.2
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeee
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 476 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~--------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 476 (808)
..++|.+.+.||+|+||.||+|... ++..||+|.++.. .....+++.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888899999999999999741 2457999998743 234457899999999999 79999999999999
Q ss_pred ccceEEEEeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCee
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 544 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNIL 544 (808)
.+..++||||+++|+|.++++.... ....++|.+++.++.|++.||+|||+++ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999975321 1235889999999999999999999998 999999999999
Q ss_pred ecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003605 545 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQE 623 (808)
Q Consensus 545 Ld~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~ 623 (808)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----- 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence 99999999999999986543322222223345678999999998889999999999999999998 778875321
Q ss_pred hhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 624 NLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 624 ~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
...+..... .. .....+......+.+++.+||+.+|++||++.||++.|+++..-
T Consensus 245 -~~~~~~~~~-~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 -VEELFKLLK-EG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHHHH-cC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111111111 00 01112234457789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.46 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=203.1
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
++|.+.+.||+|+||.||+|...++..+|||.++.. ....++|.+|+.++.+++|+||++++++|.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357788999999999999998877778999998743 2335679999999999999999999999998888999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.++++.. ...++|.++++++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999998632 236899999999999999999999988 999999999999999999999999998765432211
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|++||++.+..++.++|||||||++|||++ |+.||..... ....... .. ..
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~---~~-~~---------- 218 (256)
T cd05113 157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKV---SQ-GL---------- 218 (256)
T ss_pred -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH---hc-CC----------
Confidence 1112335678999999998889999999999999999999 9999864321 1111111 00 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
....+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111223468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.71 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=209.5
Q ss_pred CCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||++.. .+++.+|||.+... ......+|.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999995 47899999988642 2334568899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.++++........++|..++.++.++++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754444457899999999999999999999988 99999999999999999999999999875533
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
... ......++..|+|||++.+..++.++||||||+++|||++|..||..... ....+.... .....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-------~~~~~ 225 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-------EQCDY 225 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhh-------hcCCC
Confidence 221 11234588899999999988899999999999999999999999854221 111111111 01111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
+.+ ........+.+++.+||+.+|++||||.+|++.++++
T Consensus 226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111 1123456799999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.17 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=206.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCC--EEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~--~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.++||+|+||.||+|... ++. .+++|.++.. .....++|.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999875 333 4788988753 334456899999999999 799999999999998999999
Q ss_pred EeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcc
Q 003605 484 YELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~v 551 (808)
+||+++|+|.++++.... ....+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999964321 1135889999999999999999999988 9999999999999999999
Q ss_pred eecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~ 630 (808)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||..... .++..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~--- 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYE--- 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---
Confidence 99999998642211 01111223457999999988889999999999999999998 9999864321 11111
Q ss_pred hhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 631 ~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
.. ...+....+......+.+|+.+|++.+|.+||++.+|++.|+.+.+...
T Consensus 230 ~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KL-----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HH-----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11 1111111223344678999999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.84 Aligned_cols=237 Identities=23% Similarity=0.271 Sum_probs=192.7
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
||+|+||.||++... +++.||+|+++.. .......+.+|++++.+++|+||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 6789999999742 334456788999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999853 335899999999999999999999988 9999999999999999999999999987543221 2223
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...||..|+|||++.+..++.++|||||||++|||++|+.||.... ........... . ..++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~----------~--~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQE----------P--LRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcC----------C--CCCC
Confidence 4568999999999999999999999999999999999999996422 11111111111 0 0122
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEV 680 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eV 680 (808)
......+.+++.+||+.||++||++..+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 2334678899999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.70 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=199.0
Q ss_pred cceeeeeeecCcEEEEEEEeeC-CC--EEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec------cc
Q 003605 411 FDASRILGEGGFGLVYSGVLDD-GT--KVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------QA 479 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~d-g~--~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~ 479 (808)
|.+.++||+|+||.||+|.+.+ +. .||+|.++.. .....+.|.+|++++++++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999999763 33 5899988643 344467899999999999999999999987542 24
Q ss_pred eEEEEeecCCCCccccccccc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 480 RCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~--~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
.++++||+.+|+|.+++.... .....++|...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 589999999999998874221 22345899999999999999999999987 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
+++...............++..|++||++.+..++.++|||||||++|||++ |+.||..... ..+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYL----RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HcC
Confidence 9986543222111222345678999999999999999999999999999999 7888854221 1111111 111
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
+.. ..+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 11223446789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.43 Aligned_cols=257 Identities=25% Similarity=0.457 Sum_probs=205.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CC---CEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg---~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.++|+..+.||+|+||.||+|++. ++ ..+|+|.++.. .....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356888899999999999999975 33 37999998754 33445689999999999999999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||||+++++|.++++. ....++|.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999863 2346899999999999999999999988 999999999999999999999999998765
Q ss_pred ccccccccc-cccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 003605 563 MDEESRHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 563 ~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
......... .....+..|+|||++....++.++|||||||++|||++ |+.||..... ..+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i---~~------ 225 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI---ND------ 225 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH---hc------
Confidence 432211111 11223457999999998899999999999999999998 9999854321 1111111 10
Q ss_pred cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 641 ~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
........+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 226 -----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 -----GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=341.11 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=196.2
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
++||+|+||.||++... +|+.||+|+++.. .......+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999753 2334567788999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~ 570 (808)
+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988852 346899999999999999999999998 9999999999999999999999999987532211 11
Q ss_pred ccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCC
Q 003605 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 650 (808)
Q Consensus 571 ~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~ 650 (808)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+... +.... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~-------------~~~~~--~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFEL-------------ILMEE--IR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH-------------HhcCC--CC
Confidence 2235689999999999999999999999999999999999999964321 111110 00000 01
Q ss_pred CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 651 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 651 ~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
++......+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2233446788999999999999998 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.85 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=205.3
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCC----EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~----~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
.++|+..++||+|+||+||+|... +++ .||+|+++.. .....+++.+|+.++..++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888899999999999999853 454 4899998753 33446788999999999999999999999976 4568
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+++||+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999642 346899999999999999999999988 99999999999999999999999999986
Q ss_pred cccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||+... ...+..+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~----~--- 228 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLEKG----E--- 228 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCC----C---
Confidence 543222111122234678999999999999999999999999999998 899986432 12222222110 0
Q ss_pred cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 641 ~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
....+......+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 229 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 -------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00112234467889999999999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=350.78 Aligned_cols=267 Identities=23% Similarity=0.293 Sum_probs=206.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeecccch-hhHHHHHHHHHHhhcc-cccceeEEeeeeecc-ceEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ-ARCL 482 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~-~~~L 482 (808)
..++|...+.||.|.||.||+|+ ..+|+.||||++++.-.. .+.-=++|++.|++|+ |+|||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 44678889999999999999998 458899999999853222 2223468999999998 999999999999887 8999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|||||+ .+|.+++++. +..+++.++..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||..
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999995 6999999743 568999999999999999999999999 999999999999998999999999999976
Q ss_pred ccccccccccccccccccccchhhh-cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-----hhcccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR-----PLLTSR 636 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~-----~~~~~~ 636 (808)
.. ..-.+..+.|.+|+|||++. .+.|+.+.|+|++|||++||.+-+.-|-...+-++..-+--+. ..+.+.
T Consensus 161 ~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 43 33446678899999999875 5778999999999999999999888886544332211111110 000000
Q ss_pred cccccccCCCC-------CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 637 EGLERIIDPSL-------GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 637 ~~l~~ivD~~l-------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+...+.=.+ ....-.....+.++++.+|+.+||++|||+.|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111 011112367789999999999999999999999876
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.37 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=196.5
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec-----cceE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QARC 481 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~~ 481 (808)
+|++.++||+|+||.||+|+.. +++.||||+++.. ......++.+|++++++++|+||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 7899999998742 233445789999999999999999999988643 2479
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+||||+. ++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689888852 335899999999999999999999998 99999999999999999999999999975
Q ss_pred cccccc-cccccccccccccccchhhhc--CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc----
Q 003605 562 AMDEES-RHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT---- 634 (808)
Q Consensus 562 ~~~~~~-~~~~~~~~Gt~~Y~APE~l~~--~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~---- 634 (808)
...... ........||..|+|||++.+ ..++.++|||||||++|||+||+.||........ ..+......
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 432221 112234568999999999875 6789999999999999999999999964332110 010000000
Q ss_pred -------c---ccccccccCC---CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 635 -------S---REGLERIIDP---SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 635 -------~---~~~l~~ivD~---~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. .+.+..+... .+...+ ......+.+++.+||+.+|++||+++|+++.
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000000000 000000 1123567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=321.68 Aligned_cols=264 Identities=25% Similarity=0.332 Sum_probs=204.8
Q ss_pred CCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|...++||+|.||.||+|+. .+|+.||||+++-.+. .......+||+.|+.++|+||+.|+++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677788999999999999995 4899999999985322 224567899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
||+. +|+..++ .....+.-.++..++.++++||+|||.+. |+||||||.|+|+++++.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9964 9999996 34567889999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc----cccccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT----SREGLE 640 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~----~~~~l~ 640 (808)
+. ..+..+-|.+|+|||.+.+ +.|+...|+||.|||+.||+-|..-|....+-+ ++..-.+.+-+ +...+.
T Consensus 155 ~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred Cc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCcccc
Confidence 33 2334478999999999886 578999999999999999999877665433222 22211111100 011111
Q ss_pred cccC--------CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 641 RIID--------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 641 ~ivD--------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
++-| ....+..-..+.....+++..++..||.+|.++.|.+++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 111111223445667999999999999999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.81 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=199.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|.+.+.||+|+||+||+|... +++.||+|+++... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999865 68899999987432 23345788999999999999999999999998999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 589988853 2335789999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhh--------hhhccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA--------RPLLTSRE 637 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~--------~~~~~~~~ 637 (808)
.......++..|+|||++.+ ..++.++|||||||++|||+||+.||............... ++.....+
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 11233467899999998865 56899999999999999999999999654321111100000 00000011
Q ss_pred ccccccCCCCCCC----CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 638 GLERIIDPSLGND----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 638 ~l~~ivD~~l~~~----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.......+..... .......++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111111000 01122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.71 Aligned_cols=265 Identities=26% Similarity=0.446 Sum_probs=207.2
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeC-----------------CCEEEEEEeeccc-chhhHHHHHHHHHHhhccccccee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDD-----------------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVK 469 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~d-----------------g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~ 469 (808)
.++|++.+.||+|+||.||++...+ +..||+|.+.... ....++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999998642 2458999987532 345678999999999999999999
Q ss_pred EEeeeeeccceEEEEeecCCCCcccccccccc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccC
Q 003605 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 542 (808)
Q Consensus 470 L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~-------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsN 542 (808)
++++|..++..++++||+.+++|.++++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965331 1236899999999999999999999988 9999999999
Q ss_pred eeecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh--CCCCCCCCCCC
Q 003605 543 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPP 620 (808)
Q Consensus 543 ILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT--G~~P~~~~~~~ 620 (808)
|+++.++.++|+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999976543333333334556789999999998899999999999999999998 667775322
Q ss_pred CcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 621 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 621 ~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
......++........ .......+.....++.+++.+|++.+|++||++.||++.|+
T Consensus 239 -~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 -DQQVIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -hHHHHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1222222211111000 00001112233467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.86 Aligned_cols=264 Identities=23% Similarity=0.440 Sum_probs=203.1
Q ss_pred CCcceeeeeeecCcEEEEEEEeeC---------------CCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDD---------------GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIG 472 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~d---------------g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g 472 (808)
++|++.+.||+|+||.||++...+ ...||||.++.. .....++|.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987542 135899998753 3344567999999999999999999999
Q ss_pred eeeeccceEEEEeecCCCCcccccccccc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCee
Q 003605 473 ICIEEQARCLVYELIPNGSVESHLHGVDK--------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 544 (808)
Q Consensus 473 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~--------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNIL 544 (808)
++...+..++||||+.+++|.++++.... ....++|..+++++.|++.||+|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999864221 1124789999999999999999999988 999999999999
Q ss_pred ecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh--CCCCCCCCCCCCc
Q 003605 545 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPGQ 622 (808)
Q Consensus 545 Ld~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT--G~~P~~~~~~~~~ 622 (808)
+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999976543322222233445778999999999999999999999999999998 5566654321
Q ss_pred chhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 623 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 623 ~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
............... .......+......+.+|+.+|++.+|++||+|.+|++.|+
T Consensus 239 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQG-------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111110000 00001111223468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.96 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=211.2
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. .+...+.+.+|++|+++|+|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999965 6889999999653 34456679999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+.+ +|..+|.+ ...|.++....|+.++..||.|||+++ |+|||+||.||||+.++.+|+||||+|+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-- 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS-- 151 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--
Confidence 9965 99999953 346999999999999999999999998 9999999999999999999999999999654
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
....+.+.+.||+.|||||.+.++.|+..+|.||+|||||||++|+.||.. ..+...++.+..+ +
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d---------~ 216 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKD---------P 216 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcC---------C
Confidence 345666788999999999999999999999999999999999999999953 2222333222221 1
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. .++......+..++...|.+||.+|.+..+++..
T Consensus 217 v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 V---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred C---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1 1344667889999999999999999999999865
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.70 Aligned_cols=242 Identities=26% Similarity=0.346 Sum_probs=197.1
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
++||+|+||.||++... +++.||||+++.. ......++.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 7899999999753 2344567889999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~ 570 (808)
+|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 99988852 346899999999999999999999998 9999999999999999999999999987532211 11
Q ss_pred ccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCC
Q 003605 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 650 (808)
Q Consensus 571 ~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~ 650 (808)
.....||..|+|||++.+..++.++|||||||+||||++|+.||..... .. ........ + ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~---~~~~~~~~--------~----~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK---LFELILME--------D----IK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HH---HHHHhccC--------C----cc
Confidence 2345689999999999999999999999999999999999999964321 11 11111100 0 01
Q ss_pred CChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 651 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 651 ~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
++......+.+++.+||+.||++|+ ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2233446788999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=360.27 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=209.4
Q ss_pred HHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeecc-
Q 003605 403 EIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ- 478 (808)
Q Consensus 403 el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~- 478 (808)
++....++|.+.++||+|+||+||+|... +|+.||||+++.. .......+.+|+.++..++|+||+++.+.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445679999999999999999999854 7899999998642 3445567889999999999999999988765432
Q ss_pred -------ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcc
Q 003605 479 -------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 479 -------~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~v 551 (808)
..++||||+++|+|.++|+........+++..+..|+.|++.||+|||+.+ |+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 358999999999999999754444557899999999999999999999988 9999999999999999999
Q ss_pred eecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~ 631 (808)
||+|||+++...............||..|+|||++.+..++.++|||||||+||||++|+.||.... .......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHH
Confidence 9999999986543322233345679999999999999999999999999999999999999996422 1111111
Q ss_pred hcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 632 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 632 ~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.... .. ...+......+.+++.+||+.+|++||++.++++.
T Consensus 257 ~~~~------~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAG------RY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcC------CC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1110 00 11223345679999999999999999999999864
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.82 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=205.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccc
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 479 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 479 (808)
.++|.+.+.||+|+||.||++... ++..||||+++... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356889999999999999999742 34579999987543 33456799999999999 79999999999999999
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++||||+.+|+|.++++... ...+++.+++.++.+++.||+|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999996422 234899999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccc
Q 003605 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREG 638 (808)
Q Consensus 560 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~ 638 (808)
+...............++..|+|||++....++.++|||||||++|||++ |..||...... .......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~--------- 257 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLI--------- 257 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHH---------
Confidence 86543222112222345678999999999999999999999999999998 99998643221 1111111
Q ss_pred cccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 639 l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
+.......+.....++.+++.+|++.+|++||++.||++.|+++
T Consensus 258 -----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 -----KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111222346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.91 Aligned_cols=266 Identities=21% Similarity=0.347 Sum_probs=203.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.++|++.+.||+|+||.||++... +++.+|+|.++.. .....+++.+|++++++++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 6888999988753 33445679999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.++++. ...+++.....++.+++.||+|||+.+ .|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999953 235889999999999999999999742 3999999999999999999999999998754321
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHH------hhhhhcccc---
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA------WARPLLTSR--- 636 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~------w~~~~~~~~--- 636 (808)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. +........
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 1223468899999999998889999999999999999999999997533211100000 000000000
Q ss_pred ---------------cccccccCCCCCC---CC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 637 ---------------EGLERIIDPSLGN---DV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 637 ---------------~~l~~ivD~~l~~---~~-~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+.+..... .. ......++.+|+.+||+.||++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000000 00 01134568899999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.10 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=201.2
Q ss_pred CcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
+|++.+.||+|+||.||+|...++..+|+|.++... ....+|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467788999999999999998777789999986432 2345789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
++|.++++.. ...++|..++.|+.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...+... .
T Consensus 84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 9999999632 236899999999999999999999998 99999999999999999999999999876533211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
......++..|+|||++.+..++.++||||||+++|||++ |+.||+.... ........ ....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~--------------~~~~ 219 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVS--------------AGYR 219 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHH--------------cCCc
Confidence 1111223457999999998999999999999999999999 8888864321 11111110 0011
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
...+......+.+++.+||..+|++||++.||++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 112223456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.95 Aligned_cols=262 Identities=28% Similarity=0.477 Sum_probs=206.3
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeecc
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 478 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 478 (808)
...++|++.+.||+|+||.||+|... .+..||+|.++... .....++.+|+.++++++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999754 24579999886433 233457889999999999999999999999889
Q ss_pred ceEEEEeecCCCCcccccccccc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcce
Q 003605 479 ARCLVYELIPNGSVESHLHGVDK------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 552 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vK 552 (808)
..++||||+++|+|.++++.... ....+++..+++++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999964321 1235678889999999999999999988 99999999999999999999
Q ss_pred ecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 003605 553 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 553 L~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~ 631 (808)
|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... .......
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~-- 234 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFV-- 234 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH--
Confidence 999999986543222222223345678999999999999999999999999999999 7888854221 1111111
Q ss_pred hcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 632 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 632 ~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.+... ...+......+.+++.+|++.+|++||++.++++.|+..
T Consensus 235 -----------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 -----------MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -----------HcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11100 011223346899999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=332.31 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=205.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCC--EEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~--~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.+.||+|+||.||+|... ++. .+|+|.++.. .....++|.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999965 454 4588877653 334556889999999999 899999999999999999999
Q ss_pred EeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcc
Q 003605 484 YELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~v 551 (808)
+||+++|+|.++++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999964321 1235899999999999999999999988 9999999999999999999
Q ss_pred eecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~ 630 (808)
||+|||+++..... .......++..|+|||++.+..++.++|||||||+||||+| |..||..... ........
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~ 237 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP 237 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHHHh
Confidence 99999998632110 11111224567999999988889999999999999999998 9999864321 11111110
Q ss_pred hhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 631 ~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
.......+......+.+++.+|++.+|++||++.++++.|+.+.++..
T Consensus 238 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 --------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred --------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 000111122234578999999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.31 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=199.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.++||+|+||+||++... +++.||||+++.. .......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999975 6899999999753 2334456889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.++++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999863 235899999999999999999999998 99999999999999999999999999875422
Q ss_pred cccc------------------------------------ccccccccccccccchhhhcCCCccccceeeHHHHHHHHH
Q 003605 565 EESR------------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 608 (808)
Q Consensus 565 ~~~~------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELl 608 (808)
.... .......||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0011246899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003605 609 SGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF---MGEVVQA 683 (808)
Q Consensus 609 TG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---m~eVl~~ 683 (808)
+|+.||...... ..... ....... +...........+.+++.+|+. +|.+|++ +.|+++.
T Consensus 234 ~G~~Pf~~~~~~---~~~~~---i~~~~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQ---ETYRK---IINWKET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHH---HHHHH---HHcCCCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999643221 11111 1100000 0000011224567888999996 8999998 8888664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.71 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=205.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.+|...+.||+|+||.||++... ++..+|+|.++.......++|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 456899999887666667889999999999999999999999999999999
Q ss_pred EEeecCCCCcccccccccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcc
Q 003605 483 VYELIPNGSVESHLHGVDK-----------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~-----------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~v 551 (808)
++||+++|+|.++++.... ....++|.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 1135899999999999999999999988 9999999999999999999
Q ss_pred eecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~ 630 (808)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHH-
Confidence 9999999875433222122223345678999999999999999999999999999998 8998854321 1111111
Q ss_pred hhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 631 ~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.. .. ....+......+.+++.+||+.+|++||++.||++.|+
T Consensus 238 --~~-~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 --TQ-GR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --Hc-Cc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 00 00111233467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=336.74 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=208.0
Q ss_pred hCCcceeeeeeecCcEEEEEEEee--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 477 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~--------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 477 (808)
..+|.+.+.||+|+||.||++... ++..||+|.++.. .....+++.+|++++.++ +|+||++++++|.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 356888999999999999999742 1236899988753 334457899999999999 799999999999999
Q ss_pred cceEEEEeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee
Q 003605 478 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL 545 (808)
+..++++||+++|+|.+++..... ....+.|.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999864221 2235899999999999999999999988 9999999999999
Q ss_pred cCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003605 546 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 624 (808)
Q Consensus 546 d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~ 624 (808)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------ 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------
Confidence 9999999999999976543222222222334568999999999999999999999999999998 888885322
Q ss_pred hHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 625 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 625 lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
...+...... ......+......+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 242 ~~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 VEELFKLLKE-----------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHHc-----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1122111110 0111122334567899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=329.16 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=195.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee--CCCEEEEEEeeccc--chhhHHHHHHHHHHhhc---ccccceeEEeeeee-----
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICIE----- 476 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~--dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~----- 476 (808)
++|++.+.||+|+||+||+|... +++.||||+++... ......+.+|+++++++ +|+||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999863 46889999987432 22234667788887766 69999999999852
Q ss_pred ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
....++||||+. ++|.+++.... ...+++.+++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 356799999995 69999886422 235899999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHHhhhhhccc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTS 635 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~ 635 (808)
|+++..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+. ..+.+........
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999754322 222345689999999999988999999999999999999999999975432111 0111110000000
Q ss_pred cc-----ccccccCCCCCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 636 RE-----GLERIIDPSLGN---DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 636 ~~-----~l~~ivD~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.. .....+...-.. ....+....+.+++.+|++.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000000 001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.53 Aligned_cols=265 Identities=23% Similarity=0.438 Sum_probs=204.3
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-----------------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhccccccee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-----------------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 469 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-----------------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~ 469 (808)
.++|++.+.||+|+||.||++... ++..||+|+++.. .....++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357889999999999999998532 2346899999753 3444578999999999999999999
Q ss_pred EEeeeeeccceEEEEeecCCCCcccccccccc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccC
Q 003605 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 542 (808)
Q Consensus 470 L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~-------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsN 542 (808)
+++++...+..++||||+++|+|.++++.... ....++|.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999875321 1235888999999999999999999998 9999999999
Q ss_pred eeecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh--CCCCCCCCCCC
Q 003605 543 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPP 620 (808)
Q Consensus 543 ILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT--G~~P~~~~~~~ 620 (808)
||+++++.++|+|||+++...............++..|++||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999976543322222233345678999999988899999999999999999998 66777543221
Q ss_pred CcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 621 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 621 ~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.............. .... ...+..+...+.+++.+||+.||++||++.||++.|+
T Consensus 241 ---~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ---QVIENTGEFFRDQG--RQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHHhhcc--cccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111100000000 0000 0112233468899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.55 Aligned_cols=263 Identities=25% Similarity=0.413 Sum_probs=206.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeEEeeeeecc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~ 478 (808)
..++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+.+|+++|.++. |+||++++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456777899999999999999853 34679999997542 233457899999999997 999999999999999
Q ss_pred ceEEEEeecCCCCcccccccccc---------------------------------------------------------
Q 003605 479 ARCLVYELIPNGSVESHLHGVDK--------------------------------------------------------- 501 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~--------------------------------------------------------- 501 (808)
..++|+||+.+|+|.++|+....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCee
Q 003605 502 -------------------------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 544 (808)
Q Consensus 502 -------------------------------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNIL 544 (808)
....++|..+++|+.|++.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124788889999999999999999887 999999999999
Q ss_pred ecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003605 545 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQE 623 (808)
Q Consensus 545 Ld~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~ 623 (808)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~ 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--E 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--H
Confidence 99999999999999986533222112223456788999999998889999999999999999998 88888543211 1
Q ss_pred hhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 624 NLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 624 ~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
.+. ..+........+......+.+|+.+||+.+|++||+++||++.|+.++
T Consensus 350 ~~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFY--------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHH--------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 000 011111111122334568999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=342.77 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=196.3
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 6889999999753 23345678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999853 235888999999999999999999988 999999999999999999999999997543110
Q ss_pred cc---------------------------------------------cccccccccccccccchhhhcCCCccccceeeH
Q 003605 566 ES---------------------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 600 (808)
Q Consensus 566 ~~---------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSf 600 (808)
.. ........||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123469999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCc-chhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHH--ccccCCCCCCCH
Q 003605 601 GVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASM--CVQPEVQHRPFM 677 (808)
Q Consensus 601 GvvLlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~--Cl~~dP~~RPsm 677 (808)
||++|||+||+.||........ ..+..|.. .+..........++.+++.+ |+..++..|+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999975432110 00111100 00000111223566777776 556666679999
Q ss_pred HHHHHH
Q 003605 678 GEVVQA 683 (808)
Q Consensus 678 ~eVl~~ 683 (808)
.|+++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=332.39 Aligned_cols=264 Identities=26% Similarity=0.428 Sum_probs=207.6
Q ss_pred hCCcceeeeeeecCcEEEEEEEee--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 477 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~--------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 477 (808)
.++|.+.+.||+|+||.||++... +...+|+|+++.. ......++.+|++++.++ +|+||++++++|.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999742 2457899998753 234456789999999999 699999999999998
Q ss_pred cceEEEEeecCCCCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee
Q 003605 478 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL 545 (808)
+..++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999964321 1245899999999999999999999988 9999999999999
Q ss_pred cCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcch
Q 003605 546 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 624 (808)
Q Consensus 546 d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~ 624 (808)
++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||..... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EE 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999986543222211122234567999999999999999999999999999999 8888854221 11
Q ss_pred hHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 625 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 625 lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
+..... .. .....+......+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 245 ~~~~~~----~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 LFKLLR----EG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111111 00 001122334467889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.60 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=204.4
Q ss_pred hCCcceeeeeeecCcEEEEEEEe------eCCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeEEeeeeec-c
Q 003605 408 TGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE-Q 478 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l------~dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~-~ 478 (808)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788999999999999999973 356889999997532 33456788999999999 689999999988654 4
Q ss_pred ceEEEEeecCCCCcccccccccc---------------------------------------------------------
Q 003605 479 ARCLVYELIPNGSVESHLHGVDK--------------------------------------------------------- 501 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~--------------------------------------------------------- 501 (808)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999864211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccccc
Q 003605 502 ------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575 (808)
Q Consensus 502 ------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~ 575 (808)
....++|..+++++.|+++||+|||+.+ |+||||||+|||+++++++||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124788999999999999999999988 9999999999999999999999999997653322211222234
Q ss_pred cccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChh
Q 003605 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 654 (808)
Q Consensus 576 Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~ 654 (808)
++..|+|||++.+..++.++||||||+++|||++ |..||...... ..+..- +.... ....+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~----~~~~~----------~~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR----LKEGT----------RMRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHH----HhccC----------CCCCCCC
Confidence 5678999999999999999999999999999997 88888643211 111110 00000 0011112
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 655 SVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 655 ~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
....+.+++.+||+.+|++||++.||++.|+.+.+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 235689999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.88 Aligned_cols=242 Identities=26% Similarity=0.346 Sum_probs=195.6
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
++||+|+||.||++... +|+.||+|+++.. ......++.+|++++..++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999753 2334567788999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
+|.+++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99988852 3468999999999999999999997 56 9999999999999999999999999987533221 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||+||||+||+.||..... ..+... ... .. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~---i~~----------~~--~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---ILM----------EE--I 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHH---Hhc----------CC--C
Confidence 12335689999999999999999999999999999999999999964321 111111 000 00 0
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
.++......+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12223346788999999999999996 89998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=323.71 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=203.4
Q ss_pred CcceeeeeeecCcEEEEEEEee-CC---CEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg---~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.|++.+.||+|+||.||+|.+. ++ ..||||.++.. .....++|..|+.++++++|+||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4778899999999999999975 33 36999998753 3445678999999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998632 335899999999999999999999988 99999999999999999999999999875433
Q ss_pred ccccccccc-cc--cccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 003605 565 EESRHISTR-VM--GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 565 ~~~~~~~~~-~~--Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
......... .. .+..|+|||++....++.++|||||||++|||++ |..||..... .....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~-------- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQD-------- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcC--------
Confidence 221111111 11 2457999999999999999999999999999887 9999864321 1222222110
Q ss_pred cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 641 ~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.....+.+....+.+++.+|++.+|++||++.+|+..|+.+
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111223456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.59 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=197.2
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
||+|+||+||++... +++.||||.+.... ....+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 78899999987432 22345678899999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888644444457999999999999999999999988 99999999999999999999999999976533221 123
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...||..|+|||++.+..++.++|||||||++|||++|+.||........ ...... .+.... ..++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~----------~~~~~~--~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQ----------RILNDS--VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHH----------hhcccC--CCCc
Confidence 35689999999999999999999999999999999999999965332111 000000 111111 1122
Q ss_pred hhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
......+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 33456789999999999999999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=334.85 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=198.5
Q ss_pred CcceeeeeeecCcEEEEEEEe----eCCCEEEEEEeecc----cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccce
Q 003605 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRV----DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l----~dg~~VAVK~lk~~----~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 480 (808)
+|++.+.||+|+||.||++.. .+++.||+|++++. .....+.+.+|++++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588899999999999999875 35789999999742 223345688999999999 599999999999999999
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999853 345899999999999999999999988 9999999999999999999999999997
Q ss_pred ccccccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
....... .......||..|+|||++.+. .++.++|||||||+||||+||+.||.......... ........
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~----- 225 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK----- 225 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-----
Confidence 6433222 122345689999999998765 47889999999999999999999996433221111 11111110
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
.++ .++......+.+++.+||+.||++|| ++.++++.
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 12223346788999999999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=335.63 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=196.9
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||++... +++.||||+++.. .....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999853 233445688999999998 799999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 999988852 346999999999999999999999998 9999999999999999999999999987432211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCC--cchhHHhhhhhcccccccccccCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG--QENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~--~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......||..|+|||++.+..++.++|||||||++|||+||+.||+...... .....+|...... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL---------EKQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH---------cCCC
Confidence 2234578999999999999999999999999999999999999997533221 1112222211111 1111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPF------MGEVVQ 682 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs------m~eVl~ 682 (808)
..+......+.+++.+||+.||++|++ +.++++
T Consensus 223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122334567899999999999999997 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=339.75 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=199.6
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeC--CCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDD--GTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~d--g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.++|.+.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|++++..++|+||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568899999999999999998653 368999998642 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999853 345899999999999999999999998 999999999999999999999999999764
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+ ....
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~-~~i~--------- 241 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIY-QKIL--------- 241 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHH-HHHh---------
Confidence 321 1235689999999999998899999999999999999999999964321 1111 0011
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
+.. ..++......+.+++.+|++.+|++|+ +++|+++.
T Consensus 242 -~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 -EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 100 011222345678999999999999995 78777654
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=336.40 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=194.9
Q ss_pred eeeeecCcEEEEEEEe----eCCCEEEEEEeecc----cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKRV----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l----~dg~~VAVK~lk~~----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+.||+|+||.||++.. .+++.||||+++.. .......+.+|+++|++++|+||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 35789999999752 223345678999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++|+|.++++. ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999853 335788889999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.......||..|+|||++.+..++.++|||||||+||||++|+.||..... ........ ...
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~----------~~~ 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKIL----------KGK 216 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHH----------cCC
Confidence 122345689999999999988899999999999999999999999964321 11111111 111
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
...+......+.+++.+||+.+|++|| ++.++++.
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 112223346788999999999999999 77777653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=322.38 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=203.8
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.++|++.+.||+|+||.||+|...++..+|+|.++.... ..++|.+|++++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 346788899999999999999988888999999975332 3467999999999999999999999885 45679999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.++++.. ....+++.+++.++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999742 2335899999999999999999999988 99999999999999999999999999976533221
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .....+.. ..
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~--------------~~ 219 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVE--------------RG 219 (260)
T ss_pred c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH--------------cC
Confidence 1 1112235668999999988899999999999999999999 8888864321 11111111 01
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.....+.+....+.+++.+|++.+|++|||++++++.|++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233445679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=319.24 Aligned_cols=247 Identities=32% Similarity=0.463 Sum_probs=198.8
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCcc
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 493 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~ 493 (808)
++||+|+||.||+|...+++.+|+|.++... ......|.+|++++++++|+||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999987543 333457899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccc
Q 003605 494 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573 (808)
Q Consensus 494 ~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~ 573 (808)
+++... ...++|..++.++.+++.||.|||+.+ ++||||||+||++++++.+||+|||++....... ......
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCCC
Confidence 998632 235899999999999999999999988 9999999999999999999999999987532211 111112
Q ss_pred cccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 574 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 574 ~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
..++..|+|||++.++.++.++||||||+++|||++ |..||..... ....... . .......+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~~----~----------~~~~~~~~ 216 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQV----E----------KGYRMSCP 216 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHH----H----------cCCCCCCC
Confidence 234567999999999999999999999999999998 9999864321 1111111 0 01111122
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
......+.+++.+|++.+|++||++.|++++|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 334578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.09 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=204.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|...+.||+|+||.||+|+.. +++.|++|.+.. ......+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999975 689999999864 2345567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.++++.. ....+++..+++++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999743 2346899999999999999999999987 9999999999999999999999999988654322
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ........ .. .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~---~~--~--------- 216 (256)
T cd08529 156 N--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKI---IR--G--------- 216 (256)
T ss_pred c--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---Hc--C---------
Confidence 1 1233457889999999999999999999999999999999999996432 11111111 00 0
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+......+.+++.+|++.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011122344678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.18 Aligned_cols=253 Identities=23% Similarity=0.257 Sum_probs=201.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|.+.+.||+|+||+||++... +++.||||+++.. .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999865 7899999999853 2334567889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.++++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999632 246899999999999999999999998 99999999999999999999999999976543
Q ss_pred ccccccccccccccccccchhhh------cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~ 638 (808)
... .......||..|+|||++. ...++.++|||||||++|||++|+.||..... ......++....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~- 226 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQR- 226 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCC-
Confidence 221 1223346899999999986 45678999999999999999999999964321 111111111000
Q ss_pred cccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 639 l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. +.-.........+.+++..|++ +|++||++.++++.
T Consensus 227 ---~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ---F----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---c----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0000111234678889999998 99999999998653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.95 Aligned_cols=258 Identities=27% Similarity=0.472 Sum_probs=204.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccce
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 480 (808)
.++|+..+.||+|+||.||++... ++..||+|+++.. .....++|.+|+.++++++|+||++++++|.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999863 4678999998753 234457799999999999999999999999999999
Q ss_pred EEEEeecCCCCccccccccc------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccC
Q 003605 481 CLVYELIPNGSVESHLHGVD------------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 542 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~------------------~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsN 542 (808)
++||||+++|+|.++++... .....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996421 11235789999999999999999999988 9999999999
Q ss_pred eeecCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCC
Q 003605 543 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPG 621 (808)
Q Consensus 543 ILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~ 621 (808)
||+++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999875433222122222334667999999998999999999999999999998 8888753221
Q ss_pred cchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 622 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 622 ~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.....+. . +... ...+.....++.+++.+|++.+|++||++.||++.|+
T Consensus 239 -~~~~~~~---~----------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 -EEVIYYV---R----------DGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -HHHHHHH---h----------cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111111 0 0100 0112234567999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.15 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=196.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|.+.+.||+|+||+||++... +++.||||++... .....+++.+|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 7899999998642 2334567889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999853 245888999999999999999999998 99999999999999999999999999863321
Q ss_pred cccc---------------------------------------------ccccccccccccccchhhhcCCCccccceee
Q 003605 565 EESR---------------------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYS 599 (808)
Q Consensus 565 ~~~~---------------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwS 599 (808)
.... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 0001246899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCC---CC
Q 003605 600 YGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR---PF 676 (808)
Q Consensus 600 fGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R---Ps 676 (808)
|||+||||+||+.||...... ... .........+. + + . .......+.+++.+|+. +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~---~~~---~~i~~~~~~~~-~--p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH---ETY---RKIINWRETLY-F--P---D--DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH---HHH---HHHHccCCccC-C--C---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999999643321 110 00110000000 0 0 0 01234568889999997 66665 59
Q ss_pred HHHHHHH
Q 003605 677 MGEVVQA 683 (808)
Q Consensus 677 m~eVl~~ 683 (808)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9888765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=318.64 Aligned_cols=251 Identities=31% Similarity=0.523 Sum_probs=204.7
Q ss_pred eeeeecCcEEEEEEEeeC----CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d----g~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
+.||+|+||.||+|...+ +..|++|.++..... ..+++.+|++++.+++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 788999999864333 367899999999999999999999999999999999999999
Q ss_pred CCccccccccccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 490 GSVESHLHGVDKE-----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 490 GsL~~~L~~~~~~-----~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
++|.+++...... ...+++.++++++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999754221 357999999999999999999999988 99999999999999999999999999987654
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
...........++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~------------- 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLR------------- 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH-------------
Confidence 332222334557889999999988889999999999999999999 6999875421 11111111
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+ ......+......+.+++.+|++.+|++||++.|+++.|+
T Consensus 222 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 K-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred c-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0011122334578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=323.15 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=203.6
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.++|.+.+.||+|+||.||+|...+...||+|+++... ...++|.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35688999999999999999998777789999997532 234679999999999999999999998754 5679999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++|+|.++++.. ....++|..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999642 2235899999999999999999999988 99999999999999999999999999976533221
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||...... .+.. .... .
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~---~~~~-----------~ 219 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---QVER-----------G 219 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH---HHhc-----------C
Confidence 11122346678999999988899999999999999999999 88888543211 1100 0000 0
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.......+....+.+++.+|++.+|++||+++++++.|++.
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00111233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=320.95 Aligned_cols=250 Identities=30% Similarity=0.486 Sum_probs=205.2
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.++|++.+.||+|+||.||+|... |+.||||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788899999999999999875 78999999986543 5678999999999999999999999999989999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.++++... ...++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999996422 236899999999999999999999998 9999999999999999999999999998652211
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.....+..|+|||++.++.++.++||||||+++|||++ |+.||..... ..+..... ..
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~--------------~~ 215 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVE--------------KG 215 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh--------------cC
Confidence 12234668999999998899999999999999999997 9999864321 11111111 00
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.....+......+.+++.+|++.+|++||++.|++++|+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1111222345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=334.78 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=191.6
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHH---hhcccccceeEEeeeeeccceEEE
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEML---SRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL---~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ ++++|+||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999865 68999999997532 23345667776665 466799999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+++|+|..+++. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988852 35899999999999999999999988 9999999999999999999999999987532
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. ......
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~---~~~~i~---------- 214 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EE---VFDSIV---------- 214 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HH---HHHHHH----------
Confidence 211 122345689999999999999999999999999999999999999964321 11 111111
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 678 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 678 (808)
... ..++......+.+++.+||+.||++||++.
T Consensus 215 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 215 NDE--VRYPRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 100 012223346788999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=330.75 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=198.2
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999976 78999999987532 2233567889999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 688888753 2345889999999999999999999998 999999999999999999999999998754221
Q ss_pred cccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc--cc-----
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--RE----- 637 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~--~~----- 637 (808)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ............. ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccch
Confidence 1 12233467899999998865 45788999999999999999999999753221 1111111000000 00
Q ss_pred -ccccccCCCCCCCCC---------hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 638 -GLERIIDPSLGNDVP---------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 638 -~l~~ivD~~l~~~~~---------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.........+....+ ......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000000 012346789999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.86 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=201.1
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
+|+..++||+|+||+||++... +++.||||++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999865 68999999997422 2234567889999999999999999999999899999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888632 2345899999999999999999999998 999999999999999999999999998764322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ . ..... .+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~-~~~~~----------~~~~ 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--R-EEVER----------RVKE 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--H-HHHHH----------Hhhh
Confidence 1 11234688999999999988999999999999999999999999975322110 0 00000 0000
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
....++......+.+++.+|++.||++|| +++++++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01112233456789999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=323.51 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=197.2
Q ss_pred eeeeecCcEEEEEEEee-CCC--EEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~--~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||+|.+. ++. .+++|.++.. .....+.+.+|++++.++ +|+||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 343 4688988753 344556899999999999 799999999999999999999999999
Q ss_pred CCcccccccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 490 GSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 490 GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
|+|.++++.... ....+.+.++++++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 1235889999999999999999999987 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
+++..... ........+..|+|||++....++.++|||||||++|||++ |..||..... .......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~------- 224 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL------- 224 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHH-------
Confidence 98632111 11111223567999999988889999999999999999997 9999854221 1111111
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
........+......+.+++.+|++.+|.+||++.|+++.|+.+.
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111112233457889999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=321.63 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=196.2
Q ss_pred eeeecCcEEEEEEEee---CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCC
Q 003605 416 ILGEGGFGLVYSGVLD---DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~---dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
.||+|+||.||+|.+. ++..+|+|+++... ....++|.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999986432 334578999999999999999999999985 45679999999999
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~ 570 (808)
+|.+++.. ...+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999852 235899999999999999999999988 99999999999999999999999999976543222111
Q ss_pred -ccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 571 -STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 571 -~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
.....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+..... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~--------------~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIE--------------SGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------------CCCC
Confidence 122234578999999988889999999999999999998 9999964322 11211111 1111
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
...+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11233345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.58 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=193.2
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 6789999999753 233445678899998877 799999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999988852 346899999999999999999999998 9999999999999999999999999987532211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCC--cchhHHhhhhhcccccccccccCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG--QENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~--~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||+...... ......|..... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~~~- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LEKQ- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hcCC-
Confidence 2234568999999999999999999999999999999999999996432211 111112221111 1111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFM 677 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 677 (808)
..++......+.+++.+||+.||++||+.
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11333445678899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=349.03 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=204.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~ 481 (808)
..++|...++||+|.||+|+++.++ +++.+|||.+++. .....+..+.|-+|+... +||.|++|+..|..++++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4478999999999999999999976 6789999999874 344567788899998887 5999999999999999999
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+||||+.||++..+.+ ...+++..+.-+|..|+.||+|||+++ |||||||.+|||||.+|.+||+||||++.
T Consensus 446 fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999655553 346888999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
... ....+...+||+.|||||++.+..|+.+.|.|+|||+|||||.|..||...+. ++
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------------------ee 575 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------------------EE 575 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------------------HH
Confidence 542 22345678999999999999999999999999999999999999999974321 12
Q ss_pred ccCCCCCC--CCChhhHHHHHHHHHHccccCCCCCCCH
Q 003605 642 IIDPSLGN--DVPFDSVAKVAAIASMCVQPEVQHRPFM 677 (808)
Q Consensus 642 ivD~~l~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 677 (808)
++|..+.. .+|.....+.+.|+.+.+.++|++|--+
T Consensus 576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22222222 2556667889999999999999999877
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.26 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=204.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...++|.+|++++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46788999999999999999998889999999987533 34568999999999999999999999874 46789999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
.+++|.++++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999998642 2346899999999999999999999988 99999999999999999999999999876532211
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.......++..|+|||++....++.++||||||+++|||++ |+.||..... ..+..... ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~--------------~~ 219 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLE--------------RG 219 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHH--------------cC
Confidence 11122345678999999998889999999999999999999 9999964321 11111110 00
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111122334679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.36 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=207.3
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec-ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..|...++||+|.||.||||... .++.||+|++.- ......+++.+|+.+|..++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666689999999999999965 788999999973 3455568899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
|.+|++.+.|. ....+++..+.-|+.++..||.|||.++ .+|||||+.||||..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999995 3344578888889999999999999998 9999999999999999999999999997665433
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.. ....+||+.|||||++....|+.|+||||||++.+||++|..|+....+... + -.+.+-.-|.
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------l----flIpk~~PP~ 230 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------L----FLIPKSAPPR 230 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---------E----EeccCCCCCc
Confidence 32 2567899999999999988999999999999999999999999975443100 0 0011112233
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+.+ .....+.+++..||++||+.||++.++++.
T Consensus 231 L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 333 455679999999999999999999999863
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=339.54 Aligned_cols=202 Identities=26% Similarity=0.383 Sum_probs=174.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|+..+.||+|+||+||++... +++.||||+++... ......+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 68899999997532 233457888999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999963 346899999999999999999999988 99999999999999999999999999875432
Q ss_pred cccc---------------------------------ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCC
Q 003605 565 EESR---------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 611 (808)
Q Consensus 565 ~~~~---------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~ 611 (808)
.... .......||..|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112346999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 003605 612 KPVDMT 617 (808)
Q Consensus 612 ~P~~~~ 617 (808)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=324.52 Aligned_cols=269 Identities=26% Similarity=0.389 Sum_probs=205.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-----CCCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeee--ccce
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIE--EQAR 480 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-----dg~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~ 480 (808)
+.|...+.||+|+||.||++.+. ++..+|||.++..... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999864 3678999999854332 56789999999999999999999999877 5578
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++||||+++++|.++++.. ...++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999642 235999999999999999999999988 9999999999999999999999999998
Q ss_pred cccccccc-ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc--cccc
Q 003605 561 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL--TSRE 637 (808)
Q Consensus 561 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~--~~~~ 637 (808)
........ .......++..|++||++.+..++.++||||||+++|||+||+.|+....... ..++.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~ 233 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF----LRMIGIAQGQMIVT 233 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh----ccccccccccccHH
Confidence 66422211 11112345567999999998899999999999999999999999875432211 00000000 0000
Q ss_pred ccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 638 ~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.+.+.+........+.....++.+++.+|++.+|++||++.||+++|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 01111111111112223446799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=325.80 Aligned_cols=267 Identities=26% Similarity=0.377 Sum_probs=207.6
Q ss_pred ccCCHHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeee
Q 003605 397 KTFSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGIC 474 (808)
Q Consensus 397 ~~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 474 (808)
..+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.++... ....++.+|+.+++++ +|+||++++++|
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred ceEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 34556677788999999999999999999999865 67899999886432 2346788999999999 699999999998
Q ss_pred e-----eccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC
Q 003605 475 I-----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 549 (808)
Q Consensus 475 ~-----~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~ 549 (808)
. .++..++||||+++++|.++++........+++..+..++.|+++||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence 4 335679999999999999988644334456899999999999999999999987 99999999999999999
Q ss_pred cceecccccccccccccccccccccccccccccchhhhc-----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcch
Q 003605 550 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 624 (808)
Q Consensus 550 ~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~ 624 (808)
.+||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~ 237 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RA 237 (286)
T ss_pred CEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HH
Confidence 99999999987653221 11233468999999998753 45788999999999999999999998643221 11
Q ss_pred hHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 625 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 625 lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
+..+. ......+.+ +......+.+++.+|++.+|++||++.||++.+
T Consensus 238 ~~~~~------~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LFKIP------RNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hhhcc------ccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11100 000000111 111235688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.34 Aligned_cols=248 Identities=26% Similarity=0.456 Sum_probs=196.6
Q ss_pred eeeecCcEEEEEEEee---CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCC
Q 003605 416 ILGEGGFGLVYSGVLD---DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~---dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~Gs 491 (808)
.||+|+||.||+|++. ++..||+|+++... ....++|.+|++++++++|+||++++++|.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 35579999987543 3334679999999999999999999998854 57899999999999
Q ss_pred ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccc-
Q 003605 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI- 570 (808)
Q Consensus 492 L~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~- 570 (808)
|.+++.. ....+++.++++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999863 2346899999999999999999999988 99999999999999999999999999975433222111
Q ss_pred ccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 571 ~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
.....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.... ......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~--------------~~~~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFI--------------EQGKRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH--------------HCCCCC
Confidence 112234578999999988889999999999999999996 9999864321 1111111 111111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
..+.....++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22334457888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=319.58 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=202.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
++|.+.+.||+|++|.||++... +++.||+|.++... ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 68999999986422 1234578899999999999999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|+||+++++|.+++.. ...+++..+.+++.+++.||+|||+.+ |+||||+|+||+++++++++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999853 235889999999999999999999998 999999999999999999999999998754
Q ss_pred cccccccc-ccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
........ .....++..|+|||++.+..++.++||||||+++|||++|+.||..... .....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~------------ 219 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKI------------ 219 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHH------------
Confidence 32211111 1234577899999999998899999999999999999999999864321 1111110
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.........+......+.+++.+||..+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 -ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111112233345678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.35 Aligned_cols=259 Identities=26% Similarity=0.451 Sum_probs=206.3
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCC----EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~----~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
++|++.+.||+|+||.||+|... +|+ .+|+|.++... .....++.+|++++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56778899999999999999865 343 58999887543 3445789999999999999999999999987 78899
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|+||+++|+|.++++. ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999963 2335899999999999999999999987 999999999999999999999999999865
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.............++..|+|||.+....++.++|||||||++|||++ |+.||+.... .++..... . ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~-~~---- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLE---K-GE---- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHh---C-CC----
Confidence 43222111122234568999999988899999999999999999999 9999865322 12222111 0 00
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
....+..+...+.+++.+||..+|++||++.++++.|+.+.++.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 01112223457889999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.93 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=204.7
Q ss_pred HHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceE
Q 003605 403 EIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 403 el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
|++.+++++....+||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567788888899999999999999865 67889999988766666778999999999999999999999999999999
Q ss_pred EEEeecCCCCccccccccccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-CCcceeccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPL--GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGL 558 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L--~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-~~~vKL~DFGL 558 (808)
+|+||+++++|.++++.. ...+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||+
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999999632 1234 78889999999999999999988 999999999999986 67999999999
Q ss_pred ccccccccccccccccccccccccchhhhcCC--CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
+....... .......++..|+|||++.... ++.++||||||+++|||++|+.||..... .....|......
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~---~~~~~~~~~~~~-- 228 (268)
T cd06624 156 SKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE---PQAAMFKVGMFK-- 228 (268)
T ss_pred heecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC---hhhhHhhhhhhc--
Confidence 87543221 1122345788999999986643 78899999999999999999999864321 111111110000
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+.....++.+++.+||+.+|++||++.||++.
T Consensus 229 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111233344678899999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=319.53 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=206.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..++|.+.+.||+|+||.||+|..+++..||||.++.. ....+++.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45789999999999999999999888889999998753 23457899999999999999999999999988899999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.++++... ...+++.+++.++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999997432 246899999999999999999999998 9999999999999999999999999987654311
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
........++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .........
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~-------------- 219 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVER-------------- 219 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc--------------
Confidence 111112234568999999998889999999999999999999 9999853221 111111100
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.+....+.+....+.+++.+|++.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111122234678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.19 Aligned_cols=241 Identities=22% Similarity=0.299 Sum_probs=194.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
+|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999866 67899999997532 23345677788888877 5899999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998853 235889999999999999999999988 99999999999999999999999999875432
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+... +.+
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~-------------i~~ 215 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQS-------------IME 215 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHH-------------HHh
Confidence 11 122345689999999999999999999999999999999999999964321 111111 111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 677 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 677 (808)
.. ..++.....++.+++.+|++.+|++|++.
T Consensus 216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11 11233345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=341.28 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=200.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
..++|++.++||+|+||.||++... +++.||+|+++.. .....+.+.+|+++++.++|+||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999875 6889999999742 22334567899999999999999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999853 24778888899999999999999988 999999999999999999999999999764
Q ss_pred ccccccccccccccccccccchhhhcC----CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~ 638 (808)
.... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||..... .............
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~ 265 (370)
T cd05596 193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNS 265 (370)
T ss_pred cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCc
Confidence 3221 1112345699999999998653 478999999999999999999999964321 1111111110000
Q ss_pred cccccCCCCCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003605 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 683 (808)
Q Consensus 639 l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~ 683 (808)
+.-.........+.+++.+||+.+|++ |+++.|+++.
T Consensus 266 --------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000011123567889999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=332.29 Aligned_cols=277 Identities=25% Similarity=0.353 Sum_probs=212.0
Q ss_pred CCcccCCHHHHHHHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhh--cccccceeEE
Q 003605 394 GSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR--LHHRNLVKLI 471 (808)
Q Consensus 394 ~s~~~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~ 471 (808)
|++....+--......+..+.+.||+|.||.||+|.++ |+.||||++... +++.+.+|.+|++. |+|+||+.|+
T Consensus 196 GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 196 GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhh
Confidence 33444455555667788999999999999999999998 899999999743 34678899999986 5999999999
Q ss_pred eeeeec----cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCcEEeeeecccC
Q 003605 472 GICIEE----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-----DSSPRVIHRDFKSSN 542 (808)
Q Consensus 472 g~~~~~----~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-----~~~p~IiHrDIKpsN 542 (808)
+.-..+ .+++||.+|.++|||.|||. +..++-+..++++..+|.||++||. +++|.|.|||||+.|
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 986544 36799999999999999995 2469999999999999999999995 468999999999999
Q ss_pred eeecCCCcceeccccccccccccc-cc-ccccccccccccccchhhhcC----CC--ccccceeeHHHHHHHHHhC----
Q 003605 543 ILLEHDFTPKVSDFGLARSAMDEE-SR-HISTRVMGTFGYVAPEYAMTG----HL--LVKSDVYSYGVVILELLSG---- 610 (808)
Q Consensus 543 ILLd~~~~vKL~DFGLa~~~~~~~-~~-~~~~~~~Gt~~Y~APE~l~~~----~~--s~kSDVwSfGvvLlELlTG---- 610 (808)
||+..++.+.|+|+|||-...... .- ......+||.+|||||++... .+ -..+||||||+|+||++..
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 999999999999999997544321 11 112346799999999998643 22 2358999999999999763
Q ss_pred ------CCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHH
Q 003605 611 ------RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND-----VPFDSVAKVAAIASMCVQPEVQHRPFMGE 679 (808)
Q Consensus 611 ------~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 679 (808)
+.||....+.+ -..++..+-+-..+++.. ...+.+..+.+|++.||..+|.-|-|+--
T Consensus 427 gi~eey~~Pyyd~Vp~D-----------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSD-----------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred CEehhhcCCcccCCCCC-----------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 23443222211 111111111222223222 23578899999999999999999999999
Q ss_pred HHHHHHHHHHh
Q 003605 680 VVQALKLVCNE 690 (808)
Q Consensus 680 Vl~~Le~i~~~ 690 (808)
|.+.|.++.+.
T Consensus 496 iKKtl~~l~~~ 506 (513)
T KOG2052|consen 496 IKKTLAKLSNS 506 (513)
T ss_pred HHHHHHHHhcC
Confidence 99999888653
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.67 Aligned_cols=248 Identities=30% Similarity=0.471 Sum_probs=199.4
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCcc
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 493 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~ 493 (808)
++||+|+||.||++.+.+++.||+|.++.... ...++|.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999875433 35678999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccc
Q 003605 494 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573 (808)
Q Consensus 494 ~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~ 573 (808)
++++.. ...+++..++.++.+++.||+|||+++ ++||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998632 235889999999999999999999988 99999999999999999999999999875432111111112
Q ss_pred cccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 574 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 574 ~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...+..|+|||++.++.++.++|||||||++|||+| |..||...... ...... ........+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~~--------------~~~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERI--------------ESGYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHHH--------------hcCCCCCCC
Confidence 234567999999998899999999999999999999 88888543221 111111 001111122
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
......+.+++.+|++.+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 334568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.77 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=202.8
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
++|.+.+.||+|+||.||+|...++..+|+|++.... ...+.|.+|++++++++|+|++++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998877789999886532 33467899999999999999999999875 456799999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.++++.. ....++|..++.++.+++.||+|||+.+ ++||||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999743 2345899999999999999999999988 999999999999999999999999999765332211
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|+|||++.+..++.++|||||||++|||+| |+.||..... .....+... . .
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~----~----------~ 220 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVER----G----------Y 220 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----C----------C
Confidence 1122345678999999998899999999999999999999 8989864321 111111110 0 0
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
....+......+.+++.+|++.+|++||++++|++.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011222345679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.77 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=204.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-C---CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-D---GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-d---g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.+.||+|+||.||+|... + +..+|+|.++... ....+.|.+|+.++.+++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999864 2 3379999987532 33456899999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+++++|.++++.. ...+++.+++.|+.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999632 245899999999999999999999988 9999999999999999999999999998654
Q ss_pred ccccccc-ccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 564 DEESRHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 564 ~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
....... .....++..|+|||++.+..++.++|||||||++||+++ |..||..... .....+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~----~----- 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEE----G----- 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhC----C-----
Confidence 3221111 111223568999999998899999999999999999887 9999864322 122222111 0
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.....+......+.+++.+|++.+|++||+|.++++.|+.+
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 -----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111223346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.59 Aligned_cols=237 Identities=25% Similarity=0.324 Sum_probs=188.5
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHH-HHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||+|+.. +++.||+|++.... ....+++.+|+. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 68899999997422 223345666655 57889999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+.+..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 999888852 345788889999999999999999988 9999999999999999999999999987532211 2
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...... +.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----------i~~~~--~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDN----------ILHKP--L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHH----------HhcCC--C
Confidence 22345689999999999988999999999999999999999999964321 111111 11111 1
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMG 678 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 678 (808)
..+......+.+++.+||+.+|++|++..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12334456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.59 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=201.8
Q ss_pred hCCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.++.+++|+||+++++++..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688899999999999999996 47889999999755445556788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.++++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999863 235899999999999999999999988 9999999999999999999999999997653221
Q ss_pred ccccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
. ......|+..|+|||.+. ...++.++|||||||++|||++|+.|+....... ....+.. . .+.
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~--~~~~~~~------~---~~~ 227 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMSK------S---NFQ 227 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh--hheeeec------C---CCC
Confidence 1 112345788999999874 3457889999999999999999999985332111 0000000 0 000
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.+.+.. .......+.+++.+||+.+|++||++++|++.|
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111110 112346789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.22 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=194.3
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||+|+.. +++.||||+++.. .....+.+..|++++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 5789999999753 233445678899999876 799999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999988853 235889999999999999999999998 9999999999999999999999999987543222 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+... .... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~---i~~~----------~~-- 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFES---ILHD----------DV-- 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHH---HHcC----------CC--
Confidence 22345689999999999998999999999999999999999999974321 111111 1110 00
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRP-------FMGEVVQA 683 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RP-------sm~eVl~~ 683 (808)
..+......+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01122345788999999999999999 67777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.60 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=193.1
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
+|+..++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999864 68899999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999853 235788889999999999999999998 999999999999999999999999997532100
Q ss_pred c---------------------------------------------ccccccccccccccccchhhhcCCCccccceeeH
Q 003605 566 E---------------------------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 600 (808)
Q Consensus 566 ~---------------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSf 600 (808)
. .........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCc-chhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCC---
Q 003605 601 GVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF--- 676 (808)
Q Consensus 601 GvvLlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs--- 676 (808)
||+||||++|+.||........ ..+..|. ..+...........+.+++.+|+ .+|++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQ---------------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccC---------------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 9999999999999965322100 0011110 00000011122345666666665 49999997
Q ss_pred HHHHHH
Q 003605 677 MGEVVQ 682 (808)
Q Consensus 677 m~eVl~ 682 (808)
+.|+++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.33 Aligned_cols=248 Identities=30% Similarity=0.482 Sum_probs=200.2
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeee-ccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LV~Ey~ 487 (808)
++|.+.+.||+|+||.||++... |+.||+|.++.. ...+.|.+|+.++++++|+|++++++++.. .+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999775 788999998743 234679999999999999999999998654 45689999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.++++.. ....++|..+++++.+++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999998642 2235899999999999999999999988 9999999999999999999999999987543211
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+..+... .
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~--------------~ 215 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEK--------------G 215 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhc--------------C
Confidence 22334568999999998899999999999999999998 999885321 1122221110 0
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=340.60 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=196.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.+|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++|++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999865 68999999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999963 235888889999999999999999998 99999999999999999999999999753210
Q ss_pred cc-----------------------------------------ccccccccccccccccchhhhcCCCccccceeeHHHH
Q 003605 565 EE-----------------------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 603 (808)
Q Consensus 565 ~~-----------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvv 603 (808)
.. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0001123469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCc-chhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCC---CHHH
Q 003605 604 ILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP---FMGE 679 (808)
Q Consensus 604 LlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP---sm~e 679 (808)
||||++|+.||........ ..+..|. .. +...........+.+++.+|+ .+|++|+ ++.|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~-------~~--------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE-------TT--------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC-------cc--------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 9999999999975432110 0011110 00 000011123345677777766 5999999 8888
Q ss_pred HHHH
Q 003605 680 VVQA 683 (808)
Q Consensus 680 Vl~~ 683 (808)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.93 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=194.4
Q ss_pred eeeeecCcEEEEEEEeeC---CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCC
Q 003605 415 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d---g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
+.||+|+||.||+|...+ +..+|+|.++... ......|.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 3578999987543 334467899999999999999999999999988999999999999
Q ss_pred Ccccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 491 SVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 491 sL~~~L~~~~~-~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
+|.++++.... ....+++..+++++.|+++||+|||+.+ ++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 2235678888999999999999999988 9999999999999999999999999987543322222
Q ss_pred cccccccccccccchhhhcC-------CCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 570 ISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~-------~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
......++..|+|||++... .++.++|||||||++|||++ |+.||...... ....+.. .+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~~-----~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYTV-----REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHh-----hcccCC
Confidence 22334577889999988642 35789999999999999996 99999653321 1111110 011111
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+.++.+.. .....+.+++.+|+ .+|++||+++||++.|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222211 23346788999998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=321.96 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=200.1
Q ss_pred HHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeeec-----
Q 003605 405 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE----- 477 (808)
Q Consensus 405 ~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~----- 477 (808)
+.+++.|+..+.||+|+||.||+|... +++.||+|++... .....++.+|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346778889999999999999999865 6789999998753 33456788999999998 699999999998753
Q ss_pred -cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 478 -QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 478 -~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
...++||||+.+|+|.+++... ....+.|..+..++.|++.||+|||+.+ |+|||||++||++++++.+||+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 3578999999999999998642 2346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~ 631 (808)
|+++...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..+...
T Consensus 156 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~~ 228 (272)
T cd06637 156 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLI 228 (272)
T ss_pred CCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHHH
Confidence 9987543211 1223456889999999986 345788999999999999999999999643211 111100
Q ss_pred hcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 632 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 632 ~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
. ... ...+ ........+.+++.+||..+|++||++.||++
T Consensus 229 -~--~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 -P--RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -h--cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 000 0000 11123457889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.97 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=194.3
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhccc-ccceeEEeeeeeccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV~ 484 (808)
+|++.+.||+|+||.||+|... +++.||||+++.. .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999865 5788999999753 23445678899999999965 56888999999889999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998853 235889999999999999999999988 99999999999999999999999999874322
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
.. .......||..|+|||++.+..++.++|||||||++|||+||+.||..... ..+.... .+
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i-------------~~ 215 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSI-------------ME 215 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH-------------Hc
Confidence 11 112345689999999999999999999999999999999999999964321 1111111 11
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 677 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 677 (808)
. ...++......+.+++.+||+.+|++|++.
T Consensus 216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 H--NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 011222344678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=333.09 Aligned_cols=257 Identities=26% Similarity=0.346 Sum_probs=204.6
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--------------chhhHHHHHHHHHHhhcccccceeE
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--------------QQGGREFLAEVEMLSRLHHRNLVKL 470 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--------------~~~~~~f~~Ei~iL~~L~HpNIV~L 470 (808)
...++|++.+.||+|.||.|-+|... +++.||||++.+.. ....+...+||.+|++++|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999865 78999999995311 1123578999999999999999999
Q ss_pred Eeeeee--ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC
Q 003605 471 IGICIE--EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 548 (808)
Q Consensus 471 ~g~~~~--~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~ 548 (808)
+.+..+ .+..|||+|||..|.+...= .....|...++++++.++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 999765 46789999999988876543 22223999999999999999999999999 9999999999999999
Q ss_pred Ccceecccccccccccc---cccccccccccccccccchhhhcCC----CccccceeeHHHHHHHHHhCCCCCCCCCCCC
Q 003605 549 FTPKVSDFGLARSAMDE---ESRHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVILELLSGRKPVDMTQPPG 621 (808)
Q Consensus 549 ~~vKL~DFGLa~~~~~~---~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~ 621 (808)
+++||+|||.+..+... +....-.+.+||+.|+|||...++. .+.+.||||+||.||.|+.|+.||.....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 99999999998755221 1112223468999999999887743 25678999999999999999999953211
Q ss_pred cchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 622 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 622 ~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
-+..++|+...+.-....+....+.+|++++|++||++|.+..+|..+..
T Consensus 325 --------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 --------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred --------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 12234455554433333456778999999999999999999999987764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.68 Aligned_cols=240 Identities=24% Similarity=0.353 Sum_probs=191.1
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||+|... +++.||||+++.. .....+.+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 6788999999753 223345566777777754 899999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998853 235889999999999999999999988 9999999999999999999999999997543222 2
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ...... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~---~~i~~~------------~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELF---DSILND------------RP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHcC------------CC
Confidence 22345689999999999998999999999999999999999999964321 1111 111100 01
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVV 681 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl 681 (808)
.++......+.+++.+||+.+|++||++. +++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12223345688999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.52 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=199.7
Q ss_pred eeeeecCcEEEEEEEeeC--CC--EEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLDD--GT--KVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d--g~--~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|++|.||+|.+.+ ++ .||||.++.... ...++|.+|++++++++|+||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 33 689999986544 566789999999999999999999999988 888999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++..... ..++|...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999975322 46899999999999999999999988 9999999999999999999999999998664322211
Q ss_pred -cccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 570 -ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 570 -~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|+|||++.+..++.++|||||||++|||++ |+.||+.... .++..... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~---~~~~---------- 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKID---KEGE---------- 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH---hcCC----------
Confidence 1123457789999999998899999999999999999999 9999864321 11111111 0000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
....+......+.+++.+|++.+|++||++.||++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00112233467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.60 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=202.8
Q ss_pred CcceeeeeeecCcEEEEEEEe-----eCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeec--cceE
Q 003605 410 NFDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARC 481 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l-----~dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~ 481 (808)
.|.+.+.||+|+||.||++.+ .++..||+|.++.. .....+++.+|++++++++|+||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999974 35788999998743 234456899999999999999999999998775 5679
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+||||+++++|.+++.. ....++|.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999853 2235899999999999999999999988 99999999999999999999999999986
Q ss_pred ccccccc-ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCC---------CcchhHHhhhh
Q 003605 562 AMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP---------GQENLVAWARP 631 (808)
Q Consensus 562 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~---------~~~~lv~w~~~ 631 (808)
....... .......++..|+|||++.+..++.++|||||||++|||+|++.|....... .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-
Confidence 5432211 1122345677899999999888999999999999999999987664321100 0000001100
Q ss_pred hcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 632 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 632 ~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.+........+......+.+|+.+|++.+|++||++.+|++.|+.+
T Consensus 238 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 ----------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ----------HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000111112234557899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.74 Aligned_cols=255 Identities=20% Similarity=0.285 Sum_probs=199.8
Q ss_pred HHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccc
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 479 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 479 (808)
+....++|++.+.||+|+||.||++... +++.+|+|.+++. .....+.+.+|+++++.++|+||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999975 6789999998642 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||||++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999852 24788899999999999999999988 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccchhhhcC----CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 560 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
+...... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||..... .....
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~----- 257 (370)
T cd05621 190 MKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYS----- 257 (370)
T ss_pred eecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHH-----
Confidence 8653221 1112345699999999998754 378899999999999999999999964321 11111
Q ss_pred ccccccccCCCCCCCCC--hhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003605 636 REGLERIIDPSLGNDVP--FDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 683 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~ 683 (808)
.+.+......++ ......+.+++..|+..++.+ |+++.|+++.
T Consensus 258 -----~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 -----KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111001111 123456788899999865544 8899998775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=321.45 Aligned_cols=251 Identities=29% Similarity=0.508 Sum_probs=198.8
Q ss_pred eeeeecCcEEEEEEEeeC-------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 415 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d-------g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+.||+|+||.||+|+..+ +..+|||.+.... .....+|.+|++++++++|+||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886532 24456899999999999999999999999998999999999
Q ss_pred cCCCCcccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-----cceeccccc
Q 003605 487 IPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-----TPKVSDFGL 558 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~---~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-----~vKL~DFGL 558 (808)
+++++|.++++.... ....++|.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999974322 2245889999999999999999999887 99999999999999877 899999999
Q ss_pred ccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccc
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
++...............++..|+|||++.++.++.++|||||||++|||+| |+.||..... .....+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----AG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----cC-
Confidence 976543322222223345678999999999999999999999999999998 9999863221 11111110 00
Q ss_pred ccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 638 ~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.....+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 230 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 ---------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001122234567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.82 Aligned_cols=238 Identities=26% Similarity=0.345 Sum_probs=192.0
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||+|... +++.||||+++.. .....+.+..|++++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 6889999999752 233456778899999877 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.++++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 999998853 245899999999999999999999988 9999999999999999999999999987532211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ..... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~---~i~~~----------~--~ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFE---AILND----------E--V 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHH---HHhcC----------C--C
Confidence 22345689999999999998999999999999999999999999964321 11111 11110 0 0
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGE 679 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 679 (808)
..+......+.+++.+||+.||++|+++.+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 112223457889999999999999999844
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.99 Aligned_cols=251 Identities=28% Similarity=0.502 Sum_probs=201.8
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
.+|++.+.||+|+||.||++...+++.+|+|.++.. .....+|.+|++++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467788999999999999999877889999998743 2334679999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+++|.++++.. ...+.|..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999998632 235889999999999999999999988 99999999999999999999999999875533211
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.......++.+|+|||++.++.++.++||||||+++|||++ |+.||..... ..+.... .. . .....
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~---~~---~-~~~~~--- 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETI---NA---G-FRLYK--- 222 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH---hC---C-CCCCC---
Confidence 11112234678999999998899999999999999999998 9999864221 1111111 00 0 00111
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
+......+.+|+.+||+.+|++||++.||++.|
T Consensus 223 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 ----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 112346799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.30 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=199.0
Q ss_pred CCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|+..++||+|+||.||+|.. .+++.||+|++... .....++|.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3677889999999999999986 47889999998643 334456799999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999987653 3678889999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhcccccccccccCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~-~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ....+... +.+.
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~ 215 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC----------IVDE 215 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH----------Hhcc
Confidence 123346889999999999989999999999999999999999999653321110 00011100 0111
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
............++.+++.+|++.+|++||++.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000111234578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.79 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=194.4
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
||+|+||.||++... +|+.||+|++.... ....+.+..|++++++++|+||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 68999999986421 22334566799999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9888632 2345899999999999999999999988 9999999999999999999999999987653221 123
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....... ......+... ...+.. ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~----------~~~~~~-~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTL----------EDEVKF-EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhh----------cccccc-cc
Confidence 3468899999999999899999999999999999999999996432211 1111111111 111100 01
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.....++.+++.+||+.||++||+++|+++.+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12345789999999999999999998876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=312.88 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=216.0
Q ss_pred HhCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeecc-----ce
Q 003605 407 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----AR 480 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~ 480 (808)
..++|.+.+.||+|||..||.+. +.++..+|+|++.....++.+..++|++..++++|+||+++++++..+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999998 5688999999998777778889999999999999999999999986543 47
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
||+++|+..|+|.+++.....++..+++.+.++|+.++++||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999877667778999999999999999999999985 679999999999999999999999999987
Q ss_pred ccccccccc-------cccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 003605 561 SAMDEESRH-------ISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 561 ~~~~~~~~~-------~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~ 630 (808)
...-.-... -......|.-|+|||.+. +...++++|||||||+||+|+.|..||+.....+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 542111000 001234688999999875 4567899999999999999999999997543311
Q ss_pred hhcccccccc-cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 003605 631 PLLTSREGLE-RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 631 ~~~~~~~~l~-~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
..+. .+....+...-.....+.+.+++++|++.||.+||++.+++..++.+.
T Consensus 249 ------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 112222222222236688999999999999999999999999988653
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.12 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=205.0
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeC----CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~d----g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.++|.+.+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3567888999999999999998653 2468999887543 4456789999999999999999999999875 56789
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||||+++|+|.+++... ...++|.+++.++.+++.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999632 335899999999999999999999988 999999999999999999999999998765
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.... ....+...++..|+|||.+....++.++|||||||++|||++ |+.||..... .....+.. ....
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~----~~~~--- 226 (270)
T cd05056 158 EDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIE----NGER--- 226 (270)
T ss_pred cccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHH----cCCc---
Confidence 4322 111222334568999999988889999999999999999986 9999964432 11111111 0000
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
...+......+.+++.+|+..+|++||++.++++.|+.+.++
T Consensus 227 -------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 -------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011223346789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=333.29 Aligned_cols=238 Identities=26% Similarity=0.359 Sum_probs=192.8
Q ss_pred eeeeecCcEEEEEEEe----eCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l----~dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 367899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.++++. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 9999999852 346899999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...... ... ..
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~---i~~----------~~-- 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTM---ILK----------AK-- 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHH---HHc----------CC--
Confidence 122345689999999999988899999999999999999999999964321 111111 111 00
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 679 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 679 (808)
...+......+.+++.+||+.||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122233467889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.39 Aligned_cols=248 Identities=31% Similarity=0.450 Sum_probs=198.0
Q ss_pred eeeeecCcEEEEEEEee--C--CCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD--D--GTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~--d--g~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||+|++. + +..+|+|.++.... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 26899999875433 35578999999999999999999999876 4568999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.++++.. ..++|..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999632 26899999999999999999999988 9999999999999999999999999998654322211
Q ss_pred c-ccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 570 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 570 ~-~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||+.... ..+..+.... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~----~---------- 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESG----E---------- 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcC----C----------
Confidence 1 111223567999999998899999999999999999998 9999864321 2232322111 0
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
....+......+.+++.+|+..+|++||++.+|++.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0112233446789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=329.83 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=194.0
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||+||++... +++.||||+++.. .....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 6789999999853 233456688999999988 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 999988852 246999999999999999999999998 9999999999999999999999999987532211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||+||||++|+.||+........+...+...... ... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~--~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL---------EKP--I 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH---------hCC--C
Confidence 22345689999999999999999999999999999999999999975433222222222211111 110 1
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMG 678 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 678 (808)
..+......+.+++.+||+.||++|+++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 12223346788999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=338.66 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=203.1
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
..++|+.+++||+|+||.||.++-+ +|..+|+|+|++.. ....+..+.|-.+|....+++||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999865 79999999998743 3445678889999999999999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||||++||++..+|. ....|+++.....+.+++.|++-||+.+ +|||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999995 3457999999999999999999999999 999999999999999999999999998422
Q ss_pred cc----------------------ccccc----cc-------------------cccccccccccchhhhcCCCccccce
Q 003605 563 MD----------------------EESRH----IS-------------------TRVMGTFGYVAPEYAMTGHLLVKSDV 597 (808)
Q Consensus 563 ~~----------------------~~~~~----~~-------------------~~~~Gt~~Y~APE~l~~~~~s~kSDV 597 (808)
.. .+... .. ...+||+.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 00000 00 02569999999999999999999999
Q ss_pred eeHHHHHHHHHhCCCCCCCCCCCC-cchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 003605 598 YSYGVVILELLSGRKPVDMTQPPG-QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 676 (808)
Q Consensus 598 wSfGvvLlELlTG~~P~~~~~~~~-~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 676 (808)
||||||+||||.|..||....+.. -..++.|-..+.... ......+..+||.+|+. ||++|--
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999998765532 345566643332211 11223678899999999 9999975
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.04 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=194.6
Q ss_pred eeeeecCcEEEEEEEee----CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeee-ccceEEEEeecC
Q 003605 415 RILGEGGFGLVYSGVLD----DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYELIP 488 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~----dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LV~Ey~~ 488 (808)
++||+|+||.||+|.+. +...||+|++... .....+.+.+|+.+++.++|+||++++++|.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2357999998643 33446788999999999999999999998764 456799999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.++++.. ...+.+..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999632 234788889999999999999999987 999999999999999999999999999754332111
Q ss_pred c--cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCC-CCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 569 H--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 569 ~--~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~-~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ......++..|+|||++.+..++.++|||||||++|||++|. .||.... ...+..+.. . ...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~---~-~~~------- 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLL---Q-GRR------- 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHh---c-CCC-------
Confidence 1 112334577899999998889999999999999999999954 4554221 112222111 0 000
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
...+......+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111223578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.50 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=205.3
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..++|++.+.||+|+||.||++.+.++..+|+|.++.. ....+.|.+|++++++++|+||+++.+++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34678999999999999999999877888999988753 3345689999999999999999999999887 778999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++|+|.+++... ....++|.+++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999642 2346889999999999999999999987 9999999999999999999999999987553322
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. .......++..|+|||++..+.++.++|||||||++|||+| |+.||..... ..+..+.. ..
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~----~~--------- 219 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE----RG--------- 219 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh----CC---------
Confidence 1 11122345678999999998889999999999999999999 8999864321 12222211 00
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
............+.+++.+|++.+|++||++.++.+.|+.
T Consensus 220 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011122334678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.56 Aligned_cols=263 Identities=23% Similarity=0.363 Sum_probs=203.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|++.+.||+|+||.||++... ++..+|+|.++.. .....+++.+|++++.+++|+||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47899999999999999999865 6788999998743 233456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~-~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
+++++|.++++. ...+++..+..++.|+++||+|||+. + ++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999963 24588999999999999999999974 5 999999999999999999999999998754322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc---c----
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE---G---- 638 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~---~---- 638 (808)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .+..+......... .
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccc
Confidence 122346889999999998888999999999999999999999998643321 11111110000000 0
Q ss_pred ------------cccccCCCCC---CCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 639 ------------LERIIDPSLG---NDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 639 ------------l~~ivD~~l~---~~~~-~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
..++.+.... ...+ ......+.+++.+||..+|++||++.||++..-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000000 0001 113456899999999999999999999988743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.03 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=203.8
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999854 78899999998655555678999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.++++. ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999852 34889999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+. ... . +.+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~----~~~--~-----~~~ 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIA----TNG--T-----PEL 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHh----cCC--C-----CCC
Confidence 122346888999999999888999999999999999999999999643321 1111111 000 0 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+......+.+++.+|+..+|++||++.||++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122334578899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.75 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=189.4
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHH-HHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||+||+|... +|+.||||++... .....+++.+|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 7899999999742 1223345556655 45778999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 999998852 346889999999999999999999998 9999999999999999999999999987532211 2
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ........ ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~----------~~~~-- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL----------NKPL-- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH----------cCCC--
Confidence 22345689999999999999999999999999999999999999964321 11111111 1111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGE 679 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 679 (808)
..+......+.+++.+||+.+|++||++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 111223467889999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.63 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=196.8
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.++||+|+||.||+++.. +++.+|+|++.+. .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999976 5788999998642 2233456888999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.++++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999963 2345899999999999999999999988 99999999999999999999999999875433
Q ss_pred ccccccccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
.. ........||+.|+|||++. ...++.++|||||||+||||++|+.||.... ...............
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~ 227 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERF 227 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCccc
Confidence 22 12223356999999999986 3467899999999999999999999996432 111111111111000
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 683 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~ 683 (808)
. + + .........+.+++.+|+..++++ |+++.|+++.
T Consensus 228 ~--~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q--F-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c--C-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 0 001123456788888888655444 6889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.50 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=203.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
++|+..+.||+|+||.||+|... +++.+++|.++.... .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888899999999999999976 478999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.+++.. ....++|..++.++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999853 2356899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|+|||++.+..++.++|||||||++|||++|+.||........ .... .. ...+.+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~----~~-------~~~~~~ 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMI----PN-------KPPPTL 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhh----cc-------CCCCCC
Confidence 22334578899999999998999999999999999999999999974322110 0000 00 000000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
..+......+.+++.+|++.+|++||++.||++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223457899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.76 Aligned_cols=259 Identities=27% Similarity=0.475 Sum_probs=203.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCC----EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~----~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
++|+..+.||+|+||.||+|... +|. .||+|.++... .....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46777889999999999999864 444 47889887533 23345789999999999999999999999754 5679
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
++||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999863 2335889999999999999999999988 999999999999999999999999999865
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+..+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~----~~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLE----KGERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----CCCCC--
Confidence 43222212223345678999999998899999999999999999998 889985422 122222221 11100
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
..+......+.+++..|+..+|++||+++++++.|+.+.++.
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 011223457889999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=345.58 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=206.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
+-|++.+.||+|+-|.|-.|++. +|+.+|||++.+. .......+.+||-||+-|.|||+++|++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34677889999999999999964 8999999999653 2233456789999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|-|.++|- .+.+|.+.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|..-.
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 9999999999995 3456899999999999999999999998 9999999999999999999999999997532
Q ss_pred ccccccccccccccccccchhhhcCCC-ccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
....-..-+|.+.|.|||++++..| ..++||||.|||||.||||+.||+. .++-...... ..+..
T Consensus 164 --~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV---~~G~f--- 229 (786)
T KOG0588|consen 164 --PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKV---QRGVF--- 229 (786)
T ss_pred --CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHH---HcCcc---
Confidence 2233355689999999999999988 5799999999999999999999973 2221111111 11111
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
++|.....+..+|+.+|+..||++|.|++||+++-
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 13445567888999999999999999999998863
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=339.57 Aligned_cols=261 Identities=20% Similarity=0.279 Sum_probs=196.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.++|.+.+.||+|+||.||++... +++.||+|.... ..+.+|++++++|+|+||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999864 788999997542 3578999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. ++|.+++.. ...+++.+++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 94 788888752 245899999999999999999999988 9999999999999999999999999997533221
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc----chhHHhhhhhc---------
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ----ENLVAWARPLL--------- 633 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~----~~lv~w~~~~~--------- 633 (808)
........||+.|+|||++.+..++.++|||||||+||||+||+.|+........ ...........
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1122345799999999999999999999999999999999999988643221110 00000000000
Q ss_pred cccccccccc---------CCCCCCCC--ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 634 TSREGLERII---------DPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 ~~~~~l~~iv---------D~~l~~~~--~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+..+. .+...... ..+....+.+|+.+||+.||++|||+.|+++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00000000 01234578899999999999999999999753
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.62 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=194.2
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||+||++... +++.||||+++.. .....+.+..|++++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 5789999999853 233456678899999888 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999988853 236899999999999999999999988 9999999999999999999999999987432211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. .... .. .
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~---~i~~----------~~--~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQ---SILE----------DE--V 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHH---HHHc----------CC--C
Confidence 12334689999999999999999999999999999999999999964321 11111 1110 00 0
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFM-----GEVVQ 682 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm-----~eVl~ 682 (808)
.++......+.+++.+||+.||++||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1122334678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.35 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=199.0
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhh--HHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~--~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
|++.+.||+|+||+||++... +++.||+|++........ ....+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999976 567899999986543332 23456999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
.+++|.+++. ....+++.+++.++.|+++||+|||+.+ |+|+||||+||+++++++++|+|||++.... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cc
Confidence 9999999996 2346899999999999999999999998 9999999999999999999999999987531 11
Q ss_pred cccccccccccccccchhhh-cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~-~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
........++..|+|||++. +...+.++||||+|+++|+|++|..||..... .+........... .... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~-----~~~~-~ 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKR-----PLPS-S 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHT-----HHHH-H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhcccc-----cccc-c
Confidence 22234456889999999998 78899999999999999999999999975411 1111111100000 0000 0
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
. .........+.+++.+||+.||++||++.++++
T Consensus 223 ~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000111378999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.70 Aligned_cols=255 Identities=21% Similarity=0.283 Sum_probs=195.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||++... +++.||||+++.. .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999965 6899999999742 2233456889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999953 2345889999999999999999999998 99999999999999999999999999875433
Q ss_pred ccccccccccccccccccchhhhc-----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
... .......||..|+|||++.. +.++.++|||||||++|||++|+.||..... ..............
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF 227 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 221 11223468999999999873 4578899999999999999999999964321 11111111111100
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEV--QHRPFMGEVVQA 683 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP--~~RPsm~eVl~~ 683 (808)
.+ .+ ........+.+++.+|+..++ ..|+++.++++.
T Consensus 228 -~~-~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -QF-PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cC-CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 00 011234567778888775433 347899888766
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.59 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=213.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccc-eEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA-RCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-~~LV~ 484 (808)
++|...+++|+|+||.++..+.+ +++.+++|.+.- ......+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999988865 678999999863 344445578899999999999999999999999988 89999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
+||+||+|.+.|...+ +..+.++.+++++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997432 456888999999999999999999887 99999999999999999999999999998754
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
.. .....+.||+.||+||.+.+..|..|+|||||||++|||++-+++|+..+.. .+ +. ++..
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~L---i~----------ki~~ 220 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---EL---IL----------KINR 220 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HH---HH----------HHhh
Confidence 43 2345678999999999999999999999999999999999999999754321 11 11 1111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
......+..+..++..++..|++.+|+.||++.+++.+
T Consensus 221 -~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 -GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11233566778899999999999999999999999987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.95 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=190.5
Q ss_pred eeeecCcEEEEEEEeeC---CCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCC
Q 003605 416 ILGEGGFGLVYSGVLDD---GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~d---g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~Gs 491 (808)
.||+|+||.||+|...+ ...+|+|.++.. ......+|.+|+++++.++|+||++++++|.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998653 346888887643 23345678999999999999999999999999999999999999999
Q ss_pred ccccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccc
Q 003605 492 VESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570 (808)
Q Consensus 492 L~~~L~~~~~~-~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~ 570 (808)
|.++++..... ....++...+.++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999754321 234578889999999999999999988 99999999999999999999999999875433222122
Q ss_pred ccccccccccccchhhhc-------CCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 571 STRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 571 ~~~~~Gt~~Y~APE~l~~-------~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... ....... .. +....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~---~~--~~~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQV---VR--EQDIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH---hh--ccCccC
Confidence 223345678999998753 356789999999999999999 7788754321 1111110 00 111111
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.++.+ +......+.+++..|+ .||++||+++||++.|
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 22222 2234456777888898 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=327.53 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=191.7
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||.||+|... +|+.||||.++... ....+.+..|++++..+ +|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 68899999997531 23445677788888765 899999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999998853 345889999999999999999999998 9999999999999999999999999987432111 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... .. ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~---~~--------~~~---- 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESI---RV--------DTP---- 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH---Hh--------CCC----
Confidence 22345689999999999999999999999999999999999999964321 1111110 00 001
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVV 681 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl 681 (808)
.++.....++.+++.+||+.||++|+++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11222345788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.98 Aligned_cols=265 Identities=27% Similarity=0.385 Sum_probs=208.5
Q ss_pred cCCHHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeee
Q 003605 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICI 475 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 475 (808)
.+..+++..++++|.+.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.+++++ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4666778888999999999999999999999874 78899999986532 2346778899999999 7999999999987
Q ss_pred ec-----cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCc
Q 003605 476 EE-----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550 (808)
Q Consensus 476 ~~-----~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~ 550 (808)
.. +..++|+||+++|+|.++++........+.|..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 54 3579999999999999998754334456899999999999999999999987 999999999999999999
Q ss_pred ceecccccccccccccccccccccccccccccchhhhcC-----CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003605 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 625 (808)
Q Consensus 551 vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~l 625 (808)
+||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||..... ...+
T Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~ 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTL 242 (291)
T ss_pred EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHH
Confidence 99999999876533221 11234578899999987643 368899999999999999999999864321 1111
Q ss_pred HHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 626 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 626 v~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.+. ....+. .+......+.+++.+|++.+|++||++.|+++.
T Consensus 243 ~~~~~~------~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIPRN------PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHhcC------CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111110 000111 112234578999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.68 Aligned_cols=238 Identities=26% Similarity=0.483 Sum_probs=189.7
Q ss_pred eeeeecCcEEEEEEEeeCCC-----------EEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 415 RILGEGGFGLVYSGVLDDGT-----------KVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~-----------~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
+.||+|+||.||+|.+.+.. .+++|.++..... ...|.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986433 5788887654333 6789999999999999999999999988 778999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-------cceeccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-------TPKVSDF 556 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-------~vKL~DF 556 (808)
|||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999632 226899999999999999999999988 99999999999999887 7999999
Q ss_pred ccccccccccccccccccccccccccchhhhcC--CCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
|++..... .....++..|+|||++... .++.++|||||||++|||++ |..|+...... ....+..
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQ--- 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHh---
Confidence 99876432 1223466789999998876 78999999999999999999 56777543211 1111110
Q ss_pred ccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 634 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+. ...+......+.+++.+|+..+|++||++.||++.|+
T Consensus 221 ----------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ----------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0011111267899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.46 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=199.3
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556688999999999999976 5778899998765556677899999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
++|.++++. ....++|..++.++.|++.||+|||+.+ ++||||||+|||++.++++||+|||+++...... .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 999998863 2346999999999999999999999988 9999999999999999999999999987543221 1
Q ss_pred cccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 570 ISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
......++..|+|||++. +..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~-----------~~ 225 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS-----------EP 225 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhc-----------CC
Confidence 123346889999999884 345778999999999999999999998643211 111111100 00
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+.+ ..+......+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 PTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0112234678999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=344.73 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=212.5
Q ss_pred eeeeeecCcEEEEEEEe-eCCC----EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 414 SRILGEGGFGLVYSGVL-DDGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l-~dg~----~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.++||+|+||+||||.+ .+|+ +||||++... ..+...++++|+-+|.+|.|+||++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 57999999999999985 3454 5899998753 4455689999999999999999999999998765 78999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
+.|+|.||++. ++..+.-...+.|..|||+||.|||++. ++||||.++|||+.+-..+||.|||+++....+..
T Consensus 780 P~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 780 PLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred ccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999974 4456888999999999999999999887 99999999999999999999999999998766555
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
........-.+.|||-|.+....|+.++|||||||.+|||+| |..|++.....+ +..++...
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------------I~dlle~g 916 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------------IPDLLEKG 916 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------------hhHHHhcc
Confidence 444444455678999999999999999999999999999999 999997543211 12222222
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhh
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
.+-..+.-+...+..++.+||..|++.||+++++...+.+..++..
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 2223455677889999999999999999999999999887776543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.01 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=202.3
Q ss_pred CcceeeeeeecCcEEEEEEEeeC--CCEEEEEEeecc----------cchhhHHHHHHHHHHhh-cccccceeEEeeeee
Q 003605 410 NFDASRILGEGGFGLVYSGVLDD--GTKVAVKVLKRV----------DQQGGREFLAEVEMLSR-LHHRNLVKLIGICIE 476 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~d--g~~VAVK~lk~~----------~~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~ 476 (808)
+|++.+.||+|+||.||+|.... ++.+|+|.++.. ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 688999988531 22334567889998875 799999999999999
Q ss_pred ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeeecCCCcceecc
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSD 555 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILLd~~~~vKL~D 555 (808)
.+..++||||+++++|.+++.........+++..+++++.|++.||.|||+ .+ ++|+||+++|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886544445569999999999999999999996 45 99999999999999999999999
Q ss_pred cccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 556 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 556 FGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
||++....... ......|+..|++||++.++.++.++||||||+++|||++|+.||..... ........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~-- 226 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIV-- 226 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHh--
Confidence 99997654322 22345688899999999988899999999999999999999999864321 11111111
Q ss_pred ccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+..............+.+++.+|++.||++||++.||..+|+
T Consensus 227 --------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 --------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111000011123467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=328.26 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=194.5
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~ 484 (808)
+|+..++||+|+||.||++... +|+.||||+++.. .....+.+..|++++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 7899999999753 2334456888999998885 678888999999889999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++.+++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998852 245899999999999999999999988 99999999999999999999999999875322
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+... +..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~-------------i~~ 215 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQS-------------IME 215 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH-------------HHh
Confidence 21 112335689999999999998999999999999999999999999964321 111111 111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 678 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 678 (808)
.. ..++......+.+++.+|++.+|++|++..
T Consensus 216 ~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 216 HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CC--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 10 112233446788999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.67 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=199.2
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.|+..++||+|+||+||+|... +++.||+|.++... ....+.+.+|++++++++|+||+.+.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677899999999999999865 78899999986432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999988632 2336999999999999999999999988 999999999999999999999999998754321
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~~~~---------- 220 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRVLET---------- 220 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhhcc----------
Confidence 1 1123468999999999998999999999999999999999999996432211 111111111000
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 683 (808)
...+.......+.+|+..|++.+|++||+ +.++++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00122233457889999999999999999 5566553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.65 Aligned_cols=241 Identities=25% Similarity=0.349 Sum_probs=192.2
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
+.||+|+||+||+|... +++.||||+++... ....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997531 23345677788888764 899999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999853 245889999999999999999999988 9999999999999999999999999987532211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... . ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~---~--------~~~~--- 214 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIR---M--------DNPC--- 214 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---h--------CCCC---
Confidence 22345689999999999999999999999999999999999999964321 11111110 0 0011
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVVQ 682 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl~ 682 (808)
++......+.+++.+||+.+|++||++. ++.+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1122335688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=312.93 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=202.0
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+++.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999865 7889999998642 2344567889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++|+|.+++... ....+++...+.++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999988532 2345789999999999999999999988 9999999999999999999999999987553321
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||+.... ......... ...
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~--~~~-------- 217 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQ--GSY-------- 217 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhc--CCC--------
Confidence 122335688899999999988899999999999999999999999964221 111111110 000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+......+.+++.+||+.+|++||++.||+..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.98 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=196.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|.+.+.||+|+||+||+++.. +++.||+|+++.. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999965 6788999999742 2233456888999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.++++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999632 246889999999999999999999988 99999999999999999999999999976533
Q ss_pred ccccccccccccccccccchhhhc-----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
... .......||..|+|||++.+ +.++.++|||||||+||||++|+.||..... ..............
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERF 227 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcc
Confidence 221 11223568999999999875 5678899999999999999999999964321 11111111110000
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 683 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~ 683 (808)
. +.. ...+....+.+++.+|+..++++ |+++.++++.
T Consensus 228 ~--~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 Q--FPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c--CCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 000 01123467888999988866544 4678777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=315.79 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=191.5
Q ss_pred eeeecCcEEEEEEEeeCCC---EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCC
Q 003605 416 ILGEGGFGLVYSGVLDDGT---KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~dg~---~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~Gs 491 (808)
.||+|+||+||+|...++. .+++|.++... ....++|.+|+++++.++|+||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999865443 45667665432 3456789999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccc
Q 003605 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571 (808)
Q Consensus 492 L~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~ 571 (808)
|.++++........+.+..++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999754333345677888999999999999999987 999999999999999999999999998643222211222
Q ss_pred cccccccccccchhhhc-------CCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 572 TRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 572 ~~~~Gt~~Y~APE~l~~-------~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .. .....+. +....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~---~~~~~~~--~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---RE---VLNHVIK--DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HH---HHHHHHh--hcccccC
Confidence 34567889999998753 245789999999999999997 5667753221 11 1111111 1112233
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
++.+... ....+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333322 3456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=347.18 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=196.6
Q ss_pred HHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccc------cceeEEee
Q 003605 401 ASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR------NLVKLIGI 473 (808)
Q Consensus 401 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~Hp------NIV~L~g~ 473 (808)
.+++...+++|++.++||+|+||+||+|... +++.||||+++... ...+++..|++++.+++|. ++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3455567789999999999999999999865 67889999997532 2334566788888777654 58899998
Q ss_pred eeec-cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeeeecccCeeecCCC--
Q 003605 474 CIEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDF-- 549 (808)
Q Consensus 474 ~~~~-~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~-~~p~IiHrDIKpsNILLd~~~-- 549 (808)
+..+ +..|+|||++ +++|.+++.. ...+++..+..|+.|++.||+|||.+ + ||||||||+||||+.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcc
Confidence 8764 5679999988 7788888853 24699999999999999999999974 6 99999999999998765
Q ss_pred --------------cceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCC
Q 003605 550 --------------TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615 (808)
Q Consensus 550 --------------~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~ 615 (808)
.+||+|||++.... ...+...||..|+|||++.+..++.++|||||||+||||++|+.||+
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 49999999876321 22234679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhHH---------hhhh--------hcccccccccccCCC----CCCCC---ChhhHHHHHHHHHHccccCC
Q 003605 616 MTQPPGQENLVA---------WARP--------LLTSREGLERIIDPS----LGNDV---PFDSVAKVAAIASMCVQPEV 671 (808)
Q Consensus 616 ~~~~~~~~~lv~---------w~~~--------~~~~~~~l~~ivD~~----l~~~~---~~~~~~~l~~Li~~Cl~~dP 671 (808)
.....+...++. |... +......+....++. +.... .......+.+|+.+||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 543221111111 1100 000000000000000 00000 01123567899999999999
Q ss_pred CCCCCHHHHHHH
Q 003605 672 QHRPFMGEVVQA 683 (808)
Q Consensus 672 ~~RPsm~eVl~~ 683 (808)
++|||++|++++
T Consensus 427 ~~R~ta~e~L~H 438 (467)
T PTZ00284 427 QKRLNARQMTTH 438 (467)
T ss_pred hhCCCHHHHhcC
Confidence 999999999874
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.90 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=191.2
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHH-HHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
++||+|+||+||++... +|+.||||+++.. .....+++..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 7899999999743 2233455666665 46778999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence 999988852 346899999999999999999999988 9999999999999999999999999987532211 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~---~~~~~~----------~~~-- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AEM---YDNILH----------KPL-- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HHH---HHHHHc----------CCc--
Confidence 22345689999999999999999999999999999999999999964321 111 111111 010
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.........+.+++.+|++.+|++||++++.++.
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 0112234678899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.81 Aligned_cols=238 Identities=24% Similarity=0.409 Sum_probs=188.1
Q ss_pred eeeecCcEEEEEEEeeC-------------------------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeE
Q 003605 416 ILGEGGFGLVYSGVLDD-------------------------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 470 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~d-------------------------g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L 470 (808)
.||+|+||.||+|.+.. ...||+|++.........+|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13589999876555556789999999999999999999
Q ss_pred EeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-
Q 003605 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF- 549 (808)
Q Consensus 471 ~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~- 549 (808)
+++|.+....++||||+++|+|.++++. ....+++..+++++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999863 2346889999999999999999999887 99999999999997643
Q ss_pred ------cceecccccccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHH-hCCCCCCCCCCCC
Q 003605 550 ------TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPG 621 (808)
Q Consensus 550 ------~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELl-TG~~P~~~~~~~~ 621 (808)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999998643221 12346788999998865 56899999999999999995 6999886433211
Q ss_pred cchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 622 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 622 ~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
...+.. ... ..+......+.+++.+||+.+|++||++.+|++.|
T Consensus 230 ---~~~~~~--------------~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 ---KERFYE--------------KKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ---HHHHHH--------------hcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111110 000 01111234688999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=333.68 Aligned_cols=202 Identities=27% Similarity=0.401 Sum_probs=174.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|+..+.||+|+||+||++... +++.||||+++.. .....+.+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999875 6899999999743 2334567888999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999853 345889999999999999999999988 99999999999999999999999999875422
Q ss_pred ccc---------------------------------cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCC
Q 003605 565 EES---------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 611 (808)
Q Consensus 565 ~~~---------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~ 611 (808)
... ........||..|+|||++.+..++.++|||||||+||||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 00112346999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 003605 612 KPVDMT 617 (808)
Q Consensus 612 ~P~~~~ 617 (808)
.||...
T Consensus 234 ~Pf~~~ 239 (360)
T cd05627 234 PPFCSE 239 (360)
T ss_pred CCCCCC
Confidence 999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=315.39 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=200.4
Q ss_pred cceeeeeeecCcEEEEEEEee----CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeecc------
Q 003605 411 FDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 478 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~----dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 478 (808)
|.+.++||+|+||.||+|.+. ++..||||+++.. .....+++.+|++++++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999864 3678999998742 3445678999999999999999999999986532
Q ss_pred ceEEEEeecCCCCccccccccc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~--~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
..++++||+.+|+|.+++.... .....+++...++++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998875322 12235889999999999999999999988 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
|+++...............++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc----
Confidence 99986543222222223345678999999998889999999999999999999 8888854321 222222211
Q ss_pred ccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.... ..+......+.+++.+|++.+|++||++.||++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 01123346899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=314.60 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=200.1
Q ss_pred CcceeeeeeecCcEEEEEEEeeCCCEEEEEEeeccc------chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
+|...+.||+|+||.||+|...+++.+|||.++... ....+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998889999999986321 22335688999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999952 235889999999999999999999988 9999999999999999999999999987542
Q ss_pred ccc----ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 564 DEE----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 564 ~~~----~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
... .........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~----~-~~-- 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYIG----A-HR-- 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--HHHHHhh----h-cc--
Confidence 111 111122345889999999999888999999999999999999999999643211 1100000 0 00
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
......+......+.+++.+||+.+|++||++.|+++
T Consensus 225 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 ------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011122334567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.02 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=205.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.++|+..+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999865 6788999999866555678899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999998863 2246899999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccccccccchhhhcC---CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~---~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
.......++..|+|||.+.+. .++.++|||||||++|||+||+.||...... ........ . .+.
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~~~~~------~---~~~ 222 (262)
T cd06613 156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFLISK------S---NFP 222 (262)
T ss_pred --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh------c---cCC
Confidence 112334678899999998776 8899999999999999999999999643321 11111100 0 000
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
...+ .........+.+++.+|+..+|++||++.+|++
T Consensus 223 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Cccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111 112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=324.48 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=198.9
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999865 67889999997432 23345678999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 974 88888753 2345889999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhh--------hhhccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA--------RPLLTSRE 637 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~--------~~~~~~~~ 637 (808)
.......++..|+|||++.+ ..++.++|||||||++|||+||+.||......+........ ++.+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11223457899999998865 46789999999999999999999999654332111111100 00000000
Q ss_pred ccccccCCCCCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 638 GLERIIDPSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 638 ~l~~ivD~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....-.+.... .........+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000 0001234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=343.08 Aligned_cols=263 Identities=21% Similarity=0.261 Sum_probs=197.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..+|.+.+.||+|+||.||++... +++.||||.... ..+.+|+++|++|+|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999976 578899996432 3467899999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+ .++|.+++.. ....++|.+++.|+.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 Y-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9 5788888853 2236999999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCC-C----cchhHHhhhhhccccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-G----QENLVAWARPLLTSREGLER 641 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~-~----~~~lv~w~~~~~~~~~~l~~ 641 (808)
.........||..|+|||++.+..++.++|||||||+||||++|..++...... . ...+...++...........
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 222233457999999999999999999999999999999999988765322111 1 11111111110000000000
Q ss_pred ---------c-------cCCCCC-CCCC--hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 642 ---------I-------IDPSLG-NDVP--FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ---------i-------vD~~l~-~~~~--~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. ..+... ..+. ......+.+|+.+||+.||++|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000000 0000 0112367889999999999999999999874
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=312.28 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=203.7
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeee--ccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~ 484 (808)
+|++.+.||.|+||.||++... +++.+|+|+++.. .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 7889999998742 34445678899999999999999999998764 34578999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~--~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||+++++|.+++.........+++..++.++.+++.||+|||..+ ...++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999754444567999999999999999999999332 233999999999999999999999999999865
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
.... .......++..|+|||++.+..++.++||||||+++|+|++|+.||.... ...+.....
T Consensus 161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~------------ 223 (265)
T cd08217 161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIK------------ 223 (265)
T ss_pred cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHh------------
Confidence 4322 11233468899999999998889999999999999999999999997532 111111111
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.......+......+.+++.+|++.+|++||++.+|++.
T Consensus 224 --~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 --EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 001112233445789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=344.15 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=195.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeec--------
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-------- 477 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-------- 477 (808)
..++|.+.++||+|+||.||+|+.. +++.||||++.... ....+|+.+|++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999974 68899999886432 2345799999999999999999986432
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-cceeccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDF 556 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-~vKL~DF 556 (808)
...++||||++ ++|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 13578999997 5787777544444567999999999999999999999998 99999999999998664 7999999
Q ss_pred ccccccccccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
|+|+...... ......||..|+|||++.+. .++.++|||||||+||||++|+.||...... ..+......+-..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence 9998653221 12234679999999988764 6899999999999999999999999653321 1111111100000
Q ss_pred c-cc-------cc-----cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 636 R-EG-------LE-----RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 ~-~~-------l~-----~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. +. .. .+....+...++.....++.+|+.+||+.||++|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00 00 0000111111222344678999999999999999999999865
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=330.91 Aligned_cols=264 Identities=24% Similarity=0.323 Sum_probs=197.7
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeecc-----
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----- 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----- 478 (808)
..++|.+.+.||+|+||.||++... +|+.||||+++.. ......++.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999865 6899999999642 3344567889999999999999999999986543
Q ss_pred -ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 479 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 479 -~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
..++||||+.+ +|.+.++ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999964 6666663 24788999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc------------hh
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE------------NL 625 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~------------~l 625 (808)
+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......... ..
T Consensus 169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 99754221 1223456899999999999999999999999999999999999999754321000 00
Q ss_pred HH----hhhhhccccc-----ccccccCCCCC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 626 VA----WARPLLTSRE-----GLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 626 v~----w~~~~~~~~~-----~l~~ivD~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.. .......... .+.++...... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000000000 00000000000 00111224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=335.00 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=198.0
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeecc-----ceE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARC 481 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 481 (808)
+|+..+.||+|+||.||++... +++.||||++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 7899999998643 2334567899999999999999999999998766 789
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+|+||+. ++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57877774 2346899999999999999999999998 99999999999999999999999999975
Q ss_pred cccccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc------
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT------ 634 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~------ 634 (808)
...... .......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+........
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 432221 122334578899999998764 578999999999999999999999975432211111000000000
Q ss_pred ccccccccc-C----C-CC--CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 635 SREGLERII-D----P-SL--GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 635 ~~~~l~~iv-D----~-~l--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.....+ . + .. ..........++.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0 0 00 001112234678899999999999999999999765
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=316.06 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=196.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHH-HhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEM-LSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~i-L~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|++.+.||+|+||.||+++.. +|+.||+|+++.. ......++..|+++ ++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999975 6899999999753 23344566677776 555689999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~-~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
|++ |+|.++++........+++..++.++.|++.||+|||++ + ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 788888865433445799999999999999999999986 5 99999999999999999999999999876532
Q ss_pred ccccccccccccccccccchhhhc----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
. ...+...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+.... . .
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~----~--~--- 223 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVV----E--E--- 223 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHH----h--c---
Confidence 2 11233457889999998764 45688999999999999999999998632211 01111100 0 0
Q ss_pred cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 641 ~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.+ ........+.+++.+||..+|++||++.+|++.
T Consensus 224 --~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 --PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 011234578999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.58 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=200.2
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.|+..++||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++|+|++.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999865 78899999986432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++++|.++++.. ....+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999998642 2235899999999999999999999987 999999999999999999999999998754322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .+ ..+.+.
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~~-----------~~~~~~ 219 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EV-----------ERLVKE 219 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--HH-----------Hhhhhh
Confidence 1 1123468999999999999999999999999999999999999997532211100 00 000000
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 683 (808)
....++......+.+++.+||+.||++||+ +.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001122233456889999999999999999 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=333.50 Aligned_cols=261 Identities=20% Similarity=0.259 Sum_probs=202.5
Q ss_pred HHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeee
Q 003605 401 ASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476 (808)
Q Consensus 401 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 476 (808)
..++....++|++.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+++++.++|+||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556789999999999999999999976 6789999998642 22334568899999999999999999999999
Q ss_pred ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
.+..++||||+++|+|.++++. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999852 24788888999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhcC----CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
|+++...... ........||+.|+|||++... .++.++|||||||+||||++|+.||..... ......+
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i 259 (371)
T cd05622 187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKI 259 (371)
T ss_pred CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence 9998653322 1122345699999999998754 378999999999999999999999964321 1111111
Q ss_pred cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 003605 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQAL 684 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~L 684 (808)
+..... +.-.........+.+++.+|+..++.+ |+++.|+++..
T Consensus 260 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111100 000011234567888999999854443 77888887754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=316.52 Aligned_cols=239 Identities=23% Similarity=0.441 Sum_probs=188.6
Q ss_pred eeeeecCcEEEEEEEeeC-------------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceE
Q 003605 415 RILGEGGFGLVYSGVLDD-------------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d-------------g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.+++.++|+||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998542 2258899887655555668899999999999999999999999989999
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCc-------ceec
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT-------PKVS 554 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~-------vKL~ 554 (808)
+||||+++|+|+.+++. ....+++..+++|+.|+++||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999998853 2346899999999999999999999988 999999999999987654 8999
Q ss_pred ccccccccccccccccccccccccccccchhhh-cCCCccccceeeHHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhhh
Q 003605 555 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 555 DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~kSDVwSfGvvLlELl-TG~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+........ ..
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~---- 220 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ER---- 220 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HH----
Confidence 99998654321 1234778899999886 466899999999999999998 58888753221100 00
Q ss_pred cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
+...... ........+.+|+.+||+.||++||++.+|++.|
T Consensus 221 ---------~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 ---------FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000000 0112235788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=313.40 Aligned_cols=249 Identities=23% Similarity=0.419 Sum_probs=199.0
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc---------hhhHHHHHHHHHHhhcccccceeEEeeeeeccc
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 479 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~---------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 479 (808)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 678999998864221 123568899999999999999999999999999
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999953 245889999999999999999999988 999999999999999999999999999
Q ss_pred ccccccccc----ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 560 RSAMDEESR----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 560 ~~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
+........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~-~-------- 222 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAI-F-------- 222 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHH-H--------
Confidence 865421111 0111245788999999999888999999999999999999999999643210 000 0
Q ss_pred ccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.+.. ......+......+.+++.+||+.+|++||++.||++
T Consensus 223 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 -----KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 0111122334567889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=315.64 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=203.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
++|+..+.||+|+||.||+|+.. +.+.|++|.+...... ..++|.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999864 3467999988654333 4578999999999999999999999999989999
Q ss_pred EEEeecCCCCccccccccccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 482 LVYELIPNGSVESHLHGVDKE-----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~-----~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
+||||+++|+|.++++..... ...++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999743321 125899999999999999999999988 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
|+++....... .......++..|+|||.+.+...+.++||||||+++|||++ |..||..... ..++....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~----- 232 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQ----- 232 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHH-----
Confidence 99875432211 11223346778999999988888999999999999999999 7888853221 11111111
Q ss_pred ccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
...+....+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 233 --------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 --------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000001112234467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=331.35 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=197.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec------
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 477 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 477 (808)
..++|...+.||+|+||.||++... .++.||||+++.. .....+++.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 5578999999999999999999864 6889999999743 333456788999999999999999999988643
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
...++||||++ ++|.+++. ..+++..+..++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 34699999996 46766663 24889999999999999999999988 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcch-hH----------
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LV---------- 626 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~-lv---------- 626 (808)
+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99754321 12233568999999999999899999999999999999999999996533111000 00
Q ss_pred -----HhhhhhcccccccccccCCC------C--CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 627 -----AWARPLLTSREGLERIIDPS------L--GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 627 -----~w~~~~~~~~~~l~~ivD~~------l--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...............+..+. . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000000000000 0 001111234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.50 Aligned_cols=192 Identities=24% Similarity=0.355 Sum_probs=164.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
...+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++.+.+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4467999999999999999999975 5678999975432 34569999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+ .++|.+++.. ....++|..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred cc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99 5688888853 3346899999999999999999999998 999999999999999999999999998743221
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 614 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~ 614 (808)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1122356899999999999999999999999999999999966554
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.34 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=189.4
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHH-HHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
+.||+|+||+||+++.. +++.||+|++.... .....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 67889999997422 222344555544 56778999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+.+.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 999999853 235778888899999999999999998 9999999999999999999999999987543221 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...... ... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~---i~~----------~~~-- 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDN---ILN----------KPL-- 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHH---HHh----------CCc--
Confidence 22345699999999999999999999999999999999999999964321 111111 111 000
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.........+.+++.+|++.+|++|+++.+.+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 111233467889999999999999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=318.90 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
++|++.+.||+|+||.||+|... +++.|++|.+........+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999975 58899999998766666788999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|..++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++++||+|||++......
T Consensus 92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999888753 2345899999999999999999999987 999999999999999999999999998753221
Q ss_pred cccccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 568 RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
........++..|+|||++. ...++.++|||||||++|||++|+.||...... .....+. ..
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~------- 230 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIA----KS------- 230 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHh----cC-------
Confidence 11123345788999999884 345678999999999999999999998643211 1111110 00
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.+ ..+......+.+++.+||..+|++||++.||++.
T Consensus 231 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 231 EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 1122334578899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.07 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=200.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec-cceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-QARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LV~E 485 (808)
+|++.+.||+|++|.||++... +++.||+|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999965 5788999998643 234456789999999999999999999987644 45789999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++++|.++++.. ....+++.+++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999642 2346899999999999999999999998 999999999999999999999999998765322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. .......++..|+|||++.+..++.++||||||++++||++|+.||+... ...+.......
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~---------- 217 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG---------- 217 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc----------
Confidence 1 12234567889999999999999999999999999999999999986422 11111111110
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. ....+......+.+++.+|++.+|++||++.++++.
T Consensus 218 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 K-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 011223344679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.02 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=200.5
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999976 78999999986432 23456899999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
+||+++++|.++++. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999853 235889999999999999999999988 9999999999999999999999999987643
Q ss_pred cccccccccccccccccccchhhhcCC-CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
... ......++..|++||.+.... ++.++|||||||++|||++|+.||..... ......+. . ....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~----~-~~~~--- 220 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIG----R-SKEL--- 220 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHH----h-cccC---
Confidence 322 123456888999999988776 89999999999999999999999964331 11111110 0 0000
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
...+......+.+++.+||+.+|++||++.++++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122233467889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.74 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=204.2
Q ss_pred hCCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788999999999999999996 47899999999865555567889999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.+++.. ..+++.+++.++.+++.||+|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999852 35889999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||........ +.. ... ... +.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~----~~~--~~~-----~~ 234 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IAT--NGT-----PE 234 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee----ecc--CCC-----CC
Confidence 112334688899999999988899999999999999999999999964332110 000 000 000 00
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+......+.+++.+||+.+|++||++++|++.
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122334567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.15 Aligned_cols=264 Identities=23% Similarity=0.283 Sum_probs=193.8
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhc---ccccceeEEeeeeec-----c
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICIEE-----Q 478 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~-----~ 478 (808)
+|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|++++.++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5788999999999999999865 68899999987432 22234566788877766 699999999998642 4
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
..++||||+. ++|.++++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999997 58888886422 235899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHHhhhhhcccc-
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSR- 636 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~~- 636 (808)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ..+..+........
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 97653221 12335678999999999988999999999999999999999999864322110 01111110000000
Q ss_pred ----cccccccCCCCC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 637 ----EGLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 637 ----~~l~~ivD~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
........+... .....+....+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000 0011133456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=315.09 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=202.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46788899999999999999965 68899999987532 34456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.++++. ..+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999863 26899999999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.......++..|+|||++.+..++.++|||||||++|||+||+.||...... . ....... . ..+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~---~~~~~~~--~-----~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---R---VLFLIPK--N-----NPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---H---HHHHhhh--c-----CCCC
Confidence 1123346788999999999988999999999999999999999999643311 1 0000000 0 0111
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+... .....+.+++.+||..+|++||+++++++.
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 134568899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.45 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=203.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|+..++||+|+||.||.+... +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999988854 6889999998642 345567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.+++.... ...+++.+++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999996422 346899999999999999999999988 9999999999999999999999999997653322
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||+..... ........ ..
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~----------~~ 217 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQ----------GN 217 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc----------CC
Confidence 1 223456889999999998888899999999999999999999998643211 11111110 00
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
+ ..........+.+++.+|++.+|++||++.|+++.+
T Consensus 218 ~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 Y-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0 011123346788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.46 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=204.0
Q ss_pred CCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.+|+..+.||.|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4689999999999999999985 478999999997655555678899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.+++.. ..++|.+++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998852 35899999999999999999999998 99999999999999999999999999875433221
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+... .... .. .+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~~----~~~~--~~-----~~ 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLI----ATNG--TP-----EL 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH----HhcC--Cc-----cc
Confidence 122346888999999999888999999999999999999999999653321 111100 0000 00 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+......+.+++.+||..+|++||++.+|++.
T Consensus 236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1122334578899999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.60 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=200.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47888999999999999999976 68999999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++++|..++. ....++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888764 2235899999999999999999999988 999999999999999999999999999865432
Q ss_pred cccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---hhcc-------
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR---PLLT------- 634 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~---~~~~------- 634 (808)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+..... ....
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhcc
Confidence 21 1223457789999999876 557899999999999999999999996543211 1111110 0000
Q ss_pred cccccccccCCCCCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 635 SREGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 635 ~~~~l~~ivD~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.......+..+......+ ......+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000111100000 122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=334.06 Aligned_cols=263 Identities=21% Similarity=0.259 Sum_probs=199.7
Q ss_pred hCCcceeeeeeecCcEEEEEEEee---CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~---dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
..+|.+.+.||+|+||.||++... .+..||||.+... +.+.+|+++|++++|+||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999753 3578999988643 34568999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
|++. ++|.+++. ....++|.+++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9995 68888883 2346999999999999999999999998 99999999999999999999999999976544
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc------cc-
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS------RE- 637 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~------~~- 637 (808)
...........||..|+|||++....++.++|||||||+||||++|+.||.............-+...+.. ..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 33322333467999999999999999999999999999999999999999654432211111000000000 00
Q ss_pred --cccc---ccCCCCCCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 638 --GLER---IIDPSLGNDVP-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 638 --~l~~---ivD~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.+ .........+. ......+.+++.+||..||++||++.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000000000 1123467889999999999999999999876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=336.15 Aligned_cols=260 Identities=30% Similarity=0.453 Sum_probs=218.1
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeC---C--CEEEEEEeec-ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccce
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDD---G--TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~d---g--~~VAVK~lk~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 480 (808)
..+.....++||+|-||.||+|++.+ | -.||||.-|. ......+.|+.|..+|+.++|||||+|+|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34455566899999999999999642 3 3589999886 455667899999999999999999999999986 577
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++|||.++-|-|..||+. +...|+..+...++.||+.||+|||+.. +|||||..+|||+....-+||+||||+|
T Consensus 466 WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 999999999999999973 4456888999999999999999999887 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
...+....+. ++..-...|||||.+.-++++.+||||-|||.+||++. |..||..-...+ .+
T Consensus 540 ~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI 602 (974)
T KOG4257|consen 540 YLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VI 602 (974)
T ss_pred hccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eE
Confidence 8876655444 35556789999999999999999999999999999988 999996433211 11
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
- .+...-+-..|..+...+..|+.+||+.+|.+||++.|+...|.+++++.
T Consensus 603 ~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 603 G-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred E-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 1 11222233467788899999999999999999999999999999988753
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.15 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=198.3
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|++.+.||+|++|.||+|+.. +++.||||+++.. .....+.+.+|+.++++++|+||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 6899999998642 223346788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
++ ++|.++++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 96 689888864332 346899999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh----------ccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL----------LTS 635 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~----------~~~ 635 (808)
........++..|+|||++.+. .++.++|||||||++|||+||+.||...... ..+....... ...
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchh
Confidence 1122234578899999988654 4688999999999999999999999643221 1111100000 000
Q ss_pred ccccccccCCCCC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 636 REGLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 636 ~~~l~~ivD~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.......++.... .........++.+++.+||+.||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0011123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.61 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=200.3
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999865 6788999998743 2344567999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.+++.. ..+.+..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998852 35889999999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.......++..|+|||++.+..++.++|||||||++|||++|+.|+...... ....+. ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~--------------~~~~ 217 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLFLI--------------PKNS 217 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHhhh--------------hcCC
Confidence 1112345788999999999989999999999999999999999998643221 111100 0000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...........+.+++.+|++.+|++||++.+|++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111222345678999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.88 Aligned_cols=236 Identities=28% Similarity=0.374 Sum_probs=198.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|+..+.||.|+||+|..++.+ +|..+|+|++++. .....+...+|..+|+.+.||+++++++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45677889999999999999976 7889999999753 3344567788999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++|-|.++|+. ..++++....-+|.+|+.||+|||..+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999963 346888999999999999999999998 99999999999999999999999999997643
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. +-..+||+.|+|||+++...+..++|.|+|||++|||+.|..||....+. ...++|+.
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~KI~~ 255 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEKILE 255 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHHHHh
Confidence 2 34678999999999999999999999999999999999999999754331 11122222
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCC
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHR 674 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 674 (808)
..+ .+|.-....+.+|+...++.|-.+|
T Consensus 256 ~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 221 1333445667888888888888777
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=313.96 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=199.8
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 68899999997655555567889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.++++. ...+++.+.+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999853 236899999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 568 RHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
.......|+..|+|||++. .+.++.++|||||||++|||++|+.||....... .+..... . ....
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~~~------~---~~~~ 228 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMTK------S---NFQP 228 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhhhc------c---CCCC
Confidence 1123446899999999874 4568899999999999999999999985432211 1100000 0 0000
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
+.+.. .......+.+++.+|++.+|++||++++|++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11111 0112346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=317.20 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=203.5
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.++|++.+.||+|+||.||++... ++..+|+|.++.......++|.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999975 6889999999866666677899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999863 2346899999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.......++..|++||++. ...++.++|||||||++|||++|+.||...... ..+..+. ..
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~----~~------ 223 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKIL----KS------ 223 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHh----cC------
Confidence 1123346889999999875 344678999999999999999999998643211 1111111 00
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.+ ..+......+.+++.+||+.+|++||++.+|++.
T Consensus 224 -~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 -EPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00011 1122334578899999999999999999999775
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.86 Aligned_cols=240 Identities=24% Similarity=0.447 Sum_probs=190.2
Q ss_pred eeeeecCcEEEEEEEeeC--------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 415 RILGEGGFGLVYSGVLDD--------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d--------g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+.||+|+||.||+|.... ...+|+|.+........++|.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 234888888765555567899999999999999999999999998999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCc--------ceeccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT--------PKVSDFGL 558 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~--------vKL~DFGL 558 (808)
+++|+|.++++.. ...++|..+++++.|++.||+|||+.+ |+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999642 236899999999999999999999988 999999999999987765 58999998
Q ss_pred ccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCC-CCCCCCCCCCcchhHHhhhhhcccc
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGR-KPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~-~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+...... ..... ...
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---~~~~~----~~~- 220 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---KKLQF----YED- 220 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---HHHHH----HHc-
Confidence 8644321 22457889999999886 45789999999999999999985 555322111 00000 000
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
....+.....++.+++.+||+.+|++||+++++++.|+
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122233467899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.48 Aligned_cols=246 Identities=31% Similarity=0.495 Sum_probs=198.0
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
++|.+.+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.++++++|+|++++++++.. +..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4578889999999999999975 5788999998643 234678999999999999999999999876 45799999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999996432 235889999999999999999999988 999999999999999999999999998754221
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......+..|+|||++.++.++.++|||||||++|||++ |+.||...... .+.... ....
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~--------------~~~~ 214 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECV--------------EKGY 214 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHH--------------hCCC
Confidence 112234568999999998899999999999999999998 99998643211 111111 0011
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
....+......+.+++.+|++.+|++||++++|++.|+
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 11122234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.53 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=193.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeEEeeeeec--cce
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 480 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 480 (808)
.+|...+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 68899999986321 22345788999999999999999999988653 567
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999853 235889999999999999999999887 9999999999999999999999999987
Q ss_pred ccccccc-cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 561 SAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 561 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
....... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... .. ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~~~~~~----- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-IFKIAT----- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-HHHHhc-----
Confidence 5432111 11112345788999999999888999999999999999999999999643210 00 000000
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.... ...+......+..++ +|+..+|++||+++||++
T Consensus 224 -~~~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 -QPTN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0001 112222234555666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=317.32 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=204.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|++.+.||+|+||+||++... +++.||+|++... .....+++.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999865 6889999988653 234467899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
+++++|.++++. ...+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999998853 2358999999999999999999997 45 999999999999999999999999998654221
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCC-----cchhHHhhhhhcccccccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-----QENLVAWARPLLTSREGLE 640 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~-----~~~lv~w~~~~~~~~~~l~ 640 (808)
......|+..|+|||++.+..++.++|||||||++|||+||+.||+...... ...+..+........
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 1123568999999999988899999999999999999999999997544321 111222222211100
Q ss_pred cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 641 ~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.+.+ ...+....+.+++.+|++.||++||++.||+++..
T Consensus 230 ---~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 ---PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ---CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0111 11123467899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.16 Aligned_cols=251 Identities=31% Similarity=0.526 Sum_probs=200.5
Q ss_pred cceeeeeeecCcEEEEEEEeeC-----CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 411 FDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~d-----g~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
|.+.+.||+|+||.||++...+ +..||+|+++..... ..+.+.+|++++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999763 378999999754433 5678999999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.++++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999964221 12899999999999999999999998 99999999999999999999999999976543
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
..... .....++..|+|||.+.+..++.++||||||++++||++ |+.||.... ...+...... ..
T Consensus 156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~----~~------ 221 (258)
T smart00219 156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLKK----GY------ 221 (258)
T ss_pred ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhc----CC------
Confidence 32211 112336789999999988889999999999999999999 788876421 1122221110 00
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
....+......+.+++.+|+..+|++||++.|+++.|
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111122456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.10 Aligned_cols=256 Identities=31% Similarity=0.494 Sum_probs=202.1
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeeecc-----
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ----- 478 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~----- 478 (808)
..+++|++.+.||+|+||.||+|... +++.+++|++.... ...++|.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35789999999999999999999975 67899999987543 3456899999999999 6999999999997644
Q ss_pred -ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 479 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 479 -~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
..++||||+++++|.++++........+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 479999999999999998754433457899999999999999999999988 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhc-----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
++....... .......|+..|+|||++.. ..++.++|||||||+||||++|+.||..... ...+.....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-- 232 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFKIPR-- 232 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHHhhc--
Confidence 987543221 11223458889999998753 3467899999999999999999999963221 111111100
Q ss_pred cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
. ..+.+ ..+......+.+++.+||..||++||++.||++
T Consensus 233 ----~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 ----N-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----c-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 00011 112234567899999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.56 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=204.1
Q ss_pred CCHHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeee
Q 003605 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 476 (808)
Q Consensus 399 fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 476 (808)
.++.++....+.|++.+.||+|+||.||+|... +++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 467777778899999999999999999999974 6889999998653 23446788999999998 69999999999853
Q ss_pred ------ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCc
Q 003605 477 ------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550 (808)
Q Consensus 477 ------~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~ 550 (808)
.+..+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 356799999999999999986422 235888899999999999999999988 999999999999999999
Q ss_pred ceecccccccccccccccccccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003605 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 625 (808)
Q Consensus 551 vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~l 625 (808)
++|+|||+++...... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||...........
T Consensus 160 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 160 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred EEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 9999999987543211 1122356889999999875 34678899999999999999999999964321110000
Q ss_pred HHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 626 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 626 v~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
......+.+ ........+.+++.+||+.||++||++.|+++
T Consensus 238 -------------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -------------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000111 11123467999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.13 Aligned_cols=266 Identities=26% Similarity=0.347 Sum_probs=201.8
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|+..+.||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47889999999999999999976 6789999998743 23345789999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|++++.|..++. ....+++.+++.++.+++.||+|||+.+ ++|+||+++||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766553 2345899999999999999999999988 999999999999999999999999998765433
Q ss_pred cccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhh-------cccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPL-------LTSR 636 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~-lv~w~~~~-------~~~~ 636 (808)
.. .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+... +..+.... ....
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122345678899999999888 88999999999999999999999986432211000 00000000 0000
Q ss_pred ccc-----ccccCCC-CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 637 EGL-----ERIIDPS-LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 637 ~~l-----~~ivD~~-l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
... ....+.. +...++.....++.+++.+||..+|++||++++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000000 000112223578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=355.50 Aligned_cols=264 Identities=24% Similarity=0.311 Sum_probs=206.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.++||+|+||.||+|... +|+.||||+++.. .....++|.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999865 6899999999742 2234567999999999999999999999999999999999
Q ss_pred eecCCCCcccccccccc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 485 ELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~-------~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
||+++|+|.++++.... ....+++.++++|+.|+++||+|||+.+ |+||||||+|||++.++++||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1234678889999999999999999988 9999999999999999999999999
Q ss_pred cccccccccc----------------cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCC
Q 003605 558 LARSAMDEES----------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG 621 (808)
Q Consensus 558 La~~~~~~~~----------------~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~ 621 (808)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9976521110 01112356999999999999999999999999999999999999999642211
Q ss_pred cchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHh
Q 003605 622 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCNE 690 (808)
Q Consensus 622 ~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-sm~eVl~~Le~i~~~ 690 (808)
... +.. .+.++.-.. ...+....+.+++.+|++.||++|+ ++.++++.|+...+.
T Consensus 238 --ki~-~~~----------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 --KIS-YRD----------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --hhh-hhh----------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000 000 001110000 0112335688999999999999995 677788888876653
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.46 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=198.7
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc----------chhhHHHHHHHHHHhhcccccceeEEeeeeecc
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD----------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 478 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~----------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 478 (808)
+|...+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999864 68999999885311 112346888999999999999999999999999
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
..++||||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+++||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999642 46899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhcCC--CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
++...............++..|+|||.+.... ++.++||||||+++|||++|..||..... ...+.. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~-- 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFK-LGN-- 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHH-hhc--
Confidence 97643221111223356888999999987654 78999999999999999999999853221 111110 000
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
......++.. ...+....+.+++.+|+..+|++||++.+|++.
T Consensus 227 ~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KRSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0001111111 112234678999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.26 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=202.7
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|+..+.||+|+||.+|++... +|+.||+|++... .....+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999865 7899999998742 334456899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+.+++|.++++.. ....+++.++++++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988632 2235789999999999999999999988 9999999999999999999999999997653321
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
. ......|+..|+|||++.++.++.++|||||||+++||++|+.||..... .......... .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~----------~ 217 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRG----------S 217 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcC----------C
Confidence 1 11234578899999999998999999999999999999999999864221 1111111110 0
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
....+......+.+++.+|++.+|++||++.||++.
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011222345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=306.58 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=205.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999964 67899999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.++++.... ...+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999964322 235899999999999999999999988 9999999999999999999999999987655432
Q ss_pred cc--ccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 567 SR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 567 ~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
.. .......|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+..+... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~-----------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN-----------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcC-----------C
Confidence 22 122344688999999998877 7899999999999999999999999643321 111111110 0
Q ss_pred CCCCCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 644 DPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 644 D~~l~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.+.+.... .......+.+++.+|++.||++||++.||++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01111111 1133467899999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=311.98 Aligned_cols=260 Identities=26% Similarity=0.354 Sum_probs=205.3
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~ 484 (808)
++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++|+||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999975 68899999987532 34567899999999999999999999998654 4679999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.+++.........+++.....|+.|++.||+|||+.+ ++|+||+++||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987644344456899999999999999999999988 99999999999999999999999999865432
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCC--CcchhHHhhhhhcccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP--GQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~--~~~~lv~w~~~~~~~~~~l~~i 642 (808)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||+..... ....+..|..... ...+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-----NPEL 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-----chhh
Confidence 11 12345788999999999999999999999999999999999999755321 1122223321100 0001
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+. . .........+.+++.+||+.+|++||++.||++.
T Consensus 229 ~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 0 0012245678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.89 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=196.3
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeEEeeeeec--cce
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 480 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 480 (808)
++|++.++||+|+||.||+|... +++.||||.++... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999865 68999999886321 22346788999999999999999999988764 457
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
+++|||+++++|.+++.. ...+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999852 235788999999999999999999988 9999999999999999999999999987
Q ss_pred cccccccc-ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 561 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 561 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
........ .......++..|+|||.+.+..++.++|||||||++|||++|+.||..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~---------- 219 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAAIF---------- 219 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHHHH----------
Confidence 54321111 111234588899999999888899999999999999999999999863211 11100
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+..........+......+.+++.+|+. +|++||+++||++.
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 220 -KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000001112233445678889999985 89999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=316.92 Aligned_cols=265 Identities=22% Similarity=0.341 Sum_probs=200.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 58999999986432 2235678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+++++|.++.+. ...++|.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999998887642 234899999999999999999999988 999999999999999999999999998765332
Q ss_pred cccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHHhhhhhcccc-------
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSR------- 636 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~~------- 636 (808)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+..+........
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22233457889999999875 4578899999999999999999988864321110 01111111110000
Q ss_pred cccccccCCCCCC-----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 637 EGLERIIDPSLGN-----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 637 ~~l~~ivD~~l~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
........+.... .........+.+++.+||+.+|++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000000 001123467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.16 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=199.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999875 67899999987432 23345678999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. ++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 689888863 2345889999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc-----------c
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL-----------T 634 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~-----------~ 634 (808)
.......++..|+|||.+.+. .++.++|||||||++|||+||+.||...... .........+ .
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhh
Confidence 111234568899999988654 5788999999999999999999999754321 1111111000 0
Q ss_pred cccccccccCCCCCCC----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 635 SREGLERIIDPSLGND----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 635 ~~~~l~~ivD~~l~~~----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.....-.+....+ ........+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000111000 111234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.51 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=197.6
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec------
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 477 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 477 (808)
..++|.+.+.||+|+||.||++... .++.||||+++.. .....+++.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999865 6889999999742 334456788999999999999999999987543
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
...++||||+. ++|.+++. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 34699999996 47777663 24788999999999999999999988 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-------
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR------- 630 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~------- 630 (808)
+++..... .......||..|+|||++.+..++.++|||||||+||||++|+.||........ +.....
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 246 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP 246 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence 99754321 122334689999999999999999999999999999999999999965432110 000000
Q ss_pred -----------hhcccccc-----cccccCCCC---CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 631 -----------PLLTSREG-----LERIIDPSL---GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 631 -----------~~~~~~~~-----l~~ivD~~l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
........ ...+....+ ...........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000000000 001111234578899999999999999999999774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.26 Aligned_cols=248 Identities=22% Similarity=0.354 Sum_probs=208.3
Q ss_pred hCCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
..+|++.+.||+|.||+|-+|.. ..|+.||||.+++. +++..-.+.+||+||+.|+||||+.++.+|.+.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999985 58999999999753 455666789999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||..+|.|+||+. ....|++.+...++.||..|+.|+|.++ ++|||||.+|||||.|+++||+||||+-.+.
T Consensus 132 MEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999995 4457999999999999999999999998 9999999999999999999999999998764
Q ss_pred cccccccccccccccccccchhhhcCCC-ccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
+. ..-+..+|++-|.+||++.+..| ....|-|||||+||-|+.|..||+..+ ...++...
T Consensus 205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQI------------- 265 (668)
T KOG0611|consen 205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQI------------- 265 (668)
T ss_pred cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHh-------------
Confidence 32 33456789999999999998888 478999999999999999999998643 22333221
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
-.-.+. ..+......-||+|||..||++|.|+.+|....
T Consensus 266 s~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 SRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred hccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111111 112234566799999999999999999998765
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.67 Aligned_cols=264 Identities=19% Similarity=0.230 Sum_probs=194.6
Q ss_pred eeeeeeec--CcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 413 ASRILGEG--GFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 413 ~~~~LG~G--~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
+.++||+| +||+||++... +|+.||||+++.. .....+.+.+|+++++.++|+||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999865 7899999999743 2333456778999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++|+|.+++.... ...+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985322 235899999999999999999999988 99999999999999999999999987643322111
Q ss_pred c-----ccccccccccccccchhhhc--CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc-----
Q 003605 568 R-----HISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS----- 635 (808)
Q Consensus 568 ~-----~~~~~~~Gt~~Y~APE~l~~--~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~----- 635 (808)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhcCCcccccccc
Confidence 0 01112346778999999876 45889999999999999999999999643211 1111100000000
Q ss_pred ---cccc-----ccccCC-----------------CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 636 ---REGL-----ERIIDP-----------------SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 ---~~~l-----~~ivD~-----------------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.+ ....+. .............+.+++.+||+.||++|||+.||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 000000 00001112334578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=311.41 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=202.3
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.|+..+.||+|+||.||+|... +++.||||.++... ......+.+|+++++++.|+||+++++++.+.+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999975 68899999987432 345678999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++|+|.++++. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999999852 35889999999999999999999987 9999999999999999999999999997653322
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.......++..|+|||++.+..++.++|||||||++|||+||+.||....... ... .+....
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~--------------~~~~~~ 217 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF--------------LIPKNN 217 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh--------------hhhcCC
Confidence 11223457889999999988889999999999999999999999986432210 000 000011
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112233456788999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=316.80 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=160.6
Q ss_pred eeeeeecCcEEEEEEEee---CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeee--ccceEEEEeecC
Q 003605 414 SRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVYELIP 488 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~---dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~Ey~~ 488 (808)
.++||+|+||+||+|+.. +++.||+|.++... ....+.+|++++++++|+||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 46789999987432 23567899999999999999999999854 356789999995
Q ss_pred CCCccccccccc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee----cCCCcceecccccc
Q 003605 489 NGSVESHLHGVD-----KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLA 559 (808)
Q Consensus 489 ~GsL~~~L~~~~-----~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL----d~~~~vKL~DFGLa 559 (808)
++|.+++.... .....+++..+..|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877764321 12235889999999999999999999998 9999999999999 45678999999999
Q ss_pred cccccccc-cccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCC
Q 003605 560 RSAMDEES-RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQ 618 (808)
Q Consensus 560 ~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~ 618 (808)
+....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 86533211 111234568999999999876 458999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.37 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=207.7
Q ss_pred eeeeeeecCcEEEEEEEee--CCC--EEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 413 ASRILGEGGFGLVYSGVLD--DGT--KVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~--dg~--~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
+.++||+|.||.|++|.+. +|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....||+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999976 454 4799999865443 67899999999999999999999999987 6779999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
+.|+|.+.|++ ..+..|-......++.|||.||.||..++ +|||||..+|+||-....+||+||||.+.+...+.
T Consensus 193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999986 33456777888999999999999999888 99999999999999999999999999998765444
Q ss_pred ccc-ccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 568 RHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 568 ~~~-~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
.+. .....-.+.|+|||.+..+.|+.+||||+|||.||||+| |..||-.... -.+-+.+|.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHhccc
Confidence 332 223345678999999999999999999999999999999 8888854221 111223343
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.-+-.-+..+.++++++++.||..+|++||++..|.+.+-
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 3333456788999999999999999999999999986553
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.59 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=207.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|++.+.||+|++|.||+++.. +++.|+||++..... ...+++.+|++++.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999976 589999999876443 4567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
+++++|.+++... ..+++..+++++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999632 468999999999999999999999 87 999999999999999999999999998765332
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
.. ......++..|+|||.+.+..++.++||||||+++|||+||+.||..........+..+.. ..
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------~~ 218 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-------------DG 218 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------cC
Confidence 21 1124467889999999999999999999999999999999999997554312222222211 00
Q ss_pred CCCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. ....+.. ....+.+++.+|+..+|++||++.|+++.
T Consensus 219 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 P-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0111222 45789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=304.83 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=201.1
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|+..+.||+|+||.||++... +++.+|||++... .....+++.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 6889999998643 344567899999999999999999999999988999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Ccceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DFGLa~~~~~~ 565 (808)
+++++|.++++.. ....+++..+++++.++++||+|||+++ ++|+||||+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999642 2345899999999999999999999988 9999999999999865 46899999999765332
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+.... .....+. .. ..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~---~~--~~------- 217 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKI---MS--GT------- 217 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHH---Hh--cC-------
Confidence 1 12234678899999999988899999999999999999999999864322 1111111 10 00
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
....+......+.+++.+||+.+|++||++.|+++.
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011122344678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=320.08 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=198.3
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeecc-----ceEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARCLV 483 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~LV 483 (808)
.|...+++|.|+||.||+|++. +++.||||+.....+ .-.+|+++|+++.|||||+|+-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667899999999999999975 678999999864332 2236899999999999999999986432 34689
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Ccceeccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSA 562 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DFGLa~~~ 562 (808)
||||+. +|.++++.+...+..++.-.+.-+..|+.+||+|||+.+ |+||||||.|+|+|.+ +.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 999999866555667887888889999999999999988 9999999999999976 99999999999987
Q ss_pred ccccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc-cc---
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-RE--- 637 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~-~~--- 637 (808)
...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|...... .+++..+.-+-.. ++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHHh
Confidence 654332 223457889999998864 7899999999999999999999988654332 2222222111100 00
Q ss_pred ---------ccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 638 ---------GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 638 ---------~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...++....+..-+......+.++++.++++.+|.+|.+..|++..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111111111111233455788999999999999999999999764
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.35 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=195.7
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|+..+.||+|+||.||+|+.. +|+.||+|+++.. .......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 7899999998642 222345678899999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. ++|.++++. ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++++||+|||+++......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 588887753 2345899999999999999999999988 9999999999999999999999999987543211
Q ss_pred ccccccccccccccccchhhhcCC-CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc--cc---ccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--RE---GLE 640 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~-~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~--~~---~l~ 640 (808)
.......++..|+|||++.+.. ++.++|||||||++|||+||+.|+...... ............. .. ...
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhh
Confidence 1112345788999999987654 689999999999999999999986432211 1111100000000 00 000
Q ss_pred cccCCC----CC-----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 641 RIIDPS----LG-----NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 641 ~ivD~~----l~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.+.+.. .. ..........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 00 0011123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=305.15 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=201.0
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|...+.||+|+||.||+|... +++.|++|.++.... ...+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 788999999975443 3667899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.++++. ...+++..++.|+.+++.||+|||+.+ |+|+||+++||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999863 235889999999999999999999988 9999999999999999999999999987654332
Q ss_pred cccc--ccccccccccccchhhhcCC---CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 567 SRHI--STRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 567 ~~~~--~~~~~Gt~~Y~APE~l~~~~---~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.... .....++..|++||++.... ++.++||||||+++|||++|+.||...... ... .+. ... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~-~~~--~~~--~---- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQI-MFH--VGA--G---- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHH-HHH--Hhc--C----
Confidence 2111 11345788999999998766 889999999999999999999999643211 111 110 000 0
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
..+.+.. .......+.+++.+||+.+|++||++.|++.
T Consensus 223 -~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001100 1122466789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=300.84 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=205.2
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~ 484 (808)
+|...+.||+|++|.||+|... +++.|++|+++... ....+.+.+|++++++++|+||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 78999999987543 24567899999999999999999999999988 8899999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.+++... ..++|.+++.++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998632 27999999999999999999999987 99999999999999999999999999886544
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
...........++..|++||.+.....+.++||||||+++++|++|+.||..... ....... +..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~----------~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYK----------IGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHh----------ccc
Confidence 3221112345688899999999888899999999999999999999999975431 1111100 111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.......+......+.+++.+|++.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111233334578999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.82 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=198.4
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc-----hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-----QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
+|+..+.||+|+||.||+|... +++.||||+++.... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999965 689999999975332 2345677899999999999999999999998999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+ +|+|.++++.. ...+++..+++++.|+++||+|||+++ |+|+||||+|||++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999999632 236999999999999999999999998 9999999999999999999999999997654
Q ss_pred cccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc-------cc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL-------TS 635 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~-------~~ 635 (808)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|...... ..+........ ..
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhhh
Confidence 3221 1123356788999998865 45789999999999999999997777543221 11100000000 00
Q ss_pred ccccccccCCCCCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 636 REGLERIIDPSLGND-----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+........... ........+.+++.+||+.+|++||+++||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000001 112335678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=307.08 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=200.7
Q ss_pred CcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeeccc------chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
+|+..++||+|+||.||+|.. .+++.||+|.++... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 478999999986422 1234688999999999999999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-cceecccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 561 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-~vKL~DFGLa~~ 561 (808)
|+||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999853 236889999999999999999999998 99999999999998775 699999999876
Q ss_pred ccccccc--ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 562 AMDEESR--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 562 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
....... .......++..|+|||++.+..++.++||||+|+++|||++|+.||......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~-------- 222 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFK-------- 222 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHH--------
Confidence 5432111 1112345788999999998888999999999999999999999998643221111 11100
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
+.........+......+.+++.+|++.+|++||++.|+++
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 --IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00001112233344567889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.53 Aligned_cols=198 Identities=23% Similarity=0.331 Sum_probs=160.0
Q ss_pred eeeeeecCcEEEEEEEee---CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeee--ccceEEEEeecC
Q 003605 414 SRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVYELIP 488 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~---dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~Ey~~ 488 (808)
..+||+|+||+||+|+.. ++..||+|.++... ....+.+|++++++++|+||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999965 35789999987532 23567899999999999999999999854 456799999996
Q ss_pred CCCccccccccc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee----cCCCcceecccccc
Q 003605 489 NGSVESHLHGVD-----KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLA 559 (808)
Q Consensus 489 ~GsL~~~L~~~~-----~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL----d~~~~vKL~DFGLa 559 (808)
++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 12235889999999999999999999988 9999999999999 56679999999999
Q ss_pred ccccccccc-ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCC
Q 003605 560 RSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMT 617 (808)
Q Consensus 560 ~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~ 617 (808)
+........ .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865432211 11233568999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=315.87 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=199.2
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc---hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47889999999999999999976 589999999975322 24567899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+.+++|.++++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998632 2346899999999999999999999988 99999999999999999999999999865422
Q ss_pred cccc---------------------------ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCC
Q 003605 565 EESR---------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 617 (808)
Q Consensus 565 ~~~~---------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~ 617 (808)
.... .......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111245788999999999888999999999999999999999999643
Q ss_pred CCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 003605 618 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 680 (808)
Q Consensus 618 ~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eV 680 (808)
... .. + ..+.+....-.........+.+++.+|++.+|++||+++..
T Consensus 236 ~~~--~~---~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 236 NRD--ET---F-----------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred chH--HH---H-----------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 221 11 1 11111111111111245789999999999999999994443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.85 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=203.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|+..+.||+|+||.||++... +++.+|+|++.... ....+++.+|++++++++|+||+++++++..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 68899999987542 34557899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
+++++|.+++.... ..+++..+.+++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999986422 568899999999999999999998 76 999999999999999999999999998754322
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
.. ....++..|+|||++.+..++.++||||||+++|+|++|+.||...... ............. .
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~----------~ 219 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVN----------E 219 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhc----------C
Confidence 11 1256788999999999999999999999999999999999999654221 1112222211111 0
Q ss_pred CCCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.. ...+. .....+.+++.+|+..+|++||++.|+++.
T Consensus 220 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00 00111 144678999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.39 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=196.4
Q ss_pred HHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec----
Q 003605 405 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE---- 477 (808)
Q Consensus 405 ~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~---- 477 (808)
....++|...+.||+|+||.||+|... +++.||||+++.. .....+++.+|++++++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345688999999999999999999864 7789999998743 223446788999999999999999999987543
Q ss_pred --cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecc
Q 003605 478 --QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 555 (808)
Q Consensus 478 --~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~D 555 (808)
...++++|++ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3468999988 789988774 235899999999999999999999998 99999999999999999999999
Q ss_pred cccccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc
Q 003605 556 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 634 (808)
Q Consensus 556 FGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~ 634 (808)
||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+....-.
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~ 234 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGT 234 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCC
Confidence 9999864321 123468999999999876 56889999999999999999999999643211 111111100000
Q ss_pred c-cc--------ccccccCCCCCCCCC--------hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 635 S-RE--------GLERIIDPSLGNDVP--------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 635 ~-~~--------~l~~ivD~~l~~~~~--------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. .+ .....+. .+. ..+ ......+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 0000000 000 000 0122457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.10 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=200.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|++.+.||+|+||.||++... +++.||+|.++.. .....+++.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36778899999999999999976 7899999998743 334456899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~-~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
+++++|.++++... ....+++..+.+++.+++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999886421 123689999999999999999999974 5 999999999999999999999999998754322
Q ss_pred cccccccccccccccccchhhhcC------CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~------~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ....-.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~---------- 219 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQL---------- 219 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHH----------
Confidence 12234578899999988544 3588999999999999999999999643211 111100
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.+.. ....+.+....+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 220 SAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111110 011223355678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=315.40 Aligned_cols=256 Identities=21% Similarity=0.313 Sum_probs=200.9
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|+..+.||+|+||.||++... +++.||+|.++... ....+.+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999975 67899999987532 233467889999999999999999999999989999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.+++.. ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999953 235899999999999999999999988 99999999999999999999999999863211
Q ss_pred ccc-------------cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 003605 565 EES-------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 565 ~~~-------------~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~ 631 (808)
... ........++..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 000 0111224578899999999888899999999999999999999999863221 111111
Q ss_pred hcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 632 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 632 ~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
.... .+..+.. .......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 228 ~~~~-----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISD-----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhc-----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1100 0001111 11234568999999999999999998776666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.44 Aligned_cols=236 Identities=22% Similarity=0.278 Sum_probs=183.5
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc---ccccceeEEeeeeeccceEEEEeecCC
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL---HHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
||+|+||+||+|+.. +++.||||++.... ......+..|..++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 68999999996422 22334556677777765 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999998852 345899999999999999999999998 9999999999999999999999999987533221 1
Q ss_pred cccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
......||..|+|||++.+. .++.++|||||||+||||+||+.||..... ........... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~--------~~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGK--------VRFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCC--------CCCC
Confidence 22345689999999998765 478999999999999999999999964321 11111111000 0010
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMG 678 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 678 (808)
.......+.+++.+||+.+|++||++.
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 011235678999999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=310.33 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=196.2
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|+..+.||+|++|.||+|... +++.||||.++.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999976 689999999874322 2234677899999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. ++|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 5999988632 236889999999999999999999988 9999999999999999999999999987532211
Q ss_pred ccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc--ccccc---
Q 003605 567 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--REGLE--- 640 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~--~~~l~--- 640 (808)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....-....+.. .+...
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhh
Confidence 11122346788999998875 45789999999999999999999999643311 0000000000000 00000
Q ss_pred ---c-------cc-CCCCCCCC-ChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 641 ---R-------II-DPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 641 ---~-------iv-D~~l~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
. .. ...+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 00000000 1112257789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.00 Aligned_cols=250 Identities=28% Similarity=0.349 Sum_probs=207.2
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+...++.+|++|-+.|+||||+++++|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357889999999999999999966 6788999998642 233456899999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
+||..+|.|...|.+. ....+++.....+..|+|.||.|+|..+ ||||||||+|+|++.++..||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999742 3345788888999999999999999887 9999999999999999999999999986432
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
.......+||..|.+||...+..++.+.|+|++|++.||++.|..||+.... . +...+|.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~-------------etYkrI~ 235 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---S-------------ETYKRIR 235 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---H-------------HHHHHHH
Confidence 2334567899999999999999999999999999999999999999975331 1 1111111
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.-. -.++........+++.+|+..+|.+|....||++.-
T Consensus 236 k~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 236 KVD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred Hcc--ccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 111 112233446788999999999999999999998753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=310.26 Aligned_cols=263 Identities=23% Similarity=0.288 Sum_probs=201.1
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999965 78999999987543 33456899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+ +++|.++++.. ...+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998632 246999999999999999999999988 9999999999999999999999999987654322
Q ss_pred ccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc-----------
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT----------- 634 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~----------- 634 (808)
. .......++..|+|||++.+. .++.++|||||||+++||+||+.+|..... .....+......
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhcc
Confidence 1 112334688999999988654 468999999999999999999777754321 111111111000
Q ss_pred cccccccccCCCC----CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 635 SREGLERIIDPSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 635 ~~~~l~~ivD~~l----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.......+..+.- ......+....+.+++.+|++.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 000111334788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.03 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=203.4
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
+|+..+.||+|++|.||++... +++.+++|+++.......+++.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999976 788999999986555566789999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998642 246899999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
.....++..|++||++....++.++||||||+++++|++|+.||...... ..+.... ......+.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~------~~~~~~~~----- 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIA------TNGPPGLR----- 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHH------hcCCCCcC-----
Confidence 23456888999999999888999999999999999999999998643211 0000000 00000010
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
........+.+++.+|++.+|++||++.|+++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112467899999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.80 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=203.2
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
++|...+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++|+||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999854 67899999987555555678999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++++|.+++.. ..+++.+++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999852 24789999999999999999999998 99999999999999999999999999875433221
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
......++..|++||++....++.++|||||||++|||++|+.||........ +..+ .. ....
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~----~~---------~~~~ 233 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI----AT---------NGTP 233 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh----hc---------CCCC
Confidence 12234688899999999888899999999999999999999999965332110 0000 00 0000
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
....+......+.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122234568899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.77 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=199.2
Q ss_pred CcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcc---cccceeEEeeeeeccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.|+..+.||+|+||.||+|.. .+++.||+|.++.. .....+++.+|++++++++ |+|++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999996 47899999998643 3344567889999999997 999999999999989999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.++++. ..+++...+.++.+++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998852 26899999999999999999999998 99999999999999999999999999876543
Q ss_pred ccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... ......|+..|+|||++.++ .++.++|||||||++|||++|+.||...... .+.... ....
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~~-------~~~~ 218 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMMLI-------PKSK 218 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhcc-------ccCC
Confidence 321 12334688899999988754 4688999999999999999999999643221 111000 0000
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.+.. ......+.+++.+|++.+|++||++.|+++.
T Consensus 219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111111 1144678999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.82 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=198.3
Q ss_pred eeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCC
Q 003605 413 ASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~Gs 491 (808)
....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3467999999999999865 688999999876555666789999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccc
Q 003605 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571 (808)
Q Consensus 492 L~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~ 571 (808)
|.+++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... ...
T Consensus 106 L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~ 175 (292)
T cd06658 106 LTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKR 175 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccC
Confidence 9998842 24889999999999999999999988 9999999999999999999999999987543221 112
Q ss_pred cccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCC
Q 003605 572 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651 (808)
Q Consensus 572 ~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~ 651 (808)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....-. ...+.+.+..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~----------~~~~~~~~~~-- 240 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRI----------RDNLPPRVKD-- 240 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----------HhcCCCcccc--
Confidence 2346889999999998888999999999999999999999998643211 100000 0011111111
Q ss_pred ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 652 ~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.......+.+++.+|+..+|++||+++|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=347.15 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=201.1
Q ss_pred HHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec--cc
Q 003605 405 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QA 479 (808)
Q Consensus 405 ~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~ 479 (808)
+...++|.+.+.||+|+||+||++... ++..||+|.+... .......|..|+.+|.+|+|+|||+++++|.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345678999999999999999999965 5778999988642 334456899999999999999999999988654 46
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CcEEeeeecccCeeecCC-------
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS----PRVIHRDFKSSNILLEHD------- 548 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~----p~IiHrDIKpsNILLd~~------- 548 (808)
.+|||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. ..||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 799999999999999997543334569999999999999999999998542 349999999999999642
Q ss_pred ----------Ccceecccccccccccccccccccccccccccccchhhhc--CCCccccceeeHHHHHHHHHhCCCCCCC
Q 003605 549 ----------FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDM 616 (808)
Q Consensus 549 ----------~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~kSDVwSfGvvLlELlTG~~P~~~ 616 (808)
..+||+|||+++..... .......||+.|+|||++.. ..++.++||||||||||||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34899999999765322 12234568999999999864 4588999999999999999999999964
Q ss_pred CCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 617 TQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 617 ~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
... ...+... +... +.+. .......+.+|+..||+.+|++||++.|++..
T Consensus 246 ~~~-----~~qli~~-lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANN-----FSQLISE-LKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCc-----HHHHHHH-HhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 221 1111111 1000 0000 01234678999999999999999999999853
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.26 Aligned_cols=269 Identities=20% Similarity=0.258 Sum_probs=198.4
Q ss_pred CcceeeeeeecCcEEEEEEEee---CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARC 481 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~---dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~ 481 (808)
+|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++.+++|+||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999965 47899999997632 33446788999999999999999999999988 7889
Q ss_pred EEEeecCCCCccccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC----CCcceeccc
Q 003605 482 LVYELIPNGSVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH----DFTPKVSDF 556 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~-~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~----~~~vKL~DF 556 (808)
+||||+++ +|.+++...... ...+++..++.|+.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 677766433222 236889999999999999999999988 999999999999999 899999999
Q ss_pred ccccccccccc-cccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-------chhHH
Q 003605 557 GLARSAMDEES-RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-------ENLVA 627 (808)
Q Consensus 557 GLa~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-------~~lv~ 627 (808)
|+++....... ........++..|+|||++.+. .++.++|||||||+|+||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 1112234678899999988764 578999999999999999999999975443220 01111
Q ss_pred hhhhhc----------ccccccccccCCCCCCCCC-----------hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 628 WARPLL----------TSREGLERIIDPSLGNDVP-----------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 628 w~~~~~----------~~~~~l~~ivD~~l~~~~~-----------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
....+- ..........+......++ .....++.+++.+||+.||++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 100000 0000000000000000111 033457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.14 Aligned_cols=244 Identities=26% Similarity=0.375 Sum_probs=199.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|.+.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999865 6899999998753 2234567889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.++++. ...+++..+..++.|++.||+|||+.+ ++||||+|+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999853 246899999999999999999999988 99999999999999999999999999886543
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. .....++..|+|||.+.+...+.++||||||+++|||++|+.||..... ...... +..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~-------------~~~ 212 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEK-------------ILE 212 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-------------Hhc
Confidence 2 2334688999999999888889999999999999999999999864321 111010 111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQ 682 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~ 682 (808)
.. ...+......+.+++.+||..+|++|+ +++|+++
T Consensus 213 ~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 GK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00 112222346788999999999999998 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.78 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=199.6
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
|+..+.||+|+||.||+|... +++.||||.+.... ....+.|.+|++++.+++|+||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566789999999999999864 68899999986432 3345678999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+++|.+++.. ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999999852 35899999999999999999999988 9999999999999999999999999987653322
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
.......++..|+|||++.+..++.++|||||||++|||++|..|+..... .. +...... . ..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~---~~~~~~~--~---------~~ 218 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MK---VLFLIPK--N---------NP 218 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HH---HHHHHhc--C---------CC
Confidence 112234578899999999888899999999999999999999999864221 11 1110000 0 00
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..........+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122334678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=303.35 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=204.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|++.+.||+|+||.||++... +++.+|+|.++.. ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999854 7889999998753 234456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.+++.........+++..++.++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998654333457899999999999999999999988 999999999999999999999999999765432
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
......++..|++||++.+..++.++|+||||+++|||++|+.||..... ..+.... ...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~--------------~~~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKV--------------QRG 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH--------------hcC
Confidence 22234578899999999998999999999999999999999999964321 1111110 001
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+......+.+++.+|+..+|++||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111223445679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.79 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=196.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 68899999987533 223346789999999999999999999999989999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+. ++|.+++.. ....+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++++||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 677777642 2235788899999999999999999988 99999999999999999999999999875432
Q ss_pred ccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc--------
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-------- 635 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~-------- 635 (808)
... ......++..|+|||++.+. .++.++|||||||++|||++|+.||+........-...|...-...
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 211 11233468899999988754 5788999999999999999999999754321110000110000000
Q ss_pred --ccccccccC---C-CCCCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 636 --REGLERIID---P-SLGND-VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 636 --~~~l~~ivD---~-~l~~~-~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
......... + .+... ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0 00000 00112457889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.96 Aligned_cols=267 Identities=25% Similarity=0.331 Sum_probs=206.0
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeEEeeeee-----cc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-----EQ 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-----~~ 478 (808)
....|...+.||+|+||.|+++... +|+.||||++.+ .+....++-.+|+++|++++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4556666789999999999999965 789999999973 455667888999999999999999999999865 25
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
..|+|+|+| .-+|...++ .+..|+.+....+..|+++||.|+|+.+ |+||||||+|+|++.+...||+||||
T Consensus 100 DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 679999999 558888885 3445899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
|+...........+..+.|.+|.|||++.+ ..|+.+.||||.||||.||++|+.-|...+...+..+........ ..+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHH
Confidence 997654322233356678999999998764 578999999999999999999999887655433322222111111 011
Q ss_pred cccccc--------C--CC-----CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 638 GLERII--------D--PS-----LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 638 ~l~~iv--------D--~~-----l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+..+- . +. +..-+ .......++|+.+||..||.+|+|++|.++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111 0 00 00011 1345678899999999999999999999775
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.22 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=198.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccch-h-hHHHHHHHHHHhhcccccceeEEeeeeec--cceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQ-G-GREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~-~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~ 484 (808)
.|+..+.|++|.||.||+|+.+ +++.||+|+++-..+. + --..++||.+|.+++|+|||.+..+.... +..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4556789999999999999965 7899999999843211 1 12467999999999999999999887543 5689999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
|||+. +|...++.. ..++...+..-+..|+++|++|||.+. |+|||||++|+|+.+.|.+||+||||||.+..
T Consensus 157 e~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99976 898888643 356888899999999999999999998 99999999999999999999999999997754
Q ss_pred ccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc--cccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL--TSREGLER 641 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~--~~~~~l~~ 641 (808)
. ....+..+-|.+|+|||.+.+ ..|+...|+||+|||+.||++++.-|......++.+.+--....- .....+.+
T Consensus 230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 3 334567788999999999886 468999999999999999999998886654433322111000000 00001111
Q ss_pred c-----------cCCCCCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 642 I-----------IDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 642 i-----------vD~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
+ .-..++..+... ....-.+|+...|..||++|-|+.|-++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 001112222211 2356778999999999999999999765
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=314.41 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=197.9
Q ss_pred eeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 414 SRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
...||+|+||.||++... +++.||+|.++.......+.+.+|+.++..++|+||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999865 6899999999765555567889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 987742 35899999999999999999999988 9999999999999999999999999987543221 1122
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...|+..|+|||++.+..++.++|||||||++|||++|+.||..... .......... ...... ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~----------~~~~~~--~~ 240 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDS----------PPPKLK--NA 240 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcc----------CCCCcc--cc
Confidence 35688999999999988899999999999999999999999964321 1111111000 000000 01
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
......+.+++.+|++.+|++||++.||++.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1223568899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.70 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=205.0
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
..+++|+..+.||+|+||.||+|..+ ++..|++|+++.... ..+.+.+|++++++++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35677888899999999999999987 688999999976444 5678899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+++++|.+++.... ..+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999996422 36999999999999999999999987 99999999999999999999999999865432
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
.. .......++..|++||++.+..++.++|||||||++|||++|+.||...... .....+. . .....+
T Consensus 169 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~----~--~~~~~~-- 236 (286)
T cd06614 169 EK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLIT----T--KGIPPL-- 236 (286)
T ss_pred ch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH----h--cCCCCC--
Confidence 21 1122345788999999998888999999999999999999999998642211 1111110 0 000000
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.........+.+++.+|++.+|.+||++.+|++.
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 -----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111134678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=311.73 Aligned_cols=270 Identities=23% Similarity=0.358 Sum_probs=226.8
Q ss_pred CHHHHHHHhCCcceeeeeeecCcEEEEEEEee------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEe
Q 003605 400 SASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIG 472 (808)
Q Consensus 400 s~~el~~at~~f~~~~~LG~G~fG~VYkg~l~------dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g 472 (808)
...+|.....+++...++.+|.||.||.|.+. +.+.|.||.++.. ++-....++.|--++..+.|+|+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34567777788999999999999999999654 3456788988754 4455678999999999999999999999
Q ss_pred eeeec-cceEEEEeecCCCCcccccccccc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC
Q 003605 473 ICIEE-QARCLVYELIPNGSVESHLHGVDK----ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH 547 (808)
Q Consensus 473 ~~~~~-~~~~LV~Ey~~~GsL~~~L~~~~~----~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~ 547 (808)
++.++ ...+.+|.++.-|+|..||..++. ..+.+...+...+|.|++.||+|||+++ |||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 99876 456889999999999999984432 2345778889999999999999999998 999999999999999
Q ss_pred CCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 003605 548 DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLV 626 (808)
Q Consensus 548 ~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv 626 (808)
..++||+|-.|+|.+...++............||++|.+.+..|+.++|||||||+||||+| |+.|+..-++.+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----- 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----- 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----
Confidence 99999999999999999888888887788899999999999999999999999999999999 999986443321
Q ss_pred HhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 003605 627 AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 627 ~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
++..+....+-.-|.++..++..++.-||+..|++||+++|++.-|.+...
T Consensus 507 ------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 507 ------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 111222233334466788999999999999999999999999988876543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.91 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=200.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|...+.||+|+||.||+|... +|..+|+|.+... .....+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999976 6889999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-cceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-~vKL~DFGLa~~~~~~ 565 (808)
+++++|.+++... ....++|..++.++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998642 2335899999999999999999999988 99999999999998885 4699999998765332
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+....... . +.
T Consensus 156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~--~----~~- 220 (257)
T cd08225 156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG--Y----FA- 220 (257)
T ss_pred c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc--c----CC-
Confidence 1 11223458889999999988889999999999999999999999986422 12222211110 0 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.........+.+++.+|++.+|++||++.||++.
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112234578999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=297.83 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=205.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|+..+.||+|+||.||++... ++..+|+|++.... ....+++.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999975 68899999997542 35567899999999999999999999999998999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.++++........+++.+++.++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999754333467999999999999999999999998 9999999999999999999999999987653322
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.......|+..|+|||.+....++.++||||||+++++|++|+.||+.... ......... ..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~----------~~ 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK----------GQ 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc----------CC
Confidence 122334688899999999888899999999999999999999999864321 111111110 00
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
....+......+.+++.+||..+|++||++.|+++
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.25 Aligned_cols=246 Identities=30% Similarity=0.400 Sum_probs=195.8
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+++.+|+++++.++|+||++++++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55888899999999999999865 68999999986432 234467899999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 677777642 2346899999999999999999999988 99999999999999999999999999875422
Q ss_pred ccccccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
. ....++..|+|||++. .+.++.++||||||+++|||+||+.||...... ..... ... .+
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~---~~~-~~---- 230 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYH---IAQ-ND---- 230 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHH---Hhc-CC----
Confidence 1 2345788999999874 456889999999999999999999998543211 10000 000 00
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.+ ........+.+++.+||+.+|++||++.+|++.
T Consensus 231 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 --SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 112344678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.24 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=196.7
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999865 78999999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. ++|.++++... ...+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 68988886422 346899999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccchhhhcCC-CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc---------
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR--------- 636 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~-~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~--------- 636 (808)
.......++..|+|||++.+.. ++.++|||||||++|||+||+.||..... ...+.......-...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhhhhH
Confidence 1122335688999999876644 58899999999999999999999864321 111111110000000
Q ss_pred -----cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 637 -----EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 637 -----~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
..........+. .........+.+++.+|++.||++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.51 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=198.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV 483 (808)
++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++|+||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 68899999997432 22234678899999999999999999999877 889999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+. ++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 5998888632 236899999999999999999999988 9999999999999999999999999988654
Q ss_pred cccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHH---------hhh--
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVA---------WAR-- 630 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~---------w~~-- 630 (808)
.... ......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ..+.. |..
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 3221 11234578899999988754 468999999999999999999999975332110 00000 100
Q ss_pred hhcccc-cccccccCCCCCCCCChh-hHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 631 PLLTSR-EGLERIIDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 631 ~~~~~~-~~l~~ivD~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.+.... ..........+...++.. ....+.+++.+|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 000011111111222222 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.93 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=195.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcc-cccceeEEeeeeeccc-----
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQA----- 479 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~----- 479 (808)
++|+..+.||+|+||.||+|... +++.||||.++... ......+.+|++++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999965 68999999886432 223467889999999995 6999999999887665
Q ss_pred eEEEEeecCCCCccccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-CCcceecccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFG 557 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~-~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-~~~vKL~DFG 557 (808)
.++||||+++ +|.+++...... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 898888643322 346899999999999999999999988 999999999999998 8899999999
Q ss_pred cccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc-
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS- 635 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~- 635 (808)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||...... ..+..........
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 987543221 11122346788999998865 45789999999999999999999998643211 1111100000000
Q ss_pred ccccccc---cC----CCCC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 636 REGLERI---ID----PSLG----NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 636 ~~~l~~i---vD----~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
....... .+ +... ..........+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00 0000 0001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.87 Aligned_cols=267 Identities=23% Similarity=0.297 Sum_probs=200.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccch--hhHHHHHHHHHHhhccccc-ceeEEeeeeecc------
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRN-LVKLIGICIEEQ------ 478 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~--~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~------ 478 (808)
..|...++||+|+||+||+|+.. +|+.||+|+++-...+ .-....+|+.+|.+|+|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999955 7899999999754331 2345689999999999999 999999998877
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
..+||+||+. -+|..++.........++...+..++.|+++||+|||+++ |+||||||.||||++++.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7789999995 5999999765433245777889999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc----
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL---- 633 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~---- 633 (808)
|+...-. ....+..++|.+|+|||++.+. .|+...||||+|||+.||++++.-|......+ .+..-.+-+-
T Consensus 167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCCc
Confidence 9865422 2224566789999999999876 78999999999999999999988886544311 1111000000
Q ss_pred ccccccccccCC--CCCCCC-C----h---hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 634 TSREGLERIIDP--SLGNDV-P----F---DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 ~~~~~l~~ivD~--~l~~~~-~----~---~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
........+.+- .+.... + . .......+++.+|++.+|.+|.+++..+++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000111111110 010000 0 0 111468899999999999999999999875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.96 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=201.8
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999976 68999999997432 2446789999999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+.+++|.+++.. ...+++.++..|+.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999853 246899999999999999999999988 999999999999999999999999998765432
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ..+.......
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------
Confidence 2 1223457889999999998889999999999999999999999997543221 1111111100
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCH--HHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM--GEVV 681 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm--~eVl 681 (808)
.....+......+.+++.+|++.+|.+||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111223344788999999999999999999 5553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.59 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=199.7
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
|...+.||+|++|.||++... +++.+++|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 7889999998765555567789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
++|.+++.. ..+++.+++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~ 170 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--P 170 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--c
Confidence 999999853 35899999999999999999999998 9999999999999999999999999887543221 1
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+....... ..+.+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-------~~~~~~~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-------LPPKLKN 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-------CCCCCcc
Confidence 11234588999999999888899999999999999999999999864221 1111111100 0011111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1123467999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.97 Aligned_cols=247 Identities=29% Similarity=0.386 Sum_probs=196.2
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
|...+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999964 68899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. |+|.+++.. ....++|.++..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 588777742 2346899999999999999999999988 999999999999999999999999998654221
Q ss_pred ccccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||..... ...+..+..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~------------- 238 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQ------------- 238 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHh-------------
Confidence 2345788999999874 45788999999999999999999999854211 111111110
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
..............+.+++.+|++.+|++||++.+|++.+..
T Consensus 239 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 239 -NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 000011112344578999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=326.96 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=200.2
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcc-c-----ccceeEEeeeeeccceEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-H-----RNLVKLIGICIEEQARCL 482 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-H-----pNIV~L~g~~~~~~~~~L 482 (808)
+|++.++||+|.||.|.|+... +++.||||+++.. ..-.++-..|+.+|..|+ | -|+|++++|+...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999854 7999999999863 344566778999999997 4 489999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC--Ccceeccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD--FTPKVSDFGLAR 560 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~--~~vKL~DFGLa~ 560 (808)
|+|.+ .-+|.++|+... -..++...+..|+.||+.||.+||+.+ |||+||||+||||.+- .++||+|||.+.
T Consensus 266 VfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999 459999998543 345889999999999999999999998 9999999999999653 589999999998
Q ss_pred ccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHH--------hh---
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA--------WA--- 629 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~--------w~--- 629 (808)
.....-. ...-+..|+|||++.+..|+.+.||||||||+.||++|..-|-.....++...+. |.
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6433222 3445778999999999999999999999999999999977775443322211110 00
Q ss_pred ----hhhccc----------ccc------------cccccCCCC--------CCCCChhhHHHHHHHHHHccccCCCCCC
Q 003605 630 ----RPLLTS----------REG------------LERIIDPSL--------GNDVPFDSVAKVAAIASMCVQPEVQHRP 675 (808)
Q Consensus 630 ----~~~~~~----------~~~------------l~~ivD~~l--------~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 675 (808)
....+. .+. .....+... ........-..+++++++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 000000 000 000000000 0011124456789999999999999999
Q ss_pred CHHHHHHH
Q 003605 676 FMGEVVQA 683 (808)
Q Consensus 676 sm~eVl~~ 683 (808)
|..|.++.
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.76 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=194.4
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeecc------
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 478 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 478 (808)
-++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999965 68999999986432 222345678999999999999999999987654
Q ss_pred --ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 479 --ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 479 --~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
..++||||+. ++|.+++.. ....+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3499999996 588887753 2336899999999999999999999998 999999999999999999999999
Q ss_pred cccccccccccc--ccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 003605 557 GLARSAMDEESR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 557 GLa~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
|++......... .......++..|+|||++.+. .++.++||||||+++|||+||+.||...................
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999765332211 111234578899999988664 46889999999999999999999986543211111111110000
Q ss_pred c-----cccccc---c---------ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 634 T-----SREGLE---R---------IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 634 ~-----~~~~l~---~---------ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
. ...... . .+...+. .......+.+++.+||..||++||+++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000000 0 0000000 0012346779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.95 Aligned_cols=258 Identities=24% Similarity=0.315 Sum_probs=193.8
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcc-cccceeEEeeeeec--cceEEEEe
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE--QARCLVYE 485 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LV~E 485 (808)
|++.+.||+|+||.||+|... +++.||+|+++.. .........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999865 6899999998753 2223345567999999985 99999999999887 88999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+. |+|.+++.. ....++|.+++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 688888753 2246899999999999999999999988 999999999999999 99999999999765332
Q ss_pred cccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc-ccccc---
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-REGLE--- 640 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~-~~~l~--- 640 (808)
.. .....++..|+|||++.. +.++.++|||||||++|||++|..||..... .+.+.+....... .+.+.
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhh
Confidence 11 123457889999997654 5578899999999999999999999965332 1222222111100 00000
Q ss_pred ------cccCCC-CCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 641 ------RIIDPS-LGN---DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 641 ------~ivD~~-l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
....+. ... .........+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 000 001134578999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=302.98 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=198.2
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
+|+..+.||+|++|.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 688999999875432 23467788999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
+ ++|.+++..... ...+++..+++++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 7 488888864322 246899999999999999999999988 9999999999999999999999999987543211
Q ss_pred cccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHHhhhhhcccccccccccC-
Q 003605 568 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIID- 644 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~w~~~~~~~~~~l~~ivD- 644 (808)
.......++..|++||++.+. .++.++|||||||++|||++|+.||......+. ..+........ ......+.+
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT--ESTWPGISQL 231 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC--hhhHHHHhcC
Confidence 111234568899999988654 568899999999999999999999875432111 00000000000 000000000
Q ss_pred CCCCCC-----------CChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 645 PSLGND-----------VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 645 ~~l~~~-----------~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
+.+... ........+.+++.+|++.+|++||++.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 11123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.88 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=197.4
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceEEEEe
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVYE 485 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV~E 485 (808)
|++.+.||+|+||.||+|+.. +++.+|+|+++... ....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58899999998642 33446788999999999999999999999887 78999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|++ ++|.+++... ...+++.+++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 4888888532 246899999999999999999999988 999999999999999999999999999765433
Q ss_pred cccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhccc-ccccccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTS-REGLERI 642 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~-~lv~w~~~~~~~-~~~l~~i 642 (808)
.. ...+...++..|+|||.+.+ ..++.++||||||+++|||+||+.||+........ .+.......... ......+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11223456788999997764 45789999999999999999999999754321110 000100000000 0000000
Q ss_pred -----------cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 643 -----------IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 643 -----------vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
....+...+...+...+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000111112567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.08 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=195.1
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|...+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999865 6899999998743 2344567899999999996 99999999999998999999999
Q ss_pred cCCCCcccccccc-ccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 487 IPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 487 ~~~GsL~~~L~~~-~~~~~~L~~~~~l~Ia~qia~gL~yLH~~-~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
+. ++|.++.... ......+++..+.+++.+++.||+|||+. + ++||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 4655543211 12234689999999999999999999975 5 99999999999999999999999999875432
Q ss_pred ccccccccccccccccccchhhhcC---CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~------- 225 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK------- 225 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-------
Confidence 21 11233578899999998776 68999999999999999999999986432 11111111100
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+.+...........+.+++.+|++.+|++||++.||++.
T Consensus 226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112222223355689999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.81 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=196.5
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999865 79999999987432 223467889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
+++|.+++.... ...+++..+++++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 -DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred -CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 479999886422 136899999999999999999999987 9999999999999999999999999987543211
Q ss_pred cccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc---------
Q 003605 568 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE--------- 637 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~--------- 637 (808)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+....+......+
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhhhhhc
Confidence 111223468899999987654 568899999999999999999999864322 1111111110000000
Q ss_pred -c----cccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 638 -G----LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 638 -~----l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
. ......... ..........+.+++.+|++.+|++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 1111233467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.08 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=195.2
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 58899999986432 23456899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.++++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999963 235889999999999999999999988 9999999999999999999999999998654322 122
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...++..|++||.+.+..++.++||||||+++|||++|..||...... ....... +.+......++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~----------~~~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYND----------ILKGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHH----------HhccCCCCCCC
Confidence 345788999999998888999999999999999999999999654321 1111111 11111112223
Q ss_pred hhhHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQ 682 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~ 682 (808)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 333568999999999999999999 566544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=322.32 Aligned_cols=254 Identities=21% Similarity=0.332 Sum_probs=208.7
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEee--cccchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk--~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV 483 (808)
....|++.+.||+||.++||++...+.+.+|+|++. ..+.+...-|..||++|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 345688889999999999999998888999999875 356777888999999999996 99999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||= +.+|..+|++. .....+| .+..+..|++.|+.++|.++ |||.||||.|+|+- .|.+||+|||+|....
T Consensus 439 mE~G-d~DL~kiL~k~--~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKK--KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhc--cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9976 56999999743 2334556 77888999999999999999 99999999999995 4599999999999877
Q ss_pred cccccccccccccccccccchhhhcC-----------CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
.+...-.....+||+.||+||.+... +.+.+|||||+|||||+|+.|+.||.... -.|
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~---- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQI---- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHH----
Confidence 66555566678999999999988643 25679999999999999999999995211 122
Q ss_pred cccccccccccCCCCCCCCCh-hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 633 LTSREGLERIIDPSLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+..|.|+.-..+++. ....+++++++.||+.||++||++.|+++.
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 23556777755444443 222339999999999999999999999864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.22 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=195.7
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeecccc---hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++.+++|+||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999999875332 4556889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc-----
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES----- 567 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~----- 567 (808)
.++++.. ..+++..+++++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999632 26899999999999999999999988 99999999999999999999999999875432211
Q ss_pred -cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 568 -RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 568 -~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
........++..|++||.+.....+.++||||||+++|||++|+.||..... ...... .... .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~---~~~~----------~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQN---ILNG----------K 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HhcC----------C
Confidence 1122334578899999999888899999999999999999999999964321 111111 1110 0
Q ss_pred CCCCCChh--hHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 647 LGNDVPFD--SVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 647 l~~~~~~~--~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+ ..+.. ....+.+++.+|++.+|++||++.+|.+.|+
T Consensus 218 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 01111 2467899999999999999999976666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.61 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=197.5
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-----cchhhHHHHHHHHHHhhcccccceeEEeeeeec--cce
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 480 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 480 (808)
.+|++.+.||+|+||.||+|... +++.||+|.+... ..+..+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999865 6899999987521 233456889999999999999999999998664 457
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++++||+++++|.+++.. ...+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999852 235889999999999999999999988 9999999999999999999999999997
Q ss_pred ccccccc-cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 561 SAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 561 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
....... ....+...++..|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~------------- 219 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MAAIF------------- 219 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--HHHHH-------------
Confidence 5432111 1111234588999999999988899999999999999999999999864211 11111
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
++.........+......+.+++.+|++ ++.+||+..++++
T Consensus 220 -~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 220 -KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111122344455779999999999 4699999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=312.72 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=198.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec------
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 477 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 477 (808)
..++|+..+.||+|+||.||+|... +++.||||++... .....+++.+|++++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 7899999998642 334456788899999999999999999988643
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFG 557 (808)
...++||||+. ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 34699999995 588887742 2888999999999999999999988 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhH--------Hh
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLV--------AW 628 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv--------~w 628 (808)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ..+. .|
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998653221 12234578899999999999999999999999999999999999964331100 0000 00
Q ss_pred h-------hhhcccc-----cccccccCCCC----CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 629 A-------RPLLTSR-----EGLERIIDPSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 629 ~-------~~~~~~~-----~~l~~ivD~~l----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. ....... ..+.+++...+ ...........+.+++.+||+.||++||++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000 00111111111 011112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=336.78 Aligned_cols=268 Identities=25% Similarity=0.426 Sum_probs=214.4
Q ss_pred HHHHhCCcceeeeeeecCcEEEEEEEee----C----CCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeEEee
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLD----D----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGI 473 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~----d----g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~ 473 (808)
++...++..+.+.||+|.||.|++|.+. . ...||||.++.. .....+.+..|+++|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3344445556679999999999999853 1 346999999853 345678899999999998 69999999999
Q ss_pred eeeccceEEEEeecCCCCccccccccc---c---C----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeeccc
Q 003605 474 CIEEQARCLVYELIPNGSVESHLHGVD---K---E----S--APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSS 541 (808)
Q Consensus 474 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~---~---~----~--~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKps 541 (808)
|..++..++|.||+..|+|.++|+..+ . . . ..|...+.+.++.|||+||+||++.. +|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998655 0 0 0 23889999999999999999999887 999999999
Q ss_pred CeeecCCCcceecccccccccccccccccc-cccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCC
Q 003605 542 NILLEHDFTPKVSDFGLARSAMDEESRHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQP 619 (808)
Q Consensus 542 NILLd~~~~vKL~DFGLa~~~~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~ 619 (808)
||||.++..+||+|||+|+...+.+..... +...-...|||||.+....|+.|||||||||+||||+| |..||....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~- 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP- 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-
Confidence 999999999999999999965544433211 11113567999999999999999999999999999999 888885311
Q ss_pred CCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 620 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 620 ~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
...++..+ +.+..+...|..+..++.+|++.||+.+|++||++.|+++.|+..+.+
T Consensus 527 -~~~~l~~~--------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 527 -PTEELLEF--------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred -cHHHHHHH--------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 11222222 222233345666778999999999999999999999999999986554
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.17 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=201.9
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+++.+|++++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999976443 4567899999999999999999999999998999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+++++|.+++.. ...++|..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999853 246899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~ 646 (808)
.. .....++..|+|||.+.+..++.++|||+||+++|||++|+.|+..... ....|.. .. ..
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~--~~--~~-------- 215 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRI--VQ--DD-------- 215 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHH--hc--cC--------
Confidence 21 2234678899999999888889999999999999999999999864321 1111110 00 00
Q ss_pred CCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 647 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
....+......+.+++.+||..+|++||++.|++.
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01122233467889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.21 Aligned_cols=242 Identities=26% Similarity=0.353 Sum_probs=187.6
Q ss_pred eeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhh---cccccceeEEeeeeeccceEEEEeecC
Q 003605 416 ILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSR---LHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~---L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999865 68999999986421 2223345555554444 369999999999999899999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.+++.. ...++|..+..|+.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998852 245999999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+.... . ..
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~------------~~ 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L------------TV 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h------------cC
Confidence 123458999999998874 45789999999999999999999999754322111111100 0 00
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
....+......+.+++.+||+.||++|| +++|+++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112333456788999999999999999 58888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.04 Aligned_cols=265 Identities=26% Similarity=0.360 Sum_probs=197.4
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeec-----cc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QA 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 479 (808)
.+++|.+.++||+|+||.||+|+.. +|+.||||+++.. ......++.+|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999864 7899999998743 233456788999999999999999999987654 34
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++|+||+. ++|.+++. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 47877764 235899999999999999999999998 999999999999999999999999998
Q ss_pred ccccccccc-ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc--
Q 003605 560 RSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-- 635 (808)
Q Consensus 560 ~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~-- 635 (808)
+........ .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence 764332111 11123468899999998765 4688999999999999999999999964321 1111111111100
Q ss_pred ccccccccCCCC---------CCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 636 REGLERIIDPSL---------GNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 ~~~l~~ivD~~l---------~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.+..+.+... ....+ .....++.+++.+||+.+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111111000 00000 1224568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.47 Aligned_cols=266 Identities=25% Similarity=0.306 Sum_probs=197.6
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeecc----
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ---- 478 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~---- 478 (808)
.+.++|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 68899999997532 223456788999999999999999999987654
Q ss_pred ------ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcce
Q 003605 479 ------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 552 (808)
Q Consensus 479 ------~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vK 552 (808)
..++|+||+++ +|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999975 77776642 2346899999999999999999999988 99999999999999999999
Q ss_pred ecccccccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 003605 553 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 553 L~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~ 631 (808)
|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+......
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISRL 233 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHH
Confidence 999999976543221 11222346778999998765 35688999999999999999999999743221 111111000
Q ss_pred hccc-ccccccc--------cC------CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 632 LLTS-REGLERI--------ID------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 632 ~~~~-~~~l~~i--------vD------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.... ......+ .+ ..+.... ......+.+++.+||+.+|++||++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000000 00 0000000 112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.69 Aligned_cols=261 Identities=24% Similarity=0.296 Sum_probs=194.6
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhc---ccccceeEEeeeeeccc-----
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRL---HHRNLVKLIGICIEEQA----- 479 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~----- 479 (808)
|++.+.||+|+||.||+|+.. +++.||+|+++.. .......+.+|++++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999986 5899999999742 222234677788887776 59999999999988776
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.+++|||+. ++|.+++.... ...++|..++.++.|+++||+|||+.+ ++|+||+++||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 58988886422 235899999999999999999999988 999999999999999999999999998
Q ss_pred cccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc-c-
Q 003605 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR-E- 637 (808)
Q Consensus 560 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~-~- 637 (808)
....... ......++..|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+........ .
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHh
Confidence 7653221 112334788999999999989999999999999999999999988643321 11111111000000 0
Q ss_pred -ccc-----cccCCCCC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 638 -GLE-----RIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 638 -~l~-----~ivD~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
... ........ .....+....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 00000000 0011123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=304.79 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=194.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|++.+.||+|+||.||+|... +++.||||+++... .....++..|++++.+++ |+||++++++|.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56788899999999999999987 48999999997532 334456778888887775 9999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
|+. ++|.+++.. ....+++..+.+++.++++||+|||+ .+ |+||||+|+||++++++.+||+|||++.....
T Consensus 95 ~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 577766642 12368999999999999999999997 45 99999999999999999999999999876533
Q ss_pred ccccccccccccccccccchhhhcCC----CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ...+.. ..... ..
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~~~~--~~ 237 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK----ILQEE--PP 237 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH----HhcCC--CC
Confidence 221 12335778999999987554 788999999999999999999998642111 011111 11100 00
Q ss_pred cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 641 ~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.+ ........++.+++.+||+.+|++||++.++++.-
T Consensus 238 -----~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 -----SL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -----CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00 00112346789999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.81 Aligned_cols=267 Identities=20% Similarity=0.275 Sum_probs=195.8
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|+..+.||+|++|.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999975 78899999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-CCcceeccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMD 564 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-~~~vKL~DFGLa~~~~~ 564 (808)
|++ ++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||+++. ++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 5888877432 2234678888999999999999999987 999999999999985 56799999999975432
Q ss_pred ccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhccc-cc---c
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTS-RE---G 638 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~-~lv~w~~~~~~~-~~---~ 638 (808)
. ....+...++..|+|||++.+. .++.++|||||||++|||+||+.||......+.. ....+....... .. .
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1 1112334578899999988764 5789999999999999999999999653221100 000000000000 00 0
Q ss_pred cccccC--CCCCC----CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 639 LERIID--PSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 639 l~~ivD--~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+..... +.... ........++.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0112234568899999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=311.34 Aligned_cols=268 Identities=24% Similarity=0.313 Sum_probs=198.7
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhc-ccccceeEEeeeeec--cce
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE--QAR 480 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~--~~~ 480 (808)
..++|++.+.||+|+||.||+|... +++.+|||++.. ........+.+|+.++.++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578888999999999999999975 688999998854 2233446788899999999 999999999998654 357
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++||||+. ++|.+++.. . .++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----N-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 599888852 2 6889999999999999999999988 9999999999999999999999999998
Q ss_pred cccccccc---ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc-
Q 003605 561 SAMDEESR---HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS- 635 (808)
Q Consensus 561 ~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~- 635 (808)
........ .......|+..|+|||++.+ ..++.++||||||+++|||+||+.||.............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65433221 12234568899999998765 45788999999999999999999999643321110000000000000
Q ss_pred ------ccccccccC----CCC--CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 636 ------REGLERIID----PSL--GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 ------~~~l~~ivD----~~l--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
......+++ ... ...........+.+++.+|++.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000111 000 000111235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=314.58 Aligned_cols=243 Identities=30% Similarity=0.413 Sum_probs=199.8
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
|...+.||.|+||.||-|+.. +.+.||||++.- ...+...+++.|+..|++|+|||+|.+.|+|..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 556678999999999999854 788999999964 3445567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
| -|+-.|.|. -...+|.+.++..|..|.+.||+|||+++ .||||||+.||||.+.+.|||+|||.|......
T Consensus 108 C-lGSAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 C-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred H-hccHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9 567777774 34467999999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
...+||+.|||||++. .+.|+-|.||||||+...||.-.+.|+.... ....+..-++ . -
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHIAQ----N-------e 241 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQ----N-------E 241 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHHHh----c-------C
Confidence 3457999999999885 5789999999999999999999999874321 1111111111 0 1
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.|.|. ..+....+.+++..||++-|.+|||..++++
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12221 3466788999999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.22 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=196.0
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeec--cceEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 482 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 482 (808)
.++|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999975 68999999987432 22234567899999999999999999998765 46799
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||||+. ++|.+++... ...++|.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 5888887532 246899999999999999999999998 999999999999999999999999999865
Q ss_pred ccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHHhhh-------hhc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWAR-------PLL 633 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~w~~-------~~~ 633 (808)
.... ...+...++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+..+.. +..
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 4322 11122345788999998875 4578999999999999999999999964332111 00111100 000
Q ss_pred cccccccccc-CCCCCCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 634 TSREGLERII-DPSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 ~~~~~l~~iv-D~~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.......... ........ .......+.+++.+|++.||++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00000000 01124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.70 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=215.8
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
|++.++||+|+||.|||+.++ .|..+|||.+.. ....+++..||.|+++.+.+++|++||.|.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566789999999999999976 799999999864 34457899999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|++.+.++. ++.+|.++++..|+...++||+|||... -||||||+.||||+.+|.+||+|||.|..+.+. -.
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 999999973 4568999999999999999999999886 799999999999999999999999999766432 22
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
....+.||+.|||||++..-.|..++||||||+...||..|+.||..-.+- +.++.. . .+|.-.-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------RAIFMI----P--T~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------RAIFMI----P--TKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------ceeEec----c--CCCCCCC
Confidence 334578999999999999999999999999999999999999999643221 111100 0 0111111
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH-----------HHHHHHhhhhhhhcCC
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA-----------LKLVCNECDEAKEVGS 699 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~-----------Le~i~~~~~~~~~~~~ 699 (808)
..++....++-++++.||.++|++|-|+.++++. |+.+.++..+.+..+.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~e~~~~~q 310 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQEKAILGQ 310 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHHHHHHhcc
Confidence 2356778899999999999999999999999764 4555555544444333
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.87 Aligned_cols=250 Identities=26% Similarity=0.308 Sum_probs=208.1
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc---hhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARC 481 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~---~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~ 481 (808)
..+.|++.+.||+|.||.||+++.. +|+.+|+|.+.+... ...+.+.+|+.+|+++. |+|||.+.+++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567888899999999999999976 599999999976433 23468999999999998 999999999999999999
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC----Ccceecccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD----FTPKVSDFG 557 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~----~~vKL~DFG 557 (808)
+|||++.+|.|.+.+... .+++.+...++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999643 2899999999999999999999988 9999999999999543 479999999
Q ss_pred cccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||..........
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------- 248 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------- 248 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------
Confidence 9987644 334456789999999999999999999999999999999999999997543221100
Q ss_pred ccccccCC--CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 638 GLERIIDP--SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 638 ~l~~ivD~--~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+... .+....-........+++..|+..||.+|+++.++++.
T Consensus 249 ---~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ---AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 11112223446788999999999999999999999883
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.27 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=190.1
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
||+|+||+||++... +|+.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999855 78999999986421 23345678899999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.+++.... ...+++.+++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++...... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 99986432 236899999999999999999999988 999999999999999999999999998754321 1112
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...++..|++||++.++.++.++|||||||++|||++|+.||.......... ..... ... .....+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~----------~~~--~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRR----------TLE--MAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhc----------ccc--ccccCC
Confidence 3457789999999988889999999999999999999999996543211100 00000 000 011122
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGE 679 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~e 679 (808)
......+.+++.+||+.+|++||+.+|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 234567899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=306.88 Aligned_cols=254 Identities=25% Similarity=0.307 Sum_probs=204.6
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
+.|++.+.||+|.-|+||++.+. .+..+|+|++.+. ......+...|-+||+.+.||.++.||+.+..++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34666789999999999999987 3588999999753 2444567788999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
|||+||+|...++. +....++...+.-+|.+++.||+|||..| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999874 34457899999999999999999999999 99999999999999999999999999742210
Q ss_pred ---------------------------------cccc---------------------ccccccccccccccchhhhcCC
Q 003605 565 ---------------------------------EESR---------------------HISTRVMGTFGYVAPEYAMTGH 590 (808)
Q Consensus 565 ---------------------------------~~~~---------------------~~~~~~~Gt~~Y~APE~l~~~~ 590 (808)
.... ..+...+||-.|+|||++.+.-
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0000 0011256899999999999999
Q ss_pred CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccC
Q 003605 591 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 670 (808)
Q Consensus 591 ~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~d 670 (808)
.+.+.|.|+|||+||||+.|..||..... ++.+..++-..+.-....+.+..+.+||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999975432 22333333333222222255678999999999999
Q ss_pred CCCCCC----HHHHHHH
Q 003605 671 VQHRPF----MGEVVQA 683 (808)
Q Consensus 671 P~~RPs----m~eVl~~ 683 (808)
|++|-. +.||.+.
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999988 7777553
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.21 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=195.5
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEEeec
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
|.+.+.||+|+||+||+|+.. +++.|+||+++.... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999976 578899999875322 22334567999999999 999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
+|+|.++++... ...++|.+++.++.|++.+|.|||+++ ++|+||+++||++++++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 889999886422 246899999999999999999999988 9999999999999999999999999987553221
Q ss_pred cccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhc----cccccccc
Q 003605 568 RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLL----TSREGLER 641 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~-~lv~w~~~~~----~~~~~l~~ 641 (808)
......++..|+|||++.. ..++.++||||||+++|||++|+.||......+.. ....+..... .....+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1223457889999998754 45789999999999999999999998644321110 0000000000 00000000
Q ss_pred ccCCCCC-------CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 642 IIDPSLG-------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 642 ivD~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.++..+. ..........+.+++.+|++.+|++||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0011122467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.14 Aligned_cols=268 Identities=23% Similarity=0.279 Sum_probs=194.3
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeecc------
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 478 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 478 (808)
.++|++.+.||+|+||.||+|+.. +++.+|||++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 68999999986432 222346788999999999999999999875443
Q ss_pred --ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 479 --ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 479 --~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
..++|+||+. ++|.+.++. ....+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4599999996 467776653 2346999999999999999999999998 999999999999999999999999
Q ss_pred cccccccccccc---------ccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchh-
Q 003605 557 GLARSAMDEESR---------HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL- 625 (808)
Q Consensus 557 GLa~~~~~~~~~---------~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~l- 625 (808)
|+++........ ...+...++..|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754322111 111234578889999987654 578999999999999999999999864332111100
Q ss_pred HHhhhhh----cccccccccccCCCCCCCCC-------hhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 626 VAWARPL----LTSREGLERIIDPSLGNDVP-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 626 v~w~~~~----~~~~~~l~~ivD~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
....... +.....+....+.......+ ......+.+++.+||+.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 00000000000000000000 112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.16 Aligned_cols=261 Identities=23% Similarity=0.269 Sum_probs=198.3
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
|+..+.||+|++|.||++... +++.+++|+++.... .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999865 788999999875322 34568889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
++ +|.+++.. ....+++.+++.++.+++.||+|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 64 88888853 2246899999999999999999999988 9999999999999999999999999987654332
Q ss_pred cccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhcccccccccccC-
Q 003605 568 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPLLTSREGLERIID- 644 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~-lv~w~~~~~~~~~~l~~ivD- 644 (808)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+... ......... .+....+.+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 229 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD--PEVWPKFTSL 229 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc--hHhcccchhh
Confidence 112234578899999998876 78999999999999999999999986433211000 000000000 000000000
Q ss_pred -----CCC-------CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 645 -----PSL-------GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 645 -----~~l-------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
..+ ......+...++.+++.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111234568999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=324.71 Aligned_cols=244 Identities=23% Similarity=0.394 Sum_probs=192.9
Q ss_pred eeeeeecCcEEEEEEEee-CCCEEEEEEee--c--ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccc--eEEEEee
Q 003605 414 SRILGEGGFGLVYSGVLD-DGTKVAVKVLK--R--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--RCLVYEL 486 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk--~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~--~~LV~Ey 486 (808)
..+||+|+|-+||||.+. +|..||.-.++ + ......++|..|+++|+.|+|+|||+++.+|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999875 67788755443 2 234455899999999999999999999999988765 6789999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Ccceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DFGLa~~~~~~ 565 (808)
|..|+|..|++.. ..++...+..|+.||++||.|||++ .|+|||||||.+||||+.+ |.|||+|.|||......
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999643 4578889999999999999999998 5889999999999999765 89999999999865332
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. ...+.||+.|||||+.. ..|.+..||||||++++||+|+..||..=... ..+..-+..-+. ...+.++-
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiK-P~sl~kV~-- 269 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIK-PAALSKVK-- 269 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCC-HHHhhccC--
Confidence 2 23478999999999776 78999999999999999999999999632111 111111111000 11122222
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..++.+||.+|+.. .++|+++.|+++.
T Consensus 270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 ----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 24688999999999 9999999999864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.81 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=197.2
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-----cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
+|.+.+.||+|+||.||++... .+..+++|.++.. ......++..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999865 3455666666532 223345677899999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+++++|.++++........++|.+++.++.|++.||+|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998754444567999999999999999999999988 999999999999976 469999999987654
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ..........
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~--------- 219 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE--------- 219 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc---------
Confidence 322 12223457889999999988888999999999999999999999985321 1111111110
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
......+......+.+++.+|++.+|++||++.|+++
T Consensus 220 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 --GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0001122344567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.41 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=201.9
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV 483 (808)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++.+++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999975 7899999998642 2344567889999999998 99999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+++++|.+++.. ...+++.+++.|+.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999963 236999999999999999999999988 9999999999999999999999999987654
Q ss_pred ccccc------------------ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchh
Q 003605 564 DEESR------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 625 (808)
Q Consensus 564 ~~~~~------------------~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~l 625 (808)
..... .......++..|++||.+....++.++||||||++++||++|+.||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH
Confidence 32211 111234578899999999888899999999999999999999999974431 010
Q ss_pred HHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 003605 626 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM----GEVVQ 682 (808)
Q Consensus 626 v~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm----~eVl~ 682 (808)
... +.+ .....+......+.+++.+||+.+|++||++ .++++
T Consensus 231 ~~~-------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQK-------------ILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH-------------HHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 010 000 0111222334678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.75 Aligned_cols=267 Identities=22% Similarity=0.335 Sum_probs=199.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeee----ccc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE----EQA 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~ 479 (808)
..++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3478999999999999999999865 6899999998753 22345678889999999999999999998753 346
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++|+||+. |+|.++++. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 799999995 689888852 235899999999999999999999988 999999999999999999999999999
Q ss_pred ccccccccc--ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc--
Q 003605 560 RSAMDEESR--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT-- 634 (808)
Q Consensus 560 ~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~-- 634 (808)
+........ .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~ 231 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSP 231 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCC
Confidence 765332211 11123468899999998865 4678999999999999999999999965332111 111000000
Q ss_pred --------cccccccccCCC-CCCCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 635 --------SREGLERIIDPS-LGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 635 --------~~~~l~~ivD~~-l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
..+.+.+.++.. ..... .......+.+++.+||+.+|++||++.++++.-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000011111100 00011 112356799999999999999999999988753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=321.56 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=202.6
Q ss_pred eeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCccc
Q 003605 416 ILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES 494 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~ 494 (808)
+||+|.||+||-|+.. +...+|||-+...+.+..+-+++||.+.++|+|+|||+++|.|.+.+..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999965 556789999987777777789999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-CCcceecccccccccccccccccc
Q 003605 495 HLHGVDKESAPL--GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMDEESRHIS 571 (808)
Q Consensus 495 ~L~~~~~~~~~L--~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-~~~vKL~DFGLa~~~~~~~~~~~~ 571 (808)
+|+. .=.+| ++.+.-.+..||++||.|||++. |||||||-+|||++. .|.+||+|||-++.+. .....+
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 9963 22345 67788888999999999999998 999999999999964 6899999999998664 233445
Q ss_pred cccccccccccchhhhcC--CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 572 TRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 572 ~~~~Gt~~Y~APE~l~~~--~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
....||..|||||++..+ .|..++|||||||.+.||.||+.||-...... .... +-++.+ ...
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----AAMF------kVGmyK-----vHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----AAMF------KVGMYK-----VHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----Hhhh------hhccee-----cCC
Confidence 567899999999999865 57889999999999999999999996433210 0000 011111 123
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+|.+...+...++.+|+..+|.+||+++++++.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 4677888899999999999999999999999753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.04 Aligned_cols=255 Identities=25% Similarity=0.318 Sum_probs=199.9
Q ss_pred CcceeeeeeecCcEEEEEEEe----eCCCEEEEEEeeccc----chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccce
Q 003605 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l----~dg~~VAVK~lk~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 480 (808)
+|++.+.||+|+||.||++.. .+++.||||.++... ....+.+.+|++++.++ +|+||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999884 257889999997432 23345788999999999 599999999999988899
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++||||+++|+|.+++.. ...+.+..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999852 235889999999999999999999987 9999999999999999999999999987
Q ss_pred ccccccccccccccccccccccchhhhcCC--CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~ 638 (808)
....... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... .............
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS--- 227 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc---
Confidence 6543221 1122345788999999987665 788999999999999999999998642211 1111111111110
Q ss_pred cccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 639 l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
+ ...+......+.+++.+||+.+|++|||++++.+.|+.
T Consensus 228 -----~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -----K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 11222234568899999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.31 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=198.1
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec-----c
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----Q 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~ 478 (808)
+.++|.+.+.||+|+||+||+|+.. +++.||||.++.. ......++.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467999999999999999999864 7899999998742 233455778899999999999999999988654 3
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 4799999995 688888752 346899999999999999999999988 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhh-----
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARP----- 631 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~-~lv~w~~~----- 631 (808)
++...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......... .+......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 155 ARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 98653321 11223457889999998865 46889999999999999999999999643211000 00000000
Q ss_pred --hccccccccccc-------CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 632 --LLTSREGLERII-------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 632 --~~~~~~~l~~iv-------D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..... .....+ +..+. .........+.+++.+||+.+|++||+++|+++.
T Consensus 233 ~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNE-KARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCch-hhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 000000 00000 0112345678999999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.51 Aligned_cols=248 Identities=29% Similarity=0.373 Sum_probs=195.3
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
+.|...+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999965 6788999998632 2334467889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
||+. |+|.+++.. ....+++.+++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 688877742 2345899999999999999999999988 99999999999999999999999999875432
Q ss_pred ccccccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 565 EESRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
. ....++..|+|||++. ...++.++|||||||++|||++|+.|+...... ..+..+... ..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~------~~-- 231 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN------ES-- 231 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhhc------CC--
Confidence 1 2345788999999975 356788999999999999999999998532210 111111100 00
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
+.. ........+.+++.+||+.+|++||++.+|++...
T Consensus 232 ---~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 ---PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 000 11234467889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.65 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=188.8
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHh-hcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLS-RLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~-~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
+.||+|+||.||+|... +++.||||+++... ......+..|..++. ..+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 68999999986532 222334555655544 45899999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
++|.++++. ...+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999853 235889999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
.....++..|+|||.+.+..++.++||||||+++|||++|..||..... ... + ....... . ....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~--~-~~~~~~~------~--~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAV--F-DNILSRR------I--NWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHH--H-HHHHhcc------c--CCCC
Confidence 2234578899999999888889999999999999999999999964321 111 1 1000000 0 0001
Q ss_pred CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 003605 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 650 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.........+.+++.+||+.+|++||++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111133467899999999999999998776655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.94 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=196.6
Q ss_pred eeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCcc
Q 003605 415 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 493 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~ 493 (808)
.+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 78999999987555556678999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccc
Q 003605 494 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573 (808)
Q Consensus 494 ~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~ 573 (808)
+++.. ..+++...+.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ ....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 98742 25899999999999999999999988 99999999999999999999999999875433211 1223
Q ss_pred cccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCCh
Q 003605 574 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 653 (808)
Q Consensus 574 ~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~ 653 (808)
..++..|++||++.+..++.++|||||||++|||++|..||..... ......... .....+.. ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~----------~~~~~~~~--~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRD----------NLPPKLKN--LH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----------hCCcccCC--cc
Confidence 4578999999999888889999999999999999999999864221 111111110 01111100 11
Q ss_pred hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 654 DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 654 ~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 223567889999999999999999999773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.19 Aligned_cols=259 Identities=16% Similarity=0.216 Sum_probs=183.3
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeC----CCEEEEEEeecccchh-----------hHHHHHHHHHHhhcccccceeEEe
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQG-----------GREFLAEVEMLSRLHHRNLVKLIG 472 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~d----g~~VAVK~lk~~~~~~-----------~~~f~~Ei~iL~~L~HpNIV~L~g 472 (808)
.++|.+.++||+|+||+||+|...+ +..+|+|......... ......++..+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999754 3456666543221111 011223334455678999999999
Q ss_pred eeeecc----ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC
Q 003605 473 ICIEEQ----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 548 (808)
Q Consensus 473 ~~~~~~----~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~ 548 (808)
++.... ..++++|++. .++.+.+.. ....++..+..|+.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 876543 2367777763 355555532 223578889999999999999999988 9999999999999999
Q ss_pred Ccceeccccccccccccccc-----ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc
Q 003605 549 FTPKVSDFGLARSAMDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE 623 (808)
Q Consensus 549 ~~vKL~DFGLa~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~ 623 (808)
+.++|+|||+|+........ .......||..|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999865432111 11123469999999999999999999999999999999999999997543211
Q ss_pred hhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 624 NLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 624 ~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
.+..-... +.+..+....+ ........+.+++..|+..+|++||++.++++.|
T Consensus 241 ~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKC-----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHH-----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111100 00111111111 0112346789999999999999999999998876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=296.09 Aligned_cols=241 Identities=26% Similarity=0.348 Sum_probs=186.8
Q ss_pred eeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHh---hcccccceeEEeeeeeccceEEEEeecC
Q 003605 416 ILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLS---RLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~---~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
+||+|+||.||++... +++.||+|.+.... ......+..|..++. ...|+||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 68899999986421 222233455544443 4579999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|+|.+++.. ...++|.++..|+.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998852 346999999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.....|+..|+|||++.++ .++.++|||||||++|||++|+.||........... ... .. ..+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~--~~--------~~~--- 215 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRM--TL--------TMA--- 215 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHH--hh--------ccC---
Confidence 1234688999999998755 589999999999999999999999975432111110 000 00 001
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQ 682 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~ 682 (808)
...+......+.+++.+|+..+|++|| ++.++++
T Consensus 216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 112223356899999999999999999 8999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=326.31 Aligned_cols=271 Identities=21% Similarity=0.226 Sum_probs=189.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeC--CCEEEEE------------------EeecccchhhHHHHHHHHHHhhccccc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDD--GTKVAVK------------------VLKRVDQQGGREFLAEVEMLSRLHHRN 466 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~d--g~~VAVK------------------~lk~~~~~~~~~f~~Ei~iL~~L~HpN 466 (808)
..++|++.+.||+|+||+||++.++. +...++| .++ .......++.+|+++|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987642 2222222 111 12233457889999999999999
Q ss_pred ceeEEeeeeeccceEEEEeecCCCCcccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee
Q 003605 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 467 IV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~-~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL 545 (808)
|+++++++...+..++|+|++. ++|.+++..... ........+...|+.|++.||+|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 577777643211 1122345667789999999999999988 9999999999999
Q ss_pred cCCCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCC-CCCCCCCCcch
Q 003605 546 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQEN 624 (808)
Q Consensus 546 d~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P-~~~~~~~~~~~ 624 (808)
+.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||+||||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999998654322 1222345799999999999999999999999999999999998754 43322211122
Q ss_pred hHHhhhhhccccc-------ccccccCCC-CC---CCC-----ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 625 LVAWARPLLTSRE-------GLERIIDPS-LG---NDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 625 lv~w~~~~~~~~~-------~l~~ivD~~-l~---~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+......+....+ .+...++.. +. ... .......+.+++.+||+.||++||++.|+++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2211111000000 000001000 00 000 00122457788999999999999999999864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=307.07 Aligned_cols=264 Identities=24% Similarity=0.350 Sum_probs=194.3
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec------c
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------Q 478 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~ 478 (808)
.++|...+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 488999999999999999999964 7899999998742 223345688999999999999999999998654 2
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
..++|+||+. .+|.+++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4699999996 46665542 35889999999999999999999988 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh------
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP------ 631 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~------ 631 (808)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............+...
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8754221 123457889999999876 4688999999999999999999999975321110000000000
Q ss_pred --hcccccccccccC--CCC-CCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 003605 632 --LLTSREGLERIID--PSL-GNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA--LKLV 687 (808)
Q Consensus 632 --~~~~~~~l~~ivD--~~l-~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~--Le~i 687 (808)
.... ......++ +.. .... .......+.+++.+||+.||++||++.|+++. ++..
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 239 VQKLED-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcc-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 00000000 000 0000 01233568899999999999999999999864 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=304.42 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=193.4
Q ss_pred eeeeec--CcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEG--GFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G--~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
..||+| +||+||++... +|+.||||+++.. .....+.+.+|+.+++.++|+||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999864 7899999998742 233456788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999986432 235889999999999999999999988 9999999999999999999999998654322211100
Q ss_pred -----cccccccccccccchhhhcC--CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh---------hc
Q 003605 570 -----ISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP---------LL 633 (808)
Q Consensus 570 -----~~~~~~Gt~~Y~APE~l~~~--~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~---------~~ 633 (808)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCcccccc
Confidence 00112345679999998764 4789999999999999999999999653211 111110000 00
Q ss_pred cc----------------------ccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 634 TS----------------------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 ~~----------------------~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.. ......+.+..+...........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 000001111112222233456789999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=295.82 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=196.2
Q ss_pred CcceeeeeeecCcEEEEEEEe----eCCCEEEEEEeeccc----chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccce
Q 003605 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l----~dg~~VAVK~lk~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 480 (808)
+|++.+.||+|+||.||++.. .+|+.||+|+++... ....+++.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999997532 22346788999999999 599999999999988889
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
++||||+++++|.+++.. ...+.+..+..++.|+++||+|||+.+ ++||||+|+|||+++++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999853 245889999999999999999999988 9999999999999999999999999997
Q ss_pred ccccccccccccccccccccccchhhhcC--CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~ 638 (808)
........ ......|+..|+|||++... .++.++||||||+++|||++|+.||...... .....+.......
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~--- 227 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS--- 227 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc---
Confidence 65332211 11234588899999998753 4678999999999999999999998643221 1111121111110
Q ss_pred cccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003605 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQ 682 (808)
Q Consensus 639 l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~ 682 (808)
...++......+.+++.+|++.+|++|| +..++++
T Consensus 228 ---------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ---------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0112233446788999999999999997 5666644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=300.07 Aligned_cols=262 Identities=21% Similarity=0.249 Sum_probs=193.3
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCC
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~Gs 491 (808)
.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666655 6899999998753 44556789999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc----
Q 003605 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES---- 567 (808)
Q Consensus 492 L~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~---- 567 (808)
|.++++... ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999997432 235888999999999999999999998 99999999999999999999999999865432211
Q ss_pred -cccccccccccccccchhhhc--CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh----hccc-----
Q 003605 568 -RHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP----LLTS----- 635 (808)
Q Consensus 568 -~~~~~~~~Gt~~Y~APE~l~~--~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~----~~~~----- 635 (808)
........++..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+...... .+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 111123456788999999876 35788999999999999999999999753221 111111000 0000
Q ss_pred -cccccc----ccCCCC----CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 636 -REGLER----IIDPSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 -~~~l~~----ivD~~l----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...... ..++.. ...........+.+++.+||+.||++||++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 001110 011122344678899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=300.17 Aligned_cols=244 Identities=29% Similarity=0.415 Sum_probs=192.3
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
|...+.||+|+||+||+|+.. +++.|++|++... .....+++.+|++++++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 6889999998642 223345788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
+. |+|.+++.. ....++|.+++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 678777742 2346899999999999999999999988 99999999999999999999999999864321
Q ss_pred ccccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
.....|+..|+|||++. ...++.++|||||||++|||++|..|+...... ....+. .. ...
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~---~~--~~~---- 237 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI---AQ--NDS---- 237 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHH---Hh--cCC----
Confidence 12346788999999974 456888999999999999999999998643211 111110 00 000
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+.. ........+.+++.+||+.+|++||++.++++.
T Consensus 238 -~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 111223468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.89 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=192.0
Q ss_pred HHHHHHhCCcceeeee--eecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeeec
Q 003605 402 SEIEKATGNFDASRIL--GEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 477 (808)
Q Consensus 402 ~el~~at~~f~~~~~L--G~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 477 (808)
.++....++|++.+.+ |+|+||.||++... ++..+|+|.++..... + .|+.....+ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677777766 99999999999864 6888999998643211 1 122222222 699999999999999
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-cceeccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDF 556 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-~vKL~DF 556 (808)
+..++||||+++++|.++++. ...++|.+++.++.|+++||+|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999963 237999999999999999999999988 99999999999999988 9999999
Q ss_pred ccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
|+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+...|.... .
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~-- 224 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-Q-- 224 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-c--
Confidence 998754321 1235788999999999889999999999999999999999999743221 11222222211 0
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-MGEVVQ 682 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-m~eVl~ 682 (808)
.. ..........+.+++.+||+.+|++||+ ++|+++
T Consensus 225 --------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 --------KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0111134467899999999999999995 688864
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.47 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=201.5
Q ss_pred cceeeeeeecCcEEEEEEEeeC-CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCC
Q 003605 411 FDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~d-g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
|++...||.|+||+||||+.++ +-..|-|.+........++|+-||+||..+.||+||+|++.|+.++.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4455679999999999999774 344577888777788889999999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|-++..+-. -+..|.+.++.-++.+++.||.|||+++ |||||||+.|||++-+|.++|+|||.+.... ....
T Consensus 114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q 185 (1187)
T KOG0579|consen 114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ 185 (1187)
T ss_pred chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence 999888753 3457999999999999999999999998 9999999999999999999999999975432 2223
Q ss_pred cccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccC
Q 003605 570 ISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
......||+.|||||+++ ...|+.++||||||+.|.||..+..|-....+ ......+... --
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKS-------eP 252 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKS-------EP 252 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhc-------CC
Confidence 334578999999999876 46789999999999999999999998753322 1111111100 01
Q ss_pred CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 645 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
|.|. -+......+.+++.+||.+||+.||+++++++
T Consensus 253 PTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 PTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred Cccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111 13355678999999999999999999999985
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=305.10 Aligned_cols=271 Identities=24% Similarity=0.332 Sum_probs=201.8
Q ss_pred cCCHHHHHHHhCCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeee
Q 003605 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 474 (808)
.....++..++++|.+.+.||+|+||.||+|.. .+++.||+|+++.. .....+.+.+|++++.+++|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 345667778899999999999999999999985 47899999999753 223356788999999999999999999988
Q ss_pred eec------cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC
Q 003605 475 IEE------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 548 (808)
Q Consensus 475 ~~~------~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~ 548 (808)
... ...+++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 643 3467888887 7899887742 25899999999999999999999998 9999999999999999
Q ss_pred Ccceecccccccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhH
Q 003605 549 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLV 626 (808)
Q Consensus 549 ~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv 626 (808)
+.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+.
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998754221 123457889999998876 5678899999999999999999999864322110 0000
Q ss_pred Hhhh-------hhcccc--cc----cccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 627 AWAR-------PLLTSR--EG----LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 627 ~w~~-------~~~~~~--~~----l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.. ..+... .. +..+....+. +........+.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000 00 0000000000 0001234568899999999999999999999765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=292.51 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=197.2
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
|+..+.||+|+||.||+|+.. +++.+|+|.++... ....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999976 58999999997542 333467889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~ 567 (808)
. ++|.+++... ...+++..+++++.++++||+|||+.+ |+||||+++||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5999999632 146899999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHHhh-------hhhccc---
Q 003605 568 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWA-------RPLLTS--- 635 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~w~-------~~~~~~--- 635 (808)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ..+.... +.....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 11233457789999998776 789999999999999999999999864321100 0000000 000000
Q ss_pred -ccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 636 -REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 636 -~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
................ ......+.+++.+||+.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000000 112457999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.44 Aligned_cols=266 Identities=25% Similarity=0.334 Sum_probs=200.6
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeEEeeeeecc-----ceE
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARC 481 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 481 (808)
+|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999975 58999999987543 444578999999999999999999999998765 789
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+||||+. ++|.++++. ...+++..++.++.++++||+|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 588888853 237999999999999999999999998 99999999999999999999999999986
Q ss_pred ccccccc-ccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhc-----
Q 003605 562 AMDEESR-HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLL----- 633 (808)
Q Consensus 562 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~-~lv~w~~~~~----- 633 (808)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .+..+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 5432210 112334578899999999887 7899999999999999999999999654321100 0000000000
Q ss_pred -ccccccccccC---CCCC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 634 -TSREGLERIID---PSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 -~~~~~l~~ivD---~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.........+. .... ..........+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 0000 00111234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=302.18 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=194.0
Q ss_pred CCcc-eeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchh--------------hHHHHHHHHHHhhcccccceeEEe
Q 003605 409 GNFD-ASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQG--------------GREFLAEVEMLSRLHHRNLVKLIG 472 (808)
Q Consensus 409 ~~f~-~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~--------------~~~f~~Ei~iL~~L~HpNIV~L~g 472 (808)
++|. +.+.||+|+||+||+|... +++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3477999999999999965 78999999986432211 125789999999999999999999
Q ss_pred eeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcce
Q 003605 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 552 (808)
Q Consensus 473 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vK 552 (808)
++..++..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||+++||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999996 689888842 345889999999999999999999988 99999999999999999999
Q ss_pred eccccccccccccc------------ccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCC
Q 003605 553 VSDFGLARSAMDEE------------SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQP 619 (808)
Q Consensus 553 L~DFGLa~~~~~~~------------~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~ 619 (808)
|+|||+++...... .........++..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987543110 00111123467889999998764 468999999999999999999999965432
Q ss_pred CCcchhHHhhhhhccc--cccccc------------ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 620 PGQENLVAWARPLLTS--REGLER------------IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 620 ~~~~~lv~w~~~~~~~--~~~l~~------------ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. ............ ...... .....+. .........+.+++.+|++.+|++||++.|++..
T Consensus 240 ~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 I---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 111111000000 000000 0000000 0011234678899999999999999999999763
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.66 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=192.5
Q ss_pred CcceeeeeeecCcEEEEEEEee-C--CCEEEEEEeecc--cchhhHHHHHHHHHHhhc-ccccceeEEeeeeec----cc
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-D--GTKVAVKVLKRV--DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE----QA 479 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-d--g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~----~~ 479 (808)
+|++.+.||+|+||.||+++.. + +..||||++... .....+.+.+|++++.++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5788899999999999999965 3 778999998742 223356788999999999 599999999976432 45
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++++||+. ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889885 689888852 346899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc--ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhH--------H
Q 003605 560 RSAMDEESR--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLV--------A 627 (808)
Q Consensus 560 ~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv--------~ 627 (808)
+........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 765432211 11123468899999998766 4678999999999999999999999865332100 0000 0
Q ss_pred hhhhhccccc-ccccccCCCCC---CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 628 WARPLLTSRE-GLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 628 w~~~~~~~~~-~l~~ivD~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+...+..... ......+..-. ..........+.+++.+|++.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00000000000 00011224678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=343.55 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=202.1
Q ss_pred HhCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
.+-++....+||.|.||.||-|+ +++|+..|||-++. ........+.+|+.+|..|+|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34456677899999999999998 56899999998863 3344567788999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
||||++|+|.+.+. .+...++.....+..|++.|++|||+++ ||||||||.|||||.+|-+|++|||.|....
T Consensus 1313 MEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999995 3334556666677889999999999999 9999999999999999999999999998765
Q ss_pred cccc--cccccccccccccccchhhhcCC---CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccc
Q 003605 564 DEES--RHISTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638 (808)
Q Consensus 564 ~~~~--~~~~~~~~Gt~~Y~APE~l~~~~---~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~ 638 (808)
.... .......+||+-|||||++.+.. ...+.||||+|||++||+||++||...+. .|+.-..
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~----- 1453 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYH----- 1453 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhH-----
Confidence 4321 11123568999999999987533 45689999999999999999999964432 2321111
Q ss_pred cccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 639 l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+-..-...+|.....+-.+++.+||+.||++|+++.|+++.
T Consensus 1454 ----V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 ----VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11111233455566778899999999999999988877553
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=291.50 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=201.6
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--------chhhHHHHHHHHHHhhc-ccccceeEEeeeee
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--------QQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 476 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--------~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 476 (808)
..++|...++||.|..++|-+...+ +|..+|+|++.... ..-.++-.+|++||+++ -||||+.+.++|..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 4466778889999999999888765 78899999985321 11234566799999998 59999999999999
Q ss_pred ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
....++|+|.|+.|-|.|+|. ....+++....+|+.|+.+|++|||..+ ||||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 999999999999999999995 4567999999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhc------CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~ 630 (808)
|++..+.... .-...+||++|+|||.+.. ..|+...|+|+.|||||-|+.|..||-.... + -..+
T Consensus 168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m-lMLR 238 (411)
T KOG0599|consen 168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M-LMLR 238 (411)
T ss_pred ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H-HHHH
Confidence 9998765432 3356889999999998864 2467889999999999999999999942110 0 0011
Q ss_pred hhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 631 ~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.++ ++-.++-.+.+ .+......+|+.+||+.||.+|.|.+|+++.
T Consensus 239 ~Im---eGkyqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIM---EGKYQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHH---hcccccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111 11111111111 2445678999999999999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.45 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=197.2
Q ss_pred HHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeecc--
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-- 478 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-- 478 (808)
+....++|.+.+.||+|+||.||++... +++.||||+++.. .....+.+.+|++++++++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3446788999999999999999999854 7899999998642 2333457889999999999999999999987543
Q ss_pred ----ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceec
Q 003605 479 ----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 554 (808)
Q Consensus 479 ----~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~ 554 (808)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 7789888742 35899999999999999999999988 9999999999999999999999
Q ss_pred ccccccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhH------
Q 003605 555 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLV------ 626 (808)
Q Consensus 555 DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv------ 626 (808)
|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+.
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998754321 123457889999999876 4578999999999999999999999964321100 0000
Q ss_pred --HhhhhhcccccccccccC--CCCC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 627 --AWARPLLTSREGLERIID--PSLG----NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 627 --~w~~~~~~~~~~l~~ivD--~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.|...+... ....... +... ..........+.+++.+|++.||++||++.++++.
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQSE--DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcch--hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000000 0000 00112234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=314.57 Aligned_cols=272 Identities=25% Similarity=0.358 Sum_probs=207.8
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeecc------ceEE
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ARCL 482 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------~~~L 482 (808)
+...+.||+|+||.||+|+.+ .|+.||||.++.. .....+...+|+++|++|+|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 334578999999999999954 8999999999863 3445678899999999999999999999865543 5589
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeec--CCC--cceeccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDF--TPKVSDFGL 558 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd--~~~--~vKL~DFGL 558 (808)
|||||.+|||+..|..-.+ ...|.+.+.+.+..+++.||.|||+++ |+||||||.||++- +++ --||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999976443 457999999999999999999999998 99999999999993 333 469999999
Q ss_pred ccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
||...++. ..+.++||..|++||.... +.|+...|.|||||++||.+||..||..........-+.|..... ...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk-kp~ 246 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK-KPS 246 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc-CCC
Confidence 99775433 4567889999999999984 889999999999999999999999998765443222233321111 111
Q ss_pred ccccccCCCCC------------CCCChhhHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHHHh
Q 003605 638 GLERIIDPSLG------------NDVPFDSVAKVAAIASMCVQPEVQHRP--FMGEVVQALKLVCNE 690 (808)
Q Consensus 638 ~l~~ivD~~l~------------~~~~~~~~~~l~~Li~~Cl~~dP~~RP--sm~eVl~~Le~i~~~ 690 (808)
......++... ..........+......++..++++|. ...+....+..|++.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11111111111 111234456777888888899999999 777777777666654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.16 Aligned_cols=267 Identities=23% Similarity=0.314 Sum_probs=194.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeec---------
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--------- 477 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--------- 477 (808)
..+|...+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999865 6889999999765556667899999999999999999999876543
Q ss_pred -----cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-CCcc
Q 003605 478 -----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTP 551 (808)
Q Consensus 478 -----~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-~~~v 551 (808)
...++|+||+. ++|.+++.. ..+.+...+.++.|++.||+|||+.+ |+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35689999996 588887742 35889999999999999999999998 999999999999974 5678
Q ss_pred eeccccccccccccccc-ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 003605 552 KVSDFGLARSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 629 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~ 629 (808)
||+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998754321111 11123357889999998754 56788999999999999999999999654321111000000
Q ss_pred hhhccc--cccc----cc-ccCCCCCCC-----CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 630 RPLLTS--REGL----ER-IIDPSLGND-----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 630 ~~~~~~--~~~l----~~-ivD~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.... .... .. +.+...... .......++.+++.+|++.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 0000 00 000000000 011233568899999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=331.24 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=190.7
Q ss_pred HHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeEEeeeeec-----
Q 003605 405 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE----- 477 (808)
Q Consensus 405 ~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~----- 477 (808)
-+...+|++.++||+||||.|||++.+ ||+.||||++.-. .......+.+|++.|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 346678999999999999999999987 8999999998642 445556789999999999999999997544310
Q ss_pred --------------------------------------------------------------------------------
Q 003605 478 -------------------------------------------------------------------------------- 477 (808)
Q Consensus 478 -------------------------------------------------------------------------------- 477 (808)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHH
Q 003605 478 ----------------------------------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523 (808)
Q Consensus 478 ----------------------------------~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~ 523 (808)
..+|+-||||+..+|.++++...-. -.-...|+++.+|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence 1146778888887777777532111 135678999999999999
Q ss_pred HHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc------cc----------cccccccccccccccccchhhh
Q 003605 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM------DE----------ESRHISTRVMGTFGYVAPEYAM 587 (808)
Q Consensus 524 yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~------~~----------~~~~~~~~~~Gt~~Y~APE~l~ 587 (808)
|+|+.+ ||||||||.|||||++..|||+|||+|.... +. ......+..+||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999998 9999999999999999999999999997621 00 0111224567999999999987
Q ss_pred cC---CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC--CCCChhhHHHHHHH
Q 003605 588 TG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG--NDVPFDSVAKVAAI 662 (808)
Q Consensus 588 ~~---~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~--~~~~~~~~~~l~~L 662 (808)
+. .|+.|+|+||+||||+||+. ||... +.-+ ..+..+-+..+. .++..+.+..=..+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa----------~iL~~LR~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERA----------SILTNLRKGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCch-----HHHH----------HHHHhcccCCCCCCcccccccchHHHHH
Confidence 65 49999999999999999986 34321 1111 111111122221 22344556667889
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 003605 663 ASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 663 i~~Cl~~dP~~RPsm~eVl~ 682 (808)
+.+++++||.+|||+.|+++
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999975
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=299.06 Aligned_cols=265 Identities=25% Similarity=0.337 Sum_probs=198.3
Q ss_pred HHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeee-ccc
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQA 479 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~ 479 (808)
+..++++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|++++.+++|+||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4457899999999999999999999855 7899999988642 23345678899999999999999999999865 457
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++|+||+ +++|.++++. ..+.+.....++.|+++||+|||+.+ |+||||+|+|||+++++.+||+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999999 5688888752 34788888999999999999999988 999999999999999999999999998
Q ss_pred cccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCc-chhHH--------hh
Q 003605 560 RSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVA--------WA 629 (808)
Q Consensus 560 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~-~~lv~--------w~ 629 (808)
+..... .....++..|+|||++.+ ..++.++|||||||++|||+||+.||........ ..+.+ |.
T Consensus 156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 753221 122356788999998766 5689999999999999999999999864321100 00111 11
Q ss_pred hhhcccccccccccCCCCCCCCC-----hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 630 RPLLTSREGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 630 ~~~~~~~~~l~~ivD~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..... ......+.+-......+ ......+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred Hhccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11000 00000000000001111 1234678999999999999999999998665
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.09 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=197.7
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccc---
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--- 479 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~--- 479 (808)
...++|...+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35688999999999999999999975 6789999998642 23344678889999999999999999998876554
Q ss_pred ---eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 480 ---RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 480 ---~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 79999999 6799988852 35899999999999999999999988 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcc-
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT- 634 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~- 634 (808)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+........
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~ 234 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGT 234 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCC
Confidence 998764322 123457889999998865 36789999999999999999999999643221 11110000000
Q ss_pred c---------ccccccccCCCC---CCCC---ChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 635 S---------REGLERIIDPSL---GNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 635 ~---------~~~l~~ivD~~l---~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. .+....++.... ...+ .......+.+++.+||+.+|++|||+.||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 000000000000 0000 01235679999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.85 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=202.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
.+.|..-++||+|+||.||-.+.. +|+.+|.|++.+ ...+++.-.++|-.||.+++.+.||.+-..|...+.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 366888999999999999998865 799999998853 2344556678999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
+..|+||+|.-||..... ..+++...+-+|.+|+.||++||+.. ||.|||||+|||||+.|+++|+|.|||..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999975432 46899999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
.... + +..+||.+|||||+++++.|+...|.|||||+||||+.|+.||...... +.| +.+++.+
T Consensus 339 ~g~~--~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-----vk~--------eEvdrr~ 402 (591)
T KOG0986|consen 339 EGKP--I-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-----VKR--------EEVDRRT 402 (591)
T ss_pred CCCc--c-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-----hhH--------HHHHHHH
Confidence 4322 2 2337999999999999999999999999999999999999999643321 111 1111110
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 677 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 677 (808)
-. -...+++....+...|....|.+||++|-.-
T Consensus 403 ~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 403 LE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hc-chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 00 0123455666788889999999999999644
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-34 Score=293.24 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=200.2
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEee--cccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk--~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
.+++|++.++||+|.|+.||+.... +|+.+|+|++. +....+.+++.+|++|-+.|+|||||+|.+.+.+++..+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3567788889999999999998754 78999999875 33445678899999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC---CCcceeccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLAR 560 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~---~~~vKL~DFGLa~ 560 (808)
+|+|.+++|..-+-. +...++...-..+.||+++|.|+|.++ |||||+||.|+||-. .--+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999876632 234566677788999999999999998 999999999999943 3468999999998
Q ss_pred ccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccc
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
...+. ......+||++|||||++....|+..+|||+.|||||-|+.|+.||...+ +..+... +....-
T Consensus 162 ~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~---I~~g~y--- 229 (355)
T KOG0033|consen 162 EVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQ---IKAGAY--- 229 (355)
T ss_pred EeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHH---Hhcccc---
Confidence 77522 23344679999999999999999999999999999999999999996422 1222111 111100
Q ss_pred cccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 641 ~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
-+++... .....+..+|+++||..||.+|.|+.|.++.
T Consensus 230 -d~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 -DYPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -CCCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 0111111 1234567889999999999999999998754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=283.32 Aligned_cols=236 Identities=31% Similarity=0.364 Sum_probs=192.3
Q ss_pred eeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 417 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 417 LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
||+|+||.||++... +++.+|+|.++... ....+.+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 58999999987532 22456889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~ 572 (808)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999853 235899999999999999999999987 9999999999999999999999999987653321 1223
Q ss_pred ccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 573 ~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
...++..|++||.+.+...+.++|+||||+++|||++|+.||..... ....... . .. ....+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~----------~~--~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---L----------KD--PLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---h----------cC--CCCCC
Confidence 45678899999999888889999999999999999999999964321 1111111 1 00 01122
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGE 679 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~e 679 (808)
......+.+++.+|+..||++||++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 223467899999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=300.47 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=208.6
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.+-|++++.||+|.|..|-.|++- +|+.||||++.+ .+......+++|++.|+.++|||||+||.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 455777789999999999888743 799999999975 34455567889999999999999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee-cCCCcceecccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL-d~~~~vKL~DFGLa~~~~ 563 (808)
|+=.+|+|.|||-. ....+.++-..+++.||..|+.|+|+.+ +|||||||+||.+ ..-|-+||.|||++-.+.
T Consensus 97 ELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999963 4456999999999999999999999998 9999999999977 455889999999997765
Q ss_pred cccccccccccccccccccchhhhcCCCc-cccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
... .-+..+|...|.|||++.+..|+ .+.||||||||||-|++|+.||+..... +.+-.|
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmI 231 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMI 231 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhh
Confidence 433 23456899999999999999886 5789999999999999999999765432 333344
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
+|=. -..+.-...++.+||..||..||++|.+.+||+.
T Consensus 232 mDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4432 2345566788999999999999999999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=306.55 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=206.3
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.....|.+...||+|.|+.|..|+.. ++..||||.+.+. +....+.+.+|+++|..|+|||||+++.+...+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34578999999999999999999965 7999999999763 33334568899999999999999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
||||+.+|.+.+||... ..+...+...++.|+.+|++|||+++ |+|||||++|||||.+.++||+|||++..+
T Consensus 133 V~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999643 24555788889999999999999998 999999999999999999999999999866
Q ss_pred ccccccccccccccccccccchhhhcCCC-ccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
. ........+|++.|.|||++++..| ....|+||+|++||-|+.|..||+.... .+
T Consensus 206 ~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k~ 262 (596)
T KOG0586|consen 206 D---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------KE 262 (596)
T ss_pred c---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------cc
Confidence 3 3444556789999999999998876 6799999999999999999999974321 11
Q ss_pred ccCCCCCCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 642 IIDPSLGND--VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ivD~~l~~~--~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+-++.+.+. ++.-...++.+++++++..+|.+|+++.++-+.
T Consensus 263 Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 112222221 233345578899999999999999999998653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=284.18 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=199.2
Q ss_pred cCCHHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcc-cccceeEEeee
Q 003605 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH-HRNLVKLIGIC 474 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~ 474 (808)
.-+..||+.. ..||.|..|.|+++++. .|..+|||.+.+. +.+..++++..+.++..-+ +|.||+.+|||
T Consensus 88 ~~dindl~~l-------~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 88 QADINDLENL-------GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccChHHhhhH-------HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 3455565544 46999999999999976 6899999999763 4556678888888887775 89999999999
Q ss_pred eeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceec
Q 003605 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 554 (808)
Q Consensus 475 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~ 554 (808)
......++.||.|. -.++.+|+ .-..++.+..+-++...+.+||.||.+++ .|||||+||+|||+|+.|++|+|
T Consensus 161 i~n~dV~IcMelMs-~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 161 ITNTDVFICMELMS-TCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eeCchHHHHHHHHH-HHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence 99999999999994 35555554 22346888888899999999999999876 69999999999999999999999
Q ss_pred ccccccccccccccccccccccccccccchhhhc---CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 003605 555 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 555 DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~ 631 (808)
|||++-.+.+. ...++..|-+.|||||.+.- ..|+-++||||||+.|+||.||+.||..-...
T Consensus 235 DFGIsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----------- 300 (391)
T KOG0983|consen 235 DFGISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----------- 300 (391)
T ss_pred cccccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----------
Confidence 99999766442 22356679999999998863 46888999999999999999999999753221
Q ss_pred hcccccccccccC---CCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 632 LLTSREGLERIID---PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 632 ~~~~~~~l~~ivD---~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
-+.+..+++ |.|.. .......+.+++..||.+|+.+||.+.++++.
T Consensus 301 ----Fe~ltkvln~ePP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 301 ----FEVLTKVLNEEPPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ----HHHHHHHHhcCCCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111112222 22211 12256789999999999999999999999865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=320.18 Aligned_cols=146 Identities=31% Similarity=0.410 Sum_probs=131.2
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
.++|.+.+.||+|+||+||+|... +++.||||+++... ......+.+|++++..++|+||+++++++...+..+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999976 78999999997532 33346788999999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
|||+.+++|.++++. ...+++..+++|+.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999863 235888999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=290.24 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=200.7
Q ss_pred cCCHHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeEEeee
Q 003605 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGIC 474 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 474 (808)
.|+.++|+.. ..||.|+||+|+|-.++ .|+.+|||+++... ....++++.|.+...+- +++|||+++|.+
T Consensus 60 ~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 4665666544 46999999999999876 79999999998543 45667899999987665 699999999999
Q ss_pred eeccceEEEEeecCCCCccccccc-cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCccee
Q 003605 475 IEEQARCLVYELIPNGSVESHLHG-VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 553 (808)
Q Consensus 475 ~~~~~~~LV~Ey~~~GsL~~~L~~-~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL 553 (808)
..++..++.||.|. -||+.+... +......+++...-.|+.-..+||.||.+.. +||||||||+|||||..|.+||
T Consensus 133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEee
Confidence 99999999999994 577665431 1223456888888899999999999999765 6999999999999999999999
Q ss_pred cccccccccccccccccccccccccccccchhhhc--CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 003605 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 554 ~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~ 631 (808)
||||++-.+.+. ...+.-.|-.-|||||.+.. ..|+-+|||||||+.|+|+.||+.|+..+. ++.+....
T Consensus 210 CDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~ 281 (361)
T KOG1006|consen 210 CDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQ 281 (361)
T ss_pred ecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHH
Confidence 999999765432 22345568889999998863 348889999999999999999999997432 12222211
Q ss_pred hcccccccccccCC-CCCCC-CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 632 LLTSREGLERIIDP-SLGND-VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 632 ~~~~~~~l~~ivD~-~l~~~-~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
... -|+ .+..+ -..+....+..++..|+.+|-..||.+.++.++
T Consensus 282 Vv~--------gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 VVI--------GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHc--------CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 111 11111 123466789999999999999999999998765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=285.55 Aligned_cols=240 Identities=26% Similarity=0.351 Sum_probs=195.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
.++|+..++||+|.||+|..++-+ .|+.+|||++++. .......-+.|-++|+..+||.+..|...+...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888999999999999999855 7899999999863 334445567899999999999999999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||..+|.|.-+|. +...++++...-.-..|..||.|||+++ ||.||||.+|.|||.+|++||+||||++.-.
T Consensus 247 MeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999995 2345777777778889999999999988 9999999999999999999999999998543
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
. ........+||+.|+|||++....|..+.|.|.+|||+|||++|+.||...+. + .+.+++
T Consensus 320 ~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~--------------kLFeLI 380 (516)
T KOG0690|consen 320 K--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---E--------------KLFELI 380 (516)
T ss_pred c--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---h--------------HHHHHH
Confidence 2 22334567899999999999999999999999999999999999999964221 1 111111
Q ss_pred C-CCCCCCCChhhHHHHHHHHHHccccCCCCCC
Q 003605 644 D-PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675 (808)
Q Consensus 644 D-~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 675 (808)
- .. -.++.....+...|+...|.+||.+|.
T Consensus 381 l~ed--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 381 LMED--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred Hhhh--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1 11 113334445677788889999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=270.43 Aligned_cols=237 Identities=30% Similarity=0.398 Sum_probs=192.4
Q ss_pred CcEEEEEEEee-CCCEEEEEEeecccchh-hHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCccccccc
Q 003605 421 GFGLVYSGVLD-DGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG 498 (808)
Q Consensus 421 ~fG~VYkg~l~-dg~~VAVK~lk~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~ 498 (808)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58999999997654433 68999999999999999999999999998999999999999999999863
Q ss_pred cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccccccccc
Q 003605 499 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578 (808)
Q Consensus 499 ~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~ 578 (808)
. ..+++..++.++.+++++|+|||+.+ ++|+||+++||++++++.++|+|||++....... ......++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 23889999999999999999999987 9999999999999999999999999998654322 223455788
Q ss_pred ccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCCh-hhHH
Q 003605 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF-DSVA 657 (808)
Q Consensus 579 ~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~-~~~~ 657 (808)
.|++||.+....++.++|||+||++++||++|..||+... ....+..+... ......... ....
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~-------------~~~~~~~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGK-------------PKPPFPPPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhc-------------cCCCCccccccCCH
Confidence 9999999988889999999999999999999999986421 11222222110 000000000 0346
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 003605 658 KVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 658 ~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 7999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=276.81 Aligned_cols=222 Identities=20% Similarity=0.190 Sum_probs=176.5
Q ss_pred cCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCccccccc
Q 003605 420 GGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG 498 (808)
Q Consensus 420 G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~ 498 (808)
|.||.||++... +++.||+|+++... .+.+|...+....|+||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999865 78999999997542 233455555566799999999999999999999999999999999853
Q ss_pred cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccccccccc
Q 003605 499 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578 (808)
Q Consensus 499 ~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~ 578 (808)
...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 235899999999999999999999988 999999999999999999999999987654321 12234567
Q ss_pred ccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHH
Q 003605 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 658 (808)
Q Consensus 579 ~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~ 658 (808)
.|+|||++....++.++||||+||++|||++|+.+++..... .. ... ....+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~------~~~----~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------IN------THT----TLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cc------ccc----ccCCcccCCHH
Confidence 899999998888899999999999999999999876432110 00 000 00122223467
Q ss_pred HHHHHHHccccCCCCCCCHHHH
Q 003605 659 VAAIASMCVQPEVQHRPFMGEV 680 (808)
Q Consensus 659 l~~Li~~Cl~~dP~~RPsm~eV 680 (808)
+.+++.+|++.||++|+++.+.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCcc
Confidence 8899999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=305.46 Aligned_cols=261 Identities=27% Similarity=0.405 Sum_probs=212.9
Q ss_pred CCHHHHHHHhCCcceeeeeeecCcEEEEEEEe-eCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeee
Q 003605 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 476 (808)
Q Consensus 399 fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l-~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 476 (808)
..++.+..-++-|++.++||+|.+|.||+++. ++++.+|||++.- +....++...|.+||+.+ +|+|++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44555566778899999999999999999994 5889999998864 344557888999999988 69999999999864
Q ss_pred -----ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcc
Q 003605 477 -----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 477 -----~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~v 551 (808)
+++++||||||.+||..|++++.. +..+.|..+..|+..+++||++||.+. ++|||||-.||||+.++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 478899999999999999998765 567999999999999999999999987 9999999999999999999
Q ss_pred eecccccccccccccccccccccccccccccchhhhc-----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 626 (808)
Q Consensus 552 KL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv 626 (808)
||+|||.+..+.. .........||+.|||||++.. ..|+.++|+||||++..||.-|..|+-...+.
T Consensus 163 KLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------ 234 (953)
T KOG0587|consen 163 KLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------ 234 (953)
T ss_pred EEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------
Confidence 9999999876533 2333344679999999999864 35678999999999999999999998543221
Q ss_pred Hhhhhhcccccccccc-cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 627 AWARPLLTSREGLERI-IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 627 ~w~~~~~~~~~~l~~i-vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+. +..+ -+|...-.-+.....++.++|..||.+|-++||++.+++++
T Consensus 235 ---ra-------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 ---RA-------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---hh-------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 1111 11222222356778899999999999999999999998753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=298.85 Aligned_cols=262 Identities=18% Similarity=0.260 Sum_probs=183.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEe-----------------eCCCEEEEEEeecccchhhHHH--------------HHH
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVL-----------------DDGTKVAVKVLKRVDQQGGREF--------------LAE 455 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l-----------------~dg~~VAVK~lk~~~~~~~~~f--------------~~E 455 (808)
..++|++.++||+|+||+||+|.+ .+++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2456899999975433333333 447
Q ss_pred HHHHhhcccccc-----eeEEeeeee--------ccceEEEEeecCCCCcccccccccc--------------------C
Q 003605 456 VEMLSRLHHRNL-----VKLIGICIE--------EQARCLVYELIPNGSVESHLHGVDK--------------------E 502 (808)
Q Consensus 456 i~iL~~L~HpNI-----V~L~g~~~~--------~~~~~LV~Ey~~~GsL~~~L~~~~~--------------------~ 502 (808)
+.++.+++|.|+ ++++++|.. ++..+|||||+++|+|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 678888753 3567999999999999999974211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccccccccccccccccc
Q 003605 503 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582 (808)
Q Consensus 503 ~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~A 582 (808)
...++|..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 124678899999999999999999988 99999999999999999999999999975432211 11112335789999
Q ss_pred chhhhcCCC----------------------ccccceeeHHHHHHHHHhCCC-CCCCCCCCC------cchhHHhhhhhc
Q 003605 583 PEYAMTGHL----------------------LVKSDVYSYGVVILELLSGRK-PVDMTQPPG------QENLVAWARPLL 633 (808)
Q Consensus 583 PE~l~~~~~----------------------s~kSDVwSfGvvLlELlTG~~-P~~~~~~~~------~~~lv~w~~~~~ 633 (808)
||.+..... ..+.||||+||||+||++|.. |+....... ..++..|.. .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence 998754321 234799999999999999875 664221100 111122211 0
Q ss_pred ccccccccccCCCCCCCCChhhHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 003605 634 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEV---QHRPFMGEVVQA 683 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP---~~RPsm~eVl~~ 683 (808)
.. ....-...........+++.+++..++ .+|+|++|++++
T Consensus 457 ~~---------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KG---------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cc---------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 000000112234567889999998765 689999999764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.67 Aligned_cols=204 Identities=25% Similarity=0.338 Sum_probs=168.4
Q ss_pred CCcceeeeeeecCcEEEEEEEee---C--CCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeEEeeeee-ccce
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD---D--GTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQAR 480 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~---d--g~~VAVK~lk~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~ 480 (808)
..|+....||+|.||.||||+-. + ...+|||+++.... .......+||.+++.|+|+||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999643 2 23689999975322 123467899999999999999999999887 7788
Q ss_pred EEEEeecCCCCccccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC----Ccceecc
Q 003605 481 CLVYELIPNGSVESHLHGVD-KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD----FTPKVSD 555 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~-~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~----~~vKL~D 555 (808)
+|++||.+. +|...++-.+ .....++-.....|++||+.|+.|||++. |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999975 8888886433 23356888899999999999999999998 9999999999999766 9999999
Q ss_pred ccccccccccccc-ccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCC
Q 003605 556 FGLARSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDM 616 (808)
Q Consensus 556 FGLa~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~ 616 (808)
||++|.+.+.-.. .....++-|++|+|||.+.+ ..||.+.|||+.|||+.||+|-..-|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999987543322 23356788999999999987 4689999999999999999998877754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=302.44 Aligned_cols=262 Identities=20% Similarity=0.217 Sum_probs=171.2
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-C----CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEee------ee
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-D----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI------CI 475 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-d----g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~------~~ 475 (808)
..++|++.+.||+|+||.||+|++. + +..||||+++..... +.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999975 4 689999998643221 111111 1222222333322222 24
Q ss_pred eccceEEEEeecCCCCccccccccccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeec
Q 003605 476 EEQARCLVYELIPNGSVESHLHGVDKE----------------SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 539 (808)
Q Consensus 476 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~----------------~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIK 539 (808)
.++..++||||+.+++|.++++..... .....+..+..|+.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 557889999999999999988642110 011123445679999999999999988 9999999
Q ss_pred ccCeeecC-CCcceecccccccccccccccccccccccccccccchhhhcC----------------------CCccccc
Q 003605 540 SSNILLEH-DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG----------------------HLLVKSD 596 (808)
Q Consensus 540 psNILLd~-~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~kSD 596 (808)
|+||||++ ++.+||+|||+|+..... .........+++.|+|||.+... .+..++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999754322 22233456789999999965322 2345679
Q ss_pred eeeHHHHHHHHHhCCCCCCCCCC-------CCcchhHHhhhhhcccccccccccCCCCCCC--CChhhHHHHHHHHHHcc
Q 003605 597 VYSYGVVILELLSGRKPVDMTQP-------PGQENLVAWARPLLTSREGLERIIDPSLGND--VPFDSVAKVAAIASMCV 667 (808)
Q Consensus 597 VwSfGvvLlELlTG~~P~~~~~~-------~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~--~~~~~~~~l~~Li~~Cl 667 (808)
||||||+||||+++..+.+.... ....++..|....... ..+.+... ..........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999998766542100 0011122222111100 00000000 00111234568999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 003605 668 QPEVQHRPFMGEVVQA 683 (808)
Q Consensus 668 ~~dP~~RPsm~eVl~~ 683 (808)
+.||++|||+.|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=272.93 Aligned_cols=267 Identities=23% Similarity=0.363 Sum_probs=203.6
Q ss_pred CHHHHHHHhCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeEEeeeeec
Q 003605 400 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE 477 (808)
Q Consensus 400 s~~el~~at~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~ 477 (808)
.++|+-+.|+ ++||+|+|+.|--++ +.+|.++|||++.+.......+..+|++++.+.+ |+||++|+++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3566666663 789999999999887 6689999999998877777889999999999996 99999999999999
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC---cceec
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVS 554 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~---~vKL~ 554 (808)
...|||||-|.+|.|..+|++ +..+++.++.++..+||.||.|||.++ |.||||||+|||..... -+|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999963 346899999999999999999999998 99999999999996653 48999
Q ss_pred ccccccccccc-ccccc----ccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcch
Q 003605 555 DFGLARSAMDE-ESRHI----STRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 624 (808)
Q Consensus 555 DFGLa~~~~~~-~~~~~----~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~ 624 (808)
||.|..-.... +-... -...+|+..|||||+.. ...|+.++|.||||||||-|++|..||...-..+
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--- 298 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--- 298 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---
Confidence 99987432111 11111 12356888999999764 2467889999999999999999999997654322
Q ss_pred hHHhhhhhccc--ccccccccCCCCCCCCChh----hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 625 LVAWARPLLTS--REGLERIIDPSLGNDVPFD----SVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 625 lv~w~~~~~~~--~~~l~~ivD~~l~~~~~~~----~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..|-+..... .+.+.+-+.... -++|+. ...+..+++...+..++.+|-++.++++.
T Consensus 299 -CGWdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 299 -CGWDRGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred -CCccCCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 2233221111 111111111111 122322 24566778888888999999999998773
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=307.79 Aligned_cols=258 Identities=23% Similarity=0.311 Sum_probs=205.2
Q ss_pred HHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEeeeee
Q 003605 401 ASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 476 (808)
Q Consensus 401 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 476 (808)
..++....++|++.++||+|+||.|..++.+ +++.||+|++++ .......-|..|-.+|..-+.+-|++|...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455556689999999999999999999976 688999999986 233445678889999998899999999999999
Q ss_pred ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccc
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
+.++|||||||+||+|-.+|..+. .++++.+..++..+..||.-||+.| +|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999996432 5888888888999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhc-----CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~ 631 (808)
|.|-.+.. +....+...+||+.|++||++.. +.|+..+|.||+||++|||+.|..||.. ..++.--..
T Consensus 220 GsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~K 292 (1317)
T KOG0612|consen 220 GSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGK 292 (1317)
T ss_pred hhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHH
Confidence 99876543 33344455789999999999863 6789999999999999999999999963 233332222
Q ss_pred hcccccccccccCCCCCCCCC--hhhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003605 632 LLTSREGLERIIDPSLGNDVP--FDSVAKVAAIASMCVQPEVQHRPF---MGEVVQA 683 (808)
Q Consensus 632 ~~~~~~~l~~ivD~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~RPs---m~eVl~~ 683 (808)
++.-.+. -.+| .+.+....+||++.+. +++.|-. +.++-.+
T Consensus 293 Im~hk~~----------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 293 IMNHKES----------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred Hhchhhh----------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 2222111 1122 2345667778877654 6777776 7777654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=281.24 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=194.7
Q ss_pred CCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEee--cccch-----hhHHHHHHHHHHhhcccccceeEEeeee-eccc
Q 003605 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQ-----GGREFLAEVEMLSRLHHRNLVKLIGICI-EEQA 479 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk--~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~ 479 (808)
++|-+.++||+|||+.||||. +...+.||||+-. +.... -.+...+|.+|...|.|+.||++|+|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 457778899999999999998 4567889999743 22111 1234678999999999999999999985 4577
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC---CCcceeccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDF 556 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~---~~~vKL~DF 556 (808)
.|-|+|||++.+|+-||+. ...+++.++..|+.||+.||.||.+. +++|||-||||.||||.+ -|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 8999999999999999963 45689999999999999999999988 588999999999999954 478999999
Q ss_pred ccccccccccccc-----cccccccccccccchhhhcC----CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 003605 557 GLARSAMDEESRH-----ISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 627 (808)
Q Consensus 557 GLa~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~----~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~ 627 (808)
||++.+.++...+ .+....||.+|++||.+.-+ +.+.|.||||.|||+|..+.|+.||..... +.++..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence 9999765544332 33456799999999987643 578999999999999999999999975332 222222
Q ss_pred hhhhhcccccccccccCCCCCCCCC-hhhHHHHHHHHHHccccCCCCCCCHHHHH
Q 003605 628 WARPLLTSREGLERIIDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVV 681 (808)
Q Consensus 628 w~~~~~~~~~~l~~ivD~~l~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl 681 (808)
... |+...-....+ .....+...+|++||+..-++|....++.
T Consensus 696 eNT-----------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ENT-----------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhc-----------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 211 11111000011 12345677899999999999997666553
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=277.55 Aligned_cols=241 Identities=23% Similarity=0.320 Sum_probs=194.1
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEE
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 483 (808)
.+|+...+||+|+||+|.+|.-+ +.+.+|||+|++.- ....+--+.|-++|... +-|.+++|..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46999999999999999999865 56789999998531 22223345566777665 578899999999999999999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+.+|+|-.++++.. .+.+..+.-+|..||-||-+||+++ ||.||||.+|||||.+|.+||+|||+++.-.
T Consensus 429 MEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999997543 3556678889999999999999998 9999999999999999999999999998543
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
-.+ ..+....||+.|+|||++..+.|+...|.|||||+||||+.|+.||+..+. . +....|.
T Consensus 502 ~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~-------------elF~aI~ 563 (683)
T KOG0696|consen 502 FDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---D-------------ELFQAIM 563 (683)
T ss_pred cCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---H-------------HHHHHHH
Confidence 222 233457899999999999999999999999999999999999999986432 1 1122222
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 676 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 676 (808)
+.. -.++...+.+.+.|....+.+.|.+|..
T Consensus 564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred Hcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 222 2355566678888999999999999953
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=287.85 Aligned_cols=241 Identities=24% Similarity=0.277 Sum_probs=192.9
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.++.|.....+|.|+|+.|-++... +++..+||++.+. ..+-.+|+.++... +|+||+++.+.|.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4677888888999999999888854 7788999999754 23345678777776 6999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee-cCCCcceecccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL-d~~~~vKL~DFGLa~~~~ 563 (808)
|++.++-|.+.+... +....++..|+.+++.|+.|||+++ ||||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999998777776421 2222677789999999999999998 9999999999999 588999999999998654
Q ss_pred cccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccccccc
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
.. ....+-|..|.|||++....|++++|+||||++||+|++|+.||...... .++ +..+-
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei-------------~~~i~ 527 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI-------------HTRIQ 527 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-------------HHhhc
Confidence 32 22335678999999999999999999999999999999999999753321 111 11111
Q ss_pred CCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 644 D~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+.+....+....+|+.+||+.||.+|++|.++...
T Consensus 528 ----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 ----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 122224455678899999999999999999998654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=245.78 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=191.8
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|+..++||+|.||+||||+.. +++.||+|+++-. ++.--...++||-+|+.++|+|||++++....+..+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999965 6889999998742 222235678999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
|. .+|..+.. .-+..++.+....++.|+++||.|.|+++ +.||||||.|.||+.+|+.|++|||+++.+.-.-
T Consensus 83 cd-qdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 95 47777664 33446888999999999999999999998 9999999999999999999999999998764221
Q ss_pred ccccccccccccccccchhhhcCC-CccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhccc--ccccccc
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS--REGLERI 642 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~-~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~--~~~l~~i 642 (808)
. -....+-|.+|.+|.++.+.+ |+...|+||-|||+.||.. |+.-|...+..++..-+-|......+ ...+.++
T Consensus 156 -r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 -R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 1 123345689999999998765 6788899999999999998 55545433322221112222211111 1122233
Q ss_pred cCCCCCCCCCh---------hhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 643 IDPSLGNDVPF---------DSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 643 vD~~l~~~~~~---------~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
-|-....-++. .....=.++....+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 33222111211 11223356777777789999998887654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=272.19 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=199.2
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcc-c-cc----ceeEEeeeeeccc
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-H-RN----LVKLIGICIEEQA 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-H-pN----IV~L~g~~~~~~~ 479 (808)
.+++|.+..++|+|.||.|-+.... .+..||||+++..... .+..+-|+++|++|. + |+ +|++.+|+.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999998865 5789999999875433 345677999999994 2 22 7888899999999
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC------------
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH------------ 547 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~------------ 547 (808)
.|+|+|.+ +-|+.++|..+ .-.++.-..+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999 56999999743 3346777899999999999999999998 999999999999832
Q ss_pred --------CCcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCC
Q 003605 548 --------DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 619 (808)
Q Consensus 548 --------~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~ 619 (808)
+..+||+|||.|....... ..++.|..|+|||++.+-.++..+||||+||||.||.||..-|.....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3458999999997532221 456789999999999999999999999999999999999998875542
Q ss_pred CCcchhHHhhhhhcc-------ccc---------cc-----------ccccCCC--C--CCCCChhhHHHHHHHHHHccc
Q 003605 620 PGQENLVAWARPLLT-------SRE---------GL-----------ERIIDPS--L--GNDVPFDSVAKVAAIASMCVQ 668 (808)
Q Consensus 620 ~~~~~lv~w~~~~~~-------~~~---------~l-----------~~ivD~~--l--~~~~~~~~~~~l~~Li~~Cl~ 668 (808)
. +.|. ..+.++. .+. .+ ....++. + .......+..+|.+|+..||.
T Consensus 315 ~--EHLa-MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 315 L--EHLA-MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred H--HHHH-HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 2 2221 1100000 000 00 0000000 0 011234567789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 003605 669 PEVQHRPFMGEVVQA 683 (808)
Q Consensus 669 ~dP~~RPsm~eVl~~ 683 (808)
.||.+|+|++|+++.
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999998764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=277.43 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=194.1
Q ss_pred eeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCC
Q 003605 414 SRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
.++||.|-||+||-|+.+ +|+.||||++.+. ....+.++.+|+.||+.++||.||.|...|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 479999999999999975 8999999999753 34455789999999999999999999999999999999999995 5
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC---Ccceecccccccccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD---FTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~---~~vKL~DFGLa~~~~~~~~ 567 (808)
+..+.+-. .+...|++..-..+..||+.||.|||.++ |+|+||||+||||.+. -.+||||||+||.+...
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 55555432 33456888888888999999999999998 9999999999999653 47999999999987543
Q ss_pred cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
.....++||+.|+|||++.++.|...-|+||.|||+|--++|..||... +++-+..+. ..-+.-+.-
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQN-------AaFMyPp~P 787 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQN-------AAFMYPPNP 787 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhhc-------cccccCCCc
Confidence 3345688999999999999999999999999999999999999999642 222211110 000011110
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. .+.....+++|...|+..-++|-+..+-+..
T Consensus 788 W----~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 W----SEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred h----hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 0 1334567889999999999999998877643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=261.69 Aligned_cols=250 Identities=24% Similarity=0.279 Sum_probs=193.4
Q ss_pred HhCCccee-eeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeee----ccc
Q 003605 407 ATGNFDAS-RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE----EQA 479 (808)
Q Consensus 407 at~~f~~~-~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~----~~~ 479 (808)
.+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|+|.+. ....+|+++.-+. .|+|||.++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45556544 58999999999998865 7899999999753 3456788877666 59999999999864 357
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC---CCcceeccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDF 556 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~---~~~vKL~DF 556 (808)
+++|||+|+||.|.+.+.+ +....+++.++-.|..||+.|+.|||+.+ |.||||||+|+|... |-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 7899999999999999974 33457999999999999999999999998 999999999999954 457899999
Q ss_pred ccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
|+|+.... ...-...+-|+.|.|||++-..+|+..+|+||+||++|-|++|..||........ . .
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------s-p 273 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------S-P 273 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------C-h
Confidence 99986432 1222345679999999999999999999999999999999999999964332100 0 0
Q ss_pred cccccccCCCCCCCCCh----hhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 637 EGLERIIDPSLGNDVPF----DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
....+|.... -.++. +.++...++++..|..+|.+|.|+.|+...
T Consensus 274 gMk~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 274 GMKRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHHhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0011111110 11222 335667889999999999999999999754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.92 Aligned_cols=203 Identities=31% Similarity=0.406 Sum_probs=170.8
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec-ccchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~-~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.......||+|++|.|-+-++. +|+.+|+|+++. .+.+..++.++|+.+..+. .+|.+|.|+|.+.+++..++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3334567999999999888754 899999999974 4566677888999987765 699999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~ 566 (808)
|. -||+.+-++.-..+..+.+..+-+||..+.+||.|||++- .+||||+||+|||||.+|++|+||||++-.+.+.-
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 94 5888887665556677999999999999999999999875 59999999999999999999999999997664322
Q ss_pred ccccccccccccccccchhhhc----CCCccccceeeHHHHHHHHHhCCCCCCCCC
Q 003605 567 SRHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILELLSGRKPVDMTQ 618 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~----~~~s~kSDVwSfGvvLlELlTG~~P~~~~~ 618 (808)
. .+...|-..|||||.+.. ..|+-||||||||+.+.||.+++.||+...
T Consensus 204 A---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 A---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred H---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 1 122457788999998753 378899999999999999999999997544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=239.94 Aligned_cols=210 Identities=37% Similarity=0.592 Sum_probs=182.3
Q ss_pred eeecCcEEEEEEEeeC-CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCccc
Q 003605 417 LGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES 494 (808)
Q Consensus 417 LG~G~fG~VYkg~l~d-g~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~ 494 (808)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.+++++|++++++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999754332 35789999999999999999999999999889999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-CCcceecccccccccccccccccccc
Q 003605 495 HLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMDEESRHISTR 573 (808)
Q Consensus 495 ~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-~~~vKL~DFGLa~~~~~~~~~~~~~~ 573 (808)
++.... ..+++..++.++.+++++|+|||+.+ ++|+||++.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 986321 36899999999999999999999998 999999999999999 89999999999876533221 1223
Q ss_pred cccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCC
Q 003605 574 VMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652 (808)
Q Consensus 574 ~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~ 652 (808)
..+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577899999998877 788999999999999999
Q ss_pred hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 653 ~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467889999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=276.85 Aligned_cols=205 Identities=27% Similarity=0.371 Sum_probs=170.4
Q ss_pred CcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
-|..++.||-|+||+|.++. .++...+|+|.|++.+ ........+|-.||..-..+-||+|+..|.+++++|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47788999999999999987 4456678999997643 3344567789999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc--
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM-- 563 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~-- 563 (808)
|+++|++-.+|.. ...+.++.+..++.+++.|+++.|..+ +|||||||+|||||.+|.+||+|||||.-+.
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999853 234666666677778999999999998 9999999999999999999999999984221
Q ss_pred -------cccc-------------------------------cccccccccccccccchhhhcCCCccccceeeHHHHHH
Q 003605 564 -------DEES-------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVIL 605 (808)
Q Consensus 564 -------~~~~-------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLl 605 (808)
..+. +...-..+||..|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1000 00001257999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCC
Q 003605 606 ELLSGRKPVDMTQPPG 621 (808)
Q Consensus 606 ELlTG~~P~~~~~~~~ 621 (808)
||+.|+.||....+.+
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999998766543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=257.07 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=199.1
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 482 (808)
.++|++.++||+|+|.+|..+++. +.+.+|+|++++ ++.+..+=.+.|-.+..+- +||.+|-|..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999875 678899999985 2333344455677777765 79999999999999999999
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|.||+++|+|--+++ ....|.++.+..+...|.-||.|||+.+ ||.||||.+|+|||..+.+||+|||+++..
T Consensus 329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999988885 3346888988889999999999999999 999999999999999999999999999864
Q ss_pred ccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCC-CcchhHHhhhhhccccccccc
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-GQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~-~~~~lv~w~~~~~~~~~~l~~ 641 (808)
... ...+...+||+.|+|||++.+..|....|.|++||+++||+.|+.||+..... ..++-.++.-..+
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-------- 471 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-------- 471 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------
Confidence 432 23345678999999999999999999999999999999999999999864432 2233333332222
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCC
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 675 (808)
+...+ .++.....+...+++.-|++||.+|.
T Consensus 472 -lekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 -LEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -hhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 22222 12333445677888999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=284.46 Aligned_cols=247 Identities=27% Similarity=0.354 Sum_probs=187.1
Q ss_pred cceeeeeeecCcEE-EEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeeeeeccceEEEEeecC
Q 003605 411 FDASRILGEGGFGL-VYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 411 f~~~~~LG~G~fG~-VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
|...+++|.|+-|+ ||+|.++ |+.||||++-. .-..-..+||..|+.- +|+|||++++.-.++...|++.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44557899999885 7999997 89999999853 2234567899999988 5999999999988889999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-----CCcceecccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLARSAM 563 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-----~~~vKL~DFGLa~~~~ 563 (808)
..+|++++...........-...+.+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999753111111111345778889999999999987 999999999999965 3579999999999775
Q ss_pred ccccc-ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhhhccccccccc
Q 003605 564 DEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 564 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG-~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
..... .......||-||+|||.+....-+.+.||||+|||+|..++| .+||...... +.+ ++.....+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------Il~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------ILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------hhcCccceee
Confidence 43322 123456799999999999998888899999999999999995 8999643211 111 1222222221
Q ss_pred ccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 642 ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
+.. ..++ +..+||.+|++.+|..||++.+|+.
T Consensus 735 L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 LEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 110 1112 6789999999999999999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-29 Score=258.99 Aligned_cols=266 Identities=21% Similarity=0.324 Sum_probs=192.2
Q ss_pred cceeeeeeecCcEEEEEEEee-CCCEEEEEEeec-cc-chhhHHHHHHHHHHhhcccccceeEEeeeeec--------cc
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR-VD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--------QA 479 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~-~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--------~~ 479 (808)
|+...+||+|.||.||+|+.+ .|+.||+|++-- .. ..--...++|+++|..|+|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444568999999999999965 577889887532 11 11224567999999999999999999998542 34
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.+|||++|+. +|.-.|. .....++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 7999999975 7777774 23356888999999999999999999887 999999999999999999999999999
Q ss_pred cccccccc--cccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHh--------
Q 003605 560 RSAMDEES--RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-------- 628 (808)
Q Consensus 560 ~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w-------- 628 (808)
+.+..... ....+..+-|..|+.||.+.+ +.|+.+.|||.-|||+.||+||.+-+.......+..++..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 86643222 222345567999999999886 4689999999999999999999887765433222222211
Q ss_pred hhhhccccccccccc-CCCCCCCCC--hh------hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 629 ARPLLTSREGLERII-DPSLGNDVP--FD------SVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 629 ~~~~~~~~~~l~~iv-D~~l~~~~~--~~------~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+|+.+..-+....+- .|.-.+.+. .+ ...+.++|+..++..||.+|+...+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111111111110 111111110 11 12367789999999999999999998754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=256.16 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=194.9
Q ss_pred ceeeeeeecCcEEEEEEEee-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeEEeeeeec-----cceEEE
Q 003605 412 DASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QARCLV 483 (808)
Q Consensus 412 ~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~~LV 483 (808)
+..+-||-|+||.||..+.. +|+.||.|++... +-...+++.+|+++|.-++|.|++..++..... .+.|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999998865 8999999998642 334567899999999999999999988876433 356888
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
+|.| ..+|...+ -....|+-+...-+..||++||.|||+.+ |.||||||.|.|++.|...|||||||++...
T Consensus 136 TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 9988 44666665 33456888888889999999999999998 9999999999999999999999999999755
Q ss_pred cccccccccccccccccccchhhhc-CCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc-------
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS------- 635 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~------- 635 (808)
..+..+. +..+-|..|+|||++++ ++|+.+.||||.|||+.||+..+.-|....+..+.+++.-....-..
T Consensus 208 ~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 4444443 44567899999999987 57899999999999999999998888766554333222111000000
Q ss_pred ccccccccC-----CCCC----CCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003605 636 REGLERIID-----PSLG----NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 684 (808)
Q Consensus 636 ~~~l~~ivD-----~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 684 (808)
+.....++. +.+. -.-+.....+-+.+...++..||++|.+..+.+..+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000000111 1110 011123345667788899999999999988887665
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=274.61 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=196.2
Q ss_pred CcceeeeeeecCcEEEEEEEeeCCC-EEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 410 NFDASRILGEGGFGLVYSGVLDDGT-KVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~dg~-~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
+++....||-|+||.|=.+..+... .+|+|++++ .+....+....|-.||...+.+.||+||-.|.+....||+||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455567999999999988876433 488998875 445556778899999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
-|-+|.|+..|++ +..++..+...++..+.+|++|||+++ ||.|||||+|.+||.+|-+||.|||+|+.+...
T Consensus 501 aClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999963 345788888888999999999999998 999999999999999999999999999987543
Q ss_pred cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCC
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~ 645 (808)
. .+-..+||+.|.|||++.+...+.+.|.||||+++|||++|..||...++-..-++ ++. .++.
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------ILk---Gid~---- 637 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------ILK---GIDK---- 637 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------HHh---hhhh----
Confidence 2 33457899999999999999999999999999999999999999986554211111 111 1111
Q ss_pred CCCCCCChhhHHHHHHHHHHccccCCCCCCC
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 676 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 676 (808)
..+|........+++++.+..+|.+|-.
T Consensus 638 ---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 ---IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1233344456778999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=238.25 Aligned_cols=199 Identities=36% Similarity=0.487 Sum_probs=171.7
Q ss_pred cceeeeeeecCcEEEEEEEeeC-CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecC
Q 003605 411 FDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~d-g~~VAVK~lk~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999874 889999999865444 57789999999999999999999999999899999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+++|.+++.... ..+++...+.++.+++++|.|||+.+ ++|+||+++||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999986322 11889999999999999999999987 999999999999999999999999998865433211
Q ss_pred ccccccccccccccchhh-hcCCCccccceeeHHHHHHHHHhCCCCCCC
Q 003605 569 HISTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVILELLSGRKPVDM 616 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l-~~~~~s~kSDVwSfGvvLlELlTG~~P~~~ 616 (808)
......++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=246.59 Aligned_cols=133 Identities=26% Similarity=0.409 Sum_probs=112.9
Q ss_pred hCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcc-----c---ccceeEEeeeee--
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-----H---RNLVKLIGICIE-- 476 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-----H---pNIV~L~g~~~~-- 476 (808)
.++|.+.++||.|.|++||++... +.+.||+|+.+.. +.-.+..+.||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 478999999999999999999854 6788999999853 344567789999999984 2 469999999975
Q ss_pred --ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeec
Q 003605 477 --EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 546 (808)
Q Consensus 477 --~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd 546 (808)
+.+.|||+|++ +.+|..+|..... +.+......+|+.||+.||.|||+.+ .|||-||||+||||.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45789999999 7799999875443 35778899999999999999999998 799999999999983
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=234.12 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=194.7
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEee-eeeccceEEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI-CIEEQARCLV 483 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~-~~~~~~~~LV 483 (808)
..+.|++.+.||+|.||.+-++.++ ..+.+++|.+.+. ....++|.+|...--.| .|.||+.-++. |...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4467888999999999999999977 5688999988652 34568999998876666 59999998876 5666788999
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee-cC-CCcceecccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EH-DFTPKVSDFGLARS 561 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL-d~-~~~vKL~DFGLa~~ 561 (808)
+||++.|+|.+.+.. ..+.+....+++.|++.||.|+|+++ +||||||.+|||| +. ..++||||||+.+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999998842 45778888999999999999999998 9999999999999 33 35899999999875
Q ss_pred cccccccccccccccccccccchhhhc---CC--CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccc
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMT---GH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 636 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~--~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~ 636 (808)
... ......-+..|.+||.... +. ....+|||.||+|++.++||+.||+... ......+.|..-.-...
T Consensus 173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC
Confidence 421 1122334567999997653 22 3567899999999999999999998433 23344444432111100
Q ss_pred cccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 637 ~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
-.+ |..-+ ....++.++.++-+..++++|-...++.++......+.
T Consensus 247 ~~~-----P~~F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 247 PAL-----PKKFN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ccC-----chhhc----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 011 11111 12356778889999999999988888877776655544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=253.18 Aligned_cols=275 Identities=21% Similarity=0.247 Sum_probs=206.3
Q ss_pred CCHHHHHHHhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcc------cccceeEE
Q 003605 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH------HRNLVKLI 471 (808)
Q Consensus 399 fs~~el~~at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~------HpNIV~L~ 471 (808)
|.+.--+....+|.+....|+|-|++|.+|... -|..||||+++.. +.-.+.=+.|++||.+|+ --|+++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 444444556788999999999999999999865 5789999999853 444566678999999996 24899999
Q ss_pred eeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Cc
Q 003605 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FT 550 (808)
Q Consensus 472 g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~ 550 (808)
-.|...+++|||||-+ .-+|.+.|..+.. ...|.......++.|+.-||..|...+ |+|.||||.|||+++. ..
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 9999999999999988 4699999987654 346888899999999999999999988 9999999999999876 56
Q ss_pred ceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhh-
Q 003605 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA- 629 (808)
Q Consensus 551 vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~- 629 (808)
+||||||.|-.+.+... +....+..|.|||++.+-.|+...|+||.||.||||.||+.-|.....+....+..-+
T Consensus 576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 89999999976544322 2233456799999999999999999999999999999999988654432211111000
Q ss_pred ----hhhccccccccc--------------------------ccCC------CCCC--CCCh---hhHHHHHHHHHHccc
Q 003605 630 ----RPLLTSREGLER--------------------------IIDP------SLGN--DVPF---DSVAKVAAIASMCVQ 668 (808)
Q Consensus 630 ----~~~~~~~~~l~~--------------------------ivD~------~l~~--~~~~---~~~~~l~~Li~~Cl~ 668 (808)
..++....-.++ .+.| .|.. .++. .....|.+|+..|+.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 000000000000 1111 1111 1332 345678899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 003605 669 PEVQHRPFMGEVVQA 683 (808)
Q Consensus 669 ~dP~~RPsm~eVl~~ 683 (808)
.||++|-+..|.++.
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999988753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-26 Score=258.63 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=202.6
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
-.++|+....+|.|.||.|||++.. .++..|||.++-.......-..+|+-+++..+|+|||.++|.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3567889999999999999999965 789999999986555556677889999999999999999999999999999999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
||.+|+|++.-|. ..+|++.++..+.....+||+|||+.+ -+|||||-.|||+.+.+++|++|||.+..+..
T Consensus 93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-
Confidence 9999999998863 347889999999999999999999998 79999999999999999999999999865432
Q ss_pred cccccccccccccccccchhhh---cCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 566 ESRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
.-.......||+.|||||+.. .+.|..++|||+.|+...||---+.|.....+. .. ..+++ + ..
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~-----l~LmT-k----S~ 231 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RA-----LFLMT-K----SG 231 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HH-----HHHhh-c----cC
Confidence 222334567999999999763 567899999999999999998777664321110 00 01111 1 11
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
+++.-.++ .......+.++++.|+-++|++||+.+.+++
T Consensus 232 ~qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22221111 1244567999999999999999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-26 Score=251.58 Aligned_cols=196 Identities=20% Similarity=0.342 Sum_probs=165.0
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc--------chhhHHHHHHHHHHhhcc---cccceeEEeeeee
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--------QQGGREFLAEVEMLSRLH---HRNLVKLIGICIE 476 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~--------~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~ 476 (808)
.+|...+.||+|+||.|+.++++ +...|+||.+.+.. ....-..-.||.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999987 55678999886421 111223556999999997 9999999999999
Q ss_pred ccceEEEEeecC-CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecc
Q 003605 477 EQARCLVYELIP-NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 555 (808)
Q Consensus 477 ~~~~~LV~Ey~~-~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~D 555 (808)
.+.+||++|-.. +-+|.+++. ....+++.+...|+.|++.|+++||+.+ |||||||-+||.+|.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999764 447888884 4557999999999999999999999999 99999999999999999999999
Q ss_pred cccccccccccccccccccccccccccchhhhcCCCc-cccceeeHHHHHHHHHhCCCCCC
Q 003605 556 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVD 615 (808)
Q Consensus 556 FGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~kSDVwSfGvvLlELlTG~~P~~ 615 (808)
||.|....... ....+||.+|.|||++.+..|- ..-|||++|++||-++....||.
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987543322 2346799999999999988874 55799999999999998888873
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=236.33 Aligned_cols=256 Identities=22% Similarity=0.322 Sum_probs=192.7
Q ss_pred CCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeEEeeeeec------cc
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------QA 479 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~ 479 (808)
.+|...+.+|.|.- .|..+... .++.||+|++.. .+....++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 55555433 578999998753 3345567788999999999999999999998643 35
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.|+||||| ..+|...++ ..++-.+...|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 69999999 569998886 24677888999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---------
Q 003605 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR--------- 630 (808)
Q Consensus 560 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~--------- 630 (808)
+.... ....+..+.|..|.|||++.+..+.+..||||.||++.||++|+.-|...+ .+-+|.+
T Consensus 166 r~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred cccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 86432 234466778999999999998889999999999999999999998876322 2222221
Q ss_pred ------------hhccccc-----cccccc-CCCCCCC--CChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 631 ------------PLLTSRE-----GLERII-DPSLGND--VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 631 ------------~~~~~~~-----~l~~iv-D~~l~~~--~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
......+ ...+++ |..+... .+.-......+++.+||..+|++|-++.++++.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000 011111 1111111 111234567889999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=225.74 Aligned_cols=259 Identities=20% Similarity=0.324 Sum_probs=192.9
Q ss_pred hCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeEEeeeeec--cceEEE
Q 003605 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE--QARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LV 483 (808)
.++|++.+.+|+|.++.||.|. ..+.+.++||+|+.. ..+.+.+|++||..|. |+||+.|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678888999999999999998 457889999999853 4568899999999997 99999999998765 455899
Q ss_pred EeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Ccceeccccccccc
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSA 562 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DFGLa~~~ 562 (808)
+||++|-+..... ..|+..++...+.++++||.|+|+.| |+|||+||.|++||.. ...+|+|+|||...
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999887765544 24677788889999999999999998 9999999999999865 57999999999866
Q ss_pred ccccccccccccccccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc------
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS------ 635 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~------ 635 (808)
.......+ .+.+..|.-||.+..- .|+..-|+|||||+|.+|+..+.||-....+ ..+++.-+.-+-++
T Consensus 184 Hp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHH
Confidence 44332221 2356678899988764 5677889999999999999999998654332 23344333221111
Q ss_pred -------ccccccccCCCCCCC----C---C-hhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 636 -------REGLERIIDPSLGND----V---P-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 -------~~~l~~ivD~~l~~~----~---~-~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
......++....+.. . + .-...+.++++...|..|-.+|+|++|....
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 011111111111110 0 0 1123678899999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=274.23 Aligned_cols=196 Identities=19% Similarity=0.258 Sum_probs=141.0
Q ss_pred hccc-ccceeEEeee-------eeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003605 461 RLHH-RNLVKLIGIC-------IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532 (808)
Q Consensus 461 ~L~H-pNIV~L~g~~-------~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~ 532 (808)
.++| .||++++++| .+.+..++++||+ +++|.++|+. ....+++.+++.|+.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4555 6888888887 3334567888988 6699999963 2345999999999999999999999988
Q ss_pred EEeeeecccCeeecC-------------------CCcceecccccccccccccc--------------cccccccccccc
Q 003605 533 VIHRDFKSSNILLEH-------------------DFTPKVSDFGLARSAMDEES--------------RHISTRVMGTFG 579 (808)
Q Consensus 533 IiHrDIKpsNILLd~-------------------~~~vKL~DFGLa~~~~~~~~--------------~~~~~~~~Gt~~ 579 (808)
|+||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 45677777777764211000 000112457889
Q ss_pred cccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHH
Q 003605 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKV 659 (808)
Q Consensus 580 Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l 659 (808)
|||||++.+..++.++|||||||+||||++|..|+.... .....+.. ....+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~----------~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRH----------RVLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHH----------hhcChhh-----hhcCHHH
Confidence 999999999999999999999999999999988764211 00101100 0111111 1122345
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 003605 660 AAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 660 ~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
..++.+||+.+|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=214.72 Aligned_cols=170 Identities=23% Similarity=0.216 Sum_probs=127.1
Q ss_pred CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccc
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~ 569 (808)
|+|.++++. .+..++|.+++.|+.|+++||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 688999863 2346999999999999999999999875 999999999999999 9998764321
Q ss_pred cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCC
Q 003605 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649 (808)
Q Consensus 570 ~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~ 649 (808)
...||..|||||++.+..++.++|||||||++|||+||+.||...... ...+..+...... . ++. ..
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~-------~-~~~-~~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGMPA-------D-DPR-DR 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHhcc-------C-Ccc-cc
Confidence 125789999999999999999999999999999999999998643211 1111111111000 0 000 00
Q ss_pred CCChhhH--HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 003605 650 DVPFDSV--AKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 650 ~~~~~~~--~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
....... ..+.+++.+||+.+|++||++.|+++.+..+..+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0111222 2699999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=233.78 Aligned_cols=267 Identities=24% Similarity=0.304 Sum_probs=196.7
Q ss_pred HHHhCCcceeeeeeecCcEEEEEEEee----CCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccc
Q 003605 405 EKATGNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQA 479 (808)
Q Consensus 405 ~~at~~f~~~~~LG~G~fG~VYkg~l~----dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~ 479 (808)
....+.|...++||+|.|++||++++. ..+.||+|.+..... -.++.+|+++|..+. +.||+.+.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 345577889999999999999999854 357899999975433 357899999999995 9999999999999999
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Ccceeccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGL 558 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DFGL 558 (808)
.++|+||++.....+++. .++..++...++.+..||+++|.++ ||||||||+|+|.+.. +.-.|.||||
T Consensus 110 v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999988888874 3677889999999999999999999 9999999999999754 7789999999
Q ss_pred cccccc-------cc--------------------------c---------cccccccccccccccchhhhc-CCCcccc
Q 003605 559 ARSAMD-------EE--------------------------S---------RHISTRVMGTFGYVAPEYAMT-GHLLVKS 595 (808)
Q Consensus 559 a~~~~~-------~~--------------------------~---------~~~~~~~~Gt~~Y~APE~l~~-~~~s~kS 595 (808)
|..... .. . ........||+||.|||++.. ..-+.+.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 851100 00 0 000012569999999999875 4568899
Q ss_pred ceeeHHHHHHHHHhCCCCCCCCCCCCc--chhH---Hhh--------hhh--cccccc----------cccc-cCCCC--
Q 003605 596 DVYSYGVVILELLSGRKPVDMTQPPGQ--ENLV---AWA--------RPL--LTSREG----------LERI-IDPSL-- 647 (808)
Q Consensus 596 DVwSfGvvLlELlTG~~P~~~~~~~~~--~~lv---~w~--------~~~--~~~~~~----------l~~i-vD~~l-- 647 (808)
||||-|||++-+++++.||-....... ..++ .|. ... +.++.. .+.+ +....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999865443211 1111 110 000 000000 1111 00000
Q ss_pred ------CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 648 ------GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.....+.....+++++.+|+..||.+|.+++|.++.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 011122334578999999999999999999999865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-22 Score=218.06 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=198.1
Q ss_pred CcceeeeeeecCcEEEEEEEeeCC--CEEEEEEeecccchhhHHHHHHHHHHhhccc----ccceeEEeee-eeccceEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLDDG--TKVAVKVLKRVDQQGGREFLAEVEMLSRLHH----RNLVKLIGIC-IEEQARCL 482 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~dg--~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~H----pNIV~L~g~~-~~~~~~~L 482 (808)
+|.+.+.||+|+||.||++...+. ..+|+|............+..|+.++..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997643 4788888775433333378889999998873 6889999888 46778899
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-----Ccceecccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-----FTPKVSDFG 557 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-----~~vKL~DFG 557 (808)
||+.+ +-+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 789999775433 356899999999999999999999999 9999999999999754 469999999
Q ss_pred ccc--cccccccc---cc---ccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 003605 558 LAR--SAMDEESR---HI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 629 (808)
Q Consensus 558 La~--~~~~~~~~---~~---~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~ 629 (808)
+++ ........ .. .....||..|.++..+.+...+.+.|+||++.++.||+.|..||...........+.-
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~- 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK- 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH-
Confidence 998 43322211 11 1234599999999999999999999999999999999999999965433211110000
Q ss_pred hhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 003605 630 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 630 ~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
......... ........+.++...+-..+...+|....+...|+....+.
T Consensus 252 -------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 -------DPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -------Hhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000001110 11122345666666666689999999999999998877664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=224.79 Aligned_cols=166 Identities=20% Similarity=0.171 Sum_probs=130.0
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEee--CCCEEEEEEeecc-----cchhhHHHHHHHHHHhhccccccee-EEeeeeec
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVK-LIGICIEE 477 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~--dg~~VAVK~lk~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~-L~g~~~~~ 477 (808)
...++|.+.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|.+++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 45678999999999999999999865 5778899987532 1223567999999999999999985 4432
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeee-cccCeeecCCCcceeccc
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF-KSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDI-KpsNILLd~~~~vKL~DF 556 (808)
+..+|||||+++++|... . ... ...++.++++||+|||+.+ |+|||| ||+|||++.++++||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~---~~~-------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R---PHG-------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C---ccc-------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 467999999999999632 1 110 1467889999999999988 999999 999999999999999999
Q ss_pred cccccccccccccc------ccccccccccccchhhhcC
Q 003605 557 GLARSAMDEESRHI------STRVMGTFGYVAPEYAMTG 589 (808)
Q Consensus 557 GLa~~~~~~~~~~~------~~~~~Gt~~Y~APE~l~~~ 589 (808)
|+|+.......... .+...+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99986644321111 1356788999999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=203.26 Aligned_cols=261 Identities=31% Similarity=0.433 Sum_probs=197.2
Q ss_pred cceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccch---hhHHHHHHHHHHhhcccc-cceeEEeeeeeccceEEEEee
Q 003605 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ---GGREFLAEVEMLSRLHHR-NLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~---~~~~f~~Ei~iL~~L~Hp-NIV~L~g~~~~~~~~~LV~Ey 486 (808)
|...+.||.|+||.||++... ..+++|.+...... ..+.|.+|+.+++.+.|+ |++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999876 78999998753322 467899999999999988 799999999777778999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC-cceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~-~vKL~DFGLa~~~~~~ 565 (808)
+.+++|.+++...... ..+.......++.+++.++.|+|+.+ ++||||||+||+++... .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766422111 26888999999999999999999998 99999999999999988 7999999999855433
Q ss_pred cccc----cccccccccccccchhhhc---CCCccccceeeHHHHHHHHHhCCCCCCCCCCC-CcchhHHhhhhhccccc
Q 003605 566 ESRH----ISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-GQENLVAWARPLLTSRE 637 (808)
Q Consensus 566 ~~~~----~~~~~~Gt~~Y~APE~l~~---~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~-~~~~lv~w~~~~~~~~~ 637 (808)
.... ......|+..|++||.+.. ..+....|+|++|++++++++|..|+...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 2221 2355679999999999987 57889999999999999999999996543321 011111111111100
Q ss_pred ccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 638 ~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223578899999999999999999987765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-23 Score=214.77 Aligned_cols=244 Identities=21% Similarity=0.370 Sum_probs=193.3
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEee--cccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk--~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
.+|.+...|..|+|+++ |..+++|+++ .......++|..|.-.|+.+.||||+.++|.|....++.++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 46888999999999997 6677778875 33455567899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceec--cccccccccccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS--DFGLARSAMDEESRHI 570 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~--DFGLa~~~~~~~~~~~ 570 (808)
...||+ .....++-.+..++|.++|+|++|||+.. |-|.---|.+..++||++.+++|+ |--++. ..
T Consensus 275 ynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--qe------ 343 (448)
T KOG0195|consen 275 YNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE------ 343 (448)
T ss_pred HHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--ec------
Confidence 999995 34456788899999999999999999985 435555799999999999998884 221111 10
Q ss_pred ccccccccccccchhhhcCCC---ccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCC
Q 003605 571 STRVMGTFGYVAPEYAMTGHL---LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 571 ~~~~~Gt~~Y~APE~l~~~~~---s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l 647 (808)
....-.+.||+||.++...- -+++|+|||.++||||.|...||....+-+.. -++.-+.+
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mkialegl 406 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKIALEGL 406 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhhhhccc
Confidence 11234678999999987643 35789999999999999999999754432111 11222334
Q ss_pred CCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
+-.++......+.+++.-|...||.+||.+..|+-.||+.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 4556667778899999999999999999999999999865
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-21 Score=193.04 Aligned_cols=272 Identities=22% Similarity=0.304 Sum_probs=210.3
Q ss_pred CHHHHHHHhCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeecccchhhHHHHHHHHHHhhccc-ccceeEEeeeeec
Q 003605 400 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEE 477 (808)
Q Consensus 400 s~~el~~at~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~ 477 (808)
+.+++. ..++|.+.+.||.|+||.+|.|. ..+|+.||||.-+... ..-++..|.++++.|+| ..|..+..|..++
T Consensus 7 s~~~~i-v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 7 SLEELI-VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred chhhhe-eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 344444 34689999999999999999998 5689999999876432 23467789999999975 6777788888888
Q ss_pred cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC---Ccceec
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD---FTPKVS 554 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~---~~vKL~ 554 (808)
+...||||.+ +-+|+++..-+. ..++..+.+.+|-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEE
Confidence 8889999999 779999886433 35788899999999999999999999 9999999999999643 578999
Q ss_pred cccccccccccccc-cc----ccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 003605 555 DFGLARSAMDEESR-HI----STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 629 (808)
Q Consensus 555 DFGLa~~~~~~~~~-~~----~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~ 629 (808)
|||||+.+.+.... ++ .....||..|.+-..+.+..-+.+.|+-|+|.+|..+.-|..||+........+-
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK---- 232 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK---- 232 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH----
Confidence 99999877654332 22 2357799999998888888889999999999999999999999986554332211
Q ss_pred hhhcccccccccccCCCCCC---CCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhhh
Q 003605 630 RPLLTSREGLERIIDPSLGN---DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEA 694 (808)
Q Consensus 630 ~~~~~~~~~l~~ivD~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~~~ 694 (808)
.+.|....+.. ..-.....++.-.+.-|-..--++-|...-+.+.+..+...++..
T Consensus 233 ---------yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~ 291 (341)
T KOG1163|consen 233 ---------YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ 291 (341)
T ss_pred ---------HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence 11222211111 111234567888889999999999999999988888887776654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.4e-20 Score=193.13 Aligned_cols=272 Identities=19% Similarity=0.259 Sum_probs=205.2
Q ss_pred hCCcceeeeeeecCcEEEEEEE-eeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEEe
Q 003605 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~-l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.-.|.+.++||+|.||.++.|+ +-+++.||||.-... ...-++..|.+.++.|. .++|...+.|-.++..-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3468899999999999999998 447999999976432 22346778888888884 7899988888777778899999
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-----CCcceeccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 560 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-----~~~vKL~DFGLa~ 560 (808)
++ +-||+|+..-+. ..++..+.+.||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99 779999875433 45888999999999999999999998 999999999999954 3468999999999
Q ss_pred cccccccc-ccc----cccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccc
Q 003605 561 SAMDEESR-HIS----TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 561 ~~~~~~~~-~~~----~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
...+.... ++. ...-||.+||+-..+.+++-+.+.|.-|+|-|++..|-|..||........
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn------------- 244 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN------------- 244 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-------------
Confidence 87765432 222 346799999999999999999999999999999999999999986543321
Q ss_pred ccccccccCCCCCCC---CChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhhhhhhcCCCC
Q 003605 636 REGLERIIDPSLGND---VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSAS 701 (808)
Q Consensus 636 ~~~l~~ivD~~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~~~~~~~~~~ 701 (808)
++..++|-|..-... .-.....++..-+.-.-..+-++-|...-+...+..++.......+-..+|
T Consensus 245 K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW 313 (449)
T KOG1165|consen 245 KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDW 313 (449)
T ss_pred HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 122222222211111 011123344444444445678888999999988888888877665544444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.9e-21 Score=224.61 Aligned_cols=254 Identities=20% Similarity=0.201 Sum_probs=186.9
Q ss_pred eeeeeeecCcEEEEEEEee-CCCEEEEEEee----c-ccch-hhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 413 ASRILGEGGFGLVYSGVLD-DGTKVAVKVLK----R-VDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk----~-~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
..+++|.|++|.|+..... ..+..+.|..+ . .... ....+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999977776633 33434444332 1 1111 11225667778888999999998888887777666699
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
||+. +|..++.. ...+...++..++.|+.+|++|||..+ |.|||||++|+++..++.+||+|||.+..+...
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99998842 235778889999999999999999999 999999999999999999999999999766544
Q ss_pred ccc--ccccccccccccccchhhhcCCCcc-ccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccc
Q 003605 566 ESR--HISTRVMGTFGYVAPEYAMTGHLLV-KSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 566 ~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~-kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
... .......|.-.|+|||.+....|.. ..||||.|+++..|++|+.||......+.... . .......
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--~-------~~~~~~~ 544 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--T-------NNYSDQR 544 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--h-------hcccccc
Confidence 443 5556778999999999999988865 57999999999999999999987655433210 0 0000000
Q ss_pred cCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 643 vD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
-+..-..........+...++.++|+.+|.+|-|+++|++.
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000011112345677889999999999999999999763
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=191.06 Aligned_cols=172 Identities=13% Similarity=0.146 Sum_probs=134.0
Q ss_pred HHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhH---H------HHHHHHHHhhcccccceeEEeeeee
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR---E------FLAEVEMLSRLHHRNLVKLIGICIE 476 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~---~------f~~Ei~iL~~L~HpNIV~L~g~~~~ 476 (808)
-..++|+..++||+|+||.||.... ++..+|||.++.......+ . |.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3578999999999999999999655 5778999999743222222 2 6899999999999999999988654
Q ss_pred c--------cceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC
Q 003605 477 E--------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 548 (808)
Q Consensus 477 ~--------~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~ 548 (808)
. +..+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35789999999999987741 222 24558999999999998 9999999999999988
Q ss_pred CcceecccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHH
Q 003605 549 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 608 (808)
Q Consensus 549 ~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELl 608 (808)
+ ++|+|||........... -.++....+..++|+|+||+.+.-+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988654211110 01455556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-20 Score=185.72 Aligned_cols=139 Identities=20% Similarity=0.232 Sum_probs=107.9
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeecccch--h-------hHHH-----------------HHHHHHHhhcccccc
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--G-------GREF-----------------LAEVEMLSRLHHRNL 467 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~--~-------~~~f-----------------~~Ei~iL~~L~HpNI 467 (808)
...||+|+||.||+|...+|+.||||+++..... . ..+| ..|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999753211 1 1122 349999999988876
Q ss_pred eeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEeeeecccCeeec
Q 003605 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL-HEDSSPRVIHRDFKSSNILLE 546 (808)
Q Consensus 468 V~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yL-H~~~~p~IiHrDIKpsNILLd 546 (808)
.....+.. ...+|||||+++++|...+. ....+++.+..+++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 44333222 23489999998877665432 123688999999999999999999 6877 99999999999998
Q ss_pred CCCcceeccccccccc
Q 003605 547 HDFTPKVSDFGLARSA 562 (808)
Q Consensus 547 ~~~~vKL~DFGLa~~~ 562 (808)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-20 Score=222.25 Aligned_cols=247 Identities=23% Similarity=0.251 Sum_probs=184.1
Q ss_pred CcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecc-cchhhHHHHHHHHHHh--hcccccceeEEeeeeeccceEEEEee
Q 003605 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV-DQQGGREFLAEVEMLS--RLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~-~~~~~~~f~~Ei~iL~--~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+|...+.||.+.|=+|.+|+.++|. |+||++-+. .....+.|.++++-++ .++|||.+.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777889999999999999998887 889987543 3444555655554444 45899999999887777777999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc-cc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM-DE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~-~~ 565 (808)
+.+ +|.|.|. .+.-|..-+...|+.|++.||..+|+.+ |+|||||.+||||+.-+-+.|+||..-+... .+
T Consensus 103 vkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 955 8999883 5556778889999999999999999998 9999999999999999999999997654221 11
Q ss_pred cc----cccccccccccccccchhhhcC-----------CCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 003605 566 ES----RHISTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 629 (808)
Q Consensus 566 ~~----~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~ 629 (808)
+. ......-..-.+|+|||.+... .++.+-||||+||++.||++ |+.+|+. .+|..|-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHh
Confidence 11 1111112233589999987542 26788999999999999999 7888864 2333332
Q ss_pred hhh-cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 630 RPL-LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 630 ~~~-~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
+.- ...+..++++-| ..+.+++..|++.||++|-++++.++.
T Consensus 249 ~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 221 111122333322 246789999999999999999999886
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-19 Score=202.62 Aligned_cols=218 Identities=23% Similarity=0.378 Sum_probs=162.9
Q ss_pred HhhcccccceeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeee
Q 003605 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 538 (808)
Q Consensus 459 L~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDI 538 (808)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....++|.....+..++++||+|||.-. -..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 4578899999999999999999999999999999999963 4567999999999999999999999653 3499999
Q ss_pred cccCeeecCCCcceecccccccccccccccccccccccccccccchhhhcC-------CCccccceeeHHHHHHHHHhCC
Q 003605 539 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVILELLSGR 611 (808)
Q Consensus 539 KpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~kSDVwSfGvvLlELlTG~ 611 (808)
+.+|+++|..+.+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998655321111111112234579999988753 2477899999999999999999
Q ss_pred CCCCCCCCCCc-chhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 003605 612 KPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 612 ~P~~~~~~~~~-~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
.||+....... ..++.++.. .....+-|.+... .+....+..++.+||..+|++||++++|-..++.+..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99986443222 233343322 0111112222111 1333479999999999999999999999877765443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.7e-19 Score=178.35 Aligned_cols=139 Identities=22% Similarity=0.221 Sum_probs=110.1
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeecccch--------------------------hhHHHHHHHHHHhhcccccc
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--------------------------GGREFLAEVEMLSRLHHRNL 467 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~--------------------------~~~~f~~Ei~iL~~L~HpNI 467 (808)
...||+|+||.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753210 01224578999999999987
Q ss_pred eeEEeeeeeccceEEEEeecCCCCcccc-ccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeee
Q 003605 468 VKLIGICIEEQARCLVYELIPNGSVESH-LHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 468 V~L~g~~~~~~~~~LV~Ey~~~GsL~~~-L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILL 545 (808)
.....+... ..+|||||++++++... +. ...++..+..+++.+++.+|.+||. .+ |+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 544444332 34899999988755433 32 2347788899999999999999999 87 9999999999999
Q ss_pred cCCCcceecccccccccc
Q 003605 546 EHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 546 d~~~~vKL~DFGLa~~~~ 563 (808)
+ +++++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.5e-18 Score=180.75 Aligned_cols=234 Identities=21% Similarity=0.338 Sum_probs=150.7
Q ss_pred CcceeeeeeecCcEEEEEEEee-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcc----------cccceeEEeeee
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH----------HRNLVKLIGICI 475 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~---~~~~~~~~f~~Ei~iL~~L~----------HpNIV~L~g~~~ 475 (808)
.+...+.||.|+++.||.+++. +++.+|||.... ......+++.+|.-.+..+. |-.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999976 689999999853 23344567777766555532 212221111111
Q ss_pred ---------ec---c-----ceEEEEeecCCCCccccccccc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 003605 476 ---------EE---Q-----ARCLVYELIPNGSVESHLHGVD---KESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 535 (808)
Q Consensus 476 ---------~~---~-----~~~LV~Ey~~~GsL~~~L~~~~---~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiH 535 (808)
.. . +.+++|+-+ .++|.+++.... .....+....++.+..|+++.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 346788877 578888764321 11223555677888899999999999999 999
Q ss_pred eeecccCeeecCCCcceecccccccccccccccccccccccccccccchhhhcC--------CCccccceeeHHHHHHHH
Q 003605 536 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG--------HLLVKSDVYSYGVVILEL 607 (808)
Q Consensus 536 rDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--------~~s~kSDVwSfGvvLlEL 607 (808)
+|||++|+|++.+|.++|+||+......... . . ...+..|.+||..... .++.+.|.|++|++||.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---E-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---e-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999998876543211 1 1 2345789999976442 468899999999999999
Q ss_pred HhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCC
Q 003605 608 LSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR 674 (808)
Q Consensus 608 lTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 674 (808)
++|+.||+......... | . ...+. +..+.+..|+..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~---~-----------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE---W-----------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG---G-----------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc---c-----------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999997543221111 0 1 12233 556789999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.4e-18 Score=173.46 Aligned_cols=185 Identities=19% Similarity=0.155 Sum_probs=137.6
Q ss_pred ceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccc----hhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEEee
Q 003605 412 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ----QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 412 ~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~----~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.+...|++|+||+||.+.- ++.+++.+.+..... .....|.+|+++|++|+ |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997655 678888888765322 11235889999999995 5889999886 456999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeee-cccCeeecCCCcceecccccccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF-KSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDI-KpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
+.+.+|.+.+. . ....++.+++++|+++|+++ |+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99988865431 0 11356789999999999998 999999 799999999999999999999754322
Q ss_pred cc----------ccc-ccccccccccccchhhhcC-CCc-cccceeeHHHHHHHHHhCCCCCC
Q 003605 566 ES----------RHI-STRVMGTFGYVAPEYAMTG-HLL-VKSDVYSYGVVILELLSGRKPVD 615 (808)
Q Consensus 566 ~~----------~~~-~~~~~Gt~~Y~APE~l~~~-~~s-~kSDVwSfGvvLlELlTG~~P~~ 615 (808)
.. .++ ......++.|++|+-..-- ..+ .+.+.++-|+.+|.++|++.+.-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 11 000 1123367788888744321 222 45688999999999999988753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.9e-19 Score=199.47 Aligned_cols=225 Identities=27% Similarity=0.358 Sum_probs=175.7
Q ss_pred eeeecCcEEEEEEE----eeCCCEEEEEEeecccch--hhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEEeecC
Q 003605 416 ILGEGGFGLVYSGV----LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 416 ~LG~G~fG~VYkg~----l~dg~~VAVK~lk~~~~~--~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
++|+|.||.|+... .+.|..+|+|.+++.... .......|..++..++ |+.+|++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998665 335778899988753211 1125566888899887 9999999999999999999999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccccccc
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~ 568 (808)
+|.|..++.. ....++.........++-++++||+.+ |+|||+|++||+++.+|.+++.|||+++...+....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988853 233555555666678899999999998 999999999999999999999999999876543322
Q ss_pred ccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCC
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~ 648 (808)
+||..|||||++. ......|.||||++++||+||..||.. +.+..|... .
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~--~ 203 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA--E 203 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh--c
Confidence 7899999999987 456789999999999999999999953 111111111 1
Q ss_pred CCCChhhHHHHHHHHHHccccCCCCCCCH
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFM 677 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 677 (808)
-..+.+.......++.+++..+|..|--.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12455566677888889999999999755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=201.28 Aligned_cols=199 Identities=22% Similarity=0.259 Sum_probs=155.9
Q ss_pred HHHHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc---cccceeEEeeeeeccce
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQAR 480 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~ 480 (808)
.+.-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+.... -+|.-=.+++.||+ -+-|..+..++.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3444567889999999999999999988899999999764221 12222233444444 23344455555556777
Q ss_pred EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-------CCccee
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-------DFTPKV 553 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-------~~~vKL 553 (808)
+||+||.+.|+|.+++. ....++|.-.+.++.|+++.++.||..+ |||+||||+|.||.. +.-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999995 4567999999999999999999999998 999999999999932 346899
Q ss_pred cccccccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCC
Q 003605 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRK 612 (808)
Q Consensus 554 ~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~ 612 (808)
+|||.+-.+.--..........+|-.+-.+|+..++.++...|-|.|..+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999865432222223345668889999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=169.73 Aligned_cols=136 Identities=17% Similarity=0.267 Sum_probs=105.5
Q ss_pred eeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhc-----ccccceeEEeeeeecc---c-eEEE
Q 003605 413 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-----HHRNLVKLIGICIEEQ---A-RCLV 483 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-----~HpNIV~L~g~~~~~~---~-~~LV 483 (808)
..++||+|+||.||. ...++.. +||++........+++.+|+++++.+ .|+||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 457899999999996 3234444 69988754444567899999999999 5799999999998763 3 2378
Q ss_pred Eee--cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCcEEeeeecccCeeecC----CCcceeccc
Q 003605 484 YEL--IPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL-AYLHEDSSPRVIHRDFKSSNILLEH----DFTPKVSDF 556 (808)
Q Consensus 484 ~Ey--~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL-~yLH~~~~p~IiHrDIKpsNILLd~----~~~vKL~DF 556 (808)
+|| +.+|+|.+++.. . .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~----~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----C-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHc----c-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 557999999953 1 25444 35577788777 9999998 999999999999974 348999995
Q ss_pred cccc
Q 003605 557 GLAR 560 (808)
Q Consensus 557 GLa~ 560 (808)
+.++
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7e-17 Score=165.23 Aligned_cols=134 Identities=21% Similarity=0.285 Sum_probs=113.4
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecccc--------hhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ--------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
+.||+|++|.||+|.. +|..|+||+...... ....++.+|++++..++|+|+.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 578899998653211 1234688899999999999998888787777888999999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+++++|.+++.. ..+ ++..++.+++.+|++||+.+ ++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~-------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS-------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh-------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998852 122 88899999999999999998 99999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=162.78 Aligned_cols=145 Identities=19% Similarity=0.118 Sum_probs=113.5
Q ss_pred HHHHHHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccc----------------------hhhHHHHHHHHHH
Q 003605 402 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ----------------------QGGREFLAEVEML 459 (808)
Q Consensus 402 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~----------------------~~~~~f~~Ei~iL 459 (808)
.++......|.+.+.||+|+||.||++...+|+.||||+++.... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445788899999999999999988899999998753210 0112367789999
Q ss_pred hhccccc--ceeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeee
Q 003605 460 SRLHHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRD 537 (808)
Q Consensus 460 ~~L~HpN--IV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrD 537 (808)
..+.|.+ +...++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ |+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 9998874 4445442 455899999999998775420 234678899999999999987 99999
Q ss_pred ecccCeeecCCCcceecccccccccc
Q 003605 538 FKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 538 IKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
|||+||+++++++++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=167.16 Aligned_cols=143 Identities=17% Similarity=0.139 Sum_probs=111.2
Q ss_pred CCcceeeeeeecCcEEEEEEE--eeCCCEEEEEEeecccch------------------------hhHHHHHHHHHHhhc
Q 003605 409 GNFDASRILGEGGFGLVYSGV--LDDGTKVAVKVLKRVDQQ------------------------GGREFLAEVEMLSRL 462 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~--l~dg~~VAVK~lk~~~~~------------------------~~~~f~~Ei~iL~~L 462 (808)
..|.+.+.||+|+||.||+|+ ..+|+.||||+++..... ....+..|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 568999999998743210 112356899999999
Q ss_pred cccc--ceeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecc
Q 003605 463 HHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKS 540 (808)
Q Consensus 463 ~HpN--IV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKp 540 (808)
.+.+ +.+++++ ...++||||+++++|..++.. ...+...+...++.|++.+|++||..+ .|+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 7633 3444443 235899999999888776521 223555667899999999999999875 499999999
Q ss_pred cCeeecCCCcceeccccccccc
Q 003605 541 SNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 541 sNILLd~~~~vKL~DFGLa~~~ 562 (808)
+||+++ +++++|+|||++...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998743
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-16 Score=187.40 Aligned_cols=137 Identities=18% Similarity=0.267 Sum_probs=112.5
Q ss_pred hCCcceeeeeeecCcEEEEEEEeeCCCEEEEEE-eecc-------cchhhHHHHHHHHHHhhcccccceeEEeeeeeccc
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKV-LKRV-------DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 479 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~-lk~~-------~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 479 (808)
...|...++||+|+||+||+|.+.+. .+++|+ +.+. .....+++.+|++++.+++|+|++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999987644 344443 2211 11223578899999999999999998888887778
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.++||||+++++|.+++. ....++.+++++|+|||+.+ ++||||||+|||+ +++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999998874 45778999999999999998 9999999999999 5779999999998
Q ss_pred cc
Q 003605 560 RS 561 (808)
Q Consensus 560 ~~ 561 (808)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=160.69 Aligned_cols=130 Identities=20% Similarity=0.314 Sum_probs=106.7
Q ss_pred eeeecCcEEEEEEEeeCCCEEEEEEeeccc--------chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeec
Q 003605 416 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~--------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
+||+|+||.||+|.+ +|..|++|+..... ....+++.+|++++..++|.++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 57889999865321 112356788999999999887666555666667779999999
Q ss_pred CCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
++++|.+++... . ..++.+++.+|++||+.+ ++|||++|+||+++ ++++++.|||+++.
T Consensus 80 ~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887421 1 078999999999999998 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.7e-17 Score=174.36 Aligned_cols=198 Identities=20% Similarity=0.210 Sum_probs=135.8
Q ss_pred ccccceeEEeeeee---------------------------ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHH
Q 003605 463 HHRNLVKLIGICIE---------------------------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 515 (808)
Q Consensus 463 ~HpNIV~L~g~~~~---------------------------~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia 515 (808)
+|||||++.++|.+ ...+|+||.-++ .+|.++|-. ...+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999988764 224578887774 488888742 235566777788
Q ss_pred HHHHHHHHHHHhcCCCcEEeeeecccCeeec--CC--Ccceeccccccccccccc----ccccccccccccccccchhhh
Q 003605 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLE--HD--FTPKVSDFGLARSAMDEE----SRHISTRVMGTFGYVAPEYAM 587 (808)
Q Consensus 516 ~qia~gL~yLH~~~~p~IiHrDIKpsNILLd--~~--~~vKL~DFGLa~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~ 587 (808)
.|+++|+.|||.++ |.|||+|++||||. +| -...|+|||++-.-.... ...-.-...|.-.-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 89999999999999 99999999999993 33 346889999974221100 000011234677899999875
Q ss_pred cC--C----CccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHH
Q 003605 588 TG--H----LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA 661 (808)
Q Consensus 588 ~~--~----~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~ 661 (808)
.. . -..|+|.|+.|.+.||+++...||..... ..-+...|. +--- ...+......+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yq-----------e~qL----Palp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQ-----------ESQL----PALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhh-----------hhhC----CCCcccCChHHHH
Confidence 42 1 13689999999999999999999965221 111111111 1001 1233344567888
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 003605 662 IASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 662 Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
++...|+.||.+|++..-....|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999998876666654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.6e-17 Score=182.15 Aligned_cols=174 Identities=27% Similarity=0.366 Sum_probs=130.5
Q ss_pred ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
..++.|++|...+|.+||.+.+ .....+|...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999997543 33467889999999999999999 55 89999999999999999999999999
Q ss_pred cccccccc----ccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhc
Q 003605 559 ARSAMDEE----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 559 a~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
........ .....+...||..||+||.+.+..|+.|+||||||+||+||++ =...++- .-
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------------~~ 467 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------------IA 467 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------------HH
Confidence 86544322 1223356789999999999999999999999999999999997 1111110 00
Q ss_pred ccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHH
Q 003605 634 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 679 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 679 (808)
...+..+.++++....+++ .=..++.+++...|.+||++.+
T Consensus 468 t~~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 468 TLTDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 1111222233333333343 2346889999999999994433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=141.37 Aligned_cols=135 Identities=21% Similarity=0.213 Sum_probs=115.4
Q ss_pred eeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccc--ccceeEEeeeeeccceEEEEeecCCC
Q 003605 413 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH--RNLVKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
+.+.||+|.++.||++...+ ..++||..+.... ..++.+|+.++..++| .++.+++++....+..++++||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999864 7899999865433 5679999999999986 58999999988888899999999887
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 491 sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
.+..+ ++.....++.+++++|++||......++|+||+++||+++.++.+++.|||+++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 5567788899999999999987555699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.1e-15 Score=147.54 Aligned_cols=135 Identities=24% Similarity=0.276 Sum_probs=98.5
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeecccch--hhHHH----------------------HHHHHHHhhccccc--c
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--GGREF----------------------LAEVEMLSRLHHRN--L 467 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~--~~~~f----------------------~~Ei~iL~~L~HpN--I 467 (808)
.+.||+|+||+||+|...+++.||||+++..... ....+ ..|.+.+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998742211 11111 35666666665443 4
Q ss_pred eeEEeeeeeccceEEEEeecCCCCcccc-ccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeeeecccCeee
Q 003605 468 VKLIGICIEEQARCLVYELIPNGSVESH-LHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 468 V~L~g~~~~~~~~~LV~Ey~~~GsL~~~-L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~-~~~p~IiHrDIKpsNILL 545 (808)
.+.+++ ...++||||++++.+... +... ... .+..+++.+++.++.++|. .+ |+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 444443 245899999998654322 2110 011 5678899999999999998 76 9999999999999
Q ss_pred cCCCcceeccccccccc
Q 003605 546 EHDFTPKVSDFGLARSA 562 (808)
Q Consensus 546 d~~~~vKL~DFGLa~~~ 562 (808)
+ ++.++|+|||++...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-15 Score=177.55 Aligned_cols=210 Identities=22% Similarity=0.324 Sum_probs=141.0
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEe
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
...+|+.+++|..|+||.||..+++ ..+.+|+|+-++. .+++- ++.....+.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee-----------------
Confidence 3468899999999999999999876 4567888543321 11110 22222223222
Q ss_pred ecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccc
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~ 565 (808)
|+-...+.. -..+.- +.+.+++|||+.+ |+|||+|++|.+|..-|.+|+.|||+.+.....
T Consensus 136 ----gDc~tllk~----~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333333421 112221 2277899999888 999999999999999999999999998743221
Q ss_pred cc-------------cccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 003605 566 ES-------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632 (808)
Q Consensus 566 ~~-------------~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~ 632 (808)
.. ......++||+.|+|||++..+.|....|.|++|+|+||.+-|..||+...++ .|+..+...
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd 273 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISD 273 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhh
Confidence 11 11123468999999999999999999999999999999999999999865432 222111000
Q ss_pred cccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCC
Q 003605 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675 (808)
Q Consensus 633 ~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 675 (808)
. .+. .+-......+..+++.+.|+.+|..|-
T Consensus 274 ~--i~w----------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 D--IEW----------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h--ccc----------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0 000 011223345778899999999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.1e-14 Score=147.50 Aligned_cols=135 Identities=22% Similarity=0.282 Sum_probs=105.7
Q ss_pred eeee-ecCcEEEEEEEeeCCCEEEEEEeeccc-------------chhhHHHHHHHHHHhhcccccc--eeEEeeeeecc
Q 003605 415 RILG-EGGFGLVYSGVLDDGTKVAVKVLKRVD-------------QQGGREFLAEVEMLSRLHHRNL--VKLIGICIEEQ 478 (808)
Q Consensus 415 ~~LG-~G~fG~VYkg~l~dg~~VAVK~lk~~~-------------~~~~~~f~~Ei~iL~~L~HpNI--V~L~g~~~~~~ 478 (808)
.+|| .|+.|+||++... +..++||+++... ......+.+|++++.+|+|.+| ++.++++..+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999998875 7789999885311 1233568889999999998875 77777754432
Q ss_pred c----eEEEEeecCC-CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCccee
Q 003605 479 A----RCLVYELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 553 (808)
Q Consensus 479 ~----~~LV~Ey~~~-GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL 553 (808)
. .++|+||+++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 2599999997 689888742 234433 3567899999999998 999999999999999889999
Q ss_pred ccccccccc
Q 003605 554 SDFGLARSA 562 (808)
Q Consensus 554 ~DFGLa~~~ 562 (808)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.6e-15 Score=173.18 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=186.9
Q ss_pred CcceeeeeeecCcEEEEEEEeeC--CCEEEEEEeeccc--chhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEE
Q 003605 410 NFDASRILGEGGFGLVYSGVLDD--GTKVAVKVLKRVD--QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~d--g~~VAVK~lk~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~ 484 (808)
.|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |.|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45556679999999998776532 3456677665432 222334445777777776 999999999999999999999
Q ss_pred eecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEEeeeecccCeeecCCC-cceeccccccccc
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH-EDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSA 562 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH-~~~~p~IiHrDIKpsNILLd~~~-~vKL~DFGLa~~~ 562 (808)
||..++++.+.+.. ......+....-....|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Cccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988831 12223455666778899999999999 777 99999999999999999 9999999999877
Q ss_pred cc-cccccccccccc-ccccccchhhhcC-CCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccccc
Q 003605 563 MD-EESRHISTRVMG-TFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 563 ~~-~~~~~~~~~~~G-t~~Y~APE~l~~~-~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
.. ...........| ++.|+|||...+. ......|+||.|+++.-+++|..|++...... .....|.... ..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~----~~- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK----GR- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc----cc-
Confidence 66 444444455677 9999999988874 44677899999999999999999998655432 2222332111 00
Q ss_pred ccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 640 ~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.. ...-........++..+++..++..|.+.+++..
T Consensus 250 ---~~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 ---FT----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cc----cCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 0011122345677888899899999999888743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.6e-13 Score=151.87 Aligned_cols=145 Identities=25% Similarity=0.253 Sum_probs=103.8
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchh----------------------------------------
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG---------------------------------------- 448 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~---------------------------------------- 448 (808)
..|+ .+.||.|++|.||+|++.+|+.||||+.+......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 36899999999999999999999999985321100
Q ss_pred hHHHHHHHHHHhhcc----cccceeEEeeeee-ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHH-HH
Q 003605 449 GREFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR-AL 522 (808)
Q Consensus 449 ~~~f~~Ei~iL~~L~----HpNIV~L~g~~~~-~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~-gL 522 (808)
+-+|.+|.+.+.+++ |.+-+.+-..+.+ ....+|||||+++++|.+++.... ... .+.+++..+++ .+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFL 270 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHH
Confidence 113556666666653 3333443333322 345799999999999998764211 112 24566776666 47
Q ss_pred HHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccc
Q 003605 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 523 ~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~ 563 (808)
..+|..+ ++|+|++|.||+++.+++++++|||++..+.
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8899888 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.3e-13 Score=144.67 Aligned_cols=205 Identities=22% Similarity=0.303 Sum_probs=142.5
Q ss_pred HHHhhcccccceeEEeeeeecc-----ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003605 457 EMLSRLHHRNLVKLIGICIEEQ-----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531 (808)
Q Consensus 457 ~iL~~L~HpNIV~L~g~~~~~~-----~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p 531 (808)
..|-.+-|-|||++..|+.+.. ...++.|||..|+|..+|+...+....+......+|+-||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3455567999999999987543 45899999999999999987776677788888899999999999999987 68
Q ss_pred cEEeeeecccCeeecCCCcceeccccc--ccccccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHh
Q 003605 532 RVIHRDFKSSNILLEHDFTPKVSDFGL--ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 609 (808)
Q Consensus 532 ~IiHrDIKpsNILLd~~~~vKL~DFGL--a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlT 609 (808)
+|+|+++..+-|++..++-+|+.---- ...........-.....+-++|.+||+=.....+.++|||+||...+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 899999999999999998888742110 000000000111122346789999998777777889999999999999988
Q ss_pred CCCC-CCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003605 610 GRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 610 G~~P-~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
|..- -+.... ... ++.....+- .+.+. .-..++..|++.+|..||+|++++..
T Consensus 278 lEiq~tnseS~--~~~-----------ee~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESK--VEV-----------EENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcce--eeh-----------hhhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhcC
Confidence 7642 111100 000 000000000 00010 11246789999999999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.7e-12 Score=145.39 Aligned_cols=248 Identities=23% Similarity=0.250 Sum_probs=177.5
Q ss_pred Ccceeeeeee--cCcEEEEEEEe--e-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceE
Q 003605 410 NFDASRILGE--GGFGLVYSGVL--D-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARC 481 (808)
Q Consensus 410 ~f~~~~~LG~--G~fG~VYkg~l--~-dg~~VAVK~lk~--~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~ 481 (808)
.|...+.+|. |.+|.||++.. . ++..+|+|+-+. ........=.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999987 3 678899998543 22233333456777777774 999999999999999999
Q ss_pred EEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCcEEeeeecccCeeecCC-Ccceeccc
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR----ALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDF 556 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~----gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DF 556 (808)
+-+|++ +.+|.++.+.... .+.....+.+..+... ||.++|... ++|-|+|+.||++..+ ...+++||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 999999 4788888874322 2444555666666666 999999887 9999999999999999 88999999
Q ss_pred ccccccccccccc---cccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhc
Q 003605 557 GLARSAMDEESRH---ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 557 GLa~~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
|+...+.+..... ...+..|...|++||.+ ++.++.++|||++|.+.+|-.+|........ ...|.+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~--- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQ--- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC------CCCccc---
Confidence 9998776554222 22334678899999965 5577899999999999999999876543211 112221
Q ss_pred ccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003605 634 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 634 ~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
++... +..++...-..++...+.++++.++..|++.+.+..
T Consensus 338 -----~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -----LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 111121222344555889999999999998877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=120.28 Aligned_cols=131 Identities=18% Similarity=0.067 Sum_probs=98.1
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eEEeeeeeccceEEEEeecCCCCc
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV-~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
.+.|+.|.++.||++... +..+++|....... ....+.+|++++..+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999875 77899998764321 233567899999999766654 444433 2345899999999887
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 493 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 493 ~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~--~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
.+.. .....++.+++++|+.||..+ ...++|+|+++.||+++ ++.++++|||.+..
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6431 011245678999999999886 23469999999999999 66899999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.2e-12 Score=145.73 Aligned_cols=148 Identities=20% Similarity=0.195 Sum_probs=96.3
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeC-CCEEEEEEeecccc----------------------------------hhh--
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQ----------------------------------QGG-- 449 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~d-g~~VAVK~lk~~~~----------------------------------~~~-- 449 (808)
....|+. +.||.|++|.||+|++.+ |+.||||+++..-. +-.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999987 99999999963210 001
Q ss_pred ----HHHHHHHHHHhhcc----cccceeEEeeeee-ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHH-
Q 003605 450 ----REFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA- 519 (808)
Q Consensus 450 ----~~f~~Ei~iL~~L~----HpNIV~L~g~~~~-~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia- 519 (808)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++-.- .. ...+. ..++...+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~--~g~d~---~~la~~~v~ 270 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RA--AGTDM---KLLAERGVE 270 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hh--cCCCH---HHHHHHHHH
Confidence 12445555555553 3334444444433 3567899999999999874211 11 11221 12222222
Q ss_pred HHHHHHHhcCCCcEEeeeecccCeeecCCC----cceeccccccccccc
Q 003605 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDF----TPKVSDFGLARSAMD 564 (808)
Q Consensus 520 ~gL~yLH~~~~p~IiHrDIKpsNILLd~~~----~vKL~DFGLa~~~~~ 564 (808)
.-+..++..+ ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 271 ~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2233445566 99999999999999887 999999999976644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.3e-10 Score=115.91 Aligned_cols=142 Identities=22% Similarity=0.296 Sum_probs=112.1
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecccc-hhhHHHHHHHHHHhhccc--ccceeEEeeeeecc---ceEEEEeecC
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHH--RNLVKLIGICIEEQ---ARCLVYELIP 488 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~-~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~---~~~LV~Ey~~ 488 (808)
+.|+.|.++.||++...+|+.+++|....... ....++..|++++..+++ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999999764322 235678999999999975 34577888776542 5689999999
Q ss_pred CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--------------------------------------- 529 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~--------------------------------------- 529 (808)
+.++.+.+.. ..++..++..++.+++++|++||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988886631 24777888888889999999998531
Q ss_pred --------------CCcEEeeeecccCeeecC--CCcceecccccccc
Q 003605 530 --------------SPRVIHRDFKSSNILLEH--DFTPKVSDFGLARS 561 (808)
Q Consensus 530 --------------~p~IiHrDIKpsNILLd~--~~~vKL~DFGLa~~ 561 (808)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.9e-10 Score=129.45 Aligned_cols=166 Identities=22% Similarity=0.264 Sum_probs=126.8
Q ss_pred eeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHH
Q 003605 430 LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 509 (808)
Q Consensus 430 l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~ 509 (808)
..++..|.|+..+...........+-++.|+.|+||||++++..+..++..|||+|-+ --|..++.. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hHHH
Confidence 3478889999888665544455677788999999999999999999999999999988 366777742 2345
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccccccccccccccchhhhcC
Q 003605 510 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589 (808)
Q Consensus 510 ~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~ 589 (808)
.....+.||+.||.|||+.+ .++|++|.-+.|++++.|+-||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 56667889999999999776 599999999999999999999999998865432221 01111122356777754332
Q ss_pred CCccccceeeHHHHHHHHHhC
Q 003605 590 HLLVKSDVYSYGVVILELLSG 610 (808)
Q Consensus 590 ~~s~kSDVwSfGvvLlELlTG 610 (808)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-09 Score=109.99 Aligned_cols=135 Identities=19% Similarity=0.202 Sum_probs=98.0
Q ss_pred eeeeecCcEEEEEEEeeC-------CCEEEEEEeecc-------------c---------chhhHHHH----HHHHHHhh
Q 003605 415 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRV-------------D---------QQGGREFL----AEVEMLSR 461 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d-------g~~VAVK~lk~~-------------~---------~~~~~~f~----~Ei~iL~~ 461 (808)
..||.|--+.||.|...+ +..+|||+.+.. + ....+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 479999987420 0 01122333 79999999
Q ss_pred ccc--ccceeEEeeeeeccceEEEEeecCCCCccc-cccccccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEeee
Q 003605 462 LHH--RNLVKLIGICIEEQARCLVYELIPNGSVES-HLHGVDKESAPLGWDARLKIALGAARALAYL-HEDSSPRVIHRD 537 (808)
Q Consensus 462 L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~-~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yL-H~~~~p~IiHrD 537 (808)
+.. -++...+++ ...+|||||+.++.+.. .|+ ...++..+...+..+++.+|.+| |+.+ |||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 964 456667754 45689999997653322 221 11344456677889999999999 7887 99999
Q ss_pred ecccCeeecCCCcceeccccccccc
Q 003605 538 FKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 538 IKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
|++.|||+++ +.++|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 68999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-10 Score=131.41 Aligned_cols=250 Identities=21% Similarity=0.191 Sum_probs=177.4
Q ss_pred HHHhCCcceeeeeeecCcEEEEEEEee--CCCEEEEEEeecccchhhH--HHHHHHHHHhhc-ccccceeEEeeeeeccc
Q 003605 405 EKATGNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRVDQQGGR--EFLAEVEMLSRL-HHRNLVKLIGICIEEQA 479 (808)
Q Consensus 405 ~~at~~f~~~~~LG~G~fG~VYkg~l~--dg~~VAVK~lk~~~~~~~~--~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 479 (808)
...+.+|.+...||.|.|+.|++...+ ++..+++|.+.+....... .-+.|+-+...+ .|.|+++.+..+..-++
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 345678999999999999999988754 6788999988754333222 234566666666 48899998888877788
Q ss_pred eEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC-Ccceeccccc
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGL 558 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~-~~vKL~DFGL 558 (808)
.++=-|||+++++...+ .....++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||+
T Consensus 341 ~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence 88999999999887766 22345778889999999999999999776 9999999999999876 8899999999
Q ss_pred cccccccccccccccccccccc-ccchhhhcCCCccccceeeHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhccccc
Q 003605 559 ARSAMDEESRHISTRVMGTFGY-VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y-~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
+..+.-... ...-.+..| .+++......+..+.|+||||.-+.|.++|..--. +.+.|..
T Consensus 414 ~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~------- 474 (524)
T KOG0601|consen 414 WTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLT------- 474 (524)
T ss_pred ccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCc--------cccccee-------
Confidence 863211110 111122233 35555556678899999999999999999865321 1122211
Q ss_pred ccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 003605 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 638 ~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
+....+ ...+.. ...+..++..+...++..||.+.++..+.+.
T Consensus 475 ----i~~~~~-p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 475 ----IRSGDT-PNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----eecccc-cCCCch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000000 011111 2567778888999999999999888766553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-08 Score=115.15 Aligned_cols=169 Identities=17% Similarity=0.245 Sum_probs=127.6
Q ss_pred cEEEEEEEee-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeEEeeeee----ccceEEEEeecCC-CCcccc
Q 003605 422 FGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE----EQARCLVYELIPN-GSVESH 495 (808)
Q Consensus 422 fG~VYkg~l~-dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LV~Ey~~~-GsL~~~ 495 (808)
-.+.||+... ||..|++||++....+.......-+++++++.|.|+|+|..++.. +..++|||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4678999855 899999999954333333333455789999999999999998763 4567999999985 467665
Q ss_pred ccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 496 LHGVD-----------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 496 L~~~~-----------~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
-.... ..+..+.+..+|.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43221 12345778899999999999999999998 88899999999999999999998888665433
Q ss_pred ccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCC
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRK 612 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~ 612 (808)
+.. |-+.. -.+-|.=.||.+++.|.||..
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 221 11111 135688899999999999964
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.8e-08 Score=101.24 Aligned_cols=131 Identities=20% Similarity=0.293 Sum_probs=98.8
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEE-eecc-------cchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEEee
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKV-LKRV-------DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~-lk~~-------~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..+.+|+-..+|.+.+- |..+++|. +.+. ..-..++-.+|.++|.+++--.|..-+=|..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999765 44466663 3221 112234567899999999766665555556667788899999
Q ss_pred cCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+++-.|.+.|... +..++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888421 3556777778888899998 99999999999997764 99999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.3e-09 Score=130.69 Aligned_cols=249 Identities=19% Similarity=0.230 Sum_probs=164.2
Q ss_pred HhCCcceeeeeeecCcEEEEEEEee-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeEEeeeeeccceEE
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-dg~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
..+.|.+.+-+..|.++.++.+.-. .|...++|..+... ....+....+-.++-..+||-+++...-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3466777778889999999877633 33333444433211 1122222233333333345666665555555678899
Q ss_pred EEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
+++|+.+++|...||... .++.+........+..+++|||... ++|+|++|.|+|+..++..+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998533 3443444444556778899999876 899999999999999999999999843211
Q ss_pred ccc-----------------------------cccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCC
Q 003605 563 MDE-----------------------------ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613 (808)
Q Consensus 563 ~~~-----------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P 613 (808)
... +.........||..|.+||...+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 000111235689999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhcccccccccccCCCC-CCCCChhhHHHHHHHHHHccccCCCCCCCHH
Q 003605 614 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSL-GNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 678 (808)
Q Consensus 614 ~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 678 (808)
|+...+... ++.+....+ ....+.+...+..+++...+..++.+|-.+.
T Consensus 1035 ~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 976543211 111111111 0112234445667788888888999997665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.5e-08 Score=99.82 Aligned_cols=142 Identities=21% Similarity=0.310 Sum_probs=104.1
Q ss_pred eeeeeeecCcEEEEEEEeeCCCEEEEEE-eec-------ccchhhHHHHHHHHHHhhcccccceeEEeeeeeccceEEEE
Q 003605 413 ASRILGEGGFGLVYSGVLDDGTKVAVKV-LKR-------VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~dg~~VAVK~-lk~-------~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
...+|-+|+-+.|+++.+. |+...||. +.+ ...-...+-.+|+++|.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999886 77777774 322 11233467788999999987656655555566666678999
Q ss_pred eecCC-CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC---cceeccccccc
Q 003605 485 ELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVSDFGLAR 560 (808)
Q Consensus 485 Ey~~~-GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~---~vKL~DFGLa~ 560 (808)
||+++ -++.+++...... .........++..|-+.+.-||.++ |||+||..+||+|..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99965 3788887643221 1222223678888889999999998 99999999999996543 45899999975
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-07 Score=102.37 Aligned_cols=140 Identities=16% Similarity=0.092 Sum_probs=101.1
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecccc-----------hhhHHHHHHHHHHhhccccc--ceeEEeeeee-----
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-----------QGGREFLAEVEMLSRLHHRN--LVKLIGICIE----- 476 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~-----------~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~----- 476 (808)
+++-+-....|++..+ +|+.+.||+...... .....+.+|.+.+.+|...+ ....+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444455777666 478899997743221 11124789999999996444 4455666543
Q ss_pred ccceEEEEeecCCC-CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecC-------C
Q 003605 477 EQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-------D 548 (808)
Q Consensus 477 ~~~~~LV~Ey~~~G-sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~-------~ 548 (808)
...-+||+|++++- +|.+++.... ....+...+..++.+++..++-||..+ |+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23468999999875 7888874221 123455677889999999999999999 999999999999975 4
Q ss_pred Ccceeccccccc
Q 003605 549 FTPKVSDFGLAR 560 (808)
Q Consensus 549 ~~vKL~DFGLa~ 560 (808)
..+.|+||+.++
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-07 Score=96.72 Aligned_cols=125 Identities=24% Similarity=0.273 Sum_probs=81.5
Q ss_pred EEEEEEeeCCCEEEEEEeecc---------------c-----------chhhHHHHHHHHHHhhcccc--cceeEEeeee
Q 003605 424 LVYSGVLDDGTKVAVKVLKRV---------------D-----------QQGGREFLAEVEMLSRLHHR--NLVKLIGICI 475 (808)
Q Consensus 424 ~VYkg~l~dg~~VAVK~lk~~---------------~-----------~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~ 475 (808)
.||.|...+|..+|||+.+.. . ........+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999888999999987420 0 00123467799999999755 45666644
Q ss_pred eccceEEEEeecC--CCCccccccccccCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCcEEeeeecccCeeecCCCcce
Q 003605 476 EEQARCLVYELIP--NGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-LHEDSSPRVIHRDFKSSNILLEHDFTPK 552 (808)
Q Consensus 476 ~~~~~~LV~Ey~~--~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~y-LH~~~~p~IiHrDIKpsNILLd~~~~vK 552 (808)
...+|||||++ +..+.. |... .++......++.+++..+.. +|..+ |+|+||...|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 24479999998 434433 3211 11134456677777775555 56777 9999999999999988 999
Q ss_pred eccccccccc
Q 003605 553 VSDFGLARSA 562 (808)
Q Consensus 553 L~DFGLa~~~ 562 (808)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.3e-06 Score=91.96 Aligned_cols=265 Identities=17% Similarity=0.167 Sum_probs=155.2
Q ss_pred eeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeEEeee------eeccc-eEEEE
Q 003605 413 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGIC------IEEQA-RCLVY 484 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~------~~~~~-~~LV~ 484 (808)
..+-||+|+-+.+|-. ..-...+-|+...-...... +.++.|... .|+-+-.-+.+= -+++. .-++|
T Consensus 15 ~gr~LgqGgea~ly~l--~e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTL--GEVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeec--chhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3467999999999943 22223345776543222222 223344444 455433212110 11222 45667
Q ss_pred eecCCC-Cccccccc--cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 485 ELIPNG-SVESHLHG--VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 485 Ey~~~G-sL~~~L~~--~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
..+.+. -+..++.- .++.-...+|+..++++..+|.+.+-||+.+ .+-+|++++|+|+.++..+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 766543 12222211 1122345899999999999999999999999 88999999999999999999987543221
Q ss_pred cccccccccccccccccccccchhhh-----cCCCccccceeeHHHHHHHHHhC-CCCCCCCCCCC------cchhHHhh
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPG------QENLVAWA 629 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~kSDVwSfGvvLlELlTG-~~P~~~~~~~~------~~~lv~w~ 629 (808)
...+ ......+|...|.+||.-. +-.-+..+|.|.|||++++|+.| ++||..-.... +.++....
T Consensus 167 -~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 -NANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred -ccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 1111 1222346888999999543 22346779999999999999986 99996532211 11111100
Q ss_pred hhhcccccccccccCCCCCCCCChh-hHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHHHhhh
Q 003605 630 RPLLTSREGLERIIDPSLGNDVPFD-SVAKVAAIASMCVQPE--VQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 630 ~~~~~~~~~l~~ivD~~l~~~~~~~-~~~~l~~Li~~Cl~~d--P~~RPsm~eVl~~Le~i~~~~~ 692 (808)
-. ...+......-. -..++.. ....+..+..+|+... +.-||+.+-.+..|..+.+++.
T Consensus 244 f~-ya~~~~~g~~p~---P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 244 FA-YASDQRRGLKPP---PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred ee-echhccCCCCCC---CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00 000000000000 1112222 2345667778888654 5689999999999988777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.4e-07 Score=91.63 Aligned_cols=107 Identities=22% Similarity=0.246 Sum_probs=84.9
Q ss_pred hhHHHHHHHHHHhhccc--ccceeEEeeeeecc----ceEEEEeecCCC-CccccccccccCCCCCCHHHHHHHHHHHHH
Q 003605 448 GGREFLAEVEMLSRLHH--RNLVKLIGICIEEQ----ARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAAR 520 (808)
Q Consensus 448 ~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~----~~~LV~Ey~~~G-sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~ 520 (808)
....+.+|...+.+|.. -...+.+++..... ..+||+|++++. +|.+++.... .++......++.++++
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALAR 129 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHH
Confidence 34578889999998864 34566777765532 348999999874 7888885321 1555677889999999
Q ss_pred HHHHHHhcCCCcEEeeeecccCeeecCCC---cceecccccccc
Q 003605 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVSDFGLARS 561 (808)
Q Consensus 521 gL~yLH~~~~p~IiHrDIKpsNILLd~~~---~vKL~DFGLa~~ 561 (808)
.++-||+.+ |+|+|+++.|||++.+. ++.++||+-++.
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999 99999999999998886 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.7e-06 Score=88.05 Aligned_cols=139 Identities=18% Similarity=0.128 Sum_probs=103.2
Q ss_pred eeecCcEEEEEEEeeCCCEEEEEEeec-----c-cchhhHHHHHHHHHHhhccc--ccceeEEeeeeec----cceEEEE
Q 003605 417 LGEGGFGLVYSGVLDDGTKVAVKVLKR-----V-DQQGGREFLAEVEMLSRLHH--RNLVKLIGICIEE----QARCLVY 484 (808)
Q Consensus 417 LG~G~fG~VYkg~l~dg~~VAVK~lk~-----~-~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~----~~~~LV~ 484 (808)
-|+||.+.|++-.++ |..+-+|+-.. . ...+...|.+|+..|.+|.. -++.+.+.+.... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999987776 55788998752 1 14466789999999999964 3345555222221 2348999
Q ss_pred eecCC-CCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCc--ceecccccccc
Q 003605 485 ELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT--PKVSDFGLARS 561 (808)
Q Consensus 485 Ey~~~-GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~--vKL~DFGLa~~ 561 (808)
|-+.+ -+|.+++... ...+.+...+..+..++++.++-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98853 4888887432 1224567778899999999999999999 999999999999986666 99999987653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.9e-07 Score=108.70 Aligned_cols=151 Identities=18% Similarity=0.292 Sum_probs=101.7
Q ss_pred HHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccccccccccccc-------cccccccccccchhhhc
Q 003605 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-------TRVMGTFGYVAPEYAMT 588 (808)
Q Consensus 516 ~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~-------~~~~Gt~~Y~APE~l~~ 588 (808)
.+++.||.|||... ++||++|.|++|.++.++..||+.|+.+............ --..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34569999999754 7999999999999999999999999988654331111111 01123457999999999
Q ss_pred CCCccccceeeHHHHHHHHHhCCCC-CCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHcc
Q 003605 589 GHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCV 667 (808)
Q Consensus 589 ~~~s~kSDVwSfGvvLlELlTG~~P-~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl 667 (808)
...+.++|+||+||++|-+..|..+ +...... ..+..... ..+.. .-.+..+...++.+-+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~--------~~~~~-~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRN--------LLNAG-AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhc--------ccccc-cccccccCcHHHHHHHHHHh
Confidence 8889999999999999999954443 3322111 11110000 00100 01122344567888899999
Q ss_pred ccCCCCCCCHHHHHH
Q 003605 668 QPEVQHRPFMGEVVQ 682 (808)
Q Consensus 668 ~~dP~~RPsm~eVl~ 682 (808)
..+...||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877743
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.3e-06 Score=89.66 Aligned_cols=135 Identities=23% Similarity=0.164 Sum_probs=94.6
Q ss_pred cceeeeeeecCcEEEEEEEeeCCCEEEEEEeec----------cc------------chhhHHHHHHHHHHhhcccc--c
Q 003605 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKR----------VD------------QQGGREFLAEVEMLSRLHHR--N 466 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~----------~~------------~~~~~~f~~Ei~iL~~L~Hp--N 466 (808)
..+.+.||.|--+.||.|...+|..+|||.=+. .. ........+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345689999999999999999999999996321 00 01223467799999999654 6
Q ss_pred ceeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeec
Q 003605 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 546 (808)
Q Consensus 467 IV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd 546 (808)
+.+.+++ +...+||||+++--|...- ++-...-.|+..|++-+.-+-..+ |||+|+..-|||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 6666654 4557999999875444321 122223334444444444444666 99999999999999
Q ss_pred CCCcceecccccccc
Q 003605 547 HDFTPKVSDFGLARS 561 (808)
Q Consensus 547 ~~~~vKL~DFGLa~~ 561 (808)
+++.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.2e-06 Score=98.45 Aligned_cols=146 Identities=25% Similarity=0.253 Sum_probs=97.1
Q ss_pred CCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccch----------------------------------------h
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ----------------------------------------G 448 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~----------------------------------------~ 448 (808)
..|+. +-|+.++-|.||+|++.+|+.||||+.+..-.. .
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 44543 678999999999999999999999997421000 1
Q ss_pred hHHHHHHHHHHhhcc----cccceeEEeeeee-ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHH-H
Q 003605 449 GREFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA-L 522 (808)
Q Consensus 449 ~~~f~~Ei~iL~~L~----HpNIV~L~g~~~~-~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~g-L 522 (808)
+-+|.+|...+.+++ +..-+++=..|++ .....|+|||++|-.+.+...-. ...++ +..|+..++++ +
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d---~k~ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGID---RKELAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCC---HHHHHHHHHHHHH
Confidence 113455655555553 2223344444443 46779999999998888874311 12344 33344333333 3
Q ss_pred HHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccccc
Q 003605 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 523 ~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~ 564 (808)
..+-.++ ++|.|..|.||+++.++++.+.|||+......
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3444456 99999999999999999999999999875543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.5e-05 Score=83.79 Aligned_cols=141 Identities=18% Similarity=0.225 Sum_probs=86.4
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeEEeeeeeccceEEEEeecCCCC-
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGICIEEQARCLVYELIPNGS- 491 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~~~~~LV~Ey~~~Gs- 491 (808)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 24567788876432 2345688999999997544 4677777777777889999998863
Q ss_pred cccc---------------------ccccccCCCCCCH-HHHH-HHH-------HHHH-HHHHHHHhc-CCCcEEeeeec
Q 003605 492 VESH---------------------LHGVDKESAPLGW-DARL-KIA-------LGAA-RALAYLHED-SSPRVIHRDFK 539 (808)
Q Consensus 492 L~~~---------------------L~~~~~~~~~L~~-~~~l-~Ia-------~qia-~gL~yLH~~-~~p~IiHrDIK 539 (808)
+... ||........+.. ..++ ..+ ..+. ....+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2211 1211111111110 0000 000 0001 112223221 13457999999
Q ss_pred ccCeeecCCCcceecccccccc
Q 003605 540 SSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 540 psNILLd~~~~vKL~DFGLa~~ 561 (808)
+.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.2e-05 Score=80.40 Aligned_cols=145 Identities=22% Similarity=0.243 Sum_probs=87.6
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeEEeeeeec---cceEEEEeecC
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGICIEE---QARCLVYELIP 488 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~---~~~~LV~Ey~~ 488 (808)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.++... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999999876 68999987643 45577889999999986443 55677654332 34589999999
Q ss_pred CCCccc----------------c---ccccccCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 003605 489 NGSVES----------------H---LHGVDKESAPLGWDA---------RLKI------------ALGAAR-ALAYLHE 527 (808)
Q Consensus 489 ~GsL~~----------------~---L~~~~~~~~~L~~~~---------~l~I------------a~qia~-gL~yLH~ 527 (808)
+..+.. . ||..........+.. .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 888777 1 111111111112111 0000 111222 3344443
Q ss_pred c----CCCcEEeeeecccCeeec-CCCcceecccccccc
Q 003605 528 D----SSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARS 561 (808)
Q Consensus 528 ~----~~p~IiHrDIKpsNILLd-~~~~vKL~DFGLa~~ 561 (808)
. ....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 345699999999999999 666678999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.5e-07 Score=103.35 Aligned_cols=193 Identities=18% Similarity=0.134 Sum_probs=138.3
Q ss_pred HHHHhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc-ceeEEeeeeeccceEE
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN-LVKLIGICIEEQARCL 482 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~L 482 (808)
++..+.-+...+-+++|+++++||.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..++..++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34444445555678999999999987543334445554322 34556899999999999 7777777877888899
Q ss_pred EEeecCCC-CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 483 VYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 483 V~Ey~~~G-sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+++++..+ +-..-.. .....+...+...+...-+++++|||+.. =+|+| ||+..+ ...|..||+....
T Consensus 312 ~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred hhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence 99999877 2222111 11123444455566677788999999764 48999 877765 5899999999876
Q ss_pred cccccccccccccccccccccchhhhcCCCccccceeeHHHHHHHHHhCCCCCC
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~kSDVwSfGvvLlELlTG~~P~~ 615 (808)
+.... ......++..|+|||+...+.+..+.|+|++|+-..++.-|-.|-.
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 54322 2344568999999999999999999999999998778877776643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.5e-05 Score=82.18 Aligned_cols=140 Identities=21% Similarity=0.189 Sum_probs=86.9
Q ss_pred eeecCc-EEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeEEeeeeeccceEEEEeecCCCCccc
Q 003605 417 LGEGGF-GLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIPNGSVES 494 (808)
Q Consensus 417 LG~G~f-G~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~ 494 (808)
|-.|.. ..||+...+ +..++||+..... ..++.+|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789998765 4788888876432 346778999999884 4445677877766667799999999887764
Q ss_pred cc-------------------cccccCCCCCC--HHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 003605 495 HL-------------------HGVDKESAPLG--WDARLKIAL--------------------GAARALAYLHED----S 529 (808)
Q Consensus 495 ~L-------------------~~~~~~~~~L~--~~~~l~Ia~--------------------qia~gL~yLH~~----~ 529 (808)
.. |.......... +..++.... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 42 21111111111 001110000 011122222211 2
Q ss_pred CCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 530 ~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
.+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3569999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.5e-05 Score=79.43 Aligned_cols=138 Identities=15% Similarity=0.173 Sum_probs=93.8
Q ss_pred HhCCcceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHH---------HHHHHHHhhccc---ccceeEEeee
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF---------LAEVEMLSRLHH---RNLVKLIGIC 474 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f---------~~Ei~iL~~L~H---pNIV~L~g~~ 474 (808)
..++|...+++-......|.+-.. +|..+++|..+......++.| .+++..+.+++. .....++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 557888888888877777766555 478999998875333333332 344555555543 2333333333
Q ss_pred ee-----ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCC
Q 003605 475 IE-----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 549 (808)
Q Consensus 475 ~~-----~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~ 549 (808)
.. ....+|+|||++|-.|.++.. ++. .++..++++|.-||+.| +.|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22 234478999999988877642 222 24556778899999999 9999999999999865
Q ss_pred cceecccccccc
Q 003605 550 TPKVSDFGLARS 561 (808)
Q Consensus 550 ~vKL~DFGLa~~ 561 (808)
.+++.||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.6e-05 Score=92.51 Aligned_cols=141 Identities=18% Similarity=0.168 Sum_probs=91.6
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecccch-------------------------------------hhHHHHHHHH
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ-------------------------------------GGREFLAEVE 457 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~-------------------------------------~~~~f~~Ei~ 457 (808)
+-||.-+.|.||+|++++|+.||||+-+..-+. .+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 679999999999999999999999996421100 1123666666
Q ss_pred HHhhc----cccc---ceeEEeeeee-ccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 003605 458 MLSRL----HHRN---LVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529 (808)
Q Consensus 458 iL~~L----~HpN---IV~L~g~~~~-~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~ 529 (808)
-..+. +|-+ -|.+-.++++ .....|+||||+|..+.|.-.- ....++-..+..-+.++..-+ |=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~q--If~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQ--IFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHH--HHhcC
Confidence 55554 3555 1223333333 2577999999999988776421 122355444433333322111 22234
Q ss_pred CCcEEeeeecccCeeecC----CCcceecccccccccc
Q 003605 530 SPRVIHRDFKSSNILLEH----DFTPKVSDFGLARSAM 563 (808)
Q Consensus 530 ~p~IiHrDIKpsNILLd~----~~~vKL~DFGLa~~~~ 563 (808)
++|.|=.|.||+++. ++++.+-|||+.....
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 899999999999983 6789999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=9.9e-05 Score=77.85 Aligned_cols=152 Identities=20% Similarity=0.221 Sum_probs=99.4
Q ss_pred cCCHHHHHHHhCCcceeeeeee---cCcEEEEEEEeeCCCEEEEEEeecccchh---------hHH--------------
Q 003605 398 TFSASEIEKATGNFDASRILGE---GGFGLVYSGVLDDGTKVAVKVLKRVDQQG---------GRE-------------- 451 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~~~LG~---G~fG~VYkg~l~dg~~VAVK~lk~~~~~~---------~~~-------------- 451 (808)
..+++.|....++..+..+.|. |.-..||+|.-.++..+|||+.+...... ..+
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3566777777777777777664 55567999998889999999986321110 011
Q ss_pred -HHHHHHHHhhcc--cccceeEEeeeeeccceEEEEeecCCC-CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 003605 452 -FLAEVEMLSRLH--HRNLVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527 (808)
Q Consensus 452 -f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LV~Ey~~~G-sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~ 527 (808)
..+|+..|.++. +-.+.+-+++. .-.|||||+... .-.-.|. ...+...+...+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHH
Confidence 234555666653 33334444433 337999999643 1111121 1123333566667778888888776
Q ss_pred -cCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 528 -DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 528 -~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
.+ +||+||..-|||+. ++.+.|+|||-|...
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 44 99999999999999 789999999988643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.3e-05 Score=78.88 Aligned_cols=103 Identities=24% Similarity=0.214 Sum_probs=81.3
Q ss_pred HHHHHHHhhccc-ccceeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003605 453 LAEVEMLSRLHH-RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531 (808)
Q Consensus 453 ~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p 531 (808)
..|.-+++.+++ +++.+++|+|- .++|.||...+++...-.. -..-..-+|..|.+||.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 69999999993 3678999987766432100 00112478999999999999999999986544
Q ss_pred cEEeeeecccCeeecCCCcceeccccccc
Q 003605 532 RVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 532 ~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
.+.-.|++++|+-+++++++|+.|...+.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 58899999999999999999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00029 Score=77.01 Aligned_cols=79 Identities=15% Similarity=0.137 Sum_probs=59.0
Q ss_pred cceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccc---ccceeEEeeeeec---cceEEEE
Q 003605 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH---RNLVKLIGICIEE---QARCLVY 484 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~~---~~~~LV~ 484 (808)
....+-||.|..+.||+....++ .+++|..+.. .....|.+|.+.|+.|.- -.+.+++++|..+ +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34456899999999999876655 4666775431 123588999999999953 3678889887543 5689999
Q ss_pred eecCCCCc
Q 003605 485 ELIPNGSV 492 (808)
Q Consensus 485 Ey~~~GsL 492 (808)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998766
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00015 Score=89.94 Aligned_cols=148 Identities=15% Similarity=0.239 Sum_probs=93.2
Q ss_pred eeeeeecCcEEEEEEEeeCC---CEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccc--eeEEeeeeec---cceEEE
Q 003605 414 SRILGEGGFGLVYSGVLDDG---TKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNL--VKLIGICIEE---QARCLV 483 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg---~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~-HpNI--V~L~g~~~~~---~~~~LV 483 (808)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999877654 367777754322 123457889999999995 6665 7888888764 467899
Q ss_pred EeecCCCCcccc-----------------------ccccccC-------CCCCCHHH--HHHH---------------HH
Q 003605 484 YELIPNGSVESH-----------------------LHGVDKE-------SAPLGWDA--RLKI---------------AL 516 (808)
Q Consensus 484 ~Ey~~~GsL~~~-----------------------L~~~~~~-------~~~L~~~~--~l~I---------------a~ 516 (808)
|||+++..+.+. ||..... +.+..+.. ...+ .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999987654321 2221111 01111111 1111 01
Q ss_pred HHHHHHHHHHhcCC--------CcEEeeeecccCeeecCC-Cc-ceecccccccc
Q 003605 517 GAARALAYLHEDSS--------PRVIHRDFKSSNILLEHD-FT-PKVSDFGLARS 561 (808)
Q Consensus 517 qia~gL~yLH~~~~--------p~IiHrDIKpsNILLd~~-~~-vKL~DFGLa~~ 561 (808)
.+.+.+++|..+-. +.+||+|+++.|||++.+ .+ +-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 23345677754321 349999999999999853 33 57899998753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00023 Score=73.36 Aligned_cols=128 Identities=21% Similarity=0.301 Sum_probs=91.1
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeeccc----------------chhhHHHHHHHHHHhhcc------cccceeEE
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD----------------QQGGREFLAEVEMLSRLH------HRNLVKLI 471 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~----------------~~~~~~f~~Ei~iL~~L~------HpNIV~L~ 471 (808)
...||+|+.=.||. +.+.....||+.+... ....+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999994 5556678889886543 223567788888777776 78899999
Q ss_pred eeeeeccceEEEEeecCC--C----CccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeee
Q 003605 472 GICIEEQARCLVYELIPN--G----SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 545 (808)
Q Consensus 472 g~~~~~~~~~LV~Ey~~~--G----sL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILL 545 (808)
|+..+....-+|+|.+.+ | +|.+++. ...++. +..+. +-+-..||-+++ |+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEE
Confidence 999999899999998753 3 4566663 123444 33333 334456777776 9999999999999
Q ss_pred cCC---C-cceecc
Q 003605 546 EHD---F-TPKVSD 555 (808)
Q Consensus 546 d~~---~-~vKL~D 555 (808)
..+ . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 543 2 455655
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00022 Score=74.78 Aligned_cols=141 Identities=23% Similarity=0.284 Sum_probs=79.1
Q ss_pred eeeeecCcE-EEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccc---cceeEEeeeeec---cceEEEEeec
Q 003605 415 RILGEGGFG-LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR---NLVKLIGICIEE---QARCLVYELI 487 (808)
Q Consensus 415 ~~LG~G~fG-~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~~~---~~~~LV~Ey~ 487 (808)
+.|+.|+.. .||+. +..+++|..+.. ....++.+|.++|..+... .+.+.++..... +..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 58875 235677765532 2345788999999988532 344455444332 2348899999
Q ss_pred CCCCcccc------------------ccccccCCCC------------C-CHHHHH--HHH-------HHHHHH-HHH-H
Q 003605 488 PNGSVESH------------------LHGVDKESAP------------L-GWDARL--KIA-------LGAARA-LAY-L 525 (808)
Q Consensus 488 ~~GsL~~~------------------L~~~~~~~~~------------L-~~~~~l--~Ia-------~qia~g-L~y-L 525 (808)
+|.++.+. ||........ + .|.... .+. .+.+.. ++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98777543 2221111100 0 122111 010 011111 111 1
Q ss_pred Hh--cCCCcEEeeeecccCeeecCCCcceecccccccc
Q 003605 526 HE--DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 526 H~--~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
+. ...+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234599999999999998775567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0005 Score=71.72 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=82.8
Q ss_pred eeeeeecCcEEEEEEEeeC--CCEEEEEEeecccchhhHHHHHHHHHHhhcccccc-eeEEeeeeeccceEEEEeecCCC
Q 003605 414 SRILGEGGFGLVYSGVLDD--GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYELIPNG 490 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~d--g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~~~G 490 (808)
.+.|..|-...+|+....+ +..|++|+....... .-+..+|+.++..+...++ .++++.+. ..+||||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788889999988764 678889976543221 1233478889998864444 44444332 24899999987
Q ss_pred Ccccc-----------------ccccccCC-------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 003605 491 SVESH-----------------LHGVDKES-------APL-GWDARLKIAL----------------------GAARALA 523 (808)
Q Consensus 491 sL~~~-----------------L~~~~~~~-------~~L-~~~~~l~Ia~----------------------qia~gL~ 523 (808)
++... +|...... ... -|..+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76422 12111110 011 1222111111 1111112
Q ss_pred HH----Hhc-CCCcEEeeeecccCeeecC-CCcceeccccccc
Q 003605 524 YL----HED-SSPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 560 (808)
Q Consensus 524 yL----H~~-~~p~IiHrDIKpsNILLd~-~~~vKL~DFGLa~ 560 (808)
.| ... ....++|+|+.+.|||++. +..+.|.||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 211 2345999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00064 Score=72.21 Aligned_cols=139 Identities=19% Similarity=0.144 Sum_probs=81.4
Q ss_pred eeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccc-eeEEeeeeeccceEEEEeecCCCCcccc
Q 003605 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYELIPNGSVESH 495 (808)
Q Consensus 417 LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~~~GsL~~~ 495 (808)
+..|-.+.+|+... ++..+++|+.........-+..+|.++++.+....+ .++++.+. ..+||||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 467888887654322211245789999999865444 34444432 3689999998776532
Q ss_pred -----------------ccccccCCCCCCHHHHH-HHH---------HHHHHHHHHHHhc-----CCCcEEeeeecccCe
Q 003605 496 -----------------LHGVDKESAPLGWDARL-KIA---------LGAARALAYLHED-----SSPRVIHRDFKSSNI 543 (808)
Q Consensus 496 -----------------L~~~~~~~~~L~~~~~l-~Ia---------~qia~gL~yLH~~-----~~p~IiHrDIKpsNI 543 (808)
||........++...++ ... ..+.+.+..+-.. ..+.++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 23222112223322211 111 0111222222221 123589999999999
Q ss_pred eecCCCcceecccccccc
Q 003605 544 LLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 544 LLd~~~~vKL~DFGLa~~ 561 (808)
++++++ +.|.||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0011 Score=68.39 Aligned_cols=125 Identities=26% Similarity=0.421 Sum_probs=89.2
Q ss_pred CCcceeeeeeecCc-EEEEEEEeeCCCEEEEEEeecc------------cc---------hhhHHHHHHHHHHhhcc---
Q 003605 409 GNFDASRILGEGGF-GLVYSGVLDDGTKVAVKVLKRV------------DQ---------QGGREFLAEVEMLSRLH--- 463 (808)
Q Consensus 409 ~~f~~~~~LG~G~f-G~VYkg~l~dg~~VAVK~lk~~------------~~---------~~~~~f~~Ei~iL~~L~--- 463 (808)
.+|+..+.||.|.- |.|||+.+. |+.+|+|.++.. .. ....-|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 999999986 789999994320 00 11235888999999985
Q ss_pred cccc--eeEEeeeeec-c-----------------ceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHH
Q 003605 464 HRNL--VKLIGICIEE-Q-----------------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523 (808)
Q Consensus 464 HpNI--V~L~g~~~~~-~-----------------~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~ 523 (808)
+.++ |+.+||..-. + ...+|.||++... .+. .+-+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 4466 8999997322 1 1245666654322 122 223445667788
Q ss_pred HHHhcCCCcEEeeeecccCeeecCCCcceecccccc
Q 003605 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 524 yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa 559 (808)
.+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 899998 999999999975 5689999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00057 Score=73.94 Aligned_cols=143 Identities=20% Similarity=0.166 Sum_probs=88.1
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeEEeee------eeccceEEEEe
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGIC------IEEQARCLVYE 485 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~------~~~~~~~LV~E 485 (808)
.+.|..|....+|+...++ ..+++|+... ....+...|++++..|++.+ +.+++... ...+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987654 4688888764 23356777888888886443 44544321 22345689999
Q ss_pred ecCCCCcccc--------------cccccc-------CCCCCCHHHHHH----------HHHHHHHHHHHHHhc----CC
Q 003605 486 LIPNGSVESH--------------LHGVDK-------ESAPLGWDARLK----------IALGAARALAYLHED----SS 530 (808)
Q Consensus 486 y~~~GsL~~~--------------L~~~~~-------~~~~L~~~~~l~----------Ia~qia~gL~yLH~~----~~ 530 (808)
|++|..+... ||.... ......|..... ....+..++.++.+. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9988776431 111100 011223432211 112234455555541 12
Q ss_pred CcEEeeeecccCeeecCCCcceeccccccc
Q 003605 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 531 p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
..++|+|+.+.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00053 Score=69.05 Aligned_cols=127 Identities=20% Similarity=0.203 Sum_probs=86.1
Q ss_pred eeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccccccee-EEeeeeeccceEEEEeecCCCC
Q 003605 413 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK-LIGICIEEQARCLVYELIPNGS 491 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~-L~g~~~~~~~~~LV~Ey~~~Gs 491 (808)
..+.|++|.+|.||+|.+. |..+|+|+-+.. .....+..|+++|..++--++-. ++.|- ...+.|||+.+-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 4568999999999999987 568898886643 34578899999999998766644 44432 3345699998878
Q ss_pred ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeec-ccCeeecCCCcceeccccccc
Q 003605 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK-SSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 492 L~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIK-psNILLd~~~~vKL~DFGLa~ 560 (808)
|.++-.+ .+-.+.+. +++.---|-..+ |-|+.|. +..++|-.+.++.|+||.-|.
T Consensus 99 L~~~~~~-------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 99 LGKLEIG-------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhc-------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 7766532 12223333 333323344445 8888886 444444444599999999886
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0021 Score=73.13 Aligned_cols=76 Identities=21% Similarity=0.200 Sum_probs=54.8
Q ss_pred eeeeeecCcEEEEEEEeeCC-CEEEEEEeecc-----c--chhhHHHHHHHHHHhhcc-c--ccceeEEeeeeeccceEE
Q 003605 414 SRILGEGGFGLVYSGVLDDG-TKVAVKVLKRV-----D--QQGGREFLAEVEMLSRLH-H--RNLVKLIGICIEEQARCL 482 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg-~~VAVK~lk~~-----~--~~~~~~f~~Ei~iL~~L~-H--pNIV~L~g~~~~~~~~~L 482 (808)
.+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|..+. + .++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998877 48999984311 1 224567788888888873 2 456677766 3356789
Q ss_pred EEeecCCCC
Q 003605 483 VYELIPNGS 491 (808)
Q Consensus 483 V~Ey~~~Gs 491 (808)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.003 Score=69.09 Aligned_cols=159 Identities=20% Similarity=0.232 Sum_probs=91.4
Q ss_pred CCHHHHHHHhCCcce-----eeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeEE
Q 003605 399 FSASEIEKATGNFDA-----SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLI 471 (808)
Q Consensus 399 fs~~el~~at~~f~~-----~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~ 471 (808)
.+.++|...-+.|.+ .+.++.|....+|+...++| .+++|+.+... ..++...|++++..|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555445544 34566676789998876555 57788765421 2345566778888875333 34444
Q ss_pred eee------eeccceEEEEeecCCCCcccc--------------cccccc----CC----CCCCHHHHHH----------
Q 003605 472 GIC------IEEQARCLVYELIPNGSVESH--------------LHGVDK----ES----APLGWDARLK---------- 513 (808)
Q Consensus 472 g~~------~~~~~~~LV~Ey~~~GsL~~~--------------L~~~~~----~~----~~L~~~~~l~---------- 513 (808)
... ...+..++++||++|..+... +|.... .. ..-.|.....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 422 123456899999988654321 121100 00 0112321110
Q ss_pred --HHHHHHHHHHHHHh----cCCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 514 --IALGAARALAYLHE----DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 514 --Ia~qia~gL~yLH~----~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
....+.+.+++|.. .....++|+|+++.||+++.+....|.||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11123345555543 123469999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0015 Score=80.86 Aligned_cols=196 Identities=19% Similarity=0.190 Sum_probs=132.9
Q ss_pred HHHHHHHHhhcccccceeEEeeeeeccce----EEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 003605 452 FLAEVEMLSRLHHRNLVKLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527 (808)
Q Consensus 452 f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~----~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~ 527 (808)
..-|++.+.++.|.|++.++.|-.++... .+..|++..-++.+.+. ....++..+.+.+..++.+||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34466677788999999999997665433 23447777777777764 33467788888899999999999999
Q ss_pred cCCCcEEeeeeccc---CeeecCCCcceec--ccccccccccccccccccccccccccccchhhhcCCCc--cccceeeH
Q 003605 528 DSSPRVIHRDFKSS---NILLEHDFTPKVS--DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL--VKSDVYSY 600 (808)
Q Consensus 528 ~~~p~IiHrDIKps---NILLd~~~~vKL~--DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s--~kSDVwSf 600 (808)
.. +.|.-+..+ +--.+.++...++ ||+..+...+..... ...-+..|.++|......+. .+.|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 86 777777666 5555666777776 998887654332211 12234567788877655544 34799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhcccccccccccCCCCCCCCChhhHHHHHHHHHHccccCCCCCCCHHHH
Q 003605 601 GVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 680 (808)
Q Consensus 601 GvvLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eV 680 (808)
|..+..+..|...-.... ....+.+.. ....+.+....|+..+.++|++..++
T Consensus 379 gll~~~~~~~~~i~~~~~-------------------~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-------------------VPVSLLDVL--------STSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCccccccc-------------------chhhhhccc--------cchhhhhhhhhhcchhhhhccchhhh
Confidence 999999998765432111 011111110 11146677888999999999999998
Q ss_pred HHHH
Q 003605 681 VQAL 684 (808)
Q Consensus 681 l~~L 684 (808)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 7754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0048 Score=67.63 Aligned_cols=158 Identities=17% Similarity=0.194 Sum_probs=86.6
Q ss_pred CCHHHHHHHhCCcce-----eeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeEE
Q 003605 399 FSASEIEKATGNFDA-----SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLI 471 (808)
Q Consensus 399 fs~~el~~at~~f~~-----~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~ 471 (808)
.+.+++...-..|.+ .+.|+.|....+|+...++| .+++|+.... ..++...|++++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 455556555455544 34566777788999877655 6888887521 2234445666776664322 33333
Q ss_pred ee------eeeccceEEEEeecCCCCcccc--------------cccccc-------CCCCCCH-HHHHHH---------
Q 003605 472 GI------CIEEQARCLVYELIPNGSVESH--------------LHGVDK-------ESAPLGW-DARLKI--------- 514 (808)
Q Consensus 472 g~------~~~~~~~~LV~Ey~~~GsL~~~--------------L~~~~~-------~~~~L~~-~~~l~I--------- 514 (808)
.. ....+..++++||++|..+... +|.... ....+.| .....-
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 21 1224557899999988754321 121110 0011222 221111
Q ss_pred ---H-HHHHHHHHHHHhc----CCCcEEeeeecccCeeecCCCcceeccccccc
Q 003605 515 ---A-LGAARALAYLHED----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 515 ---a-~qia~gL~yLH~~----~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
. ..+...++.+... -...+||+|+.+.|||++.+...-|.||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1 1111222333211 12359999999999999976556899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0045 Score=67.33 Aligned_cols=141 Identities=28% Similarity=0.322 Sum_probs=85.2
Q ss_pred eeeeecCcEEEEEEEeeC-------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccc-eeEEeeeeeccceEEEEee
Q 003605 415 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d-------g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey 486 (808)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777999988765 4788899876432 223456788889988864444 355555432 368999
Q ss_pred cCCCCcccc-----------------ccccccCC-------CCCCHHHHHH--------------------------HHH
Q 003605 487 IPNGSVESH-----------------LHGVDKES-------APLGWDARLK--------------------------IAL 516 (808)
Q Consensus 487 ~~~GsL~~~-----------------L~~~~~~~-------~~L~~~~~l~--------------------------Ia~ 516 (808)
++|..+... ||...... ...-|..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776531 12211110 0111211111 111
Q ss_pred HHHHHHHHHHh------cCCCcEEeeeecccCeeecCC----Ccceeccccccc
Q 003605 517 GAARALAYLHE------DSSPRVIHRDFKSSNILLEHD----FTPKVSDFGLAR 560 (808)
Q Consensus 517 qia~gL~yLH~------~~~p~IiHrDIKpsNILLd~~----~~vKL~DFGLa~ 560 (808)
.+.+.+.+|.. .....++|+|+.+.|||++++ +.++|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233444432 134568999999999999885 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0099 Score=64.88 Aligned_cols=144 Identities=25% Similarity=0.297 Sum_probs=75.3
Q ss_pred cceeeeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc---cccceeEEeeeeeccceEEEEeec
Q 003605 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
....+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678889999999877 567889999876 334467889999999884 345778888877777779999999
Q ss_pred CCC--Cccc---------cccc-ccc-----------------CCCCCCHHH-----HHHHHHHHHH-----------HH
Q 003605 488 PNG--SVES---------HLHG-VDK-----------------ESAPLGWDA-----RLKIALGAAR-----------AL 522 (808)
Q Consensus 488 ~~G--sL~~---------~L~~-~~~-----------------~~~~L~~~~-----~l~Ia~qia~-----------gL 522 (808)
+.+ +..+ .||. ... ....-+|.+ |+.-..+.+. .+
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 876 1111 1232 110 001123432 1111111111 11
Q ss_pred HH----HHhc-CCCcEEeeeecccCeeecCCCcceeccccc
Q 003605 523 AY----LHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 523 ~y----LH~~-~~p~IiHrDIKpsNILLd~~~~vKL~DFGL 558 (808)
+- |+.. -.|.++|+||.+.|++.+.++++.|.|=..
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~ 215 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPAC 215 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecccc
Confidence 22 2222 157899999999999999999899988653
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.012 Score=63.88 Aligned_cols=31 Identities=23% Similarity=0.441 Sum_probs=25.9
Q ss_pred CcEEeeeecccCeeecCCCc-ceecccccccc
Q 003605 531 PRVIHRDFKSSNILLEHDFT-PKVSDFGLARS 561 (808)
Q Consensus 531 p~IiHrDIKpsNILLd~~~~-vKL~DFGLa~~ 561 (808)
+.++|+|+++.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.024 Score=63.31 Aligned_cols=141 Identities=18% Similarity=0.176 Sum_probs=82.9
Q ss_pred eeeeecCcEEEEEEEeeC-----CCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eEEeeeeeccceEEEEeecC
Q 003605 415 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d-----g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV-~L~g~~~~~~~~~LV~Ey~~ 488 (808)
+.|-.|-.-.+|+....+ ++.|++|+.......... -.+|..++..+...++. ++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345457777899887532 367888887654332222 36799999998655554 55565532 2 5899998
Q ss_pred CCCcccc-----------------ccccccCC--CCCCHHHHHHHHHH-----------------HHHHHHHHH----h-
Q 003605 489 NGSVESH-----------------LHGVDKES--APLGWDARLKIALG-----------------AARALAYLH----E- 527 (808)
Q Consensus 489 ~GsL~~~-----------------L~~~~~~~--~~L~~~~~l~Ia~q-----------------ia~gL~yLH----~- 527 (808)
+.+|... +|...... ...-|.+..++..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7676421 23221111 11223333333211 112222222 2
Q ss_pred cCCCcEEeeeecccCeeecC-CCcceeccccccc
Q 003605 528 DSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 560 (808)
Q Consensus 528 ~~~p~IiHrDIKpsNILLd~-~~~vKL~DFGLa~ 560 (808)
.....++|+|+++.|||+++ +..+.|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12345899999999999986 4689999998875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.0012 Score=83.17 Aligned_cols=176 Identities=11% Similarity=-0.016 Sum_probs=120.4
Q ss_pred EEEEeecccchhh-----HHHHHHHHHHhhcccccceeEEeeeee--ccceEEEEeecCCCCccccccccccCCCCCCHH
Q 003605 437 AVKVLKRVDQQGG-----REFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVYELIPNGSVESHLHGVDKESAPLGWD 509 (808)
Q Consensus 437 AVK~lk~~~~~~~-----~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~ 509 (808)
-+|+.+..+-+.. +-...|...++...|.++.....-... ..+.+.+++|+..|.+.+.|-...++...++..
T Consensus 1256 k~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~ 1335 (2724)
T KOG1826|consen 1256 KFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRS 1335 (2724)
T ss_pred EEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhc
Confidence 4555554333322 223344445556688887766654433 345588999999999999886554455555554
Q ss_pred HHHHHHHHHHHHHHHHHhcC--CCcEEeeeecccCeeecCCCcceecccccccccccccccccccccccccccccchhhh
Q 003605 510 ARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 587 (808)
Q Consensus 510 ~~l~Ia~qia~gL~yLH~~~--~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 587 (808)
-....-.+......-.|... ....+|+++|+-|.+|+.+.++|++++|+.+... ..........+++.|+.++...
T Consensus 1336 ~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1336 PVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred hHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHH
Confidence 44443333344444444332 3457999999999999999999999999988211 2222233456788899999988
Q ss_pred cCCCccccceeeHHHHHHHHHhCCCCC
Q 003605 588 TGHLLVKSDVYSYGVVILELLSGRKPV 614 (808)
Q Consensus 588 ~~~~s~kSDVwSfGvvLlELlTG~~P~ 614 (808)
.-.++.++|+|..|+.+|++.-|..++
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 889999999999999999998887665
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.048 Score=60.28 Aligned_cols=138 Identities=20% Similarity=0.277 Sum_probs=79.3
Q ss_pred EEEEEEeeCCCEEEEEEee-cccchhhHHHHHHHHHHhhcc--cccceeEEeeeeecc--ceEEEEeecCCCCccccccc
Q 003605 424 LVYSGVLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLH--HRNLVKLIGICIEEQ--ARCLVYELIPNGSVESHLHG 498 (808)
Q Consensus 424 ~VYkg~l~dg~~VAVK~lk-~~~~~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~--~~~LV~Ey~~~GsL~~~L~~ 498 (808)
.+|..... ++.+++.+-. ...........+|.++|+.+. ---+...+++|.++. ..+.||+|+++..+.+.+..
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 34443333 6777777221 122233345567788888774 234456677787765 56999999987544433321
Q ss_pred ---------------------ccc-------------CCCCCCHHHHHHHH--------HHHHHHHHHHHhcC-----CC
Q 003605 499 ---------------------VDK-------------ESAPLGWDARLKIA--------LGAARALAYLHEDS-----SP 531 (808)
Q Consensus 499 ---------------------~~~-------------~~~~L~~~~~l~Ia--------~qia~gL~yLH~~~-----~p 531 (808)
.+. .++.-.|...++.+ -...+-..||+.+. .+
T Consensus 119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 100 00111122222111 11223345555443 35
Q ss_pred cEEeeeecccCeeecCCCcceeccccccccc
Q 003605 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 532 ~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
.++|+|+.+.||+++.+..+-|.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 6999999999999999888999999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.0052 Score=67.21 Aligned_cols=146 Identities=18% Similarity=0.217 Sum_probs=96.7
Q ss_pred cCCHHHHHHHhCC---cceeeeeeecCcEEEEEEEeeCCCEEEEEEee--c--------c-------cc-h----hhHHH
Q 003605 398 TFSASEIEKATGN---FDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--R--------V-------DQ-Q----GGREF 452 (808)
Q Consensus 398 ~fs~~el~~at~~---f~~~~~LG~G~fG~VYkg~l~dg~~VAVK~lk--~--------~-------~~-~----~~~~f 452 (808)
.+++-.|....++ +.+.+.||-|.-+-+|.+...+|+..++|.=+ + . .. . ..-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 3455555544433 56778999999999999999999999888521 0 0 00 0 01124
Q ss_pred HHHHHHHhhccc-c-cceeEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003605 453 LAEVEMLSRLHH-R-NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530 (808)
Q Consensus 453 ~~Ei~iL~~L~H-p-NIV~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~ 530 (808)
.+|...|..|.. - -+.+.+++ +..|+|||++.+..|...-+ ..+-.++.. .+..-+--|-.++
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~---~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPPTLYD---DLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-------cCChHHHHH---HHHHHHHHHHHcC-
Confidence 567778888753 2 23444443 45689999998888876543 122233333 2333344566677
Q ss_pred CcEEeeeecccCeeecCCCcceeccccccc
Q 003605 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 531 p~IiHrDIKpsNILLd~~~~vKL~DFGLa~ 560 (808)
+||+|..-=||+++++..++++||--+.
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999996543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.036 Score=61.83 Aligned_cols=137 Identities=21% Similarity=0.269 Sum_probs=89.6
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecc-------cc--hhhHH-----------------HHHHHHHHhhcccccce
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRV-------DQ--QGGRE-----------------FLAEVEMLSRLHHRNLV 468 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~-------~~--~~~~~-----------------f~~Ei~iL~~L~HpNIV 468 (808)
..|..|--..||.++-.+|..+|||+.+.. +. .+.-+ ...|++-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456778888999999999999999997520 00 00011 23466666666544322
Q ss_pred eEEeeeeeccceEEEEeecCCCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCC
Q 003605 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 548 (808)
Q Consensus 469 ~L~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~ 548 (808)
----... ....|||+|+.. + .|-.- .-....|+...+..+-.++++-|.-|...| ++||.||.--|+|+. +
T Consensus 230 ~PePIlL--k~hVLVM~FlGr-d--gw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGR-D--GWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCceee--ecceEeeeeccC-C--CCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 1110011 244799999952 2 22210 112235677778888888999999998887 699999999999985 4
Q ss_pred Ccceeccccccc
Q 003605 549 FTPKVSDFGLAR 560 (808)
Q Consensus 549 ~~vKL~DFGLa~ 560 (808)
|.+.|+|-+-+.
T Consensus 301 G~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 GKLYIIDVSQSV 312 (520)
T ss_pred CEEEEEEccccc
Confidence 589999988664
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.045 Score=59.44 Aligned_cols=65 Identities=17% Similarity=0.187 Sum_probs=40.1
Q ss_pred EEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccc--cceeEEee------eeeccceEEEEeecCCCCcc
Q 003605 424 LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR--NLVKLIGI------CIEEQARCLVYELIPNGSVE 493 (808)
Q Consensus 424 ~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~------~~~~~~~~LV~Ey~~~GsL~ 493 (808)
.||+...++| .+++|+.... .++...|+..+..|... .+.+++.. ...++..+.++||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888776555 5788887521 23455677777777533 33444432 12245678999999886554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.085 Score=58.73 Aligned_cols=137 Identities=23% Similarity=0.322 Sum_probs=83.2
Q ss_pred CcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccc------eeEEeeee--ecc--ceEEEEeecCCC
Q 003605 421 GFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL------VKLIGICI--EEQ--ARCLVYELIPNG 490 (808)
Q Consensus 421 ~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNI------V~L~g~~~--~~~--~~~LV~Ey~~~G 490 (808)
.-..+|+....+|+. ++|+.+.. ....+...|+..|..|.-.+| ..+-|-.. -.+ ..+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789888887776 77777653 445677788888888853222 22222211 123 667899999988
Q ss_pred Cccc-c--------------cc----ccc----cCCCCCCHHH-------------HHHHHHHHHHHHHHHHhcC----C
Q 003605 491 SVES-H--------------LH----GVD----KESAPLGWDA-------------RLKIALGAARALAYLHEDS----S 530 (808)
Q Consensus 491 sL~~-~--------------L~----~~~----~~~~~L~~~~-------------~l~Ia~qia~gL~yLH~~~----~ 530 (808)
.+.. . || +.. .......|.. ......++...+..+.+.- .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 1 11 111 1112345541 1112333444455544331 1
Q ss_pred ---CcEEeeeecccCeeecCCCc-ceeccccccc
Q 003605 531 ---PRVIHRDFKSSNILLEHDFT-PKVSDFGLAR 560 (808)
Q Consensus 531 ---p~IiHrDIKpsNILLd~~~~-vKL~DFGLa~ 560 (808)
..+||+|+.+.|||+|.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12899999999999999875 8899999875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.047 Score=56.25 Aligned_cols=124 Identities=25% Similarity=0.232 Sum_probs=61.7
Q ss_pred CCEEEEEEeecccchhhHHHHHHHHHHhhcccccc-eeEEeeeeeccceEEEEeecCCCCcccc----------------
Q 003605 433 GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYELIPNGSVESH---------------- 495 (808)
Q Consensus 433 g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~Ey~~~GsL~~~---------------- 495 (808)
.+.|+||+...... ..-+-..|.++++.+..-++ .++++++.+ .+|+||+++..|..-
T Consensus 2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 46788888876533 23455688999999875555 456655433 267799966554331
Q ss_pred -cccccc---CCCCCCHHHHHHH----------------------HHHHHHHHHHHH----hcCC-CcEEeeeecccCee
Q 003605 496 -LHGVDK---ESAPLGWDARLKI----------------------ALGAARALAYLH----EDSS-PRVIHRDFKSSNIL 544 (808)
Q Consensus 496 -L~~~~~---~~~~L~~~~~l~I----------------------a~qia~gL~yLH----~~~~-p~IiHrDIKpsNIL 544 (808)
+|.... ....--|....++ ...+..-+..+. .... ..++|+|+.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 111111 0111112222222 011112222222 1112 24799999999999
Q ss_pred e-cCCCcceecccccccc
Q 003605 545 L-EHDFTPKVSDFGLARS 561 (808)
Q Consensus 545 L-d~~~~vKL~DFGLa~~ 561 (808)
+ +.++.++++||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.025 Score=68.28 Aligned_cols=69 Identities=9% Similarity=0.011 Sum_probs=43.9
Q ss_pred cccCCchhhHhhhcccccceeeecccCCCCceEEeeeCC---CCCCCCCCCCCCCCccCCCCCCCCCCCCCCCC
Q 003605 232 GEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYP---GLPPSPPSASSSIGIIDDGPYSGNNGRATKPE 302 (808)
Q Consensus 232 ~~~~~~~~~~~l~~~~~~g~vp~~~~~~~~~~~~~~~~~---g~~P~~p~~~~~~~~~~~~~~~Gn~~~~~~p~ 302 (808)
-..+.+|+.|+|++|.++|.+|...+.+.+.+.+++... |.+|..-.... .......+.||..+|+.|.
T Consensus 462 ~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~--~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 462 LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL--LHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred HhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcc--ccCceEEecCCccccCCCC
Confidence 456788999999999999999987888888777766543 44443211100 0011123567888887654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.52 Score=52.25 Aligned_cols=94 Identities=17% Similarity=0.152 Sum_probs=54.8
Q ss_pred cCCHHHHHHHhCCccee---e-eeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcccc--cceeEE
Q 003605 398 TFSASEIEKATGNFDAS---R-ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR--NLVKLI 471 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~---~-~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~ 471 (808)
.++.+.+..+...+.+. + ..=.+.-..||+...++++.+++|..+.. .....+...|++.+..|... .++..+
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 34555555554444221 1 22234567899998888888999987532 22445677888888877422 222211
Q ss_pred ---e--eeeeccceEEEEeecCCCCc
Q 003605 472 ---G--ICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 472 ---g--~~~~~~~~~LV~Ey~~~GsL 492 (808)
| ....++..+.++++++|...
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 11223556789999987654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.15 Score=56.00 Aligned_cols=31 Identities=16% Similarity=0.174 Sum_probs=27.8
Q ss_pred CcEEeeeecccCeeecCCCcceecccccccc
Q 003605 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 531 p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~ 561 (808)
..++|+|+.+.|||++.++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.41 Score=54.79 Aligned_cols=73 Identities=11% Similarity=0.116 Sum_probs=50.1
Q ss_pred eeeeeecCcEEEEEEEeeCCCEEEEEEeec----ccc---hhhHHHHHHHHHHhhcc---cccceeEEeeeeeccceEEE
Q 003605 414 SRILGEGGFGLVYSGVLDDGTKVAVKVLKR----VDQ---QGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~dg~~VAVK~lk~----~~~---~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV 483 (808)
.+.||.|....||+.... +..++||+-.. ... ....+-..|.+.|..+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998764 55688997541 111 12334445577776653 247888898887 456789
Q ss_pred EeecCC
Q 003605 484 YELIPN 489 (808)
Q Consensus 484 ~Ey~~~ 489 (808)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.45 Score=50.34 Aligned_cols=136 Identities=24% Similarity=0.321 Sum_probs=82.9
Q ss_pred eeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc---cccceeEEeeeeeccceEEEEeecCCCCc
Q 003605 416 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
.+.-|.--..|.... +...+.||+-. ......|.+|+.-|..|. .-++.+.+.+-.+.+..++|+||++-|.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 344444444554433 34678888643 344567889998888774 35577888888888999999999998877
Q ss_pred ccc-----------cccccc--------------CCCC----CCHH-----HHHHHHHHHH--------------HHHHH
Q 003605 493 ESH-----------LHGVDK--------------ESAP----LGWD-----ARLKIALGAA--------------RALAY 524 (808)
Q Consensus 493 ~~~-----------L~~~~~--------------~~~~----L~~~-----~~l~Ia~qia--------------~gL~y 524 (808)
+.. ||.-.. ...+ -+|. +|+-+..++| ..+..
T Consensus 99 d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~e 178 (286)
T COG3001 99 DAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQE 178 (286)
T ss_pred CchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHH
Confidence 621 221100 0011 2232 2332223322 23333
Q ss_pred HHhcC--CCcEEeeeecccCeeecCCCcceeccc
Q 003605 525 LHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 525 LH~~~--~p~IiHrDIKpsNILLd~~~~vKL~DF 556 (808)
|=... .|.++|+||...|+.+..++ +.+.|=
T Consensus 179 lL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDP 211 (286)
T COG3001 179 LLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDP 211 (286)
T ss_pred HHhcCCCCcceeecccccccccccCCC-Ceeecc
Confidence 33333 37899999999999999888 766553
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.18 Score=56.73 Aligned_cols=73 Identities=16% Similarity=0.142 Sum_probs=48.1
Q ss_pred eeeecCcEEEEEEEeeCC-CEEEEEEeec-------ccchhhHHHHHHHHHHhhcc--ccc-ceeEEeeeeeccceEEEE
Q 003605 416 ILGEGGFGLVYSGVLDDG-TKVAVKVLKR-------VDQQGGREFLAEVEMLSRLH--HRN-LVKLIGICIEEQARCLVY 484 (808)
Q Consensus 416 ~LG~G~fG~VYkg~l~dg-~~VAVK~lk~-------~~~~~~~~f~~Ei~iL~~L~--HpN-IV~L~g~~~~~~~~~LV~ 484 (808)
.||.|-...||++...+| +.|+||.-.. ......++..-|.+.|.... .|. +.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478899999999998755 5899997431 11334456667788887663 343 344443 3445667999
Q ss_pred eecCCC
Q 003605 485 ELIPNG 490 (808)
Q Consensus 485 Ey~~~G 490 (808)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.21 E-value=0.45 Score=52.86 Aligned_cols=141 Identities=18% Similarity=0.237 Sum_probs=81.0
Q ss_pred eeeeecCcEEEEEEEeeC----CCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eEEeeeeeccceEEEEeecCC
Q 003605 415 RILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~d----g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV-~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
+.|..|-...+|+....+ +..|++|+....... .-+-.+|..++..+..-++- ++++++. +. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 445457777889887543 237888887654332 22346789999999765553 5666553 22 58999977
Q ss_pred CCcccc-----------------ccccccC--CCCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 003605 490 GSVESH-----------------LHGVDKE--SAPLGWDARLKIALGA----------------------ARALAYLH-- 526 (808)
Q Consensus 490 GsL~~~-----------------L~~~~~~--~~~L~~~~~l~Ia~qi----------------------a~gL~yLH-- 526 (808)
..|... ||...-. ...--|....++..++ .+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 2221111 1111233332222111 11122221
Q ss_pred --hcC-CCcEEeeeecccCeeecC-CCcceeccccccc
Q 003605 527 --EDS-SPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 560 (808)
Q Consensus 527 --~~~-~p~IiHrDIKpsNILLd~-~~~vKL~DFGLa~ 560 (808)
..+ ...++|+|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 112 234799999999999975 5789999999875
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.041 Score=52.24 Aligned_cols=38 Identities=8% Similarity=0.026 Sum_probs=27.1
Q ss_pred ccCCCCceeehhhhhHHHHHHHHHHHHHHHHhhccccc
Q 003605 312 KYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHA 349 (808)
Q Consensus 312 ~~gls~~~I~iIvv~~vv~lvl~~~v~~~~~~rrk~~~ 349 (808)
.++++.+.|++|++|+++++++++++++++++|+|||.
T Consensus 58 ~h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~ 95 (122)
T PF01102_consen 58 VHRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKKS 95 (122)
T ss_dssp SSSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred ccCccccceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 34688889999999998888887777777777766553
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.37 Score=54.84 Aligned_cols=74 Identities=19% Similarity=0.213 Sum_probs=44.9
Q ss_pred eeeeecCcEEEEEEEeeCC--CE-----EEEEEeecccchhhHHHHHHHHHHhhcccccce-eEEeeeeeccceEEEEee
Q 003605 415 RILGEGGFGLVYSGVLDDG--TK-----VAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYEL 486 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg--~~-----VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV-~L~g~~~~~~~~~LV~Ey 486 (808)
+.|..|-...+|++...++ .. |.++..... ....-+-.+|++++..+...++- ++++.+.. .+|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 4555577889999876533 22 333332111 11112335789999999766654 45555532 599999
Q ss_pred cCCCCcc
Q 003605 487 IPNGSVE 493 (808)
Q Consensus 487 ~~~GsL~ 493 (808)
+++.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987765
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.76 E-value=0.52 Score=50.94 Aligned_cols=30 Identities=40% Similarity=0.479 Sum_probs=25.2
Q ss_pred cEEeeeecccCeeecCC--C---cceecccccccc
Q 003605 532 RVIHRDFKSSNILLEHD--F---TPKVSDFGLARS 561 (808)
Q Consensus 532 ~IiHrDIKpsNILLd~~--~---~vKL~DFGLa~~ 561 (808)
.++|||++.+|||+..+ + ++++.||-+++.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 48999999999999654 3 689999988764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.034 Score=64.25 Aligned_cols=47 Identities=23% Similarity=0.313 Sum_probs=36.5
Q ss_pred HHHHHHHHHHhhcccccceeEEeeeeecc-ceEEEEeecCCCCcccccc
Q 003605 450 REFLAEVEMLSRLHHRNLVKLIGICIEEQ-ARCLVYELIPNGSVESHLH 497 (808)
Q Consensus 450 ~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LV~Ey~~~GsL~~~L~ 497 (808)
.+++-...+++.+.|+|+...+++-.... ...+|+|++ +-||++.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 34556677888999999999998876543 357889999 669998885
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.61 E-value=0.48 Score=60.45 Aligned_cols=142 Identities=22% Similarity=0.274 Sum_probs=78.5
Q ss_pred eeeeecCcEEEEEEEeeCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-------cccceeEE-ee----eee-cc--c
Q 003605 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-------HRNLVKLI-GI----CIE-EQ--A 479 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~dg~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-------HpNIV~L~-g~----~~~-~~--~ 479 (808)
+.|+ |..-.+|+....+|..+++|+.+... .......|.+.|..|. -|.+++-. |- ... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4553 45678899888888899999987532 2234445556666553 22222211 11 111 22 3
Q ss_pred eEEEEeecCCCCccccc-----------------c----cc--ccCCCCCCHHHH-----------------HHHHHHHH
Q 003605 480 RCLVYELIPNGSVESHL-----------------H----GV--DKESAPLGWDAR-----------------LKIALGAA 519 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L-----------------~----~~--~~~~~~L~~~~~-----------------l~Ia~qia 519 (808)
.+-+++|+++..|.+.. | +. ......+.|... ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999987776511 1 01 011123445321 12222222
Q ss_pred HHHH-----HHHhcCCCcEEeeeecccCeeecCCC--cce-eccccccc
Q 003605 520 RALA-----YLHEDSSPRVIHRDFKSSNILLEHDF--TPK-VSDFGLAR 560 (808)
Q Consensus 520 ~gL~-----yLH~~~~p~IiHrDIKpsNILLd~~~--~vK-L~DFGLa~ 560 (808)
+... .|.+ -...+||+|+.+.|||++.+. ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 1211 123599999999999998875 555 99999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.091 Score=58.66 Aligned_cols=55 Identities=22% Similarity=0.277 Sum_probs=48.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeeeecccCeeecCCCcceeccccccccc
Q 003605 505 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 505 ~L~~~~~l~Ia~qia~gL~yLH~~~~p~IiHrDIKpsNILLd~~~~vKL~DFGLa~~~ 562 (808)
.-.|.+.+.|+++.+..++-|..+- +.=|||+.-.||||| +|++-|+||-++|.-
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence 3678999999999988887777654 689999999999999 999999999999843
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 808 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-62 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-44 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-22 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-22 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-22 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-22 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-22 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-22 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-22 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-21 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-21 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-21 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-18 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 808 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-179 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-177 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-169 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-89 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-67 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-65 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-63 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-62 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-62 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-61 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-60 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 9e-60 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-57 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 7e-53 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-52 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-52 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-46 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-43 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-43 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-42 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-42 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 6e-42 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-42 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 9e-42 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-41 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-41 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-41 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-41 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-41 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-41 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-41 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-41 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-40 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-40 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-40 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-40 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-40 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-40 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 9e-40 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-39 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-39 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-39 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-39 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-39 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-39 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-39 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-39 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-38 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-38 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-38 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-38 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-38 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 9e-38 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-37 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-37 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-37 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-37 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-36 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-36 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-35 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-35 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-35 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 6e-35 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-35 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-35 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-34 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-34 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-34 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-34 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-33 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-33 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 5e-33 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-33 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 9e-33 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-32 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-32 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 9e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-31 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-31 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-31 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-31 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-31 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 7e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-30 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-30 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-30 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 9e-30 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-29 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-29 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-29 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-29 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-28 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-27 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 9e-27 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-26 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-26 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-25 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-25 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-25 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-24 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-24 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-24 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-24 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-24 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 6e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-24 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-23 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-23 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-23 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-23 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-23 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 6e-23 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-23 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 7e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 9e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-22 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-22 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-22 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-22 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 7e-22 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-22 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-21 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-21 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-21 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-21 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-21 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-21 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-21 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-21 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-21 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-20 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-20 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-20 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-20 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-20 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-20 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-20 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 5e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-20 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-20 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-20 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 8e-20 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-19 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-19 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-18 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-18 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 8e-18 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-17 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-17 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 7e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-15 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 9e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-10 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-14 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-14 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 4e-14 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-13 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-13 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-13 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 7e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-12 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-12 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-12 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-12 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-12 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 5e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-11 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-09 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 2e-07 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 9e-07 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 3e-06 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 1e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-06 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-06 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-06 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-05 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-05 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-05 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 3e-05 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 2e-04 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-04 | |
| 2pff_A | 1688 | Fatty acid synthase subunit alpha, 3-oxoacyl-[acyl | 3e-04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 5e-04 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 6e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 514 bits (1327), Expect = e-179
Identities = 125/315 (39%), Positives = 181/315 (57%), Gaps = 7/315 (2%)
Query: 374 VGSGLDSASLSFG---SSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL 430
+GS A+ S SS + ++E+AT NFD ++G G FG VY GVL
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 431 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 490
DG KVA+K QG EF E+E LS H +LV LIG C E L+Y+ + NG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 491 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550
+++ HL+G D + + W+ RL+I +GAAR L YLH + +IHRD KS NILL+ +F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 610
PK++DFG+++ + + H+ST V GT GY+ PEY + G L KSDVYS+GVV+ E+L
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 611 RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 670
R + + P NL WA + + LE+I+DP+L + + +S+ K A C+
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 671 VQHRPFMGEVVQALK 685
+ RP MG+V+ L+
Sbjct: 297 SEDRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 510 bits (1316), Expect = e-177
Identities = 130/297 (43%), Positives = 181/297 (60%), Gaps = 5/297 (1%)
Query: 392 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG-R 450
+ G K FS E++ A+ NF ILG GGFG VY G L DGT VAVK LK QGG
Sbjct: 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 451 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 510
+F EVEM+S HRNL++L G C+ R LVY + NGSV S L + PL W
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 511 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570
R +IALG+AR LAYLH+ P++IHRD K++NILL+ +F V DFGLA+ MD + H+
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHV 191
Query: 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE--NLVAW 628
+T V GT G++APEY TG K+DV+ YGV++LEL++G++ D+ + + L+ W
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 629 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ LL ++ LE ++D L + + V ++ +A +C Q RP M EVV+ L+
Sbjct: 252 VKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 490 bits (1265), Expect = e-169
Identities = 110/310 (35%), Positives = 174/310 (56%), Gaps = 19/310 (6%)
Query: 386 GSSIATYTGSAKTFSASEIEKATGNFD------ASRILGEGGFGLVYSGVLDDGTKVAVK 439
S+ +FS E++ T NFD +GEGGFG+VY G ++ T VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60
Query: 440 VLKRVD----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESH 495
L + ++ ++F E++++++ H NLV+L+G + CLVY +PNGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 496 LHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 555
L +D + PL W R KIA GAA + +LHE+ IHRD KS+NILL+ FT K+SD
Sbjct: 121 LSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 556 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
FGLAR++ +++R++GT Y+APE + G + KSD+YS+GVV+LE+++G VD
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 616 MTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675
+ P + L+ + + +E ID + + SV + ++AS C+ + RP
Sbjct: 236 EHREP--QLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 676 FMGEVVQALK 685
+ +V Q L+
Sbjct: 293 DIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 4e-89
Identities = 71/308 (23%), Positives = 115/308 (37%), Gaps = 28/308 (9%)
Query: 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 458
+ + + G FG V+ L VAVK+ D+Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 459 LSRLHHRNLVKLIGICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 514
L + H N+++ IG + L+ GS+ L + W+ I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHI 126
Query: 515 ALGAARALAYLHED-------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567
A AR LAYLHED P + HRD KS N+LL+++ T ++DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 568 RHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
+ +GT Y+APE ++ D+Y+ G+V+ EL S D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 623 ENLVAWARPLLTSRE----GLERIIDPSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFM 677
+ + + + P L + + A + C + + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 678 GEVVQALK 685
G V + +
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-67
Identities = 73/339 (21%), Positives = 127/339 (37%), Gaps = 43/339 (12%)
Query: 399 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 458
+ASE N ++G G +G VY G LD VAVKV ++Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58
Query: 459 --LSRLHHRNLVKLIGICIE-----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 511
+ + H N+ + I LV E PNGS+ +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 512 LKIALGAARALAYLHED------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR----- 560
++A R LAYLH + P + HRD S N+L+++D T +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 561 -SAMDEESRHISTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVILELLSGRK 612
E + + +GT Y+APE L + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 613 PVDMTQPPGQENLV-AWARPLLTSREGLERIID-----PSLGNDVPFDSVA--KVAAIAS 664
+ + + + + E ++ ++ P +S+A +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 665 MCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSS 703
C + + R + + + + K V +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-65
Identities = 78/287 (27%), Positives = 139/287 (48%), Gaps = 42/287 (14%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG-------REFLAEVEMLSRLHHRN 466
+ +G+GGFGLV+ G + D + VA+K L D +G +EF EV ++S L+H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+VKL G+ +V E +P G + L ++ P+ W +L++ L A + Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 527 EDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
+ +P ++HRD +S NI L KV+DFGL++ +S H + ++G F ++
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 582 APEYAMTGHLLV--KSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREG 638
APE K+D YS+ +++ +L+G P + + + + + EG
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFI--NMIREEG 246
Query: 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
L R P++ D P ++ + +C + + RP +V+ L
Sbjct: 247 L-R---PTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-64
Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIG 472
+G G FG V+ G+ VAVK+L D EFL EV ++ RL H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+ +V E + GS+ LH L RL +A A+ + YLH +P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
++HR+ KS N+L++ +T KV DFGL+R + + S GT ++APE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 593 VKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651
KSDVYS+GV++ EL + ++P ++ P Q V A R + ++
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLN--PAQ---VVAAVGFKCKR--------LEIPRNL 264
Query: 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+VAAI C E RP ++ L+
Sbjct: 265 N----PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-63
Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
++G G FG+V VA+K ++ ++ + F+ E+ LSR++H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+ CLV E GS+ + LHG + + L ++ +AYLH +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 535 HRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 593
HRD K N+LL K+ DFG A + + T G+ ++APE +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 594 KSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 652
K DV+S+G+++ E+++ RKP ++ P + + WA G R P L ++P
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWA-----VHNGT-R---PPLIKNLP 230
Query: 653 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ ++ + C + RP M E+V+ +
Sbjct: 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-62
Identities = 63/287 (21%), Positives = 118/287 (41%), Gaps = 42/287 (14%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
L E G ++ G G + VKVLK + R+F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 473 ICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
C A L+ +P GS+ + LH + + + +K AL AR +A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 584
P + S +++++ D T ++S + S S M +VAPE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKP 184
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERII 643
+D++S+ V++ EL++ P D++ + + + EGL R
Sbjct: 185 EDTNRR---SADMWSFAVLLWELVTREVPFADLS--NME---IGMK----VALEGL-R-- 229
Query: 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690
P++ + V+ + +C+ + RP +V L+ + ++
Sbjct: 230 -PTIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-62
Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKL 470
I+G GGFG VY G +VAVK + + E ++ + L H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
G+C++E CLV E G + L G + D + A+ AR + YLH+++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 531 PRVIHRDFKSSNILLEHDFTP--------KVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
+IHRD KSSNIL+ K++DFGLAR E R G + ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMA 182
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLER 641
PE SDV+SYGV++ ELL+G P + VA+ +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLA---VAYGVAMNKLA----- 232
Query: 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ + P A + C P+ RP ++ L
Sbjct: 233 ---LPIPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-61
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 40/307 (13%)
Query: 415 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+LG+G FG + G + +K L R D++ R FL EV+++ L H N++K IG+
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+++ + E I G++ + + W R+ A A +AYLH S +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES------------RHISTRVMGTFGYV 581
IHRD S N L+ + V+DFGLAR +DE++ R V+G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARPLLTSREG 638
APE K DV+S+G+V+ E++ N+ +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR------- 242
Query: 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVG 698
P + I C + + RP ++ L+ + +G
Sbjct: 243 -----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 699 SASSSQD 705
D
Sbjct: 292 PQLEQLD 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 9e-60
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 26/276 (9%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
+ +G G FG VY G VAVK+L Q + F EV +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
Q +V + S+ HLH + IA AR + YLH +
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE---YAMTG 589
+IHRD KS+NI L D T K+ DFGLA H ++ G+ ++APE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 590 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649
+SDVY++G+V+ EL++G+ P Q + G + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM-----VGRGSLSPDLSKVRS 252
Query: 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ P ++ + + C++ + RP ++ ++
Sbjct: 253 NCP----KRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-57
Identities = 60/310 (19%), Positives = 116/310 (37%), Gaps = 49/310 (15%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
++G+G FG VY G +VA++++ R ++ + F EV + H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
C+ ++ L ++ S + L + +IA + + YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM---GTFGYVAPEYAMTG 589
++H+D KS N+ ++ ++DFGL + ++ ++ G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 590 HLLV---------KSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA-----RPLLTS 635
SDV++ G + EL + P TQP + W +P L
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPNL-- 263
Query: 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK 695
+++ I C E + RP +++ L+ +
Sbjct: 264 ---------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
Query: 696 EVGSASSSQD 705
G S +
Sbjct: 309 HPGHFWKSAE 318
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIG 472
+G+G +G V+ G G VAVK+ D++ + E E+ L H N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 473 ICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+ + L+ GS+ +L L + L+I L A LA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 529 -----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMGTFGYV 581
P + HRD KS NIL++ + ++D GLA S + + +GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 582 APE------YAMTGHLLVKSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARPL 632
APE + D++++G+V+ E+ V+ +PP + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD--------V 236
Query: 633 LTSREGLERIID--------PSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFMGEVVQA 683
+ + E + P++ N D +A + C R + +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 684 LK 685
L
Sbjct: 297 LT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-52
Identities = 71/310 (22%), Positives = 123/310 (39%), Gaps = 50/310 (16%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIG 472
+ +G+G +G V+ G G KVAVKV ++ + E E+ + H N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 473 ICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
I+ L+ + NGS+ +L S L + LK+A + L +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 529 -----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH--ISTRVMGTFGYV 581
P + HRD KS NIL++ + T ++D GLA + + + +GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 582 APEYAMTGHLLV-------KSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARP 631
PE + L +D+YS+G+++ E+ V+ Q P +
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD-------- 264
Query: 632 LLTSREGLERIID--------PSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFMGEVVQ 682
L+ S E + + PS N D ++ + + C R V +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 683 ALKLVCNECD 692
L + D
Sbjct: 325 TLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 7e-50
Identities = 65/306 (21%), Positives = 124/306 (40%), Gaps = 44/306 (14%)
Query: 416 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIGI 473
+G+G FG V+ G G +VAVK+ +++ + E E+ L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA 104
Query: 474 CIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED- 528
++ LV + +GS+ +L+ + + +K+AL A LA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 529 ----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMGTFGYVA 582
P + HRD KS NIL++ + T ++D GLA + + +GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 583 PEYAMTGHLLV-------KSDVYSYGVVILELLSGRKPVDMT---QPPGQENLVAWARPL 632
PE + + + ++D+Y+ G+V E+ + Q P + + + P
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD--LVPSDPS 276
Query: 633 LTS------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686
+ + L I + +++ +A I C R + + L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSC---EALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 687 VCNECD 692
+ +
Sbjct: 334 LSQQEG 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-46
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 34/278 (12%)
Query: 415 RILGEGGFGLVYSGVL-DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
+G G FG V+SG L D T VAVK + + +FL E +L + H N+V+LIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+C ++Q +V EL+ G + L E A L L++ AA + YL
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY--VAPEYAMTGH 590
IHRD + N L+ K+SDFG++R D + ++ + APE G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGR 291
Query: 591 LLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649
+SDV+S+G+++ E S G P P N ++ E + G
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPY-----PNLSN-----------QQTREFVEK---GG 332
Query: 650 --DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P V + C E RP + Q L+
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 3e-43
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ LG G FG+V G VAVK++K EF E + + +L H LVK G+C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+E +V E I NG + ++L K L L++ +A+L S + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 589
HRD + N L++ D KVSDFG+ R +D++ + T+ APE
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYF 180
Query: 590 HLLVKSDVYSYGVVILELLS-GRKP 613
KSDV+++G+++ E+ S G+ P
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ +G G FGLV+ G + KVA+K ++ +F+ E E++ +L H LV+L G+C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+E+ CLV E + +G + +L + L + L +AYL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 589
HRD + N L+ + KVSDFG+ R +D++ + T+ +PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPEVFSFS 180
Query: 590 HLLVKSDVYSYGVVILELLS-GRKP 613
KSDV+S+GV++ E+ S G+ P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 415 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN 466
LG+G F ++ GV T+V +KVL + + F M+S+L H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
LV G+C+ LV E + GS++++L K + +L++A A A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTP--------KVSDFGLARSAMDEESRHISTRVMGTF 578
+IH + + NILL + K+SD G++ + + ++ +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184
Query: 579 GYVAPEYAMTGHLL-VKSDVYSYGVVILELLS-GRKP 613
PE L + +D +S+G + E+ S G KP
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-42
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 415 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
++LG G FG VY G+ VA+K L+ + +E L E +++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+GIC+ L+ +L+P G + ++ + +G L + A+ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
R++HRD + N+L++ K++DFGLA+ EE + + ++A E +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKP 613
+SDV+SYGV + EL++ G KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-42
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 415 RILGEGGFGLVYSGVL---DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 469
+ LG G FG V G VAVK+LK D E LAE ++ +L + +V+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+IGIC E LV E+ G + +L +++ + +++ + + YL
Sbjct: 83 MIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAM 587
+HRD + N+LL K+SDFGL++ A+ + + + G + + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 588 TGHLLVKSDVYSYGVVILELLS-GRKP 613
KSDV+S+GV++ E S G+KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ LG G FG+V G VA+K++K EF+ E +++ L H LV+L G+C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+++ ++ E + NG + ++L + L++ A+ YL S + +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 589
HRD + N L+ KVSDFGL+R +D+E + + ++ PE M
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVLMYS 196
Query: 590 HLLVKSDVYSYGVVILELLS-GRKP 613
KSD++++GV++ E+ S G+ P
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-42
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ +G+G FG V G G KVAVK +K + FLAE ++++L H NLV+L+G+
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 475 IEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYAMTG 589
+HRD + N+L+ D KVSDFGL + + S + ++ APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 189
Query: 590 HLLVKSDVYSYGVVILELLS-GRKP 613
KSDV+S+G+++ E+ S GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
LG G FG V+ G + TKVAVK LK FLAE ++ +L H+ LV+L +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+E ++ E + NGS+ L L + L +A A +A++ I
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 593
HRD +++NIL+ + K++DFGLAR D E + + + APE G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTI 189
Query: 594 KSDVYSYGVVILELLS-GRKP 613
KSDV+S+G+++ E+++ GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 16/237 (6%)
Query: 415 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+ LG+G FG V D G VAVK L+ ++ R+F E+E+L L H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 470 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
G+C R L+ E +P GS+ +L K + L+ + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 585
+ R IHRD + NIL+E++ K+ DFGL + + ++ + G + APE
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
V SDV+S+GVV+ EL + + + + + +E +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-41
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ +G+G FG V G G KVAVK +K + FLAE ++++L H NLV+L+G+
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 475 IEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYAMTG 589
+HRD + N+L+ D KVSDFGL + + S + ++ APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 361
Query: 590 HLLVKSDVYSYGVVILELLS-GRKP 613
KSDV+S+G+++ E+ S GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 19/238 (7%)
Query: 415 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
LG+G FG V D G VAVK L+ R+F E+++L LH +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 470 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
G+ + LV E +P+G + L + A L L + + + YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 585
S R +HRD + NIL+E + K++DFGLA+ + + + R G + APE
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 586 AMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
+SDV+S+GVV+ EL + K + ++ R + LE +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELL 257
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 20/239 (8%)
Query: 415 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
R LGEG FG V D G +VAVK LK + E+E+L L+H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 469 KLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
K GIC E+ L+ E +P+GS++ +L K + +LK A+ + + YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPE 584
S + +HRD + N+L+E + K+ DFGL + A++ + + + + + APE
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
M + SDV+S+GV + ELL+ + ++ +T + +
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTL 256
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 415 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
LG G +G VY GV VAVK LK D EFL E ++ + H NLV+L+G+
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
C E ++ E + G++ +L +++ + L +A + A+ YL
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMT 588
IHRD + N L+ + KV+DFGL+R + + H + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAY 186
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKP 613
+KSDV+++GV++ E+ + G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 417 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+C E LV E+ G + L G +E + ++ + + YL
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGH 590
+HRD + N+LL + K+SDFGL++ A+ + + + R G + + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 591 LLVKSDVYSYGVVILELLS-GRKP 613
+SDV+SYGV + E LS G+KP
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 16/237 (6%)
Query: 415 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+ LG+G FG V D G VAVK L+ ++ R+F E+E+L L H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 470 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
G+C R L+ E +P GS+ +L K + L+ + + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 585
+ R IHRD + NIL+E++ K+ DFGL + + ++ + + G + APE
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
V SDV+S+GVV+ EL + + + + + +E +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 467
LG+G FG+V G VAVK LK + +F+ EV + L HRNL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
++L G+ + +V EL P GS+ L K + A+ A + YL
Sbjct: 84 IRLYGVVLTPPM-KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYL-- 137
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPE 584
S R IHRD + N+LL K+ DFGL R+ + ++ F + APE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 194
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
T SD + +GV + E+ + G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 469
+I+G G G V G L VA+K LK ++ R+FL+E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L G+ + +V E + NGS+++ L + + G + YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV-------MGTFGYVA 582
+HRD + N+L++ + KVSDFGL+R D+ +T A
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT------A 222
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
PE SDV+S+GVV+ E+L+ G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 469
RILGEG FG VY GV + VAVK K+ +F++E ++ L H ++VK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
LIGI EE ++ EL P G + +L L + +L +A+AYL
Sbjct: 78 LIGIIEEEPT-WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYL---E 130
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPE 584
S +HRD NIL+ K+ DFGL+R DE+ + TR+ M +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------SPE 184
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
SDV+ + V + E+LS G++P
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 415 RILGEGGFGLVYSGVL-DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 471
LG G +G VY GV VAVK LK ++ + EFL E ++ + H NLV+L+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 472 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 531
G+C E ++ E + G++ +L + + L +A + A+ YL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKK 337
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGH 590
IHR+ + N L+ + KV+DFGL+R + + H + + APE
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNK 395
Query: 591 LLVKSDVYSYGVVILELLS-GRKP 613
+KSDV+++GV++ E+ + G P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-40
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+ LG G FG V+ + TKVAVK +K FLAE ++ L H LVKL +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
+E ++ E + GS+ L E + + + A +A++ I
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV---APEYAMTGHL 591
HRD +++NIL+ K++DFGLAR D E T G + APE G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAINFGSF 362
Query: 592 LVKSDVYSYGVVILELLS-GRKP 613
+KSDV+S+G++++E+++ GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 415 RILGEGGFGLVYSGVL-----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
+++G G FG VY G+L VA+K LK ++ +FL E ++ + H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L G+ + + ++ E + NG+++ L D E + + G A + YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL--- 163
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV-------MGTFGYV 581
++ +HRD + NIL+ + KVSDFGL+R D+ +T
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT------ 217
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
APE SDV+S+G+V+ E+++ G +P
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 469
++G G FG VY G L D AVK L R+ D +FL E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 470 LIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
L+GIC+ + + +V + +G + + + E+ + L A+ + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 586
+S + +HRD + N +L+ FT KV+DFGLAR D+E + + ++A E
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 587 MTGHLLVKSDVYSYGVVILELLS-GRKP 613
T KSDV+S+GV++ EL++ G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 469
R++G+G FG+VY G D + A+K L R+ + Q FL E ++ L+H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 470 LIGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
LIGI + + + + +G + + + L AR + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 586
+ + +HRD + N +L+ FT KV+DFGLAR +D E + + A E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 587 MTGHLLVKSDVYSYGVVILELLS-GRKP 613
T KSDV+S+GV++ ELL+ G P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 468
R+LG+G FG V L KVAVK+LK + EFL E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 469 KLIGICIEEQAR------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAAR 520
KL+G+ + +A+ ++ + +G + + L + + L ++ + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV---- 574
+ YL SS IHRD + N +L D T V+DFGL+R + + ++++
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ A E V SDV+++GV + E+++ G+ P
Sbjct: 206 L------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
EE +V E + GS+ L + L + +A A +AY+ +
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 593
HRD +++NIL+ + KV+DFGLAR D E + + + APE A+ G +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 360
Query: 594 KSDVYSYGVVILELLS-GRKP 613
KSDV+S+G+++ EL + GR P
Sbjct: 361 KSDVWSFGILLTELTTKGRVP 381
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 469
R +GEG FG V+ G+ VA+K K +FL E + + H ++VK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
LIG+ E ++ EL G + S L L + + A + ALAYL
Sbjct: 81 LIGVITENPV-WIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL---E 133
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPE 584
S R +HRD + N+L+ + K+ DFGL+R D + ++ M APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------APE 187
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
SDV+ +GV + E+L G KP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 415 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
++LG G FG V+ GV V +KV++ +Q + + + L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+G+C LV + +P GS+ H+ + LG L + A+ + YL
Sbjct: 79 RLLGLCPGSSL-QLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
++HR+ + N+LL+ +V+DFG+A ++ + + + ++A E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKP 613
G +SDV+SYGV + EL++ G +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 415 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 469
+++G G FG V SG L VA+K LK ++ R+FL E ++ + H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L G+ + + +V E + NGS++S L K A + + G A + YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY--VAPEYAM 587
+HRD + NIL+ + KVSDFGL R ++++ T G +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 588 TGHLLVKSDVYSYGVVILELLS-GRKP 613
SDV+SYG+V+ E++S G +P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 415 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
++LG G FG VY G+ VA+K L+ + +E L E +++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+GIC+ L+ +L+P G + ++ + +G L + A+ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
R++HRD + N+L++ K++DFGLA+ EE + + ++A E +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 589 GHLLVKSDVYSYGVVILELLS-GRKP 613
+SDV+SYGV + EL++ G KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 468
+ILGEG FG V G L KVAVK +K Q+ EFL+E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 469 KLIGICIEEQARC-----LVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 521
+L+G+CIE ++ ++ + G + ++L ++ + LK + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV----M 575
+ YL S+ +HRD + N +L D T V+DFGL++ + + ++ +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
A E KSDV+++GV + E+ + G P
Sbjct: 217 ------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 415 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 467
R LG+G FG+VY GV T+VA+K + + EFL E ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL------HGVDKESAPLGWDARLKIALGAARA 521
V+L+G+ + Q ++ EL+ G ++S+L + AP +++A A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV----M 575
+AYL ++ + +HRD + N ++ DFT K+ DFG+ R + + + + M
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+PE G SDV+S+GVV+ E+ + +P
Sbjct: 208 ------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 74/239 (30%), Positives = 107/239 (44%), Gaps = 22/239 (9%)
Query: 415 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
R LGEG FG V D G VAVK LK Q + E+++L L+H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 469 KLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
K G C + A LV E +P GS+ +L +G L A +AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLH 151
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPE 584
+ IHRD + N+LL++D K+ DFGLA+ A+ E + R G + APE
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 585 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
SDV+S+GV + ELL+ + P L+ A+ +T E +
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQGQMTVLRLTELL 264
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
R LGEG FG V+ D VAVK LK ++F E E+L+ L H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR----------LKIAL 516
K G+C + +V+E + +G + L HG D G + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 574
A + YL +S +HRD + N L+ + K+ DFG++R + T +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 575 ----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
M PE M +SDV+S+GV++ E+ + G++P
Sbjct: 198 PIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 415 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 469
++G G FG VY G L D AVK L R+ D +FL E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 470 LIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
L+GIC+ + + +V + +G + + + E+ + L A+ + +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 586
+S + +HRD + N +L+ FT KV+DFGLAR D+E + + ++A E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 587 MTGHLLVKSDVYSYGVVILELLS-GRKP 613
T KSDV+S+GV++ EL++ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 6e-38
Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 30/293 (10%)
Query: 332 VLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIAT 391
L + A + + + +A L + + + + V D A I
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAE------IID 372
Query: 392 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDG----TKVAVKVLKR-VDQ 446
+ S + E + R +GEG FG V+ G+ VA+K K
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 447 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPL 506
+FL E + + H ++VKLIG+ E ++ EL G + S L L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ---VRKFSL 488
Query: 507 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566
+ + A + ALAYL S R +HRD + N+L+ + K+ DFGL+R D
Sbjct: 489 DLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 567 -----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ + M APE SDV+ +GV + E+L G KP
Sbjct: 546 YYKASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 415 RILGEGGFGLVYSGVLDDG------TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
LGEG FG V+ + VAVK LK + ++F E E+L+ L H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHL-----------HGVDKESAPLGWDARLKIALG 517
+ G+C E + +V+E + +G + L G D PLG L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV--- 574
A + YL + +HRD + N L+ K+ DFG++R + + R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 575 ---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
M PE + +SDV+S+GVV+ E+ + G++P
Sbjct: 224 IRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-37
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 475 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 534
EE +V E + GS+ L + L + +A A +AY+ +
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 593
HRD +++NIL+ + KV+DFGLAR D E + + + APE A+ G +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 443
Query: 594 KSDVYSYGVVILELLS-GRKP 613
KSDV+S+G+++ EL + GR P
Sbjct: 444 KSDVWSFGILLTELTTKGRVP 464
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-37
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 417 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+C E LV E+ G + L G +E + ++ + + YL
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY--VAPEYAMTGH 590
+HR+ + N+LL + K+SDFGL++ A+ + + + R G + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 591 LLVKSDVYSYGVVILELLS-GRKP 613
+SDV+SYGV + E LS G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 415 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 467
LGE FG VY G L VA+K LK + EF E + +RL H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR----------LKIA 515
V L+G+ ++Q +++ +G + L + D + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST--- 572
A + YL SS V+H+D + N+L+ K+SD GL R + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 573 ---RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
R M APE M G + SD++SYGVV+ E+ S G +P
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 24/231 (10%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
++ + LGEGGF V L DG A+K + +QQ E E +M +H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 469 KLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+L+ C+ E+ L+ G++ + + + + L D L + LG R L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-------GT 577
+H + HRD K +NILL + P + D G A + T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 578 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
Y APE + + ++DV+S G V+ ++ G P DM G
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 415 RILGEGGFGLVYSGVLDDG---TKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVK 469
++GEG FG V + A+K +K + R+F E+E+L +L HH N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 470 LIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARLKIALG 517
L+G C L E P+G++ L + ++ L L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV--- 574
AR + YL S + IHRD + NIL+ ++ K++DFGL+R + + R+
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKTMGRLPVR 206
Query: 575 -MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
M A E SDV+SYGV++ E++S G P
Sbjct: 207 WM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 467
R LG G FG VY G + +VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAY 524
V+ IG+ ++ R ++ EL+ G ++S L + + L L +A A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 525 LHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
L IHRD + N LL K+ DFG+AR G +
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAML 207
Query: 582 -----APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
PE M G K+D +S+GV++ E+ S G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 466
+ LG G FG V D KVAVK+LK ++E++++S L H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHL----------HGVDKESAPLGWDARLKIAL 516
+V L+G C ++ E G + + L ++ L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 576
A+ +A+L +S IHRD + N+LL + K+ DFGLAR M++ + +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 577 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
++APE V+SDV+SYG+++ E+ S G P
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 467
R LG G FG VY G + +VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAY 524
V+ IG+ ++ R ++ EL+ G ++S L + + L L +A A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 525 LHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
L IHRD + N LL K+ DFG+AR G +
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAML 248
Query: 582 -----APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
PE M G K+D +S+GV++ E+ S G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 415 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 464
+ LGEG FG V + VAVK+LK ++ + ++E+EM+ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 512
+N++ L+G C ++ ++ E G++ +L + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 570
AR + YL +S + IHRD + N+L+ + K++DFGLAR + + +
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 571 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 415 RILGEGGFGLVYSGVLDDG------TKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 467
+ LGEG FG V T VAVK+LK R+ L+E +L +++H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL--------------------HGVDKESAPLG 507
+KL G C ++ L+ E GS+ L + L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 508 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 566
+ A ++ + YL + +++HRD + NIL+ K+SDFGL+R +E+
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 567 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ R+ M A E +SDV+S+GV++ E+++ G P
Sbjct: 206 YVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-35
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 415 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 464
+ LGEG FG V + VAVK+LK ++ + ++E+EM+ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 512
+N++ L+G C ++ ++ E G++ +L + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 570
AR + YL +S + IHRD + N+L+ + K++DFGLAR + + +
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 571 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-35
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 415 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 464
+ LGEG FG V + TKVAVK+LK ++ + ++E+EM+ + H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 512
+N++ L+G C ++ ++ E G++ +L + L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 570
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 571 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 415 RILGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLV 468
LG GG VY +L+ KVA+K + R ++ + F EV S+L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+I + E+ LV E I ++ ++ PL D + + + H+
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
R++HRD K NIL++ + T K+ DFG+A+ A+ E S + V+GT Y +PE A
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 589 GHLLVKSDVYSYGVVILELLSGRKP 613
+D+YS G+V+ E+L G P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 466
+ LG G FG V VAVK+LK R ++E+++L + HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 467 LVKLIGIC-IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR------------LK 513
+V L+G C ++ E G++ ++L E P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHIS 571
+ A+ + +L +S + IHRD + NILL K+ DFGLAR + R
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 572 TRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
R+ M APE ++SDV+S+GV++ E+ S G P
Sbjct: 210 ARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 466
+ LG G FG V D VAVK+LK ++E+++LS L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHL--------------HGVDKESAPLGWDARL 512
+V L+G C ++ E G + + L ++ + L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
+ A+ +A+L +S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 573 ------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ M APE +SDV+SYG+ + EL S G P
Sbjct: 206 NARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 415 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 467
R +GEG FG V+ T VAVK+LK +F E +++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL--------------------HGVDKESAPLG 507
VKL+G+C + CL++E + G + L PL
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 508 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 566
+L IA A +AYL S + +HRD + N L+ + K++DFGL+R+ +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 567 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ + M PE +SDV++YGVV+ E+ S G +P
Sbjct: 230 YKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 58/241 (24%), Positives = 110/241 (45%), Gaps = 19/241 (7%)
Query: 388 SIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ 446
S+ + E + +LG+G +G+VY+G L + ++A+K + D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 447 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES---HLHGVDKES 503
+ + E+ + L H+N+V+ +G E + E +P GS+ + G K++
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 504 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSA 562
+I G L YLH++ +++HRD K N+L+ + K+SDFG ++
Sbjct: 121 EQTIGFYTKQILEG----LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 563 MDEESRHISTRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQ 618
+ GT Y+APE G+ +D++S G I+E+ +G+ P ++ +
Sbjct: 174 AGINPCTET--FTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGE 230
Query: 619 P 619
P
Sbjct: 231 P 231
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 37/270 (13%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
+G G F VY G+ + +VA +++ + + F E EML L H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 473 ICIEEQAR----CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLH 526
LV EL+ +G+++++L V K W R +I G L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW-CR-QILKG----LQFLH 146
Query: 527 EDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
+P +IHRD K NI + + K+ D GLA + + V+GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEM 201
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645
+ DVY++G+ +LE+ + P Q Q + +++ P
Sbjct: 202 YEEKYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG---VKPASFDKVAIP 257
Query: 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675
+V I C++ R
Sbjct: 258 ------------EVKEIIEGCIRQNKDERY 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 21/246 (8%)
Query: 378 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKV 436
+D S K NF + +G G F VY L DG V
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 437 AVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 493
A+K ++ D + + E+++L +L+H N++K IE+ +V EL G +
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 494 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 553
+ K+ + K + AL ++H RV+HRD K +N+ + K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 177
Query: 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILEL 607
D GL R ++ + V GT Y++PE Y KSD++S G ++ E+
Sbjct: 178 GDLGLGR-FFSSKTTAAHSLV-GTPYYMSPERIHENGYNF------KSDIWSLGCLLYEM 229
Query: 608 LSGRKP 613
+ + P
Sbjct: 230 AALQSP 235
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
+F+ +LG+G FG V D A+K ++ +++ L+EV +L+ L+H+ +V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVV 65
Query: 469 KLIGICIEEQAR-------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 515
+ +E + + E NG++ +H E+ D ++
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLF 122
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-------------A 562
AL+Y+H S +IHRD K NI ++ K+ DFGLA++
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 563 MDEESRHISTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYGVVILELLSG 610
+ S ++++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 466
+++ +G G +G DG + K + + + ++EV +L L H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 467 LVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+V+ I+ +V E G + S + KE L + L++ AL
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 525 LHE--DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
H D V+HRD K +N+ L+ K+ DFGLAR ++ ++ T V GT Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFV-GTPYYMS 184
Query: 583 PE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
PE Y KSD++S G ++ EL + P
Sbjct: 185 PEQMNRMSYNE------KSDIWSLGCLLYELCALMPP 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-33
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 43/233 (18%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 466
++LG G FG V + +VAVK+LK D ++E++M+++L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR------------- 511
+V L+G C L++E G + ++L + ++ +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 512 ----LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 566
L A A+ + +L +HRD + N+L+ H K+ DFGLAR M +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 567 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 613
+ R+ M APE G +KSDV+SYG+++ E+ S G P
Sbjct: 228 YVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 41/227 (18%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
+F ++G GGFG V+ DG +K +K ++ + EV+ L++L H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIV 67
Query: 469 KLIGICIEEQAR----------------CLVYELIPNGSVESHLHGVDKESAPLGWDARL 512
G + E G++E + + L L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLAL 125
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
++ + + Y+H S ++I+RD K SNI L K+ DFGL S ++ R T
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---T 179
Query: 573 RVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
R GT Y++PE Y G + D+Y+ G+++ ELL
Sbjct: 180 RSKGTLRYMSPEQISSQDY---GK---EVDLYALGLILAELLHVCDT 220
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 466
+ + +GEG FG +DG + +K + R+ + E EV +L+ + H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+V+ E + +V + G + ++ ++ D L + AL ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE-- 584
+++HRD KS NI L D T ++ DFG+AR ++ + GT Y++PE
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSPEIC 197
Query: 585 ----YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
Y KSD+++ G V+ EL + +
Sbjct: 198 ENKPYNN------KSDIWALGCVLYELCTLKHA 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRL--HHRNLVKL 470
+ +G GG V+ + + A+K L+ D Q + E+ L++L H +++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
I +Q +V E N + S L K+ + R A+ +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 584
++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 128 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 585 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 613
+ KSDV+S G ++ + G+ P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNL--VKL 470
+ +G GG V+ + + A+K L+ D Q + E+ L++L + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
I +Q +V E N + S L K+S W+ + A+ +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDP-WERK-SYWKNMLEAVHTIHQH-- 146
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 584
++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 147 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 585 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 613
+ KSDV+S G ++ + G+ P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 401 ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEV 456
A+ I + +F +LG+G F VY + G +VA+K++ K + + G + EV
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 457 EMLSRLHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLG-WDARLKI 514
++ +L H ++++L E+ LV E+ NG + +L K P +AR +
Sbjct: 63 KIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFM 118
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 574
+ YLH S ++HRD SN+LL + K++DFGLA +H T +
Sbjct: 119 H-QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-L 172
Query: 575 MGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKP 613
GT Y++PE A + H L +SDV+S G + LL GR P
Sbjct: 173 CGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 415 RILGEGGFGLVYSG---VLDDGTKVAVKVLKRVDQQGGREFLA----EVEMLSRLHHRNL 467
ILG GG V+ VAVKVL R D F E + + L+H +
Sbjct: 18 EILGFGGMSEVHLARDLRDHR--DVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 468 VKL--IGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
V + G +V E + ++ +H P+ +++ A +AL
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALN 130
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI--STRVMGTFGYV 581
+ H++ +IHRD K +NI++ KV DFG+AR A+ + + + V+GT Y+
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVIGTAQYL 186
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+PE A + +SDVYS G V+ E+L+G P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 23/216 (10%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 464
+ R LG+GGF + D A K++ + + RE E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 521
+++V G E+ +V EL S+ E +AR
Sbjct: 75 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 580
YLH RVIHRD K N+ L D K+ DFGLA + R +V+ GT Y
Sbjct: 128 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNY 181
Query: 581 VAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVD 615
+APE GH + DV+S G ++ LL G+ P +
Sbjct: 182 IAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-31
Identities = 47/238 (19%), Positives = 89/238 (37%), Gaps = 31/238 (13%)
Query: 415 RILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKL 470
+ GG G +Y + D +G V +K L + +AE + L+ + H ++V++
Sbjct: 86 GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 471 --IGICIEEQARCLVY---ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+ + Y E + S++ L + L AL+YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYL 198
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H +++ D K NI+L + K+ D G ++ + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEI 248
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643
V +D+Y+ G + L + G + P+L + + R++
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LPEDDPVLKTYDSYGRLL 301
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-31
Identities = 68/308 (22%), Positives = 116/308 (37%), Gaps = 45/308 (14%)
Query: 394 GSAKTFSASEIEKATG-------NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ 446
GS+ + + ++ T +F +LG G G + + D VAVK +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 447 QGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP 505
EV++L H N+++ + Q + + EL +++ ++ K+ A
Sbjct: 62 SFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAH 115
Query: 506 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 560
LG + + LA+LH S ++HRD K NIL+ +SDFGL +
Sbjct: 116 LGLEPI-TLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 561 SAMDEE-SRHISTRVMGTFGYVAPEY---AMTGHLLVKSDVYSYGVVILELLSGRKPVDM 616
S + V GT G++APE + D++S G V ++S
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--- 228
Query: 617 TQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA--IASMCVQPEVQHR 674
P G+ R+ + SL P +A I M + + Q R
Sbjct: 229 --PFGKSL----------QRQANILLGACSLDCLHPEKHEDVIARELIEKM-IAMDPQKR 275
Query: 675 PFMGEVVQ 682
P V++
Sbjct: 276 PSAKHVLK 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 70/213 (32%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 464
+F+ R LG+G FG VY +A+KVL ++++ G EVE+ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 465 RNLVKLIGICIEEQARC-LVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 521
N+++L G + R L+ E P G+V L E I A A
Sbjct: 69 PNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITE-LANA 121
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
L+Y H S RVIHRD K N+LL K++DFG S SR GT Y+
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDL--CGTLDYL 174
Query: 582 APEYAMT-GHLLVKSDVYSYGVVILELLSGRKP 613
PE H K D++S GV+ E L G+ P
Sbjct: 175 PPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPP 206
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 415 RILGEGGFGLVYSG---VLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLV 468
R++G GG G VY V + VA+K++ D E RL ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+ + + LI + + L + PL + I AL H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
HRD K NIL+ D + DFG+A A +E +GT Y+APE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 589 GHLLVKSDVYSYGVVILELLSGRKP 613
H ++D+Y+ V+ E L+G P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNL 467
+F+ + LG GGFG+V+ D A+K ++ +++ RE + EV+ L++L H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 468 VKLIGICIEEQAR------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 515
V+ +E+ + +L ++ L I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHIF 124
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH------ 569
L A A+ +LH S ++HRD K SNI D KV DFGL + +E
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 570 ----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 608
T +GT Y++PE K D++S G+++ ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 32/279 (11%), Positives = 63/279 (22%), Gaps = 43/279 (15%)
Query: 379 DSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVA 437
+A + ++ + T S + + L G +V+ ++ A
Sbjct: 33 PAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 438 VKVL---KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC-------------------- 474
+KV + +RL + +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 475 ------IEEQARCLVYELIP--NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
L+ + S L V G A + R A L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
S ++H F N+ + D + D Y E+
Sbjct: 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFL 263
Query: 587 MTGHLLV--KSDVYSYGVVILELLSGRKPVDMTQPPGQE 623
+ + G+ I + P + P +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 464
+ R LG+GGF + D A K++ + + RE E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 521
+++V G E+ +V EL S+ E +AR
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE-----PEAR-YYLRQIVLG 153
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 580
YLH RVIHRD K N+ L D K+ DFGLA + R +V+ GT Y
Sbjct: 154 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNY 207
Query: 581 VAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKP 613
+APE GH + DV+S G ++ LL G+ P
Sbjct: 208 IAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPP 240
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNL--VKL 470
+ +G GG V+ + + A+K L+ D Q + E+ L++L + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
I +Q +V E N + S L K+ + R A+ +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 584
++H D K +N L+ D K+ DFG+A + + + +G Y+ PE
Sbjct: 175 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 585 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 613
+ KSDV+S G ++ + G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 22/229 (9%)
Query: 405 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRL 462
+ G ++ LG GGFG V + D G +VA+K ++ RE E++++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 463 HHRNLVKLIGICIEEQAR-------CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKI 514
+H N+V + + + L E G + +L E+ L +
Sbjct: 70 NHPNVVSAREV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTL 126
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHIS 571
+ AL YLHE+ R+IHRD K NI+L K+ D G A+ E +
Sbjct: 127 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCT 181
Query: 572 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 620
V GT Y+APE V D +S+G + E ++G +P P
Sbjct: 182 EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 28/236 (11%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRN 466
+ S ILG+G V+ G G A+KV + + E E+L +L+H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 467 LVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIALGAARAL 522
+VKL I EE L+ E P GS+ + L + +A L L + +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 523 AYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
+L E+ ++HR+ K NI+ + K++DFG AR D+E + GT
Sbjct: 126 NHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLY-GTE 179
Query: 579 GYVAPEYAMTGHLLV--------KSDVYSYGVVILELLSGRKP-VDMTQPPGQENL 625
Y+ P+ L D++S GV +G P P + +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 45/231 (19%), Positives = 90/231 (38%), Gaps = 36/231 (15%)
Query: 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA-------------- 454
++ R L +G F + D A+K ++ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 455 ---EVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLG- 507
E+++++ + + + GI I ++YE + N S+ V ++
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 508 --WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565
+ I + +Y+H + + HRD K SNIL++ + K+SDFG + +D+
Sbjct: 149 PIQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 566 ESRHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVILELLSGRKP 613
I GT+ ++ PE + K D++S G+ + + P
Sbjct: 206 ---KIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+G G FG V+ G + AVK L+ + E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
E + EL+ GS+ + K+ L D L A L YLH R+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 534 IHRDFKSSNILLEHDFTP-KVSDFGLA-RSAMDEESRHISTR--VMGTFGYVAPEYAM-T 588
+H D K+ N+LL D + + DFG A D + + T + GT ++APE M
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 589 GHLLVKSDVYSYGVVILELLSGRKP 613
K D++S ++L +L+G P
Sbjct: 232 PCDA-KVDIWSSCCMMLHMLNGCHP 255
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 25/240 (10%)
Query: 386 GSSIATYTGSAKTFSASEIEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKV 440
G + G + I G+ + LG G +G V + A+K+
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 441 L--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL-- 496
+ V + L EV +L L H N++KL +++ LV E G + +
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 497 HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKV 553
E DA I + YLH ++HRD K N+LL E D K+
Sbjct: 130 RMKFNEV-----DAA-VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 554 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
DFGL SA+ E + + R+ GT Y+APE + K DV+S GV++ LL+G P
Sbjct: 181 VDFGL--SAVFENQKKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 405 EKATGN--FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLS 460
++T N + S ILG+G V+ G G A+KV + + E E+L
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 461 RLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIAL 516
+L+H+N+VKL I EE L+ E P GS+ + L + +A L L +
Sbjct: 63 KLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLR 119
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEESRHIST 572
+ +L E+ ++HR+ K NI+ + K++DFG AR D+E +
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVS 174
Query: 573 RVMGTFGYVAPEYAMTGHLLV--------KSDVYSYGVVILELLSGRKP-VDMTQPPGQE 623
GT Y+ P+ L D++S GV +G P P +
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 624 NL 625
+
Sbjct: 234 EV 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 48/285 (16%), Positives = 87/285 (30%), Gaps = 31/285 (10%)
Query: 351 QAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFS-ASEIEKATG 409
+ P + + L+ SGL +S + + +E + +
Sbjct: 9 GTVDAPNFIVGNPWDDKLIFKLL--SGLSK-PVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 410 NFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGREFLAEVEMLSRL- 462
+LGEG F VY D K +KV K + EF +++ RL
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLK 122
Query: 463 --HHRNLVKLIGICIEEQARCLVYELIPNGSVESHL-HGVDKESAPLGWDARLKIALGAA 519
+K + + LV EL G++ + + + + + A+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-----------KVSDFGLARSAMDEESR 568
+ +H +IH D K N +L + F + D G +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
I T T G+ E + D + + +L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 400 SASEIEKAT---GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFL 453
+ +E+ K +FD R LG+G FG VY + +A+KVL + ++++G L
Sbjct: 2 ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 454 A-EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDA 510
E+E+ S L H N++++ + + L+ E P G + L HG E +
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRS 116
Query: 511 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570
+ A AL Y H +VIHRD K N+L+ + K++DFG S R
Sbjct: 117 ATFMEE-LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRR 170
Query: 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ GT Y+ PE K D++ GV+ E L G P
Sbjct: 171 TM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 55/208 (26%), Positives = 80/208 (38%), Gaps = 15/208 (7%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRL-HHR 465
+F LG G +G V+ +DG AVK + + LAEV ++ H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
V+L E L EL S++ H A L ALA+L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAHL 173
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S ++H D K +NI L K+ DFGL + + G Y+APE
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPEL 227
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ +DV+S G+ ILE+ +
Sbjct: 228 LQGSYGT-AADVFSLGLTILEVACNMEL 254
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 404 IEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAE 455
++ +T F R+LG+G FG V G + AVKV+ ++V Q+ +E L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 456 VEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLK 513
V++L +L H N++KL ++ LV E+ G + + E DA +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAA-R 130
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHI 570
I + Y+H +++HRD K N+LL D ++ DFGL S E S+ +
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL--STHFEASKKM 185
Query: 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
++ GT Y+APE + G K DV+S GV++ LLSG P
Sbjct: 186 KDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 29/233 (12%)
Query: 392 YTGSAKTFSASE-IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQ 447
++ + + ++ +LG+G FG V + AVKV+ +
Sbjct: 7 HSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 448 GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDKES 503
L EVE+L +L H N++KL I + + +V EL G + + ++
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 504 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLAR 560
A +I + Y+H ++HRD K NILL E D K+ DFGL
Sbjct: 124 A--------RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL-- 170
Query: 561 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
S +++ + R+ GT Y+APE + G K DV+S GV++ LLSG P
Sbjct: 171 STCFQQNTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 39/280 (13%), Positives = 80/280 (28%), Gaps = 54/280 (19%)
Query: 378 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKV 436
+ SA+ S S+ TG SE+ + +LG+ + G
Sbjct: 43 MQSAADSLVSTSLWNTGQPFRV-ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 437 AVKVLKRVDQQGGRE----------------------------FLAEVEMLSRLHHRNLV 468
V V ++ F+ +++ + ++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 469 KLIGIC--IEEQARCLVYELI--PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
++ + +R +Y + + L L ARL++ L R LA
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH ++H + +I+L+ ++ F + G+ PE
Sbjct: 222 LH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVSRGFEPPE 272
Query: 585 YAMTGHLLV-----------KSDVYSYGVVILELLSGRKP 613
+ D ++ G+VI + P
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 404 IEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-------------VD 445
+ K G R LG G +G V + ++ A+KV+K+
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 446 QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDK 501
++ E E+ +L L H N++KL + +++ LV E G + + +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 502 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGL 558
++A I + YLH ++HRD K NILLE+ K+ DFGL
Sbjct: 147 DAA--------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ + + R+ GT Y+APE + K DV+S GV++ LL G P
Sbjct: 196 SS--FFSKDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 24/221 (10%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 472
R+L EGGF VY + G + A+K L +++ R + EV + +L H N+V+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 473 ICI-------EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
QA L+ + G + L + + PL D LKI RA+ ++
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM---------- 575
H P +IHRD K N+LL + T K+ DFG A + S +
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 576 GTFGYVAPE-YAMTGHLLV--KSDVYSYGVVILELLSGRKP 613
T Y PE + + + K D+++ G ++ L + P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 44/229 (19%), Positives = 75/229 (32%), Gaps = 35/229 (15%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRL-HHR 465
F +G G FG V+ V DG A+K K+ + L EV + L H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
++V+ E+ + E GS+ + + + + L R L Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 526 HEDSSPRVIHRDFKSSNILLEHD-------------------FTPKVSDFGLARSAMDEE 566
H S ++H D K SNI + K+ D G +
Sbjct: 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 567 SRHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVILELLSGRKP 613
G ++A E HL K+D+++ + ++
Sbjct: 189 V------EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 7e-27
Identities = 29/237 (12%), Positives = 64/237 (27%), Gaps = 42/237 (17%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE---------------------- 451
+LG+ + G V V ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 452 ------FLAEVEMLSRLHHRNLVKLI--GICIEEQARCLVYELI--PNGSVESHLHGVDK 501
F+ +++ + ++++ + +R +Y + + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 502 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561
L ARL++ L R LA LH ++H + +I+L+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 562 AMDEESRHISTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ R A + D ++ G+ I + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 37/231 (16%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVK 469
+ +ILG G G V G VAVK + L E+++L+ H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIR 73
Query: 470 LIGICIEEQARCLVYELIPNGS----VESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
++ + EL N + VES + ++ + A +A+L
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHL 131
Query: 526 HEDSSPRVIHRDFKSSNILL-------------EHDFTPKVSDFGLARSAMDEES---RH 569
H S ++IHRD K NIL+ + +SDFGL + +S +
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 570 ISTRVMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVILELLSGRKP 613
++ GT G+ APE + L D++S G V +LS K
Sbjct: 189 LNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 67/272 (24%), Positives = 107/272 (39%), Gaps = 46/272 (16%)
Query: 371 GLMVGSGLDSASLSFGSSIATYTGSAKTF-----SASEIEKATGNF----DASRILGEGG 421
+VG G L+ S IA K F + + S+ LG G
Sbjct: 89 TELVGKG-KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 422 FGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
G V KVA++++ + + E+E+L +L+H ++K+
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207
Query: 473 ICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
+ + +V EL+ G V + KE+ + A+ YLHE
Sbjct: 208 F-FDAEDYYIVLELMEGGELFDKVVG---NKRLKEA-----TCK-LYFYQMLLAVQYLHE 257
Query: 528 DSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
+ +IHRD K N+LL E D K++DFG ++ + E+ + T GT Y+APE
Sbjct: 258 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLC-GTPTYLAPE 311
Query: 585 ---YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
T D +S GV++ LSG P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 39/228 (17%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGREFLAEVEML 459
G + +LGEG +G V + + + AVK+LK+ + +E +++L
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLL 60
Query: 460 SRLHHRNLVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 517
RL H+N+++L+ + E+ + +V E G E +K R +
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------RFPVC-- 109
Query: 518 AAR--------ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569
A L YLH S ++H+D K N+LL T K+S G+A + +
Sbjct: 110 QAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 570 ISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKPVD 615
G+ + PE A K D++S GV + + +G P +
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 394 GSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGR 450
G++ S ++ + GN+ + +G+G F V + G +VA+K++ +++ +
Sbjct: 1 GNSIA-SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ 59
Query: 451 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGW 508
+ EV ++ L+H N+VKL + E+ L+ E G V +L HG KE
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----- 114
Query: 509 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568
+AR A+ Y H R++HRD K+ N+LL+ D K++DFG S
Sbjct: 115 EAR-SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF--SNEFTVGG 168
Query: 569 HISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
+ G Y APE Y G + DV+S GV++ L+SG P D
Sbjct: 169 KLDAFC-GAPPYAAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 27/232 (11%)
Query: 393 TGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE 451
+G + I+ F R LG G FG V+ G + +K + + Q E
Sbjct: 9 SGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 452 -FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG------SVESHLHGVDKESA 504
AE+E+L L H N++K+ + + +V E G E
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG- 124
Query: 505 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARS 561
++ ALAY H V+H+D K NIL K+ DFGLA
Sbjct: 125 ----YVA-ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE- 175
Query: 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ + H + GT Y+APE + K D++S GVV+ LL+G P
Sbjct: 176 -LFKSDEHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 28/225 (12%)
Query: 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEV 456
+ + I K F +LG G F V+ G A+K +K+ E+
Sbjct: 1 SMQTTNIRK---TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI 57
Query: 457 EMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDAR 511
+L ++ H N+V L I LV +L+ G +E GV E DA
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE---RGVYTEK-----DAS 109
Query: 512 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESR 568
+ A+ YLH ++HRD K N+L + ++DFGL++ M++
Sbjct: 110 -LVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGI 163
Query: 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ST GT GYVAPE D +S GV+ LL G P
Sbjct: 164 -MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRN 466
++ +LG+G FG V + AVKV+ + L EVE+L +L H N
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 467 LVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARAL 522
++KL I + + +V EL G + + ++A + +K +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GI 134
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
Y+H+ + ++HRD K NILLE D K+ DFGL+ +++ + R+ GT
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI-GTAY 188
Query: 580 YVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
Y+APE Y K DV+S GV++ LLSG P
Sbjct: 189 YIAPEVLRGTYDE------KCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+G G +G V V + A K + + + F E+E++ L H N+++L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 474 CIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+ LV EL G V + ++A + +K L A+AY H
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS---AVAYCH--- 123
Query: 530 SPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
V HRD K N L D K+ DFGLA + + + T+V GT YV+P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKV-GTPYYVSPQ-V 179
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
+ G + D +S GV++ LL G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
++ LG+G FG VY + G A KV++ ++ +++ E+E+L+ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L+G + ++ E P G+V++ + +D+ L + AL +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
R+IHRD K+ N+L+ + +++DFG++ + + S +GT ++APE M
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 590 HLL-----VKSDVYSYGVVILELLSGRKP 613
+ K+D++S G+ ++E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 47/214 (21%), Positives = 75/214 (35%), Gaps = 31/214 (14%)
Query: 418 GEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
G V G V V+ L+ + E+ + +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 475 IEEQARCLVYELIPNGSV----ESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHE 527
I + +V + GS +H E A IA G +AL Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVLKALDYIHH 146
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH-----ISTRVMGTFGYVA 582
+HR K+S+IL+ D +S S + R + +++
Sbjct: 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 583 PEYAMTGHLL---VKSDVYSYGVVILELLSGRKP 613
PE + +L KSD+YS G+ EL +G P
Sbjct: 204 PE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 38/239 (15%)
Query: 396 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQ 446
+ S + N++ ILG G +V + + AVK++ +
Sbjct: 7 PGSHSTHGFYE---NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 447 QGGREFLA-EVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVD 500
Q RE EV++L ++ H N+++L LV++L+ G + + +
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 501 KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560
KE+ + ++ L + LH+ ++HRD K NILL+ D K++DFG +
Sbjct: 124 KETRKI-----MRALLEV---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 561 SAMDEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ + GT Y+APE + D++S GV++ LL+G P
Sbjct: 173 --QLDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 26/280 (9%)
Query: 346 KSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIE 405
+S C+ + G G + + K + +E
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 406 KATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 460
+ D LG G FG+V+ G A K + + E++ +S
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIA 515
L H LV L ++ ++YE + G + H + E+ ++
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQV 264
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTR 573
L ++HE++ +H D K NI+ + K+ DFGL + + +
Sbjct: 265 CK---GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVT 316
Query: 574 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
GT + APE A + +D++S GV+ LLSG P
Sbjct: 317 T-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRN 466
++D + LGEG +G V V VAVK++ E + E+ + L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 467 LVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALGAA 519
+VK G E L E G + + E DA+ +A
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---- 116
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
+ YLH + HRD K N+LL+ K+SDFGLA + ++ GT
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 580 YVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
YVAPE + DV+S G+V+ +L+G P D
Sbjct: 173 YVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE------FLAEVEMLS 460
+ S+ LG G G V KVA+K++ ++ RE E+E+L
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIA 515
+L+H ++K+ + + +V EL+ G V + KE+ +
Sbjct: 71 KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG---NKRLKEA-----TCK-LYF 120
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHIST 572
A+ YLHE+ +IHRD K N+LL D K++DFG ++ + E+ + T
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 175
Query: 573 RVMGTFGYVAPE----YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
GT Y+APE G+ D +S GV++ LSG P
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 44/235 (18%)
Query: 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGRE 451
T + + + + LG+G F +V V + G + A + L D Q +
Sbjct: 3 TITCTRFTE---EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---K 56
Query: 452 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLG 507
E + L H N+V+L EE L+++L+ G + + + + +++
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC- 115
Query: 508 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMD 564
++ L A + + H+ V+HR+ K N+LL K++DFGLA ++
Sbjct: 116 ----IQQILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VE 164
Query: 565 EESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
E + GT GY++PE Y D+++ GV++ LL G P
Sbjct: 165 GEQQAWFGFA-GTPGYLSPEVLRKDPYGK------PVDLWACGVILYILLVGYPP 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 65/270 (24%)
Query: 399 FSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREF 452
F + + + +G+G +G+V + A+K+ +++++ +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 453 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDKESAPLGW 508
EV ++ +LHH N+ +L + +EQ CLV EL G + + + A
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 509 DARLKIALG-------------------------AAR-------ALAYLHEDSSPRVIHR 536
++ + AL YLH + + HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHR 192
Query: 537 DFKSSNILLEHD--FTPKVSDFGLAR---SAMDEESRHISTRVMGTFGYVAPE------- 584
D K N L + F K+ DFGL++ + E ++T+ GT +VAPE
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNE 251
Query: 585 -YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
Y K D +S GV++ LL G P
Sbjct: 252 SYGP------KCDAWSAGVLLHLLLMGAVP 275
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI 473
+LGEG V + + L + AVK++++ EVEML + HRN+++LI
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAYLHEDSSP 531
EE LV+E + GS+ SH+H E +A + A AL +LH +
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASALDFLH---NK 130
Query: 532 RVIHRDFKSSNILLEH---DFTPKVSDFGLAR------SAMDEESRHISTRVMGTFGYVA 582
+ HRD K NIL EH K+ DF L + + T G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMA 189
Query: 583 PEYAMTGHLLVKS-----DVYSYGVVILELLSGRKP 613
PE D++S GV++ LLSG P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 54/234 (23%), Positives = 87/234 (37%), Gaps = 26/234 (11%)
Query: 392 YTGSAKTFSASEIEKATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ 446
Y K + +E G+ D LG G FG+V+ V G K +
Sbjct: 30 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 89
Query: 447 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDK 501
E+ ++++LHH L+ L ++ L+ E + G +
Sbjct: 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA 149
Query: 502 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLA 559
E ++ A L ++HE ++H D K NI+ E K+ DFGLA
Sbjct: 150 EVINY-----MRQACEG---LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+E I T + APE + +D+++ GV+ LLSG P
Sbjct: 199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 57/258 (22%), Positives = 107/258 (41%), Gaps = 12/258 (4%)
Query: 411 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 468
F+ LG G G+V+ G +A K++ + + + E+++L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
G + + E + GS++ L K++ + K+++ + L YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
+++HRD K SNIL+ K+ DFG++ +D + + V GT Y++PE
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQG 204
Query: 589 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648
H V+SD++S G+ ++E+ GR P+ E + +
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 649 NDVPFDSVAKVAAIASMC 666
N DS +A +
Sbjct: 265 NKFGMDSRPPMAIFELLD 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEM-LSRLHHRNLVKLIGI 473
LG G +G+V + G +AVK ++ V+ Q + L ++++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
E + EL+ + S++ V + + D KIA+ +AL +LH V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE----YAMTG 589
IHRD K SN+L+ K+ DFG++ +D+ ++ G Y+APE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQK 188
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
VKSD++S G+ ++EL R P
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 400 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGR 450
A+ + + + LG G FG V++ V + +V VK +K+ ++
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 451 EFLAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGS------VESHLHGVDKES 503
+ E+ +LSR+ H N++K++ I E Q LV E +G H E
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEP 130
Query: 504 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563
A I A+ YL +IHRD K NI++ DFT K+ DFG +A
Sbjct: 131 -----LAS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS--AAY 179
Query: 564 DEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
E + T GT Y APE Y G + +++S GV + L+ P
Sbjct: 180 LERGKLFYTFC-GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEENPFC 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 65/233 (27%), Positives = 97/233 (41%), Gaps = 21/233 (9%)
Query: 394 GSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF 452
S S + G F+ ++G G +G VY G + G A+KV+ V E
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEI 67
Query: 453 LAEVEMLSRL-HHRNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAP 505
E+ ML + HHRN+ G I++ LV E GSV + +
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 506 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565
W A I R L++LH +VIHRD K N+LL + K+ DFG++
Sbjct: 128 EEWIA--YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 566 ESRHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKP 613
R + +GT ++APE KSD++S G+ +E+ G P
Sbjct: 183 VGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
D+ +GEG G+V G +VAVK++ QQ EV ++ H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+ + + ++ E + G++ + L + + +ALAYLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH--- 158
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
+ VIHRD KS +ILL D K+SDFG + + S ++GT ++APE
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRS 216
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
+ D++S G++++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+ +G+G G VY+ + + G +VA++ + Q + E+ ++ + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+ + +V E + GS+ + + + +AL +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
S +VIHRD KS NILL D + K++DFG E+S+ + ++GT ++APE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 191
Query: 590 HLLVKSDVYSYGVVILELLSGRKP 613
K D++S G++ +E++ G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRN 466
++D + LGEG +G V V VAVK++ E + E+ + L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 467 LVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALGAA 519
+VK G E L E G + + E DA+ +A
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---- 116
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 579
+ YLH + HRD K N+LL+ K+SDFGLA + ++ GT
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 580 YVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
YVAPE + DV+S G+V+ +L+G P D
Sbjct: 173 YVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 51/233 (21%), Positives = 102/233 (43%), Gaps = 43/233 (18%)
Query: 401 ASEIEKATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAE 455
++ + + F + +G G + + + + AVK++ + ++ E E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTE---E 65
Query: 456 VEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK----ESAPLGWDA 510
+E+L R H N++ L + + + +V EL+ G + + + + E +A
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSER-----EA 118
Query: 511 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEE 566
+ + + YLH + V+HRD K SNIL + + ++ DFG A+ + E
Sbjct: 119 S-AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAE 173
Query: 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVILELLSGRKP 613
+ + T T +VAPE +L + D++S GV++ +L+G P
Sbjct: 174 NGLLMTPC-YTANFVAPE------VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 36/294 (12%)
Query: 345 YKSHACQAEEVPQSLQTSHVKPSGA--------------AGLMVGSGLDSASLSFGSSIA 390
+ H+ + ++L +K SG + + + S +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64
Query: 391 TYTGSAKTFSASEIEKATGNF------DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR 443
F + G + ILG G FG V+ G K+A K++K
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 444 VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES 503
+ E E+ ++++L H NL++L + LV E + G E +D+
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG--ELFDRIIDESY 182
Query: 504 APLGWDAR--LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLA 559
D +K + ++H ++H D K NIL + K+ DFGLA
Sbjct: 183 NLTELDTILFMKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
R E + GT ++APE + +D++S GV+ LLSG P
Sbjct: 237 RRYKPREK--LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 414 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 471
+ LGEG F + V AVK++ + + ++ E+ L H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 472 GICIEEQARCLVYELIPNGS----VESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
+ ++ LV EL+ G ++ H + E++ I A++++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSAVSHMH- 123
Query: 528 DSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
V+HRD K N+L + K+ DFG AR +++ + T T Y APE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPC-FTLHYAAPE 179
Query: 585 YAMTGHLLVKS------DVYSYGVVILELLSGRKP 613
LL ++ D++S GV++ +LSG+ P
Sbjct: 180 ------LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 67/209 (32%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
LG G +VY A+KVL K VD++ R E+ +L RL H N++KL
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKE 115
Query: 473 ICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
I LV EL+ G VE G E DA A+AYLHE
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVE---KGYYSER-----DAA-DAVKQILEAVAYLHE 166
Query: 528 DSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
+ ++HRD K N+L D K++DFGL++ + E + T GT GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKTVC-GTPGYCAPE 220
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ D++S G++ LL G +P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 41/249 (16%)
Query: 386 GSSIATYTGSAKTFSASE-IEKATGNFDAS----RILGEGGFGLVYSGV-LDDGTKVAVK 439
G +A+ TG + SE + A+ F + LG+G F +V V G + A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 440 VL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVE 493
++ K++ + ++ E + +L H N+V+L EE LV++L+ G +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 494 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFT 550
+ + +++ ++ L + +AY H + ++HR+ K N+LL
Sbjct: 121 AREFYSEADASHC-----IQQILES---IAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVI 604
K++DFGLA +S GT GY++PE +L K D+++ GV++
Sbjct: 170 VKLADFGLAI--EVNDSEAWHGFA-GTPGYLSPE------VLKKDPYSKPVDIWACGVIL 220
Query: 605 LELLSGRKP 613
LL G P
Sbjct: 221 YILLVGYPP 229
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN 466
FD LGEG +G VY + + G VA+K + +E + E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPH 85
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+VK G + +V E GSV + +K L D I + L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLH 142
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
R IHRD K+ NILL + K++DFG+A D ++ + V+GT ++APE
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 27/219 (12%)
Query: 405 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSR 461
++ + + LG G FG+V+ V K + K DQ E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIAL 516
HRN++ L + +++E I S ++E +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVC 112
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTRV 574
A L +LH + + H D + NI+ + + K+ +FG AR + +
Sbjct: 113 EA---LQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLF 164
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
Y APE + +D++S G ++ LLSG P
Sbjct: 165 -TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR--EFLAEVEMLSRLHHRNL 467
F +G+G FG V+ G+ VA+K++ +++ + E+ +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL---GAARAL 522
K G +++ ++ E + GS L G E+ +IA + L
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDET---------QIATILREILKGL 132
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
YLH + + IHRD K++N+LL K++DFG+A D + + + +GT ++A
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMA 187
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
PE K+D++S G+ +EL G P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 401 ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLAEVE 457
+++ N+D LG+G F +V V G + A K++ K++ + ++ E
Sbjct: 1 STKFSD---NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 458 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLK 513
+ +L H N+V+L EE LV++L+ G + + + +++ ++
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQ 112
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHI 570
L + +AY H S ++HR+ K N+LL K++DFGLA D E+
Sbjct: 113 QILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--W 164
Query: 571 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
GT GY++PE Y+ D+++ GV++ LL G P
Sbjct: 165 HGFA-GTPGYLSPEVLKKDPYSK------PVDIWACGVILYILLVGYPP 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 29/219 (13%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRL 462
+++ LG G F +V G + A K +K+ R E EV +L +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGA 518
H N++ L I + L+ EL+ G + + E+ LK L
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILDG 120
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRV 574
+ YLH R+ H D K NI+L P K+ DFG+A E
Sbjct: 121 ---VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 172
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREFLA-EVEMLSRLH 463
+D LG G F +V G + A K K + RE + EV +L +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAA 519
H N++ L + + L+ EL+ G + ++E+ LK L
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNG- 126
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRVM 575
+ YLH + H D K NI+L P K+ DFGLA +D + +
Sbjct: 127 --VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEF--KNIF 178
Query: 576 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 464
G++ LG G FG V G G KVAVK+L R + + E++ L H
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 517
+++KL + I +V E + G + ++ HG +E +AR ++
Sbjct: 71 PHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----EARRLFQQILS-- 122
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
A+ Y H V+HRD K N+LL+ K++DFGL S M + + T G+
Sbjct: 123 ---AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSC-GS 173
Query: 578 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
Y APE YA G + D++S GV++ LL G P D
Sbjct: 174 PNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGTLPFD 212
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLK--RVDQQGGREF-LAEVEMLSRLHHR 465
F R+LG GGFG V++ + K+ A K L R+ ++ G + + E ++L+++H R
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 466 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWD-ARL---KIALGAAR 520
+V L E + CLV ++ G + H++ VD+++ A +I
Sbjct: 246 FIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS---- 300
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
L +LH+ +I+RD K N+LL+ D ++SD GLA +++ GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGF 355
Query: 581 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
+APE + G S D ++ GV + E+++ R P
Sbjct: 356 MAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 32/232 (13%)
Query: 397 KTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGR 450
+ F ++E +D LG G F +V G + A K + + R
Sbjct: 3 EPFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 451 EFLA-EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAP 505
E + EV +L ++ H N++ L + L+ EL+ G + ++E+
Sbjct: 60 EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 506 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARS 561
+K L + YLH + H D K NI+L P K+ DFGLA
Sbjct: 120 F-----IKQILDG---VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+++ + GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 169 -IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREFLAEVEMLSRLHH 464
++ ++G+G F +V + + G + AVK+ + E + L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 465 RNLVKLIGICIEEQARCLVYELIPNG------SVESHLHGVDKESAPLGWDAR--LKIAL 516
++V+L+ + +V+E + + V E+ A ++ L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-----VASHYMRQIL 140
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTR 573
AL Y H++ +IHRD K +LL E+ K+ FG+A + E R
Sbjct: 141 E---ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ-LGESGLVAGGR 193
Query: 574 VMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
V GT ++APE G DV+ GV++ LLSG P
Sbjct: 194 V-GTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 32/231 (13%)
Query: 398 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGRE 451
TF ++E +D LG G F +V G + A K + + RE
Sbjct: 4 TFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 452 FL-AEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPL 506
+ EV +L ++ H N++ L + L+ EL+ G + ++E+
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 507 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSA 562
+K L + YLH + H D K NI+L P K+ DFGLA
Sbjct: 121 -----IKQILDG---VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE- 168
Query: 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
E + GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 169 --IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEM 458
I + +D + +G G FG+ VAVK ++R +D+ RE +
Sbjct: 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IIN 69
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLK--- 513
L H N+V+ + + ++ E G + + G E +AR
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQ 124
Query: 514 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHI 570
++ ++Y H S ++ HRD K N LL+ P K+ DFG ++S++
Sbjct: 125 LLS-----GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 175
Query: 571 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
+ V GT Y+APE Y G +DV+S GV + +L G P +
Sbjct: 176 -STV-GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 60/248 (24%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLA----------- 454
+ +G+G +G+V +D T A+KVL K++ +Q G
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 455 -------------EVEMLSRLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHG 498
E+ +L +L H N+VKL+ + +++ +V+EL+ G V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV------ 125
Query: 499 VDKESAPLGWDARLKIALGAAR--------ALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550
++ + L AR + YLH ++IHRD K SN+L+ D
Sbjct: 126 MEVPTLK-----PLSEDQ--ARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGH 175
Query: 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVILEL 607
K++DFG+ S + S + + +GT ++APE + DV++ GV +
Sbjct: 176 IKIADFGV--SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 608 LSGRKPVD 615
+ G+ P
Sbjct: 234 VFGQCPFM 241
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 32/237 (13%)
Query: 395 SAKTFSASEIEKATGNFD-----ASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQ 446
+ + ++ NF+ S+ LG G F +V + G + A K LK R Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 447 QGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDK 501
E L E+ +L ++ L + L+ E G L +
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 502 ESAPLGWDAR--LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDF 556
E+ D +K L + YLH++ ++H D K NILL K+ DF
Sbjct: 130 EN-----DVIRLIKQILEG---VYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
G++R + + + GT Y+APE + +D+++ G++ LL+ P
Sbjct: 179 GMSR--KIGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 66/256 (25%), Positives = 99/256 (38%), Gaps = 58/256 (22%)
Query: 386 GSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVK--VLK 442
S+ + +A S K F R+ G+G FG V G G VA+K +
Sbjct: 2 PGSMMSLNAAAAADERSR--KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD 59
Query: 443 RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR-------CLVYELIPNGSVESH 495
+ RE L ++ L+ LHH N+V+L R +V E +P
Sbjct: 60 PRFRN--RE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DT 111
Query: 496 LHGVDKESAPLGWDARLKIALGAA----------RALAYLHEDSSPRVIHRDFKSSNILL 545
LH + R ++A R++ LH S V HRD K N+L+
Sbjct: 112 LHRCCRNYY------RRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLV 164
Query: 546 -EHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKS------- 595
E D T K+ DFG A+ E +I +R Y APE L+ +
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPE------LIFGNQHYTTAV 213
Query: 596 DVYSYGVVILELLSGR 611
D++S G + E++ G
Sbjct: 214 DIWSVGCIFAEMMLGE 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 37/286 (12%)
Query: 351 QAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATG- 409
E+ +++ PS +A L+ + + + G+ + + A
Sbjct: 33 NREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF 92
Query: 410 --NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-------LKRVDQQGGREFLA-EVEM 458
+D ++G G +V V G + AVK+ L + RE E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 459 LSRLH-HRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLK 513
L ++ H +++ LI LV++L+ G + + +KE+ + ++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MR 207
Query: 514 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 573
L A +++LH + ++HRD K NILL+ + ++SDFG + E +
Sbjct: 208 SLLEA---VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC--HLEPGEKLREL 259
Query: 574 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 613
GT GY+APE + D+++ GV++ LL+G P
Sbjct: 260 C-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 57/272 (20%), Positives = 97/272 (35%), Gaps = 51/272 (18%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 471
++G G +G VY + VA+K + R+ D + L E+ +L+RL +++L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 472 GICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYL 525
+ I + +V E+ +S L + K L + +K I ++
Sbjct: 92 DLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-EEHIKTILYNLLLGENFI 145
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H +IHRD K +N LL D + KV DFGLAR+ E+ +I +
Sbjct: 146 H---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 586 A----MTGH----------LLVKSDVYSYGV----V--IL-ELLSGRKPVDMTQP----- 619
+T H L++ + Y+ + I ELL+ +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 620 -PGQENLVAWARPLLTSREG------LERIID 644
PG L I +
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKLIGI 473
+G G +G V V G +AVK ++ VD++ ++ L +++++ R +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
E + EL+ + + + + + KI L +AL +L E+ ++
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 592
IHRD K SNILL+ K+ DFG++ +D ++ TR G Y+APE
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQ 204
Query: 593 ---VKSDVYSYGVVILELLSGRKPVDMTQPP 620
V+SDV+S G+ + EL +GR P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 33/217 (15%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG--REF---------LAEVEMLSRLH 463
R + G +G V +GV +G VA+K + G L E+ +L+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 464 HRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALG 517
H N++ L I + + LV EL+ + L V + + ++
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVM 575
L LH V+HRD NILL + + DF LAR + + +++ R
Sbjct: 143 ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW- 198
Query: 576 GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 611
Y APE M K D++S G V+ E+ + +
Sbjct: 199 ----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 410 NFDASRILGEGGFGLVYSG-VLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH-- 463
+F RI+G GGFG VY D G A+K L + +QG L E MLS +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 464 -HRNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIAL 516
+V + + + +L+ G + HL HGV E+ D R +I L
Sbjct: 250 DCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIIL 303
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 576
L ++H V++RD K +NILL+ ++SD GLA ++ V G
Sbjct: 304 ----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-G 352
Query: 577 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
T GY+APE G S D +S G ++ +LL G P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 464
G++ LG G FG V G G KVAVK+L R + + E++ L H
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 517
+++KL + I + +V E + G + ++ +G E ++R ++
Sbjct: 76 PHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQILS-- 127
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
+ Y H V+HRD K N+LL+ K++DFGL S M + + T G+
Sbjct: 128 ---GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSC-GS 178
Query: 578 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
Y APE YA G + D++S GV++ LL G P D
Sbjct: 179 PNYAAPEVISGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHH 464
+ + +G G +G V S V G KVA+K L R + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 465 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
N++ L+ + ++ LV + + L + K LG D +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMK-HEKLGEDRIQFLVYQM 137
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
+ L Y+H + +IHRD K N+ + D K+ DFGLAR A E + ++ TR
Sbjct: 138 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190
Query: 579 GYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 611
Y APE + ++ D++S G ++ E+++G+
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 58/206 (28%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
+GEG +G+V+ D G VA+K + + +A E+ ML +L H NLV L+ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 474 CIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
++ LV+E + + D+ + I +A+ + H
Sbjct: 71 FRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
IHRD K NIL+ K+ DFG AR + S + V T Y +PE LL
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVA-TRWYRSPE------LL 174
Query: 593 VKSDVYSYGV-------VILELLSGR 611
V Y V V ELLSG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 38/255 (14%)
Query: 373 MVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-D 431
M G+ + + A + +F +ILGEG F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELA 53
Query: 432 DGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486
+ A+K+L+ + ++ E +++SRL H VKL +++
Sbjct: 54 TSREYAIKILEKRHIIKENKV--PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 487 IPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLHEDSSPRVIHRDFKSSNI 543
NG + ++ + R +I AL YLH +IHRD K NI
Sbjct: 112 AKNGELLKYIRKIGSFDET---CTRFYTAEIVS----ALEYLHGKG---IIHRDLKPENI 161
Query: 544 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK-----SDVY 598
LL D +++DFG A+ E + + +GT YV+PE L K SD++
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-----LTEKSACKSSDLW 216
Query: 599 SYGVVILELLSGRKP 613
+ G +I +L++G P
Sbjct: 217 ALGCIIYQLVAGLPP 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 471
+G G +G V S + G KVA+K L R + + E+ +L + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 472 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAY 524
+ + LV + ++ L + + +++ + + L Y
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMG--LKFS-EEKIQYLVYQMLKGLKY 141
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
+H S V+HRD K N+ + D K+ DFGLAR A E + ++ TR Y APE
Sbjct: 142 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 193
Query: 585 YAMTGHLLVKS-DVYSYGVVILELLSGR 611
++ ++ D++S G ++ E+L+G+
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
+GEG +G+V D G VA+K D + +A E+++L +L H NLV L+ +
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 474 CIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
C +++ LV+E V+ + + L + K + + H S
Sbjct: 93 CKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHN 144
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 592
+IHRD K NIL+ K+ DFG AR + V T Y APE LL
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVA-TRWYRAPE------LL 196
Query: 593 VKSDVYSYGV-------VILELLSGR 611
V Y V ++ E+ G
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 29/255 (11%)
Query: 376 SGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGT 434
+ + K E E + +LG GGFG VYSG+ + D
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 435 KVAVKVL--KRVDQQGGREFLA----EVEMLSRLHHR--NLVKLIGICIEEQARCLVYEL 486
VA+K + R+ G EV +L ++ +++L+ + L+ E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 487 I-PNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 543
P + + G +E AR A+ + H + V+HRD K NI
Sbjct: 130 PEPVQDLFDFITERGALQEE-----LAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENI 180
Query: 544 LL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSY 600
L+ + K+ DFG A+ +++ + GT Y PE+ + H + V+S
Sbjct: 181 LIDLNRGELKLIDFGS--GALLKDT-VYTDFD-GTRVYSPPEW-IRYHRYHGRSAAVWSL 235
Query: 601 GVVILELLSGRKPVD 615
G+++ +++ G P +
Sbjct: 236 GILLYDMVCGDIPFE 250
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 471
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 472 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAY 524
+ +++ +V EL+ +++L V + L R+ L + +
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ--MEL-DHERMSYLLYQMLCGIKH 142
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH S +IHRD K SNI+++ D T K+ DFGLAR+A + T + T Y APE
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 196
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGR 611
+ D++S G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 464
G + LGEG FG V KVA+K + R + + + E+ L L H
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 517
+++KL + I +V E G + ++ E + R I
Sbjct: 69 PHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQIIC-- 119
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
A+ Y H +++HRD K N+LL+ + K++DFGL S + + + T G+
Sbjct: 120 ---AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGL--SNIMTDGNFLKTSC-GS 170
Query: 578 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
Y APE YA G + DV+S G+V+ +L GR P D
Sbjct: 171 PNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFD 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 466
++ +GEG +G V+ + VA+K ++ D G A E+ +L L H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYL 525
+V+L + ++ LV+E + L D + L + + L +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S V+HRD K N+L+ + K+++FGLAR A R S V+ T Y P+
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV-TLWYRPPD- 171
Query: 586 AMTGHLLVKSDVYSYGV-------VILELLSGRKP 613
+L + +YS + + EL + +P
Sbjct: 172 -----VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-20
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLK--RVDQQGGREF-LAEVEMLSRLHHR 465
F R+LG+GGFG V + + K+ A K L+ R+ ++ G L E ++L +++ R
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 466 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+V L E + CLV L+ G ++ H++ + + P A A L
Sbjct: 245 FVVSLAY-AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAA-EICCGLED 301
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH + R+++RD K NILL+ ++SD GLA + ++ I RV GT GY+APE
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPE 355
Query: 585 -YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
+ S D ++ G ++ E+++G+ P
Sbjct: 356 VVKNERY--TFSPDWWALGCLLYEMIAGQSP 384
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 470
+ +++G G FG+V+ L + +VA +K+V Q + E++++ + H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVA---IKKVLQDKRFK-NRELQIMRIVKHPNVVDL 97
Query: 471 IGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALA 523
+ LV E +P +V K + +K+ + R+LA
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLA 155
Query: 524 YLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM-DEESRH-ISTRVMGTFGY 580
Y+H S + HRD K N+LL K+ DFG A+ + E + I +R Y
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----Y 207
Query: 581 VAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 611
APE L+ + D++S G V+ EL+ G+
Sbjct: 208 RAPE------LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+G G +V + KVA+K + Q E L E++ +S+ HH N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 475 IEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL---GAARALAYLHEDS 529
+ + LV +L+ GSV + H V K G IA L YLH++
Sbjct: 83 VVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFG----LARSAMDEESRHISTRVMGTFGYVAPEY 585
IHRD K+ NILL D + +++DFG LA ++ T V GT ++APE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197
Query: 586 AMTGHLL-VKSDVYSYGVVILELLSGRKP 613
K+D++S+G+ +EL +G P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 56/229 (24%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
++ ++++G G FG+VY L D G VA +K+V Q + E++++ +L H N+V
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKVLQDKRFK-NRELQIMRKLDHCNIV 110
Query: 469 KLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA--- 519
+L + LV + +P ++ V + + R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYS------RAKQTLPVIYVK 159
Query: 520 -------RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARS-AMDEESRH- 569
R+LAY+H S + HRD K N+LL K+ DFG A+ E +
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 570 ISTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 611
I +R Y APE L+ + DV+S G V+ ELL G+
Sbjct: 217 ICSRY-----YRAPE------LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 467
+ +GEG +G+VY G VA+K ++ + G A E+ +L LHH N+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLH 526
V LI + E+ LV+E +E L V D+ L R +A+ H
Sbjct: 82 VSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
R++HRD K N+L+ D K++DFGLAR A R + V+ T Y AP+
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAPD-- 189
Query: 587 MTGHLLVKSDVYSYGV-------VILELLSGR 611
+L+ S YS V + E+++G+
Sbjct: 190 ----VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 400 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-------VDQQGGRE 451
+ E + +LG+GGFG V++G L D +VA+KV+ R
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 452 FLAEVEMLSRLH----HRNLVKLIGICIEEQARCLVYEL-IPNGSVESHL--HGVDKESA 504
L EV +L ++ H +++L+ ++ LV E +P + ++ G E
Sbjct: 82 PL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG- 139
Query: 505 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM 563
+R A+ + H S V+HRD K NIL+ K+ DFG
Sbjct: 140 ----PSR-CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKPVD 615
DE + GT Y PE+ ++ H + V+S G+++ +++ G P +
Sbjct: 192 DE---PYTDFD-GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 3e-20
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 467
+ +GEG +G+VY + G A+K ++ + G E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLH 526
VKL + ++ LV+E ++ L + D L L +AY H
Sbjct: 63 VKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
RV+HRD K N+L+ + K++DFGLAR A R + ++ T Y AP+
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIV-TLWYRAPD-- 170
Query: 587 MTGHLLVKSDVYSYGV-------VILELLSGR 611
+L+ S YS + + E+++G
Sbjct: 171 ----VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVL---------KRVDQQGGREFLAEVEMLSRLHH 464
+LGEG +G+V S G VA+K + R L E+++L H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT--------LREIKILKHFKH 68
Query: 465 RNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKI----A 515
N++ + I + ++ EL+ ++ LH V + L D ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVIS-TQMLS-DDHIQYFIYQT 121
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
L RA+ LH VIHRD K SN+L+ + KV DFGLAR + + +
Sbjct: 122 L---RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 576 GTF--GYV------APEYAMTGHLLVKS-DVYSYGVVILELLSGR 611
+ +V APE +T ++ DV+S G ++ EL R
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 37/270 (13%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLH-HRNLVKLIGI 473
+G G G V+ G +AVK ++R +++ + L +++++ + H +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
I + EL+ E + P+ K+ + +AL YL E V
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GV 146
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 592
IHRD K SNILL+ K+ DFG++ +D++++ R G Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTK 203
Query: 593 ----VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID---P 645
+++DV+S G+ ++EL +G+ P + E L +++ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTD---------------FEVLTKVLQEEPP 248
Query: 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP 675
L + F + + C+ + + RP
Sbjct: 249 LLPGHMGFSGDFQ--SFVKDCLTKDHRKRP 276
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-20
Identities = 53/247 (21%), Positives = 97/247 (39%), Gaps = 42/247 (17%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRN 466
++ ++G G +G V + VA+K + RV D + L E+ +L+RL+H +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 467 LVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
+VK++ I I + +V E+ +S + + L +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
+ Y+H S ++HRD K +N L+ D + KV DFGLAR+ E+ + + +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 582 APEYA---------MTGH----------LLVKSDVYSYGV----V--IL-ELLSGRKPVD 615
+TGH L++ + Y+ + + I ELL+ K
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 616 MTQPPGQ 622
Sbjct: 286 AYHADRG 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 6e-20
Identities = 49/271 (18%), Positives = 91/271 (33%), Gaps = 79/271 (29%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVA-------------------VKVLKRVDQQG- 448
+F+ + +G GGFG+V+ D A VK L +++ G
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 449 --------------------------------------GREFLAEVEMLSRLHHRNLVKL 470
++ + +N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 471 IGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAYLHE 527
+ + + +L +++ ++ ++ + ++IA + +LH
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH- 181
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH----------ISTRVMGT 577
S ++HRD K SNI D KV DFGL + +E T +GT
Sbjct: 182 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 578 FGYVAPEYAMTGHLLVKSDVYSYGVVILELL 608
Y++PE + K D++S G+++ ELL
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 471
+G G +G V + G +VAVK L R + E+ +L + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 472 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAY 524
+ ++ LV L+ + L+ + K L D ++ + R L Y
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-----GADLNNIVK-CQKLT-DDHVQFLIYQILRGLKY 147
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
+H S +IHRD K SN+ + D K+ DFGLAR DE + +++TR Y APE
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPE 199
Query: 585 YAMTGHLLVKS-DVYSYGVVILELLSGR 611
+ ++ D++S G ++ ELL+GR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 60/224 (26%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 472
R LG G + V+ + + + KV VK+LK V ++ + E+++L L N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLAD 98
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA------------- 519
I + +R V H++ D K
Sbjct: 99 IVKDPVSRTPAL-------VFEHVNNTD-----------FKQLYQTLTDYDIRFYMYEIL 140
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESR--HISTRVMG 576
+AL Y H S ++HRD K N++++H+ ++ D+GLA + +++R
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 577 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGRKP 613
+ PE LLV D++S G ++ ++ ++P
Sbjct: 196 ---FKGPE------LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 473
LG G + VY G+ G VA+K + ++D + G A E+ ++ L H N+V+L +
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSSP 531
E LV+E + N ++ ++ + P G + L + LA+ HE+
Sbjct: 72 IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--- 127
Query: 532 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 591
+++HRD K N+L+ K+ DFGLAR A S+ V+ T Y AP+ +
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVV-TLWYRAPD------V 179
Query: 592 LVKSDVYSYGV-------VILELLSGR 611
L+ S YS + ++ E+++G+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 41/216 (18%)
Query: 416 ILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 472
+LG G G V G K A+K+L + EV+ + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR------QEVDHHWQASGGPHIVCILD 89
Query: 473 ICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLG-WDARLKIALGAARALAYLH 526
+ E ++ E + G + S + ++ +A +I A+ +LH
Sbjct: 90 VY-ENMHHGKRCLLIIMECMEGGELFSRI--QERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 527 EDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
S + HRD K N+L D K++DFG A+ + T T YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAP 198
Query: 584 EYAMTGHLLVKS------DVYSYGVVILELLSGRKP 613
E +L D++S GV++ LL G P
Sbjct: 199 E------VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 52/223 (23%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVL---------KRVDQQGGREFLAEVEMLSRLHH 464
+GEG +G+V S + +VA+K + +R L E+++L R H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--------LREIKILLRFRH 84
Query: 465 RNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKI----A 515
N++ + I +V +L+ E+ L+ + K + L + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLK-TQHLS-NDHICYFLYQI 137
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR------H 569
L R L Y+H S V+HRD K SN+LL K+ DFGLAR A + +
Sbjct: 138 L---RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 570 ISTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 611
++TR Y APE + KS D++S G ++ E+LS R
Sbjct: 192 VATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 410 NFDASRILGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 466
+ LGEG + VY G VA+K + R++ + G A EV +L L H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYL 525
+V L I E++ LV+E ++ L D + R LAY
Sbjct: 62 IVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H +V+HRD K N+L+ K++DFGLAR A ++ V+ T Y P+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVV-TLWYRPPD- 170
Query: 586 AMTGHLLVKSDVYSYGV-------VILELLSGR 611
+L+ S YS + + E+ +GR
Sbjct: 171 -----ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
+ LG GG GLV+S V D +VA+K + D Q + L E++++ RL H N+VK+ I
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 474 CIEEQARC--------------LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGA 518
++ +V E + E+ L V + PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE-QGPLL-EEHARLFMYQL 129
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESR------HIS 571
R L Y+H S V+HRD K +N+ + D K+ DFGLAR S +
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 572 TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 611
T+ Y +P ++ + K+ D+++ G + E+L+G+
Sbjct: 187 TK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 471
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 472 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAY 524
+ ++ LV EL+ +++L V + L R+ L + +
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQ--MEL-DHERMSYLLYQMLCGIKH 179
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVMGTFGYVA 582
LH S +IHRD K SNI+++ D T K+ DFGLAR+A + ++ TR Y A
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRA 231
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGR 611
PE + D++S G ++ E++ +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHRN 466
F R +G G FG VY + + VA+K + +Q ++ + EV L +L H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
++ G + E LV E GS L K PL + GA + LAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH 171
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR--VMGTFGYVAPE 584
S +IHRD K+ NILL K+ DFG + ++ +GT ++APE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGS--------ASIMAPANSFVGTPYWMAPE 220
Query: 585 YAMTGHLL---VKSDVYSYGVVILELLSGRKP 613
+ K DV+S G+ +EL + P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL 462
+F+ R +G+G FG V + D A+K + + V++ R E++++ L
Sbjct: 16 HFEILRAIGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIALG 517
H LV L +E+ +V +L+ G + HL + KE +L ++ +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-----VKLFICELVM- 126
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
AL YL + R+IHRD K NILL+ ++DF +A E T + GT
Sbjct: 127 ---ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 578 FGYVAPE----YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
Y+APE G+ + D +S GV ELL GR+P
Sbjct: 178 KPYMAPEMFSSRKGAGYS--FAVDWWSLGVTAYELLRGRRP 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE---FLA--EVEMLSRLHHRNLVKL 470
LGEG F VY + VA+K +K + ++ A E+++L L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALAYLHED 528
+ + LV++ +E+ L + S L + +K L + L YLH+
Sbjct: 78 LDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEYLHQH 131
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
++HRD K +N+LL+ + K++DFGLA+ + +R + +V+ T Y APE
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV-TRWYRAPE---- 182
Query: 589 GHLLVKSDVYSYGV-------VILELLSGR 611
LL + +Y GV ++ ELL
Sbjct: 183 --LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 31/217 (14%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 466
+ LGEG +G VY + VA+K ++ ++ G A EV +L L HRN
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+++L + L++E E+ L ++ + + + H
Sbjct: 95 IIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTP-----KVSDFGLARSAMDEESRHISTRVMGTFGYV 581
S R +HRD K N+LL K+ DFGLAR A R + ++ T Y
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEII-TLWYR 204
Query: 582 APEYAMTGHLLVKSDVYSYGV-------VILELLSGR 611
PE +L+ S YS V + E+L
Sbjct: 205 PPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 42/219 (19%)
Query: 414 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 471
S++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIV 121
Query: 472 GICIEEQARC----LVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALA 523
+ A +V E + G ++ E +A +I A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSIGEAIQ 175
Query: 524 YLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
YLH S + HRD K N+L + K++DFG A+ S ++T T Y
Sbjct: 176 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYY 229
Query: 581 VAPEYAMTGHLLVKS------DVYSYGVVILELLSGRKP 613
VAPE +L D++S GV++ LL G P
Sbjct: 230 VAPE------VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLH-HRNLVKL 470
+ LG+G +G+V+ + G VAVK + + + E+ +L+ L H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 471 IGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHE 527
+ + + R LV++ + E+ LH V + + L + + + + YLH
Sbjct: 75 LNVLRADNDRDVYLVFDYM-----ETDLHAVIR-ANILE-PVHKQYVVYQLIKVIKYLH- 126
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY-- 585
S ++HRD K SNILL + KV+DFGL+RS ++ + + +
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 586 -AMTGH----------LLVKSDVYSYGV------VIL-ELLSGR 611
+T + +L+ S Y+ G+ IL E+L G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 54/255 (21%), Positives = 98/255 (38%), Gaps = 66/255 (25%)
Query: 405 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH 463
E ++ + + LG G FG+V ++ G + A+K +V Q + E++++ L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRYK-NRELDIMKVLD 58
Query: 464 HRNLVKLIGI----CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD---------- 509
H N++KL+ EE + +++ +S +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 510 -------------ARLKIALGAA----------RALAYLHEDSSPRVIHRDFKSSNILL- 545
R ++ RA+ ++H S + HRD K N+L+
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175
Query: 546 EHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKS-------D 596
D T K+ DFG A+ + E +I +R Y APE L++ + D
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE------LMLGATEYTPSID 224
Query: 597 VYSYGVVILELLSGR 611
++S G V EL+ G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 410 NFDASRILGEGGFGLVY-SGVLDDGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLH 463
FD + LG G FG V + G A+K+L ++ Q L E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQAVN 99
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAAR 520
LVKL + +V E + G + SHL + + S P AR +I L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAAQIVL---- 152
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFG 579
YLH +I+RD K N+L++ +V+DFG A+ T + GT
Sbjct: 153 TFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPE 203
Query: 580 YVAPEYAMT-GHLLVKS-DVYSYGVVILELLSGRKP 613
+APE ++ G+ K+ D ++ GV+I E+ +G P
Sbjct: 204 ALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 40/266 (15%), Positives = 77/266 (28%), Gaps = 59/266 (22%)
Query: 417 LGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLVKL 470
G + LD +VA+ + + +E L+ LSR+ + ++
Sbjct: 39 HGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 471 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 530
+ + +V E I GS++ ++ A A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 590
V S + + D G V+ +
Sbjct: 150 --VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDANP---- 181
Query: 591 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS-LGN 649
+ D+ G + LL R P+ R+ + I+P+ +
Sbjct: 182 ---QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPADIDR 230
Query: 650 DVPFDSVAKVAAIASMCVQPEVQHRP 675
D+PF ++A+A+ VQ + R
Sbjct: 231 DIPFQ----ISAVAARSVQGDGGIRS 252
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLH 463
++ +G+G FG V+ G KVA LK+V + +E F L E+++L L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQLLK 74
Query: 464 HRNLVKLIGICIEEQARC--------LVYELIPNGSVESHLHGV-DKESAPLGWDARLKI 514
H N+V LI IC + + LV++ E L G+ ++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIKRV 129
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS---AMDEESRHIS 571
L Y+H + +++HRD K++N+L+ D K++DFGLAR+ A + + +
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 572 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VILELLSGR 611
RV+ T Y PE LL+ Y + ++ E+ +
Sbjct: 187 NRVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 48/224 (21%)
Query: 417 LGEGGFGLVYSGVLDD---GTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+G G +G VY D A+K ++ + RE + +L L H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84
Query: 472 GICIEEQARC--LVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAA--------R 520
+ + R L+++ E L + A +++ G
Sbjct: 85 KVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLAR--SAMDEESRHISTRV 574
+ YLH + V+HRD K +NIL+ + K++D G AR ++ + + V
Sbjct: 140 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 575 MGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 611
+ TF Y APE LL+ + D+++ G + ELL+
Sbjct: 197 V-TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 465
F+ ++LG+G FG V G A+K+LK+ V + L E +L H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 466 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
L L + R C V E G + HL S AR A AL Y
Sbjct: 209 FLTALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGA-EIVSALDY 263
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVAP 583
LH + + V++RD K N++L+ D K++DFGL + + + + + GT Y+AP
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAP 318
Query: 584 EYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
E + + ++ D + GVV+ E++ GR P
Sbjct: 319 E-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 417 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF-----LAEVEMLSRLH---HRNL 467
+G G +G VY G VA+K ++ + GG + EV +L RL H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 468 VKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 520
V+L+ +C + LV+E V+ L ++ P G A + R
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
L +LH + ++HRD K NIL+ T K++DFGLAR + ++ V+ T Y
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA-LTPVVV-TLWY 185
Query: 581 VAPEYAMTGHLLVKS------DVYSYGVVILELLSGR 611
APE +L++S D++S G + E+ +
Sbjct: 186 RAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 410 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLH 463
F+ ++LG+G FG V+ D A+KVLK + + E ++L ++
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 464 HRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAA 519
H +VKL + + + L+ + + G + + L + D + ++AL
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELAL--- 137
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTF 578
AL +LH +I+RD K NILL+ + K++DFGL++ ++D E + GT
Sbjct: 138 -ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 579 GYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
Y+APE GH +S D +S+GV++ E+L+G P
Sbjct: 191 EYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTLP 225
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 20/248 (8%)
Query: 378 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 435
+++ L +I Y AK F++ + +F+ +++G G FG V L + K
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 436 V-AVKVLKRVD--QQGGRE-FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491
V A+K+L + + ++ F E ++L + + L ++ LV + G
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 492 VESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 550
+ + L K L + AR +A A+ +H +HRD K NIL++ +
Sbjct: 161 LLTLL---SKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGH 213
Query: 551 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVIL 605
+++DFG M++ + S V GT Y++PE D +S GV +
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 606 ELLSGRKP 613
E+L G P
Sbjct: 273 EMLYGETP 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 38/219 (17%)
Query: 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 460
+F R LG G FG V+ L +G A+KVLK R+ Q E MLS
Sbjct: 7 DFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQV--EHTNDERLMLS 61
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 517
+ H ++++ G + Q ++ + I G + S L + P A+ ++ L
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCL- 117
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 576
AL YLH +I+RD K NILL+ + K++DFG A+ D T + G
Sbjct: 118 ---ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCG 165
Query: 577 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
T Y+APE + + KS D +S+G++I E+L+G P
Sbjct: 166 TPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 49/221 (22%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHR----- 465
++G+G FG V + VA+K++K Q EV +L ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 466 -NLVKLIGICIEEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL--KIALGAARA 521
+V L + CLV+E++ N L+ + + + G L K A A
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRH---ISTRVMG 576
L +L +IH D K NILL + K+ DFG S+ R I +R
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSR--- 222
Query: 577 TFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 611
F Y +PE Y + D++S G +++E+ +G
Sbjct: 223 -F-YRSPEVLLGMPYDL------AIDMWSLGCILVEMHTGE 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 394 GSAKTFSASEIEKAT-GNFDASRILGEGGFGLVY----SGVLDDGTKVAVKVL-KRVDQQ 447
GS++T EK F+ R+LG+GG+G V+ + G A+KVL K + +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 448 GGREF---LAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKES 503
++ AE +L + H +V LI + + L+ E + G + L
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIY-AFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
Query: 504 APLGWDARL---KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560
A +I++ AL +LH+ +I+RD K NI+L H K++DFGL +
Sbjct: 120 ED---TACFYLAEISM----ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 561 SAMDEESRHISTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
++ + + T GT Y+APE +GH ++ D +S G ++ ++L+G P
Sbjct: 170 ESIHDGTV---THTFCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 44/286 (15%)
Query: 345 YKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEI 404
+ H + E G G ++ A TG A+
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGG------DGGEQLLTVKHELRTANLTGHAEKVGIE-- 54
Query: 405 EKATGNFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREF-LAEV 456
NF+ ++LG G +G V+ D G A+KVLK+ V + E E
Sbjct: 55 -----NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 457 EMLSRL-HHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL-- 512
++L + LV L + + + L+ + I G + +HL ++ + + ++
Sbjct: 110 QVLEHIRQSPFLVTLHY-AFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYV 165
Query: 513 -KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571
+I L AL +LH+ +I+RD K NILL+ + ++DFGL++ + +E+
Sbjct: 166 GEIVL----ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 572 TRVMGTFGYVAPE---YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
GT Y+AP+ +GH K+ D +S GV++ ELL+G P
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 35/123 (28%), Positives = 55/123 (44%), Gaps = 4/123 (3%)
Query: 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551
VE D L + + + A+ + +L +S + IHRD + NILL
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 232
Query: 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-G 610
K+ DFGLAR + ++APE ++SDV+S+GV++ E+ S G
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292
Query: 611 RKP 613
P
Sbjct: 293 ASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 34/163 (20%), Positives = 57/163 (34%), Gaps = 20/163 (12%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRN 466
+ LG G FG V VAVK+LK R ++E+++L + HH N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 467 LVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+V L+G C + ++ E G++ ++L R + + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYKTKGARFR 136
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568
I D K + + S F +S D E
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 19/246 (7%)
Query: 378 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 435
LD +L +I + K + +++ +++G G FG V K
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 436 V-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 491
V A+K+L + + + F E ++++ + +V+L +++ +V E +P G
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 492 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551
+ + + P W AR A AL +H S IHRD K N+LL+
Sbjct: 156 LVNLM---SNYDVPEKW-ARFYTAEVVL-ALDAIH---SMGFIHRDVKPDNMLLDKSGHL 207
Query: 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK----SDVYSYGVVILEL 607
K++DFG E T V GT Y++PE + D +S GV + E+
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 608 LSGRKP 613
L G P
Sbjct: 267 LVGDTP 272
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 22/217 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHR 465
+F+ +++G G F V + +V A+K++ + + + F E ++L R
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 466 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWD-ARLKIALGAARALA 523
+ +L +++ LV E G + + L K + + AR +A A+
Sbjct: 122 WITQLHF-AFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLA-EIVMAID 176
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 583
+H +HRD K NILL+ +++DFG + + V GT Y++P
Sbjct: 177 SVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 584 EYAMTGHLLVKSDVY-------SYGVVILELLSGRKP 613
E + Y + GV E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHR 465
+FD ++LG+G FG V G A+K+L++ E + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 466 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARA 521
L L + R C V E G + HL + AR +I A
Sbjct: 66 FLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVS----A 117
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 580
L YLH V++RD K N++L+ D K++DFGL + + + + + GT Y
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEY 171
Query: 581 VAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
+APE + ++ D + GVV+ E++ GR P
Sbjct: 172 LAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLP 204
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 49/227 (21%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---------- 463
R LG G F V+ + + T VA+K+++ D+ E+++L R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 464 -HRNLVKLIG----ICIEEQARCLVYELIPNGSVESHLHGVDKES--APLGWDARLKIAL 516
+++KL+ +V+E++ +L + K+ + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-----GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEH------DFTPKVSDFGLARSAMDEESRHI 570
L Y+H +IH D K N+L+E K++D G A + + I
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 571 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 611
TR Y +PE + +D++S +I EL++G
Sbjct: 197 QTRE-----YRSPEVLLGAPWGC------GADIWSTACLIFELITGD 232
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 410 NFDASRILGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGG------RE--FLAEVEML 459
++ +GEG +G V+ + + G VA+K ++ + G RE L L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---L 68
Query: 460 SRLHHRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGV-DKESAPLGWDARLK 513
H N+V+L +C + LV+E V+ L DK P +K
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIK 123
Query: 514 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
+ R L +LH S RV+HRD K NIL+ K++DFGLAR + +++
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA-LTS 178
Query: 573 RVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVILELLSGR 611
V+ T Y APE +L++S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 29/159 (18%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 472
++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVD 78
Query: 473 ICIEEQARC-----LVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALA 523
+ E +V E + G ++ E +A +I A+
Sbjct: 79 VY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSIGEAIQ 131
Query: 524 YLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLA 559
YLH S + HRD K N+L + K++DFG A
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 51/221 (23%)
Query: 415 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 465
+++G+G FG V D VA+K+++ +Q E+ +L L +
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDN 157
Query: 466 --NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARA 521
N++ ++ C+ +EL+ +L+ + K++ G+ L K A +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-----SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRH---ISTRVMG 576
L LH R+IH D K NILL+ KV DFG S+ E R I +R
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSR--- 263
Query: 577 TFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 611
F Y APE Y M D++S G ++ ELL+G
Sbjct: 264 -F-YRAPEVILGARYGM------PIDMWSLGCILAELLTGY 296
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 464
+F+ +LG+G FG V AVK+LK+ + + E +L+
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
L +L C + R V E + G + H+ V + P A A A L
Sbjct: 402 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAA-EIAIGLF 456
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVA 582
+L +I+RD K N++L+ + K++DFG+ + + + T+ GT Y+A
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIA 510
Query: 583 PEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
PE + KS D +++GV++ E+L+G+ P
Sbjct: 511 PE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSR- 461
+F ++LG+G FG V+ L A+K LK+ + + E +LS
Sbjct: 18 DFILHKMLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 462 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 517
H L + + + V E + G + H+ K A +I L
Sbjct: 75 WEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIIL- 129
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 576
L +LH +++RD K NILL+ D K++DFG+ + M +++ T G
Sbjct: 130 ---GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180
Query: 577 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
T Y+APE + G S D +S+GV++ E+L G+ P
Sbjct: 181 TPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 464
+F+ +LG+G FG V AVK+LK+ + + E +L+
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAAR 520
L +L C + R V E + G + H+ V + P A +IA+
Sbjct: 81 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAI---- 132
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFG 579
L +L +I+RD K N++L+ + K++DFG+ + + + T+ GT
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 186
Query: 580 YVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
Y+APE A + KS D +++GV++ E+L+G+ P
Sbjct: 187 YIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAP 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 1e-12
Identities = 34/202 (16%), Positives = 55/202 (27%), Gaps = 55/202 (27%)
Query: 407 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--------QQGGREFLAEVEM 458
T +GEG FG V+ + D T VA+K++ Q+ E L E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 459 LSRLH---------HRNLVKLIGICI------------------------------EEQA 479
L + L + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 539
+V E G + + I +LA S R HRD
Sbjct: 137 LFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 540 SSNILLEHDFTPKVSDFGLARS 561
N+LL+ K+ +S
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKS 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 464
+FD R++G G + V L A+KV+K+ D + E + + +H
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 465 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAAR 520
LV L C + ++R V E + G + H+ K AR +I+L
Sbjct: 70 PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISL---- 121
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFG 579
AL YLHE +I+RD K N+LL+ + K++D+G+ + + T GT
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPN 175
Query: 580 YVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 176 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 460
+F +++G+G FG V L + AVKVL+ + ++ + ++E +L
Sbjct: 39 DFHFLKVIGKGSFGKVL---LARHKAEEVFYAVKVLQKKAILKKKEE--KHIMSERNVLL 93
Query: 461 R-LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIA 515
+ + H LV L + + V + I G + HL P AR +IA
Sbjct: 94 KNVKHPFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIA 149
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
AL YLH + +++RD K NILL+ ++DFGL + ++ S T
Sbjct: 150 S----ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTF 199
Query: 576 -GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
GT Y+APE + ++ D + G V+ E+L G P
Sbjct: 200 CGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSR- 461
NF+ R+LG+G FG V L + G AVKVLK+ + + E +LS
Sbjct: 24 NFEFIRVLGKGSFGKVM---LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 462 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 517
+H L +L C + R V E + G + H+ + AR +I
Sbjct: 81 RNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIIS- 135
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 576
AL +LH+ +I+RD K N+LL+H+ K++DFG+ + + T G
Sbjct: 136 ---ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCG 186
Query: 577 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
T Y+APE + + D ++ GV++ E+L G P
Sbjct: 187 TPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLK--------RVDQ-QGGREFLAEVEML 459
+FD R++G G + V L A++V+K +D Q + +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA--- 109
Query: 460 SRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIA 515
+H LV L C + ++R V E + G + H+ K AR +I+
Sbjct: 110 --SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEIS 163
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 575
L AL YLHE +I+RD K N+LL+ + K++D+G+ + + T
Sbjct: 164 L----ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTF 213
Query: 576 -GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 613
GT Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 214 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 57/250 (22%), Positives = 92/250 (36%), Gaps = 89/250 (35%)
Query: 415 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRL-----HH 464
R +G+G FG V K AVKV++ + + E ++L ++ ++
Sbjct: 41 RKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINN 95
Query: 465 RNLVKLIG-------ICI--EEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARLKI 514
N+VK G +C+ E L YE+I N H+ + +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPSL-YEIITRNNYNGFHIEDI-----------K-LY 142
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----------------------- 551
+ +AL YL + + H D K NILL+ +
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 552 --KVSDFGLARSAMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSY 600
K+ DFG A + H I+TR Y APE + + SD++S+
Sbjct: 200 GIKLIDFG---CATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWSF 245
Query: 601 GVVILELLSG 610
G V+ EL +G
Sbjct: 246 GCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 51/238 (21%), Positives = 84/238 (35%), Gaps = 69/238 (28%)
Query: 415 RILGEGGFGLVYSGV--LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 465
LGEG FG V + ++VA+K+++ V + E+ +L ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKEN 80
Query: 466 --NLVKLIGICIEEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 520
V + C+ +EL+ N KE+ + +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKN------TFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-------------------KVSDFGLARS 561
AL +LHE ++ H D K NIL + +V+DFG S
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---S 188
Query: 562 AMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSG 610
A + H ++TR Y PE +A DV+S G ++ E G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCILFEYYRG 235
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 41/227 (18%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 466
NF + +G G FG + G L VA+K+ + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 467 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDK----ESAPLGWDARLKIALGAARA 521
+ ++ + +V EL+ G S+E D+ ++ L IA+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV-------LMIAIQLISR 117
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS-----DFGLARSAMDEES-RHISTR-- 573
+ Y+H + +I+RD K N L+ DF LA+ +D E+ +HI R
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 574 --VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 613
+ GT Y + HL + D+ + G + + L G P
Sbjct: 175 KSLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 60/246 (24%), Positives = 91/246 (36%), Gaps = 85/246 (34%)
Query: 415 RILGEGGFGLVYSGVLDDGTK---VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR--- 465
LGEG FG V +D VAVK++K VD + +E+++L L+
Sbjct: 20 DTLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPN 74
Query: 466 ---NLVKLIG-------ICI--EEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL 512
V+++ ICI E Y+ I NG + L + R
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLGLST-YDFIKENGFLPFRLDHI-----------R- 121
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-------------------KV 553
K+A +++ +LH ++ H D K NIL KV
Sbjct: 122 KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 554 SDFGLARSAMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVI 604
DFG SA ++ H +STR Y APE ++ DV+S G ++
Sbjct: 179 VDFG---SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCIL 224
Query: 605 LELLSG 610
+E G
Sbjct: 225 IEYYLG 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 45/233 (19%), Positives = 85/233 (36%), Gaps = 47/233 (20%)
Query: 415 RILGEGGFGLVYSGVLDDGT------KVAVKVLKRVDQQGGREF-----LAEVEMLSRLH 463
+G+GGFG +Y ++ VKV + E A+ E + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 464 HRNLVKLIGIC----------IEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARL 512
+K +G+ + R ++ + G ++ + + L
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---EANAKRFSRKTVL 155
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEES-RH 569
+++L L Y+HE +H D K+SN+LL + +V D+GLA E +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 570 ISTR----VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 613
+ GT E+ + H V + D+ G +++ L+G P
Sbjct: 213 YAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 466
+ R +G G FG +Y G + G +VA+K+ + + E ++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 467 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+ + E +V EL+ G S+E + ++ L +A + Y+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYI 121
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPK---VSDFGLARSAMDEESR-HISTR----VMGT 577
H S IHRD K N L+ + DFGLA+ D + HI R + GT
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 578 FGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 613
YA + HL + + D+ S G V++ G P
Sbjct: 179 -----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 41/227 (18%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 466
++ R +GEG FG+++ G L + +VA+K R + + E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 467 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDK----ESAPLGWDARLKIALGAARA 521
+ + E LV +L+ G S+E L + ++ A
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV-------AMAAKQMLAR 118
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPK-----VSDFGLARSAMDEES-RHISTR-- 573
+ +HE S +++RD K N L+ + V DFG+ + D + +HI R
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 574 --VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 613
+ GT Y + HL + D+ + G V + L G P
Sbjct: 176 KNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 50/231 (21%), Positives = 90/231 (38%), Gaps = 46/231 (19%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--------LAEVEMLSRLHHR 465
+ +G GGFGL+Y + K A V+K Q+ G F +A+ + + + R
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 466 NLVKLIGI----------CIEEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARLKI 514
+ +GI R +V E + + L + ++ L++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID------LQKISGQNGTFKKSTVLQL 156
Query: 515 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEES-RHIS 571
+ L Y+HE+ +H D K++N+LL + +V +D+GL+ + +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 572 TRV----MGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 613
GT E+ + H V +SDV G +L L G+ P
Sbjct: 214 ENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 54/269 (20%), Positives = 82/269 (30%), Gaps = 79/269 (29%)
Query: 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH--- 463
G + R LG G F V+ + VA+KV+K + L E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSD 94
Query: 464 -----HRNLVKLIGICIEEQA-----RCLVYELIPNGSVESHLHGVDKESAPLGWDARL- 512
+V+L+ + C+V+E G HL +S G
Sbjct: 95 PNDPNREMVVQLLD-DFKISGVNGTHICMVFE--VLGH---HLLKWIIKSNYQGLPLPCV 148
Query: 513 -KIALGAARALAYLHEDSSPRVIHRDFKSSNILLE------------------------- 546
KI + L YLH R+IH D K NILL
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 547 ------------------------HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
K++D G A + I TR Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRS 261
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGR 611
E + +D++S + EL +G
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 43/234 (18%), Positives = 83/234 (35%), Gaps = 49/234 (20%)
Query: 415 RILGEGGFGLVYSGV---------LDDGTKVAVKVLKRVDQQGGREF-----LAEVEMLS 460
G++Y K ++K+ + D + E A+ ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK-DGRLFNEQNFFQRAAKPLQVN 106
Query: 461 RLHHRNLVKLIGI-------CIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARL 512
+ L+ I +++ R LV + G S++S L K + L
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER--SVL 162
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEESRHI 570
++A AL +LHE+ +H + + NI ++ + +V + +G A +H+
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHV 218
Query: 571 STR------VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 613
+ G E+ M H +SD+ S G +L+ L G P
Sbjct: 219 AYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL 467
F R +G G FG +Y G + +VA+K+ + + L E ++ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 468 V-KLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+ + +E LV +L+ G S+E + S L L +A + ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLF---NFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPK---VSDFGLARSAMDEES-RHISTR----VMGT 577
H S +HRD K N L+ + DFGLA+ D + +HI R + GT
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 578 FGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 613
YA + HL + + D+ S G V++ L G P
Sbjct: 177 -----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/173 (28%), Positives = 66/173 (38%), Gaps = 27/173 (15%)
Query: 18 GFAFTVQGSADPDVPPSTPPLSVDGKRVGKP---VAEPSYDIPMPPPVNHSPSKGPVVP- 73
+ + G+A P +P + P + PSY P P + SP+ P P
Sbjct: 1519 FGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYS-PSSPGYSTSPAYMPSSPS 1577
Query: 74 -----PSFIPTSRKRHYGP---------PPLNSVSPSHSPL-----PTPVSRVPTSPSPS 114
PS+ PTS Y P P ++ SPS+SP PT S PTSPS S
Sbjct: 1578 YSPTSPSYSPTSPS--YSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYS 1635
Query: 115 PTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTP-PGSP 166
PTS S P P S P P + T+ P + + P SP
Sbjct: 1636 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1688
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 34/104 (32%), Positives = 45/104 (43%), Gaps = 9/104 (8%)
Query: 48 PVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGP--PPLNSVSPSHSPLPTPVS 105
P P+ P ++SP+ P S + Y P P + SPS+SP S
Sbjct: 1653 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1712
Query: 106 RVPTSPSPSPTSASGQTELPLLPPKS---SPSEPIRAFPPPPPN 146
PTSPS SPTS S P P S SP+ P ++ P P+
Sbjct: 1713 --PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP--SYSPTSPS 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 40/132 (30%), Positives = 51/132 (38%), Gaps = 14/132 (10%)
Query: 23 VQGSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRK 82
+ + K V P Y P + SP G PS+ P+S
Sbjct: 1508 LVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAM--SPGYGLT-SPSYSPSSPG 1564
Query: 83 RHYGPPPLNSVSPSHSPL-----PTPVSRVPTSPSPSPTSASGQTELPLLPPKS---SPS 134
P + S SPS+SP PT S PTSPS SPTS S P P S SP+
Sbjct: 1565 YSTSPAYMPS-SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPT 1623
Query: 135 EPIRAFPPPPPN 146
P ++ P P+
Sbjct: 1624 SP--SYSPTSPS 1633
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 40/141 (28%), Positives = 55/141 (39%), Gaps = 29/141 (20%)
Query: 48 PVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPL------- 100
P P+ P ++SP+ PS+ PTS P + SPS+SP
Sbjct: 1611 PSYSPTSPSYSPTSPSYSPT-----SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1665
Query: 101 -----PTPVSRVPTSPSP-------SPTSASGQTELPLLPPKS---SPSEPIRAFPPPPP 145
PT S PTSPS SPTS S P P S SP+ P ++ P P
Sbjct: 1666 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP--SYSPTSP 1723
Query: 146 NADCSTTICTEPYTNTPPGSP 166
+ ++ + + P SP
Sbjct: 1724 SYSPTSPSYSPTSPSYSPTSP 1744
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 65/443 (14%), Positives = 127/443 (28%), Gaps = 133/443 (30%)
Query: 418 GEGGFG---LVYSGVLDDGTKVAVKVLKRVDQQG-----GREFLAE--VEMLSRLHHRNL 467
G G G + L KV ++D + E +EML +L ++
Sbjct: 157 GVLGSGKTWVALDVCLSY------KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-- 208
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
+ PN + S D S +L+I A L
Sbjct: 209 ------------------IDPNWTSRS-----DHSSNI-----KLRIHSIQAELRRLLKS 240
Query: 528 DSSPR--VIHRDFKSSNILLEHDFTPKV----SDFGLARSAMDEESRHIS---------- 571
++ + +++ + + K+ + + HIS
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 572 TRVMGTFGYVA-------PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 624
V P +T + S +I E + ++
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLS-------IIAESI-------------RDG 340
Query: 625 LVAWARPLLTSREGLERIIDPSLGNDVP------FDSVA---KVAAIAS--MCV---QPE 670
L W + + L II+ SL P FD ++ A I + + +
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 671 VQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHY 730
+V+ + + K+ ++ S + ++L K+ L + HY
Sbjct: 401 KS------DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE-NEYALHRSIVDHY 453
Query: 731 SVP-NYDLGLDTGRRLSLSYLFS------SSARSGKEESELFRR-YSSSGPLRTGRGRQF 782
++P +D D Y +S + E LFR + R
Sbjct: 454 NIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNIEHP-ERMTLFRMVFLD---FR------- 501
Query: 783 W--QRIRRLVGGSDSEHGAVFSL 803
+ Q+IR + + G++ +
Sbjct: 502 FLEQKIRH-DSTAWNASGSILNT 523
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 39/153 (25%), Positives = 49/153 (32%), Gaps = 23/153 (15%)
Query: 23 VQGSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRK 82
V ++ + G E + SP G P F PTS
Sbjct: 1496 VDSGSNDAMAGGFTAYG------GADYGEATSPFGAYGEAPTSPGFGVS-SPGFSPTS-- 1546
Query: 83 RHYGPPPLNSVSPSHSP-----LPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPI 137
P + SP++SP PT S PTSPS SPTS S P P S P
Sbjct: 1547 -----PTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1601
Query: 138 RAFPPPPPNADCSTTICTEP----YTNTPPGSP 166
P + T+ P Y+ T P
Sbjct: 1602 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1634
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 40/158 (25%), Positives = 54/158 (34%), Gaps = 14/158 (8%)
Query: 22 TVQGSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSR 81
+ G + G+ P + + P SP+ P P++ PTS
Sbjct: 1503 AMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPT-SPAYSPTSP 1561
Query: 82 KRHYGPPPLNSVSPSHSPL------------PTPVSRVPTSPSPSPTSASGQTELPLLPP 129
P + SPS+SP PT S PTSPS SPTS S P P
Sbjct: 1562 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1621
Query: 130 KSSPSEPIRAFPPPPPNADCSTTICTEPYTNTP-PGSP 166
S P P + T+ P + + P SP
Sbjct: 1622 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1659
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 39/114 (34%), Positives = 44/114 (38%), Gaps = 8/114 (7%)
Query: 52 PSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSP 111
PSY P SPS P PS+ PTS P + SPS+SP T S PTSP
Sbjct: 1624 PSYSPTSPSYSPTSPSYSPT-SPSYSPTSPSYSPTSPAYSPTSPSYSP--TSPSYSPTSP 1680
Query: 112 SPSPTSASGQTELPLLPPKS---SPSEPIRAFPPPPPNADCSTTICTEPYTNTP 162
S SPTS S P P S SP+ P + P P
Sbjct: 1681 SYSPTSPSYSPTSPNYSPTSPSYSPTSP--GYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 33/122 (27%), Positives = 42/122 (34%), Gaps = 19/122 (15%)
Query: 29 PDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPP 88
P P++P S PSY P P + + PS+ PTS P
Sbjct: 1624 PSYSPTSPSYSPTS--PSYSPTSPSYS-PTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSP 1680
Query: 89 PLNSVSPSHSPL-----PTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPP 143
+ SPS+SP PT S PTSP SP S P SP + +
Sbjct: 1681 SYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGS-----------PAYSPKQDEQKHNEN 1729
Query: 144 PP 145
Sbjct: 1730 EN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 44/127 (34%), Positives = 52/127 (40%), Gaps = 15/127 (11%)
Query: 52 PSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSP 111
PSY P SPS P P S+ PTS P + SPS+SP S PTSP
Sbjct: 1582 PSYSPTSPSYSPTSPSYSPTSP-SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS--PTSP 1638
Query: 112 SPSPTSASGQTELPLLPPKS----------SPSEPIRAFPPPPPNADCSTTICTEP-YTN 160
S SPTS S P P S SP+ P + P + + T P Y+
Sbjct: 1639 SYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSP 1698
Query: 161 TPPG-SP 166
T P SP
Sbjct: 1699 TSPSYSP 1705
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 22/120 (18%), Positives = 34/120 (28%), Gaps = 5/120 (4%)
Query: 52 PSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYG----PPPLNSVSPSHSPLPTPVSRV 107
S P +PS P + P + + H P+N + P S + +P+
Sbjct: 22 SSLTSPTGRGSMAAPSLHPSLGPGI-GSPGQLHSPISTLSSPINGMGPPFSVISSPMGPH 80
Query: 108 PTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSPC 167
S +PT L P + S PP N + C
Sbjct: 81 SMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHIC 140
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 42.8 bits (99), Expect = 2e-04
Identities = 23/153 (15%), Positives = 38/153 (24%), Gaps = 11/153 (7%)
Query: 46 GKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPP----------LNSVSP 95
G P A P + P + G +P S + PPP +S
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSL 61
Query: 96 SHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICT 155
+S S + +G T+ + + A P T T
Sbjct: 62 FEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPAT 121
Query: 156 EPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFP 188
T G + + A + +
Sbjct: 122 VNGTVEGGSGA-GRLDLPPGFMFKVQAQHDYTA 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 23/142 (16%), Positives = 38/142 (26%), Gaps = 4/142 (2%)
Query: 25 GSADPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRH 84
+ D+ S+ ++ G P+ + P + SP + + P +
Sbjct: 12 QAMPSDLTISSAIQNIHSASKGLPLNHAALP---PTDYDRSPFVTSPISMTMPPHGSLQG 68
Query: 85 YGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPP 144
Y S P P + P S S QT P P E ++ P P
Sbjct: 69 YQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLI-LELLKCEPDEP 127
Query: 145 PNADCSTTICTEPYTNTPPGSP 166
+ N
Sbjct: 128 QVQAKIMAYLQQEQANRSKHEK 149
|
| >2pff_A Fatty acid synthase subunit alpha, 3-oxoacyl-[acyl-carrier-PR; fatty acid synthase, acyl-carrier-protein, beta-ketoacyl RED beta-ketoacyl synthase, dehydratase; 4.00A {Saccharomyces cerevisiae} Length = 1688 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 51/341 (14%), Positives = 87/341 (25%), Gaps = 106/341 (31%)
Query: 312 KYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQ-AEEVPQSLQTSHVKPSGAA 370
SG + V A C+ + + E SG A
Sbjct: 1092 LISSSGPIKTPV--GA------CATSV---------ESVDIGVETIL---------SGKA 1125
Query: 371 GLMVGSGLDSA----SLSFGSSIATYTGSAKTFSASEIEKATGNFDASR---ILGEGGFG 423
+ + G D S FG+ AT + + + +R + +G G
Sbjct: 1126 RICIVGGYDDFQEEGSFEFGNMKATSNTLEEFEHGRTPAEMSRPATTTRNGFMEAQGA-G 1184
Query: 424 LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEV---EMLSRLHHRNLVKLIGICIEEQAR 480
+ ++ +A LK G V + R++ G I AR
Sbjct: 1185 IQ---IIMQA-DLA---LKM-----GVPIYGIVAMAATATDKIGRSVPA-PGKGILTTAR 1231
Query: 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYL--HEDSSP------ 531
SV+ ++ + R I L L + P
Sbjct: 1232 EHH------SSVKYASPNLNMKYRKRQLVTREAQIKDWVENELEALKLEAEEIPSEDQNE 1285
Query: 532 ------RVIHRDFKSSNILLEHDFTPK--------------VSDFGLARSAMDEESRH-I 570
R IH + +S + + ++ +GL + S H
Sbjct: 1286 FLLERTREIHNEAESQLRAAQQQWGNDFYKRDPRIAPLRGALATYGLTIDDLGVASFHGT 1345
Query: 571 ST------------RVMGTFG-------YVAPEYAMTGHLL 592
ST +M G + +TGH
Sbjct: 1346 STKANDKNESATINEMMKHLGRSEGNPVIGVFQKFLTGHPK 1386
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 31/208 (14%), Positives = 54/208 (25%), Gaps = 48/208 (23%)
Query: 400 SASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEML 459
S + + +D ++ V+ + +K E E L
Sbjct: 11 SPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVL---FVKTDLSGALNELQDEAARL 67
Query: 460 SRLHHRNL--VKLIGICIEEQARCLVYELIPNGSVESH-----------------LHGVD 500
S L + ++ + E L+ +P + S LH +D
Sbjct: 68 SWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLD 127
Query: 501 KESAPLGW--DARLKIAL--------------------GAARALAYLH----EDSSPRVI 534
+ P R++ A A A L + V
Sbjct: 128 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT 187
Query: 535 HRDFKSSNILLEHDFTPKVSDFGLARSA 562
H D NI++E+ D G A
Sbjct: 188 HGDACLPNIMVENGRFSGFIDCGRLGVA 215
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 21/192 (10%), Positives = 44/192 (22%), Gaps = 48/192 (25%)
Query: 417 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICI 475
EG ++ + + +K+ + + E +M+ L + V K++
Sbjct: 21 DTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80
Query: 476 EEQARCLVYELIPN--------------------GSVESHLHGVDKESAPLGWDARLKIA 515
+ L+ H +D P ++A
Sbjct: 81 HDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140
Query: 516 LG------------------------AARALAYLHE---DSSPRVIHRDFKSSNILLEHD 548
+L + H D SNI ++
Sbjct: 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG 200
Query: 549 FTPKVSDFGLAR 560
D G +
Sbjct: 201 KVSGFIDLGRSG 212
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 808 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-26 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 3e-72
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 26/288 (9%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLS 460
+ E G + +G G FG VY G VAVK+L Q + F EV +L
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
+ H N++ +G Q +V + S+ HLH + IA A+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQ 115
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
+ YLH +IHRD KS+NI L D T K+ DFGLA H ++ G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 581 VAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637
+APE +SDVY++G+V+ EL++G+ P Q +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------- 223
Query: 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ P L + V + + + + C++ + RP +++ +++
Sbjct: 224 --RGYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-68
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 28/278 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
LG G FG V+ G + TKVAVK LK+ FLAE ++ +L H+ LV+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L + +E ++ E + NGS+ L L + L +A A +A++
Sbjct: 73 LYAVVTQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
IHRD +++NIL+ + K++DFGLAR +++ + APE G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 590 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ--ENLVAWARPLLTSREGLERIIDPSL 647
+KSDV+S+G+++ E+++ + + +NL R +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------- 231
Query: 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P + ++ + +C + + RP + L+
Sbjct: 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 6e-67
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 24/276 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+ +G G FGLV+ G + KVA+K ++ +F+ E E++ +L H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L G+C+E+ CLV+E + +G + +L + + L + L +AYL E
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
VIHRD + N L+ + KVSDFG+ R +D++ ST + +PE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 590 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649
KSDV+S+GV++ E+ S K + + ++ R+ P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 228
Query: 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
V I + C + + RP +++ L
Sbjct: 229 T-------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (559), Expect = 6e-66
Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 398 TFSASEIEKATGNFDAS---------RILGEGGFGLVYSGVL----DDGTKVAVKVLKR- 443
F+ + +A F +++G G FG V SG L VA+K LK
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 444 VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES 503
++ R+FL+E ++ + H N++ L G+ + ++ E + NGS++S L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QND 122
Query: 504 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563
+ + G A + YL + +HRD + NIL+ + KVSDFGL+R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 564 DEESRHISTRV---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 620
D+ S T + APE SDV+SYG+V+ E++S + P
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------RP 233
Query: 621 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 680
+ + + + I+ P D + + + C Q + HRP G++
Sbjct: 234 YWDM----------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 681 VQALK 685
V L
Sbjct: 284 VNTLD 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-65
Identities = 72/293 (24%), Positives = 117/293 (39%), Gaps = 40/293 (13%)
Query: 415 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRL-HHRN 466
+ LG G FG V D VAVK+LK RE ++E+++LS L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHG--------------VDKESAPLGWDARL 512
+V L+G C ++ E G + + L ++ + L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
+ A+ +A+L S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632
++APE +SDV+SYG+ + EL S P +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256
Query: 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
++I P + A++ I C + RP ++VQ ++
Sbjct: 257 ------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (549), Expect = 1e-64
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 24/289 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
+ LG G +G VY GV VAVK LK D EFL E ++ + H NLV
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
+L+G+C E ++ E + G++ +L +++ + L +A + A+ YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLE-- 132
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
IHRD + N L+ + KV+DFGL+R M ++ + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 589 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648
+KSDV+++GV++ E+ + Q + +++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKDYR 234
Query: 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEV 697
+ P KV + C Q RP E+ QA + + E + EV
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-64
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 24/276 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+ + LG G FG+V G VA+K++K EF+ E +++ L H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L G+C +++ ++ E + NG + ++L + L++ A+ YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
+ +HRD + N L+ KVSDFGL+R +D+E S + PE M
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYS 176
Query: 590 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649
KSD++++GV++ E+ S K + I L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRL 220
Query: 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P + KV I C + RP ++ +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 5e-64
Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 12/214 (5%)
Query: 404 IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSR 461
+E +F+ LG G G+V+ G +A K++ + R + E+++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 462 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 521
+ +V G + + E + GS++ L ++ + K+++ +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKG 116
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
L YL +++HRD K SNIL+ K+ DFG++ +D ++ +GT Y+
Sbjct: 117 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 615
+PE H V+SD++S G+ ++E+ GR P+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-64
Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 30/277 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+ +G+G FG V G G KVAVK +K + + FLAE ++++L H NLV+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 470 LIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
L+G+ +EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
+HRD + N+L+ D KVSDFGL + A + + APE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE 174
Query: 589 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648
KSDV+S+G+++ E+ S + P + ++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYK 218
Query: 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
D P V + C + RP ++ + L+
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-63
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 32/291 (10%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGG-REFLAEVE 457
+F+ ++G G FG VY G L D AVK L R+ G +FL E
Sbjct: 23 GPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 458 MLSRLHHRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL 516
++ H N++ L+GIC+ E + +V + +G + + + E+ + L
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGL 137
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 574
A+ + +L + +HRD + N +L+ FT KV+DFGLAR D+E S H T
Sbjct: 138 QVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 634
++A E T KSDV+S+GV++ EL++ P P N LL
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQ 249
Query: 635 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
R R++ P + + C P+ + RP E+V +
Sbjct: 250 GR----RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (542), Expect = 2e-63
Identities = 68/314 (21%), Positives = 121/314 (38%), Gaps = 46/314 (14%)
Query: 402 SEIEKATGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLA 454
+E N + R +GEG FG V+ + T VAVK+LK +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 455 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES----------- 503
E +++ + N+VKL+G+C + CL++E + G + L + +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 504 ---------APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 554
PL +L IA A +AYL + +HRD + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 555 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 614
DFGL+R+ + ++ PE +SDV++YGVV+ E+ S
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 615 DMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR 674
E + + D ++ P + ++ + +C R
Sbjct: 243 YYGMAH---------------EEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADR 286
Query: 675 PFMGEVVQALKLVC 688
P + + L+ +C
Sbjct: 287 PSFCSIHRILQRMC 300
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-63
Identities = 67/291 (23%), Positives = 124/291 (42%), Gaps = 31/291 (10%)
Query: 402 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGT-----KVAVKVLKRVDQQGGR-EFLAE 455
+EI +++G G FG VY G+L + VA+K LK + R +FL E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 456 VEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 515
++ + H N+++L G+ + + ++ E + NG+++ L ++ + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGML 116
Query: 516 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM-DEESRHISTRV 574
G A + YL + +HRD + NIL+ + KVSDFGL+R D E+ + ++
Sbjct: 117 RGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 575 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 634
+ APE SDV+S+G+V+ E+++ + +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221
Query: 635 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ + I+ P D + + + C Q E RP ++V L
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-63
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 45/303 (14%)
Query: 410 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRL 462
N + ++LG G FG V + +VAVK+LK RE ++E++M+++L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 463 -HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG-------------------VDKE 502
H N+V L+G C L++E G + ++L +++
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 503 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562
L ++ L A A+ + +L +HRD + N+L+ H K+ DFGLAR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 622
M + + + ++APE G +KSDV+SYG+++ E+ S P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 623 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
++I D PF + ++ I C + + RP +
Sbjct: 275 N---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 683 ALK 685
L
Sbjct: 320 FLG 322
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 7e-63
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 30/293 (10%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474
+G+G FG V+ G G +VAVK+ +++ AE+ L H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66
Query: 475 IEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-- 528
++ LV + +GS+ +L+ + + +K+AL A LA+LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 529 ---SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAP 583
P + HRD KS NIL++ + T ++D GLA +GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 584 EYAMTGHLL------VKSDVYSYGVVILELLSGRKP----VDMTQPPGQENLVAWARPLL 633
E + ++D+Y+ G+V E+ D P + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 634 TSREGLERIIDPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ E+ + P++ N +++ +A I C R + + L
Sbjct: 242 R-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-61
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 26/280 (9%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 466
+++ +G G +G DG + K L + + + ++EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 467 LVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
+V+ I+ +V E G + S + KE L + L++ AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 525 LHE--DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
H D V+HRD K +N+ L+ K+ DFGLAR + S + +GT Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182
Query: 583 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642
PE KSD++S G ++ EL + P +E +I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------------KELAGKI 226
Query: 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
+ +P+ ++ I + + + HRP + E+++
Sbjct: 227 REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 24/276 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 469
+ LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
L + EE +V E + GS+ L G + L + +A A +AY+
Sbjct: 77 LYAVVSEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 589
+HRD +++NIL+ + KV+DFGLAR +++ + APE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 590 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 649
+KSDV+S+G+++ EL + + + + ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYRM 233
Query: 650 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P + + + C + E + RP + L+
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 30/275 (10%)
Query: 417 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 472
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 532
+C + +A LV E+ G + L G + + ++ + + YL E
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 533 VIHRDFKSSNILLEHDFTPKVSDFGLARSA-MDEESRHISTRVMGTFGYVAPEYAMTGHL 591
+HRD + N+LL + K+SDFGL+++ D+ + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 592 LVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 650
+SDV+SYGV + E LS G+KP + P + + + +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----------------E 232
Query: 651 VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P + ++ A+ S C + + RP V Q ++
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 8e-60
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 30/277 (10%)
Query: 415 RILGEGGFGLVYSGVLDD---GTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 469
+ LG G FG V G VAVK+LK D E LAE ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 470 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 529
+IGIC E LV E+ G + +L ++ + +++ + + YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAPEYAMT 588
+HRD + N+LL K+SDFGL+++ DE T + APE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 589 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648
KSDV+S+GV++ E S + + + +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER 228
Query: 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P ++ + ++C +V++RP V L+
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-58
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTK--VAVKVLKRV-DQQGGREFLAEVEMLSRL-HH 464
+ ++GEG FG V + DG + A+K +K + R+F E+E+L +L HH
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHG------------VDKESAPLGWDARL 512
N++ L+G C L E P+G++ L + ++ L L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 513 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 572
A AR + YL + IHRD + NIL+ ++ K++DFGL+R + T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184
Query: 573 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632
++A E SDV+SYGV++ E++S P
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY--- 236
Query: 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
+ + P + +V + C + + RP +++ +L
Sbjct: 237 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 69/277 (24%), Positives = 105/277 (37%), Gaps = 33/277 (11%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHR 465
+F+ R LG+G FG VY +A+KVL + + EVE+ S L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
N+++L G + L+ E P G+V L + + A AL+Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 122
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S RVIHRD K N+LL K++DFG + A + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEM 175
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645
K D++S GV+ E L G+ P + ++
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------------- 221
Query: 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
P + S ++ RP + EV++
Sbjct: 222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
LG+G FG VY + A KV+ ++ +++ E+++L+ H N+VKL+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
E ++ E G+V++ + +++ PL + AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 592
IHRD K+ NIL D K++DFG++ R +GT ++APE M
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKD 189
Query: 593 ----VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648
K+DV+S G+ ++E+ P P +A + P P+L
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------------PTLA 236
Query: 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
+ S K C++ V R +++Q
Sbjct: 237 QPSRWSSNFK--DFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 2e-57
Identities = 75/295 (25%), Positives = 114/295 (38%), Gaps = 41/295 (13%)
Query: 396 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG---RE 451
A+ F + EK F R +G G FG VY + + VA+K + +Q ++
Sbjct: 5 AELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 452 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 511
+ EV L +L H N ++ G + E LV E + + PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEI 117
Query: 512 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 571
+ GA + LAYLH S +IHRD K+ NILL K+ DFG A +
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168
Query: 572 TRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVA 627
+GT ++APE + G K DV+S G+ +EL + P +M ++
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 628 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
P L S E + C+Q Q RP +++
Sbjct: 229 NESPALQSGHWSEYFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 72/284 (25%), Positives = 108/284 (38%), Gaps = 30/284 (10%)
Query: 410 NFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL 462
+ LG+G FG+V G D VAVK LK + +F+ EV + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 463 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 522
HRNL++L G+ + +V EL P GS+ L K + A+ A +
Sbjct: 69 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGM 124
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI-STRVMGTFGYV 581
YL S R IHRD + N+LL K+ DFGL R+ + ++ F +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641
APE T SD + +GV + E+ + + P N + E L R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPR 236
Query: 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P D + + C + + RP + L
Sbjct: 237 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-57
Identities = 62/278 (22%), Positives = 100/278 (35%), Gaps = 27/278 (9%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRN 466
++D + LGEG +G V V VAVK++ E E+ + L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+VK G E + L E G + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+ HRD K N+LL+ K+SDFGLA + ++ GT YVAPE
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 587 MTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645
DV+S G+V+ +L+G P D QE + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN---------- 227
Query: 646 SLGNDVPFDSVAKVA-AIASMCVQPEVQHRPFMGEVVQ 682
P+ + A+ + R + ++ +
Sbjct: 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-57
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 34/299 (11%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGRE-FLAEVE 457
EI++ + R +GEG FG V+ G+ + VA+K K RE FL E
Sbjct: 3 EIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 458 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 517
+ + H ++VKLIG+ E ++ EL G + S L L + + A
Sbjct: 61 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQ 116
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 577
+ ALAYL R +HRD + N+L+ + K+ DFGL+R M++ + + +++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLP 172
Query: 578 FGYVAPEYAMTGHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPGQENLVAWARPLLTSR 636
++APE SDV+ +GV + E+L G KP + + L
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 228
Query: 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK 695
+P + + ++ + C + RP E+ L + E ++A+
Sbjct: 229 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE-EKAQ 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-57
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 33/276 (11%)
Query: 415 RILGEGGFGLVYSGVL-DDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+G G F VY G+ + +VA L+ ++ + + F E EML L H N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 472 GICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
++ LV EL+ +G+++++L + + L +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 528 DSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+P +IHRD K NI + + K+ D GLA + + V+GT ++APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEM- 184
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646
DVY++G+ +LE+ + P Q Q R+
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSGV 229
Query: 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
++ +V I C++ R + +++
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-57
Identities = 76/307 (24%), Positives = 140/307 (45%), Gaps = 32/307 (10%)
Query: 392 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD 445
Y +A + E E A SR LG+G FG+VY GV + T+VA+K +
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 446 QQGGR-EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH------G 498
R EFL E ++ + ++V+L+G+ + Q ++ EL+ G ++S+L
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 499 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558
+ AP +++A A +AYL+ + + +HRD + N ++ DFT K+ DFG+
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
Query: 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQ 618
R + + + + +++PE G SDV+S+GVV+ E+ + +
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----- 234
Query: 619 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 678
L++ + L +++ L D P + + + MC Q + RP
Sbjct: 235 ----------PYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFL 283
Query: 679 EVVQALK 685
E++ ++K
Sbjct: 284 EIISSIK 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 7e-57
Identities = 65/281 (23%), Positives = 117/281 (41%), Gaps = 29/281 (10%)
Query: 411 FDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHH 464
F ++LG G FG VY G+ VA+K L+ + +E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
++ +L+GIC+ L+ +L+P G L V + +G L + A+ + Y
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGC---LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
L + R++HRD + N+L++ K++DFGLA+ EE + + ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644
+ +SDV+SYGV + EL++ P + + I++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE 227
Query: 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
P V I C + RP E++
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 8e-54
Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 410 NFDASRILGEGGFGLVYSGV------LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSR- 461
+ LG G FG V VAVK+LK R ++E+++L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 462 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAP------------LGW 508
HH N+V L+G C + ++ E G++ ++L E P L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 509 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568
+ + + A+ + +L S + IHRD + NILL K+ DFGLAR +
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 628
++APE ++SDV+S+GV++ E+ S P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEE 245
Query: 629 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
R + P + ++ C E RP E+V+ L
Sbjct: 246 ----------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 26/284 (9%)
Query: 400 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEM 458
S + + +G+G G VY+ + + G +VA++ + Q + E+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 459 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
+ + N+V + + +V E + GS+ + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCREC 125
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
+AL +LH S +VIHRD KS NILL D + K++DFG E+S+ + ++GT
Sbjct: 126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTP 180
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638
++APE K D++S G++ +E++ G P P L+A G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNG 232
Query: 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
+ +P ++ + + C+ +V+ R E++Q
Sbjct: 233 TPELQNPE-----KLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-53
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 410 NFDASRILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLS 460
+ LGEG FG V + TKVAVK+LK ++ + ++E+EM+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 461 RL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH------------GVDKESAPLG 507
+ H+N++ L+G C ++ ++ E G++ +L L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 508 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567
+ A AR + YL S + IHRD + N+L+ D K++DFGLAR +
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 627
+T ++APE +SDV+S+GV++ E+ + P +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245
Query: 628 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
L +++ D P + ++ + C RP ++V+ L
Sbjct: 246 -----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 11/213 (5%)
Query: 405 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLS 460
+K +F +ILGEG F V L + A+K+L++ + + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
RL H VKL +++ NG + ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
AL YLH +IHRD K NILL D +++DFG A+ E + + +GT Y
Sbjct: 120 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
V+PE SD+++ G +I +L++G P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (447), Expect = 1e-49
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 26/276 (9%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
++D LG G FG+V+ G A K + + E++ +S L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
L ++ ++YE + G + + E + D ++ + L ++HE
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 529 SSPRVIHRDFKSSNILL--EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
+H D K NI+ + K+ DFGL ++S GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVA 197
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 646
+ +D++S GV+ LLSG P V +D S
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------NMDDS 247
Query: 647 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
+ + D + + R + + ++
Sbjct: 248 AFSGISED----GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 1e-48
Identities = 55/271 (20%), Positives = 93/271 (34%), Gaps = 26/271 (9%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
LG G FG+V+ V G K + E+ ++++LHH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
++ L+ E + G + + E + + A L ++H +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EHSI 148
Query: 534 IHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 591
+H D K NI+ E K+ DFGLA +E T + APE +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPV 205
Query: 592 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651
+D+++ GV+ LLSG P E L R E + P
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDAFSSVSPEA---- 259
Query: 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
+Q E + R + + ++
Sbjct: 260 --------KDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (432), Expect = 2e-48
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 31/292 (10%)
Query: 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH 463
+ ++ ILG GG V+ L VAVKVL+ D F E + + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 464 HRNLVKLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 519
H +V + E +V E + ++ +H P+ +++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-RVMGTF 578
+AL + H +IHRD K +NI++ KV DFG+AR+ D + T V+GT
Sbjct: 122 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638
Y++PE A + +SDVYS G V+ E+L+G P P P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------- 231
Query: 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCN 689
I + + A + A+ + ++R E+ L V N
Sbjct: 232 ---IPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (421), Expect = 7e-47
Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 41/290 (14%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK---------RVDQQGGREFLAEVEML 459
N++ ILG G +V + + AVK++ Q+ L EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 460 SRLH-HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 518
++ H N+++L LV++L+ G + +L E L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 519 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
+ LH ++HRD K NILL+ D K++DFG + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173
Query: 579 GYVAPEYAMTGHLL------VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 632
Y+APE + D++S GV++ LL+G P + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 633 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
S E +D V + S + + Q R E +
Sbjct: 234 FGSPE----------WDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (427), Expect = 9e-47
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 19/227 (8%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH-- 463
+F RI+G GGFG VY D G A+K L + +QG L E MLS +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 464 -HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 522
+V + + +L+ G + HL + A L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGL 120
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 582
++H + V++RD K +NILL+ ++SD GLA ++ +GT GY+A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 173
Query: 583 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 628
PE G +D +S G ++ +LL G P + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 4e-46
Identities = 53/287 (18%), Positives = 92/287 (32%), Gaps = 29/287 (10%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL 467
+ R +G G FG +Y G + G +VA+K+ + + E ++ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 468 VKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+ I C E +V EL+ + S L +A + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 527 EDSSPRVIHRDFKSSNIL---LEHDFTPKVSDFGLARSAMDEES-----RHISTRVMGTF 578
S IHRD K N L + + DFGLA+ D + + + GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 579 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 638
Y + + + D+ S G V++ G P + + E
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------ISEK 231
Query: 639 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
L P ++ A + C +P + Q +
Sbjct: 232 KMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 7e-46
Identities = 55/282 (19%), Positives = 95/282 (33%), Gaps = 23/282 (8%)
Query: 403 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLS 460
+ E +D +LG G F V VA+K + + +G E+ +L
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 461 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
++ H N+V L I L+ +L+ G + + E ++
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLD 118
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
A+ YLH+ + L+ D +SDFGL++ E+ + + GT GY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 175
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640
VAPE D +S GV+ LL G P + A
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--------- 226
Query: 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
D +D+ ++ + + R + +Q
Sbjct: 227 -EFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 72/324 (22%), Positives = 125/324 (38%), Gaps = 25/324 (7%)
Query: 408 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHR 465
+ +GEG +G+V S + +VA+K + + Q + L E+++L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
N++ + I + + + + L+ + K L D R L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA-MDEESRHISTRVMGTFGYVAPE 584
H S V+HRD K SN+LL K+ DFGLAR A D + T + T Y APE
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 585 YAMTGHLLVKS-DVYSYGVVILELLSGRKP-------------VDMTQPPGQENLVAWAR 630
+ KS D++S G ++ E+LS R + + P QE+L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA--LKLVC 688
+ + N + ++ +K + + R + + + L+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 689 NECDE--AKEVGSASSSQDDMSID 710
+ DE A+ DD+ +
Sbjct: 303 DPSDEPIAEAPFKFDMELDDLPKE 326
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-45
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 14/227 (6%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 464
+F ++LG+G FG V+ A+K LK+ + + E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
L + ++ V E + G + H+ A L +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
LH +++RD K NILL+ D K++DFG+ + M +++ GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631
+ D +S+GV++ E+L G+ P + + P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (405), Expect = 1e-44
Identities = 45/289 (15%), Positives = 86/289 (29%), Gaps = 31/289 (10%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRN 466
++ R +GEG FG+++ G L + +VA+K R + + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+ + E LV +L+ S +D A + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 527 EDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMDEESR-----HISTRVMG 576
+++RD K N L+ ++ V DFG+ + D ++ + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 577 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 636
T Y++ + + D+ + G V + L G P + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------G 229
Query: 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685
E + L P + P +
Sbjct: 230 EKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-44
Identities = 52/271 (19%), Positives = 92/271 (33%), Gaps = 27/271 (9%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
LG G FG+V+ V K +K V E+ +L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 474 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 533
+ +++E I + ++ + L + AL +LH S +
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 534 IHRDFKSSNILL--EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 591
H D + NI+ T K+ +FG AR ++ + + Y APE +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVV 180
Query: 592 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 651
+D++S G ++ LLSG P + A D ++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------TFDEEAFKEI 230
Query: 652 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
+ + E + R E +Q
Sbjct: 231 S----IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (403), Expect = 2e-44
Identities = 54/286 (18%), Positives = 107/286 (37%), Gaps = 21/286 (7%)
Query: 410 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNL 467
+ +GEG +G+VY + G A+K ++ + D+ + E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 468 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
VKL + ++ LV+E + +D L L +AY H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDL----KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 528 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 587
RV+HRD K N+L+ + K++DFGLAR+ R + ++ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 588 TGHLLVKSDVYSYGVVILELLSGRKPVD----------MTQPPGQENLVAWARPLLTSRE 637
+ D++S G + E+++G + + G N W +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 638 GLERIIDPSLGNDVPFDSVAKVAA-IASMCVQPEVQHRPFMGEVVQ 682
+ L + + + + S ++ + R + ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (401), Expect = 1e-43
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 465
+F R LG G FG V+ +G A+KVLK+ V + E MLS + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
++++ G + Q ++ + I L + ++S A AL YL
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H +I+RD K NILL+ + K++DFG A+ D + GT Y+APE
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKP 613
T D +S+G++I E+L+G P
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 28/297 (9%)
Query: 406 KATGNFDASRILGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSR 461
+A ++ +GEG +G V+ + + G VA+K ++ + G + EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 462 L---HHRNLVKLIGICIEEQARCLVYELIPNGSV--ESHLHGVDKESAPLGWDARLKIAL 516
L H N+V+L +C + + V + + + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 517 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 576
R L +LH S RV+HRD K NIL+ K++DFGLAR + T V+
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 177
Query: 577 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV---------- 626
T Y APE + D++S G + E+ + + Q +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 627 AWARPLLTSREGLERIIDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
W R + R+ + V D + K + C+ R +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 10/207 (4%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 466
NF +GEG +G+VY G VA+K ++ + + E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+VKL+ + E LV+E + + + + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCH 119
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
S RV+HRD K N+L+ + K++DFGLAR+ R + V+ +
Sbjct: 120 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILL 175
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
+ D++S G + E+++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-41
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 18/212 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 468
++ ++++G G FG+VY L D G VA+K + Q R E++++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 469 KLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 522
+L + LV + +P H + L R+L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSL 135
Query: 523 AYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 581
AY+H S + HRD K N+LL+ D K+ DFG A+ + E + + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190
Query: 582 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
DV+S G V+ ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNLV 468
LGEG F VY + VA+K +K + ++ L E+++L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 469 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 528
L+ + LV++ + + S L L + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 529 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 588
++HRD K +N+LL+ + K++DFGLA+S + T + T Y APE
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFG 174
Query: 589 GHLL-VKSDVYSYGVVILELLSGRKP 613
+ V D+++ G ++ ELL
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-41
Identities = 62/283 (21%), Positives = 100/283 (35%), Gaps = 35/283 (12%)
Query: 411 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRLH 463
+D LG G F +V G + A K +K+ + R + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 464 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 523
H N++ L + + L+ EL+ G L E L + + +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 524 YLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRVMGTFG 579
YLH S ++ H D K NI+L P K+ DFGLA + GT
Sbjct: 128 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 580 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639
+VAPE L +++D++S GV+ LLSG P QE L + +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAVNYEFEDEY 239
Query: 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
+ + + R + + +Q
Sbjct: 240 FSNTSALA------------KDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-41
Identities = 60/278 (21%), Positives = 97/278 (34%), Gaps = 32/278 (11%)
Query: 414 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 471
S++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71
Query: 472 GIC----IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 527
+ + +V E + G + S + D+ +I A+ YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH- 128
Query: 528 DSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
S + HRD K N+L + K++DFG A+ S T YVAPE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPE 183
Query: 585 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644
D++S GV++ LL G P L R G +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
P K + ++ E R + E +
Sbjct: 239 PEWSE---VSEEVK--MLIRNLLKTEPTQRMTITEFMN 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-39
Identities = 54/208 (25%), Positives = 84/208 (40%), Gaps = 13/208 (6%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 465
+FD ++LG+G FG V G A+K+L++ + + + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
L L C V E G + HL + AL YL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL 121
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H V++RD K N++L+ D K++DFGL + + + + GT Y+APE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEV 176
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKP 613
D + GVV+ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 45/285 (15%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR------VDQQGGREFLAEVEMLSR 461
+ +LG GGFG VYSG+ + D VA+K +++ + G EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 462 LH--HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 519
+ +++L+ + L+ E E L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL 120
Query: 520 RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 578
A+ + H V+HRD K NIL+ + K+ DFG D + T GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTR 173
Query: 579 GYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637
Y PE+ +S V+S G+++ +++ G P E
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------------------FE 211
Query: 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682
E II + S + + C+ RP E+
Sbjct: 212 HDEEIIRGQVFFRQRVSSECQ--HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 14/237 (5%)
Query: 397 KTFSASEIEKATGNFDAS----RILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGG 449
F E+ K A + +G G +G V S V G KVA+K L R +
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 450 REFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 509
+ E+ +L + H N++ L+ + ++ + G + LG D
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 510 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 569
+ + L Y+H + +IHRD K N+ + D K+ DFGLAR +
Sbjct: 122 RIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSE 174
Query: 570 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 626
++ V+ + D++S G ++ E+++G+ + Q +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 409 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHR 465
++ +G+G FG V+ G KVA+K + +++ G L E+++L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 466 NLVKLIGICIEEQAR--------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 517
N+V LI IC + + LV++ + + + K ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 518 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVM 575
L Y+H +++HRD K++N+L+ D K++DFGLAR S + T +
Sbjct: 126 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 576 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 626
T Y PE + D++ G ++ E+ + + Q L+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 11/207 (5%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 466
++ +GEG +G V+ + VA+K ++ D+ L E+ +L L H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 467 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 526
+V+L + ++ LV+E D + L + + L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 527 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 586
V+HRD K N+L+ + K+++FGLAR+ R S V+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 587 MTGHLLVKSDVYSYGVVILELLSGRKP 613
D++S G + EL + +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 4e-37
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 16/226 (7%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 465
FD + LG G FG V + G A+K+L + V + L E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 466 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
LVKL + +V E + G + SHL A YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S +I+RD K N+L++ +V+DFG A+ + GT +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEI 209
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 631
++ D ++ GV+I E+ +G P QP + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 7e-34
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 471
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 472 GICI------EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+ E Q LV EL+ + +D + + + +L
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135
Query: 526 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 585
H S +IHRD K SNI+++ D T K+ DFGLAR+A T + T Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEV 189
Query: 586 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 626
+ D++S G ++ E++ + Q N V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 8e-34
Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 410 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNL 467
++ R LG G + V+ + + + KV VK+LK V ++ + E+++L L N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 468 VKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 525
+ L I + +R LV+E + N + L +AL Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYC 145
Query: 526 HEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 584
H S ++HRD K N++++H+ ++ D+GLA + + + + PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 585 YAMTGHLL-VKSDVYSYGVVILELLSGRKP 613
+ + D++S G ++ ++ ++P
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 4e-33
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 410 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRV----DQQGGREFLAEVEMLSR 461
NF+ ++LG G +G V+ D G A+KVLK+ + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 462 L-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 520
+ LV L E L+ + I G + +HL ++ + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ-------IYVGE 137
Query: 521 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
+ L +I+RD K NILL+ + ++DFGL++ + +E+ + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 196
Query: 581 VAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKP 613
+AP+ G D +S GV++ ELL+G P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 14/223 (6%)
Query: 398 TFSASEIEKA----TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--R 450
TF E+ K + +G G +G V + G +VAVK L R Q +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 451 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 510
E+ +L + H N++ L+ + ++ ++ + + L D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 511 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 570
+ R L Y+H S +IHRD K SN+ + D K+ DFGLAR +
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEM 175
Query: 571 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 613
+ V + H D++S G ++ ELL+GR
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (295), Expect = 3e-29
Identities = 54/297 (18%), Positives = 106/297 (35%), Gaps = 24/297 (8%)
Query: 415 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 473
R LG G F V+ + + T VA+K+++ D+ E+++L R++ + K +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 474 CIEEQARCLVY--ELIPNGSVESHLHGVD----------KESAPLGWDARLKIALGAARA 521
+ L + PNG + V E + +I+
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 522 LAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 580
L Y+H +IH D K N+L+E D + +A T + T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 581 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD-MTQPPGQENLVAWARPLLTSREGL 639
+PE + +D++S +I EL++G + ++ A+ + E
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKE 696
++ F+S + I +++ P + + K +E E +
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNI------SKLKFWPLEDVLTEKYKFSKDEAKEISD 306
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 105 bits (262), Expect = 2e-26
Identities = 35/203 (17%), Positives = 65/203 (32%), Gaps = 28/203 (13%)
Query: 415 RILGEGGFGLVYSGVLDDGTKVAVKVLK----------RVDQQGGREFLAEVEMLSRLHH 464
+++GEG V++ + + VK K G F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 465 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 524
R L KL G+ + + Y N + + + + + +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 525 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFGYVAP 583
+ ++H D N+L+ + + DF + +E R I R V Y +
Sbjct: 119 FY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 584 EYAMTGHLLVKSDVYSYGVVILE 606
Y + D+ S IL+
Sbjct: 175 TYRT------EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 808 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.73 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=388.57 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=213.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CC---CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 99421145631483789999960-89---78999995115-612358999999997620236510277333203516788
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g---~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.++||+|+||+||+|.+. ++ ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 84138998011223555678999998999999999999999984699938842103468153589952010456431135
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~ 563 (808)
||||++|+|.++++. ....++|.+++.|+.|+|+||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCEEEECC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 972279853002104---5679999999999999999889885279---8357615044898899919988844315756
Q ss_pred CCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 4334343---222124433446112202988622434007999999971-999999999998503677432001342210
Q 003605 564 DEESRHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 564 ~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
....... .....||+.|||||++.++.++.++|||||||+||||+| |+.||..... ..+...+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i---------- 246 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI---------- 246 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----------
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHH----------
T ss_conf 777765365025666883003878883699786121445357899998679999999999---9999999----------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 10027878999993369999999998126497899999999999999997602
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 640 ~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
........+.+....+.+|+.+||+.+|++||+|.||++.|+.+.+..+
T Consensus 247 ----~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 247 ----EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ----HCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCHH
T ss_conf ----7378899974226999999999758797689299999999999841862
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.83 Aligned_cols=265 Identities=27% Similarity=0.463 Sum_probs=212.7
Q ss_pred HHHCCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 881994211456314837899999608978999995115--612358999999997620236510277333203516788
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
...++|.+.+.||+|+||+||+|+++ ..||||+++.. .....++|.+|++++++++|+|||+++|++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred CCCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEE
T ss_conf 15451899889830788589999999--989999997346998999999999999984799878645679715-589999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 84138998011223555678999998999999999999999984699938842103468153589952010456431135
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~ 563 (808)
+||+++|+|.++++. ....++|..++.|+.|+|+||+|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 82 ~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EECCCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf 965899888999852---3578999999999999999988875099---9516147899798189978875002213335
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 4334343222124433446112202---9886224340079999999719999999999985036774320013422101
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
............||+.|||||++.+ +.++.++|||||||+||||+||+.||...... ..+.......
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~-------- 225 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRG-------- 225 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHT--------
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHCC--------
T ss_conf 567763125665574317999995056899995315163599999999788998998969--9999999658--------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 002787899999336999999999812649789999999999999999760
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 641 ~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
...+.+ ...+.+....+.+|+.+||+.+|++||||.||++.|+.+.+..
T Consensus 226 -~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 226 -YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -CCCCCC-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf -889860-0036555499999999975889768929999999999999709
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.45 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=212.8
Q ss_pred CCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECC
Q ss_conf 99421145631483789999960897899999511561235899999999762023651027733320351678884138
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
++|++.+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|+|||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 995888898208882999999889999999998788-6768999999999996689975653524315993379998369
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCCCC
Q ss_conf 99801122355567899999899999999999999998469993884210346815358995201045643113543343
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~~ 568 (808)
+|+|.++++. ....++|..++.|+.|+|.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC-
T ss_conf 9918997520---1347889999999999999877653164---31044315326666887768655321002368873-
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 43222124433446112202988622434007999999971999999999998503677432001342210100278789
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 648 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l~ 648 (808)
.......||..|+|||++.+..++.++|||||||++|||+|+..|+.... ....+...... ...
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~--------------~~~ 220 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDIST--------------GFR 220 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHH--------------TCC
T ss_pred EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHH--------------CCC
T ss_conf 35043001766678578607999840332105999999987898887789--99999999980--------------688
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 999933699999999981264978999999999999999976
Q 003605 649 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 649 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
...+..+..++.+++.+||+.+|++||+|+||++.|+++.+.
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 899543679999999997657976891999999999999857
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.76 Aligned_cols=262 Identities=27% Similarity=0.475 Sum_probs=214.5
Q ss_pred HHHCCCCEEEEEEECCCEEEEEEEEEC-C-----CEEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC
Q ss_conf 881994211456314837899999608-9-----78999995115-612358999999997620-236510277333203
Q 003605 406 KATGNFDASRILGEGGFGLVYSGVLDD-G-----TKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 477 (808)
Q Consensus 406 ~at~~f~~~~~LG~G~fG~VYkg~l~~-g-----~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 477 (808)
...++|++.++||+|+||+||+|++.. + ..||+|.+... .......+.+|+.++.++ +|+|||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 77899397019830788199999985788554204999999663358789999999999999715899686877888629
Q ss_pred CCEEEEEEECCCCCCCCCCCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 516788841389980112235556-------------------7899999899999999999999998469993884210
Q 003605 478 QARCLVYELIPNGSVESHLHGVDK-------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 538 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~-------------------~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDL 538 (808)
+..++||||+++|+|.++|+.... ....++|..++.|+.|++.||+|||+.+ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCC
T ss_conf 95899997279995999998625777510221000012220012577899999999999999999997399---050527
Q ss_pred CCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCC
Q ss_conf 34681535899520104564311354334343222124433446112202988622434007999999971-99999999
Q 003605 539 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMT 617 (808)
Q Consensus 539 KpsNILLd~~~~vKI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~ 617 (808)
||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf 03214434598289851422220457786156234357876578388727999963303000399999983899999998
Q ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999850367743200134221010027878999993369999999998126497899999999999999
Q 003605 618 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 618 ~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
... ..+. +++......+.+......+.+|+.+||+.+|++||||.||+++|..
T Consensus 271 ~~~--~~~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVD--ANFY--------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCS--HHHH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHH--HHHH--------------HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 989--9999--------------9985699899887678999999999758896689399999999748
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=387.22 Aligned_cols=265 Identities=26% Similarity=0.395 Sum_probs=217.1
Q ss_pred HHHHHHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 99988199421145631483789999960-89789999951156123589999999976202365102773332035167
Q 003605 403 EIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 403 el~~at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
+++...++|++.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEE
T ss_conf 5174579939865982088808999999999969999997776-103999999999998679998826775274578547
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCC
Q ss_conf 88841389980112235556789999989999999999999999846999388421034681535899520104564311
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~ 561 (808)
+||||+++|+|.++++.. ....++|..++.|+.|+|.||+|||+.+ |+||||||+||||++++.+||+|||+|+.
T Consensus 90 iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf 876314676067775303--5541579999999999999788898789---30576045768998999289832445465
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 35433434322212443344611220298862243400799999997199999999999850367743200134221010
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.... .........|+..|+|||++.++.++.++|||||||++|||++|..|+..... ...+. +
T Consensus 165 ~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~--------------~ 227 (287)
T d1opja_ 165 MTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY--------------E 227 (287)
T ss_dssp CCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH--------------H
T ss_pred CCCC-CCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHH--------------H
T ss_conf 3788-72210355665466692787279998104302178999999867998877425--99999--------------9
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 0278789999933699999999981264978999999999999999976
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 642 ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
++........+......+.+|+.+||+.||++||+|.||++.|+.+.++
T Consensus 228 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 9855888888743309999999997577976893999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.10 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=212.1
Q ss_pred HHHHHCCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 99881994211456314837899999608978999995115612358999999997620236510277333203516788
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
++...++|++.+.||+|+||.||+|.+++++.||||+++.. ....++|.+|++++++++|+|||+++|+|.+ +..++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred EECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEE
T ss_conf 00388993886798107982899999999999999998647-6888999999999986799988578731045-976999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 84138998011223555678999998999999999999999984699938842103468153589952010456431135
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~ 563 (808)
|||+++|+|.++++.. ....++|..+++|+.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+|+...
T Consensus 86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEECCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECC
T ss_conf 9957898288887514--7898878899999999999999997489---5467564225156202440423410147735
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 43343432221244334461122029886224340079999999719999999999985036774320013422101002
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... ........|+..|+|||++.++.++.++|||||||++|||+||..|+..... ...+.....
T Consensus 161 ~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~------------- 224 (272)
T d1qpca_ 161 DNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE------------- 224 (272)
T ss_dssp SSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------------
T ss_pred CCC-CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH-------------
T ss_conf 886-4420356774444582898379998245645257999999968988888889--999999997-------------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 78789999933699999999981264978999999999999999976
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 644 Dp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
.......+......+.+|+.+||+.+|++||||.||++.|+.....
T Consensus 225 -~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 225 -RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -0688889655719999999997588976893999999986113213
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.27 Aligned_cols=264 Identities=24% Similarity=0.424 Sum_probs=214.2
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEECC-----CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 19942114563148378999996089-----78999995115-6123589999999976202365102773332035167
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDG-----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~~g-----~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
...|+..++||+|+||.||+|.+++. ..||||+++.. ......+|.+|++++++++|+|||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCC
Q ss_conf 88841389980112235556789999989999999999999999846999388421034681535899520104564311
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~ 561 (808)
+|+||+.+|++.+++. .....++|.++++|+.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEECCCCCCHHHHH---CCCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 9997213574022210---23454208999999999998541212123---42576564427888998499845510300
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 354334-3432221244334461122029886224340079999999719999999999985036774320013422101
Q 003605 562 AMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 562 ~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
...... ........||..|+|||++.++.++.++|||||||++|||++|..|+..... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~------------- 224 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMK------------- 224 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHH-------------
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC--HHHHHH-------------
T ss_conf 35787652674267777343488887049999735563448989999967988655689--999999-------------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 00278789999933699999999981264978999999999999999976022
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 693 (808)
Q Consensus 641 ~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~~ 693 (808)
.+........+.+....+.+|+.+||+.+|++||+|.||++.|+.+.+..+.
T Consensus 225 -~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 225 -AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp -HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -HHHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCC
T ss_conf -9863578998504579999999997767976893999999999998669564
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.07 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=211.5
Q ss_pred HCCCCEEEE-EEECCCEEEEEEEEE---CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 199421145-631483789999960---8978999995115-61235899999999762023651027733320351678
Q 003605 408 TGNFDASRI-LGEGGFGLVYSGVLD---DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 408 t~~f~~~~~-LG~G~fG~VYkg~l~---~g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.++|.+.++ ||+|+||+||+|.+. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCC
Q ss_conf 88413899801122355567899999899999999999999998469993884210346815358995201045643113
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~ 562 (808)
||||+++|+|.+++.. ....+++..+++|+.|+|.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 9980789968997521---2569999999999999999878998688---105767646604546885420331342115
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 543343-43222124433446112202988622434007999999971-9999999999985036774320013422101
Q 003605 563 MDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 563 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
...... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~---------- 226 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIE---------- 226 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHH----------
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----------
T ss_conf 54343211356211374335868872799995412322017899999389999999799---99999998----------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 0027878999993369999999998126497899999999999999997602
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 641 ~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
.......+......+.+|+.+||+.+|++||+|.+|++.|+.+..+..
T Consensus 227 ----~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 227 ----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf ----189999997678999999999757797689099999999999999854
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.24 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=207.7
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 199421145631483789999960-89789999951156-1235899999999762023651027733320351678884
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.++|++.+.||+|+||+||+|... +++.||||+++... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCC
Q ss_conf 13899801122355567899999899999999999999998469993884210346815358995201045643113543
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~ 565 (808)
|+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCCCHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 458980899975----3799999999999999999999999759---835754689978878998798323142240468
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 34343222124433446112202988-62243400799999997199999999999850367743200134221010027
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
......+...||+.|||||++.+..+ +.++||||+||++|||++|+.||........ ....+. .
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~--------------~ 221 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK--------------E 221 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHH--------------T
T ss_pred CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHH--------------C
T ss_conf 8653111325574742872861899999710161737999999829978888985999-999986--------------3
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 87899999336999999999812649789999999999
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 645 p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
..............+.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 88878864469999999999976799668909999961
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.84 Aligned_cols=260 Identities=25% Similarity=0.447 Sum_probs=213.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCC----EEEEEEEEC-CCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 99421145631483789999960-897----899999511-561235899999999762023651027733320351678
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~----~VAVK~lk~-~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 482 (808)
.+|++.++||+|+||+||+|.+. +|+ .||+|+++. ......++|.+|++++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCC
Q ss_conf 88413899801122355567899999899999999999999998469993884210346815358995201045643113
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 562 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~ 562 (808)
++||+.+|+|.+++.. ....+++..+++|+.|+|.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEECCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 9984268740101113---3457999999999999999999998769---504762120311679987586025522233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 54334343222124433446112202988622434007999999971-99999999999850367743200134221010
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.............||..|+|||++.++.++.++|||||||+||||+| |..||+..... .+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~-------------- 224 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS-------------- 224 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHH--------------
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH--------------
T ss_conf 54445322365105864467088746999835654407999999997799999999989---9999--------------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 027878999993369999999998126497899999999999999997602
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 642 ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
.+........+......+.+|+.+||+.+|++||++.||++.|+.+.+...
T Consensus 225 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~ 275 (317)
T d1xkka_ 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275 (317)
T ss_dssp HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCHH
T ss_conf 997599899985568999999998478993469199999999999875868
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=374.80 Aligned_cols=269 Identities=26% Similarity=0.449 Sum_probs=219.0
Q ss_pred HHHHHHHHCCCCEEEEEEECCCEEEEEEEEE------CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 8999988199421145631483789999960------8978999995115-61235899999999762023651027733
Q 003605 401 ASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGI 473 (808)
Q Consensus 401 ~~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~ 473 (808)
+.+++...++|++.+.||+|+||+||+|.+. +++.||||+++.. .....++|.+|++++++++|+||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCCEEEEEEECCCCCCCCCCCCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 3203516788841389980112235556--------------------78999998999999999999999984699938
Q 003605 474 CIEEQARCLVYELIPNGSVESHLHGVDK--------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRV 533 (808)
Q Consensus 474 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~--------------------~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~I 533 (808)
|...+..++++||+++|+|.++++.... ....++|..++.|+.|++.||+|||+.+ +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---E
T ss_conf 6059803899981589929999985275542100001110012103467889899999999999999855413578---6
Q ss_pred EEEEECCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCC-C
Q ss_conf 842103468153589952010456431135433434322212443344611220298862243400799999997199-9
Q 003605 534 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-K 612 (808)
Q Consensus 534 iHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~-~ 612 (808)
+||||||+|||||.++.+||+|||+|+...........+...|+..|+|||++.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99999999850367743200134221010027878999993369999999998126497899999999999999997
Q 003605 613 PVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 613 P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
||.... ...+...+ .+.. ....+...+.++.+|+.+||+.+|++||||.||+++|+.+++
T Consensus 242 p~~~~~---~~e~~~~v-------------~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 242 PYYGMA---HEEVIYYV-------------RDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTTSC---HHHHHHHH-------------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCC---HHHHHHHH-------------HCCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 999989---99999999-------------7399-788873252999999999748896579399999999998429
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.47 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=204.2
Q ss_pred EEEEECCCEEEEEEEEEC---CCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECCC
Q ss_conf 456314837899999608---978999995115--612358999999997620236510277333203516788841389
Q 003605 415 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 489 (808)
Q Consensus 415 ~~LG~G~fG~VYkg~l~~---g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~~ 489 (808)
+.||+|+||+||+|.+++ ++.||||+++.. +....++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCCCC-
Q ss_conf 9801122355567899999899999999999999998469993884210346815358995201045643113543343-
Q 003605 490 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR- 568 (808)
Q Consensus 490 GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~~- 568 (808)
|+|.++++ ....++|..+++|+.|+|.||+|||+.+ |+||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 96899975----2257899999999999999976687479---5567776113102356751234134533134323443
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 43222124433446112202988622434007999999971-99999999999850367743200134221010027878
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l 647 (808)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+.... ....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i--------------~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAML--------------EKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH--------------HTTC
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHH--------------HCCC
T ss_conf 2244567784203916653799984344303403132896589999999899---9999999--------------8289
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999933699999999981264978999999999999999976
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
....+......+.+|+.+||+.+|++||+|.+|++.|+....+
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 9999865679999999997588976890989999985288750
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.43 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=211.7
Q ss_pred CCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECC
Q ss_conf 99421145631483789999960897899999511561235899999999762023651027733320351678884138
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 488 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~~ 488 (808)
++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|+||++++|+|.+.+..++|+||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 997996898207883999999889989999998747-5778999999999996689860158899850781699997048
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCCCC
Q ss_conf 99801122355567899999899999999999999998469993884210346815358995201045643113543343
Q 003605 489 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 568 (808)
Q Consensus 489 ~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~~ 568 (808)
+|+|.+++.. ....+.+..+++|+.|+|+||+|||+.+ |+|||||++|||+++++.+||+|||+++...... .
T Consensus 83 ~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~ 155 (258)
T d1k2pa_ 83 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y 155 (258)
T ss_dssp TEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-C
T ss_pred CCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC-C
T ss_conf 9938886410---2467768999999999999999875468---4346654135887699847988614420235787-2
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 43222124433446112202988622434007999999971-99999999999850367743200134221010027878
Q 003605 569 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 569 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l 647 (808)
.......||..|+|||++.+..++.++||||||+++|||+| |+.||..... ..+...+ . ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i---~-----------~~~ 218 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHI---A-----------QGL 218 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHH---H-----------TTC
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH---HHHHHHH---H-----------HCC
T ss_conf 2524657887757807863799885210336432467397559999889999---9999999---8-----------079
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999993369999999998126497899999999999999
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 686 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~ 686 (808)
....+......+.+++.+||+.+|++|||+.|+++.|.+
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 789965465999999999766897689399999987418
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.69 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=206.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 99421145631483789999960-89789999951156123589999999976202365102773332035167888413
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
++|+..+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCCC
Q ss_conf 89980112235556789999989999999999999999846999388421034681535899520104564311354334
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~ 567 (808)
++|+|.+++.. ..+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++++||+|||+|+......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-
T ss_conf 79808988641-----59999999999999999999999879---7226776888688789968642515641321366-
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 34322212443344611220298862243400799999997199999999999850367743200134221010027878
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l 647 (808)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... .... . .+.
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~---~~~~-~------~~~- 235 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYL---IATN-G------TPE- 235 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH---HHHH-C------SCC-
T ss_pred -CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHHC-C------CCC-
T ss_conf -644444447773682664479988012031372999998048899899799---999999---9857-9------998-
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999993369999999998126497899999999999
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+......+.+++.+||+.||++||++.|+++.
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -88855379999999999866996689099999649
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.77 Aligned_cols=266 Identities=21% Similarity=0.323 Sum_probs=207.9
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 8199421145631483789999960-8978999995115-6123589999999976202365102773332035167888
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
..++|++.+.||+|+||+||+|... +++.||+|+++.. .....+++.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846-99938842103468153589952010456431135
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~-~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~ 563 (808)
||+++|+|.++++. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 76799868998742----4999999999999999999999998599---9714457799468789989995487762567
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHH-HHHHC---------
Q ss_conf 43343432221244334461122029886224340079999999719999999999985036774-32001---------
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-ARPLL--------- 633 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w-~~~~~--------- 633 (808)
+. ..+...||..|+|||++.+..|+.++||||+||++|||++|+.||.............. .....
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CC----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 88----62111377141194687589989488899899999999988899899887899999988751775457742123
Q ss_pred ----------------CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----------------34221010027878999993369999999998126497899999999999
Q 003605 634 ----------------TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 ----------------~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+....+...............++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 332211112223541347788766502687667644489999999999868994679089999609
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.15 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=208.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--CCEEE
Q ss_conf 199421145631483789999960-8978999995115--612358999999997620236510277333203--51678
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 482 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 482 (808)
.++|++.+.||+|+||+||+|... +|+.||+|.++.. .....+.+.+|++++++++|||||++++++.+. +..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEEEEECCCCEEECCCCCCEECCCCCCC
Q ss_conf 88413899801122355567899999899999999999999998469--9938842103468153589952010456431
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~--~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~ 560 (808)
||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 13543343432221244334461122029886224340079999999719999999999985036774320013422101
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+....
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i----------- 226 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI----------- 226 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH-----------
T ss_pred ECCCCC--CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH---HHHHHHH-----------
T ss_conf 224577--755667788232799998399999389887527899998018899899899---9999999-----------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 002787899999336999999999812649789999999999
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 641 ~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.+... ...+.....++.+|+.+||+.||++||++.|+++
T Consensus 227 --~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 --REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --71899-8897435999999999976799557918999972
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=363.49 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=207.0
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 199421145631483789999960-8978999995115612358999999997620236510277333203516788841
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
-++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|+|||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECC--CCCCEECCCCCCCCCCC
Q ss_conf 3899801122355567899999899999999999999998469993884210346815358--99520104564311354
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH--DFTPKVSDFGLARSAMD 564 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~--~~~vKI~DFGLa~~~~~ 564 (808)
|++|+|.+++.. ....+++..+..|+.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf 799889999976---2378999999999999999999997569---7600015467364168898699954521044256
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 33434322212443344611220298862243400799999997199999999999850367743200134221010027
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. .......||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+.. .......
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~---~i~~~~~------- 242 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLR---NVKSCDW------- 242 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTCC-------
T ss_pred C---CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHHCCC-------
T ss_conf 5---432000686242188997589987267655465999999859899899799---99999---9984788-------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 878999993369999999998126497899999999999
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 645 p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+...........+.+|+.+||..||++|||+.|+++.
T Consensus 243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -98942235899999999999756896679089998629
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.67 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=206.4
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 99421145631483789999960-89789999951156123589999999976202365102773332035167888413
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
+.|++.+.||+|+||+||+|... +++.||||+++.......+++.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCCC
Q ss_conf 89980112235556789999989999999999999999846999388421034681535899520104564311354334
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~ 567 (808)
++|+|.+++.. ....+++..+..|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-
T ss_conf 99818899986---2899999999999999999999999889---8871407003148789998997161230357786-
Q ss_pred CCCCCCCCCCCCCCCCHHHH-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 34322212443344611220-----2988622434007999999971999999999998503677432001342210100
Q 003605 568 RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
.......||+.|+|||++. ...|+.++|||||||++|||++|+.||...... ..... .....
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~---i~~~~------ 231 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLK---IAKSE------ 231 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHH---HHHSC------
T ss_pred -CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHCCC------
T ss_conf -410010256264799998320257888880665787899999982088999998999---99999---97079------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 27878999993369999999998126497899999999999
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 643 vDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.+ ....+......+.+|+.+||+.||++|||+.|+++.
T Consensus 232 -~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 -PP--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -CC--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -98--777656699999999999766996689199999629
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.30 Aligned_cols=272 Identities=25% Similarity=0.360 Sum_probs=216.4
Q ss_pred CHHHHHHHHCCCCEEEEEEECCCEEEEEEEEE------CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCCEEEE
Q ss_conf 98999988199421145631483789999960------8978999995115-612358999999997620-236510277
Q 003605 400 SASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLI 471 (808)
Q Consensus 400 s~~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~ 471 (808)
....++...++|++.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEE
T ss_conf 98252616799798449841678399999986777555783999999860017178999999999988614998499741
Q ss_pred EEEEEC-CCEEEEEEECCCCCCCCCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 333203-516788841389980112235556------------7899999899999999999999998469993884210
Q 003605 472 GICIEE-QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 538 (808)
Q Consensus 472 g~~~~~-~~~~LV~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDL 538 (808)
+++.+. ...++|||||++|+|.++++.... ....++|..++.++.|+++||+|||+.+ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCC
T ss_conf 15404797579999845899299999853666665322202332146899999999999999999887379---717867
Q ss_pred CCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCC
Q ss_conf 3468153589952010456431135433434322212443344611220298862243400799999997199-999999
Q 003605 539 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPVDMT 617 (808)
Q Consensus 539 KpsNILLd~~~~vKI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~-~P~~~~ 617 (808)
||+||||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCC
T ss_conf 73106577998289845752001135665222475166721020368646889966322136789999986889999899
Q ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9998503677432001342210100278789999933699999999981264978999999999999999976
Q 003605 618 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 618 ~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
... ..+.... ........+.....++.+++.+||+.||++|||+.||+++|+.+++.
T Consensus 241 ~~~--~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KID--EEFCRRL--------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCS--HHHHHHH--------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHH--HHHHHHH--------------HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 989--9999999--------------63898888865789999999997677966791999999999799867
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.50 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=210.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 19942114563148378999996089789999951156123589999999976202365102773332035167888413
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 487 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey~ 487 (808)
.++|++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|+|||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCCC
Q ss_conf 89980112235556789999989999999999999999846999388421034681535899520104564311354334
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~ 567 (808)
++|+|..+++.. ....++|.+++.|+.|+|.||+|||+.+ |+||||||+|||||.++++||+|||+++......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC-
T ss_conf 799435420000--3553059999999999999999875411---4335312307999899929984425554256887-
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 34322212443344611220298862243400799999997199999999999850367743200134221010027878
Q 003605 568 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 647 (808)
Q Consensus 568 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp~l 647 (808)
........|++.|+|||++..+.++.++||||||+++|||++|..|+..... ...+..++. ...
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~--------------~~~ 231 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE--------------RGY 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH--------------TTC
T ss_pred CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC--HHHHHHHHH--------------HCC
T ss_conf 3352454556654580898379989177413235899999868999998888--999999998--------------268
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99999336999999999812649789999999999999999
Q 003605 648 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 688 (808)
Q Consensus 648 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~ 688 (808)
....+.....++.+++.+||+.+|++||+|.+|+++|+...
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99998323799999999975669758919999999876662
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=362.06 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=207.5
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 199421145631483789999960-8978999995115612358999999997620236510277333203516788841
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
.++|++.+.||+|+||.||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC--CCCCCEECCCCCCCCCCC
Q ss_conf 389980112235556789999989999999999999999846999388421034681535--899520104564311354
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd--~~~~vKI~DFGLa~~~~~ 564 (808)
|++|+|.+++. .....+++..++.|+.|++.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 89980888898---63899899999999999999999999779---2651314455311346788489952563034378
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 33434322212443344611220298862243400799999997199999999999850367743200134221010027
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. .......|++.|+|||++.+..++.++||||+||++|||+||+.||..... ..+.... ... +
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i---~~~--------~ 244 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNV---KRC--------D 244 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHH---HHC--------C
T ss_pred C---CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HHC--------C
T ss_conf 8---720100476453489997479989763338989999999968899899799---9999999---847--------8
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 878999993369999999998126497899999999999
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 645 p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+...........+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 898930024799999999999756996689189999609
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.94 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=207.4
Q ss_pred EEEEEECCCEEEEEEEEECC----CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCEEEEEEEC
Q ss_conf 14563148378999996089----78999995115-612358999999997620236510277333203-5167888413
Q 003605 414 SRILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-QARCLVYELI 487 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~~g----~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LV~Ey~ 487 (808)
.++||+|+||+||+|.+.+. ..||||+++.. +....++|.+|++++++++|+||++++|+|.+. +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCCC
Q ss_conf 89980112235556789999989999999999999999846999388421034681535899520104564311354334
Q 003605 488 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 567 (808)
Q Consensus 488 ~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~~ 567 (808)
++|+|.++++. ....+++..+++++.|+|.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ECCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC
T ss_conf 06741442101---3454048999999999887652003367---62577668757677999889910652322556655
Q ss_pred C--CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 3--43222124433446112202988622434007999999971999999999998503677432001342210100278
Q 003605 568 R--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 568 ~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp 645 (808)
. .......||..|+|||++.++.++.++||||||+++|||+||+.|+...... .++..+. ....
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~g~--------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGR--------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC---------
T ss_pred CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HCCC---------
T ss_conf 5310025655564556768874379997457466199999999789999888999--9999999---8089---------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 78999993369999999998126497899999999999999997602
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 692 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~ 692 (808)
....+......+.+|+.+||+.||++||+|.||++.|+.+.+...
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf --889964475999999999768897689399999999999997520
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.22 Aligned_cols=269 Identities=26% Similarity=0.396 Sum_probs=217.4
Q ss_pred HHHHHCCCCEEEEEEECCCEEEEEEEEE------CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEE
Q ss_conf 9988199421145631483789999960------8978999995115-612358999999997620-2365102773332
Q 003605 404 IEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICI 475 (808)
Q Consensus 404 l~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 475 (808)
++.-.++|++.+.||+|+||.||+|++. +++.||||+++.. ......+|.+|+.++.++ +|+|||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE
T ss_conf 63778996985498206882999999806644778869999998742487799999999999876269998878998983
Q ss_pred ECCCEEEEEEECCCCCCCCCCCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCC
Q ss_conf 03516788841389980112235556--------------7899999899999999999999998469993884210346
Q 003605 476 EEQARCLVYELIPNGSVESHLHGVDK--------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSS 541 (808)
Q Consensus 476 ~~~~~~LV~Ey~~~GsL~~~L~~~~~--------------~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKps 541 (808)
+.+..++||||+++|+|.++++.... ....+++..++.++.|+++||+|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCC
T ss_conf 19978999973799879999985356654444453322233458899999999999999999887579---266624102
Q ss_pred CEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 81535899520104564311354334343222124433446112202988622434007999999971999999999998
Q 003605 542 NILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG 621 (808)
Q Consensus 542 NILLd~~~~vKI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~ 621 (808)
|||++.++.+|++|||+++...........+...||+.|+|||++.++.++.++||||||+++|||+|+..|+......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~- 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV- 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-
T ss_pred CCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH-
T ss_conf 1000025752102340102336788615862013596876778861799997400102589999998589988778998-
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 503677432001342210100278789999933699999999981264978999999999999999976
Q 003605 622 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 690 (808)
Q Consensus 622 ~~~lv~w~~~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~ 690 (808)
...+ .++++.......+......+.+|+.+||+.||++||+|.||+++|+.+..+
T Consensus 254 ~~~~--------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSKF--------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHHH--------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH--------------HHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 9999--------------999866898898543659999999997577965792999999999876534
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.79 Aligned_cols=246 Identities=28% Similarity=0.384 Sum_probs=205.1
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 99421145631483789999960-8978999995115---6123589999999976202365102773332035167888
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846999388421034681535899520104564311354
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 50479858988750----489999999999999999999999889---46522023441466899871155563354488
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 33434322212443344611220298862243400799999997199999999999850367743200134221010027
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+... +..
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~-------------i~~ 218 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKR-------------ISR 218 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH-------------HHT
T ss_pred C----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHH-------------HHC
T ss_conf 8----52355788763499997589989314404675999998329999888999---999999-------------971
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 878999993369999999998126497899999999999
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 645 p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.. ..++......+.+++.+||+.||++|||+.|+++.
T Consensus 219 ~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 219 VE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 89--99986689999999999764797689099999719
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.43 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=209.1
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 99421145631483789999960-8978999995115---6123589999999976202365102773332035167888
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||+||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846999388421034681535899520104564311354
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~ 564 (808)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 70489877776531----599999999999999999997621650---88476774123668885388603210242256
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 33434322212443344611220298862243400799999997199999999999850367743200134221010027
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. . +..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~---~----------i~~ 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQ---K----------IIK 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---H----------HHT
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH---HHHHH---H----------HHC
T ss_conf 7764333555677552584400268989666230456999998038899899599---99999---9----------971
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 87899999336999999999812649789999999999999
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 685 (808)
Q Consensus 645 p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le 685 (808)
.. ..++......+.+|+.+||+.||++|||+.|++....
T Consensus 225 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 225 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp TC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf 89--9998547999999999985579768919789737789
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.81 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=211.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCC--EEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEECCCEEEE
Q ss_conf 99421145631483789999960-897--8999995115-612358999999997620-236510277333203516788
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~--~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.++||+|+||.||+|.+. ++. .||||+++.. .....++|.+|++++.++ +|+|||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCCCCCCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCC
Q ss_conf 84138998011223555------------678999998999999999999999984699938842103468153589952
Q 003605 484 YELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 551 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~------------~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~v 551 (808)
+||+++|+|.++|+... .....++|..+++++.|+|+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHH
Q ss_conf 0104564311354334343222124433446112202988622434007999999971999-999999998503677432
Q 003605 552 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRK-PVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 552 KI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~-P~~~~~~~~~~~lv~w~~ 630 (808)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.... ...+...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGG
T ss_pred EECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH
T ss_conf 874344322444223---45530137755553875269999622153138899999836899999999---999999998
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 0013422101002787899999336999999999812649789999999999999999760
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 631 ~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
.......+......+.+|+.+||+.+|++||+|.||++.|+.+.++.
T Consensus 241 --------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 --------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp --------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --------------HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf --------------26888887667899999999976789668949999999999998618
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.44 Aligned_cols=245 Identities=27% Similarity=0.362 Sum_probs=199.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 99421145631483789999960-89789999951156---123589999999976202365102773332035167888
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
+.|+..+.||+|+||+||+|... +++.||||+++... ....+++.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846999388421034681535899520104564311354
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~ 564 (808)
|||.+|+|..++. ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EECCCCCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 8069994578997----3799999999999999999999998689---76667884217987999789844365334677
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 334343222124433446112202---98862243400799999997199999999999850367743200134221010
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
. ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||..... ... .......
T Consensus 168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~---~~~i~~~------ 229 (309)
T d1u5ra_ 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSA---LYHIAQN------ 229 (309)
T ss_dssp B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHS------
T ss_pred C------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHHC------
T ss_conf 8------731347663688998346788867214545589999999878899999799---999---9999828------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 02787899999336999999999812649789999999999
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 642 ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
..+.+ .+......+.+|+.+||+.||++|||+.|+++
T Consensus 230 -~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 -ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -99988---87888999999999977379657918999971
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.71 Aligned_cols=268 Identities=27% Similarity=0.460 Sum_probs=216.7
Q ss_pred HHHHHHHCCCCEEEEEEECCCEEEEEEEEE------CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 999988199421145631483789999960------8978999995115-612358999999997620236510277333
Q 003605 402 SEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGIC 474 (808)
Q Consensus 402 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~------~g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 474 (808)
++++...++|.+.+.||+|+||.||+|.+. +++.||||+++.. .......|.+|++++++++|+||++++|+|
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 10042689918835982078818999998786447789689999987012868999999999999976999884125478
Q ss_pred EECCCEEEEEEECCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCC
Q ss_conf 20351678884138998011223555------678999998999999999999999984699938842103468153589
Q 003605 475 IEEQARCLVYELIPNGSVESHLHGVD------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 548 (808)
Q Consensus 475 ~~~~~~~LV~Ey~~~GsL~~~L~~~~------~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~ 548 (808)
...+..++|+||+++|+|.++++... .....+++..+.+++.++|+||.|||+.+ |+|||||++|||++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCC
T ss_conf 4288106777604899889998750332113444688799999999999999999876479---6543286775403599
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCCCHHHH
Q ss_conf 952010456431135433434322212443344611220298862243400799999997199-9999999998503677
Q 003605 549 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPVDMTQPPGQENLVA 627 (808)
Q Consensus 549 ~~vKI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~-~P~~~~~~~~~~~lv~ 627 (808)
+.+||+|||+++...............|++.|+|||.+.+..++.++||||||+++|||+||. .|+.... ....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~-- 244 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQV-- 244 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHH--
T ss_pred CEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC---HHHH--
T ss_conf 64999424542023577630313402316323788887369988333444378999999968999999989---9999--
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 43200134221010027878999993369999999998126497899999999999999997
Q 003605 628 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 628 w~~~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
+..+.+.. ....+......+.+++.+||+.+|++||+|.+|++.|+...+
T Consensus 245 -----------~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 -----------LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----------HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----------HHHHHHCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf -----------99998088-888863353999999999757796589399999999787617
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.23 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=216.2
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEEC--------CCEEEEEEEECCC-CHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEE
Q ss_conf 81994211456314837899999608--------9789999951156-12358999999997620-23651027733320
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDD--------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 476 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~~--------g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 476 (808)
-.++|.+.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|+|||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 58996970098516782899999857875556675499999988112868899999999999981399969734652201
Q ss_pred CCCEEEEEEECCCCCCCCCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEE
Q ss_conf 3516788841389980112235556------------7899999899999999999999998469993884210346815
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 544 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~------------~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNIL 544 (808)
++..++||||+++|+|.++|+.... ....+++.++++++.|++.||+|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEE
T ss_conf 88689999736999099999860677643222334574346799999999999999998766379---786302210224
Q ss_pred ECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCC
Q ss_conf 35899520104564311354334343222124433446112202988622434007999999971-99999999999850
Q 003605 545 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQE 623 (808)
Q Consensus 545 Ld~~~~vKI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~ 623 (808)
++.++.+||+|||+++...............|++.|+|||++.++.++.++||||||+++|||++ |+.||..... .
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~ 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH---H
T ss_conf 5478976762211101135555543146678884663266751798882555477588888740179898999999---9
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 367743200134221010027878999993369999999998126497899999999999999997
Q 003605 624 NLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 624 ~lv~w~~~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
.+...+ ........+......+.+|+.+||+.+|++|||+.||++.|+.+..
T Consensus 245 ~~~~~i--------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKLL--------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHH--------------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH--------------HCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999999--------------7288889874352999999999766797679399999999988860
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.05 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=195.6
Q ss_pred CCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE----CCCEEEE
Q ss_conf 421145631483789999960-8978999995115--61235899999999762023651027733320----3516788
Q 003605 411 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE----EQARCLV 483 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LV 483 (808)
|+..+.||+|+||+||+|... ++..||+|.++.. .....++|.+|++++++++|||||++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC-CCCCCEECCCCCCCCC
Q ss_conf 841389980112235556789999989999999999999999846999388421034681535-8995201045643113
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSA 562 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd-~~~~vKI~DFGLa~~~ 562 (808)
|||+++|+|.+++.. ...+++..+..|+.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 957898948999751----355469999999999999999999789-979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 54334343222124433446112202988622434007999999971999999999998503677432001342210100
Q 003605 563 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 642 (808)
Q Consensus 563 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~i 642 (808)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ...+.... .. ..
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i---~~-~~----- 229 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRV---TS-GV----- 229 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHH---TT-TC-----
T ss_pred CC----CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHH---HC-CC-----
T ss_conf 68----76677553813008988478-999867110079999999878899987655--99999999---73-89-----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 27878999993369999999998126497899999999999
Q 003605 643 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 643 vDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. ....+.....++.+|+.+||+.||++|||+.|+++.
T Consensus 230 -~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 -K---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -C---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -C---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -9---865675578999999999763797589299999677
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.18 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=211.9
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEEC----CCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 81994211456314837899999608----978999995115-6123589999999976202365102773332035167
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~~----g~~VAVK~lk~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
..++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|++++++++||||++++|++.+ +..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred CHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEE
T ss_conf 889969877993078829999999369964499999993656687999999999999986899998569889953-7479
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCC
Q ss_conf 88841389980112235556789999989999999999999999846999388421034681535899520104564311
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~ 561 (808)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 99984069807765422---4789999999999999987752302267---44141026553206789678765034213
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 354334343222124433446112202988622434007999999971-9999999999985036774320013422101
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 640 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~ 640 (808)
.... .....+...||+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+.
T Consensus 158 ~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~---------- 223 (273)
T d1mp8a_ 158 MEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIE---------- 223 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH----------
T ss_pred CCCC-CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----------
T ss_conf 3677-623305400583103266751699887452444247899998269999888999---99999998----------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 002787899999336999999999812649789999999999999999760
Q 003605 641 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 641 ~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
+ ......+......+.+|+.+||..||++||++.||++.|+.+.++.
T Consensus 224 ---~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 224 ---N-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ---T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---C-CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf ---1-8999898777999999999976879768929999999999997786
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.11 Aligned_cols=273 Identities=23% Similarity=0.312 Sum_probs=204.1
Q ss_pred CCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHH--HHHHHHHCCCCCCEEEEEEEEECC----CEEE
Q ss_conf 9942114563148378999996089789999951156123589999--999976202365102773332035----1678
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGICIEEQ----ARCL 482 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~--Ei~iL~~L~HpNIV~L~g~~~~~~----~~~L 482 (808)
++|.+.+.||+|+||.||+|++. |+.||||+++.. ..+++.. |+..+..++|+||++++|+|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 68999889820788199999999-989999998720---04679999999999627998683268899837986048999
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEEEEECCCCEEECCCCCCEECCCC
Q ss_conf 8841389980112235556789999989999999999999999846-----99938842103468153589952010456
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-----SSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~-----~~p~IiHrDLKpsNILLd~~~~vKI~DFG 557 (808)
||||+++|+|.++|+. ..++|..+++++.++|.||+|||.. .+++|+||||||+||||+.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEECCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 9964669898999865-----89998999999999999999988766520468986615317313578688776887638
Q ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCHHHHCCC------CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf 43113543343--4322212443344611220298------862243400799999997199999999999850367743
Q 003605 558 LARSAMDEESR--HISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 629 (808)
Q Consensus 558 La~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~ 629 (808)
+++........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+.......... ....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-~~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTS
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCH-HHCC
T ss_conf 662346777620013552503547678221056545467776750122015999999962899887663112410-1225
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 20013422101002787899999-----336999999999812649789999999999999999760
Q 003605 630 RPLLTSREGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 630 ~~~~~~~~~l~~ivDp~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
............+.+..++.+.+ .+....+.+++.+||+.||++||+|.||++.|+++.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 5643099999987502468887765577689999999999976069858959999999999888865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.24 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=205.4
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 8199421145631483789999960-89789999951156-123589999999976202365102773332035167888
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
..+.|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC---CCCCCEECCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846999388421034681535---899520104564311
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARS 561 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd---~~~~vKI~DFGLa~~ 561 (808)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ECCCCCCHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 5268984888653----0367887899999999999987524130---55687046300110468882499831543587
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 35433434322212443344611220298862243400799999997199999999999850367743200134221010
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 641 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ 641 (808)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... ....
T Consensus 160 ~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i---~~~~----- 225 (307)
T d1a06a_ 160 EDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQI---LKAE----- 225 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH---HTTC-----
T ss_pred CCCC---CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HCCC-----
T ss_conf 2589---704400328422591887379998078734515999999859799999899---9999998---6168-----
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 027878999993369999999998126497899999999999
Q 003605 642 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 642 ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..+...........+.+++.+||+.||++|||+.|+++.
T Consensus 226 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 ---YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---777876666789999999999760897579189998629
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.12 Aligned_cols=252 Identities=30% Similarity=0.474 Sum_probs=208.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCEEEEEEE
Q ss_conf 1994211456314837899999608978999995115612358999999997620236510277333203-516788841
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-QARCLVYEL 486 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~LV~Ey 486 (808)
.++|++.+.||+|+||.||+|.++ |+.||||+++.. ...++|.+|++++++++|+||++++|+|.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-909999998857--77999999999998678989854987887238928999963
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 38998011223555678999998999999999999999984699938842103468153589952010456431135433
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~ 566 (808)
+++|+|.++|+.. ....++|..+++|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf 6999899998745--7888899999999999985232113376---553666567601468997763245600344787-
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 4343222124433446112202988622434007999999971-999999999998503677432001342210100278
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 645 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivDp 645 (808)
.....++..|+|||++.++.++.++||||||+++|||+| |+.|+.... ..++..++. .
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i~--------------~ 215 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVE--------------K 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHHT--------------T
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH--------------C
T ss_conf ----7655666467781787279888588777579999999978999999999---999999998--------------0
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78999993369999999998126497899999999999999997
Q 003605 646 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 689 (808)
Q Consensus 646 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~ 689 (808)
......+......+.+|+.+||+.||++||+|.+++++|+.+..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 89999976579999999999756697689399999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.78 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=204.0
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC
Q ss_conf 8199421145631483789999960-89789999951156------1235899999999762023651027733320351
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 479 (808)
..++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCC----CCEECC
Q ss_conf 6788841389980112235556789999989999999999999999846999388421034681535899----520104
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF----TPKVSD 555 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~----~vKI~D 555 (808)
.++|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf 9999986778643100103----564215578999999999987666254---221133301279825898666469643
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 56431135433434322212443344611220298862243400799999997199999999999850367743200134
Q 003605 556 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 556 FGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....... ...
T Consensus 161 fG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i---~~~ 231 (293)
T d1jksa_ 161 FGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANV---SAV 231 (293)
T ss_dssp CTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HTT
T ss_pred HHHHHHCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH---HHHHHHH---HHC
T ss_conf 3442105777---631224777743099998189999766522140999999708899889999---9999999---816
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 221010027878999993369999999998126497899999999999
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 ~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.. .+...........+.+|+.+||+.||++||++.|+++.
T Consensus 232 ~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 NY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC--------CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88--------88701047889999999999863896689199999619
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.14 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=207.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEEEC--C--CEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 994211456314837899999608--9--78999995115---6123589999999976202365102773332035167
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDD--G--TKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 481 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~~--g--~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 481 (808)
++|++.+.||+|+||.||+|.+.. + ..||||+++.. .....++|.+|++++++++|+||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCC
Q ss_conf 88841389980112235556789999989999999999999999846999388421034681535899520104564311
Q 003605 482 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 482 LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~ 561 (808)
+|+||+++|+|.+++.. ....+++..+++++.|+|.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 14654238612544421---2689999999999999999998752178---75205668881565565433256115553
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 3543343-43222124433446112202988622434007999999971-999999999998503677432001342210
Q 003605 562 AMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 562 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlT-G~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
....... .......|+..|+|||++.+..++.++||||||+++|||+| |+.||.... ......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i---------- 227 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKI---------- 227 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH----------
T ss_pred CCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHH----------
T ss_conf 03588752654763257310799998379999421566148999999968999999969---99999999----------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 100278789999933699999999981264978999999999999999
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 687 (808)
Q Consensus 640 ~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i 687 (808)
.........+......+.+|+.+||+.||++||||.||++.|++.
T Consensus 228 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 ---DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ---847999998544539999999997688966792999999999964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=349.28 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=198.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHH---HHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf 199421145631483789999960-8978999995115---61235899999---9997620236510277333203516
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAE---VEMLSRLHHRNLVKLIGICIEEQAR 480 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~E---i~iL~~L~HpNIV~L~g~~~~~~~~ 480 (808)
-++|++.++||+|+||.||+|... +|+.||||++... .......+.+| +.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCC
Q ss_conf 78884138998011223555678999998999999999999999984699938842103468153589952010456431
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~ 560 (808)
++||||+++|+|.++|.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf 999991489838999873----255327899999999999999999779---6220444221678588967982201023
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 1354334343222124433446112202-988622434007999999971999999999998503677432001342210
Q 003605 561 SAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 639 (808)
Q Consensus 561 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l 639 (808)
...... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||..........+....
T Consensus 156 ~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---------- 221 (364)
T d1omwa3 156 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 221 (364)
T ss_dssp ECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS----------
T ss_pred ECCCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC----------
T ss_conf 337886----433113455421687603899984410467789999998599988889989999999860----------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 1002787899999336999999999812649789999-----9999999
Q 003605 640 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 683 (808)
Q Consensus 640 ~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 683 (808)
... ....+......+.+|+.+||+.||++||+ +.|+++.
T Consensus 222 ---~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 ---LTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---SSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCC--CCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf ---468--88788778999999999985669888088743579999749
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.21 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=205.5
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 199421145631483789999960-8978999995115---612358999999997620236510277333203516788
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
-++|++.++||+|+||.||++... +++.||||++++. .....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 84138998011223555678999998999999999999999984699938842103468153589952010456431135
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~ 563 (808)
|||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 003579860555532----567759999999999965211343159---6224647778476589988882056520035
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 43343432221244334461122029886224340079999999719999999999985036774320013422101002
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ..+... ...
T Consensus 157 ~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~---i~~--------- 219 (337)
T d1o6la_ 157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFEL---ILM--------- 219 (337)
T ss_dssp CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---HHH---------
T ss_pred CCC--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHC---------
T ss_conf 678--620551008899666650489888333102230678899878999999699---999999---852---------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 787899999336999999999812649789999-----9999999
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 683 (808)
Q Consensus 644 Dp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 683 (808)
.. ..++.....++.+|+.+||+.||++|++ +.|+++.
T Consensus 220 -~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 220 -EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CC--CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf -89--9898668999999998666389344225652349999729
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=347.25 Aligned_cols=245 Identities=27% Similarity=0.343 Sum_probs=203.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 99421145631483789999960-8978999995115---6123589999999976202365102773332035167888
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846999388421034681535899520104564311354
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~ 564 (808)
||+++|+|..++. ....+.+.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 5037863223432----2221110079999999987655412476---77055681050386899889831752167124
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 33434322212443344611220298862243400799999997199999999999850367743200134221010027
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. .....||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+ ..... .
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~---~~~i~----------~ 215 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKT---YEKIL----------N 215 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHH----------H
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCH---HHH---HHHHH----------C
T ss_conf 5-----6434576343599998389998043046533368999759899999699---999---99997----------0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 8789999933699999999981264978999-----99999999
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 683 (808)
Q Consensus 645 p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 683 (808)
.. ..++......+.+++.+|+..+|++|+ ++.++++.
T Consensus 216 ~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 216 AE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 89--8899778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=346.01 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=202.8
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 99421145631483789999960-8978999995115---6123589999999976202365102773332035167888
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~ 484 (808)
++|++.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+++++.++|+||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846999388421034681535899520104564311354
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 564 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~ 564 (808)
||+.+|+|.+++.. ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 23346622666751----589899999999999999899998599---86176799993607789788610103332256
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 33434322212443344611220298862243400799999997199999999999850367743200134221010027
Q 003605 565 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 644 (808)
Q Consensus 565 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~ivD 644 (808)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||..... ..+.. .+. .
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~---~i~----------~ 252 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE---KIV----------S 252 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHH----------H
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH---HHHHH---HHH----------C
T ss_conf 6-----6433676356788997179988533114500789999758899899599---99999---986----------1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 8789999933699999999981264978999-----9999999
Q 003605 645 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQ 682 (808)
Q Consensus 645 p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~ 682 (808)
.. ...+......+.+++.+||+.||++|+ ++.++++
T Consensus 253 ~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 79--889766899999999998340998606553454999971
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=344.98 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=209.6
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC---
Q ss_conf 8199421145631483789999960-8978999995115---61235899999999762023651027733320351---
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--- 479 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~--- 479 (808)
..++|++.+.||+|+||+||+|... +++.||||+++.. +....++|.+|++++++++|+||+++++++...+.
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCC
T ss_conf 06206986899608992999999999998999999855664698999999999999985699988731143543268876
Q ss_pred -EEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCC
Q ss_conf -6788841389980112235556789999989999999999999999846999388421034681535899520104564
Q 003605 480 -RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 480 -~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGL 558 (808)
.++||||+++|+|.+++.. ...+++.+++.|+.|++.||+|||+.+ |+||||||+|||++.++..+|+|||.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHH
T ss_conf 69999977889871011203----589999999999999999999998579---52763467556657543201003444
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 311354334-3432221244334461122029886224340079999999719999999999985036774320013422
Q 003605 559 ARSAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 559 a~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... . ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~---~~~~~~~~~~~ 231 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---V---SVAYQHVREDP 231 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---H---HHHHHHHHCCC
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH---H---HHHHHHHHCCC
T ss_conf 32212354433334642576243699998399999663202652899999769799899699---9---99999984699
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 10100278789999933699999999981264978999-99999999999997
Q 003605 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCN 689 (808)
Q Consensus 638 ~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-sm~eVl~~Le~i~~ 689 (808)
... .....+....+.+++.+|++.||++|| ++.++++.|..+.+
T Consensus 232 ~~~--------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 232 IPP--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CCG--------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CCC--------CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 997--------100347899999999998667976777399999999999758
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.82 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=204.2
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 8199421145631483789999960-897899999511561235899999999762023651027733320351678884
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
..++|.+.+.||+|+||+||+|... +++.||||.++.. ......+.+|+++|++++|+|||++++++.+.+..++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578-6659999999999985799798909899988998899995
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCC--CCCEECCCCCCCCCC
Q ss_conf 138998011223555678999998999999999999999984699938842103468153589--952010456431135
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD--FTPKVSDFGLARSAM 563 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~--~~vKI~DFGLa~~~~ 563 (808)
||++|+|.+++.. ....+++.++..|+.|++.||.|||+.+ |+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC
T ss_conf 3899808899875---3899999999999999999999998769---975135544434437885189976441110034
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 43343432221244334461122029886224340079999999719999999999985036774320013422101002
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... ......+++.|+|||.+.+..++.++||||+||++|||++|+.||..... ..+.. ............
T Consensus 156 ~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~---~i~~~~~~~~~~- 225 (321)
T d1tkia_ 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIE---NIMNAEYTFDEE- 225 (321)
T ss_dssp TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHHTCCCCCHH-
T ss_pred CCC---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHHCCCCCCHH-
T ss_conf 677---53212233222340210487778401130279999999828999999899---99999---998389998802-
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7878999993369999999998126497899999999999
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 644 Dp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.......++.+|+.+|+..||++||++.|+++.
T Consensus 226 -------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 -------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------236789999999999866996689099999639
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.39 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=197.3
Q ss_pred HCCCCEE-EEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEE----CCCE
Q ss_conf 1994211-45631483789999960-8978999995115612358999999997620-23651027733320----3516
Q 003605 408 TGNFDAS-RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE----EQAR 480 (808)
Q Consensus 408 t~~f~~~-~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~----~~~~ 480 (808)
.++|.+. ++||+|+||+||+|... +++.||||+++.. ..+.+|++++.++ +|+|||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECC---CCCCEECCCC
Q ss_conf 7888413899801122355567899999899999999999999998469993884210346815358---9952010456
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFG 557 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~---~~~vKI~DFG 557 (808)
++|||||++|+|.++|... ....+++.++..|+.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9999778998499999862--7877579999999999999999999769---8644410022011355556631135455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 43113543343432221244334461122029886224340079999999719999999999985036774320013422
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
+|+...... ......||+.|+|||++.+..|+.++|||||||+||||+||+.||.......... ..
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~-------- 225 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GM-------- 225 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred EEEECCCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HH--------
T ss_conf 123336888---6432267756379277748988888888764516778865889988988778899---99--------
Q ss_pred CCCCCCCCCCC--CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 10100278789--99993369999999998126497899999999999
Q 003605 638 GLERIIDPSLG--NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 638 ~l~~ivDp~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+...... .........++.+|+.+||+.||++||++.|+++.
T Consensus 226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -99985388888985434699999999999756996579099999709
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=339.90 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=203.1
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCC---------HHHHHHHHHHHHHHHCC-CCCCEEEEEEEEE
Q ss_conf 199421145631483789999960-897899999511561---------23589999999976202-3651027733320
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---------QGGREFLAEVEMLSRLH-HRNLVKLIGICIE 476 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~---------~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~ 476 (808)
.++|++.+.||+|+||+||+++.. +++.||||+++.... ...+++.+|+.++++++ |+||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCC
Q ss_conf 35167888413899801122355567899999899999999999999998469993884210346815358995201045
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DF 556 (808)
.+..++||||+++|+|.++|+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCC
T ss_conf 7605999976898668999986----599999999999999999999998759---943234625489868998387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 64311354334343222124433446112202------988622434007999999971999999999998503677432
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 630 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~ 630 (808)
|+++..... ...+...||..|+|||++.+ ..++.++||||+||+||||++|+.||..... .....
T Consensus 155 G~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~--- 225 (277)
T d1phka_ 155 GFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR--- 225 (277)
T ss_dssp TTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---
T ss_pred HHEEECCCC---CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCH---HHHHH---
T ss_conf 031672688---721345246788898886053445678899233185656023103228889889999---99999---
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 00134221010027878999993369999999998126497899999999999
Q 003605 631 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 631 ~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...... ..+..........++.+++.+||+.+|++||++.|+++.
T Consensus 226 ~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 MIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHCC--------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 998189--------888985434689999999999765896689199999739
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.60 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=201.6
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC---CCHHHHHHHHHHHHHH-HCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 99421145631483789999960-8978999995115---6123589999999976-20236510277333203516788
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLS-RLHHRNLVKLIGICIEEQARCLV 483 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~---~~~~~~~f~~Ei~iL~-~L~HpNIV~L~g~~~~~~~~~LV 483 (808)
++|++.+.||+|+||+||+|... +++.||||++++. .....+.+..|+.++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 84138998011223555678999998999999999999999984699938842103468153589952010456431135
Q 003605 484 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 563 (808)
Q Consensus 484 ~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~ 563 (808)
|||+++|+|.++++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 750379808998640----478999999999999999999998689---3403476540444489963015553023235
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 43343432221244334461122029886224340079999999719999999999985036774320013422101002
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 643 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~~l~~iv 643 (808)
... ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... ...
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i---~~~-------- 218 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSI---RMD-------- 218 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHC--------
T ss_pred CCC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HCC--------
T ss_conf 665--334545787776899998279988323201122789898738899999899---9999999---718--------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 78789999933699999999981264978999999-9999
Q 003605 644 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVVQ 682 (808)
Q Consensus 644 Dp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl~ 682 (808)
.+ .++......+.+|+.+||..||++||++. |+++
T Consensus 219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 99----8975679999999999654489878388999980
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.19 Aligned_cols=259 Identities=23% Similarity=0.242 Sum_probs=195.8
Q ss_pred EEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCC-----HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 1145631483789999960-897899999511561-----2358999999997620236510277333203516788841
Q 003605 413 ASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-----QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 413 ~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
..++||+|+||+||+|... +++.||||+++.... ...+.+.+|++++++++|+|||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 38998011223555678999998999999999999999984699938842103468153589952010456431135433
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~ 566 (808)
+.++++...+. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 34507765541----2667789999999999999998863163---5503577625885377841146576100057875
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHC-C----CCCCCC
Q ss_conf 43432221244334461122029-88622434007999999971999999999998503677432001-3----422101
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL-T----SREGLE 640 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~-~----~~~~l~ 640 (808)
. ......||+.|+|||++... .++.++|||||||++|||++|+.||...... +......... . ......
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 155 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTT
T ss_pred C--CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH---HHHHHHHHHCCCCCHHHCCCHH
T ss_conf 5--4330204733363999726778880564363042899998596999999999---9999999851899725452100
Q ss_pred CCCCCC-C--CCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 002787-8--99999-----3369999999998126497899999999999
Q 003605 641 RIIDPS-L--GNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 641 ~ivDp~-l--~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...... + ....+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 021344303478988678565689999999999763894569089999679
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.58 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=200.1
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 99421145631483789999960-8978999995115--61235899999999762023651027733320351678884
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|++.+.||+|+||+||+|... +++.||||+++.. .....+++.+|++++++++|+|||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCC
Q ss_conf 13899801122355567899999899999999999999998469993884210346815358995201045643113543
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~ 565 (808)
|+.+ ++.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.+..+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ECCC-CHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 2377-44555442--02568888999999999999999865288---992135711401134676210357861343688
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCC----CCCC
Q ss_conf 3434322212443344611220298-8622434007999999971999999999998503677432001342----2101
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR----EGLE 640 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~----~~l~ 640 (808)
. .......||+.|+|||.+.... ++.++||||+||++|||++|+.||...... ..+..-........ ....
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGG
T ss_pred C--CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH--HHHHHHHHHCCCCCHHHCCCCC
T ss_conf 6--41001036521541122136657774221033331342796687998988999--9999999832898333144422
Q ss_pred CCCC--CCC----CCCC---CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0027--878----9999---93369999999998126497899999999999
Q 003605 641 RIID--PSL----GNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 641 ~ivD--p~l----~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...+ ..+ .... .......+.+++.+|+..||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2421243454322220444166789999999999763995579189999678
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=330.75 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=202.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 994211456314837899999608978999995115--612358999999997620236510277333203516788841
Q 003605 409 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 486 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~Ey 486 (808)
++|++.+.||+|+||+||+|...+++.||||+++.. .....+++.+|+.++++++|+||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 38998011223555678999998999999999999999984699938842103468153589952010456431135433
Q 003605 487 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 566 (808)
Q Consensus 487 ~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~~ 566 (808)
+.++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 00456789986----0477514456899999999999860574---8826787750568689978732366430114676
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH--H---HHCCCCCCCC
Q ss_conf 43432221244334461122029-8862243400799999997199999999999850367743--2---0013422101
Q 003605 567 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA--R---PLLTSREGLE 640 (808)
Q Consensus 567 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~--~---~~~~~~~~l~ 640 (808)
. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+... . ..+.......
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred C--CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 5--41010243110137887178888841002111758999977979989889899999999863899711042123332
Q ss_pred CC------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 00------2787899999336999999999812649789999999999
Q 003605 641 RI------IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 641 ~i------vDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
.. ..+.............+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 214333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.66 Aligned_cols=267 Identities=22% Similarity=0.303 Sum_probs=197.0
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-C-CCEEEEEEEECC--CCHHHHHHHHHHHHHHHC---CCCCCEEEEEEEEE---
Q ss_conf 8199421145631483789999960-8-978999995115--612358999999997620---23651027733320---
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-D-GTKVAVKVLKRV--DQQGGREFLAEVEMLSRL---HHRNLVKLIGICIE--- 476 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~-g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~--- 476 (808)
..++|++.+.||+|+||+||+|... + ++.||||+++.. .......+.+|+.+++.+ +|+||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEEC
Q ss_conf --351678884138998011223555678999998999999999999999984699938842103468153589952010
Q 003605 477 --EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 554 (808)
Q Consensus 477 --~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~ 554 (808)
....++++||+.++.+..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCCEEEEEEEECCCCCHHHHHH---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEEC
T ss_conf 66746999997405871444443---03789998999999999999999997588---9835798627898589975421
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHH-H------
Q ss_conf 456431135433434322212443344611220298862243400799999997199999999999850367-7------
Q 003605 555 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-A------ 627 (808)
Q Consensus 555 DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv-~------ 627 (808)
|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............ .
T Consensus 159 dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 159 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CHHHHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 00010110023---457776548511483100179888111000328999999878799899898999999998407996
Q ss_pred ---HHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---43200134221010027878999993369999999998126497899999999999
Q 003605 628 ---WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 628 ---w~~~~~~~~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
|.............. ...............+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCCHHHHHCCC-CCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 110532111103330223-4564544044589999999999874896679189999669
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.27 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=191.8
Q ss_pred CCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC------CEEE
Q ss_conf 9421145631483789999960-89789999951156123589999999976202365102773332035------1678
Q 003605 410 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ARCL 482 (808)
Q Consensus 410 ~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------~~~L 482 (808)
+|+..++||+|+||+||+|+.. +++.||||+++.... .+.+|+++|++++|+||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCC-CCEECCCCCCCC
Q ss_conf 8841389980112235556789999989999999999999999846999388421034681535899-520104564311
Q 003605 483 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 561 (808)
Q Consensus 483 V~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~-~vKI~DFGLa~~ 561 (808)
||||+++|.+. .+.........+++..+..|+.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEECCCCCCHH-HHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 98416886078-88863103689999999999999999999998668---764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH---------
Q ss_conf 354334343222124433446112202-9886224340079999999719999999999985036774320---------
Q 003605 562 AMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP--------- 631 (808)
Q Consensus 562 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~--------- 631 (808)
...... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....+.
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH--HHHHHHHHHCCCHHHHH
T ss_conf 047765---3200255555682776404688821000246527785502879989879999--99999997489817765
Q ss_pred --HCCC--CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --0134--221010027878999993369999999998126497899999999999
Q 003605 632 --LLTS--REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 632 --~~~~--~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.... ...........+...........+.+|+.+||..||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43062101103554456744443156899999999999765895579299999669
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.19 Aligned_cols=241 Identities=22% Similarity=0.353 Sum_probs=195.0
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCC------HHHHHHHHHHHHHHHCC--CCCCEEEEEEEEECC
Q ss_conf 199421145631483789999960-897899999511561------23589999999976202--365102773332035
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ------QGGREFLAEVEMLSRLH--HRNLVKLIGICIEEQ 478 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~------~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~ 478 (808)
.++|++.++||+|+||+||+|+.. +++.||||+++.... ....++.+|+.++++++ |+|||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEEEECCC-CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCC-CCCEECCC
Q ss_conf 16788841389-98011223555678999998999999999999999984699938842103468153589-95201045
Q 003605 479 ARCLVYELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDF 556 (808)
Q Consensus 479 ~~~LV~Ey~~~-GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~-~~vKI~DF 556 (808)
..++|+||+.+ +++.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 68999983368622899986----1589999999999999999999998779---7556676111477447884897754
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 64311354334343222124433446112202988-62243400799999997199999999999850367743200134
Q 003605 557 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 557 GLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
|+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||... ..... .
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i~~-------~ 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEIIR-------G 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHH-------C
T ss_pred CCCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC-----HHHHH-------C
T ss_conf 653532444----5566565877479999848997886533255403453675688998873-----67761-------5
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 221010027878999993369999999998126497899999999999
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 636 ~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.. .++.....++.+++.+||..||++|||+.|+++.
T Consensus 220 --------~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 --------QV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------CC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --------44----7787799999999999760897589399998539
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=321.51 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=201.9
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEE-EEECCCEEEEEE
Q ss_conf 199421145631483789999960-897899999511561235899999999762023651027733-320351678884
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI-CIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~-~~~~~~~~LV~E 485 (808)
.++|++.+.||+|+||.||+|... +++.||||.+.... ...++..|+++++.++|+|++.+++. ..+.+..++|+|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 888999689850788099999998899899999972100--588899999999970389960179999951987789998
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEEC---CCCCCEECCCCCCCCC
Q ss_conf 1389980112235556789999989999999999999999846999388421034681535---8995201045643113
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSA 562 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd---~~~~vKI~DFGLa~~~ 562 (808)
|+ +|+|.+.+. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EC-CCCHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf 73-871333244---30688768999999999999999999799---442667876606433577761565046751342
Q ss_pred CCCCCC-----CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHH-HHHHHHCCCC
Q ss_conf 543343-----4322212443344611220298862243400799999997199999999999850367-7432001342
Q 003605 563 MDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWARPLLTSR 636 (808)
Q Consensus 563 ~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv-~w~~~~~~~~ 636 (808)
.+.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH--
T ss_pred CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC--
T ss_conf 554455410001357767873532999991899898321886177899998498766553057799999985235678--
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 2101002787899999336999999999812649789999999999999999760
Q 003605 637 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 691 (808)
Q Consensus 637 ~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~ 691 (808)
.... .+.. ....++.+++..|++.+|++||++.++.+.|+.+..+.
T Consensus 235 ~~~~-----~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 235 TPIE-----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp SCHH-----HHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHH-----HHCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 9835-----7534----78899999999984399557919999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=319.88 Aligned_cols=267 Identities=18% Similarity=0.202 Sum_probs=210.2
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCEEEEEE
Q ss_conf 199421145631483789999960-89789999951156123589999999976202-3651027733320351678884
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV~E 485 (808)
.++|.+.+.||+|+||+||+|+.. +++.||||.+.... ....+.+|++.+..+. |+|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECC-----CCCCEECCCCCCC
Q ss_conf 13899801122355567899999899999999999999998469993884210346815358-----9952010456431
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 560 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~-----~~~vKI~DFGLa~ 560 (808)
|+ +++|.++++. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EC-CCCHHHHHHH---HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 64-8887999975---2031106899999999999999999779---662667713152347543447956872366057
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 13543343-----4322212443344611220298862243400799999997199999999999850367743200134
Q 003605 561 SAMDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 635 (808)
Q Consensus 561 ~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~ 635 (808)
...+.... .......||+.|||||.+.+..++.++||||||+++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC-
T ss_conf 7146766541110246762775102679896488888699989831999999869876788530219999999970567-
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 2210100278789999933699999999981264978999999999999999976022
Q 003605 636 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 693 (808)
Q Consensus 636 ~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~Le~i~~~~~~ 693 (808)
.....+ +...+ +.++.+++..|+..+|++||++..+.+.|+++.++...
T Consensus 234 ~~~~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 234 STPLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HSCHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCCHHH-----HCCCC----CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC
T ss_conf 999589-----65799----89999999998439930085999999999999997599
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.30 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=198.5
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC-----
Q ss_conf 8199421145631483789999960-8978999995115--6123589999999976202365102773332035-----
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----- 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----- 478 (808)
..++|++.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|+|||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -CEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCC
Q ss_conf -1678884138998011223555678999998999999999999999984699938842103468153589952010456
Q 003605 479 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 479 -~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFG 557 (808)
..++||||+ +++|..+++ ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEECC-CCCHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 1599998405-521899987-----402269999999999999999987378---7645668511112100122113431
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH------
Q ss_conf 43113543343432221244334461122029-88622434007999999971999999999998503677432------
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR------ 630 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~------ 630 (808)
+|+..... .+...|+..|+|||.+.+. .++.++||||+||++|||++|+.||................
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CEECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHH
T ss_conf 02206876-----3102455333588998178789965010300389999997869988897689999998503788488
Q ss_pred --HHCCC------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --00134------221010027878999993369999999998126497899999999999
Q 003605 631 --PLLTS------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 631 --~~~~~------~~~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..... ...+.+.....+ ..........+.+|+.+||..||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCH-HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8865300034433115786665566-77556899999999999772995579299999639
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.69 Aligned_cols=268 Identities=20% Similarity=0.261 Sum_probs=198.1
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--------
Q ss_conf 199421145631483789999960-8978999995115--61235899999999762023651027733320--------
Q 003605 408 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-------- 476 (808)
Q Consensus 408 t~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-------- 476 (808)
-++|++.+.||+|+||+||+|... +|+.||||++... .....+++.+|+++|++++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCC
Q ss_conf 35167888413899801122355567899999899999999999999998469993884210346815358995201045
Q 003605 477 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 556 (808)
Q Consensus 477 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DF 556 (808)
.+..++|+||+.++.+..... ....+....+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEECCCCCCCCHHHH----CCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEEC
T ss_conf 763899985357874101222----0344330899999999999998852299---885676722203668996876313
Q ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 643113543343--432221244334461122029-88622434007999999971999999999998503677432001
Q 003605 557 GLARSAMDEESR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 633 (808)
Q Consensus 557 GLa~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~ 633 (808)
|+++........ .......||..|+|||++.+. .++.++||||+||++|||++|+.||...................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 50022355444321135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred CCCCCCCC--------CCCCCCCCCCCH-------HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 34221010--------027878999993-------369999999998126497899999999999
Q 003605 634 TSREGLER--------IIDPSLGNDVPF-------DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 634 ~~~~~l~~--------ivDp~l~~~~~~-------~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
. .+.... ............ .....+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 T-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp C-TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8-255344320344433201334455503340444599899999999873896589099999749
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.25 Aligned_cols=269 Identities=23% Similarity=0.299 Sum_probs=199.5
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CE
Q ss_conf 8199421145631483789999960-89789999951156-123589999999976202365102773332035----16
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----AR 480 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~ 480 (808)
.+.+|++.+.||+|+||+||+|... +++.||||+++... ....+++.+|+++|++++|+|++++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCC
Q ss_conf 78884138998011223555678999998999999999999999984699938842103468153589952010456431
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~ 560 (808)
+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 999996259865664405-----89999999999999999999999789---8677787643788799977875457056
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCHHHHC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCC--
Q ss_conf 13543343-43222124433446112202-988622434007999999971999999999998503677432001342--
Q 003605 561 SAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR-- 636 (808)
Q Consensus 561 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~-- 636 (808)
........ .......|++.|+|||++.. ..++.++||||+||++|||++|+.||......+...............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 50477764101011026520003878604788874101004670133776697997888889999987652069975664
Q ss_pred ------CCCCCCCCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ------2101002787899999-----3369999999998126497899999999999
Q 003605 637 ------EGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 637 ------~~l~~ivDp~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
...............+ .....++.+++.+||+.||++||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2343322220244677557787778378999999999999764895679089998619
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=316.27 Aligned_cols=258 Identities=19% Similarity=0.267 Sum_probs=195.7
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEC--CCEEEEE
Q ss_conf 99421145631483789999960-89789999951156123589999999976202-36510277333203--5167888
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE--QARCLVY 484 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LV~ 484 (808)
++|++.+.||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|..++ |+||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCC-CCEECCCCCCCCCC
Q ss_conf 41389980112235556789999989999999999999999846999388421034681535899-52010456431135
Q 003605 485 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAM 563 (808)
Q Consensus 485 Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~-~vKI~DFGLa~~~~ 563 (808)
||+.+|+|..+.+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EECCCCCHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 6317985899746-------8999999999999999998876433---44345644123774899836641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCH-----------HHHHHHH
Q ss_conf 43343432221244334461122029-88622434007999999971999999999998503-----------6774320
Q 003605 564 DEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-----------LVAWARP 631 (808)
Q Consensus 564 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~-----------lv~w~~~ 631 (808)
... ......+|..|+|||.+.+. .++.++||||+||++|||++|+.||.......... ...|...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 887---44432248642476102688888845232335455587604889998876018999999998788415555542
Q ss_pred HCC-CCCCCCCCCC--------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 013-4221010027--------87899999336999999999812649789999999999
Q 003605 632 LLT-SREGLERIID--------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 682 (808)
Q Consensus 632 ~~~-~~~~l~~ivD--------p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 682 (808)
... .......... .............++.+|+.+||..||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 254447430000033343311211552112448999999999986699568908999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.48 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=202.8
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 99421145631483789999960-8978999995115--61235899999999762023651027733320351678884
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 485 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV~E 485 (808)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+++.++|+||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCCCCCCCC
Q ss_conf 13899801122355567899999899999999999999998469993884210346815358995201045643113543
Q 003605 486 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 565 (808)
Q Consensus 486 y~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~~~~~ 565 (808)
++.+++|..+++ ....+.+..+..++.|++.||+|||+++ |+||||||+|||++.+..+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ECCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 023322211212----3565403678999999999987743399---860014676121133782665204601104688
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCC-----CCCCC
Q ss_conf 3434322212443344611220298-86224340079999999719999999999985036774320013-----42210
Q 003605 566 ESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT-----SREGL 639 (808)
Q Consensus 566 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~-----~~~~l 639 (808)
.. ......++..|+|||.+.... ++.++||||+||++|||++|+.||..... ..+.......... .....
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred CC--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCC--HHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 75--100103443101466750698888044402654188998518999988999--99999999861189973551344
Q ss_pred CCCCC---------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 10027---------878999993369999999998126497899999999999
Q 003605 640 ERIID---------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 640 ~~ivD---------p~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
....+ ..-...........+.+|+.+|++.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 32221133444544310433065689999999999864996689099999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.43 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=200.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE----CCCEEEEEEEECC----CCHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCC
Q ss_conf 99421145631483789999960----8978999995115----61235899999999762023-651027733320351
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV----DQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQA 479 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~----~g~~VAVK~lk~~----~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~ 479 (808)
++|++.+.||+|+||+||+|... +|+.||||.++.. .....+.+.+|++++++++| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCCC
Q ss_conf 67888413899801122355567899999899999999999999998469993884210346815358995201045643
Q 003605 480 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 559 (808)
Q Consensus 480 ~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa 559 (808)
.++++||+.+|+|.+++.. ...+.......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 0012312341179999873----045437888888999999998851499---896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 113543343432221244334461122029--886224340079999999719999999999985036774320013422
Q 003605 560 RSAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 637 (808)
Q Consensus 560 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~~~~~~ 637 (808)
+........ ......|++.|++||.+... .++.++|||||||+||||++|+.||............. ...
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~----- 248 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRI----- 248 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHH-----
T ss_pred HHHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--HHC-----
T ss_conf 220344443-221222333331068760577688713251777799999976899988887777999999--833-----
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 101002787899999336999999999812649789999-----999999
Q 003605 638 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQ 682 (808)
Q Consensus 638 ~l~~ivDp~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~ 682 (808)
... ....+.....++.+++.+|++.||++||+ +.|+++
T Consensus 249 -----~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 -----LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCC--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf -----568--9988654799999999997445898819997450999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.03 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=199.8
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC------
Q ss_conf 8199421145631483789999960-8978999995115--612358999999997620236510277333203------
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 477 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 477 (808)
..++|++.++||+|+||+||+|... +|+.||||+++.. +.....++.+|+.++++++|+||+++++++...
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 33775998896217585999999999998999999882336979999999999999864898764899897025643457
Q ss_pred CCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCC
Q ss_conf 51678884138998011223555678999998999999999999999984699938842103468153589952010456
Q 003605 478 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 557 (808)
Q Consensus 478 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFG 557 (808)
...|+|+||+.++ +.+.++ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CEEEEEEECCCHH-HHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHH
T ss_conf 6269998414467-787650------38999999999999999998865221---1245677632113654431320102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHH---------HH
Q ss_conf 431135433434322212443344611220298862243400799999997199999999999850367---------74
Q 003605 558 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV---------AW 628 (808)
Q Consensus 558 La~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv---------~w 628 (808)
+++.... ....+...+|..|+|||++.+..++.++||||+||+++||++|+.||............ ++
T Consensus 165 ~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HHHCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 3211466---6553322146555581331477778774333566257898659899888977889999997205898799
Q ss_pred HHHHC-------CC-----CCCCCCCCCCCCCC-C--CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 32001-------34-----22101002787899-9--993369999999998126497899999999999
Q 003605 629 ARPLL-------TS-----REGLERIIDPSLGN-D--VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 629 ~~~~~-------~~-----~~~l~~ivDp~l~~-~--~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
..... .. .............. . ........+.+|+.+|+..||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9876566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.94 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=197.3
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-----C
Q ss_conf 8199421145631483789999960-8978999995115--612358999999997620236510277333203-----5
Q 003605 407 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----Q 478 (808)
Q Consensus 407 at~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~ 478 (808)
..++|++.+.||+|+||+||+|... +++.||||+++.. +....+++.+|++++++++|+|++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred CEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCEECCCCC
Q ss_conf 16788841389980112235556789999989999999999999999846999388421034681535899520104564
Q 003605 479 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 558 (808)
Q Consensus 479 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vKI~DFGL 558 (808)
..+++++|+.+|+|.++++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 64999996258862320022-----45309999999999999999997388---76516677633455432200132100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH-----
Q ss_conf 31135433434322212443344611220298-862243400799999997199999999999850367743200-----
Q 003605 559 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL----- 632 (808)
Q Consensus 559 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~~lv~w~~~~----- 632 (808)
+...... .....|+..|+|||...+.. ++.++||||+||++|||++|+.||...........+......
T Consensus 168 a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 0125754-----44434543555835533775678551243205899999768899788988999999997307997577
Q ss_pred CC--CCCCCCCCCCCCC-CCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 13--4221010027878-99999-----3369999999998126497899999999999
Q 003605 633 LT--SREGLERIIDPSL-GNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 683 (808)
Q Consensus 633 ~~--~~~~l~~ivDp~l-~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 683 (808)
.. ............. ..... ......+.+|+.+||..||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 32001024454443035578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=283.89 Aligned_cols=265 Identities=20% Similarity=0.207 Sum_probs=190.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEEE-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-----------CCCCEEEEEEEEE
Q ss_conf 99421145631483789999960-89789999951156123589999999976202-----------3651027733320
Q 003605 409 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-----------HRNLVKLIGICIE 476 (808)
Q Consensus 409 ~~f~~~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~L~g~~~~ 476 (808)
++|.+.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343-133689999999999840145555542276764789987631
Q ss_pred C--CCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEEEECCCCEEECCCC----
Q ss_conf 3--51678884138998011223555678999998999999999999999984-6999388421034681535899----
Q 003605 477 E--QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDF---- 549 (808)
Q Consensus 477 ~--~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~-~~~p~IiHrDLKpsNILLd~~~---- 549 (808)
. ...+++++++..+........ ......+.+..+..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred CCCCCEEEEEEECCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCC
T ss_conf 256520234320003542000001-2234678689999999999999888764058---646567705705630576564
Q ss_pred --CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCC----
Q ss_conf --52010456431135433434322212443344611220298862243400799999997199999999999850----
Q 003605 550 --TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE---- 623 (808)
Q Consensus 550 --~vKI~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLlELlTG~~P~~~~~~~~~~---- 623 (808)
.++++|||.+...... .....|+..|+|||++....++.++||||+||+++||++|+.||.........
T Consensus 168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 430567531442123445-----422366521057132146677764320123789999987889989875543210268
Q ss_pred HHHHHHHHHCC-------CCCCCCCCCCC-----C--------------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCH
Q ss_conf 36774320013-------42210100278-----7--------------8999993369999999998126497899999
Q 003605 624 NLVAWARPLLT-------SREGLERIIDP-----S--------------LGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 677 (808)
Q Consensus 624 ~lv~w~~~~~~-------~~~~l~~ivDp-----~--------------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 677 (808)
.+......+-. .........+. . ............+.+|+.+|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 99999998379987886245322000132012202432357764442100015674358999999999877994579089
Q ss_pred HHHHHH
Q ss_conf 999999
Q 003605 678 GEVVQA 683 (808)
Q Consensus 678 ~eVl~~ 683 (808)
+|+++.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHHCC
T ss_conf 999669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.7e-26 Score=168.99 Aligned_cols=171 Identities=18% Similarity=0.162 Sum_probs=120.1
Q ss_pred CCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCC------------------CHHHHHHHHHHHHHHHCCCCCCEEEEE
Q ss_conf 42114563148378999996089789999951156------------------123589999999976202365102773
Q 003605 411 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD------------------QQGGREFLAEVEMLSRLHHRNLVKLIG 472 (808)
Q Consensus 411 f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~------------------~~~~~~f~~Ei~iL~~L~HpNIV~L~g 472 (808)
+.+.+.||+|+||.||+|...+|+.||||.++... .........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCCE
Q ss_conf 33203516788841389980112235556789999989999999999999999846999388421034681535899520
Q 003605 473 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 552 (808)
Q Consensus 473 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~~~p~IiHrDLKpsNILLd~~~~vK 552 (808)
+. ..+++|||++++.+.+ +.+.....++.|++.+|+|||+.+ |+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred EC----CCEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEE
T ss_conf 62----8889999504565420-----------015789999999999999982688---8983689036114289-899
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEEHHHHHH
Q ss_conf 10456431135433434322212443344611220298862243400799999
Q 003605 553 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVIL 605 (808)
Q Consensus 553 I~DFGLa~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVySlGviLl 605 (808)
|+|||+|.............+ .... -.++ ..+.|..++|+||..--++
T Consensus 143 liDFG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCHHHHHH---HHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 987788430899870999987---7999-9999-7578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.06 E-value=1.2e-09 Score=71.60 Aligned_cols=150 Identities=15% Similarity=0.095 Sum_probs=100.7
Q ss_pred HHHHHHHCCCCEEEEEEECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCE
Q ss_conf 99998819942114563148378999996089789999951156123589999999976202-36510277333203516
Q 003605 402 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 480 (808)
Q Consensus 402 ~el~~at~~f~~~~~LG~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~ 480 (808)
.++...-..|+..+..+.+....||+.... ++.+++|+...........+.+|...+..+. +-.+.++++++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 999975135279976789987718999908-9869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------
Q ss_conf 788841389980112235556789999989999999999999999846--------------------------------
Q 003605 481 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-------------------------------- 528 (808)
Q Consensus 481 ~LV~Ey~~~GsL~~~L~~~~~~~~~L~~~~~l~Ia~qiA~gL~yLH~~-------------------------------- 528 (808)
++||+++++.++.+.... .. ....++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~------~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED------EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT------CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEECCCCCCCCCCCC------CC---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 999986043343543344------02---699999989999999855684214357644656555778998776555543
Q ss_pred ------------------------CCCCEEEEEECCCCEEECCCCCCEECCCCCCCC
Q ss_conf ------------------------999388421034681535899520104564311
Q 003605 529 ------------------------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 529 ------------------------~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~ 561 (808)
..+.++|+|+.+.|||++++....|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 033232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.61 E-value=1.2e-07 Score=59.82 Aligned_cols=143 Identities=21% Similarity=0.169 Sum_probs=84.6
Q ss_pred EEEECCC-EEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCC--CCCEEEEEEEEECCCEEEEEEECCCCCC
Q ss_conf 5631483-789999960897899999511561235899999999762023--6510277333203516788841389980
Q 003605 416 ILGEGGF-GLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH--RNLVKLIGICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 416 ~LG~G~f-G~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LV~Ey~~~GsL 492 (808)
.+..|.. ..||+....++..+++|...... ...+..|...++.+.. -.+.++++++.+.+..++|++++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred CCCC-----------------CCCCCCCCCCC--HHHHHHHH--------------------HHHHHHHHHHHHC----C
Q ss_conf 1122-----------------35556789999--98999999--------------------9999999999846----9
Q 003605 493 ESHL-----------------HGVDKESAPLG--WDARLKIA--------------------LGAARALAYLHED----S 529 (808)
Q Consensus 493 ~~~L-----------------~~~~~~~~~L~--~~~~l~Ia--------------------~qiA~gL~yLH~~----~ 529 (808)
.+.. |.......... +.....-. ......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred CCCEEEEEECCCCEEECCCCCCEECCCCCCCC
Q ss_conf 99388421034681535899520104564311
Q 003605 530 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 530 ~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~ 561 (808)
.+.++|+|+.+.|||++.+..+.|.||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 95678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.31 E-value=3.7e-06 Score=51.09 Aligned_cols=77 Identities=14% Similarity=0.108 Sum_probs=49.6
Q ss_pred EEEEEECCCEEEEEEEEE-CCCEEEEEEEEC----C---CCHHHHHHHHHHHHHHHCC-C--CCCEEEEEEEEECCCEEE
Q ss_conf 145631483789999960-897899999511----5---6123589999999976202-3--651027733320351678
Q 003605 414 SRILGEGGFGLVYSGVLD-DGTKVAVKVLKR----V---DQQGGREFLAEVEMLSRLH-H--RNLVKLIGICIEEQARCL 482 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~-~g~~VAVK~lk~----~---~~~~~~~f~~Ei~iL~~L~-H--pNIV~L~g~~~~~~~~~L 482 (808)
.+.||.|....||+.... +++.+++|.-.. . ......+...|.+.|..+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCC
Q ss_conf 8841389980
Q 003605 483 VYELIPNGSV 492 (808)
Q Consensus 483 V~Ey~~~GsL 492 (808)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.85 E-value=0.00011 Score=42.36 Aligned_cols=74 Identities=23% Similarity=0.292 Sum_probs=48.4
Q ss_pred EEEEEECCCEEEEEEEEECC--------CEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCC-EEEEEEEEECCCEEEEE
Q ss_conf 14563148378999996089--------7899999511561235899999999762023651-02773332035167888
Q 003605 414 SRILGEGGFGLVYSGVLDDG--------TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVY 484 (808)
Q Consensus 414 ~~~LG~G~fG~VYkg~l~~g--------~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV~ 484 (808)
.+.|+.|-.-.+|+....++ ..|.++.... ....-+..+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 99917853343489996887754457898179996599--61165899999999999757999808998189----5699
Q ss_pred EECCCCCCC
Q ss_conf 413899801
Q 003605 485 ELIPNGSVE 493 (808)
Q Consensus 485 Ey~~~GsL~ 493 (808)
||+++.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.78 E-value=0.00021 Score=40.83 Aligned_cols=139 Identities=17% Similarity=0.183 Sum_probs=77.2
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCC--EEEEE-----EEEECCCEEEEEEECCCCCC
Q ss_conf 483789999960897899999511561235899999999762023651--02773-----33203516788841389980
Q 003605 420 GGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL--VKLIG-----ICIEEQARCLVYELIPNGSV 492 (808)
Q Consensus 420 G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNI--V~L~g-----~~~~~~~~~LV~Ey~~~GsL 492 (808)
+.--.||++...+|+.+++|..+.. ....+++..|...+..|....+ +..+. .....+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 6120269998389997999984787-788999999999999998559987875206898056653479999865277688
Q ss_pred CCCC--------------CC----CC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHH----CCC
Q ss_conf 1122--------------35----55-6789999989-------------------99999999999999984----699
Q 003605 493 ESHL--------------HG----VD-KESAPLGWDA-------------------RLKIALGAARALAYLHE----DSS 530 (808)
Q Consensus 493 ~~~L--------------~~----~~-~~~~~L~~~~-------------------~l~Ia~qiA~gL~yLH~----~~~ 530 (808)
...- |. .. .....+++.. +-.+...+.+.++.+.. ...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEEEEECCCCEEECCCCCCEECCCCCCCC
Q ss_conf 9388421034681535899520104564311
Q 003605 531 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS 561 (808)
Q Consensus 531 p~IiHrDLKpsNILLd~~~~vKI~DFGLa~~ 561 (808)
..+||+|+.+.|||++++ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.73 E-value=0.0003 Score=39.87 Aligned_cols=160 Identities=13% Similarity=0.068 Sum_probs=84.6
Q ss_pred CCCHHHHHHHHCCCCEEEEEE-----ECCCEEEEEEEEECCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCE--EE
Q ss_conf 679899998819942114563-----14837899999608978999995115612358999999997620236510--27
Q 003605 398 TFSASEIEKATGNFDASRILG-----EGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV--KL 470 (808)
Q Consensus 398 ~fs~~el~~at~~f~~~~~LG-----~G~fG~VYkg~l~~g~~VAVK~lk~~~~~~~~~f~~Ei~iL~~L~HpNIV--~L 470 (808)
..+.++++....+|.+.++.. .|---+.|+....+| .+++|+.... ...++...|++++..|...++. ..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 88999999999867999856852378885267389997897-2899980789--99889999999987543025554556
Q ss_pred E----EE--EEECCCEEEEEEECCCCCCCCCC--------------CCC------CCCCCCCCH----------------
Q ss_conf 7----33--32035167888413899801122--------------355------567899999----------------
Q 003605 471 I----GI--CIEEQARCLVYELIPNGSVESHL--------------HGV------DKESAPLGW---------------- 508 (808)
Q Consensus 471 ~----g~--~~~~~~~~LV~Ey~~~GsL~~~L--------------~~~------~~~~~~L~~---------------- 508 (808)
+ |. ....+....++.++.+....... |.. ........+
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf 41048976213412550245311465533320467888889987645444320245310111012002456777765311
Q ss_pred -HHHHHHHHHHHHHHHHHHHC-CCCCEEEEEECCCCEEECCCCCCEECCCCCCC
Q ss_conf -89999999999999999846-99938842103468153589952010456431
Q 003605 509 -DARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 560 (808)
Q Consensus 509 -~~~l~Ia~qiA~gL~yLH~~-~~p~IiHrDLKpsNILLd~~~~vKI~DFGLa~ 560 (808)
......+......+...+.. -...+||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 412799999998764204855454503337863656402045412674222123
|